PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chinnery, PF; Elliott, HR; Patel, S; Lambert, C; Keers, SM; Durham, SE; McCarthy, MI; Hitman, GA; Hattersley, AT; Walker, M				Chinnery, PF; Elliott, HR; Patel, S; Lambert, C; Keers, SM; Durham, SE; McCarthy, MI; Hitman, GA; Hattersley, AT; Walker, M			Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes	LANCET			English	Article							MITOCHONDRIAL-DNA VARIANT; SUSCEPTIBILITY; POPULATION	Recent evidence suggests that polymorphic genetic variation in the non-coding region of mitochondrial DNA (the 16184-16193 polycytosine [poly-C] tract) contributes to the cause of type 2 diabetes, but previous studies only just reached significance. We aimed to investigate this association. We compared patients with type 2 diabetes (n=992) with two independent control groups (n=536, n=1029) from the UK, and saw no difference in the frequency of the 16184-16193 poly-C tract. This finding was confirmed by a meta-analysis of European studies of 1455 patients and 3132 controls (odds ratio 1.16, 95% CI 0.94-1.44). Genetic variation of the 16184-16193 poly-C tract is unlikely to have a major role in the cause of type 2 diabetes.	Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Diabet & Metab Med, London, England; Peninsula Med Sch, Exeter, Devon, England	Newcastle University - UK; Newcastle University - UK; University of Oxford; University of London; Queen Mary University London; University of Exeter	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Elliott, Hannah/AAP-3170-2021; McCarthy, Mark/M-3763-2015	Elliott, Hannah/0000-0002-1500-3533; Chinnery, Patrick/0000-0002-7065-6617; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X; Patel, Sheila/0000-0002-0626-1899	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Liew CF, 2004, DIABETOLOGIA, V47, P2168, DOI 10.1007/s00125-004-1575-4; Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249	7	54	59	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 5	2005	366	9497					1650	1651		10.1016/S0140-6736(05)67492-2	http://dx.doi.org/10.1016/S0140-6736(05)67492-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980VU	16271646				2022-12-01	WOS:000233047100026
J	Koren, G				Koren, G			Congenital varicella syndrome in the third trimester	LANCET			English	Editorial Material									Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Koren, G (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	gkoren@sickkids.on.ca	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875				Enders G., 2000, VARICELLA ZOSTER VIR, P317; Koren G, 2003, CAN FAM PHYSICIAN, V49, P1445; LAFORET EG, 1947, NEW ENGL J MED, V236, P534, DOI 10.1056/NEJM194704102361504; POCOCK N, 2005, DRUGS THER B, V43, P69; Sauerbrei A, 2003, MONATSSCHR KINDERH, V151, P209, DOI 10.1007/s00112-002-0478-z; Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011	6	15	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2005	366	9497					1591	1592		10.1016/S0140-6736(05)67643-X	http://dx.doi.org/10.1016/S0140-6736(05)67643-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980VU	16271630				2022-12-01	WOS:000233047100006
J	Adhikary, S; Marinoni, F; Hock, A; Hulleman, E; Popov, N; Beier, R; Bernard, S; Quarto, M; Capra, M; Goettig, S; Kogel, U; Scheffner, M; Helin, K; Eilers, M				Adhikary, S; Marinoni, F; Hock, A; Hulleman, E; Popov, N; Beier, R; Bernard, S; Quarto, M; Capra, M; Goettig, S; Kogel, U; Scheffner, M; Helin, K; Eilers, M			The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation	CELL			English	Article							SMALL-MOLECULE ANTAGONISTS; C-MYC; ONCOGENIC TRANSFORMATION; DEPENDENT DEGRADATION; PROTEIN; PROTEOLYSIS; COMPLEX; INACTIVATION; COFACTOR; PROMOTER	The Myc oncoprotein forms a binary activating complex with its partner protein, Max, and a ternary repressive complex that, in addition to Max, contains the zinc finger protein Miz1. Here we show that the E3 ubiquitin ligase HectH9 ubiquitinates Myc in vivo and in vitro, forming a lysine 63-linked polyubiquitin chain. Miz1 inhibits this ubiquitination. HectH9-mediated ubiquitination of Myc is required for transactivation of multiple target genes, recruitment of the coactivator p300, and induction of cell proliferation by Myc. HectH9 is overexpressed in multiple human tumors and is essential for proliferation of a subset of tumor cells. Our results suggest that site-specific ubiquitination regulates the switch between an activating and a repressive state of the Myc protein, and they suggest a strategy to interfere with Myc function in vivo.	European Inst Oncol, I-20141 Milan, Italy; Univ Marburg, Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany; FIRC Inst Mol Oncol, I-20135 Milan, Italy; Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; Univ Konstanz, Dept Biol, D-78457 Constance, Germany	IRCCS European Institute of Oncology (IEO); Philipps University Marburg; IFOM - FIRC Institute of Molecular Oncology; University of Konstanz	Helin, K (corresponding author), European Inst Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	kristian.helin@bric.dk; eilers@imt.uni-marburg.de	Hulleman, Esther/AAD-7073-2021; Scheffner, Martin/K-2940-2012; Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019	Scheffner, Martin/0000-0003-2229-0128; Eilers, Martin/0000-0002-0376-6533; Hulleman, Esther/0000-0001-9256-947X; Helin, Kristian/0000-0003-1975-6097				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Walker W, 2005, J CELL BIOL, V169, P405, DOI 10.1083/jcb.200411013; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	32	297	309	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					409	421		10.1016/j.cell.2005.08.016	http://dx.doi.org/10.1016/j.cell.2005.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269333	Green Submitted, Bronze			2022-12-01	WOS:000233264300010
J	Croft, MT; Lawrence, AD; Raux-Deery, E; Warren, MJ; Smith, AG				Croft, MT; Lawrence, AD; Raux-Deery, E; Warren, MJ; Smith, AG			Algae acquire vitamin B-12 through a symbiotic relationship with bacteria	NATURE			English	Article							COBALAMIN VITAMIN-B-12; ESCHERICHIA-COLI; METABOLISM; REDUCTASE; EVOLUTION; FOLATE; GENOME	Vitamin B-12 ( cobalamin) was identified nearly 80 years ago as the anti- pernicious anaemia factor in liver(1), and its importance in human health and disease has resulted in much work on its uptake(2), cellular transport(3) and utilization(4). Plants do not contain cobalamin because they have no cobalamin-dependent enzymes. Deficiencies are therefore common in strict vegetarians(5), and in the elderly, who are susceptible to an autoimmune disorder that prevents its efficient uptake(6). In contrast, many algae are rich in vitamin B-12, with some species, such as Porphyra yezoensis (Nori), containing as much cobalamin as liver(7). Despite this, the role of the cofactor in algal metabolism remains unknown, as does the source of the vitamin for these organisms. A survey of 326 algal species revealed that 171 species require exogenous vitamin B-12 for growth, implying that more than half of the algal kingdom are cobalamin auxotrophs. Here we show that the role of vitamin B-12 in algal metabolism is primarily as a cofactor for vitamin B-12-dependent methionine synthase, and that cobalamin auxotrophy has arisen numerous times throughout evolution, probably owing to the loss of the vitamin B-12-independent form of the enzyme. The source of cobalamin seems to be bacteria, indicating an important and unsuspected symbiosis.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of Cambridge; University of Kent	Smith, AG (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	as25@cam.ac.uk		Warren, Martin/0000-0002-6028-6456; Smith, Alison Gail/0000-0001-6511-5704				Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; Cantu C, 2004, STROKE, V35, P1790, DOI 10.1161/01.STR.0000132570.24618.78; Carlucci A. F., 1970, Bull. Scripps Instn Oceanogr. tech. Ser., V17, P23; CARLUCCI A F, 1970, Journal of Phycology, V6, P393, DOI 10.1111/j.1529-8817.1970.tb02413.x; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GONZALEZ JC, 1992, BIOCHEMISTRY-US, V31, P6045, DOI 10.1021/bi00141a013; HAMILTON FD, 1974, J BIOL CHEM, V249, P4428; KANAZAWA A, 1963, B JAP SOC SCI FISH, V29, P713; KESHTACHERLIEBSON E, 1995, APPL ENVIRON MICROB, V61, P2439, DOI 10.1128/AEM.61.6.2439-2441.1995; Kurata A., 1986, P185; LANE D.J., 1991, 16S 23S RRNA SEQUENC, P115, DOI DOI 10.1007/S00227-012-2133-0; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Minot George R., 2001, Yale Journal of Biology and Medicine, V74, P341; Miyamoto E, 2004, COMP BIOCHEM PHYS B, V138, P163, DOI 10.1016/j.cbpc.2004.03.006; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; PROVASOLI L, 1974, ALGAL PHYSL BIOCH, P741; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; Scott J, 1994, ESSAYS BIOCHEM, V28, P63; SEETHARAM B, 1982, ANNU REV NUTR, V2, P343, DOI 10.1146/annurev.nu.02.070182.002015; Seetharam B, 1999, J NUTR, V129, P1761, DOI 10.1093/jn/129.10.1761; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; TROXLER RF, 1972, BIOCHEMISTRY-US, V11, P4235, DOI 10.1021/bi00773a007; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Watanabe F, 2000, BIOSCI BIOTECH BIOCH, V64, P2712, DOI 10.1271/bbb.64.2712; WATANABE F, 1991, BIOCHIM BIOPHYS ACTA, V1075, P36	28	822	865	26	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					90	93		10.1038/nature04056	http://dx.doi.org/10.1038/nature04056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267554				2022-12-01	WOS:000232979000047
J	Griffith, CA; Penteado, P; Baines, K; Drossart, P; Barnes, J; Bellucci, G; Bibring, J; Brown, R; Buratti, B; Capaccioni, F; Cerroni, P; Clark, R; Combes, M; Coradini, A; Cruikshank, D; Formisano, V; Jaumann, R; Langevin, Y; Matson, D; McCord, T; Mennella, V; Nelson, R; Nicholson, P; Sicardy, B; Sotin, C; Soderblom, LA; Kursinski, R				Griffith, CA; Penteado, P; Baines, K; Drossart, P; Barnes, J; Bellucci, G; Bibring, J; Brown, R; Buratti, B; Capaccioni, F; Cerroni, P; Clark, R; Combes, M; Coradini, A; Cruikshank, D; Formisano, V; Jaumann, R; Langevin, Y; Matson, D; McCord, T; Mennella, V; Nelson, R; Nicholson, P; Sicardy, B; Sotin, C; Soderblom, LA; Kursinski, R			The evolution of Titan's mid-latitude clouds	SCIENCE			English	Article							TROPOSPHERIC CLOUDS; ATMOSPHERE; TEMPERATURES; WINDS	Spectra from Cassini's Visual and Infrared Mapping Spectrometer reveal that the horizontal structure, height, and optical depth of Titan's clouds are highly dynamic. Vigorous cloud centers are seen to rise from the middle to the upper troposphere within 30 minutes and dissipate within the next hour. Their development indicates that Titan's clouds evolve convectively; dissipate through rain; and, over the next several hours, waft downwind to achieve their great longitude extents. These and other characteristics suggest that temperate clouds originate from circulation-induced convergence, in addition to a forcing at the surface associated with Saturn's tides, geology, and/or surface composition.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Observ Paris, Meudon, France; CNR, Inst Fis Spazio Interplanetario, Rome, Italy; Univ Paris 11, Inst Astrophys Spatiale, Orsay, France; CNR, Inst Astrofis Spaziale & Fis Cosm, Rome, Italy; US Geol Survey, Denver, CO 80225 USA; NASA, Ames Res Ctr, Mountain View, CA USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Osserv Astron Capodimonte, I-80131 Naples, Italy; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Nantes, Lab Planetol & Geodynam, F-44035 Nantes, France; US Geol Survey, Flagstaff, AZ 86001 USA	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Consiglio Nazionale delle Ricerche (CNR); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); Cornell University; Nantes Universite; United States Department of the Interior; United States Geological Survey	Griffith, CA (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Jaumann, Ralf/N-1001-2018; Barnes, Jason W/B-1284-2009; Drossart, Pierre/H-8670-2013; Penteado, Paulo/F-9081-2012; Bellucci, Giancarlo/ABA-9201-2020	Jaumann, Ralf/0000-0002-9759-6597; Barnes, Jason W/0000-0002-7755-3530; Penteado, Paulo/0000-0001-6759-2037; Bellucci, Giancarlo/0000-0003-0867-8679; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741; Mennella, Vito/0000-0001-9525-895X				Adamkovics M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019929; AWAL M, 1994, GEOPHYS RES LETT, V21, P2491, DOI 10.1029/94GL01707; BOUCHEZ A, 2003, THESIS CALTECH PASAD; Bouchez AH, 2005, ASTROPHYS J, V618, pL53, DOI 10.1086/427693; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; Gendron E, 2004, ASTRON ASTROPHYS, V417, pL21, DOI 10.1051/0004-6361:20040027; Gibbard SG, 2004, ICARUS, V169, P429, DOI 10.1016/j.icarus.2003.12.026; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; GRIFFITH CS, UNPUB; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LORENZ RD, 1993, PLANET SPACE SCI, V41, P647, DOI 10.1016/0032-0633(93)90048-7; MCKELLAR ARW, 1989, ICARUS, V80, P361, DOI 10.1016/0019-1035(89)90146-2; NIEMANN HB, 2005, B AM ASTRON SOC, V37, P621; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2004, ICARUS, V170, P443, DOI 10.1016/j.icarus.2004.03.007; Rannou P, 2002, NATURE, V418, P853, DOI 10.1038/nature00961; RANNOU P, 2005, COSPAR SCI ASS 2004, P1272; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Rothman LS, 2003, J QUANT SPECTROSC RA, V82, P5, DOI 10.1016/S0022-4073(03)00146-8; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; TOMASKO MG, 1997, ESA SP PUBL, V1177, P345; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X	30	121	122	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					474	477		10.1126/science.1117702	http://dx.doi.org/10.1126/science.1117702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239472				2022-12-01	WOS:000232786000041
J	Gershon, D				Gershon, D			DNA microarrays: More than than gene expression	NATURE			English	Article																			0	37	46	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2005	437	7062					1195	1200		10.1038/4371195a	http://dx.doi.org/10.1038/4371195a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237450	Bronze			2022-12-01	WOS:000232660500052
J	Russell, JC; Towns, DR; Anderson, SH; Clout, MN				Russell, JC; Towns, DR; Anderson, SH; Clout, MN			Intercepting the first rat ashore	NATURE			English	Editorial Material							NORVEGICUS; INVASION; ISLANDS		Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Auckland, Dept Stat, Auckland 1, New Zealand; Dept Conservat, Auckland, New Zealand	University of Auckland; University of Auckland	Russell, JC (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	j.russell@auckland.ac.nz		Anderson, Sandra/0000-0002-6164-7380; Clout, Mick/0000-0003-2864-4628				Atkinson I.A.E., 1985, CONSERVATION ISLAND, V3rd ed, pp., P35; CLOUT MN, IN PRESS P INT C ASS; DILKS PJ, 2002, DOC SCI INT SER, V59; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Lacey EA, 2003, J MAMMAL, V84, P1135, DOI 10.1644/BLe-016; Macdonald David W., 1999, ACIAR Monograph Series, V59, P49; MOORS PJ, 1985, NEW ZEAL J ECOL, V8, P37; Simberloff Daniel, 2001, Trends in Ecology and Evolution, V16, P273, DOI 10.1016/S0169-5347(01)02154-1; Thorsen M, 2000, BIOL CONSERV, V96, P133, DOI 10.1016/S0006-3207(00)00059-8; Towns DR, 2003, NEW ZEAL J ZOOL, V30, P377, DOI 10.1080/03014223.2003.9518348	10	88	95	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1107	1107		10.1038/4371107a	http://dx.doi.org/10.1038/4371107a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237434	Bronze			2022-12-01	WOS:000232660500032
J	Myers, S; Bottolo, L; Freeman, C; McVean, G; Donnelly, P				Myers, S; Bottolo, L; Freeman, C; McVean, G; Donnelly, P			A fine-scale map of recombination rates and hotspots across the human genome	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; DOUBLE-STRAND BREAKS; ELEMENT COPY NUMBER; MEIOTIC RECOMBINATION; HOT-SPOT; PATTERNS; SEQUENCE; CHIMPANZEES; FREQUENCY	Genetic maps, which document the way in which recombination rates vary over a genome, are an essential tool for many genetic analyses. We present a high-resolution genetic map of the human genome, based on statistical analyses of genetic variation data, and identify more than 25,000 recombination hotspots, together with motifs and sequence contexts that play a role in hotspot activity. Differences between the behavior of recombination rates over large (megabase) and small (kilobase) scales lead us to suggest a two-stage model for recombination in which hotspots are stochastic features, within a framework in which large-scale rates are constrained.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	donnelly@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Peng, Bo/A-6920-2009	Myers, Simon R/0000-0002-2585-9626; Peng, Bo/0000-0001-8225-2284; Donnelly, Peter/0000-0001-9495-3408; Bottolo, Leonardo/0000-0002-6381-2327	NHGRI NIH HHS [U54 HG2750] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002750] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; FAN QQ, 1995, MOL CELL BIOL, V15, P1679; Fan QQ, 1997, GENETICS, V145, P661; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; STAMBERG J, 1969, HEREDITY, V24, P361, DOI 10.1038/hdy.1969.54; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	28	786	809	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					321	324		10.1126/science.1117196	http://dx.doi.org/10.1126/science.1117196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224025				2022-12-01	WOS:000232670100054
J	Kaplan, G				Kaplan, G			Rational vaccine development - A new trend in tuberculosis control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Publ Hlth Res Inst, Int Ctr Publ Hlth, Newark, NJ 07103 USA		Kaplan, G (corresponding author), Publ Hlth Res Inst, Int Ctr Publ Hlth, Newark, NJ 07103 USA.							Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998	3	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2005	353	15					1624	1625		10.1056/NEJMcibr053426	http://dx.doi.org/10.1056/NEJMcibr053426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972XF	16221789				2022-12-01	WOS:000232486000021
J	Carroll, MD; Lacher, DA; Sorlie, PD; Cleeman, JI; Gordon, DJ; Wolz, M; Grundy, SM; Johnson, CL				Carroll, MD; Lacher, DA; Sorlie, PD; Cleeman, JI; Gordon, DJ; Wolz, M; Grundy, SM; Johnson, CL			Trends in serum lipids and lipoproteins of adults, 1960-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EDUCATION-PROGRAM RECOMMENDATIONS; CHOLESTEROL LEVELS; NATIONAL-HEALTH; CORONARY EVENTS; US ADULTS; DISEASE; PRAVASTATIN; PREVENTION; PREVALENCE; OBESITY	Context Serum total and low-density lipoprotein (LDL) cholesterol contribute significantly to atherosclerosis and its clinical sequelae. Previous analyses of data from the National Health and Nutrition Examination Surveys (NHANES) showed that mean levels of total cholesterol of US adults had declined from 1960-1962 to 1988-1994, and mean levels of LDL cholesterol (available beginning in 1976) had declined between 1976-1980 and 1988-1994. Objective To examine trends in serum lipid levels among US adults between 1960 and 2002, with a particular focus on changes since the 1988-1994 NHANES survey. Design, Setting, and Participants Blood lipid measurements taken from 6098 to 15 719 adults who were examined in 5 distinct cross-sectional surveys of the US population during 1960-1962, 1971-1974, 1976-1980, 1988-1994, and 1999-2002. Main Outcome Measures Mean serum total cholesterol, LDL cholesterol, high-density lipoprotein (HDL) cholesterol, and geometric mean serum triglyceride levels, and the percentage of adults with a serum total cholesterol level of at least 240 mg/dL (>= 6.22 mmol/L). Results Between 1988-1994 and 1999-2002, total serum cholesterol level of adults aged 20 years or older decreased from 206 mg/dL (5.34 mmol/L) to 203 mg/dL (5.26 mmol/L) (P=.009) and LDL cholesterol levels decreased from 129 mg/dL (3.34 mmol/L) to 123 mg/dL (3.19 mmol/L) (P<.001). Greater and significant decreases were observed in men 60 years or older and in women 50 years or older. The percentage of adults with a total cholesterol level of at least 240 mg/dL (>= 6.22 mmol/L) decreased from 20% during 1988-1994 to 17% during 1999-2002 (P<.001). There was no change in mean HDL cholesterol levels and a nonsignificant increase in geometric mean serum triglyceride levels (P=.06). Conclusions The decrease in total cholesterol level observed during 1960-1994 and LDL cholesterol level observed during 1976-1994 has continued during 1999-2002 in men 60 to 74 years and women 50 to 74 years. The target value of no more than 17% of US adults with a total cholesterol level of at least 240 mg/dL (>= 6.22 mmol/L), an objective of Healthy People 2010, has been attained. The increase in the proportion of adults using lipid-lowering medication, particularly in older age groups, likely contributed to the decreases in total and LDL cholesterol levels observed. The increased prevalence of obesity in the US population may have contributed to the increase in mean serum triglyceride levels.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dallas, TX USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Carroll, MD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4413, Hyattsville, MD 20782 USA.	mdc3@cdc.gov						*3 NAT HLTH NUTR E, 1994, VIT HLTH STAT, V31, P1; ALLAIN CC, 1974, CLIN CHEM, V20, P470; *AM HEART ASS, HLTH LIF DIET NUTR; ASHLEY FW, 1974, J CHRON DIS, V27, P103, DOI 10.1016/0021-9681(74)90079-4; BACHORIK PS, 1984, CLIN CHEM, V30, P839; DENKE MA, 1993, ARCH INTERN MED, V153, P1093, DOI 10.1001/archinte.153.9.1093; DENKE MA, 1994, ARCH INTERN MED, V154, P401, DOI 10.1001/archinte.154.4.401; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Ernst ND, 1997, AM J CLIN NUTR, V66, P965; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; FORTHOFER RN, 1983, AM J EPIDEMIOL, V117, P507, DOI 10.1093/oxfordjournals.aje.a113568; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HERSHCOPF RJ, 1982, J CHRON DIS, V35, P101, DOI 10.1016/0021-9681(82)90111-4; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; KORN EL, 1999, WILEY S PRO STAT SUR, P1; *LAB STAND PAN NAT, 1988, CLIN CHEM, V34, P193; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Matsuzaki Y, 1996, J ANAL BIOSC, V19, P419; MCDOWELL A, 1981, VITAL HLTH STAT, V1, P15; *MESA WEB, MULT STUD ATH; Millar J, 2001, J NEUROSCI METH, V110, P1, DOI 10.1016/S0165-0270(01)00411-3; MILLER RG, 1977, J AM STAT ASSOC, V72, P779, DOI 10.2307/2286459; Miller WT, 2001, SEMIN ROENTGENOL, V36, P1, DOI 10.1053/sroe.2001.20459; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1333; *NAT CTR HLTH STAT, 1998, HLTH US 1998 SOC STA; *NAT CTR HLTH STAT, LAB PROC US 3 NAT HL; *NAT CTR HLTH STAT, NHANES 1999 2000 PUB; *NAT CTR HLTH STAT, NCHS DEF; *NAT CTR HLTH STAT, NHANES 2001 2002 DAT; *NAT CTR HLTH STAT, 1999 CURR NAT HLTH; *NAT CTR HLTH STAT, SURV QUEST EX COMP L; *NAT HEART LUNG BL, ATH RISK COMM; [National Center for Health Statistics Centers for Disease Control and Prevention], NHANES AN GUID; National Center for Health Statistics, 2004, HLTH US 2004 CHARTB; National Heart Lung and Blood Institute, COR ART RISK DEV YOU; National Heart Lung and Blood Institute, CARD HLTH STUD; National Heart Lung and Blood Institute, FRAM HEART STUD; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STEIN EA, 1995, CLIN CHEM, V41, P1421; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TUNSTALL-PEDOE H, 2003, MONICA MONOGRAPH MUL; *US BUR CENS, POP PROJ US AG SEX R; *US DEP HHS, DIET GUID AM 2005; US Department of Health and Human Services, 2000, HLTH PEOPL 2010; *US DHEW, 1974, COMP AN EX NON PERS; WAHLEFELD A., 1974, METHOD ENZYMAT AN, P1831; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Wolters K.M., 1990, VARIANCE ESTIMATION; 1965, VITAL HLTH STAT 1, V4, P1; [No title captured]	58	391	400	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1773	1781		10.1001/jama.294.14.1773	http://dx.doi.org/10.1001/jama.294.14.1773			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972RX	16219880	Bronze			2022-12-01	WOS:000232472000016
J	Merianos, A; Peiris, M				Merianos, A; Peiris, M			International Health Regulations (2005)	LANCET			English	Editorial Material									Curtin Univ Technol, Australian Biosecur CRC, Perth, WA 6008, Australia; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	Curtin University; University of Hong Kong	Merianos, A (corresponding author), Curtin Univ Technol, Australian Biosecur CRC, Perth, WA 6008, Australia.	A.Merianos@exchange.curtin.edu.au						[Anonymous], MICROBIAL THREATS HL; Fouchier R, 2005, NATURE, V435, P419, DOI 10.1038/435419a; Smith R., 2003, GLOBAL PUBLIC GOODS; *WHO, 2000, WHO M GEN SWITZ APR	4	30	31	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 8	2005	366	9493					1249	1251		10.1016/S0140-6736(05)67508-3	http://dx.doi.org/10.1016/S0140-6736(05)67508-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971ST	16214586	Bronze, Green Published			2022-12-01	WOS:000232405700009
J	Lehnart, SE; Wehrens, XHT; Reiken, S; Warrier, S; Belevych, AE; Harvey, RD; Richter, W; Jin, SLC; Conti, M; Marks, AR				Lehnart, SE; Wehrens, XHT; Reiken, S; Warrier, S; Belevych, AE; Harvey, RD; Richter, W; Jin, SLC; Conti, M; Marks, AR			Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias	CELL			English	Article							PROTEIN-KINASE-A; CAMP-SPECIFIC PHOSPHODIESTERASE; CYCLIC-AMP; SUDDEN-DEATH; CA2+ LEAK; RELEASE; PHOSPHORYLATION; FKBP12.6; MUSCLE; THEOPHYLLINE	Phosphodiesterases (PDEs) regulate the local concentration of 3',5' cyclic adenosine monophosphate (cAMP) within cells. cAMP activates the cAMP-dependent protein kinase (PKA). In patients, PDE inhibitors have been linked to heart failure and cardiac arrhythmias, although the mechanisms are not understood. We show that PDE4D gene inactivation in mice results in a progressive cardiomyopathy, accelerated heart failure after myocardial infarction, and cardiac arrhythmias. The phosphodiesterase 4D3 (PDE4D3) was found in the cardiac ryanodine receptor (RyR2)/calcium-release-channel complex (required for excitation-contraction [EC] coupling in heart muscle). PDE4D3 levels in the RyR2 complex were reduced in failing human hearts, contributing to PKA-hyperphosphorylated, "leaky" RyR2 channels that promote cardiac dysfunction and arrhythmias. Cardiac arrhythmias and dysfunction associated with PDE4 inhibition or deficiency were suppressed in mice harboring RyR2 that cannot be PKA phosphorylated. These data suggest that reduced PDE4D activity causes defective RyR2-channel function associated with heart failure and arrhythmias.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA	Columbia University; Columbia University; Case Western Reserve University; Stanford University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA.	arm42@columbia.edu	Harvey, Robert D/L-8496-2016; Tuluc, Petronel/C-2527-2011; Wehrens, Xander/AAQ-9574-2020	Harvey, Robert D/0000-0002-8499-8765; Wehrens, Xander/0000-0001-5044-672X; Richter, Wito/0000-0001-5588-9060; Warrier, Sunita/0000-0002-1981-4552; Belevych, Andriy/0000-0002-1272-5784	NHLBI NIH HHS [R01 HL056180-15, P01 HL067849, R01 HL083418, R01 HL056180, R01 HL061503-13, R01 HL068170, R01 HL083418-03, R01 HL061503, R01-HL68170, P01 HL067849-10] Funding Source: Medline; NICHD NIH HHS [R01-HD20788, R01 HD020788] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083418, R01HL068170, R01HL056180, R01HL061503, P01HL067849] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barnes PJ, 2003, AM J RESP CRIT CARE, V167, P813, DOI 10.1164/rccm.200210-1142PP; BITTAR G, 1991, CHEST, V99, P1415, DOI 10.1378/chest.99.6.1415; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Giembycz M A, 2002, Monaldi Arch Chest Dis, V57, P48; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Michel JJC, 2004, BIOCHEM J, V381, P587, DOI 10.1042/BJ20040846; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pieske B, 1999, CIRC RES, V85, P38; REGITZZAGROSEK V, 1994, EUR HEART J, V15, P7, DOI 10.1093/eurheartj/15.suppl_D.7; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Ruehr ML, 2003, J BIOL CHEM, V278, P24831, DOI 10.1074/jbc.M213279200; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; VERDE I, 1999, BRIT J PHARMACOL, V217, P65; Vignola AM, 2004, RESP MED, V98, P495, DOI 10.1016/j.rmed.2003.12.012; Wang DG, 2003, CELL SIGNAL, V15, P883, DOI 10.1016/S0898-6568(03)00042-1; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	39	375	396	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					25	35		10.1016/j.cell.2005.07.030	http://dx.doi.org/10.1016/j.cell.2005.07.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213210	Green Accepted, Bronze			2022-12-01	WOS:000232536800006
J	Akeda, Y; Galan, JE				Akeda, Y; Galan, JE			Chaperone release and unfolding of substrates in type III secretion	NATURE			English	Article							F0F1 ATPASE; PROTEINS; RECOGNITION; DELIVERY; DOMAINS; FAMILY; INVC; FLII	Type III protein secretion systems are essential virulence factors of many bacteria pathogenic to humans, animals and plants(1). These systems mediate the transfer of bacterial virulence proteins directly into the host cell cytoplasm. Proteins are thought to travel this pathway in a largely unfolded manner, and a family of customized cytoplasmic chaperones, which specifically bind cognate secreted proteins, are essential for secretion. Here we show that InvC, an ATPase associated with a Salmonella enterica type III secretion system(2), has a critical function in substrate recognition. Furthermore, InvC induces chaperone release from and unfolding of the cognate secreted protein in an ATP-dependent manner. Our results show a similarity between the mechanisms of substrate recognition by type III protein secretion systems and AAA+ ATPase disassembly machines.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu						Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; DREYFUS G, 1993, J BACTERIOL, V175, P3131, DOI 10.1128/JB.175.10.3131-3138.1993; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Fischer CJ, 2001, BBA-PROTEIN STRUCT M, V1545, P96, DOI 10.1016/S0167-4838(00)00266-1; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Lloyd SA, 2001, TRENDS MICROBIOL, V9, P367, DOI 10.1016/S0966-842X(01)02100-X; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Stebbins CE, 2003, NAT REV MOL CELL BIO, V4, P738, DOI 10.1038/nrm1201; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073	30	332	344	0	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					911	915		10.1038/nature03992	http://dx.doi.org/10.1038/nature03992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208377				2022-12-01	WOS:000232338600052
J	Meine, TJ; Patel, MR; DePuy, V; Curtis, LH; Rao, SV; Gersh, BJ; Schulman, KA; Jollis, JG				Meine, TJ; Patel, MR; DePuy, V; Curtis, LH; Rao, SV; Gersh, BJ; Schulman, KA; Jollis, JG			Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	53rd Annual Scientific Session of the American-College-of-Cardiology	MAR 07-10, 2004	New Orleans, LA	Amer Coll Cardiol			COOPERATIVE CARDIOVASCULAR PROJECT; NATIONAL REGISTRY; DEATH; CARE	Background: Previous studies suggest that patients hospitalized with acute myocardial infarction (MI) in December have poor outcomes, and some studies have hypothesized that the cause may be the infrequent use of evidence-based therapies during the December holiday season. Objective: To compare the care and outcomes of patients with acute MI hospitalized in December and patients hospitalized during other months. Design: Retrospective analysis of data from the Cooperative Cardiovascular Project. Setting: Nonfederal, acute care hospitals in the United States. Patients: 127 959 Medicare beneficiaries hospitalized between January 1994 and February 1996 with confirmed acute MI. Measurements: Use of aspirin, beta-blockers, and reperfusion therapy (thrombolytic therapy or percutaneous coronary intervention), and 30-day mortality. Results: When the authors controlled for patient hospital, and physician characteristics, the use of evidence-based therapies was not significantly lower but 30-day mortality was higher (21.7% vs. 20.1%; adjusted odds ratio, 1.07 [95% CI, 1.02 to 1.12]) among patients hospitalized in December. Limitations: This was a nonrandomized, observational study. Unmeasured characteristics may have contributed to outcome differences. Conclusions: Thirty-day mortality rates were higher for Medicare patients hospitalized with acute MI in December than in other months, although the use of evidence-based therapies was not significantly lower.			Meine, TJ (corresponding author), 877-B W Faris Rd, Greenville, SC 29605 USA.							Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kloner RA, 1999, CIRCULATION, V100, P1630, DOI 10.1161/01.CIR.100.15.1630; Kloner RA, 2001, AM J CARDIOL, V88, P1021, DOI 10.1016/S0002-9149(01)01981-6; Knight-Davis DK, 1998, J ROY COLL PHYS LOND, V32, P130; Krumholz HM, 2001, J AM COLL CARDIOL, V38, P453, DOI 10.1016/S0735-1097(01)01395-X; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCulloch CE., 2001, GEN LINEAR MIXED MOD; Otto W, 1975, Z Gesamte Inn Med, V30, P231; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Phillips DP, 2004, CIRCULATION, V110, P3781, DOI 10.1161/01.CIR.0000151424.02045.F7; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Spertus JA, 2003, J AM COLL CARDIOL, V41, P1653, DOI 10.1016/S0735-1097(03)00415-7; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Varnava AM, 2002, HEART, V87, P216, DOI 10.1136/heart.87.3.216	19	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2005	143	7					481	485		10.7326/0003-4819-143-7-200510040-00006	http://dx.doi.org/10.7326/0003-4819-143-7-200510040-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	970FM	16204160				2022-12-01	WOS:000232290600002
J	McGee, AW; Yang, YP; Fischer, QS; Daw, NW; Strittmatter, SM				McGee, AW; Yang, YP; Fischer, QS; Daw, NW; Strittmatter, SM			Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; SPINAL-CORD-INJURY; NEURITE GROWTH-INHIBITORS; AXONAL REGENERATION; CRITICAL-PERIOD; DEPENDENT PLASTICITY; OUTGROWTH INHIBITOR; CORTICAL PLASTICITY; FUNCTIONAL RECOVERY; GLYCOPROTEIN	Monocular deprivation normally alters ocular dominance in the visual cortex only during a postnatal critical period (20 to 32 days postnatal in mice). We find that mutations in the Nogo-66 receptor (NgR) affect cessation of ocular dominance plasticity. in NgR(-/-) mice, plasticity during the critical period is normal, but it continues abnormally such that ocular dominance at 45 or 120 days postnatal is subject to the same plasticity as at juvenile ages. Thus, physiological NgR signaling from myelin-derived Nogo, MAG, and OMgp consolidates the neural circuitry established during experience-dependent plasticity. After pathological trauma, similar NgR signaling limits functional recovery and axonal regeneration.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011; Yang, Yupeng/G-5107-2018	Strittmatter, Stephen/0000-0001-8188-3092; Yang, Yupeng/0000-0002-9473-9994; Fischer, Quentin/0000-0002-7803-1179	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042304, R01NS056485, R01NS039962, R37NS033020] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039962, R01 NS042304, R01 NS042304-08, R01 NS039962-10, R37 NS033020-15, R37 NS033020, R01 NS056485, R01 NS056485-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DAW N, 1995, VISUAL DEV; DEFELIPE J, 1985, J NEUROSCI, V5, P3246; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Morales B, 2002, J NEUROSCI, V22, P8084; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Rebsam A, 2005, J NEUROSCI, V25, P706, DOI 10.1523/JNEUROSCI.4191-04.2005; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1051, DOI 10.1016/0306-4522(86)90122-3; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	38	457	477	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2222	2226		10.1126/science.1114362	http://dx.doi.org/10.1126/science.1114362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195464	Green Accepted			2022-12-01	WOS:000232318000046
J	Markwell, H				Markwell, H			End-of-life: a Catholic view	LANCET			English	Editorial Material									St Michaels Hosp, Ctr Clin Eth, Toronto, ON M6R 1B5, Canada; St Josephs Hlth Ctr, Toronto, ON M6R 1B5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario)	Markwell, H (corresponding author), St Michaels Hosp, Ctr Clin Eth, 30 Queensway, Toronto, ON M6R 1B5, Canada.	markwellh@smh.toronto.on.ca						BROCK I, 1997, DYING WELL PROSPECT, P59; *CATH HLTH ASS CAN, 2001, HLTH ETH GUID, P11; CRONIN DA, 1958, MORAL LAW REGARD ORD, P471; FLANNERY A, 1988, VATICAN COUNCIL 2 CO, P905; FLANNERY A, 1988, VATICAN COUNCIL 2 CO, P903; Katz Jay, 2002, SILENT WORLD DOCTOR; KELLY G, 1958, MEDICOMORAL PROBLEMS, P129; MAY WF, 1983, PHYSICIANS COVENANT, P109; MAY WF, 1994, HASTINGS CTR REP MAY; NOUWEN H, 1994, OUR GREATEST GIFT ME, P32; PELLEGRINO ED, 1997, HELPING HEALING RELI, P45; RAMSAY P, 1978, ETHICS EDGES LIFE; ROCHE J, 2000, FACING DEATH DISCOVE, P16; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; Singer PA, 2001, BMC MED ETHICS, V2, P1, DOI DOI 10.1186/1472-6939-2-1; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; *VAT 2, SACR CONC, V22; WILDES KW, 1997, CHOOSING LIFE DIALOG; 1999, BMJ, P318	19	33	34	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 24	2005	366	9491					1132	1135		10.1016/S0140-6736(05)67425-9	http://dx.doi.org/10.1016/S0140-6736(05)67425-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	967TL	16182902				2022-12-01	WOS:000232114000032
J	Engelhardt, HT; Iltis, AS				Engelhardt, HT; Iltis, AS			End-of-life: the traditional Christian view	LANCET			English	Editorial Material									Rice Univ, Dept Philosophy MS14, Houston, TX 77005 USA; St Louis Univ, Ctr Hlth Care Eth, St Louis, MO 63103 USA	Rice University; Saint Louis University	Engelhardt, HT (corresponding author), Rice Univ, Dept Philosophy MS14, 6100 Main St, Houston, TX 77005 USA.	htengelh@rice.edu						*BISH PA, 1992, ORIGINS, V21, P541; *BISH TX, 1990, ORIGINS, V20, P53; *CHRIST MED DENT A, ETH STAT PAT REF THE; CRONIN D, 1958, THESIS PONTIFICAL GR; *DIV CHURCH SOC, 1992, MESS END OF LIF DEC; ENGELHARDT HT, 1999, CHRIST BIOET, V4, P231; ENGELHARDT HT, 2000, FDN CHRISTIAN BIOETH, P369; HAMEL R, 1991, ACTIVE EUTHANASIA RE; HARAKAS SS, 1990, HLTH MED E ORTHODOX, P145; HOLIFIELD EB, 1986, HLTH MED METHODIST T, P85; KILNER J, 1992, LIFE LINE; MARTY ME, 1983, HLTH MED LUTHERAN TR, P157; MCCORMICK RA, 1984, HLTH MED CATHOLIC TR, P107; MEILAENDER G, 1984, HASTINGS CENT REP, P11; *MENN CHURCH CAN, 1995, LIF WORTH LIV ISS EU; *MO SYN LUTH CHURC, 1993, CHRIST CAR LIF END; PEEL R, 1988, HLTH MED CHRISTIAN S, P71; *PRESB CHURCH US, 1974, 1974 STAT, P199; SCHAFF P, 1994, NICENE POSTNICENE FA, V14, P549; SCHAFF P, 1994, NICENE POSTNICENE FA, V8, P78; SCHAFF P, 1994, NICENE POSTNICENE FA, V14, P613; SMITH DH, 1986, HLTH MED ANGLICAN TR, P45; Thomasma David C, 1998, Christ Bioeth, V4, P122, DOI 10.1076/chbi.4.2.122.6905; *UN UN GEN ASS, 1988, STAT EUTH; VAUX KL, 1984, HLTH MED REFORMED TR, P131; WAGNER M, 1962, ST BASIL LONG RULES, P330; Wildes KW, 1996, THEOL STUD, V57, P500, DOI 10.1177/004056399605700306; 1947, RITUALE ROMANUM, P103; 1989, DIVINE LITURGY, P281	29	41	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1045	1049						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	965MZ	16168787				2022-12-01	WOS:000231955900040
J	Li, F; Li, WH; Farzan, M; Harrison, SC				Li, F; Li, WH; Farzan, M; Harrison, SC			Structure of SARS coronavirus spike receptor-binding domain complexed with receptor	SCIENCE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; MOUSE HEPATITIS-VIRUS; POTENT NEUTRALIZING ANTIBODIES; PROTEIN FUSION CORE; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; AMINO-ACIDS; IDENTIFICATION; GLYCOPROTEIN	The spike protein (S) of SARS coronavirus (SARS-CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The crystal structure at 2.9 angstrom resolution of the RBD bound with the peptidase domain of human ACE2 shows that the RBD presents a gently concave surface, which cradles the N-terminal lobe of the peptidase. The atomic details at the interface between the two proteins clarify the importance of residue changes that facilitate efficient cross-species infection and human-to-human transmission. The structure of the RBD suggests ways to make truncated disulfide-stabilized RBD variants for use in the design of coronavirus vaccines.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Li, Fang/ABE-9129-2021	Li, Wenhui/0000-0003-1305-7404; Farzan, Michael/0000-0002-2990-5319	NCI NIH HHS [CA13202] Funding Source: Medline; NIAID NIH HHS [AI061601] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA013202, R37CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Lai MM, 2001, FIELDS VIROLOGY; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEMISTRY-US, V43, P14064, DOI 10.1021/bi049101q; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200	33	1235	1325	11	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1864	1868		10.1126/science.1116480	http://dx.doi.org/10.1126/science.1116480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166518				2022-12-01	WOS:000231989500052
J	Kuiken, T; Leighton, FA; Fouchier, RAM; LeDuc, JW; Peiris, JSM; Schudel, A; Stohr, K; Osterhaus, ADME				Kuiken, T; Leighton, FA; Fouchier, RAM; LeDuc, JW; Peiris, JSM; Schudel, A; Stohr, K; Osterhaus, ADME			Public health - Pathogen surveillance in animals	SCIENCE			English	Article							SARS CORONAVIRUS; WILDLIFE		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Univ Saskatchewan, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 5B4, Canada; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; World Org Anim Hlth, Paris, France; World Hlth Org, Dept Communicable Dis Surveillance & Response, Geneva, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Saskatchewan; Centers for Disease Control & Prevention - USA; University of Hong Kong; World Health Organization	Osterhaus, ADME (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Kuiken, Thijs/0000-0001-5501-9049				[Anonymous], 2004, 2004 REP GLOB AIDS E; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; *ENV CAN, 2004, CAN NAT WILDL DIS ST; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; KOCH G, 2003, INFECT ZIEKTEN B, V14, P112; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; LEIGHTON FA, 1995, REV SCI TECH OIE, V14, P819; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; *OIE, 2005, UPD AV INFL AN AS TY; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; World Health Organization, CUM NUMB CONF HUM CA; World Organisation for Animal Health (OIE), 2004, TERR AN HLTH COD	15	172	185	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1680	1681		10.1126/science.1113310	http://dx.doi.org/10.1126/science.1113310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16150997				2022-12-01	WOS:000231836700028
J	Katayama, S; Tomaru, Y; Kasukawa, T; Waki, K; Nakanishi, M; Nakamura, M; Nishida, H; Yap, CC; Suzuki, M; Kawai, J; Suzuki, H; Carninci, P; Hayashizaki, Y; Wells, C; Frith, M; Ravasi, T; Pang, KC; Hallinan, J; Mattick, J; Hume, DA; Lipovich, L; Batalov, S; Engstrom, PG; Mizuno, Y; Faghihi, MA; Sandelin, A; Chalk, AM; Mottagui-Tabar, S; Liang, Z; Lenhard, B; Wahlestedt, C				Katayama, S; Tomaru, Y; Kasukawa, T; Waki, K; Nakanishi, M; Nakamura, M; Nishida, H; Yap, CC; Suzuki, M; Kawai, J; Suzuki, H; Carninci, P; Hayashizaki, Y; Wells, C; Frith, M; Ravasi, T; Pang, KC; Hallinan, J; Mattick, J; Hume, DA; Lipovich, L; Batalov, S; Engstrom, PG; Mizuno, Y; Faghihi, MA; Sandelin, A; Chalk, AM; Mottagui-Tabar, S; Liang, Z; Lenhard, B; Wahlestedt, C		RIKEN Genome Network Project Core; Genome Sci Grp; FANTOM Consortium	Antisense transcription in the mammalian transcriptome	SCIENCE			English	Article							IMPRINTED GENES; NONCODING RNAS; HUMAN GENOME; HUMAN-CELLS; COMPLEX; AIR	Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring "genes" in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.	Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Scripps Florida, Jupiter, FL 33458 USA; RIKEN Yokohama Inst, RIKEN Genome Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Univ Queensland, Australian Res Council Special Res Ctr Func & App, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Austin & Repatriat Med Ctr, T Cell Lab, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia; Genome Inst Singapore, Singapore 138672, Singapore; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Karolinska Institutet; State University System of Florida; University of Florida; RIKEN; University of Queensland; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Novartis	Wahlestedt, C (corresponding author), Karolinska Inst, Ctr Genom & Bioinformat, Berzelius v 35, S-17177 Stockholm, Sweden.		Katayama, Shintaro/F-2958-2010; Nishida, Hiromi/B-1635-2008; Faghihi, Mohammad Ali/AAD-7159-2020; Ravasi, Timothy/B-8777-2008; Liang, Zicai/A-2646-2013; Carninci, Piero/K-1568-2014; Mattick, John S/I-7789-2012; Kawai, Jun/A-6451-2016; Wells, Christine A/A-5071-2010; Wahlestedt, Claes/A-7039-2009; Suzuki, Harukazu/N-9553-2015; Kasukawa, Takeya/N-5070-2015; Chalk, Alistair/O-3522-2019; Sandelin, Albin/G-2881-2011; Lipovich, Leonard/B-2355-2019; Hayashizaki, Yoshihide/N-6590-2015; Faghihi, Mohammad Ali/AAH-3139-2019; Hume, David A/C-7695-2013; Mattick, John/ABH-6130-2020; Waki, Kazunori/T-6444-2019	Katayama, Shintaro/0000-0001-7581-5157; Faghihi, Mohammad Ali/0000-0002-8330-9067; Carninci, Piero/0000-0001-7202-7243; Mattick, John S/0000-0002-7680-7527; Wells, Christine A/0000-0003-3133-3628; Suzuki, Harukazu/0000-0002-8087-0836; Kasukawa, Takeya/0000-0001-5085-0802; Chalk, Alistair/0000-0002-9630-6236; Sandelin, Albin/0000-0002-7109-7378; Lipovich, Leonard/0000-0002-0531-3570; Mattick, John/0000-0002-7680-7527; Ravasi, Timothy/0000-0002-9950-465X; Lenhard, Boris/0000-0002-1114-1509; Pang, Ken/0000-0002-6881-775X; Hume, David/0000-0002-2615-1478; Waki, Kazunori/0000-0001-7311-7208; Batalov, Sergey/0000-0002-0925-0554; Frith, Martin/0000-0003-0998-2859; Engstrom, Par/0000-0001-5265-2121				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen AA, 2003, CURR OPIN CELL BIOL, V15, P281, DOI 10.1016/S0955-0674(03)00041-3; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Holmes R, 2003, GENOME RES, V13, P1410, DOI 10.1101/gr.955503; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; RAVASI T, IN PRESS ENCY GENETI; Shendure J, 2002, GENOME BIOL, V3; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Veeramachaneni V, 2004, GENOME RES, V14, P280, DOI 10.1101/gr.1590904; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	27	1297	1420	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1564	1566		10.1126/science.1112009	http://dx.doi.org/10.1126/science.1112009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141073				2022-12-01	WOS:000231715000050
J	Liu, P; Huang, XH; Zhou, RH; Berne, BJ				Liu, P; Huang, XH; Zhou, RH; Berne, BJ			Observation of a dewetting transition in the collapse of the melittin tetramer	NATURE			English	Article							HYDROPHOBIC HYDRATION; WATER; SIMULATION; PLATES	Marked hydration changes occur during the self-assembly of the melittin protein tetramer in water. Hydrophobicity induces a drying transition in the gap between simple sufficiently large ( more than 1 nm(2)) strongly hydrophobic surfaces as they approach each other(1-6), resulting in the subsequent collapse of the system, as well as a depletion of water next to single surfaces(7-10). Here we investigate whether the hydrophobic induced collapse of multidomain proteins or the formation of protein oligimers exhibits a similar drying transition. We performed computer simulations to study the collapse of the tetramer of melittin in water, and observed a marked water drying transition inside a nanoscale channel of the tetramer ( with a channel size of up to two or three water-molecule diameters). This transition, although occurring on a microscopic length scale, is analogous to a first-order phase transition from liquid to vapour. We find that this drying is very sensitive to single mutations of the three isoleucines to less hydrophobic residues and that such mutations in the right locations can switch the channel from being dry to being wet. Thus, quite subtle changes in hydrophobic surface topology can profoundly influence the drying transition. We show that, even in the presence of the polar protein backbone, sufficiently hydrophobic protein surfaces can induce a liquid - vapour transition providing an enormous driving force towards further collapse. This behaviour was unexpected because of the absence of drying in the collapse of the multidomain protein 2,3-dihydroxybiphenyl dioxygenase (BphC).	Columbia Univ, Dept Chem, New York, NY 10027 USA; IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	Columbia University; International Business Machines (IBM)	Zhou, RH (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	ruhongz@us.ibm.com; berne@chem.columbia.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Zhou, Ruhong/0000-0001-8624-5591				Ball P, 2003, NATURE, V423, P25, DOI 10.1038/423025a; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Huang X, 2003, P NATL ACAD SCI USA, V100, P11953, DOI 10.1073/pnas.1934837100; Huang XH, 2005, J PHYS CHEM B, V109, P3546, DOI 10.1021/jp045520l; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jensen TR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Leung K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.065502; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Sansom MSP, 2001, NATURE, V414, P156, DOI 10.1038/35102651; Shea JE, 2002, P NATL ACAD SCI USA, V99, P16064, DOI 10.1073/pnas.242293099; Steitz R, 2003, LANGMUIR, V19, P2409, DOI 10.1021/la026731p; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; WOLDE PRT, 2002, P NATL ACAD SCI USA, V99, P6539; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	20	337	344	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					159	162		10.1038/nature03926	http://dx.doi.org/10.1038/nature03926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136146				2022-12-01	WOS:000231560400061
J	Cardone, L; Hirayamna, J; Giordano, F; Tarnaru, T; Palvimo, JJ; Sassone-Corsi, P				Cardone, L; Hirayamna, J; Giordano, F; Tarnaru, T; Palvimo, JJ; Sassone-Corsi, P			Circadian clock control by SUMOylation of BMAL1	SCIENCE			English	Article							SUMO-1 MODIFICATION; GENE-EXPRESSION; UBIQUITIN; TRANSCRIPTION; DIMERIZATION; MECHANISMS; PACEMAKER; PROTEIN; CRY2	The molecular machinery that governs circadian rhythmicity is based on clock proteins organized in regulatory feedback loops. Although posttranstational modification of clock proteins is likely to finely control their circadian functions, only limited information is available to date. Here, we show that BMAL1, an essential transcription factor component of-the clock mechanism, is SUMOylated on a highly conserved lysine residue (Lys(259)) in vivo. BMAL1 shows a circadian pattern of SUMOylation that parallels its activation in the mouse liver. SUMOylation of BMAL1 requires and is induced by CLOCK, the heterodimerization partner of BMAL1. Ectopic expression of a SUMO-deficient BMAL1 demonstrates that SUMOylation plays an important role in BMAL1 circadian expression and clock rhythmicity. This reveals an additional level of regulation within the core mechanism of the circadian clock.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Toho Univ, Sch Med, Dept Physiol, Ohta Ku, Tokyo 1438540, Japan; Univ Helsinki, Biomedicum Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Helsinki	Sassone-Corsi, P (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Strasbourg, France.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011	Palvimo, Jorma/0000-0003-2373-0578; Cardone, Luca/0000-0001-8184-2856; Hirayama, Jun/0000-0002-8485-3320				Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	29	232	240	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1390	1394		10.1126/science.1110689	http://dx.doi.org/10.1126/science.1110689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16109848				2022-12-01	WOS:000231543300049
J	Gehi, A; Haas, D; Fuster, V				Gehi, A; Haas, D; Fuster, V			Primary prophylaxis with the implantable cardioverter-defibrillator - The need for improved risk stratification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUDDEN-DEATH; VALIDATION; THERAPY; TRIAL		CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Gehi, A (corresponding author), Mt Sinai Med Ctr, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	anil.gehi@msnyuhealth.org	Fuster, Valentin/H-4319-2015	Fuster, Valentin/0000-0002-9043-9986				Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bailey JJ, 2001, J AM COLL CARDIOL, V38, P1902, DOI 10.1016/S0735-1097(01)01667-9; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bloomfield DM, 2004, CIRCULATION, V110, P1885, DOI 10.1161/01.CIR.0000143160.14610.53; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Buxton Alfred E, 2003, Card Electrophysiol Rev, V7, P434, DOI 10.1023/B:CEPR.0000023159.96742.d2; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Desai Akshay S., 2004, Curr Treat Options Cardiovasc Med, V6, P3, DOI 10.1007/s11936-004-0010-y; Essebag Vidal, 2003, Card Electrophysiol Rev, V7, P43, DOI 10.1023/A:1023639006565; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gerin W, 2002, BLOOD PRESS MONIT, V7, P313, DOI 10.1097/00126097-200212000-00004; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; La Rovere MT, 2001, CIRCULATION, V103, P2072; Makikallio TH, 2002, CIRCULATION, V105, pE69, DOI 10.1161/hc1202.106048; Malm S, 2004, J AM COLL CARDIOL, V44, P1030, DOI 10.1016/j.jacc.2004.05.068; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Otterstad JE, 1997, EUR HEART J, V18, P507; Sheldon R, 2001, CIRCULATION, V104, P1622, DOI 10.1161/hc3901.096720; Steinbrook R, 2005, NEW ENGL J MED, V353, P221, DOI 10.1056/NEJMp058158; Tapanainen JM, 2004, J AM COLL CARDIOL, V43, P757, DOI 10.1016/j.jacc.2003.09.048	26	27	28	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2005	294	8					958	960		10.1001/jama.294.8.958	http://dx.doi.org/10.1001/jama.294.8.958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957JM	16118387				2022-12-01	WOS:000231366100027
J	Tu, BP; Kudlicki, A; Rowicka, M; McKnight, SL				Tu, BP; Kudlicki, A; Rowicka, M; McKnight, SL			Logic of the yeast metabolic cycle: Temporal compartmentalization of cellular processes	SCIENCE			English	Article							REDUCED PYRIDINE-NUCLEOTIDE; CIRCADIAN GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; TRANSCRIPTION; OSCILLATIONS; CLOCK; ORCHESTRATION; LOCALIZATION; DIVISION	Budding yeast grown under continuous, nutrient-limited conditions exhibit robust, highly periodic cycles in the form of respiratory bursts. Microarray studies reveal that over half of the yeast genome is expressed periodically during these metabolic cycles. Genes encoding proteins having a common function exhibit similar temporal expression patterns, and genes specifying functions associated with energy and metabolism tend to be expressed with exceptionally robust periodicity. Essential cellular and metabolic events occur in synchrony with the metabolic cycle, demonstrating that key processes in a simple eukaryotic cell are compartmentalized in time.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu	Kudlicki, Andrzej/C-7612-2012; Kudlicki, Andrzej/AAG-8537-2019; Rowicka, Maga/E-2496-2012	Kudlicki, Andrzej/0000-0001-8158-9600; Rowicka, Maga/0000-0002-4011-071X				Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; CHANCE B, 1964, P NATL ACAD SCI USA, V52, P337, DOI 10.1073/pnas.52.2.337; CHANCE B, 1964, P NATL ACAD SCI USA, V51, P1244, DOI 10.1073/pnas.51.6.1244; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GHOSH A, 1964, BIOCHEM BIOPH RES CO, V16, P174, DOI 10.1016/0006-291X(64)90357-2; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; HOMMES FA, 1964, ARCH BIOCHEM BIOPHYS, V108, P36, DOI 10.1016/0003-9861(64)90352-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753-8764.2004; MARGULIS L, 1981, SYMBIOSIS CELL EVOLU, pR22; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; STRYER L, 1995, BIOCHEMISTRY-US, pR34; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; VONMEYEN HK, 1969, ARCH MIKROBIOL, V66, P289; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672	38	653	688	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1152	1158		10.1126/science.1120499	http://dx.doi.org/10.1126/science.1120499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16254148				2022-12-01	WOS:000233437300037
J	Yu, HG; Koshland, D				Yu, HG; Koshland, D			Chromosome morphogenesis: Condensin-dependent cohesin removal during meiosis	CELL			English	Article							SISTER-CHROMATID COHESION; POLO-LIKE KINASE; SACCHAROMYCES-CEREVISIAE; CENTROMERIC COHESION; MEIOTIC CHROMOSOMES; VERTEBRATE COHESIN; XENOPUS-OOCYTES; DNA-DAMAGE; PROTEIN; ANAPHASE	During meiosis, segregation of homologous chromosomes necessitates the coordination of sister chromatid cohesion, chromosome condensation, and recombination. Cohesion and condensation require the SMC complexes, cohesin and condensin, respectively. Here we use budding yeast Saccharomyces cerevisiae to show that condensin and Cdc5, a Polo-like kinase, facilitate the removal of cohesin from chromosomes prior to the onset of anaphase I when homologs segregate. This cohesin removal is critical for homolog segregation because it helps dissolve the recombination-dependent links between homologs that form during prophase I. Condensin enhances the association of Cdc5 with chromosomes and its phosphorylation of cohesin, which in turn likely stimulates cohesin removal. Condensin/Cdc5-dependent removal of cohesin underscores the potential importance of crosstalk between chromosome structural components in chromosome morphogenesis and provides a mechanism to couple chromosome morphogenesis with other meiotic events.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Carnegie Inst,Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Koshland, D (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Carnegie Inst,Dept Embryol, Baltimore, MD 21218 USA.	koshland@ciwemb.edu		Yu, Hong-Guo/0000-0002-1311-7043				Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cha RS, 2000, GENE DEV, V14, P493; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; van Heemst D, 1999, CELL, V98, P261, DOI 10.1016/S0092-8674(00)81020-X; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Yu HG, 2003, J CELL BIOL, V163, P937, DOI 10.1083/jcb.200308027; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	42	79	82	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 4	2005	123	3					397	407		10.1016/j.cell.2005.09.014	http://dx.doi.org/10.1016/j.cell.2005.09.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269332	Bronze			2022-12-01	WOS:000233264300009
J	Keren, R; Zaoutis, TE; Bridges, CB; Herrera, G; Watson, BM; Wheeler, AB; Licht, DJ; Luan, XQ; Coffin, SE				Keren, R; Zaoutis, TE; Bridges, CB; Herrera, G; Watson, BM; Wheeler, AB; Licht, DJ; Luan, XQ; Coffin, SE			Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTPATIENT VISITS; COMPLICATIONS; EPIDEMIC; INFANTS	Context The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination for children with certain chronic medical conditions to prevent serious complications of influenza infection. Little is known about the relative contribution of each of these chronic medical conditions to the development of serious influenza-associated complications. Objective To identify chronic medical conditions that are associated with respiratory failure in children hospitalized with community-acquired laboratory-confirmed influenza. Design, Setting, and Patients A retrospective cohort study of patients aged 21 years or younger hospitalized at The Children's Hospital of Philadelphia with community-acquired laboratory-confirmed influenza during 4 consecutive influenza seasons (June 2000 through May 2004). We examined 9 ACIP-designated high-risk chronic medical conditions and 3 additional chronic medical conditions (neurological and neuromuscular disease [NNMD], gastroesophageal reflux disease [GERD], and history of prematurity) that in recent studies have been associated with influenza hospitalization and severe influenza-related complications. Main Outcome Measures Rate and odds ratio (OR) of respiratory failure, defined as need for mechanical ventilation. Results Of 745 children hospitalized with community-acquired laboratory-confirmed influenza, 322 (43%) had 1 or more ACIP-designated high-risk chronic medical conditions. Neurological and neuromuscular disease, GERD, and history of prematurity were present in 12%, 14%, and 3%, of children, respectively. Thirty-two children (4.3%) developed respiratory failure. In multivariate logistic regression analyses, conditions associated with respiratory failure included NNMID (OR, 6.0 95% confidence interval [CI], 2.7-13.5), chronic pulmonary disease other than asthma (OR, 4.8; 95% Cl, 1.5-15.1), and cardiac disease (OR, 4.0; 95% Cl, 1.6-10.2). The predicted probabilities of respiratory failure derived from the multivariate model were 12% (95% Cl, 7%-20%), 9% (95% Cl, 3%-23%), and 8% (95% Cl, 4%-18%) for children with NNMD, chronic pulmonary disease, and cardiac disease, respectively. Conclusions These results support the ACIP's recent decision to add NNMID to the list of conditions for which annual influenza vaccine is recommended in children. Neurologists and primary care pediatricians should be alerted to the increased risk of respiratory failure and the importance of influenza vaccination in children with NNMD.	Childrens Hosp Philadelphia, Div Gen Pediat, Pediat Gen Res Grp, Dept Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Med, Div Neurol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Med, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Philadelphia Dept Publ Hlth, Philadelphia, PA USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Centers for Disease Control & Prevention - USA	Keren, R (corresponding author), Childrens Hosp Philadelphia, Div Gen Pediat, Pediat Gen Res Grp, Dept Med, 3535 Market St,Room 1524, Philadelphia, PA 19104 USA.	keren@email.chop.edu	Licht, Daniel J/I-3370-2013	Licht, Daniel J/0000-0002-4080-843X	NICHD NIH HHS [K23 HD043179] Funding Source: Medline; ODCDC CDC HHS [H23/CCH32253-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD043179] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ODCDC CDC HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], MMWR MORB MORTAL WKL; Collins SDW., 1957, REV STUDY ILLNESS ME; CONNOLLY AM, 1993, BRIT MED J, V306, P1452, DOI 10.1136/bmj.306.6890.1452; EICKHOFF TC, 1961, JAMA-J AM MED ASSOC, V176, P776, DOI 10.1001/jama.1961.03040220024005; Erhart LM, 2004, J PEDIATR-US, V144, P191, DOI 10.1016/j.jpeds.2003.11.007; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Lehmann, 1953, EXCESS DEATHS INFLUE; Loughlin J, 2003, PHARMACOECONOMICS, V21, P273, DOI 10.2165/00019053-200321040-00005; Meury S, 2004, EUR J PEDIATR, V163, P359, DOI 10.1007/s00431-004-1445-6; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Quach C, 2003, PEDIATRICS, V112, pE197, DOI 10.1542/peds.112.3.e197; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vaudry W, 2004, Can Commun Dis Rep, V30, P157; Wang Ying-Hsiang, 2003, Journal of Microbiology Immunology and Infection, V36, P111	20	122	130	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2005	294	17					2188	2194		10.1001/jama.294.17.2188	http://dx.doi.org/10.1001/jama.294.17.2188			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979PQ	16264160	Bronze			2022-12-01	WOS:000232957700021
J	Hirano, Y; Hendil, KB; Yashiroda, H; Iemura, S; Nagane, R; Hioki, Y; Natsume, T; Tanaka, K; Murata, S				Hirano, Y; Hendil, KB; Yashiroda, H; Iemura, S; Nagane, R; Hioki, Y; Natsume, T; Tanaka, K; Murata, S			A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes	NATURE			English	Article							BETA-SUBUNITS; MATURATION; RESOLUTION; PROTEIN	The 26S proteasome is a multisubunit protease responsible for regulated proteolysis in eukaryotic cells(1,2). It comprises one catalytic 20S proteasome and two axially positioned 19S regulatory complexes(3). The 20S proteasome is composed of 28 subunits arranged in a cylindrical particle as four heteroheptameric rings, alpha(1-7)beta(1-7)beta(1-7)alpha(1-7) ( refs 4, 5), but the mechanism responsible for the assembly of such a complex structure remains elusive. Here we report two chaperones, designated proteasome assembling chaperone-1 (PAC1) and PAC2, that are involved in the maturation of mammalian 20S proteasomes. PAC1 and PAC2 associate as heterodimers with proteasome precursors and are degraded after formation of the 20S proteasome is completed. Overexpression of PAC1 or PAC2 accelerates the formation of precursor proteasomes, whereas knockdown by short interfering RNA impairs it, resulting in poor maturation of 20S proteasomes. Furthermore, the PAC complex provides a scaffold for alpha-ring formation and keeps the alpha-rings competent for the subsequent formation of half-proteasomes. Thus, our results identify a mechanism for the correct assembly of 20S proteasomes.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; Univ Copenhagen, Inst Mol Biol & Physiol, DK-2100 Copenhagen, Denmark; Natl Inst Adv Ind SCi & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; University of Copenhagen; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Murata, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp; smurata@rinshoken.or.jp	Murata, Shigeo/A-1426-2010; Yashiroda, Hideki/Y-7641-2019	Murata, Shigeo/0000-0002-3177-3503; 				Ahn K, 1996, J BIOL CHEM, V271, P18237, DOI 10.1074/jbc.271.30.18237; Bahar R, 2002, J BIOL CHEM, V277, P40012, DOI 10.1074/jbc.M205345200; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Gerards WLH, 1997, J BIOL CHEM, V272, P10080; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Griffin Thomas A., 2000, Molecular Cell Biology Research Communications, V3, P212, DOI 10.1006/mcbr.2000.0213; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Schmidtke G, 1997, J MOL BIOL, V268, P95, DOI 10.1006/jmbi.1997.0947; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vidal-Taboada JM, 2000, BIOCHEM BIOPH RES CO, V272, P156, DOI 10.1006/bbrc.2000.2726; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; YANG Y, 1995, J BIOL CHEM, V270, P27687, DOI 10.1074/jbc.270.46.27687; Yao Y, 1999, BIOCHEM J, V344, P349, DOI 10.1042/0264-6021:3440349; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	23	181	192	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1381	1385		10.1038/nature04106	http://dx.doi.org/10.1038/nature04106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251969				2022-12-01	WOS:000232829100059
J	Graham, LA; Davies, PL				Graham, LA; Davies, PL			Glycine-rich antifreeze proteins from snow fleas	SCIENCE			English	Article							EVOLUTION		Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca						Baardsnes J, 2001, TRENDS BIOCHEM SCI, V26, P468, DOI 10.1016/S0968-0004(01)01879-5; Bellinger P.F., 1996, CHECKLIST COLLEMBOLA; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Kuiper MJ, 2003, BIOCHEM BIOPH RES CO, V300, P645, DOI 10.1016/S0006-291X(02)02900-5; ZETTEL J, 1984, REV ECOL BIOL SOL, V21, P189	7	120	140	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					461	461		10.1126/science.1115145	http://dx.doi.org/10.1126/science.1115145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239469				2022-12-01	WOS:000232786000036
J	Raisner, RM; Hartley, PD; Meneghini, MD; Bao, MZ; Liu, CL; Schreiber, SL; Rando, OJ; Madhani, HD				Raisner, RM; Hartley, PD; Meneghini, MD; Bao, MZ; Liu, CL; Schreiber, SL; Rando, OJ; Madhani, HD			Histone variant H2A.Z marks the 5 ' ends of both active and inactive genes in euchromatin	CELL			English	Article							DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; NUCLEOSOME CORE; YEAST; ACETYLATION; H3; METHYLATION; HETEROCHROMATIN; TRANSCRIPTION	In S. cerevisiae, histone variant H2A.Z is deposited in euchromatin at the flanks of silent heterochromatin to prevent its ectopic spread. We show that H2A.Z nucleosomes are found at promoter regions of nearly all genes in euchromatin. They generally occur as two positioned nucleosomes that flank a nucleosome-free region (NFR) that contains the transcription start site. Astonishingly, enrichment at 5' ends is observed not only at actively transcribed genes but also at inactive loci. Mutagenesis of a typical promoter revealed a 22 bp segment,of DNA sufficient to program formation of a NFR flanked by two H2A.Z nucleosomes. This segment contains a binding site of the Myb-related protein Reb1 and an adjacent dT:dA tract. Efficient deposition of H2A.Z is further promoted by a specific pattern of histone H3 and H4 tall acetylation and the bromodomain protein Bdf1, a component of the Swr1 remodeling complex that deposits H2A.Z.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; Harvard University	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Rando, Oliver/0000-0003-1516-9397; Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01 GM071801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; JU QD, 1990, MOL CELL BIOL, V10, P5226, DOI 10.1128/MCB.10.10.5226; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; Ling XF, 1996, GENE DEV, V10, P686, DOI 10.1101/gad.10.6.686; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; SCHULDINER M, 2005, IN PRESS CELL; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	43	497	514	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					233	248		10.1016/j.cell.2005.10.002	http://dx.doi.org/10.1016/j.cell.2005.10.002			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239142	Green Accepted, Bronze			2022-12-01	WOS:000232794100011
J	Flum, DR; Salem, L; Elrod, JAB; Dellinger, EP; Cheadle, A; Chan, L				Flum, DR; Salem, L; Elrod, JAB; Dellinger, EP; Cheadle, A; Chan, L			Early mortality among medicare beneficiaries undergoing bariatric surgical procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTRIC BYPASS; MORBID-OBESITY; CARDIOVASCULAR RISK; HOSPITAL VOLUME; SURGERY; AGE; GENDER; ADULTS; OLDER; LIFE	Context Case series demonstrate that bariatric surgery can be performed with a low rate of perioperative mortality (0.5%), but the rate among high-risk patients and the community at large is unknown. Objectives To evaluate the risk of early mortality among Medicare beneficiaries and to determine the relative risk of death among older patients. Design Retrospective cohort study. Setting and Patients All fee-for-service Medicare beneficiaries, 1997-2002. Main Outcome Measures Thirty-day, 90-day, and 1-year postsurgical all-cause mortality among patients undergoing bariatric procedures. Results A total of 16 155 patients underwent bariatric procedures (mean age, 47.7 years [SD, 11.3 years]; 75.8% women). The rates of 30-day, 90-day, and 1-year mortality were 2.0%, 2.8%, and 4.6%, respectively. Men had higher rates of early death than women (3.7% vs 1.5%, 4.8% vs 2.1 %, and 7.5% vs 3.7% at 30 days, 90 days, and 1 year, respectively; P<.001). Mortality rates were greater for those aged 65 years or older compared with younger patients (4.8% vs 1.7% at 30 days, 6.9% vs 2.3% at 90 days, and 11.1 % vs 3.9% at 1 year; P<.001). After adjustment for sex and comorbidity index, the odds of death within 90 days were 5-fold greater for older Medicare beneficiaries (aged >= 75 years; n = 136) than for those aged 65 to 74 years (n = 1381; odds ratio, 5.0; 95% confidence interval, 3.1-8.0). The odds of death at 90 days were 1.6 times higher (95% confidence interval, 1.3-2.0) for patients of surgeons with less than the median surgical volume of bariatric procedures (among Medicare beneficiaries during the study period) after adjusting for age, sex, and comorbidity index. Conclusions Among Medicare beneficiaries, the risk of early death after bariatric surgery is considerably higher than previously suggested and associated with advancing age, male sex, and lower surgeon volume of bariatric procedures. Patients aged 65 years or older had a substantially higher risk of death within the early postoperative period than younger patients.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Ctr Medicare & Medicaid Serv, Div Clin Stand & Qual, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Medicare & Medicaid Services	Flum, DR (corresponding author), Univ Washington, Dept Surg, Box 356410,1959 NE Pacific St, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069677, U01DK066568] Funding Source: NIH RePORTER; NIDDK NIH HHS [1UO1DK066568-01, R21 DK069677-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Evans S, 2005, STAT MED, V24, P1245, DOI 10.1002/sim.2023; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Frostick SP, 2000, HAEMOSTASIS, V30, P84; Gonzalez R, 2003, AM SURGEON, V69, P547; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Harris TB, 1997, AM J CLIN NUTR, V66, P837, DOI 10.1093/ajcn/66.4.837; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; KRAL JG, 1992, AM J CLIN NUTR, V55, P611, DOI 10.1093/ajcn/55.2.611s; Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/00000658-200211000-00007; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; McTigue KM, 2003, ANN INTERN MED, V139, P933, DOI 10.7326/0003-4819-139-11-200312020-00013; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; PORIES W J, 1992, American Journal of Clinical Nutrition, V55, p582S, DOI 10.1093/ajcn/55.2.582s; PRINTEN KJ, 1977, SURG GYNECOL OBSTET, V144, P192; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sosa JL, 2004, OBES SURG, V14, P1398, DOI 10.1381/0960892042583833; Sugerman HJ, 2004, ANN SURG, V240, P243, DOI 10.1097/01.sla.0000133361.68436.da; Zenilman M E, 1998, Curr Probl Surg, V35, P99, DOI 10.1016/S0011-3840(98)80003-8; Zizza CA, 2003, OBES RES, V11, P1519, DOI 10.1038/oby.2003.203	26	418	438	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2005	294	15					1903	1908		10.1001/jama.294.15.1903	http://dx.doi.org/10.1001/jama.294.15.1903			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974OZ	16234496	Bronze			2022-12-01	WOS:000232602600019
J	Cha, TL; Zhou, BHP; Xia, WY; Wu, YD; Yang, CC; Chen, CT; Ping, B; Otte, AP; Hung, MC				Cha, TL; Zhou, BHP; Xia, WY; Wu, YD; Yang, CC; Chen, CT; Ping, B; Otte, AP; Hung, MC			Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3	SCIENCE			English	Article							CANCER; BIOLOGY; H3	Enhancer of Zeste homolog 2 (EZH2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone H3. Here, we show that Akt phosphorylates EZH2 at serine 21 and suppresses its methyltransferase activity by impeding EZH2 binding to histone H3, which results in a decrease of lysine 27 trimethylation and derepression of silenced genes. Our results imply that Akt regulates the methylation activity, through phosphorylation of EZH2, which may contribute to oncogenesis.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Amsterdam	Hung, MC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	PHS HHS [R01 109311, P01 099031] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Zhang Y, 2004, NATURE, V431, P637, DOI 10.1038/431637a; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	18	412	435	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					306	310		10.1126/science.1118947	http://dx.doi.org/10.1126/science.1118947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224021				2022-12-01	WOS:000232670100050
J	Pattingre, S; Tassa, A; Qu, XP; Garuti, R; Liang, XH; Mizushima, N; Packer, M; Schneider, MD; Levine, B				Pattingre, S; Tassa, A; Qu, XP; Garuti, R; Liang, XH; Mizushima, N; Packer, M; Schneider, MD; Levine, B			Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy	CELL			English	Article							CELL-DEATH; APOPTOSIS; MACROAUTOPHAGY; PHOSPHORYLATION; TUMORIGENESIS; DISSECTION	Apoptosis and autophagy are both tightly regulated biological processes that play a central role in tissue homeostasis, development, and disease. The antiapoptotic protein, Bcl-2, interacts with the evolutionarily conserved autophagy protein, Beclin 1. However, little is known about the functional significance of this interaction. Here, we show that wild-type Bcl-2 antiapoptotic proteins, but not Beclin 1 binding defective mutants of Bcl-2, inhibit Beclin 1-dependent autophagy in yeast and mammalian cells and that cardiac Bcl-2 transgenic expression inhibits autophagy in mouse heart muscle. Furthermore, Beclin 1 mutants that cannot bind to Bcl-2 induce more autophagy than wild-type Beclin 1 and, unlike wild-type Beclin 1, promote cell death. Thus, Bcl-2 not only functions as an antiapoptotic protein, but also as an antiautophagy protein via its inhibitory interaction with Beclin 1. This antiautophagy function of Bcl-2 may help maintain autophagy at levels that are compatible with cell survival, rather than cell death.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Biostat & Clin Sci, Dallas, TX 75390 USA; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Japan Sci & Technol Agcy, Precursory Res Embryol Sci & Technol, Kawaguchi 3320012, Japan; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Baylor College of Medicine	Levine, B (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	beth.levine@utsouthwestern.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Schneider, Michael/0000-0001-9645-1938; Pattingre, Sophie/0000-0001-6284-6050	NCI NIH HHS [R01 CA109618, CA084254, CA109618] Funding Source: Medline; NIAID NIH HHS [R01 AI151367, AI44157] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084254, R56CA109618, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044157] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; GERMAIN M, 2003, SCI STKE, V173, pPE10; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LEVINE B, 2005, IN PRESS J CLIN INVE; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Poommipanit PB, 1999, J BIOL CHEM, V274, P1033, DOI 10.1074/jbc.274.2.1033; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	39	2788	2940	7	364	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					927	939		10.1016/j.cell.2005.07.002	http://dx.doi.org/10.1016/j.cell.2005.07.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179260	Bronze			2022-12-01	WOS:000232130200016
J	Janssen, BJC; Huizinga, EG; Raaijmakers, HCA; Roos, A; Daha, MR; Nilsson-Ekdahl, K; Nilsson, B; Gros, P				Janssen, BJC; Huizinga, EG; Raaijmakers, HCA; Roos, A; Daha, MR; Nilsson-Ekdahl, K; Nilsson, B; Gros, P			Structures of complement component C3 provide insights into the function and evolution of immunity	NATURE			English	Article							INITIAL C-3 CONVERTASE; RAY CRYSTAL-STRUCTURE; 3RD COMPONENT; FACTOR-H; INTERNAL THIOESTER; DIFFRACTION DATA; PROTEIN C3; BINDING; CLEAVAGE; FRAGMENT	The mammalian complement system is a phylogenetically ancient cascade system that has a major role in innate and adaptive immunity. Activation of component C3 ( 1,641 residues) is central to the three complement pathways and results in inflammation and elimination of self and non- self targets. Here we present crystal structures of native C3 and its final major proteolytic fragment C3c. The structures reveal thirteen domains, nine of which were unpredicted, and suggest that the proteins of the alpha 2- macroglobulin family evolved from a core of eight homologous domains. A double mechanism prevents hydrolysis of the thioester group, essential for covalent attachment of activated C3 to target surfaces. Marked conformational changes in the alpha- chain, including movement of a critical interaction site through a ring formed by the domains of the beta- chain, indicate an unprecedented, conformation- dependent mechanism of activation, regulation and biological function of C3.	Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands; Univ Hosp, Dept Clin Immunol, SE-75185 Uppsala, Sweden; Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University; Uppsala University Hospital; Linnaeus University; University of Kalmar	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Janssen, Bert/I-3338-2016; Gros, Piet/AAD-6452-2019; Ekdahl, Kristina Nilsson/B-5301-2012; Gros, Piet/I-5569-2016; Nilsson, Bo/B-3102-2012	Janssen, Bert/0000-0002-8101-8370; Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Nilsson, Bo/0000-0003-0057-2730; raaijmakers, hans/0000-0002-2567-7363				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOKISCH VA, 1969, J EXP MED, V129, P1109, DOI 10.1084/jem.129.5.1109; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; Gadjeva M, 1998, J IMMUNOL, V161, P985; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; HUBER R, 1980, H-S Z PHYSIOL CHEM, V361, P1389, DOI 10.1515/bchm2.1980.361.2.1389; ISENMAN DE, 1981, BIOCHEMISTRY-US, V20, P4458, DOI 10.1021/bi00518a034; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; LACHMANN PJ, 1982, J EXP MED, V156, P205, DOI 10.1084/jem.156.1.205; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; LAMBRIS JD, 1988, IMMUNOL TODAY, V9, P387, DOI 10.1016/0167-5699(88)91240-6; Lambris JD, 1996, J IMMUNOL, V156, P4821; LAW SK, 1979, J IMMUNOL, V123, P1388; Law SKA, 1997, PROTEIN SCI, V6, P263; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1992, J BIOL CHEM, V267, P8584; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qazi U, 1998, J BIOL CHEM, V273, P8987, DOI 10.1074/jbc.273.15.8987; ROSS GD, 1982, J IMMUNOL, V129, P2051; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Solomon KR, 2004, GENE, V327, P171, DOI 10.1016/j.gene.2003.11.025; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMAS ML, 1982, P NATL ACAD SCI-BIOL, V79, P1054, DOI 10.1073/pnas.79.4.1054; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469	51	404	418	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					505	511		10.1038/nature04005	http://dx.doi.org/10.1038/nature04005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177781	Green Published			2022-12-01	WOS:000232004800040
J	Zhang, K; Lin, WC; Latham, JA; Riefler, GM; Schumacher, JM; Chan, C; Tatchell, K; Hawke, DH; Kobayashi, R; Dent, SYR				Zhang, K; Lin, WC; Latham, JA; Riefler, GM; Schumacher, JM; Chan, C; Tatchell, K; Hawke, DH; Kobayashi, R; Dent, SYR			The set1 methyltransferase orwoses IpI1 aurora kinase functions in chromosome segregation	CELL			English	Article							H3 LYSINE-4 METHYLATION; TYPE-1 PROTEIN PHOSPHATASE; HISTONE H3; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC PHOSPHORYLATION; COVALENT MODIFICATIONS; KINETOCHORE; COMPLEX; ACETYLATION	A balance in the activities of the Ipl1 Aurora kinase and the Glc7 phosphatase is essential for normal chromosome segregation in yeast. We report here that this balance is modulated by the Set1 methyltransferase. Deletion of SET1 suppresses chromosome loss in ipl1-2 cells. Conversely, combination of SET1 and GLC7 mutations is lethal. Strikingly, these effects are independent of previously defined functions for Set1 in transcription initiation and histone H3 methylation. We find that Set1 is required for methylation of conserved lysines in a kinetochore protein, Dam1. Biochemical and genetic experiments indicate that Dam1 methylation inhibits Ipl1-mediated phosphorylation of flanking serines. Our studies demonstrate that Set1 has important, unexpected functions in mitosis. Moreover, our findings suggest that antagonism between lysine methylation and serine phosphorylation is a fundamental mechanism for controlling protein function.	Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Proteom Facil, Houston, TX 77030 USA; Univ Texas, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dent, SYR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, 1515 Holcombe Blvd, Houston, TX 77030 USA.	syr@mdacc.tmc.edu	Schumacher, Jill/B-2932-2012; Tatchell, Kelly/A-9643-2009; Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Hawke, David/0000-0002-6102-7843	NCI NIH HHS [P30 CA016672, CA16672] Funding Source: Medline; NICHD NIH HHS [T32 HD007325, T32 HD07325] Funding Source: Medline; NIGMS NIH HHS [R01 GM062181-03, R01 GM062181-04, R01GM62181, R01 GM062181, R01 GM062181-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Courtwright AM, 2002, DEV CELL, V3, P610, DOI 10.1016/S1534-5807(02)00332-5; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hong G, 2000, ARCH BIOCHEM BIOPHYS, V376, P288, DOI 10.1006/abbi.2000.1715; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Peggie MW, 2002, J CELL SCI, V115, P195; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; SIKORSKI RS, 1989, GENETICS, V122, P19; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	53	117	119	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					723	734		10.1016/j.cell.2005.06.021	http://dx.doi.org/10.1016/j.cell.2005.06.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143104	Green Accepted, Bronze			2022-12-01	WOS:000231844300012
J	Woodall, AA; Sandbach, EJ; Woodward, CM; Aveyard, P; Merrington, G				Woodall, AA; Sandbach, EJ; Woodward, CM; Aveyard, P; Merrington, G			The partial smoking ban in licensed establishments and health inequalities in England: modelling study	BRITISH MEDICAL JOURNAL			English	Article									Telford & Wrekin Primary Care Trust, Telford TF1 5RY, Shrops, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Borough Telford & Wrekin Council, Telford TF3 4LE, Shrops, England	University of Birmingham	Woodall, AA (corresponding author), Telford & Wrekin Primary Care Trust, Telford TF1 5RY, Shrops, England.	alan.woodall@telfordpct.nhs.uk		Woodall, Alan/0000-0003-2933-0508; Aveyard, Paul/0000-0002-1802-4217				*BRIT MED ASS, 2005, BOOZ FAGS FOOD; Department of Health, 2004, CHOOS HLTH MAK HLTH; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; Raine R, 2004, BRIT MED J, V329, P1247, DOI 10.1136/bmj.329.7477.1247; Wiltshire S, 2003, HEALTH EDUC RES, V18, P292, DOI 10.1093/her/cyf031	5	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 3	2005	331	7515					488	489		10.1136/bmj.38576.467292.EB	http://dx.doi.org/10.1136/bmj.38576.467292.EB			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16113033	Green Published, Bronze			2022-12-01	WOS:000231820400016
J	McGarvey, EL; Brenin, DR				McGarvey, EL; Brenin, DR			Myths about cancer might interfere with screening decisions	LANCET			English	Editorial Material							CARCINOMA IN-SITU; BREAST-CANCER; RACIAL-DIFFERENCES; ATTITUDES; WOMEN		Dept Psychiat Med, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Surg, Charlottesville, VA 22908 USA	University of Virginia	McGarvey, EL (corresponding author), Dept Psychiat Med, Charlottesville, VA 22908 USA.	rel8s@virginia.edu		Brenin, David/0000-0003-2589-121X				Bazargan M, 2004, PREV MED, V39, P465, DOI 10.1016/j.ypmed.2004.05.003; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Cady B, 1998, J SURG ONCOL, V69, P60, DOI 10.1002/(SICI)1096-9098(199810)69:2<60::AID-JSO2>3.0.CO;2-3; Denberg TD, 2005, PATIENT EDUC COUNS, V57, P280, DOI 10.1016/j.pec.2004.07.015; Desai MM, 1999, INT J PSYCHIAT MED, V29, P29, DOI 10.2190/0C63-U15V-5NUR-TVXE; Donovan RJ, 2004, MED J AUSTRALIA, V181, P23, DOI 10.5694/j.1326-5377.2004.tb06153.x; Feig SA, 2000, RADIOL CLIN N AM, V38, P653, DOI 10.1016/S0033-8389(05)70192-5; Feig SA, 2005, BREAST J, V11, pS3, DOI 10.1111/j.1075-122X.2005.217161.x; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hsia J, 2000, PREV MED, V31, P261, DOI 10.1006/pmed.2000.0697; McGarvey EL, 2003, ETHNIC HEALTH, V8, P71, DOI 10.1080/13557850303556; *NCI, 2005, GEN BREAST OV CANC; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Paskett ED, 2004, CANCER-AM CANCER SOC, V101, P2650, DOI 10.1002/cncr.20671; Pirraglia PA, 2004, J WOMENS HEALTH, V13, P731, DOI 10.1089/jwh.2004.13.731; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Smart CR, 1997, CA-CANCER J CLIN, V47, P134, DOI 10.3322/canjclin.47.3.134; *US BUR CENS, 1990, FOR BORN RES POP EST; Wu Tsu-Yin, 2005, Health Care Women Int, V26, P225, DOI 10.1080/07399330590917780; Yen MF, 2003, EUR J CANCER, V39, P1746, DOI 10.1016/S0959-8049(03)00260-0	20	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2005	366	9487					700	702		10.1016/S0140-6736(05)67156-5	http://dx.doi.org/10.1016/S0140-6736(05)67156-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	958UV	16125574				2022-12-01	WOS:000231474600010
J	Connolly, SR; Hughes, TP; Bellwood, DR; Karlson, RH				Connolly, SR; Hughes, TP; Bellwood, DR; Karlson, RH			Community structure of corals and reef fishes at multiple scales	SCIENCE			English	Article							SPECIES ABUNDANCE DISTRIBUTIONS; NEUTRAL THEORY; BIODIVERSITY; POPULATION; RESILIENCE; PATTERNS; COMPETITION; ECOSYSTEMS; DIVERSITY	Distributions of numerical abundance and resource use among species are fundamental aspects of community structure. Here we characterize these patterns for tropical reef fishes and corals across a 10,000-kilometer biodiversity gradient. Numerical abundance and resource-use distributions have similar shapes, but they emerge at markedly different scales. These results are consistent with a controversial null hypothesis regarding community structure, according to which abundance distributions arise from the interplay of multiple stochastic environmental and demographic factors. Our findings underscore the importance of robust conservation strategies that are appropriately scaled to the broad suite of environmental processes that help sustain biodiversity.	James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	James Cook University; University of Delaware	Connolly, SR (corresponding author), James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia.		Connolly, Sean R./E-7773-2011; Hughes, Terry P/L-4721-2013	Connolly, Sean R./0000-0003-1537-0859; Hughes, Terry P/0000-0002-5257-5063				Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Engen S, 1996, J THEOR BIOL, V178, P325, DOI 10.1006/jtbi.1996.0028; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Hubbell Stephen P., 2001, V32, pi; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; May R.M., 1975, P81; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Pachepsky E, 2001, NATURE, V410, P923, DOI 10.1038/35073563; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Sole RV, 2002, PHILOS T R SOC B, V357, P667, DOI 10.1098/rstb.2001.0992; Taper ML, 1996, AM NAT, V147, P1072, DOI 10.1086/285893; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tokeshi M., 1999, SPECIES COEXISTENCE; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	28	112	119	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1363	1365		10.1126/science.1113281	http://dx.doi.org/10.1126/science.1113281			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123298				2022-12-01	WOS:000231543300041
J	Lee, MCS; Orci, L; Hamamoto, S; Futai, E; Ravazzola, M; Schekman, R				Lee, MCS; Orci, L; Hamamoto, S; Futai, E; Ravazzola, M; Schekman, R			Sar1p N-terminal helix initiates membrane curvature and completes the fission of a COPII vesicle	CELL			English	Article							ENDOPLASMIC-RETICULUM; COATED VESICLE; CARGO SELECTION; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL-MEMBRANES; TRANSPORT VESICLES; BAR DOMAINS; PROTEIN; ER; GTPASE	Secretory proteins traffic from the ER to the Golgi via COPII-coated transport vesicles. The five core COPII proteins (Sar1p, Sec23/24p, and Sec13/31p) act in concert to capture cargo proteins and sculpt the ER membrane into vesicles of defined geometry. The molecular details of how the coat proteins deform the lipid bilayer into vesicles are not known. Here we show that the small GTPase Sar1p directly initiates membrane curvature during vesicle biogenesis. Upon GTP binding by Sar1p, membrane insertion of the N-terminal amphipathic alpha helix deforms synthetic liposomes into narrow tubules. Replacement of bulky hydrophobic residues in the a helix with alanine yields Sar1p mutants that are unable to generate highly curved membranes and are defective in vesicle formation from native ER membranes despite normal recruitment of coat and cargo proteins. Thus, the initiation of vesicle budding by Sar1p couples the generation of membrane curvature with coat-protein assembly and cargo capture.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94702 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94702 USA; Univ Med Ctr, Dept Cell Physiol & Metab, CH-1121 Geneva, Switzerland	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Geneva	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94702 USA.	schekman@berkeley.edu		Lee, Marcus/0000-0002-4973-0915; Futai, Eugene/0000-0002-0879-6117				Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KUBALEK EW, 1994, J STRUCT BIOL, V113, P117, DOI 10.1006/jsbi.1994.1039; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Malaisse W J, 1979, Methods Achiev Exp Pathol, V9, P112; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	39	357	367	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					605	617		10.1016/j.cell.2005.07.025	http://dx.doi.org/10.1016/j.cell.2005.07.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122427	Bronze			2022-12-01	WOS:000231555100015
J	Pomerening, JR; Kim, SY; Ferrell, JE				Pomerening, JR; Kim, SY; Ferrell, JE			Systems-level dissection of the cell-cycle oscillator: Bypassing positive feedback produces damped oscillations	CELL			English	Article							XENOPUS EGG EXTRACTS; M-PHASE CONTROL; PROTEIN-KINASE; NEGATIVE FEEDBACK; OOCYTE EXTRACTS; ACTIVATION; CDC2; MODEL; PHOSPHORYLATION; MITOSIS	The cell-cycle oscillator includes an essential negative-feedback loop: Cdc2 activates the anaphase-promoting complex (APC), which leads to cyclin destruction and Cdc2 inactivation. Under some circumstances, a negative-feedback loop is sufficient to generate sustained oscillations. However, the Cdc2/APC system also includes positive-feedback loops, whose functional importance we now assess. We show that short-circuiting positive feedback makes the oscillations in Cdc2 activity faster, less temporally abrupt, and damped. This compromises the activation of cyclin destruction and interferes with mitotic exit and DNA replication. This work demonstrates a systems-level role for positive-feedback loops in the embryonic cell cycle and provides an example of how oscillations can emerge out of combinations of subcircuits whose individual behaviors are not oscillatory. This work also underscores the fundamental similarity of cell-cycle oscillations in embryos to repetitive action potentials in pacemaker neurons, with both systems relying on a combination of negative and positive-feedback loops.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Pomerening, JR (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 W Campus Dr,CCSR 3160, Stanford, CA 94305 USA.	pomereni@stanford.edu		Pomerening, Joseph/0000-0003-4120-9081	NIDDK NIH HHS [T90 DK70090] Funding Source: Medline; NIGMS NIH HHS [R01 GM61276] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061276] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; GABRIELLI BG, 1992, J BIOL CHEM, V267, P1969; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P15760, DOI 10.1073/pnas.0407111101; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Marlovits G, 1998, BIOPHYS CHEM, V72, P169, DOI 10.1016/S0301-4622(98)00132-X; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MINSHULL J, 1989, J CELL SCI, P77; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NAVE CR, 2005, RELAXATION OSCILLATO; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NOVAK B, 1993, J CELL SCI, V106, P1153; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Walter SA, 1997, MOL BIOL CELL, V8, P2157, DOI 10.1091/mbc.8.11.2157	52	265	265	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					565	578		10.1016/j.cell.2005.06.016	http://dx.doi.org/10.1016/j.cell.2005.06.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122424	Bronze			2022-12-01	WOS:000231555100012
J	Chen, C; Ouyang, W; Grigura, V; Zhou, Q; Carnes, K; Lim, H; Zhao, GQ; Arber, S; Kurpios, N; Murphy, TL; Cheng, AM; Hassell, JA; Chandrashekar, V; Hofmann, MC; Hess, RA; Murphy, KM				Chen, C; Ouyang, W; Grigura, V; Zhou, Q; Carnes, K; Lim, H; Zhao, GQ; Arber, S; Kurpios, N; Murphy, TL; Cheng, AM; Hassell, JA; Chandrashekar, V; Hofmann, MC; Hess, RA; Murphy, KM			ERM is required for transcriptional control of the spermatogonial stem cell niche	NATURE			English	Article							SERTOLI-CELLS; RECEPTOR CXCR4; SELF-RENEWAL; MICE LACKING; GERM-CELLS; GENE; CHEMOKINE; PEA3; SPERMATOGENESIS; MAINTENANCE	Division of spermatogonial stem cells(1) produces daughter cells that either maintain their stem cell identity or undergo differentiation to form mature sperm. The Sertoli cell, the only somatic cell within seminiferous tubules, provides the stem cell niche through physical support and expression of surface proteins and soluble factors(2,3). Here we show that the Ets related molecule(4) (ERM) is expressed exclusively within Sertoli cells in the testis and is required for spermatogonial stem cell self-renewal. Mice with targeted disruption of ERM have a loss of maintenance of spermatogonial stem cell self-renewal without a block in normal spermatogenic differentiation and thus have progressive germ-cell depletion and a Sertoli-cell-only syndrome. Microarray analysis of primary Sertoli cells from ERM-deficient mice showed alterations in secreted factors known to regulate the haematopoietic stem cell niche. These results identify a new function for the Ets family transcription factors in spermatogenesis and provide an example of transcriptional control of a vertebrate stem cell niche.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Univ Illinois, Dept Vet Biosci, Urbana, IL 61802 USA; Univ Texas, SW Med Sch, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada; So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; Univ Dayton, Dept Biol, Dayton, OH 45469 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Genentech; Washington State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Basel; Friedrich Miescher Institute for Biomedical Research; McMaster University; Southern Illinois University System; Southern Illinois University; University of Dayton	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	murphy@pathbox.wustl.edu	Lim, Hyunjung J/D-5343-2011; Ouyang, Wenjun/ABA-8763-2020	Lim, Hyunjung J/0000-0003-2191-666X; Chen, Chen/0000-0001-9159-4489; Hess, Rex/0000-0003-2649-3563; Ouyang, Wenjun/0000-0002-1811-5864; Arber, Silvia/0000-0002-6261-250X; Hofmann, Marie-Claude/0000-0002-4899-8039	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD054607, R01HD044543] Funding Source: NIH RePORTER; NICHD NIH HHS [K02 HD054607, R01 HD044543, R01 HD044543-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DEFRANCA LR, 1994, ANAT REC, V240, P225; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; KARL AF, 1990, METHOD ENZYMOL, V190, P71; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; MONTE D, 1994, ONCOGENE, V9, P1397; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SETH A, 1992, CELL GROWTH DIFFER, V3, P327; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613	26	247	273	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					1030	1034		10.1038/nature03894	http://dx.doi.org/10.1038/nature03894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107850	Green Accepted			2022-12-01	WOS:000231263900053
J	Fischle, W; Tseng, BS; Dormann, HL; Ueberheide, BM; Garcia, BA; Shabanowitz, J; Hunt, DF; Funabiki, H; Allis, CD				Fischle, W; Tseng, BS; Dormann, HL; Ueberheide, BM; Garcia, BA; Shabanowitz, J; Hunt, DF; Funabiki, H; Allis, CD			Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation	NATURE			English	Article							HP1 CHROMO DOMAIN; AURORA-B; MAMMALIAN-CELLS; HETEROCHROMATIN DOMAINS; FISSION YEAST; LYSINE 9; CENTROMERE; LOCALIZATION; KINETOCHORE; PROTEINS	Tri-methylation of histone H3 lysine 9 is important for recruiting heterochromatin protein 1 (HP1) to discrete regions of the genome, thereby regulating gene expression, chromatin packaging and heterochromatin formation. Here we show that HP1 alpha, -beta, and -gamma are released from chromatin during the M phase of the cell cycle, even though tri-methylation levels of histone H3 lysine 9 remain unchanged. However, the additional, transient modification of histone H3 by phosphorylation of serine 10 next to the more stable methyl-lysine 9 mark is sufficient to eject HP1 proteins from their binding sites. Inhibition or depletion of the mitotic kinase Aurora B, which phosphorylates serine 10 on histone H3, causes retention of HP1 proteins on mitotic chromosomes, suggesting that H3 serine 10 phosphorylation is necessary for the dissociation of HP1 from chromatin in M phase. These findings establish a regulatory mechanism of protein - protein interactions, through a combinatorial readout of two adjacent post-translational modifications: a stable methylation and a dynamic phosphorylation mark.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10021 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA	Rockefeller University; Rockefeller University; University of Virginia; University of Virginia	Fischle, W (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.	fischlw@rockefeller.edu; funabih@rockefeller.edu	Tseng, Boo Shan/M-6279-2018; Hunt, Donald F/I-6936-2012; Jansen, Nils/G-1835-2011	Tseng, Boo Shan/0000-0001-7563-0232; Hunt, Donald F/0000-0003-2815-6368; Ueberheide, Beatrix/0000-0003-2512-0204; Funabiki, Hironori/0000-0003-4831-4087	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; SCHOTTA, 2004, NOVARTIS FDN S, V259, P22; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sugimoto K, 2001, CELL STRUCT FUNCT, V26, P705, DOI 10.1247/csf.26.705; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	47	709	729	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1116	1122		10.1038/nature04219	http://dx.doi.org/10.1038/nature04219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16222246				2022-12-01	WOS:000234111500041
J	Okamoto, I; Arnaud, D; Le Baccon, P; Otte, AP; Disteche, CM; Avner, P; Heard, E				Okamoto, I; Arnaud, D; Le Baccon, P; Otte, AP; Disteche, CM; Avner, P; Heard, E			Evidence for de novo imprinted X-chromosome inactivation independent of meiotic inactivation in mice	NATURE			English	Article							EXPRESSION; MECHANISMS; SMCX	In mammals, one of the two X chromosomes is inactivated in females to enable dosage compensation for X-linked gene products1. In rodents and marsupials, only the X chromosome of paternal origin (Xp) is silenced during early embryogenesis. This could be due to a carry-over effect of the X chromosome's passage through the male germ line, where it becomes transiently silenced together with the Y chromosome, during meiotic sex chromosome inactivation (MSCI)(2). Here we show that Xist (X inactive specific transcript) transgenes, located on autosomes, do not undergo MSCI in the male germ line of mice and yet can induce imprinted cis-inactivation when paternally inherited, with identical kinetics to the Xp chromosome. This suggests that MSCI is not necessary for imprinted X-chromosome inactivation in mice. We also show that the Xp is transcribed, like autosomes, at zygotic gene activation rather than being 'pre-inactivated'(3). We propose that expression of the paternal Xist gene at zygotic gene activation is sufficient to trigger cis-inactivation of the X chromosome, or of an autosome carrying a Xist transgene.	Inst Curie, CNRS, UMR 218, F-75248 Paris, France; Inst Pasteur, F-75015 Paris, France; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; Univ Washington, Dept Pathol, Seattle, WA 98195 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Amsterdam; University of Washington; University of Washington Seattle	Heard, E (corresponding author), Inst Curie, CNRS, UMR 218, 26 Rue Ulm, F-75248 Paris, France.	Edith.Heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117				Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Baart EB, 2000, CHROMOSOMA, V109, P139, DOI 10.1007/s004120050422; Carrel L, 1996, HUM MOL GENET, V5, P1361, DOI 10.1093/hmg/5.9.1361; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; Heard E, 1996, HUM MOL GENET, V5, P441, DOI 10.1093/hmg/5.4.441; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Heard E, 1999, MOL CELL BIOL, V19, P3156; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hoyer-Fender S, 2000, EXP CELL RES, V258, P254, DOI 10.1006/excr.2000.4951; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Lingenfelter PA, 1998, NAT GENET, V18, P212, DOI 10.1038/ng0398-212; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; SHAO CS, 1990, DEVELOPMENT, V110, P969; Simmler MC, 1997, MAMM GENOME, V8, P760, DOI 10.1007/s003359900561; TADA T, 1993, GENET RES, V62, P139, DOI 10.1017/S0016672300031736; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; VANDEBERG JL, 1987, ISOZYM C T, V15, P225	30	153	158	1	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					369	373		10.1038/nature04155	http://dx.doi.org/10.1038/nature04155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16227973				2022-12-01	WOS:000233300200051
J	Rand, TA; Petersen, S; Du, FH; Wang, XD				Rand, TA; Petersen, S; Du, FH; Wang, XD			Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation	CELL			English	Article							INDUCED SILENCING COMPLEX; CAENORHABDITIS-ELEGANS; RNA CLEAVAGE; DROSOPHILA; ENDONUCLEASE; INTERFERENCE; INITIATION; MESSENGER; MICRORNA; ENCODES	The mRNA-cleavage step of RNA interference is mediated by an endonuclease, Argonaute2 (Ago2), within the RNA-induced silencing complex (RISC). Ago2 uses one strand of the small interfering (si) RNA duplex as a guide to find messenger RNAs containing complementary sequences and cleaves the phosphodiester backbone at a specific site measured from the guide strand's 5' end. Here, we show that both strands of siRNA get loaded onto Ago2 protein in Drosophila S2 cell extracts. The anti-guide strand behaves as a RISC substrate and is cleaved by Ago2. This cleavage event is important for the removal of the anti-guide strand from Ago2 protein and activation of RISC.	Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Med Sci Training Program, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu		Wang, Xiaodong/0000-0001-9885-356X				Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vaucheret H, 2001, J CELL SCI, V114, P3083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	29	541	643	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					621	629		10.1016/j.cell.2005.10.020	http://dx.doi.org/10.1016/j.cell.2005.10.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16271385	Bronze			2022-12-01	WOS:000233497400011
J	Chandra, S; Gallardo, G; Fernandez-Chacon, R; Schluter, OM; Sudhof, TC				Chandra, S; Gallardo, G; Fernandez-Chacon, R; Schluter, OM; Sudhof, TC			alpha-synuclein cooperates with CSP alpha in preventing neurodegeneration	CELL			English	Article							CYSTEINE-STRING PROTEIN; PARKINSONS-DISEASE; MEMBRANE-FUSION; NEUROTRANSMITTER EXOCYTOSIS; CALCIUM-CHANNEL; DROSOPHILA; MICE; DEGENERATION; BRAIN; OVEREXPRESSION	alpha-synuclein and cysteine-string protein-a (CSP alpha) are abundant synaptic vesicle proteins independently linked to neurodegeneration. Dominantly inherited mutations in alpha-synuclein cause Parkinson's disease, but the physiological role of alpha-synuclein remains unknown. Deletion of CSP alpha produces rapidly progressive neurodegeneration in mice, presumably because the cochaperone function of CSP alpha is essential for neuronal survival. Here, we report the surprising finding that transgenic expression of a-synuclein abolishes the lethality and neurodegeneration caused by deletion of CSP alpha. Conversely, ablation of endogenous synucleins exacerbates these phenotypes. Deletion of CSP alpha inhibits SNARE complex assembly; transgenic alpha-synuclein ameliorates this inhibition. In preventing neurodegeneration in CSP alpha-deficient mice, alpha-synuclein does not simply substitute for CSP alpha but acts by a downstream mechanism that requires phospholipid binding by alpha-synuclein. These observations reveal a powerful in vivo activity of alpha-synuclein in protecting nerve terminals against injury and suggest that this activity operates in conjunction with CSP alpha and SNARE proteins on the presynaptic membrane interface.	Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Sevilla, Dept Fisiol Med & Biofis, E-41009 Seville, Spain; MPI Expt Med, D-37070 Gottingen, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Sevilla	Sudhof, TC (corresponding author), Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Fernandez-Chacon, Rafael/E-6303-2010; IBIS, FISIOLOGIA/O-9485-2015	Fernandez-Chacon, Rafael/0000-0002-9845-9885	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040057] Funding Source: NIH RePORTER; NINDS NIH HHS [5 R01 NS40057-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Andra K, 1996, NEUROBIOL AGING, V17, P183, DOI 10.1016/0197-4580(95)02066-7; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Graham ME, 2000, J NEUROSCI, V20, P1281; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hardy J, 2003, ANN NY ACAD SCI, V991, P167; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Katz B., 1969, RELEASE NEURAL TRANS; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nie ZP, 1999, J NEUROSCI, V19, P10270; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Ranjan R, 1998, J NEUROSCI, V18, P956; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	55	734	749	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					383	396		10.1016/j.cell.2005.09.028	http://dx.doi.org/10.1016/j.cell.2005.09.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269331	Bronze			2022-12-01	WOS:000233264300008
J	Wadman, M				Wadman, M			Race is on for flu vaccine	NATURE			English	News Item							A/DUCK/SINGAPORE/97 H5N3 VACCINE; MF59-ADJUVANTED INFLUENZA	Drug companies are using adjuvants to boost their vaccines in a bid to be ready for a flu pandemic. The cell-surface proteins of flu viruses change, or drift, over time, so vaccine makers can't develop a vaccine in advance that they know will work if bird flu acquires the ability to pass between humans, triggering a pandemic. What is more, there aren not many companies in the race, afterlow profits drove many to stop producing vaccines at all.										Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948	3	11	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					23	23		10.1038/438023a	http://dx.doi.org/10.1038/438023a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267526				2022-12-01	WOS:000232979000016
J	Tugwell, BD; Patel, PR; Williams, IT; Hedberg, K; Chai, F; Nainan, OV; Thomas, AR; Woll, JE; Bell, BP; Cieslak, PR				Tugwell, BD; Patel, PR; Williams, IT; Hedberg, K; Chai, F; Nainan, OV; Thomas, AR; Woll, JE; Bell, BP; Cieslak, PR			Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TRANSPLANTATION; ALLOGRAFTS; INFECTION; DISEASE; HCV; PREVALENCE	Background: Although hepatitis C virus (HCV) transmission through tissue transplantation has been rarely reported, a donor with undetected viremia may infect several recipients. A patient developed acute hepatitis C shortly after tissue transplantation. Ninety-one tissues or organs had been recovered from the donor. Objective: To determine whether the donor was the source of infection and the extent of transmission to other organ and tissue recipients. Design: Descriptive epidemiologic study; serum testing for HCV infection. Setting: Recipients were located in 16 states and 2 other countries. Participants: Donor and graft recipients. Measurements: Hepatitis C virus infection was defined as the presence of anti-HCV or HCV RNA. The authors determined the genetic relatedness of viral isolates from the donor and recipients by genotype comparison and quasi-species analysis. Results: The donor was anti-HCV-negative but was HCV RNA-positive (genotype 1a). Forty persons received transplants during 22 months. Five persons were HCV-infected before transplantation or had a genotype other than la, and 5 persons had no post-transplantation serum specimens available. Of the remaining 30 recipients, HCV infection occurred in 8 recipients: 3 of 3 organ recipients, 1 of 2 saphenous vein recipients, 1 of 3 tendon recipients, and 3 of 3 tendon with bone recipients. These 8 recipients had viral isolates genetically related to those of the donor. No cases occurred in recipients of skin (n = 2), cornea (n = 1), or irradiated bone (n = 16). Limitations: Post-transplantation serum specimens were unavailable for 5 recipients. Conclusions: An anti-HCV-negative donor was the source of HCV infection for 8 recipients of organs or tissues. Although HCV transmission from anti-HCV-negative donors is probably uncommon, changes in donor screening to include routine testing for HCV RNA merit further consideration to improve the safety of transplantation.	Ctr Dis Control & Prevent, Atlanta, GA USA; Oregon Dept Human Serv, Portland, OR USA; Community Blood Ctr, Community Tissue Serv, Dayton, OH USA; Wright State Univ, Sch Med, Dayton, OH USA	Centers for Disease Control & Prevention - USA; University System of Ohio; Wright State University Dayton	Tugwell, BD (corresponding author), Queen Elizabeth 2 Hlth Sci Ctr, Div Gen Med, 1278 Tower Rd,406 Bethune Bldg, Halifax, NS B3H 2Y9, Canada.	barna.tugwell@cdha.nshealth.ca						AEDER MI, 1993, TRANSPLANT P, V25, P1469; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; [Anonymous], 2004, FED REGISTER, V69, P68611; ASWAD S, 1993, TRANSPL P, V25, P3072; Busch M. P., 2000, Transfusion (Bethesda), V40, P143; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; CONRAD EU, 1995, J BONE JOINT SURG AM, V77A, P214, DOI 10.2106/00004623-199502000-00007; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EGGEN BM, 1992, NEW ENGL J MED, V326, P411; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HUANG CC, 1993, TRANSPLANT P, V25, P1474; Kainer MA, 2004, NEW ENGL J MED, V350, P2564, DOI 10.1056/NEJMoa023222; PELKER RR, 1987, ORTHOP CLIN N AM, V18, P235; PEREIRA BJG, 1994, KIDNEY INT, V46, P886, DOI 10.1038/ki.1994.346; PEREIRA BJG, 1992, NEW ENGL J MED, V327, P910, DOI 10.1056/NEJM199209243271302; PEREIRA BJG, 1991, NEW ENGL J MED, V325, P454, DOI 10.1056/NEJM199108153250702; PEREIRA BJG, 1993, LANCET, V341, P903, DOI 10.1016/0140-6736(93)93118-K; ROTH D, 1992, ANN INTERN MED, V117, P470, DOI 10.7326/0003-4819-117-6-470; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; TESI RJ, 1994, TRANSPLANTATION, V57, P826, DOI 10.1097/00007890-199403270-00010; TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017; *US FOOD DRUG ADM, 2004, GUID IND EL DET DON; Zou SM, 2004, NEW ENGL J MED, V351, P751, DOI 10.1056/NEJMoa032510; 2004, FED REG, V69, P29785; 2001, FED REG, V66, P5447	28	96	100	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2005	143	9					648	654		10.7326/0003-4819-143-9-200511010-00008	http://dx.doi.org/10.7326/0003-4819-143-9-200511010-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980PN	16263887				2022-12-01	WOS:000233030600004
J	Calin, GA; Ferracin, M; Cimmino, A; Di Leva, G; Shimizu, M; Wojcik, SE; Iorio, MV; Visone, R; Sever, NI; Fabbri, M; Iuliano, R; Palumbo, T; Pichiorri, F; Roldo, C; Garzon, R; Sevignani, C; Rassenti, L; Alder, H; Volinia, S; Liu, CG; Kipps, TJ; Negrini, M; Croce, CM				Calin, GA; Ferracin, M; Cimmino, A; Di Leva, G; Shimizu, M; Wojcik, SE; Iorio, MV; Visone, R; Sever, NI; Fabbri, M; Iuliano, R; Palumbo, T; Pichiorri, F; Roldo, C; Garzon, R; Sevignani, C; Rassenti, L; Alder, H; Volinia, S; Liu, CG; Kipps, TJ; Negrini, M; Croce, CM			A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE MUTATION STATUS; ZAP-70 EXPRESSION; CANCER; LYMPHOMA; RNA; IDENTIFICATION; ACCUMULATION; APOPTOSIS; DIAGNOSIS; SURVIVAL	BACKGROUND: MicroRNA expression profiles can be used to distinguish normal B cells from malignant B cells in patients with chronic lymphocytic leukemia (CLL). We investigated whether microRNA profiles are associated with known prognostic factors in CLL. METHODS: We evaluated the microRNA expression profiles of 94 samples of CLL cells for which the level of expression of 70-kD zeta-associated protein (ZAP-70), the mutational status of the rearranged immunoglobulin heavy-chain variable-region (IgV(sub H)) gene, and the time from diagnosis to initial treatment were known. We also investigated the genomic sequence of 42 microRNA genes to identify abnormalities. RESULTS: A unique microRNA expression signature composed of 13 genes (of 190 analyzed) differentiated cases of CLL with low levels of ZAP-70 expression from those with high levels and cases with unmutated IgV(sub H) from those with mutated IgV(sub H). The same microRNA signature was also associated with the presence or absence of disease progression. We also identified a germ-line mutation in the miR-16-1-miR-15a primary precursor, which caused low levels of microRNA expression in vitro and in vivo and was associated with deletion of the normal allele. Germ-line or somatic mutations were found in 5 of 42 sequenced microRNAs in 11 of 75 patients with CLL, but no such mutations were found in 160 subjects without cancer (P<0.001). CONCLUSIONS: A unique microRNA signature is associated with prognostic factors and disease progression in CLL. Mutations in microRNA transcripts are common and may have functional importance.	Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Univ Ferrara, Dept Expt & Diagnost Med, Interdept Ctr Canc Res, I-44100 Ferrara, Italy; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Ferrara; Jefferson University; University of California System; University of California San Diego	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Wiseman Hall,Rm 385K,400 12th Ave, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Jones, Jeffrey A/E-9827-2013; Garzon, Ramiro/E-3104-2011; Volinia, Stefano/AAA-9264-2019; Volinia, Stefano/A-3029-2010; Iorio, Marilena V/K-5446-2016; visone, rosa/K-7910-2016; Sever, Nurettin/ABE-4592-2021; Calin, George/E-9390-2011; Ferrua, Camila/F-5439-2015; Ferracin, Manuela/K-2097-2016; Negrini, Massimo/J-2377-2016; Young, Richard A/F-6495-2012	Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Iorio, Marilena V/0000-0002-6058-1527; Ferrua, Camila/0000-0001-8071-377X; Ferracin, Manuela/0000-0002-1595-6887; Negrini, Massimo/0000-0002-0007-1920; Young, Richard A/0000-0001-8855-8647; Sever, Nurettin Ilter/0000-0002-9320-4146; Calin, George/0000-0001-6704-5615; Cimmino, Amelia/0000-0002-0004-9299; VISONE, Rosa/0000-0002-4993-0220; Di Leva, Gianpiero/0000-0001-6759-8682	NATIONAL CANCER INSTITUTE [P01CA076259, P30CA056036, P01CA081534] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA81534, P30CA56036, P01CA76259] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bullrich F, 2001, CHRONIC LYMPHOCYTIC, P9; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Catovsky D, 2004, HEMATOL ONCOL CLIN N, V18, P783, DOI 10.1016/j.hoc.2004.04.009; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Ishibe N, 2001, LEUKEMIA LYMPHOMA, V42, P99, DOI 10.3109/10428190109097681; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; KIPPS TJ, 2001, WILLIAMS HEMATOLOGY, P1163; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637	33	1864	2093	0	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1793	1801		10.1056/NEJMoa050995	http://dx.doi.org/10.1056/NEJMoa050995			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251535				2022-12-01	WOS:000232813000007
J	Soysal, A; Millington, KA; Bakir, M; Dosanjh, D; Aslan, Y; Deeks, JJ; Efe, S; Staveley, I; Ewer, K; Lalvani, A				Soysal, A; Millington, KA; Bakir, M; Dosanjh, D; Aslan, Y; Deeks, JJ; Efe, S; Staveley, I; Ewer, K; Lalvani, A			Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study	LANCET			English	Article							BACILLUS-CALMETTE-GUERIN; VACCINIA VIRUS ANKARA; SKIN-TEST; BOVIS BCG; T-CELLS; METAANALYSIS; EFFICACY; GAMMA; ENUMERATION; POPULATION	Background Little is known about factors that affect the risk of acquiring infection in children exposed to Mycobacterium tuberculosis. The effect of BCG vaccination has been difficult to ascertain because the tuberculin skin test (TST), until recently the only method for detecting M tuberculosis infection, does not reliably distinguish between tuberculosis infection and BCG vaccination. Methods We investigated risk factors for tuberculosis infection in 979 child household contacts of 414 adult index patients withildren were aged up to 16 years (median 7, IQR 3-11) and 770 of 979 (79%) had a BCG scar. A T-cell-based enzyme-linked immunospot assay (ELISpot), sputum smear-positive pulmonary tuberculosis in Istanbul, Turkey. Chwhich is not confounded by BCG vaccination, and TST were used to assess infection. Independent risk factors for infection were identified through multivariate analysis. Findings Amount of tuberculosis exposure within the household and age (a marker of tuberculosis exposure outside the household) were strongly associated with likelihood of infection as measured by both TST and ELISpot. ELISpot also identified absence of BCG scar as an independent risk factor for infection in tuberculosis-exposed children; BCG-vaccinated children had an odds ratio of 0.60 (95% Cl 0.43-0.83, p=0.003) for tuberculosis infection, compared with unvaccinated children. Interpretation Contrary to the prevailing theory that BCG vaccination protects only against tuberculosis disease, our results suggest that the vaccine also protects against tuberculosis infection. This finding has important implications for our understanding of the biology of tuberculosis infection and development of improved tuberculosis vaccines.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, TB Immunol Grp, Oxford OX3 9DU, England; Marmara Univ, Sch Med, Dept Paediat, Istanbul, Turkey; Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford, England	University of Oxford; Marmara University; University of Oxford	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, TB Immunol Grp, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Deeks, Jon/AAV-5745-2020; Aslan, Yasemin/AAP-7713-2020; Ewer, Katie J/B-4328-2011; ASLAN, YASEMİN/AAP-7409-2020; Dosanjh, Davinder/ABD-8895-2021	Deeks, Jon/0000-0002-8850-1971; Aslan, Yasemin/0000-0001-6292-2332; Ewer, Katie J/0000-0001-9827-9836; Dosanjh, Davinder/0000-0002-9169-5607; Lalvani, Ajit/0000-0002-2396-246X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; Aydinlioglu H, 1993, Paediatr Perinat Epidemiol, V7, P334, DOI 10.1111/j.1365-3016.1993.tb00408.x; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Briassoulis George, 2005, J Immune Based Ther Vaccines, V3, P1, DOI 10.1186/1476-8518-3-1; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Deeks J J, 2003, Health Technol Assess, V7, piii; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; FINE PEM, 1989, B WORLD HEALTH ORGAN, V67, P35; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; GEDDEDAHL T, 1952, AM J HYG, V56, P139, DOI 10.1093/oxfordjournals.aje.a119547; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI 10.1164/rccm.200404-512oc; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; MADICO G, 1995, LANCET, V345, P416, DOI 10.1016/S0140-6736(95)90401-8; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; NARAIN R, 1966, B WORLD HEALTH ORGAN, V34, P639; Neuenschwander BE, 2002, AM J EPIDEMIOL, V155, P654, DOI 10.1093/aje/155.7.654; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rom WN, 1996, TUBERCULOSIS, Vxxv; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; SEDAGHATIAN MR, 1990, TUBERCLE, V71, P177, DOI 10.1016/0041-3879(90)90072-G; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; TENDAM HG, 1980, B WORLD HEALTH ORGAN, V58, P37; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; *WHO, 2005, GLOB TB DAT; World Health Organization Website, 2005, IMM PROF TURK; YOUNG TK, 1992, TUBERCLE LUNG DIS, V73, P94, DOI 10.1016/0962-8479(92)90062-O; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	222	232	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2005	366	9495					1443	1451		10.1016/S0140-6736(05)67534-4	http://dx.doi.org/10.1016/S0140-6736(05)67534-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976HQ	16243089				2022-12-01	WOS:000232724600023
J	Asner, GP; Knapp, DE; Broadbent, EN; Oliveira, PJC; Keller, M; Silva, JN				Asner, GP; Knapp, DE; Broadbent, EN; Oliveira, PJC; Keller, M; Silva, JN			Selective logging in the Brazilian Amazon	SCIENCE			English	Article							LOGGED FORESTS; CANOPY DAMAGE; DEGRADATION; RECOVERY; DYNAMICS; FRONTIER; IMPACT; FIELD	Amazon deforestation has been measured by remote sensing for three decades. in comparison, selective logging has been mostly invisible to satellites. We developed a large-scale, high-resolution, automated remote-sensing analysis of selective logging in the top five timber-producing states of the Brazilian Amazon. Logged areas ranged from 12,075 to 19,823 square kilometers per year (+/- 14%) between 1999 and 2002, equivalent to 60 to 123% of previously reported deforestation area. Up to 1200 square kilometers per year of logging were observed on conservation lands. Each year, 27 million to 50 million cubic meters of wood were extracted, and a gross flux of similar to 0.1 billion metric tons of carbon was destined for release to the atmosphere by logging.	Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; US Forest Serv, USDA, Int Inst Trop Forestry, Rio Piedras, PR USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Empresa Brasileira Pesquisa Agropecuaria Amazonia, BR-66095100 Belem, Para, Brazil	Carnegie Institution for Science; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	gasner@giobalecology.stanford.edu	Asner, Gregory/G-9268-2013; Keller, Michael/A-8976-2012; Broadbent, Eben/H-2965-2013	Asner, Gregory/0000-0001-7893-6421; Keller, Michael/0000-0002-0253-3359; Oliveira, Paulo/0000-0002-4071-3924; Broadbent, Eben/0000-0002-4488-4237; Silva, Jose/0000-0003-4068-2432				Asner GP, 2004, ECOL APPL, V14, pS280; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2002, REMOTE SENS ENVIRON, V80, P483, DOI 10.1016/S0034-4257(01)00326-1; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; de Wasseige C, 2004, FOREST ECOL MANAG, V188, P161, DOI 10.1016/j.foreco.2003.07.035; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Fimbel R.A., 2001, CUTTING EDGE CONSERV; Gerwing JJ, 2002, FOREST ECOL MANAG, V157, P131, DOI 10.1016/S0378-1127(00)00644-7; *I SOC, 1999, MAP FOR TYP LAND US; *INPE, 2005, PRODES ASS DEF BRAZ; Keller M, 2004, BIOL RESOURCE MANAGE, P41; Keller M, 2004, GLOBAL CHANGE BIOL, V10, P784, DOI 10.1111/j.1529-8817.2003.00770.x; Keller M, 2001, FOREST ECOL MANAG, V154, P371, DOI 10.1016/S0378-1127(01)00509-6; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Pereira R, 2002, FOREST ECOL MANAG, V168, P77, DOI 10.1016/S0378-1127(01)00732-0; Read JM, 2003, PHOTOGRAMM ENG REM S, V69, P275, DOI 10.14358/PERS.69.3.275; SILVA JNM, 1995, FOREST ECOL MANAG, V71, P267, DOI 10.1016/0378-1127(94)06106-S; Souza C, 2003, REMOTE SENS ENVIRON, V87, P494, DOI 10.1016/j.rse.2002.08.002; Souza C, 2000, INT J REMOTE SENS, V21, P173, DOI 10.1080/014311600211064; Stone TA, 1998, INT J REMOTE SENS, V19, P2517, DOI 10.1080/014311698214604; UHL C, 1991, FOREST ECOL MANAG, V46, P243, DOI 10.1016/0378-1127(91)90235-N; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; VERISSIMO A, 1992, FOREST ECOL MANAG, V55, P169, DOI 10.1016/0378-1127(92)90099-U; [No title captured]	25	664	685	1	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					480	482		10.1126/science.1118051	http://dx.doi.org/10.1126/science.1118051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239474				2022-12-01	WOS:000232786000043
J	Costantini, DL; Arruda, EP; Agarwal, P; Kim, KH; Zhu, YH; Zhu, W; Lebel, M; Cheng, CW; Park, CY; Pierce, SA; Guerchicoff, A; Pollevick, GD; Chan, TY; Kabir, MG; Cheng, SH; Husain, M; Antzelevitch, C; Srivastava, D; Gross, GJ; Hui, CC; Backx, PH; Bruneau, BG				Costantini, DL; Arruda, EP; Agarwal, P; Kim, KH; Zhu, YH; Zhu, W; Lebel, M; Cheng, CW; Park, CY; Pierce, SA; Guerchicoff, A; Pollevick, GD; Chan, TY; Kabir, MG; Cheng, SH; Husain, M; Antzelevitch, C; Srivastava, D; Gross, GJ; Hui, CC; Backx, PH; Bruneau, BG			The homeodomain transcription factor lrx5 establishes the mouse cardiac ventricular repolarization gradient	CELL			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; TRANSIENT OUTWARD CURRENT; IROQUOIS HOMEOBOX GENES; KV4 ALPHA-SUBUNIT; SHORT-QT SYNDROME; K+ CURRENTS; I-TO; DEVELOPING HEART; SUDDEN-DEATH; HETEROGENEOUS EXPRESSION	Rhythmic cardiac contractions depend on the organized propagation of depolarizing and repolarizing wavefronts. Repolarization is spatially heterogeneous and depends largely on gradients of potassium currents. Gradient disruption in heart disease may underlie susceptibility to fatal arrhythmias, but it is not known how this gradient is established. We show that, in mice lacking the homeodomain transcription factor Irx5, the cardiac repolarization gradient is abolished due to increased K(v)4.2 potassium-channel expression in endocardial myocardium, resulting in a selective increase of the major cardiac repolarization current, I-to,I-f, and increased susceptibility to arrhythmias. Myocardial Irx5 is expressed in a gradient opposite that of K(v)4.2, and Irx5 represses K(v)4.2 expression by recruiting mBop, a cardiac transcriptional repressor. Thus, an Irx5 repressor gradient negatively regulates potassium-channel-gene expression in the heart, forming an inverse I-to,I-f gradient that ensures coordinated cardiac repolarization while also preventing arrhythmias.	Hosp Sick Children, Program Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Cardiovasc, Toronto, ON M5G 1X8, Canada; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5G 1A8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1A8, Canada; Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1A8, Canada; City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; Univ Texas, SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75230 USA; Univ Texas, SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75230 USA; Masonic Med Res Lab, Utica, NY 13501 USA; Toronto Gen Hosp, Inst Res, Div Cellular & Mol Biol, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Div Cardiol, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; City University of Hong Kong; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Masonic Medical Research Laboratory; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Backx, PH (corresponding author), Hosp Sick Children, Program Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	p.backx@utoronto.ca; bbruneau@sickkids.ca	Kim, Kyoung-Han/AAZ-4908-2021; Cheng, Shuk Han/F-9943-2012	Bruneau, Benoit/0000-0002-0804-7597; Kim, Kyoung-Han/0000-0002-0433-656X; Cheng, Shuk Han/0000-0002-5822-7238; Husain, Mansoor/0000-0002-3740-6739; Antzelevitch, Charles/0000-0001-7349-1582	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047678] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL047678] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antzelevitch C, 2004, ANN MED, V36, P5, DOI 10.1080/17431380410032553; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; CHENG CW, 2005, IN PRESS DEV BIOL; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Danik S, 2002, AM J PHYSIOL-HEART C, V283, pH372, DOI 10.1152/ajpheart.01091.2001; Deschenes I, 2002, CIRCULATION, V106, P423, DOI 10.1161/01.CIR.0000025417.65658.B6; Extramiana F, 2004, CIRCULATION, V110, P3661, DOI 10.1161/01.CIR.0000143078.48699.0C; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Habets PEMH, 2003, CARDIOVASC RES, V58, P246, DOI 10.1016/S0008-6363(02)00784-8; Itoh M, 2002, DEVELOPMENT, V129, P2317; Jia Y, 2003, CARDIOVASC RES, V60, P278, DOI 10.1016/S0008-6363(03)00528-5; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kaprielian R, 2002, AM J PHYSIOL-HEART C, V283, pH1157, DOI 10.1152/ajpheart.00518.2001; Kudoh T, 2001, P NATL ACAD SCI USA, V98, P7852, DOI 10.1073/pnas.141224098; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lebel M, 2003, MOL CELL BIOL, V23, P8216, DOI 10.1128/MCB.23.22.8216-8225.2003; Liu G, 2004, J PHYSIOL-LONDON, V555, P267, DOI 10.1113/jphysiol.2003.054064; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Mummenhoff J, 2001, MECH DEVELOP, V103, P193, DOI 10.1016/S0925-4773(01)00353-7; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; Nerbonne JM, 2002, J CARDIOVASC ELECTR, V13, P406, DOI 10.1046/j.1540-8167.2002.00406.x; Oudit GY, 2001, J MOL CELL CARDIOL, V33, P851, DOI 10.1006/jmcc.2001.1376; Roberts R, 2003, ANNU REV MED, V54, P257, DOI 10.1146/annurev.med.54.073002.182112; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Sah R, 2002, CIRC RES, V90, P165, DOI 10.1161/hh0202.103315; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sun H, 2004, CARDIOVASC RES, V62, P509, DOI 10.1016/j.cardiores.2004.01.029; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Wickenden AD, 1999, CIRC RES, V85, P1067; Wickenden AD, 1999, AM J PHYSIOL-HEART C, V276, pH1599, DOI 10.1152/ajpheart.1999.276.5.H1599; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928; Zhu Wei, 2003, J Cardiovasc Electrophysiol, V14, P982, DOI 10.1046/j.1540-8167.2003.02002.x	49	179	183	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					347	358		10.1016/j.cell.2005.08.004	http://dx.doi.org/10.1016/j.cell.2005.08.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239150	Bronze, Green Accepted			2022-12-01	WOS:000232794100019
J	Gardai, SJ; McPhillips, KA; Frasch, SC; Janssen, WJ; Starefeldt, A; Murphy-Ullrich, JE; Bratton, DL; Oldenborg, PA; Michalak, M; Henson, PM				Gardai, SJ; McPhillips, KA; Frasch, SC; Janssen, WJ; Starefeldt, A; Murphy-Ullrich, JE; Bratton, DL; Oldenborg, PA; Michalak, M; Henson, PM			Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte	CELL			English	Article							RECEPTOR-RELATED PROTEIN; CLASS-I MOLECULES; MACROPHAGE RECOGNITION; IMMUNE-RESPONSES; DEFICIENT MICE; SIRP-ALPHA; BINDING; PHOSPHATIDYLSERINE; CD47; EXPRESSION	Apoptotic-cell removal is critical for development, tissue homeostasis, and resolution of inflammation. Although many candidate systems exist, only phosphatidylserine has been identified as a general recognition ligand on apoptotic cells. We demonstrate here that calreticulin acts as a second general recognition ligand by binding and activating LDL-receptor-related protein (LRP) on the engulfing cell. Since surface calreticulin is also found on viable cells, a mechanism preventing inadvertent uptake was sought. Disruption of interactions between CD47 (integrin-associated protein) on the target cell and SIRP alpha (SHPS-1), a heavily glycosylated transmembrane protein on the engulfing cell, permitted uptake of viable cells in a calreticulin/LRP-dependent manner. On apoptotic cells, CD47 was altered and/or lost and no longer activated SIRP alpha. These changes on the apoptotic cell create an environment where "don't eat me" signals are rendered inactive and "eat me" signals, including calreticulin and phosphatidylserine, congregate together and signal for removal.	Natl Jewish Med & Res Ctr, Cell Biol Program, Dept Pediat, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care, Denver, CO 80262 USA; Univ Alberta, Dept Biochem, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; Umea Univ, Sect Histol & Cell Biol, Dept Integrat Med Biol, SE-90187 Umea, Sweden; Univ Alabama, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; Univ Alabama, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta; Umea University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Henson, PM (corresponding author), Natl Jewish Med & Res Ctr, Cell Biol Program, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	hensonp@njc.org			NHLBI NIH HHS [HL079644, HL34303, R01 HL079644, HL068864] Funding Source: Medline; NIGMS NIH HHS [GM57573-006, GM48211, GM61031] Funding Source: Medline; PHS HHS [A1058228] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079644, R01HL068864, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031, R01GM048211, R01GM057573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bu GJ, 2001, INT REV CYTOL, V209, P79; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Cant CA, 2001, CELL MOL LIFE SCI, V58, P117, DOI 10.1007/PL00000771; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dini L, 2000, EUR J HISTOCHEM, V44, P217; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1993, J IMMUNOL, V151, P4274; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Heal R, 1998, BIOCHEM J, V329, P389, DOI 10.1042/bj3290389; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Jethmalani SM, 1997, J CELL BIOCHEM, V66, P98; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Moffatt OD, 1999, J IMMUNOL, V162, P6800; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Tada K, 2003, J IMMUNOL, V171, P5718, DOI 10.4049/jimmunol.171.11.5718; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; WHITE TK, 1995, J BIOL CHEM, V270, P15926, DOI 10.1074/jbc.270.27.15926	43	968	1051	7	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					321	334		10.1016/j.cell.2005.08.032	http://dx.doi.org/10.1016/j.cell.2005.08.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239148	Bronze			2022-12-01	WOS:000232794100017
J	Courcoulas, AP; Flum, DR				Courcoulas, AP; Flum, DR			Filling the gaps in bariatric surgical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							Y GASTRIC BYPASS; MORBID-OBESITY; SURGERY; TRIAL		Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Flum, DR (corresponding author), Univ Washington, Dept Surg, 1959 NE Pacific St,Box 356410,BB431, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022					ANDERSEN B, 1979, LANCET, V2, P1255; BEELE S, 2005, AM SOC BARIATRIC SUR, V1, P145; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; FIERRO M, COST CONTAINMENT STA; GRADY D, 2000, NY TIMES        1017; Kral JG, 2005, SURGERY, V137, P279, DOI 10.1016/j.surg.2004.11.004; Meguid MM, 2004, J GASTROINTEST SURG, V8, P621, DOI 10.1016/j.gassur.2004.02.003; O'Brien P, 2004, OBES RES, V12, pA33; O'Brien PE, 2004, ANZ J SURG, V74, P200, DOI 10.1111/j.1445-2197.2004.03014.x; Schauer P, 2003, SURG ENDOSC, V17, P212, DOI 10.1007/s00464-002-8857-z; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SUGERMAN HJ, 1989, AM J SURG, V157, P93, DOI 10.1016/0002-9610(89)90427-3; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918; 1992, AM J NUCL NUTR S, V55, pS487	14	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2005	294	15					1957	1960		10.1001/jama.294.15.1957	http://dx.doi.org/10.1001/jama.294.15.1957			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974OZ	16234502				2022-12-01	WOS:000232602600025
J	Bonfil, R; Meyer, M; Scholl, MC; Johnson, R; O'Brien, S; Oosthuizen, H; Swanson, S; Kotze, D; Paterson, M				Bonfil, R; Meyer, M; Scholl, MC; Johnson, R; O'Brien, S; Oosthuizen, H; Swanson, S; Kotze, D; Paterson, M			Transoceanic migration, spatial dynamics, and population linkages of white sharks	SCIENCE			English	Article							CARCHARODON-CARCHARIAS LINNAEUS; COMMERCIAL PRAWN TRAWLERS; BASKING SHARK; BLUEFIN TUNA; SOUTH-AFRICA; SATELLITE; MOVEMENTS; TRACKING; BIOLOGY; SEA	The large-scale spatial dynamics and population structure of marine top predators are poorly known. We present electronic tag and photographic identification data showing a complex suite of behavioral patterns in white sharks. These include coastal return migrations and the fastest known transoceanic return migration among swimming fauna, which provide direct evidence of a link between widely separated populations in South Africa and Australia. Transoceanic return migration involved a return to the original capture location, dives to depths of 980 meters, and the tolerance of water temperatures as low as 3.4 degrees C. These findings contradict previous ideas that female white sharks do not make transoceanic. migrations, and they suggest natal homing behavior.	Wildlife Conservat Soc, Bronx, NY 10460 USA; Dept Environm Affairs & Tourism, Marine & Coastal Management Branch, ZA-8012 Cape Town, Western Cape, South Africa; White Shark Trust, ZA-7220 Gansbaai, Western Cape, South Africa; Univ Cape Town, ZA-7700 Rondebosch, Western Cape, South Africa; Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	Wildlife Conservation Society; University of Cape Town; University of Pretoria	Bonfil, R (corresponding author), Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA.	rbonfil@wcs.or	Scholl, Michael Christoph/ABF-5665-2021; Bonfil, Ramón/K-1226-2012	Bonfil, Ramon/0000-0002-5753-464X				[Anonymous], 1996, GREAT WHITE SHARKS B; BAKER RR, 1982, MIGRATION PATHS TIME; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; CAREY FG, 1982, COPEIA, P254; Clarke SC, 2003, THESIS U LONDON; Cliff G, 2000, S AFR J SCI, V96, P365; Compagno L. J. V., 2001, SHARKS WORLD ANNOTAT, V2; Compagno LJV, 1997, ENVIRON BIOL FISH, V50, P61, DOI 10.1023/A:1007308406137; COMPAGNO LJV, 1989, GUIDE SHARKS RAYS SO; CURY P, 1994, CAN J FISH AQUAT SCI, V51, P1664, DOI 10.1139/f94-167; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Feldheim KA, 2002, P ROY SOC B-BIOL SCI, V269, P1655, DOI 10.1098/rspb.2002.2051; FENNESSY ST, 1994, S AFR J MARINE SCI, V14, P287; FENNESSY ST, 1994, S AFR J MARINE SCI, V14, P263; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; HILTONTAYLOR C, 2000, 2002 IUCN RED LIST T; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Inagake Denzo, 2001, Bulletin of the National Research Institute of Far Seas Fisheries, V38, P53; Itoh T, 2003, FISH B-NOAA, V101, P514; JOHNSON RL, 2003, THESIS U PRETORIA S; JOHNSON RL, 2004, M CONS RES GREAT WHI; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; PRIEDE IG, 1984, FISH RES, V2, P201, DOI 10.1016/0165-7836(84)90003-1; QUINN TP, 1994, TRENDS ECOL EVOL, V9, P277, DOI 10.1016/0169-5347(94)90027-2; Soldo A, 2002, PERIOD BIOL, V104, P195	28	319	336	7	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2005	310	5745					100	103		10.1126/science.1114898	http://dx.doi.org/10.1126/science.1114898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210537				2022-12-01	WOS:000232477000046
J	Koprivica, V; Cho, KS; Park, JB; Yiu, G; Atwal, J; Gore, B; Kim, JA; Lin, E; Tessier-Lavigne, M; Chen, DF; He, ZG				Koprivica, V; Cho, KS; Park, JB; Yiu, G; Atwal, J; Gore, B; Kim, JA; Lin, E; Tessier-Lavigne, M; Chen, DF; He, ZG			EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; RETINAL GANGLION-CELLS; RECEPTOR FAMILY-MEMBER; NOGO RECEPTOR; NEURITE OUTGROWTH; SIGNALING PATHWAY; CALCIUM; GLYCOPROTEIN; INACTIVATION; CORECEPTOR	Inhibitory molecules associated with myelin and the glial. scar limit axon regeneration in the adult central nervous system (CNS), but the underlying signaling mechanisms of regeneration inhibition are not fully understood. Here, we show that suppressing the kinase function of the epidermal growth factor receptor (EGFR) blocks the activities of both myelin inhibitors and chondroitin sulfate proteoglycans in inhibiting neurite outgrowth. In addition, regeneration inhibitors trigger the phosphorylation of EGFR in a calcium-dependent manner. Local administration of EGFR inhibitors promotes significant regeneration of injured optic nerve fibers, pointing to a promising therapeutic avenue for enhancing axon regeneration after CNS injury.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; Genentech Inc, Div Res, San Francisco, CA 94080 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Roche Holding; Genentech	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Yiu, Glenn/AAF-2858-2020	Yiu, Glenn/0000-0003-3061-3310; Cho, Kin-Sang/0000-0003-4285-615X				Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; KOPRIVICA V, UNPUB; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	30	282	304	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					106	110		10.1126/science.1115462	http://dx.doi.org/10.1126/science.1115462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210539				2022-12-01	WOS:000232477000048
J	Partida-Martinez, LP; Hertweck, C				Partida-Martinez, LP; Hertweck, C			Pathogenic fungus harbours endosymbiotic bacteria for toxin production	NATURE			English	Article							MACROCYCLIC LACTONE ANTIBIOTICS; POLYKETIDE SYNTHASES; RHIZOPUS-CHINENSIS; GENE-CLUSTER; RHIZOXIN; BIOSYNTHESIS; SYMBIONT; BURKHOLDERIA; METABOLITE; AGENTS	A number of plant pathogenic fungi belonging to the genus Rhizopus are infamous for causing rice seedling blight. This plant disease is typically initiated by an abnormal swelling of the seedling roots without any sign of infection by the pathogen(1-4). This characteristic symptom is in fact caused by the macrocyclic polyketide metabolite rhizoxin that has been isolated from cultures of Rhizopus sp.(5,6). The phytotoxin exerts its destructive effect by binding to rice beta-tubulin, which results in inhibition of mitosis and cell cycle arrest(7,8). Owing to its remarkably strong antimitotic activity in most eukaryotic cells, including various human cancer cell lines, rhizoxin has attracted considerable interest as a potential antitumour drug(9,10). Here we show that rhizoxin is not biosynthesized by the fungus itself, but by endosymbiotic, that is, intracellular living, bacteria of the genus Burkholderia. Our unexpected findings unveil a remarkably complex symbiotic-pathogenic relationship that extends the fungus - plant interaction to a third, bacterial, key-player, and opens new perspectives for pest control.	HKI, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany	Hans Knoll Institute (HKI)	Hertweck, C (corresponding author), HKI, Leibniz Inst Nat Prod Res & Infect Biol, Beutenbergstr 11a, D-07745 Jena, Germany.	Christian.Hertweck@hki-jena.de	Partida, Laila Pamela/A-5935-2009; Hertweck, Christian/G-1896-2014; Hertweck, Christian/AAZ-8452-2021	Partida, Laila Pamela/0000-0001-8037-2856; Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X				Bianciotto V, 1996, APPL ENVIRON MICROB, V62, P3005, DOI 10.1128/AEM.62.8.3005-3010.1996; Bonfante P, 2003, BIOL BULL-US, V204, P215, DOI 10.2307/1543562; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; FURUYA S, 1974, P ASS PL PROT SHIKOK, V9, P49; Gho N., 1978, P ASS PLANT PROTECT, V26, P90; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; Hildebrand M, 2004, NAT PROD REP, V21, P122, DOI 10.1039/b302336m; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; IBARAKI T, 1973, Annals of the Phytopathological Society of Japan, V39, P141; IWASAKI S, 1986, J ANTIBIOT, V39, P424, DOI 10.7164/antibiotics.39.424; IWASAKI S, 1984, J ANTIBIOT, V37, P354, DOI 10.7164/antibiotics.37.354; Jennessen J, 2005, J AGR FOOD CHEM, V53, P1833, DOI 10.1021/jf048147n; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.0.CO;2-U; Kenny DJ, 1999, ANTIMICROB AGENTS CH, V43, P2773, DOI 10.1128/AAC.43.11.2773; KOBAYASHI H, 1986, J CHEM SOC CHEM COMM, P1702, DOI 10.1039/c39860001702; Kobayashi M, 2001, MYCOSES, V44, P311, DOI 10.1111/j.1439-0507.2001.00642.x; Koga-Ban Y, 1995, DNA Res, V2, P21, DOI 10.1093/dnares/2.1.21; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; NODA T, 1980, Annals of the Phytopathological Society of Japan, V46, P40, DOI 10.3186/jjphytopath.46.40; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Roberge M, 2000, CANCER RES, V60, P5052; TAKAHASHI M, 1987, J ANTIBIOT, V40, P66, DOI 10.7164/antibiotics.40.66; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSURUO T, 1986, CANCER RES, V46, P381	28	425	442	5	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					884	888		10.1038/nature03997	http://dx.doi.org/10.1038/nature03997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208371				2022-12-01	WOS:000232338600046
J	Kappers, IF; Aharoni, A; van Herpen, TWJM; Luckerhoff, LLP; Dicke, M; Bouwmeester, HJ				Kappers, IF; Aharoni, A; van Herpen, TWJM; Luckerhoff, LLP; Dicke, M; Bouwmeester, HJ			Genetic engineering of terpenoid metabolism attracts, bodyguards to Arabidopsis	SCIENCE			English	Article							PLANT VOLATILES; JASMONIC ACID; SYNTHASE; BIOSYNTHESIS; EXPRESSION; THALIANA; MITE; IDENTIFICATION; HOMOTERPENES; INVOLVEMENT	Herbivore-damaged plants release complex mixtures of volatites that attract natural enemies of the herbivore. To study the relevance of individual components of these mixtures for predator attraction, we manipulated herbivory-induced volatiles through genetic engineering. Metabolic engineering of terpenoids, which dominate the composition of many induced plant volatile bouquets, holds particular promise. By switching the subcellular localization of the introduced sesquiterpene synthase to the mitochondria, we obtained transgenic Arabidopsis thaliana plants emitting two new isoprenoids. These altered plants attracted carnivorous predatory mites (Phytoseiulus persimilis) that aid the plants' defense mechanisms.	Univ Wageningen & Res Ctr, Plant Res Int, NL-6700 AA Wageningen, Netherlands; Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; Weizmann Inst Sci, IL-76100 Rehovot, Israel	Wageningen University & Research; Wageningen University & Research; Weizmann Institute of Science	Bouwmeester, HJ (corresponding author), Univ Wageningen & Res Ctr, Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.	harro.bouwmeester@wur.nl	aharoni, asaph/W-6670-2019; Kappers, Iris/GWY-2792-2022; Bouwmeester, Harro/C-1414-2008; Dicke, Marcel/B-2300-2010	Dicke, Marcel/0000-0001-8565-8896; kappers, iris/0000-0003-3349-3473; Bouwmeester, Harro/0000-0003-0907-2732				Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; BOLAND W, 1995, ANGEW CHEM INT EDIT, V34, P1600, DOI 10.1002/anie.199516001; BOLAND W, 1992, NATURWISSENSCHAFTEN, V79, P368, DOI 10.1007/BF01140183; Bouwmeester HJ, 1999, PLANT PHYSIOL, V121, P173, DOI 10.1104/pp.121.1.173; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M., 1989, CAUSES CONSEQUENCES, P341; DONATH J, 1994, J PLANT PHYSIOL, V143, P473, DOI 10.1016/S0176-1617(11)81809-2; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; FRITZSCHEHOBALL.ME, 2001, EVOL ECOL RES, V3, P553; HOHN TM, 1991, PLANT PHYSIOL, V97, P460, DOI 10.1104/pp.97.1.460; Karban R., 2007, INDUCED RESPONSES HE; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kohler RH, 1997, PLANT J, V11, P613, DOI 10.1046/j.1365-313X.1997.11030613.x; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Loon JJA, 2000, ENTOMOL EXP APPL, V97, P219, DOI 10.1046/j.1570-7458.2000.00733.x; Van Poecke RMP, 2001, J CHEM ECOL, V27, P1911, DOI 10.1023/A:1012213116515; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; VANPOECKE RMP, UNPUB; Wallaart TE, 2001, PLANTA, V212, P460, DOI 10.1007/s004250000428	30	353	400	7	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2070	2072		10.1126/science.1116232	http://dx.doi.org/10.1126/science.1116232			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179482				2022-12-01	WOS:000232181900055
J	Mashburn, LM; Whiteley, M				Mashburn, LM; Whiteley, M			Membrane vesicles traffic signals and facilitate group activities in a prokaryote	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; IDENTIFICATION; GENES; GENTAMICIN; MECHANISM; BACTERIA; GROWTH	Many bacteria use extracellular signals to communicate and coordinate social activities, a process referred to as quorum sensing(1). Many quorum signals have significant hydrophobic character, and how these signals are trafficked between bacteria within a population is not understood. Here we show that the opportunistic human pathogen Pseudomonas aeruginosa packages the signalling molecule 2-heptyl-3-hydroxy-4-quinolone ( pseudomonas quinolone signal; PQS)(2) into membrane vesicles that serve to traffic this molecule within a population. Removal of these vesicles from the bacterial population halts cell - cell communication and inhibits PQS-controlled group behaviour. We also show that PQS actively mediates its own packaging and the packaging of other antimicrobial quinolines produced by P. aeruginosa into vesicles. These findings illustrate that a prokaryote possesses a signal trafficking system with features common to those used by higher organisms and outlines a novel mechanism for delivery of a signal critical for coordinating group behaviour in P. aeruginosa.	Univ Oklahoma, Hlth Sci Ctr, Dept Periodont, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Whiteley, M (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Periodont, Oklahoma City, OK 73104 USA.	marvin-whiteley@ouhsc.edu						Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Ciofu O, 2000, J ANTIMICROB CHEMOTH, V45, P9, DOI 10.1093/jac/45.1.9; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Kadurugamuwa JL, 1998, J BACTERIOL, V180, P2306, DOI 10.1128/JB.180.9.2306-2311.1998; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Nguyen TT, 2003, J ELECTRON MICROSC, V52, P465, DOI 10.1093/jmicro/52.5.465; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wang YJ, 2005, APPL ENVIRON MICROB, V71, P1291, DOI 10.1128/AEM.71.3.1291-1299.2005; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627	26	526	549	7	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					422	425		10.1038/nature03925	http://dx.doi.org/10.1038/nature03925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163359				2022-12-01	WOS:000231849100056
J	Tzima, E; Irani-Tehrani, M; Kiosses, WB; Dejana, E; Schultz, DA; Engelhardt, B; Cao, GY; DeLisser, H; Schwartz, MA				Tzima, E; Irani-Tehrani, M; Kiosses, WB; Dejana, E; Schultz, DA; Engelhardt, B; Cao, GY; DeLisser, H; Schwartz, MA			A mechanosensory complex that mediates the endothelial cell response to fluid shear stress	NATURE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; AFFINITY MODULATION; ACTIVATION; ATHEROSCLEROSIS; TRANSDUCTION; CADHERIN; MECHANOTRANSDUCTION; PROLIFERATION; PERMEABILITY	Shear stress is a fundamental determinant of vascular homeostasis, regulating vascular remodelling, cardiac development and atherogenesis(1), but the mechanisms of transduction are poorly understood. Previous work showed that the conversion of integrins to a high-affinity state mediates a subset of shear responses, including cell alignment and gene expression(2-4). Here we investigate the pathway upstream of integrin activation. PECAM-1 ( which directly transmits mechanical force), vascular endothelial cell cadherin ( which functions as an adaptor) and VEGFR2 ( which activates phosphatidylinositol-3-OH kinase) comprise a mechanosensory complex. Together, these receptors are sufficient to confer responsiveness to flow in heterologous cells. In support of the relevance of this pathway in vivo, PECAM-1-knockout mice do not activate NF-kappa B and downstream inflammatory genes in regions of disturbed flow. Therefore, this mechanosensing pathway is required for the earliest-known events in atherogenesis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Milan, Mario Negri Inst Pharmacol Res, I-20139 Milan, Italy; Univ Milan, Fac Sci, Dept Biomol & Biotechnol Sci, FIRC Inst Mol Oncol, I-20139 Milan, Italy; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; Univ Penn, Med Ctr, Dept Med, Div Pulm & Crit Care, Philadelphia, PA 19104 USA; Univ Virginia, Mellon Prostate Canc Res Ctr, Cardiovasc Res Ctr, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Ctr, Cardiovasc Res Ctr, Dept Biomed Engn, Charlottesville, VA 22908 USA	Scripps Research Institute; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of California System; University of California San Diego; University of Bern; University of Pennsylvania; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	maschwartz@virginia.edu	DeLisser, Horace/AFM-1942-2022; Engelhardt, Britta/K-7267-2014; Tzima, Ellie/L-9256-2017	Engelhardt, Britta/0000-0003-3059-9846; Tzima, Ellie/0000-0002-3437-0902; DEJANA, ELISABETTA/0000-0002-0007-0426; schwartz, martin/0000-0002-2071-1243				Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Davies PF, 1997, J VASC RES, V34, P208, DOI 10.1159/000159224; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Elrayess MA, 2003, ATHEROSCLEROSIS, V168, P131, DOI 10.1016/S0021-9150(03)00089-3; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI200213595; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; LU TT, 1997, J BIOL CHEM, V272, P14444; Masuda Michitaka, 1993, Frontiers of Medical and Biological Engineering, V5, P79; Mohan S, 1997, AM J PHYSIOL-CELL PH, V273, pC572, DOI 10.1152/ajpcell.1997.273.2.C572; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van der Pauw MTM, 2000, J PERIODONTAL RES, V35, P335, DOI 10.1034/j.1600-0765.2000.035006335.x; Wong CWY, 2000, MOL BIOL CELL, V11, P3109, DOI 10.1091/mbc.11.9.3109	30	1164	1203	5	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					426	431		10.1038/nature03952	http://dx.doi.org/10.1038/nature03952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163360				2022-12-01	WOS:000231849100057
J	Emery, G; Hutterer, A; Berdnik, D; Mayer, B; Wirtz-Peitz, F; Gaitan, MG; Knoblich, JA				Emery, G; Hutterer, A; Berdnik, D; Mayer, B; Wirtz-Peitz, F; Gaitan, MG; Knoblich, JA			Asymmetric Rab11 endosomes regulate delta recycling and specify cell fate in the Drosophila nervous system	CELL			English	Article							MESSENGER-RNA LOCALIZATION; NUCLEAR-FALLOUT; SENSORY ORGAN; UBIQUITIN LIGASE; IN-VITRO; DIVISION; PROTEIN; NOTCH; NUMB; MEMBRANE	Drosophila sensory organ precursor (SOP) cells are a well-studied model system for asymmetric cell division. During SOP division, the determinants Numb and Neuralized segregate into the pIIb daughter cell and establish a distinct cell fate by regulating Notch/Delta signaling. Here, we describe a Numb- and Neuralized-independent mechanism that acts redundantly in cell-fate specification. We show that trafficking of the Notch ligand Delta is different in the two daughter cells. In pIIb, Delta passes through the recycling endosome which is marked by Rab11. In pIIa, however, the recycling endosome does not form because the centrosome fails to recruit Nuclear fallout, a Rab11 binding partner that is essential for recycling endosome formation. Using a mammalian cell culture system, we demonstrate that recycling endosomes are essential for Delta activity. Our results suggest that cells can regulate signaling pathways and influence their developmental fate by inhibiting the formation of individual endocytic compartments.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University; Max Planck Society	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Hutterer, Andrea/0000-0002-5208-6008; Emery, Gregory/0000-0002-6874-6875				Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bellaiche Y, 2001, CURR OPIN GENET DEV, V11, P418, DOI 10.1016/S0959-437X(00)00212-4; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Dollar G, 2002, DEVELOPMENT, V129, P517; Duman JG, 1999, AM J PHYSIOL-CELL PH, V277, pC361, DOI 10.1152/ajpcell.1999.277.3.C361; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gho M, 1999, DEVELOPMENT, V126, P3573; Gonzalez-Gaitan M, 2003, MECH DEVELOP, V120, P1265, DOI 10.1016/j.mod.2003.06.002; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Huppert SS, 1997, DEVELOPMENT, V124, P3283; JAFARNEJAD H, 2002, IN PRESS DEV CELL; Jankovics F, 2001, GENETICS, V158, P1177; Klueg KM, 1999, J CELL SCI, V112, P3289; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roegiers F, 2001, P NATL ACAD SCI USA, V98, P14469, DOI 10.1073/pnas.261555598; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rothwell WF, 1999, J CELL SCI, V112, P2885; Rothwell WF, 1998, DEVELOPMENT, V125, P1295; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz P, 2004, SCAND J MED SCI SPOR, V14, P1, DOI 10.1111/j.1600-0838.2003.00373.x; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	63	235	239	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					763	773		10.1016/j.cell.2005.08.017	http://dx.doi.org/10.1016/j.cell.2005.08.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16137758	Bronze			2022-12-01	WOS:000231844300015
J	Schwab, SR; Pereira, JP; Matloubian, M; Xu, Y; Huang, Y; Cyster, JG				Schwab, SR; Pereira, JP; Matloubian, M; Xu, Y; Huang, Y; Cyster, JG			Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE; T-CELLS; AMMONIA PROCESS; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; THYMUS; EMIGRATION; METABOLISM; PYRIDOXINE; MIGRATION	Lymphocyte egress from the thymus and from peripheral lymphoid organs depends on sphingosine 1-phosphate (S1P) receptor-1 and is thought to occur in response to circulatory S1P. However, the existence of an S1P gradient between lymphoid organs and blood or lymph has not been established. To further define egress requirements, we addressed why treatment with the food colorant 2-acetyl-4-tetrahydroxybutylimidazole (THI) induces lymphopenia. We found that S1P abundance in lymphoid tissues of mice is normally low but increases more than 100-fold after THI treatment and that this treatment inhibits the S1P-degrading enzyme Slip lyase. We conclude that lymphocyte egress is mediated by S1P gradients that are established by S1P lyase activity and that the lyase may represent a novel immunosuppressant drug target.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, Drug Studies Unit, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu		Schwab, Susan/0000-0002-0834-0822; Pereira, Joao/0000-0002-5694-4938	NIAID NIH HHS [AI40098, AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098, R01AI045073, R37AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bradbury MG, 1996, IMMUNOLOGY, V87, P80; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; COBURN SP, 1981, CHEM METABOLISM 4 DE; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; EVANS JG, 1977, FOOD COSMET TOXICOL, V15, P523, DOI 10.1016/0015-6264(77)90066-9; GAUNT IF, 1977, FOOD COSMET TOXICOL, V15, P509, DOI 10.1016/0015-6264(77)90065-7; GOBIN SJP, 1992, THYMUS, V20, P17; Gugasyan R, 1998, IMMUNOLOGY, V93, P398; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; SINKELDAM EJ, 1988, FOOD CHEM TOXICOL, V26, P195, DOI 10.1016/0278-6915(88)90119-6; Trakatellis A, 1997, POSTGRAD MED J, V73, P617, DOI 10.1136/pgmj.73.864.617; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4	21	621	642	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1735	1739		10.1126/science.1113640	http://dx.doi.org/10.1126/science.1113640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151014				2022-12-01	WOS:000231836700048
J	Basu, U; Chaudhuri, J; Alpert, C; Dutt, S; Ranganath, S; Li, G; Schrum, JP; Manis, JP; Alt, FW				Basu, U; Chaudhuri, J; Alpert, C; Dutt, S; Ranganath, S; Li, G; Schrum, JP; Manis, JP; Alt, FW			The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; B-CELLS; MECHANISM; TRANSCRIPTION; EXPRESSION; MYC	Antibodies, which are produced by B-lineage cells, consist of immunoglobulin heavy (IgH) and light (IgL) chains that have amino-terminal variable regions and carboxy-terminal constant regions. In response to antigens, B cells undergo two types of genomic alterations to increase antibody diversity. Affinity for antigen can be increased by introduction of point mutations into IgH and IgL variable regions by somatic hypermutation. In addition, antibody effector functions can be altered by changing the expressed IgH constant region exons through IgH class switch recombination (CSR)(1-3). Somatic hypermutation and CSR both require the B-cell-specific activation-induced cytidine deaminase protein (AID)(4-6), which initiates these reactions through its single-stranded (ss)DNA-specific cytidine deaminase activity(7-11). In biochemical assays, replication protein A (RPA), a ssDNA-binding protein(12), associates with phosphorylated AID from activated B cells and enhances AID activity on transcribed double-stranded (ds)DNA containing somatic hypermutation or CSR target sequences. This AID-RPA association, which requires phosphorylation, may provide a mechanism for allowing AID to access dsDNA targets in activated B cells(13,14). Here we show that AID from B cells is phosphorylated on a consensus protein kinase A (PKA) site and that PKA is the physiological AID kinase. Thus, AID from non-lymphoid cells can be functionally phosphorylated by recombinant PKA to allow interaction with RPA and promote deamination of transcribed dsDNA substrates. Moreover, mutation of the major PKA phosphorylation site of AID preserves ssDNA deamination activity, but markedly reduces RPA-dependent dsDNA deamination activity and severely impairs the ability of AID to effect CSR in vivo. We conclude that PKA has a critical role in post-translational regulation of AID activity in B cells.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Joint Program Transfus Med,Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CBR Inst Biomed Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu						Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dominguez-Sola D, 2004, NAT CELL BIOL, V6, P288, DOI 10.1038/ncb0404-288; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Weill JC, 2004, NAT IMMUNOL, V5, P876, DOI 10.1038/ni0904-876; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	29	201	205	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					508	511		10.1038/nature04255	http://dx.doi.org/10.1038/nature04255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16251902				2022-12-01	WOS:000233458200052
J	Gregory, RI; Chendrimada, TP; Cooch, N; Shiekhattar, R				Gregory, RI; Chendrimada, TP; Cooch, N; Shiekhattar, R			Human RISC couples microRNA biogenesis and posttranscriptional gene silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DISTINCT ROLES; HUMAN DICER; INTERFERENCE; ARGONAUTE2; BINDING; COMPLEX; MATURATION	RNA interference is implemented through the action of the RNA-induced silencing complex (RISC). Although Argonaute2 has been identified as the catalytic center of RISC, the RISC polypeptide composition and assembly using short interfering RNA (siRNA) duplexes has remained elusive. Here we show that RISC is composed of Dicer, the double-stranded RNA binding protein TRBP, and Argonaute2. We demonstrate that this complex can cleave target RNA using precursor microRNA (pre-miRNA) hairpin as the source of sIRNA. Although RISC can also utilize duplex siRNA, it displays a nearly 10-fold greater activity using the pre-miRNA Dicer substrate. RISC distinguishes the guide strand of the siRNA from the passenger strand and specifically incorporates the guide strand. Importantly, ATP is not required for miRNA processing, RISC assembly, or multiple rounds of target-RNA cleavage. These results define the composition of RISC and demonstrate that miRNA processing and target-RNA cleavage are coupled.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	52	1114	1251	8	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					631	640		10.1016/j.cell.2005.10.022	http://dx.doi.org/10.1016/j.cell.2005.10.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16271387	Bronze			2022-12-01	WOS:000233497400012
J	Chen, WY; Wang, DH; Yen, RWC; Luo, JY; Gu, W; Baylin, SB				Chen, WY; Wang, DH; Yen, RWC; Luo, JY; Gu, W; Baylin, SB			Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses	CELL			English	Article							TUMOR-SUPPRESSOR GENE; HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; P53; HIC1; NAD; EXPRESSION; BINDING; BCL-2	Hypermethylated in cancer 1 (HIC1) is an epigenetically regulated transcriptional repressor that functionally cooperates with p53 to suppress age-dependent development of cancer in mice. Here we show that the mechanism by which the loss of HIC1 function promotes tumorigenesis is via activating the stress-controlling protein SIRT1 and thereby attenuating p53 function. HIC1 forms a transcriptional repression complex with SIRT1 deacetylase, and this complex directly binds the SIRT1 promoter and represses its transcription. Inactivation of HIC1 results in upregulated SIRT1 expression in normal or cancer cells; this deacetylates and inactivates p53, allowing cells to bypass apoptosis and survive DNA damage. Inhibition of SIRT1 function in cells without HIC1 abolishes the resistance to apoptosis. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, we speculate that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.	Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Biol Program, Baltimore, MD 21231 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Johns Hopkins University; Johns Hopkins Medicine; Columbia University	Baylin, SB (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Biol Program, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu	Luo, Jianyuan/ABI-7585-2020; Chen, WenYong/D-6748-2012	Luo, Jianyuan/0000-0001-6057-2914; Chen, WenYong/0000-0001-6913-5729	NCI NIH HHS [CA043318] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Chen WY, 2000, P NATL ACAD SCI USA, V97, P377, DOI 10.1073/pnas.97.1.377; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grimm C, 1999, HUM MOL GENET, V8, P697, DOI 10.1093/hmg/8.4.697; Guarente L, 2000, GENE DEV, V14, P1021; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; HALDAR S, 1994, CANCER RES, V54, P2095; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; WEINRUCH R, 1988, RETARDATION AGING DI; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	51	502	539	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					437	448		10.1016/j.cell.2005.08.011	http://dx.doi.org/10.1016/j.cell.2005.08.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269335	Bronze			2022-12-01	WOS:000233264300012
J	Rogulja, D; Irvine, KD				Rogulja, D; Irvine, KD			Regulation of cell proliferation by a morphogen gradient	CELL			English	Article							CONTROLS WING GROWTH; ORGANIZING ACTIVITY; PLANAR POLARITY; GENE-EXPRESSION; DROSOPHILA; PATTERN; APOPTOSIS; TRANSMISSION; COMPARTMENTS; INFORMATION	One model to explain the relationship between patterning and growth during development posits that growth is regulated by the slope of morphogen gradients. The Decapentaplegic (DPP) morphogen controls growth in the Drosophila wing, but the slope of the DPP activity gradient has not been shown to influence growth. By employing a method for spatial, temporal, and quantitative control over gene expression, we show that the juxtaposition of cells perceiving different levels of DPP signaling is essential for medial-wing-cell proliferation and can be sufficient to promote the proliferation of cells throughout the wing. Either activation or inhibition of the DPP pathway in clones at levels distinct from those in surrounding cells stimulates nonautonomous cell proliferation. Conversely, uniform activation of the DPP pathway inhibits cell proliferation in medial wing cells. Our observations provide a direct demonstration that the slope of a morphogen gradient regulates growth during development.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu						Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; BOHN H, 1974, J EMBRYOL EXP MORPH, V32, P81; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Day SJ, 2000, DEVELOPMENT, V127, P2977; Eaton S, 2003, MECH DEVELOP, V120, P1257, DOI 10.1016/j.mod.2003.07.002; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Garcia-Bellido AC, 1998, INT J DEV BIOL, V42, P353; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GELBART WM, 1989, DEVELOPMENT, V107, P65; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Ito K, 1997, DEVELOPMENT, V124, P761; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Lawrence P. A., 1970, Adv. Insect Physiol., V7, P197, DOI 10.1016/S0065-2806(08)60242-8; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lawrence PA, 2004, NATURE, V429, P247, DOI 10.1038/429247a; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Padgett RW, 1999, CURR BIOL, V9, pR408, DOI 10.1016/S0960-9822(99)80255-3; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thacker SA, 2003, CURR BIOL, V13, P53, DOI 10.1016/S0960-9822(02)01400-8; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; ZECCA M, 1995, DEVELOPMENT, V121, P2265	50	177	183	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					449	461		10.1016/j.cell.2005.08.030	http://dx.doi.org/10.1016/j.cell.2005.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269336	Bronze			2022-12-01	WOS:000233264300013
J	Aylward, RB; Sutter, RW; Heymann, DL				Aylward, RB; Sutter, RW; Heymann, DL			OPV cessation - the final step to a "polio-free" world	SCIENCE			English	Article							VACCINE-DERIVED POLIOVIRUS; CERTIFICATION; POLIOMYELITIS; ERADICATION; CIRCULATION		World Hlth Org, Global Polio Eradicat Initiat, Geneva 27, Switzerland	World Health Organization	Aylward, RB (corresponding author), World Hlth Org, Global Polio Eradicat Initiat, Geneva 27, Switzerland.	aylwardb@who.int						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; ASTURIAS EJ, UNPUB; AYLWARD RB, 2004, NEW GENERATION VACCI, P145; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P1113; Debanne SM, 1998, MATH BIOSCI, V150, P83, DOI 10.1016/S0025-5564(98)00007-8; *DEP VACC BIOL, 2002, WHOVB0311 DEP VACC B; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; FINE PEM, 2001, DEV BIOL SERIES, V105; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; Henderson DA, 2001, CLIN INFECT DIS, V33, P1057, DOI 10.1086/323808; HENNESSEY KA, UNPUB; Heymann DL, 2005, NATURE, V434, P699, DOI 10.1038/434699a; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; *PAHO, 1994, FIN REP INT COMM CER; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210; Sangrujee N, 2004, B WORLD HEALTH ORGAN, V82, P9; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Smith J, 2004, B WORLD HEALTH ORGAN, V82, P24; Sutter RW, 2003, VACCINES, P651; *TCG, 2002, INT M TECHN CONS GRO; Tebbens RJD, 2005, AM J EPIDEMIOL, V162, P358, DOI 10.1093/aje/kwi206; TEBBENS RJD, UNPUB RISKS PAR DIS; *WHO, 2004, IMM VACC BIOL VACC I; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P241; *WHO, 1997, 2 M GLOB COMM CERT P; *WHO, POL CAS COUNTS; *WHO, 1999, POL ER; *WHO, 2004, REP INF CONS ID MAN; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P401; *WHO, DEC INSTR ASS NOT EV; *WHO TECHN CONS GR, 2001, CLIN INFECT DIS, V34, P72; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; 1998, WKLY EPIDEMIOL REC, V73, P113	37	51	53	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					625	626		10.1126/science.1115547	http://dx.doi.org/10.1126/science.1115547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254173				2022-12-01	WOS:000232997700024
J	Steuber, T; Rauch, M; Masse, JP; Graaf, J; Malkoc, M				Steuber, T; Rauch, M; Masse, JP; Graaf, J; Malkoc, M			Low-latitude seasonality of Cretaceous temperatures in warm and cold episodes	NATURE			English	Article							SEA-SURFACE TEMPERATURES; BIVALVES	The Cretaceous period is generally considered to have been a time of warm climate(1-6). Evidence for cooler episodes exists, particularly in the early Cretaceous period(6-8), but the timing and significance of these cool episodes are not well constrained. The seasonality of temperatures is important for constraining equator-to-pole temperature gradients and may indicate the presence of polar ice sheets; however, reconstructions of Cretaceous sea surface temperatures are predominantly based on the oxygen isotopic composition of planktonic foraminifera(1-4) that do not provide information about such intra-annual variations. Here we present intra-shell variations in delta O-18 values of rudist bivalves (Hippuritoidea) from palaeolatitudes between 8 degrees and 31 degrees N, which record the evolution of the seasonality of Cretaceous sea surface temperatures in detail. We find high maximum temperatures (, 35 to 37 degrees C) and relatively low seasonal variability (< 12 degrees C) between 20 degrees and 30 degrees N during the warmer Cretaceous episodes. In contrast, during the cooler episodes our data show seasonal sea surface temperature variability of up to 18 degrees C near 25 degrees N, comparable to the range found today. Such a large seasonal variability is compatible with the existence of polar ice sheets.	Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44801 Bochum, Germany; Univ Aix Marseille 1, Ctr Sedimentol Paleontol, F-13331 Marseille, France; Vrije Univ Amsterdam, Dept Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands	Ruhr University Bochum; UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Amsterdam	Steuber, T (corresponding author), Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44801 Bochum, Germany.	thomas.steuber@ruhr-uni-bochum.de	Steuber, Thomas/G-7692-2011	Steuber, Thomas/0000-0003-3342-9885				ANDERSON TF, 1983, SOC EC PALEONT MINER, V10; [Anonymous], CLIMATE MODES PHANER; Camoin G., 1993, ATLAS TETHYS PALAEOE; Clarke LJ, 1999, GEOLOGY, V27, P699, DOI 10.1130/0091-7613(1999)027<0699:NOIEFL>2.3.CO;2; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DeConto R.M., 2000, WARM CLIMATES EARTH, P21; GILI E, 1995, PALAEOGEOGR PALAEOCL, V118, P245, DOI 10.1016/0031-0182(95)00006-X; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2; Ivany LC, 2004, J SEDIMENT RES, V74, P7, DOI 10.1306/052803740007; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Kemper E., 1987, Geologisches Jahrbuch Reihe A, V96, P5; Lecuyer C, 2004, CHEM GEOL, V213, P293, DOI 10.1016/j.chemgeo.2004.02.001; MASSE JP, 1993, ATLAS ETHYS PALAEOEN; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Norris RD, 2002, GEOLOGY, V30, P299, DOI 10.1130/0091-7613(2002)030<0299:JTTTIT>2.0.CO;2; OBRADOVICH JD, 1993, GEOL ASSOC CAN SPEC, V39, P379; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Poulsen CJ, 2004, NATURE, V432, P814, DOI 10.1038/432814a; Poulsen CJ, 1999, GEOL S AM S, P73; Poulsen CJ, 1999, PALEOCEANOGRAPHY, V14, P679, DOI 10.1029/1999PA900034; Price GD, 1999, EARTH-SCI REV, V48, P183, DOI 10.1016/S0012-8252(99)00048-3; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; SPICER RA, 2003, CRETACEOUS WORLD; Steuber T, 2005, MAR GEOL, V217, P199, DOI 10.1016/j.margeo.2005.02.012; Steuber T, 1999, INT J EARTH SCI, V88, P551, DOI 10.1007/s005310050284; WEFER G, 1991, MAR GEOL, V100, P207, DOI 10.1016/0025-3227(91)90234-U; Wilson PA, 2001, NATURE, V412, P425, DOI 10.1038/35086553; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2	30	183	188	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1341	1344		10.1038/nature04096	http://dx.doi.org/10.1038/nature04096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251961				2022-12-01	WOS:000232829100050
J	Elley, CR; Arroll, B				Elley, CR; Arroll, B			Refining the exercise prescription for hypertension	LANCET			English	Editorial Material							BLOOD-PRESSURE; PHYSICAL-ACTIVITY; CONTROLLED TRIALS; METAANALYSIS; HEALTH		Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; Univ Otago, Wellington Sch Med, Dept Gen Practice, Wellington, New Zealand	University of Auckland; University of Otago	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Aldana SG, 2005, J AM DIET ASSOC, V105, P371, DOI 10.1016/j.jada.2004.12.007; BAGRIE E, 2004, EXERCISE BLOOD PRESS; Dickerson LM, 2005, AM FAM PHYSICIAN, V71, P469; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Fagard RH, 2001, MED SCI SPORT EXER, V33, pS484, DOI 10.1097/00005768-200106001-00018; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Halbert JA, 1997, J HUM HYPERTENS, V11, P641, DOI 10.1038/sj.jhh.1000509; Kokkinos PF, 2000, CORONARY ARTERY DIS, V11, P99, DOI 10.1097/00019501-200003000-00002; Murphy M, 2002, MED SCI SPORT EXER, V34, P1468, DOI 10.1097/00005768-200209000-00011; Rauramaa R, 2001, MED SCI SPORT EXER, V33, pS516, DOI 10.1097/00005768-200106001-00022; Rondon MUP, 2002, J AM COLL CARDIOL, V39, P676, DOI 10.1016/S0735-1097(01)01789-2; STEWART R, 2002, 79 NAT HEART FDN; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006	14	7	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2005	366	9493					1248	1249						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971ST	16214585				2022-12-01	WOS:000232405700008
J	Pittet, D; Donaldson, L				Pittet, D; Donaldson, L			Clean Care is Safer Care: a worldwide priority	LANCET			English	Editorial Material							HAND HYGIENE; INFECTIONS; HEALTH; SARS		WHO, World Alliance Patient Safety, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva, Switzerland	World Health Organization; University of Geneva	Pittet, D (corresponding author), WHO, World Alliance Patient Safety, CH-1211 Geneva, Switzerland.	didier.pittet@hcuge.ch		Pittet, Didier/0000-0002-3667-7131				Donaldson L, 2004, LANCET, V364, P1567, DOI 10.1016/S0140-6736(04)17330-3; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; *NAT AUD OFF, 2004, IMPR PAT CAR RED RIS; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2005, LANCET, V366, P185, DOI 10.1016/S0140-6736(05)66886-9; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; PONCEDELEON RS, 1998, HOSP INFECT, P291; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483; TIKHOMIROV E, 1987, CHEMIOTERAPIA, V3, P148; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; *WHO, GLOB PAT SAF CHALL W; World Health Organization, WORLD ALL PAT SAF; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	14	130	132	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 8	2005	366	9493					1246	1247		10.1016/S0140-6736(05)67506-X	http://dx.doi.org/10.1016/S0140-6736(05)67506-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971ST	16214584	Bronze, Green Published			2022-12-01	WOS:000232405700007
J	Bainton, RJ; Tsai, LTY; Schwabe, T; DeSalvo, M; Gaul, U; Heberlein, U				Bainton, RJ; Tsai, LTY; Schwabe, T; DeSalvo, M; Gaul, U; Heberlein, U			moody Encodes two GPCRs that regulate cocaine behaviors and blood-brain barrier permeability in Drosophila	CELL			English	Article							HETEROTRIMERIC G-PROTEINS; CIRCADIAN GENES; SENSITIZATION; DOPAMINE; ETHANOL; EXPRESSION; REWARD; SENSITIVITY; RESPONSES; NEURONS	We identified moody in a genetic screen for Drosophila mutants with altered cocaine sensitivity. Hypomorphic mutations in moody cause an increased sensitivity to cocaine and nicotine exposure. In contrast, sensitivity to the acute intoxicating effects of ethanol is reduced. The moody locus encodes two novel GPCRs, Moody-alpha and Moody-beta. While identical in their membrane-spanning domains, the two Moody proteins differ in their long carboxy-terminal domains, which are generated by use of alternative reading frames. Both Moody forms are required for normal cocaine sensitivity, suggesting that they carry out distinct but complementary functions. Moody-alpha and Moody-beta are coexpressed in surface glia that surround the nervous system, where they are actively required to maintain the integrity of the blood-brain barrier in the adult fly. We propose that a Moody-mediated signaling pathway functions in glia to regulate nervous system insulation and drug-related behaviors.	Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94143 USA; Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University	Bainton, RJ (corresponding author), Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA.	rolandb@itsa.ucsf.edu; ulrike@itsa.ucsf.edu	Schwabe, Tina/AAA-3822-2021	Tsai, Linus/0000-0002-0134-6949	NATIONAL EYE INSTITUTE [R55EY011560, R01EY011560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014809] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011560, EY011560, R01 EY011560-08] Funding Source: Medline; NIAAA NIH HHS [AA10035] Funding Source: Medline; NIDA NIH HHS [DA14809, DA444906-33821] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Granderath S, 1999, DEVELOPMENT, V126, P1781; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Hirsh J., 2001, Pharmacogenomics Journal, V1, P97; Hortsch M, 2003, TRENDS CELL BIOL, V13, P557, DOI 10.1016/j.tcb.2003.09.004; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; MANNING G, 1993, DEV DROSPHILLA TRACH, V1; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rorth P, 1998, DEVELOPMENT, V125, P1049; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schenk S, 1997, PHARMACOL BIOCHEM BE, V57, P543, DOI 10.1016/S0091-3057(96)00447-9; Shaw SR, 1999, J NEUROBIOL, V41, P452, DOI 10.1002/(SICI)1097-4695(199912)41:4<452::AID-NEU2>3.3.CO;2-X; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Sun ZY, 2004, EUR PSYCHIAT, V19, P354, DOI 10.1016/j.eurpsy.2004.06.007; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; WEBER KE, 1990, GENETICS, V125, P585; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yager J, 2001, P NATL ACAD SCI USA, V98, P10445, DOI 10.1073/pnas.191107698	42	158	161	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					145	156		10.1016/j.cell.2005.07.029	http://dx.doi.org/10.1016/j.cell.2005.07.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213219	Bronze			2022-12-01	WOS:000232536800015
J	Primavera, JH				Primavera, JH			Mangroves, fishponds, and the quest for sustainability	SCIENCE			English	Editorial Material									SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines	Southeast Asian Fisheries Development Center	Primavera, JH (corresponding author), SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines.	jhprima@aqd.saefdec.org.ph							0	83	91	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					57	59		10.1126/science.1115179	http://dx.doi.org/10.1126/science.1115179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	972TV	16210520				2022-12-01	WOS:000232477000029
J	Kimoto, H; Haga, S; Sato, K; Touhara, K				Kimoto, H; Haga, S; Sato, K; Touhara, K			Sex-specific peptides from exocrine glands stimulate mouse vomeronasal sensory neurons	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; ACCESSORY OLFACTORY-BULB; MULTIGENE FAMILY; GENES; MICE; AGGRESSION; ACTIVATION; BEHAVIOR; MAMMALS; SIGNALS	In mammals, social and reproductive behaviours are modulated by pheromones, which are chemical signals that convey information about sex and strain(1,2). The vomeronasal organ, located at the base of the nasal septum, is responsible for mediating pheromone information in mice(3-9). Two classes of putative pheromone receptor gene families, V1R and V2R, are expressed by vomeronasal sensory neurons in mutually segregated epithelial zones of the vomeronasal organ(10-14). Although numerous studies have suggested that pheromones originate from urine(15-18), direct recordings of behaving mice have shown that neuronal firing in the vomeronasal system is modulated by physical contact with the facial area(19). Here we identify a male-specific 7-kDa peptide secreted from the extraorbital lacrimal gland. This peptide, which we named exocrine gland-secreting peptide 1 (ESP1), is encoded by a gene from a previously unrecognized large family clustered in proximity to the class I major histocompatibility complex (MHC) region. ESP1 is secreted from the eyes and is transferred to the female vomeronasal organ, where it stimulates V2R-expressing vomeronasal sensory neurons and elicits an electrical response. Our results indicate that mice respond to sex-specific peptides released from exocrine glands through the vomeronasal system during direct contact.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	touhara@k.u-tokyo.ac.jp		xing zhi, zuo teng/0000-0001-6198-6406				Berghard A, 1996, J NEUROSCI, V16, P909; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Feldhoff Richard C., 1999, P117; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Kimoto H, 2005, CHEM SENSES, V30, pI146, DOI 10.1093/chemse/bjh156; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; Norlin EM, 2003, CURR BIOL, V13, P1214, DOI 10.1016/S0960-9822(03)00452-4; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Wabnitz PA, 1999, NATURE, V401, P444, DOI 10.1038/46724; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7	29	280	291	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					898	901		10.1038/nature04033	http://dx.doi.org/10.1038/nature04033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208374				2022-12-01	WOS:000232338600049
J	Gray, RH; Li, XB; Kigozi, G; Serwadda, D; Brahmbhott, H; Wabwire-Mangen, F; Nalugoda, F; Kiddugavu, M; Sewankambo, N; Quinn, TC; Reynolds, SJ; Wawer, MJ				Gray, RH; Li, XB; Kigozi, G; Serwadda, D; Brahmbhott, H; Wabwire-Mangen, F; Nalugoda, F; Kiddugavu, M; Sewankambo, N; Quinn, TC; Reynolds, SJ; Wawer, MJ			Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study	LANCET			English	Article							UTERINE EPITHELIAL-CELLS; SEXUALLY-TRANSMITTED-DISEASES; PERINATAL TRANSMISSION; MENSTRUAL-CYCLE; COITAL ACT; INFECTION; WOMEN; COHORT; TRACT; STAGE	Background HIV acquisition is significantly higher during pregnancy than in the postpartum period. We did a prospective study to estimate HIV incidence rates during pregnancy and lactation. Methods We assessed 2188 HIV-negative sexually active women with 2625 exposure intervals during pregnancy and 2887 intervals during breastfeeding, and 8473 non-pregnant and non-lactating women with 24 258 exposure intervals. Outcomes were HIV incidence rates per 100 person years and incidence rate ratios estimated by Poisson multivariate regression, with the non-pregnant or non-lactating women as the reference group. We also assessed the husbands of the married women to study male risk behaviours. Findings HIV incidence rates were 2.3 per 100 person years during pregnancy, 1.3 per 100 person years during breastfeeding, and 1.1 per 100 person years in the non-pregnant and non-lactating women. The adjusted incidence rate ratios were 2.16 (95% Cl 1 . 39-3.37) during pregnancy and 1 . 16 (0.82-1.63) during breastfeeding. Pregnant women and their male partners reported significantly fewer external sexual partners than did the other groups. in married pregnant women who had a sexual relationship with their male spouses, the HIV incidence rate ratio was 1.36 (0.63-2.93). in married pregnant women in HIV-discordant relationships (ie, with HIV-positive men) the incidence rate ratio was 1.76 (0.62-4.03). Interpretation The risk of HIV acquisition rises during pregnancy. This change is unlikely to be due to sexual risk behaviours, but might be attributable to hormonal changes affecting the genital tract mucosa or immune responses. HIV prevention efforts are needed during pregnancy to protect mothers and their infants.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Uganda Virus Res Inst, Rakai Hlth Sci Programme, Entebbe, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Makerere Univ, Sch Med, Kampala, Uganda; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; Columbia University	Gray, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Suite 4030, Baltimore, MD 21205 USA.	rgray@jhsph.edu		Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361] Funding Source: NIH RePORTER; NICHD NIH HHS [5P30HD06826] Funding Source: Medline; PHS HHS [R01 A13426S, R01 A134826] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Asin SN, 2004, J INFECT DIS, V190, P236, DOI 10.1086/421910; Asin SN, 2003, J INFECT DIS, V187, P1522, DOI 10.1086/374782; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Brabin L, 2002, AIDS PATIENT CARE ST, V16, P211, DOI 10.1089/10872910252972267; Garcia PM, 1999, NEW ENGL J MED, V341, P1699; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; HITCHCOCK PJ, 1999, SEXUALLY TRANSMITTED; Jacobson DL, 2000, SEX TRANSM DIS, V27, P313, DOI 10.1097/00007435-200007000-00003; Kiddugavu M, 2003, AIDS, V17, P233, DOI 10.1097/00002030-200301240-00014; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Michael CW, 1997, DIAGN CYTOPATHOL, V17, P99, DOI 10.1002/(SICI)1097-0339(199708)17:2<99::AID-DC4>3.3.CO;2-6; Prakash M, 2004, BJOG-INT J OBSTET GY, V111, P1468, DOI 10.1111/j.1471-0528.2004.00283.x; ROOGPISUTHIPONG A, 2001, J ACQ IMMUN DEF SYND, V26, P348; Shelton JD, 2004, LANCET, V364, P1916, DOI 10.1016/S0140-6736(04)17489-8; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Taha TE, 2000, ANN NY ACAD SCI, V918, P84; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; WESTOFF CF, 2001, UNMET NEED END CENTU; White HD, 1997, J IMMUNOL, V158, P3017; Yeaman GR, 1997, J LEUKOCYTE BIOL, V61, P427, DOI 10.1002/jlb.61.4.427; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	283	291	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2005	366	9492					1182	1188		10.1016/S0140-6736(05)67481-8	http://dx.doi.org/10.1016/S0140-6736(05)67481-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LK	16198767				2022-12-01	WOS:000232311300028
J	Khaldoun, A; Eiser, E; Wegdam, GH; Bonn, D				Khaldoun, A; Eiser, E; Wegdam, GH; Bonn, D			Liquefaction of quicksand under stress - A person trapped in salt-lake quicksand is not in any danger of being sucked under completely.	NATURE			English	Editorial Material									Univ Amsterdam, Van der Waals Zeeman Inst, NL-1018 XE Amsterdam, Netherlands; Univ Amsterdam, HIMS, NL-1018 XE Amsterdam, Netherlands; Ecole Normale Super, Phys Stat Lab, F-75231 Paris, France	University of Amsterdam; University of Amsterdam; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Khaldoun, A (corresponding author), Univ Amsterdam, Van der Waals Zeeman Inst, Kruislaan 403, NL-1018 XE Amsterdam, Netherlands.	bonn@science.uva.nl	Bonn, Daniel/F-9928-2011					Batchelor G. K., 2000, INTRO FLUID DYNAMICS; Coussot P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.175501; Ferroir T, 2004, PHYS FLUIDS, V16, P594, DOI 10.1063/1.1640372; Huang N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028301; Lambe T.W., 1969, SOIL MECH, P553; Lohse D, 2004, NATURE, V432, P689, DOI 10.1038/432689a; Olphen, 1977, INTRO CLAY COLLOID C	7	30	30	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					635	635		10.1038/437635a	http://dx.doi.org/10.1038/437635a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193035	Bronze			2022-12-01	WOS:000232157900034
J	Kussell, E; Leibler, S				Kussell, E; Leibler, S			Phenotypic diversity, population growth, and information in fluctuating environments	SCIENCE			English	Article							BACTERIAL PERSISTENCE; CANDIDA-ALBICANS; PHASE VARIATION; STRATEGIES; MECHANISM; SURVIVAL; LOCI; GENE	Organisms in fluctuating environments must constantly adapt their behavior to survive. In clonal populations; this may be achieved through sensing followed by response or through the generation of diversity by stochastic phenotype switching. Here we show that stochastic switching can be favored over sensing when the environment changes infrequently. The optimal switching rates then mimic the statistics of environmental changes. We derive a relation between the long-term growth rate of the organism,and the information available about its fluctuating environment.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Kussell, E (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave,Box 34, New York, NY 10021 USA.	kussele@rockefeller.edu	chen, qi/C-8585-2011					Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bonifield HR, 2003, J BACTERIOL, V185, P3567, DOI 10.1128/JB.185.12.3567-3574.2003; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Cohen J.E., 1979, STOCH PROC APPL, V9, P245, DOI [10.1016/0304-4149(79)90046-2, DOI 10.1016/0304-4149(79)90046-2]; Cover T.M., 1991, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X, DOI 10.1002/047174882X.CH11]; CRISTANTI A, 1993, PRODUCTS RANDOM MATR; DEMETRIUS L, 1983, J STAT PHYS, V30, P709, DOI 10.1007/BF01009685; Grafen A, 1999, P ROY SOC B-BIOL SCI, V266, P799, DOI 10.1098/rspb.1999.0708; HACCOU P, 1995, THEOR POPUL BIOL, V47, P212, DOI 10.1006/tpbi.1995.1009; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lachke SA, 2002, MICROBIOL-SGM, V148, P2661, DOI 10.1099/00221287-148-9-2661; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Michel P, 2004, CR MATH, V338, P697, DOI 10.1016/j.crma.2004.03.006; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Robson AJ, 1999, J THEOR BIOL, V197, P541, DOI 10.1006/jtbi.1998.0894; SASAKI A, 1995, EVOLUTION, V49, P337, DOI [10.2307/2410344, 10.1111/j.1558-5646.1995.tb02246.x]; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; SOLL DR, 1988, DEV GENET, V9, P615, DOI 10.1002/dvg.1020090438; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	26	891	911	0	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2005	309	5743					2075	2078		10.1126/science.1114383	http://dx.doi.org/10.1126/science.1114383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16123265				2022-12-01	WOS:000232181900057
J	Kamer, I; Sarig, R; Zaltsman, Y; Niv, H; Oberkovitz, G; Regev, L; Haimovich, G; Lerenthal, Y; Marcellus, RC; Gross, A				Kamer, I; Sarig, R; Zaltsman, Y; Niv, H; Oberkovitz, G; Regev, L; Haimovich, G; Lerenthal, Y; Marcellus, RC; Gross, A			Proapoptotic BID is an ATM effector in the DNA-damage response	CELL			English	Article							NORMAL HUMAN FIBROBLASTS; APOPTOSIS; MITOCHONDRIA; RADIATION; PROTEINS; ARREST; PHASE	The "BH3-only" proapoptotic BCL-2 family members are sentinels of intracellular damage. Here, we demonstrated that the BH3-only BID protein partially localizes to the nucleus in healthy cells, is important for apoptosis induced by DNA damage, and is phosphorylated following induction of double-strand breaks in DNA. We also found that BID phosphorylation is mediated by the ATM kinase and occurs in mouse BID on two ATM consensus sites. Interestingly, BID-/- cells failed to accumulate in the S phase of the cell cycle following treatment with the topoisomerase 11 poison etoposide; reintroducing wildtype BID restored accumulation. In contrast, introducing a nonphosphorylatable BID mutant did not restore accumulation in the S phase and resulted in an increase in cellular sensitivity to etoposide-induced apoptosis. These results implicate BID as an ATM effector and raise the possibility that proapoptotic BID may also play a prosurvival role important for S phase arrest.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Tel Aviv, Israel; Geminx Biotechnol Inc, Montreal, PQ H2W 2M9, Canada	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il	Haimovich, Gal/H-3316-2019; Gross, Atan/ABC-2640-2020	Haimovich, Gal/0000-0002-3360-5108; 				Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Elkon R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r43; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kamijo T, 1999, CANCER RES, V59, P2464; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tripathi AK, 2003, LEUKEMIA RES, V27, P899, DOI 10.1016/S0145-2126(03)00025-0; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	18	177	183	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					593	603		10.1016/j.cell.2005.06.014	http://dx.doi.org/10.1016/j.cell.2005.06.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122426	Bronze			2022-12-01	WOS:000231555100014
J	Danielsen, F; Sorensen, MK; Olwig, MF; Selvam, V; Parish, F; Burgess, ND; Hiraishi, T; Karunagaran, VM; Rasmussen, MS; Hansen, LB; Quarto, A; Suryadiputra, N				Danielsen, F; Sorensen, MK; Olwig, MF; Selvam, V; Parish, F; Burgess, ND; Hiraishi, T; Karunagaran, VM; Rasmussen, MS; Hansen, LB; Quarto, A; Suryadiputra, N			The Asian tsunami: A protective role for coastal vegetation	SCIENCE			English	Article									NORDECO, DK-1159 Copenhagen, Denmark; Univ Copenhagen, Copenhagen, Denmark; MS Swaminathan Res Fdn, Madras 600113, Tamil Nadu, India; Global Environm Ctr, Petaling Jaya 47300, Selangor, Malaysia; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge, England; World Wildlife Fund, Washington, DC 20037 USA; Port & Airport Res Inst, Yokosuka, Kanagawa, Japan; Mangrove Act Project, Port Angeles, WA 98362 USA; Wetlands Int Indonesia, Bogor 16002, Indonesia	University of Copenhagen; University of Cambridge; World Wildlife Fund; Port & Airport Research Institute	Danielsen, F (corresponding author), NORDECO, Skindergade 23, DK-1159 Copenhagen, Denmark.	fd@nordeco.dk	Olwig, Mette Fog/Y-4322-2018	Olwig, Mette Fog/0000-0001-5081-6671; Danielsen, Finn/0000-0003-0229-2847; Rasmussen, Michael Schultz/0000-0002-7358-9421				CHAPMAN VJ, 1977, ECOSYSTEMS WORLD, V1, P3; FAO, 2003, STAT WORLDS FOR; HIRAISHI T, 2003, GREENBELT TSUNAMI PR; Massel SR, 1999, FLUID DYN RES, V24, P219, DOI 10.1016/S0169-5983(98)00024-0; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; PARISH F, 2005, ASSESSMENT COST MANG; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2	7	500	536	4	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					643	643		10.1126/science.1118387	http://dx.doi.org/10.1126/science.1118387			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254180				2022-12-01	WOS:000232997700031
J	Chang, Q; Hoefs, S; van der Kemp, AW; Topala, CN; Bindels, RJ; Hoenderop, JG				Chang, Q; Hoefs, S; van der Kemp, AW; Topala, CN; Bindels, RJ; Hoenderop, JG			The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel	SCIENCE			English	Article							BONE-DENSITY; GENE; GLYCOSYLATION; RELEASE; KIDNEY; CELL	Blood calcium concentration is maintained within a narrow range despite large variations in dietary input and body demand. The Transient Receptor Potential ion channel TRPV5 has been implicated in this process. We report here that TRPV5 is stimulated by the mammalian hormone klotho. Klotho, a beta-glucuronidase, hydrolyzes extracellular sugar residues on TRPV5, entrapping the channel in the plasma membrane. This maintains durable calcium channel activity and membrane calcium permeability in kidney. Thus, klotho activates a cell surface channel by hydrolysis of its extracellular N-linked oligosaccharides.	Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JG (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands.	J.Hoenderop@ncmls.ru.nl	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544				Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; BINDELS RJM, 1991, AM J PHYSIOL, V261, pF799, DOI 10.1152/ajprenal.1991.261.5.F799; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; CARSON DD, 1990, J BIOL CHEM, V265, P2947; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Schiffmann R, 2002, DRUGS, V62, P733, DOI 10.2165/00003495-200262050-00002; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	19	482	501	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					490	493		10.1126/science.1114245	http://dx.doi.org/10.1126/science.1114245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239475				2022-12-01	WOS:000232786000046
J	Barnes, TD; Kubota, Y; Hu, D; Jin, DZZ; Graybiel, AM				Barnes, TD; Kubota, Y; Hu, D; Jin, DZZ; Graybiel, AM			Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories	NATURE			English	Article							BASAL GANGLIA; PREDICTION; EXTINCTION; SELECTION; HABITS; CORTEX	Learning to perform a behavioural procedure as a well-ingrained habit requires extensive repetition of the behavioural sequence, and learning not to perform such behaviours is notoriously difficult. Yet regaining a habit can occur quickly, with even one or a few exposures to cues previously triggering the behaviour(1-3). To identify neural mechanisms that might underlie such learning dynamics, we made long-term recordings from multiple neurons in the sensorimotor striatum, a basal ganglia structure implicated in habit formation(4-8), in rats successively trained on a reward-based procedural task, given extinction training and then given reacquisition training. The spike activity of striatal output neurons, nodal points in cortico-basal ganglia circuits, changed markedly across multiple dimensions during each of these phases of learning. First, new patterns of task-related ensemble firing successively formed, reversed and then re-emerged. Second, task-irrelevant firing was suppressed, then rebounded, and then was suppressed again. These changing spike activity patterns were highly correlated with changes in behavioural performance. We propose that these changes in task representation in cortico-basal ganglia circuits represent neural equivalents of the explore-exploit behaviour characteristic of habit learning.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Penn State Univ, Dept Phys, Davey Lab 0104, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 43 Vassar St,46-6133, Cambridge, MA 02139 USA.	graybiel@mit.edu	Jin, Dezhe/AAE-6788-2020	Graybiel, Ann/0000-0002-4326-7720	NINDS NIH HHS [P50 NS038372] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barto A, 1998, REINFORCEMENT LEARNI, V1st; Beiser, 1995, MODELS INFORM PROCES, P215; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Djurfeldt M, 2001, NEUROCOMPUTING, V38, P573, DOI 10.1016/S0925-2312(01)00413-1; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Doya K, 1996, ADV NEURAL INFORMATI, P101; Doya Kenji, 2000, P469; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; James W, 1890, PRINCIPLES PSYCHOL, P104; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pavlov IP, 1927, CONDITIONED REFLEXES; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; ROUTTENBERG A, 1978, CHOLINERGIC MONOAMIN, P305; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	30	423	428	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2005	437	7062					1158	1161		10.1038/nature04053	http://dx.doi.org/10.1038/nature04053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237445				2022-12-01	WOS:000232660500045
J	Schwartz, RS				Schwartz, RS			Faith healers and physicians - Teaching pseudoscience by mandate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2005	353	14					1437	1439		10.1056/NEJMp058244	http://dx.doi.org/10.1056/NEJMp058244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970LZ	16207844				2022-12-01	WOS:000232313000002
J	Kim, JC; Watts, CH				Kim, JC; Watts, CH			Gaining a foothold: tackling poverty, gender inequality, and HIV in Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CREDIT PROGRAMS; BANGLADESH; WOMEN; VIOLENCE; HEALTH; POWER		Univ Witwatersrand, Sch Publ Hlth, Rural AIDs & Dev Act Res Programme, ZA-1360 Acornhoek, South Africa; Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine	Kim, JC (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Rural AIDs & Dev Act Res Programme, POB 2, ZA-1360 Acornhoek, South Africa.	jkiiu@soft.co.za						Ahmed SM, 2005, J HEALTH POPUL NUTR, V23, P95; ANNAN K, 2002, NY TIMES        1229; CHESTON S, 2002, PATHWAYS OUT POVERTY, P167; Cohen S, 2004, REPROD HEALTH MATTER, V12, P132; *COMM IN, PROGR EXP RUS GIRLS; DALEYHARRIS S, 2004, STAT MICR SUMM CAMP; Goetz AM, 1996, WORLD DEV, V24, P45, DOI 10.1016/0305-750X(95)00124-U; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; HARGREAVES J, INTERVENTION MICROFI; Holden S., 2004, MAINSTREAMING HIV AI; *HUM RIGHTS WATCH, 2003, DOUBL STAND WOM PROP; KIRUBI M, 1994, IMPACT SOCIAL EC SEX; MAYOUX L, 1998, 41 OP U; *MICR SUMM CAMP, WHAT OTH AFR; *MICR SUMM CAMP, AFR MICR AIDS IN; *POP COUNC, 1999, TOST BREAKTHR SEN EN; Population Council, 2001, POW SEX REL OP DIAL; PRONYK PM, IN PRESS SMALL ENTER; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Sachs J., 2005, END POVERTY WE CAN M; Sanders D, 2004, B WORLD HEALTH ORGAN, V82, P757; Schuler SR, 1996, SOC SCI MED, V43, P1729, DOI 10.1016/S0277-9536(96)00068-8; Schuler SR, 1997, WORLD DEV, V25, P563, DOI 10.1016/S0305-750X(96)00119-2; Sumartojo E, 2000, AIDS, V14, pS1, DOI 10.1097/00002030-200006001-00001; UNAIDS, 2004, 4 UNAIDS; *UNAIDS, 1999, GEND HIV AIDS TAK ST; *UNAIDS UN POP FUN, 2004, WOM HIV AIDS CONFR C; United Nations General Assembly Special Session, 2001, DECL COMM HIV AIDS; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472	29	53	53	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2005	331	7519					769	772		10.1136/bmj.331.7519.769	http://dx.doi.org/10.1136/bmj.331.7519.769			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971XB	16195298	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000232417100028
J	Palter, JB; Lozier, MS; Barber, RT				Palter, JB; Lozier, MS; Barber, RT			The effect of advection on the nutrient reservoir in the North Atlantic subtropical gyre	NATURE			English	Article							VARIABILITY; WATER; CIRCULATION; SEA	Though critically important in sustaining the ocean's biological pump, the cycling of nutrients in the subtropical gyres is poorly understood. The supply of nutrients to the sunlit surface layer of the ocean has traditionally been attributed solely to vertical processes. However, horizontal advection may also be important in establishing the availability of nutrients. Here we show that the production and advection of North Atlantic Subtropical Mode Water introduces spatial and temporal variability in the subsurface nutrient reservoir beneath the North Atlantic subtropical gyre. As the mode water is formed, its nutrients are depleted by biological utilization. When the depleted water mass is exported to the gyre, it injects a wedge of low-nutrient water into the upper layers of the ocean. Contrary to intuition, cold winters that promote deep convective mixing and vigorous mode water formation may diminish downstream primary productivity by altering the subsurface delivery of nutrients.	Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA; Duke Univ, Marine Lab, Nicholas Sch Environm & Earth Sci, Div Coastal Syst Sci & Policy, Beaufort, NC 28516 USA	Duke University; Duke University	Palter, JB (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA.	jbp3@duke.edu	Palter, Jaime B/B-9484-2011	Palter, Jaime/0000-0002-2656-8062				Bahamon N, 2003, DEEP-SEA RES PT I, V50, P1189, DOI 10.1016/S0967-0637(03)00145-6; Barber RT, 2001, DEEP-SEA RES PT II, V48, P1127, DOI 10.1016/S0967-0645(00)00134-X; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; FITZWATER SE, 1982, LIMNOL OCEANOGR, V27, P544, DOI 10.4319/lo.1982.27.3.0544; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; JENKINS WJ, 1982, NATURE, V300, P246, DOI 10.1038/300246a0; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; LEWIS MR, 1988, J GEOPHYS RES-OCEANS, V93, P6847, DOI 10.1029/JC093iC06p06847; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; Lozier MS, 1995, PROG OCEANOGR, V36, P1, DOI 10.1016/0079-6611(95)00013-5; Mann K.H., 1996, DYNAMICS MARINE ECOS, DOI 10.2307/2960585; McCartney MS, 1982, J MAR RES, V40, P427; McClain CR, 2004, DEEP-SEA RES PT II, V51, P281, DOI 10.1016/j.dsr2.2003.08.002; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; MENZEL DW, 1961, DEEP-SEA RES, V7, P282, DOI 10.1016/0146-6313(61)90046-6; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; PELEGRI JL, 1991, J GEOPHYS RES-OCEANS, V96, P2577, DOI 10.1029/90JC02535; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; TAKAHASHI T, 1985, J GEOPHYS RES-OCEANS, V90, P6907, DOI 10.1029/JC090iC04p06907; Talley LD, 1982, J MAR RES, V40, P757; Talley LD, 1996, PHYSICA D, V98, P625, DOI 10.1016/0167-2789(96)00123-6; TRENBERTH KE, 1989, NCARTN388STR; Walker SJ, 2000, J GEOPHYS RES-OCEANS, V105, P14285, DOI 10.1029/1999JC900273; WARNER MJ, 1985, DEEP-SEA RES, V32, P1485, DOI 10.1016/0198-0149(85)90099-8; Williams RG, 1998, DEEP-SEA RES PT I, V45, P461, DOI 10.1016/S0967-0637(97)00094-0; Wilson C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014063; Worthington L.V., 1976, N ATLANTIC CIRCULATI	32	144	145	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					687	692		10.1038/nature03969	http://dx.doi.org/10.1038/nature03969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193044				2022-12-01	WOS:000232157900043
J	Schabath, MB; Hernandez, LM; Wu, XF; Pillow, PC; Spitz, MR				Schabath, MB; Hernandez, LM; Wu, XF; Pillow, PC; Spitz, MR			Dietary phytoestrogens and lung cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-RECEPTOR-BETA; IN-VITRO; ENDOMETRIAL CANCER; PROSTATE-CANCER; SOY; CONSUMPTION; PHYTOSTEROLS; ISOFLAVONES; EXPRESSION; GENISTEIN	Context Despite lung-specific in vitro and in vivo studies that support a chemopreventive role for phytoestrogens, there has been little epidemiologic research focused on dietary intake of phytoestrogens and risk of lung cancer. Objective To examine the relationship between dietary intake of phytoestrogens and risk of lung cancer. Design, Setting, and Participants Ongoing US case-control study of 1674 patients with lung cancer (cases) and 1735 matched healthy controls. From July 1995 through October 2003, participants were personally interviewed, with epidemiologic and food frequency questionnaires to collect demographic information and to quantify dietary intake of 12 individual phytoestrogens. Main Outcome Measure Risk of lung cancer, estimated using unconditional multivariable logistic regression analyses stratified by sex and smoking status and adjusted for established and putative lung cancer risk factors. Results Reductions in risk of lung cancer tended to increase with each increasing quartile of phytoestrogen intake. The highest quartiles of total phytosterols, isoflavones, lignans, and phytoestrogens were each associated with reductions in risk of lung cancer ranging from 21% for phytosterols (odds ratio [OR], 0.79; 95% confidence interval [Cl], 0.64-0.97; P=.03 for trend) to 46% for total phytoestrogens from food sources only (OR, 0.54; 95% Cl, 0.42-0.70; P<.001 for trend). Sex-specific effects were also apparent. For men, statistically significant trends for decreasing risk with increasing intake were noted for each phytoestrogen group, with protective effects for the highest quartile of intake ranging from 24% for phytosterols (OR, 0.76; 95% Cl, 0.56-1.02; P=.04 for trend) to 44% for isoflavones (OR, 0.56; 95% Cl, 0.41 0,76; P<.001 for trend), while in women, significant trends were only present for intake of total phytoestrogens from food sources only, with a 34% (OR, 0.66; 95% Cl, 0.46-0.96; P=.01 for trend) protective effect for the highest quartile of intake. The apparent benefits of high phytoestrogen intake were evident in both never and current smokers but less apparent in former smokers. In women, statistically significant joint effects were evident between hormone therapy use and phytoestrogen intake. Specifically, high intake of the lignans enterolactone and enterodiol and use of hormone therapy were associated with a 50% (OR, 0.50; 95% Cl, 0.31-0.68; P=.04 for interaction) reduction in risk of lung cancer. Conclusions While there are limitations and concerns regarding case-control studies of diet and cancer, these data provide further support for the limited but growing epidemiologic evidence that phytoestrogens are associated with a decrease in risk of lung cancer. Confirmation of these findings is still required in large-scale, hypothesis-driven, prospective studies.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Spitz, MR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, POB 301439, Houston, TX 77030 USA.	mspitz@mdanderson.org	Schabath, Matthew/J-3763-2016	Schabath, Matthew/0000-0003-3241-3216	NCI NIH HHS [CA 70907, CA 55769, R25 CA 57730, CA 86390, L30 CA117768] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA057730, U01CA086390, P50CA070907, R01CA055769] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Adlercreutz H, 2000, J NUTR, V130, p658S, DOI 10.1093/jn/130.3.658S; Anderson JJB, 1999, PUBLIC HEALTH NUTR, V2, P489, DOI 10.1017/S1368980099000671; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965; Bouic P J, 1999, Altern Med Rev, V4, P170; CANVER CC, 1994, J THORAC CARDIOV SUR, V108, P153; Chen CC, 2000, J IMMUNOL, V165, P2719, DOI 10.4049/jimmunol.165.5.2719; de Kleijn MJJ, 2001, J NUTR, V131, P1826; De Stefani E, 2000, NUTR CANCER, V37, P140, DOI 10.1207/S15327914NC372_4; Ding H, 2003, BIOCHEM BIOPH RES CO, V305, P950, DOI 10.1016/S0006-291X(03)00873-8; Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1016/S1521-690X(02)00103-3; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Fasco MJ, 2002, MOL CELL ENDOCRINOL, V188, P125, DOI 10.1016/S0303-7207(01)00750-X; FOTSIS T, 1995, J NUTR, V125, pS790, DOI 10.1093/jn/125.suppl_3.790S; Fournier DB, 1998, CANCER EPIDEM BIOMAR, V7, P1055; GIOVANNUCCI E, 1993, AM J EPIDEMIOL, V137, P502, DOI 10.1093/oxfordjournals.aje.a116703; Goldbohm RA, 1996, J NATL CANCER I, V88, P93, DOI 10.1093/jnci/88.2.93; Goodman MT, 1997, AM J EPIDEMIOL, V146, P294, DOI 10.1093/oxfordjournals.aje.a009270; GUPTA MB, 1980, PLANTA MED, V39, P157, DOI 10.1055/s-2008-1074919; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Hebert JR, 1998, JNCI-J NATL CANCER I, V90, P1637, DOI 10.1093/jnci/90.21.1637; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; Horn-Ross PL, 2000, CANCER CAUSE CONTROL, V11, P289, DOI 10.1023/A:1008995606699; Hu JF, 1997, INT J CANCER, V71, P924, DOI 10.1002/(SICI)1097-0215(19970611)71:6&lt;924::AID-IJC2&gt;3.0.CO;2-#; Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565; Ju YH, 2004, J NUTR, V134, P1145, DOI 10.1093/jn/134.5.1145; KINLEN LJ, 1988, BRIT J CANCER, V58, P397, DOI 10.1038/bjc.1988.227; Knekt P, 1997, AM J EPIDEMIOL, V146, P223, DOI 10.1093/oxfordjournals.aje.a009257; KOO LC, 1988, NUTR CANCER, V11, P155, DOI 10.1080/01635588809513983; Kreuzer M, 2003, INT J EPIDEMIOL, V32, P263, DOI 10.1093/ije/dyg064; Kubik AK, 2004, EUR J CANCER PREV, V13, P471, DOI 10.1097/00008469-200412000-00002; Lagiou P, 2002, P NUTR SOC, V61, P217, DOI 10.1079/PNS2002145; Law M, 2000, BMJ-BRIT MED J, V320, P861, DOI 10.1136/bmj.320.7238.861; LEE HP, 1991, LANCET, V337, P1197, DOI 10.1016/0140-6736(91)92867-2; LEE Y-S, 1991, Journal of Korean Medical Science, V6, P325; Li DH, 1999, J NUTR, V129, P1075, DOI 10.1093/jn/129.5.1075; Lian FR, 1999, NUTR CANCER, V33, P125, DOI 10.1207/S15327914NC330202; LING WH, 1995, LIFE SCI, V57, P195, DOI 10.1016/0024-3205(95)00263-6; Mazur W, 1998, BAILLIERE CLIN ENDOC, V12, P729, DOI 10.1016/S0950-351X(98)80013-X; Mazur W, 1998, PURE APPL CHEM, V70, P1759, DOI 10.1351/pac199870091759; McCann SE, 2000, CANCER CAUSE CONTROL, V11, P965, DOI 10.1023/A:1026551309873; McCann SE, 2003, J NUTR, V133, P1937, DOI 10.1093/jn/133.6.1937; Mendilaharsu M, 1998, LUNG CANCER-J IASLC, V19, P101, DOI 10.1016/S0169-5002(97)00075-5; Mendilaharsu M, 1998, LUNG CANCER-J IASLC, V21, P37, DOI 10.1016/S0169-5002(98)00044-0; Michels KB, 2005, INT J CANCER, V114, P163, DOI 10.1002/ijc.20662; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Olsson H, 2003, OBSTET GYNECOL, V102, P565, DOI 10.1016/S0029-7844(03)00564-7; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Pillow PC, 1999, NUTR CANCER, V33, P3, DOI 10.1080/01635589909514742; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Schabath MB, 2004, CLIN CANCER RES, V10, P113, DOI 10.1158/1078-0432.CCR-0911-3; Seow A, 2002, INT J CANCER, V97, P365, DOI 10.1002/ijc.1615; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Stabile LP, 2002, CANCER RES, V62, P2141; STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753; Strom SS, 1999, NUTR CANCER, V33, P20, DOI 10.1080/01635589909514743; Sun AS, 2001, NUTR CANCER, V39, P85, DOI 10.1207/S15327914nc391_12; SWANSON CA, 1992, INT J CANCER, V50, P876, DOI 10.1002/ijc.2910500609; Takasaki M, 1997, BIOL PHARM BULL, V20, P776, DOI 10.1248/bpb.20.776; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; Tsourounis C, 2001, CLIN OBSTET GYNECOL, V44, P836, DOI 10.1097/00003081-200112000-00021; United States Department of Agriculture, 1998, CONT SURV FOOD INT I; US Department of Agriculture, 2002, USDA IOW STAT U DAT; *USDA, 2004, USDA NAT NUTR DAT ST; Valsta LM, 2003, BRIT J NUTR, V89, pS31, DOI 10.1079/BJN2002794; Wakai K, 1999, NUTR CANCER, V33, P139, DOI 10.1207/S15327914NC330204; Walcott FL, 2002, NUTR CANCER, V44, P44, DOI 10.1207/S15327914NC441_6; Willet W, 1998, NUTR EPIDEMIOLOGY; WU X, 2004, P AM ASSOC CANC RES, P45	74	79	82	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2005	294	12					1493	1504		10.1001/jama.294.12.1493	http://dx.doi.org/10.1001/jama.294.12.1493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967TF	16189362	Bronze			2022-12-01	WOS:000232113400019
J	Covert, MW; Leung, TH; Gaston, JE; Baltimore, D				Covert, MW; Leung, TH; Gaston, JE; Baltimore, D			Achieving stability of lipopolysaccharide-induced NF-kappa B activation	SCIENCE			English	Article							SIGNALING PATHWAY; ALPHA; BETA; EXPRESSION; INHIBITOR; PROTEINS; CANCER; TRIF	The activation dynamics of the transcription factor NF-kappa B exhibit damped oscillatory behavior when cells are stimulated by tumor necrosis factor-alpha (TNF alpha) but stable behavior when stimulated by lipopolysaccharide (LPS). LPS binding to Toll-like receptor 4 (TLR4) causes activation of NF-kappa B that requires two downstream pathways, each of which when isolated exhibits damped oscillatory behavior. Computational modeling of the two TLR4-dependent signaling pathways suggests that one pathway requires a time delay to establish early antiphase activation of NF-kappa B by the two pathways. The MyD88-independent pathway required Inferon regulatory factor 3-dependent expression of TNF alpha to activate NF-kappa B, and the time required for TNF alpha synthesis established the delay.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu		Covert, Markus/0000-0002-5993-8912	NIGMS NIH HHS [GM039458-21] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SEBORG DE, 1989, WILEY SERIES CHEM EN, P7; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	26	480	500	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1854	1857		10.1126/science.1112304	http://dx.doi.org/10.1126/science.1112304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166516				2022-12-01	WOS:000231989500049
J	Sambashivan, S; Liu, YS; Sawaya, MR; Gingery, M; Eisenberg, D				Sambashivan, S; Liu, YS; Sawaya, MR; Gingery, M; Eisenberg, D			Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure	NATURE			English	Article							DISULFIDE BRIDGES; CORE STRUCTURE; CYSTATIN-C; PROTEIN; AGGREGATION; FIBERS; MODEL	Amyloid or amyloid-like fibrils are elongated, insoluble protein aggregates, formed in vivo(1) in association with neurodegenerative diseases or in vitro(2) from soluble native proteins, respectively. The underlying structure of the fibrillar or 'cross-beta' state has presented long-standing, fundamental puzzles of protein structure. These include whether fibril-forming proteins have two structurally distinct stable states, native and fibrillar, and whether all or only part of the native protein refolds as it converts to the fibrillar state. Here we show that a designed amyloid-like fibril of the well-characterized enzyme RNase A contains native-like molecules capable of enzymatic activity. In addition, these functional molecular units are formed from a core RNase A domain and a swapped complementary domain. These findings are consistent with the zipper-spine model(3) in which a cross-beta spine is decorated with three-dimensional domain-swapped functional units, retaining native-like structure.	Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P2421; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Gotte G, 1999, EUR J BIOCHEM, V265, P680, DOI 10.1046/j.1432-1327.1999.00761.x; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pickersgill RW, 2003, STRUCTURE, V11, P137, DOI 10.1016/S0969-2126(03)00009-1; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; SELA M, 1957, SCIENCE, V125, P691, DOI 10.1126/science.125.3250.691; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Wetzel R, 2002, STRUCTURE, V10, P1031, DOI 10.1016/S0969-2126(02)00809-2	26	218	222	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					266	269		10.1038/nature03916	http://dx.doi.org/10.1038/nature03916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148936				2022-12-01	WOS:000231696900058
J	Kobayashi, T; Ganley, ARD				Kobayashi, T; Ganley, ARD			Recombination regulation by transcription-induced cohesin dissociation in rDNA repeats	SCIENCE			English	Article							RIBOSOMAL DNA REPEATS; SACCHAROMYCES-CEREVISIAE; YEAST; REPLICATION; ELEMENTS; IDENTIFICATION; EXPANSION; PROTEIN; GENOME; REGION	Organisms maintain ribosomal RNA gene repeats (rDNA) at stable copy numbers by recombination; the loss of repeats results in gene amplification. Here we report a mechanism of amplification regulation. We show that amplification is dependent on transcription from a noncoding bidirectional promoter (E-pro) within the rDNA spacer. E-pro transcription stimulates the dissociation of cohesin, a DNA binding protein complex that suppresses sister-chromatid-based changes in rDNA copy number. This transcription is regulated by the silencing gene, SIR2, and by copy number. Transcription-induced cohesin dissociation may be a general mechanism of recombination regulation.	Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Kobayashi, T (corresponding author), Natl Inst Basic Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	koba@nibb.ac.jp	Ganley, Austen/L-8120-2013	Ganley, Austen/0000-0002-1917-7522				Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HAWLEY RS, 1989, ANNU REV GENET, V23, P87, DOI 10.1146/annurev.ge.23.120189.000511; Kobayashi T, 2001, MOL CELL BIOL, V21, P136, DOI 10.1128/MCB.21.1.136-147.2001; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; RODLAND KD, 1982, BIOCHIM BIOPHYS ACTA, V697, P162, DOI 10.1016/0167-4781(82)90072-0; SANTANGELO GM, 1988, MOL CELL BIOL, V8, P4217, DOI 10.1128/MCB.8.10.4217; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SMITH GP, 1973, COLD SPRING HARB SYM, V38, P507, DOI 10.1101/SQB.1974.038.01.055; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	24	220	224	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1581	1584		10.1126/science.1116102	http://dx.doi.org/10.1126/science.1116102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141077				2022-12-01	WOS:000231715000055
J	Lu, R; Maduro, M; Li, F; Li, HW; Broitman-Maduro, G; Li, WX; Ding, SW				Lu, R; Maduro, M; Li, F; Li, HW; Broitman-Maduro, G; Li, WX; Ding, SW			Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; GENETIC INTERFERENCE; DISTINCT ROLES; SUPPRESSORS; PATHWAYS; PLANTS; INDUCTION; PROTEINS; POTENT	The worm Caenorhabditis elegans is a model system for studying many aspects of biology, including host responses to bacterial pathogens(1,2), but it is not known to support replication of any virus. Plants and insects encode multiple Dicer enzymes that recognize distinct precursors of small RNAs and may act cooperatively(3-7). However, it is not known whether the single Dicer of worms and mammals is able to initiate the small RNA-guided RNA interference (RNAi) antiviral immunity as occurs in plants(8) and insects(9). Here we show complete replication of the Flock house virus (FHV) bipartite, plus-strand RNA genome in C. elegans. We show that FHV replication in C. elegans triggers potent antiviral silencing that requires RDE-1, an Argonaute protein(10,11) essential for RNAi mediated by small interfering RNAs (siRNAs) but not by microRNAs. This immunity system is capable of rapid virus clearance in the absence of FHV B2 protein, which acts as a broad-spectrum RNAi inhibitor(9,12) upstream of rde-1 by targeting the siRNA precursor. This work establishes a C. elegans model for genetic studies of animal virus - host interactions and indicates that mammals might use a siRNA pathway as an antiviral response.	Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Grad Program Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Ding, SW (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	dingsw@ucr.edu	Ding, Shou Wei/AAC-2533-2020	Broitman-Maduro, Gina/0000-0002-8059-8246; Ding, SW/0000-0002-4697-8413	NIAID NIH HHS [R01 AI052447] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Silhavy D, 2004, TRENDS PLANT SCI, V9, P76, DOI 10.1016/j.tplants.2003.12.010; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	28	313	325	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					1040	1043		10.1038/nature03870	http://dx.doi.org/10.1038/nature03870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107851	Green Accepted, Green Submitted			2022-12-01	WOS:000231263900055
J	Ruta, V; Chen, JY; MacKinnon, R				Ruta, V; Chen, JY; MacKinnon, R			Calibrated measurement of gating-charge arginine displacement in the KvAP voltage-dependent K+ channel	CELL			English	Article							POTASSIUM CHANNEL; TRANSMEMBRANE MOVEMENT; SODIUM-CHANNELS; ION CHANNELS; S4 SEGMENT; SENSOR; ACTIVATION; DOMAIN; INHIBITION; RESIDUES	Voltage-dependent ion channels open and conduct ions in response to changes in cell-membrane voltage. The voltage sensitivity of these channels arises from the motion of charged arginine residues located on the S4 helices of the channel's voltage sensors. In KvAP, a prokaryotic voltage-dependent K channel, the S4 helix forms part of a helical hairpin structure, the voltage-sensor paddle. We have measured the membrane depth of residues throughout the KvAP channel using avidin accessibility to different-length tethered biotin reagents. From these measurements, we have calibrated the tether lengths and derived the thickness of the membrane that forms a barrier to avidin penetration, allowing us to determine the magnitude of displacement of the voltage-sensor paddles during channel gating. Here we show that the voltagesensor paddles are highly mobile compared to other regions of the channel and transfer the gating-charge arginines 15-20 angstrom through the membrane to open the pore.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu		Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hristova K, 1998, BIOPHYS J, V74, P2419, DOI 10.1016/S0006-3495(98)77950-0; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Senzel L, 1998, J GEN PHYSIOL, V112, P317, DOI 10.1085/jgp.112.3.317; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; WIENER MC, 1992, BIOPHYS J, V61, P437; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	34	175	178	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					463	475		10.1016/j.cell.2005.08.041	http://dx.doi.org/10.1016/j.cell.2005.08.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269337	Bronze			2022-12-01	WOS:000233264300014
J	Schuwirth, BS; Borovinskaya, MA; Hau, CW; Zhang, W; Vila-Sanjurjo, A; Holton, JM; Cate, JHD				Schuwirth, BS; Borovinskaya, MA; Hau, CW; Zhang, W; Vila-Sanjurjo, A; Holton, JM; Cate, JHD			Structures of the bacterial ribosome at 3.5 angstrom resolution	SCIENCE			English	Article							PEPTIDE-BOND FORMATION; AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR G; ESCHERICHIA-COLI; MESSENGER-RNA; CRYOELECTRON MICROSCOPY; PROTEIN-SYNTHESIS; CRYO-EM; SUBUNIT; TRANSLOCATION	We describe two structures of the intact bacteria[ ribosome from Escherichia coli determined to a resolution of 3.5 angstroms by x-ray crystallography. These structures provide a detailed view of the interface between the small and large ribosomal subunits and the conformation of the peptidyl transferase center in the context of the intact ribosome. Differences between the two ribosomes reveal a high degree of flexibility between the head and the rest of the small subunit. Swiveling of the head of the small subunit observed in the present structures, coupled to-the ratchet-like motion of the two subunits observed previously, suggests a mechanism for the final movements of messenger RNA (mRNA) and transfer RNAs (tRNAs) during translocation.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Physiol Biosci Div, Berkeley, CA 94720 USA; Free Univ Berlin, Inst Chem Crystallog, D-14195 Berlin, Germany	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Free University of Berlin	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jcate@lbl.gov	Classen, Scott/AAY-8176-2020; Vila-Sanjurjo, Antón/AAS-1007-2020; vila-sanjurjo, anton/L-1941-2014	Vila-Sanjurjo, Antón/0000-0001-7820-1644; vila-sanjurjo, anton/0000-0001-7820-1644; Zhang, Wen/0000-0002-4973-1168	NCI NIH HHS [CA92584] Funding Source: Medline; NIGMS NIH HHS [GM65050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Blaha G, 2000, METHOD ENZYMOL, V317, P292; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brandi L, 2004, J MOL BIOL, V335, P881, DOI 10.1016/j.jmb.2003.10.067; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Hagerman PJ, 1997, ANNU REV BIOPH BIOM, V26, P139, DOI 10.1146/annurev.biophys.26.1.139; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hoang L, 2004, P NATL ACAD SCI USA, V101, P12439, DOI 10.1073/pnas.0405227101; HUIBONHOA G, 1980, BIOCHEMISTRY-US, V19, P3080, DOI 10.1021/bi00554a038; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; MACON JB, 1968, BIOCHEMISTRY-US, V7, P3453, DOI 10.1021/bi00850a021; Maivali U, 2004, RNA, V10, P600, DOI 10.1261/rna.5220504; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; MONRO RE, 1967, J MOL BIOL, V26, P147, DOI 10.1016/0022-2836(67)90271-9; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; SPIRIN A, 1987, BIOCHIMIE, V69, P949, DOI 10.1016/0300-9084(87)90228-8; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; TATE WP, 1983, J BIOL CHEM, V258, P2816; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov A. V., 2005, J BIOL-LONDON, V4, P9; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	72	1005	1088	1	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					827	834		10.1126/science.1117230	http://dx.doi.org/10.1126/science.1117230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272117				2022-12-01	WOS:000233121800038
J	Lunzer, M; Milter, SP; Felsheim, R; Dean, AM				Lunzer, M; Milter, SP; Felsheim, R; Dean, AM			The biochemical architecture of an ancient adaptive landscape	SCIENCE			English	Article							ANTIBIOTIC-RESISTANCE; 3-ISOPROPYLMALATE DEHYDROGENASE; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; FITNESS PEAKS; ADAPTATION; EVOLUTION; PERSPECTIVE; PROTEIN; ADDITIVITY	Molecular evolution is moving from statistical descriptions of adaptive molecular changes toward predicting the fitness effects of mutations. Here, we characterize the fitness landscape of the six amino acids controlling coenzyme use in isopropylmalate dehydrogenase (IMDH). Although all natural IMDHs use, nicotinamide adenine dinucleotide (NAD) as a coenzyme, they can be engineered to use nicotinamide adenine dinucleotide phosphate (NADP) instead. Intermediates between these two phenotypic extremes show that each amino acid contributes additively to enzyme function, with epistatic contributions confined to fitness. The genotype-phenotype-fitness map shows that NAD use is a global optimum.	Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dean, AM (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	adean@biosci.umn.edu			NIGMS NIH HHS [GM060611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aita T, 2001, PROTEIN ENG, V14, P633, DOI 10.1093/protein/14.9.633; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Coyne JA, 1997, EVOLUTION, V51, P643, DOI 10.1111/j.1558-5646.1997.tb03650.x; DEAN AM, 1995, GENETICS, V139, P19; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fersht A, 1999, STRUCTURE MECH PROTE; Fisher R.A., 1930, GENETICAL THEORY NAT; HARTL DL, 1985, GENETICS, V111, P655; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; KACSER H, 1981, GENETICS, V97, P639; Lunzer M, 2002, GENETICS, V162, P485; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P355, DOI 10.1046/j.1365-2958.2002.03173.x; Qasim MA, 2003, BIOCHEMISTRY-US, V42, P6460, DOI 10.1021/bi027186u; SANDBERG WS, 1993, P NATL ACAD SCI USA, V90, P8367, DOI 10.1073/pnas.90.18.8367; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Weinreich DM, 2005, EVOLUTION, V59, P1165; Weinreich DM, 2005, EVOLUTION, V59, P1175; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; WRIGHT S, 1932, P 6 INT C GEN, P356; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	28	163	167	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					499	501		10.1126/science.1115649	http://dx.doi.org/10.1126/science.1115649			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239478				2022-12-01	WOS:000232786000049
J	Nishida, N; Katamine, S; Manuelidis, L				Nishida, N; Katamine, S; Manuelidis, L			Reciprocal interference between specific CJD and scrapie agents in neural cell cultures	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; TRANSMISSION; INFECTIONS; VIRUSES; STRAIN; MICE	Infection of mice with an attenuated Creutzfetdt-Jakob disease agent (SY-CJD) interferes with superinfection by a more virulent human-derived CJD agent (FU-CJD) and does not require pathological prion protein (PrPres). Using a rapid coculture system, we found that a neural cell line free of immune system cells similarly supported substantial CJD agent interference without PrPres. In addition, SY-CJD prevented superinfection by sheep-derived Chandler (Ch) and 22L scrapie agents. However, only 22L and not Ch prevented FU-CJD infection, even though both scrapie strains provoked abundant PrPres. This relationship between particular strains of sheep- and human-derived agents is likely to affect their prevalence and epidemic spread.	Yale Univ, Sch Med, New Haven, CT 06510 USA; Gifu Univ, Ctr Emerging Infect Dis, Gifu 5011193, Japan; Nagasaki Univ, Grad Sch Med, Dept Mol Microbiol & Immunol, Nagasaki 8528523, Japan	Yale University; Gifu University; Nagasaki University	Manuelidis, L (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.	laura.manuelidis@yale.edu			NINDS NIH HHS [NS12674, R01 NS012674] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS012674, R01NS012674] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Jackson GS, 2001, J CLIN PATHOL-MOL PA, V54, P393; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Linsell L, 2004, NEUROLOGY, V63, P2077, DOI 10.1212/01.WNL.0000145844.53251.BC; Lu ZY, 2004, J CELL BIOCHEM, V93, P644, DOI 10.1002/jcb.20220; Manuelidis L, 1998, P NATL ACAD SCI USA, V95, P2520, DOI 10.1073/pnas.95.5.2520; Manuelidis L, 2000, NEUROSCI LETT, V293, P163, DOI 10.1016/S0304-3940(00)01514-7; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; MANUELIDIS L, 1995, P NATL ACAD SCI USA, V92, P5124, DOI 10.1073/pnas.92.11.5124; Manuelidis L, 2003, P NATL ACAD SCI USA, V100, P5360, DOI 10.1073/pnas.0931192100; Manuelidis L, 2000, J VIROL, V74, P8614, DOI 10.1128/JVI.74.18.8614-8622.2000; MANUELIDIS L, UNPUB; MANUELIDIS L, 1966, TRANSMISSIBLE SUBACU, P375; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SKLAVIADIS T, 1992, VIRUS RES, V26, P241, DOI 10.1016/0168-1702(92)90016-3; Smith PG, 2004, CURR TOP MICROBIOL, V284, P161; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Wu JC, 2005, WORLD J GASTROENTERO, V11, P1658; XI YG, 1992, NATURE, V356, P598, DOI 10.1038/356598a0	25	52	54	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					493	496		10.1126/science.1118155	http://dx.doi.org/10.1126/science.1118155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239476				2022-12-01	WOS:000232786000047
J	Okamoto, N; Inouye, I				Okamoto, N; Inouye, I			A secondary symbiosis in progress?	SCIENCE			English	Article							LIGHT		Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Inouye, I (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	iinouye@sakura.cc.tsukuba.ac.jp	Okamoto, Noriko/J-6570-2012	Okamoto, Noriko/0000-0001-5493-8051				Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; FOSTER KW, 1980, MICROBIOL REV, V44, P572, DOI 10.1128/MMBR.44.4.572-630.1980; Gilson PR, 2002, GENETICA, V115, P13, DOI 10.1023/A:1016011812442; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; INOUYE I, 1984, NORD J BOT, V4, P409; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003	6	67	78	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					287	287		10.1126/science.1116125	http://dx.doi.org/10.1126/science.1116125			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224014				2022-12-01	WOS:000232670100043
J	Shi, QH; King, RW				Shi, QH; King, RW			Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines	NATURE			English	Article							MITOTIC CHECKPOINT; CYCLE PROGRESSION; MAMMALIAN-CELLS; INSTABILITY; CANCER; CYTOKINESIS; MECHANISM; DIFFERENTIATION; INACTIVATION; SEGREGATION	Although mutations in cell cycle regulators or spindle proteins can perturb chromosome segregation(1-7), the causes and consequences of spontaneous mitotic chromosome nondisjunction in human cells are not well understood. It has been assumed that nondisjunction of a chromosome during mitosis will yield two aneuploid daughter cells. Here we show that chromosome nondisjunction is tightly coupled to regulation of cytokinesis in human cell lines, such that nondisjunction results in the formation of tetraploid rather than aneuploid cells. We observed that spontaneously arising binucleated cells exhibited chromosome mis-segregation rates up to 166-fold higher than the overall mitotic population. Long-term imaging experiments indicated that most binucleated cells arose through a bipolar mitosis followed by regression of the cleavage furrow hours later. Nondisjunction occurred with high frequency in cells that became binucleated by furrow regression, but not in cells that completed cytokinesis to form two mononucleated cells. Our findings indicate that nondisjunction does not directly yield aneuploid cells, but rather tetraploid cells that may subsequently become aneuploid through further division. The coupling of spontaneous segregation errors to furrow regression provides a potential explanation for the prevalence of hyperdiploid chromosome number and centrosome amplification observed in many cancers(8,9).	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Yang, Weimei/N-2928-2013; Shi, Qinghua/N-2950-2013	Shi, QingHua/0000-0003-1180-9799; King, Randall/0000-0001-7882-8180				Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; BURHOLT DR, 1989, CANCER RES, V49, P3355; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carere A, 1999, MUTAGENESIS, V14, P491, DOI 10.1093/mutage/14.5.491; Cimini D, 1999, MUTAGENESIS, V14, P563, DOI 10.1093/mutage/14.6.563; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kaneko Y, 2000, GENE CHROMOSOME CANC, V29, P89, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1021>3.0.CO;2-Y; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Macville M, 1999, CANCER RES, V59, P141; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mitelman F, 2005, MITELMAN DATABASE CH; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SHACKNEY SE, 1989, CANCER RES, V49, P3344; Shi QH, 2000, MUTAT RES-FUND MOL M, V452, P27, DOI 10.1016/S0027-5107(00)00032-4; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TANABE K, 1991, CANCER RES, V51, P4903; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6	30	319	331	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1038	1042		10.1038/nature03958	http://dx.doi.org/10.1038/nature03958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222248				2022-12-01	WOS:000232496100048
J	Demers, C; McMurray, JJV; Swedberg, K; Pfeffer, MA; Granger, CB; Olofsson, B; McKelvie, RS; Ostergren, J; Michelson, EL; Johansson, PA; Wang, DL; Yusuf, S				Demers, C; McMurray, JJV; Swedberg, K; Pfeffer, MA; Granger, CB; Olofsson, B; McKelvie, RS; Ostergren, J; Michelson, EL; Johansson, PA; Wang, DL; Yusuf, S		CHARM Investigators	Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; ACE; MORBIDITY; CAPTOPRIL; MORTALITY; INHIBITION; ENALAPRIL; SURVIVAL; OUTCOMES	Context Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI), but it is not known whether angiotensin receptor blockers have the same effect. Objective To assess the impact of the angiotensin receptor blocker candesartan on MI and other coronary events in patients with heart failure. Design, Setting, and Participants The Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program, a randomized, placebo-controlled study enrolling patients (mean age, 66 [SD,11] years) with NewYork Heart Association class II to IV symptoms who were randomly allocated to receive candesartan (target dose, 32 mg once daily) or matching placebo given in addition to optimal therapy for heart failure. Patients were enrolled from March 1999 through March 2001. Of 7599 patients allocated, 4004 (53%) had experienced a previous MI, and 1808 (24%) currently had angina. At baseline, 3125 (41%) were receiving an ACE inhibitor; 4203 (55%), a beta-blocker; 3153 (42%), a lipid-lowering drug; 4246 (56%), aspirin; and 6286 (83%), a diuretic. Main Outcome Measure. The primary outcome of the present analysis was the composite of cardiovascular death or nonfatal MI in patients with heart failure receiving candesartan or placebo. Results During the median follow-up of 37.7 months, the primary outcome of cardiovascular death or nonfatal MI was significantly reduced in the candesartan group (775 patients [20.4%]) vs the placebo group (868 [22.9%]) (hazard ratio [HR], 0.87; 95% confidence interval [CI], 0.79-0.96; P=.004; number needed to treat [NNT], 40). Noonfatal MI alone was also significantly reduced in the candesartan group (116 [3.1%]) vs the placebo group (148 [3.9%]) (HR, 0.77; 95% CI, 0.60-0.98; P=.03; NNT, 118). The secondary outcome of fatal MI, sudden death, or nonfatal MI was significantly reduced with candesartan (459 [12.1%]) vs placebo (522 [13.8%]) (HR, 0.86; 95% CI, 0.75-0.97; P=.02; NNT, 59). Risk reductions in cardiovascular death or nonfatal MI were similar across predetermined subgroups and the component CHARM trials. There was no impact on hospitalizations for unstable angina or coronary revascularization procedures with candesartan. Conclusion In patients with heart failure, candesartan significantly reduces the risk of the composite outcome of cardiovascular death or nonfatal MI.	McMaster Univ, Hamilton, ON L8L 2X2, Canada; Univ Glasgow, Glasgow, Lanark, Scotland; Sahlgrens Univ Hosp, Gothenburg, Sweden; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Duke Univ, Med Ctr, Durham, NC USA; AstraZeneca Res & Dev, Molndal, Sweden; Karolinska Hosp, S-10401 Stockholm, Sweden; AstraZeneca LP, Wilmington, DE USA; London Sch Hyg & Trop Med, London WC1, England	McMaster University; University of Glasgow; Sahlgrenska University Hospital; Harvard University; Brigham & Women's Hospital; Duke University; AstraZeneca; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; University of London; London School of Hygiene & Tropical Medicine	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, McMaster Clin, Hamilton Gen Hosp, Room 252,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusuf@ccc.mcmaster.ca	mcmurray, John/B-2467-2013; Granger, Christopher B/D-3458-2014; Swedberg, Karl/B-2475-2008	mcmurray, John/0000-0002-6317-3975; Granger, Christopher B/0000-0002-0045-3291; Yusuf, Salim/0000-0003-4776-5601				Braunwald E, 2004, NEW ENGL J MED, V351, P2058; *CONS TRIAL STUD G, 1987, NEW ENGL J MED, V326, P1429; Dagenais GR, 2001, CIRCULATION, V104, P522, DOI 10.1161/hc3001.093502; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox KM, 2003, LANCET, V362, P782; McKelvie RS, 1999, CIRCULATION, V100, P1056, DOI 10.1161/01.CIR.100.10.1056; MCMURRAY J, IN PRESS J AM COLL C; Petrie MC, 2001, J AM COLL CARDIOL, V37, P1056, DOI 10.1016/S0735-1097(01)01111-1; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Torp-Pedersen C, 1999, LANCET, V354, P9, DOI 10.1016/S0140-6736(98)09374-X; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; Verma S, 2004, BMJ-BRIT MED J, V329, P1248, DOI 10.1136/bmj.329.7477.1248; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1992, LANCET, V340, P1173, DOI 10.1016/0140-6736(92)92889-N; Yusuf S, 2005, NEW ENGL J MED, V352, P937; Yusuf S, 2002, AM HEART J, V143, P22, DOI 10.1067/mhj.2002.119770	21	48	50	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1794	1798		10.1001/jama.294.14.1794	http://dx.doi.org/10.1001/jama.294.14.1794			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972RX	16219883	Green Accepted, Bronze			2022-12-01	WOS:000232472000019
J	Schwabe, T; Bainton, RJ; Fetter, RD; Heberlein, U; Gaul, U				Schwabe, T; Bainton, RJ; Fetter, RD; Heberlein, U; Gaul, U			GPCR signaling is required for blood-brain barrier formation in Drosophila	CELL			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL-DIVISION; SEPTATE JUNCTION; COUPLED RECEPTOR; NERVOUS-SYSTEM; GLIAL-CELLS; ALPHA; GENE; DIFFERENTIATION; EXPRESSION	The blood-brain barrier of Drosophila is established by surface glia, which ensheath the nerve cord and insulate it against the potassium-rich hemolymph by forming intercellular septate junctions. The mechanisms underlying the formation of this barrier remain obscure. Here, we show that the G protein-coupled receptor (GPCR) Moody, the G protein subunits G alpha i and G alpha o, and the regulator of G protein signaling Loco are required in the surface glia to achieve effective insulation. Our data suggest that the four proteins act in a complex common pathway. At the cellular level, the components function by regulating the cortical actin and thereby stabilizing the extended morphology of the surface glia, which in turn is necessary for the formation of septate junctions of sufficient length to achieve proper sealing of the nerve cord. Our study demonstrates the importance of morphogenetic regulation in blood-brain barrier development and places GPCR signaling at its core.	Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA; Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10021 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Rockefeller University; Rockefeller University; University of California System; University of California San Francisco	Gaul, U (corresponding author), Rockefeller Univ, Lab Dev Neurogenet, 1230 York Ave, New York, NY 10021 USA.	gaul@mail.rockefeller.edu	Schwabe, Tina/AAA-3822-2021		NEI NIH HHS [R01 EY011560, R01 EY011560-08, EY011560] Funding Source: Medline; NIDA NIH HHS [DA444906-33821, DA14809] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011560, R55EY011560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014809] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ABBOTT NJ, 1991, ANN NY ACAD SCI, V633, P378; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Casso D, 2000, MECH DEVELOP, V91, P449; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; EDWARDS JS, 1993, J COMP NEUROL, V333, P301, DOI 10.1002/cne.903330214; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Granderath S, 1999, DEVELOPMENT, V126, P1781; HALTER DA, 1995, DEVELOPMENT, V121, P317; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; QUAN F, 1993, P NATL ACAD SCI USA, V90, P4236, DOI 10.1073/pnas.90.9.4236; Salzer JL, 2002, TRENDS NEUROSCI, V25, P2, DOI 10.1016/S0166-2236(00)02006-3; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schier AF, 2003, CURR BIOL, V13, pR192, DOI 10.1016/S0960-9822(03)00122-2; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Stapleton M, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0080, DOI 10.1186/GB-2002-3-12-RESEARCH0080]; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	47	163	169	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					133	144		10.1016/j.cell.2005.08.037	http://dx.doi.org/10.1016/j.cell.2005.08.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213218	Bronze			2022-12-01	WOS:000232536800014
J	Palmer, LJ; Cordon, LR				Palmer, LJ; Cordon, LR			Genetic Epidemiology 4 - Shaking the tree: mapping complex disease genes with linkage disequilibrium	LANCET			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; HAPLOTYPE BLOCKS; POPULATION STRATIFICATION; BREAST-CANCER; HUMAN-GENOME; CLINICAL-TRIALS; CANDIDATE GENES; DRUG DISCOVERY; ASSOCIATION; FUTURE	Much effort and expense are being spent internationally to detect genetic polymorphisms contributing to susceptibility to complex human disease. Concomitantly, the technology for detecting and genotyping single nucleotide polymorphisms (SNPs) has undergone rapid development, yielding extensive catalogues of these polymorphisms across the genome. Population-based maps of the correlations amongst SNPs (linkage disequilibrium) are now being developed to accelerate the discovery of genes for complex human diseases. These genomic advances coincide with an increasing recognition of the importance of very large sample sizes for studying genetic effects. Together, these new genetic and epidemiological data hold renewed promise for the identification of susceptibility genes for complex traits. We review the state of knowledge about the structure of the human genome as related to SNPs and linkage disequilibrium, discuss the potential applications of this knowledge to mapping complex disease genes, and consider the issues facing whole genome association scanning using SNPs.	Univ Western Australia, Queen Elizabeth II Med Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; Univ Western Australia, Queen Elizabeth II Med Ctr, Med Res Ctr, Nedlands, WA 6009, Australia; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Western Australia; University of Western Australia; University of Oxford; Wellcome Centre for Human Genetics	Palmer, LJ (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Western Australian Inst Med Res, B Block,Hosp Ave, Nedlands, WA 6009, Australia.	lyle.palmer@cyllene.uwa.edu.au	Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NEI NIH HHS [EY-12562] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, AM J HUM GENET, V67, P327; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; [Anonymous], 1986, Lancet, V2, P57; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Austin Melissa A, 2003, Community Genet, V6, P37, DOI 10.1159/000069544; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Burke W, 2003, NEW ENGL J MED, V349, P969, DOI 10.1056/NEJMra012479; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2000, BRIT MED J, V320, P1223, DOI 10.1136/bmj.320.7244.1223; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Chanda SK, 2003, DRUG DISCOV TODAY, V8, P168, DOI 10.1016/S1359-6446(02)02595-3; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Edwards Joanne, 2003, Methods Mol Biol, V226, P287; EWENS WJ, 1995, AM J HUM GENET, V57, P455; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; EXCOFFIER L, 1992, GENETICS, V131, P479; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Fields S, 1997, NAT GENET, V15, P325, DOI 10.1038/ng0497-325; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Horne BD, 2004, GENET EPIDEMIOL, V26, P11, DOI 10.1002/gepi.10292; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kelada SN, 2003, ENVIRON HEALTH PERSP, V111, P1055, DOI 10.1289/ehp.6065; Khoury MJ, 1997, EPIDEMIOL REV, V19, P175, DOI 10.1093/oxfordjournals.epirev.a017940; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuhner MK, 2000, GENETICS, V156, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lee WC, 2002, EPIDEMIOLOGY, V13, P545, DOI 10.1097/00001648-200209000-00010; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Long AD, 1999, GENOME RES, V9, P720; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallinckrodt CH, 2003, BIOL PSYCHIAT, V53, P754, DOI 10.1016/S0006-3223(02)01867-X; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Molenberghs G, 2002, STAT MED, V21, P1387, DOI 10.1002/sim.1118; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Nagy A, 2003, NAT GENET, V33, P276, DOI 10.1038/ng1115; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Ohlstein EH, 2000, ANNU REV PHARMACOL, V40, P177, DOI 10.1146/annurev.pharmtox.40.1.177; Olson JM, 1999, STAT MED, V18, P2961, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2961::AID-SIM206>3.0.CO;2-U; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Palmer LJ, 2001, RESP RES, V2, P102, DOI 10.1186/rr45; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; RIBOLI E, 1992, ANN ONCOL, V3, P783, DOI 10.1093/oxfordjournals.annonc.a058097; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roses AD, 2001, HUM MOL GENET, V10, P2261, DOI 10.1093/hmg/10.20.2261; Rosner B, 1990, FUNDAMENTAL BIOSTATI; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schaid DJ, 2002, GENET EPIDEMIOL, V23, P426, DOI 10.1002/gepi.10184; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; Schulze TG, 2004, HUM MOL GENET, V13, P335, DOI 10.1093/hmg/ddh035; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9; Silverman EK, 2000, AM J RESP CELL MOL, V22, P645, DOI 10.1165/ajrcmb.22.6.f191; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Templeton AR, 1996, CIBA F SYMP, V197, P259; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 2003, ANN MED, V35, P532, DOI 10.1080/07853890310015181; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomas S, 2004, GENET EPIDEMIOL, V26, P116, DOI 10.1002/gepi.10300; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Varmus H, 2002, NAT GENET, V32, P3, DOI 10.1038/ng963; Venter JC, 2003, NAT GENET, V33, P219, DOI 10.1038/ng1114; Verbeke G., 2000, LINEAR MIXED MODELS, P41; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATKINS WS, 1994, AM J HUM GENET, V55, P348; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Weiss S. T., 2001, Pharmacogenomics Journal, V1, P157; White IR, 2003, INT J METH PSYCH RES, V12, P139, DOI 10.1002/mpr.150; Witte JS, 2000, STAT MED, V19, P369, DOI 10.1002/(SICI)1097-0258(20000215)19:3<369::AID-SIM335>3.0.CO;2-N; Wiuf C, 2003, MATH BIOSCI, V185, P205, DOI 10.1016/S0025-5564(03)00089-0; Wolfe KH, 2003, NAT GENET, V33, P255, DOI 10.1038/ng1088; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Wright A. F., 2002, Pharmacogenomics Journal, V2, P75, DOI 10.1038/sj.tpj.6500085; Wright AF, 2001, GENOME BIOL, V2; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhao LP, 1998, AM J HUM GENET, V63, P225, DOI 10.1086/301909; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	153	147	152	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2005	366	9492					1223	1234		10.1016/S0140-6736(05)67485-5	http://dx.doi.org/10.1016/S0140-6736(05)67485-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LK	16198771				2022-12-01	WOS:000232311300032
J	Hochwagen, A; Tham, WH; Brar, GA; Amon, A				Hochwagen, A; Tham, WH; Brar, GA; Amon, A			The FK506 binding protein Fpr3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SISTER-CHROMATID RECOMBINATION; SACCHAROMYCES-CEREVISIAE; YEAST MEIOSIS; FK506-BINDING PROTEIN; CDC14 PHOSPHATASE; PACHYTENE CHECKPOINT; CHROMOSOME SYNAPSIS; PROLINE ISOMERASES; RAPAMYCIN-BINDING	The meiotic recombination checkpoint delays gamete precursors in G2 until DNA breaks created during recombination are repaired and chromosome structure has been restored. Here, we show that the FK506 binding protein Fpr3 prevents premature adaptation to damage and thus serves to maintain recombination checkpoint activity. Impaired checkpoint function is observed both in cells lacking FPR3 and in cells treated with rapamycin, a small molecule inhibitor that binds to the proline isomerase (PPlase) domain of Fpr3. FPR3 functions in the checkpoint through controlling protein phosphatase 1 (PP1). Fpr3 interacts with PP1 through its PPlase domain, regulates PP1 localization, and counteracts the activity of PP1 in vivo. Our findings define a branch of the recombination checkpoint involved in the adaptation to persistent chromosomal damage and a critical function for FK506 binding proteins during meiosis.	MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Ctr Canc Res, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu	Tham, Wai-Hong/L-3173-2018; Tham, Wai-Hong/P-6474-2019	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Amon, Angelika/0000-0001-9837-0314; Hochwagen, Andreas/0000-0002-6184-443X	NIGMS NIH HHS [GM62207, R01 GM062207] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; BENTON BM, 1994, J CELL BIOL, V127, P623, DOI 10.1083/jcb.127.3.623; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Davey M, 2000, MOL GEN GENET, V263, P520, DOI 10.1007/s004380051197; DeCenzo MT, 1996, PROTEIN ENG, V9, P173, DOI 10.1093/protein/9.2.173; DEMASSY B, 1994, P NATL ACAD SCI USA, V91, P11929, DOI 10.1073/pnas.91.25.11929; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Grushcow JM, 1999, GENETICS, V153, P607; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; HEITMAN J, 1992, NEW BIOL, V4, P448; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; KOSER PL, 1993, GENE, V129, P159, DOI 10.1016/0378-1119(93)90264-4; Kuzuhara T, 2004, NAT STRUCT MOL BIOL, V11, P275, DOI 10.1038/nsmb733; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; MANNINGKRIEG UC, 1994, FEBS LETT, V352, P98, DOI 10.1016/0014-5793(94)00927-9; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Munn K, 2000, GENETICS, V156, P245; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Petes TD, 1995, ADV GENET, V33, P41, DOI 10.1016/S0065-2660(08)60330-2; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WAGSTAFF JE, 1982, P NATL ACAD SCI-BIOL, V79, P2986, DOI 10.1073/pnas.79.9.2986; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	63	99	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					861	873		10.1016/j.cell.2005.07.010	http://dx.doi.org/10.1016/j.cell.2005.07.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179256	Bronze			2022-12-01	WOS:000232130200011
J	Sharkis, SJ				Sharkis, SJ			Canadian stem cell scientists take the prize	CELL			English	Editorial Material							BONE-MARROW CELLS	This year, the recipients of the Lasker Award for Basic Medical Research are Ernest A. McCulloch and James E. Till. The landmark studies of McCulloch and Till in the 1960s defined the hallmark properties of stem cells: the ability to self-renew and differentiate.	Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Sharkis, SJ (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Med Inst, Baltimore, MD 21231 USA.	ssharkis@jhmi.edu						BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810	5	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					817	819		10.1016/j.cell.2005.09.008	http://dx.doi.org/10.1016/j.cell.2005.09.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179246	Bronze			2022-12-01	WOS:000232130200001
J	Simmons, LW; Roberts, B				Simmons, LW; Roberts, B			Bacterial immunity traded for sperm viability in male crickets	SCIENCE			English	Article							PARASITES; COSTS; OFFS		Univ Western Australia, Sch Anim Biol M092, Evolutionary Biol Res Grp, Crawley, WA 6009, Australia	University of Western Australia	Simmons, LW (corresponding author), Univ Western Australia, Sch Anim Biol M092, Evolutionary Biol Res Grp, Crawley, WA 6009, Australia.	lsimmons@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474				Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Liljedal S, 1999, P ROY SOC B-BIOL SCI, V266, P1893, DOI 10.1098/rspb.1999.0863; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; SCHNEIDER PM, 1985, INSECT BIOCHEM, V15, P463, DOI 10.1016/0020-1790(85)90058-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Skau PA, 2005, BEHAV ECOL, V16, P410, DOI 10.1093/beheco/ari004	10	89	92	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2031	2031		10.1126/science.1114500	http://dx.doi.org/10.1126/science.1114500			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179472				2022-12-01	WOS:000232181900042
J	Wolff, JL; Boult, C				Wolff, JL; Boult, C			Moving beyond round pegs and square holes: Restructuring medicare to improve chronic care	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH MAINTENANCE ORGANIZATION; RANDOMIZED CONTROLLED-TRIAL; OUTPATIENT GERIATRIC EVALUATION; CONGESTIVE-HEART-FAILURE; NURSE CASE-MANAGEMENT; LATE-LIFE DEPRESSION; ADVERSE DRUG EVENTS; QUALITY-OF-CARE; CHRONIC ILLNESS; CLINICAL-TRIAL	Chronic disease is the norm rather than the exception among Medicare beneficiaries, yet Medicare's benefit structure and reimbursement mechanisms are poorly aligned with high-quality chronic care. This disconnect is thought to undermine the quality of chronic care, thereby contributing to excess program spending and placing beneficiaries at risk foe undesirable health outcomes. Despite widespread recognition of this mismatch, there is little compelling evidence to suggest that successful quality improvement initiatives would reduce the costs of the Medicare program. This paper describes state-of-the-art chronic care innovations to date, discusses ongoing and planned efforts by the Centers for Medicare & Medicaid Services to test related changes to Medicare's benefit structure and provider reimbursement, and suggests opportunities for future progress in this area.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Lipitz Ctr Integrated Hlth Care, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wolff, JL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Lipitz Ctr Integrated Hlth Care, 624 N Broadway,Room 692, Baltimore, MD 21205 USA.	jwolff@jhsph.edu						Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anderson G, 2002, CHRONIC CONDITIONS M; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boult C, 2000, J AM GERIATR SOC, V48, P996; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Boyd CM, 2005, J AM GERIATR SOC, V53, pS205; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; *C BUDG OFF, 2004, AN LIT DIS; Callahan CM, 2001, MED CARE, V39, P772, DOI 10.1097/00005650-200108000-00004; Cassel CK, 1999, HEALTH AFFAIR, V18, P118, DOI 10.1377/hlthaff.18.1.118; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; *COUNC GRAD MED ED, 2000, FIN GRAD MED ED CHAN; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; GOLD M, 2005, HLTH AFF W, V5, P199; Goldman DP, 2003, HEALTH AFFAIR, V22, P194, DOI 10.1377/hlthaff.22.3.194; Gross DJ, 1999, HEALTH SERV RES, V34, P241; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kane RL, 1997, J AM GERIATR SOC, V45, P101, DOI 10.1111/j.1532-5415.1997.tb00987.x; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; MedPAC, 2004, REP C NEW APPR MED; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Newcomer R, 2000, J AM GERIATR SOC, V48, P829; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; *PARTN SOL, 2002, MED COST PREV CHRON; *PARTN SOL, 2001, MED 5 PERC STAND AN; Phelan EA, 2002, J AM GERIATR SOC, V50, P1519, DOI 10.1046/j.1532-5415.2002.50407.x; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Reuben DB, 2002, MED CARE, V40, P416, DOI 10.1097/00005650-200205000-00007; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; *S HMO MED PAYM AD, 2003, REC FUT DEM; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Selden TM, 2003, MED CARE, V41, P13; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; VLADECK BC, 2002, MEDICARE CHRONIC CAR; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; WHITE AJ, 2000, EVALUATION PROGRAM A; Williams MV, 2002, FAM MED, V34, P383; Windham BG, 2003, AM J MANAG CARE, V9, P447; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	66	48	48	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					439	445		10.7326/0003-4819-143-6-200509200-00008	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967OG	16172442				2022-12-01	WOS:000232099900005
J	Chipuk, JE; Bouchier-Hayes, L; Kuwana, T; Newmeyer, DD; Green, DR				Chipuk, JE; Bouchier-Hayes, L; Kuwana, T; Newmeyer, DD; Green, DR			PUMA couples the nuclear and cytoplasmic proapoptotic function of p53	SCIENCE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CELL-DEATH; APOPTOTIC RESPONSE; DNA-DAMAGE; BAX; ACTIVATION; PROTEINS; COMPLEX; BCL-2; GENE	The Trp53 tumor suppressor gene product (p53) functions in the nucleus to regulate proapoptotic genes, whereas cytoplasmic p53 directly activates proapoptotic Bcl-2 proteins to permeabilize mitochondria and initiate apoptosis. Here, we demonstrate that a tripartite nexus between Bcl-xL, cytoplasmic p53, and PUMA coordinates these distinct p53 functions. After genotoxic stress, Bcl-xL sequestered cytoplasmic p53. Nuclear p53 caused expression of PUMA, which then displaced p53 from Bcl-xL, allowing p53 to induce mitochondria) permeabilization. Mutant Bcl-xL that bound p53, but not PUMA, rendered cells resistant to p53-induced apoptosis irrespective of PUMA expression. Thus, PUMA couples the nuclear and cytoplasmic proapoptotic functions of p53.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	La Jolla Institute for Immunology; University of Iowa	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	dgreen5240@aol.com	Bouchier-Hayes, Lisa/T-9491-2019; Green, Douglas R/N-8083-2018	Bouchier-Hayes, Lisa/0000-0003-3886-5977; Green, Douglas R/0000-0002-7332-1417; Chipuk, Jerry Edward/0000-0002-1337-842X				CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Klockel BJ, 2002, CELL DEATH DIFFER, V9, P1063, DOI 10.1038/sj.cdd.4401067; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	27	444	471	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1732	1735		10.1126/science.1114297	http://dx.doi.org/10.1126/science.1114297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151013				2022-12-01	WOS:000231836700047
J	Ogawa, S; Lozach, J; Benner, C; Pascual, G; Tangirala, RK; Westin, S; Hoffmann, A; Subramaniam, S; David, M; Rosenfeld, MG; Glass, CK				Ogawa, S; Lozach, J; Benner, C; Pascual, G; Tangirala, RK; Westin, S; Hoffmann, A; Subramaniam, S; David, M; Rosenfeld, MG; Glass, CK			Molecular determinants of crosstalk between nuclear receptors and toll-like receptors	CELL			English	Article							NF-KAPPA-B; OXIDE SYNTHASE GENE; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; MACROPHAGE ACTIVATION; FUNCTIONAL ANTAGONISM; REGULATORY FACTOR-3; SIGNALING PATHWAYS; RESPONSE ELEMENT; P65 SUBUNIT	Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal- and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPAR gamma and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Exelixis Inc, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Chem & Biochem, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Exelixis, Inc.; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Benner, Christopher/0000-0002-4618-0719	NCI NIH HHS [R01 CA052599, CA52599] Funding Source: Medline; NIAID NIH HHS [R01 AI047182] Funding Source: Medline; NIDDK NIH HHS [R01 DK091183, DK063491] Funding Source: Medline; NIGMS NIH HHS [U54 GM069338, GM069338] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashburner M, 2001, GENOME RES, V11, P1425; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Halees AS, 2003, NUCLEIC ACIDS RES, V31, P3554, DOI 10.1093/nar/gkg549; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kanehisa M, 1996, SCI TECHNOLOGY JAPAN, V59; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Nagpal S, 2001, CURR MED CHEM, V8, P1661, DOI 10.2174/0929867013371950; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pitha PM, 2004, P NATL ACAD SCI USA, V101, P695, DOI 10.1073/pnas.0307303101; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SEGAL E, 2002, P 6 INT C RES COMP M, P263; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200	50	527	546	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					707	721		10.1016/j.cell.2005.06.029	http://dx.doi.org/10.1016/j.cell.2005.06.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143103	Bronze, Green Accepted			2022-12-01	WOS:000231844300011
J	Beauchamp, GK; Keast, RSJ; Morel, D; Lin, JM; Pika, J; Han, Q; Lee, CH; Smith, AB; Breslin, PAS				Beauchamp, GK; Keast, RSJ; Morel, D; Lin, JM; Pika, J; Han, Q; Lee, CH; Smith, AB; Breslin, PAS			Phytochemistry - Ibuprofen-like activity in extra-virgin olive oil	NATURE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HYDROXYTYROSOL		Univ Sci Philadelphia, Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Univ Sci Philadelphia, Dept Pharmacol & Toxicol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; Konkuk Univ, Anim Resources Res Ctr, Seoul 143130, South Korea; Firmenich Co, Princeton, NJ 08543 USA	Monell Chemical Senses Center; University of Pennsylvania; Konkuk University; Firmenich	Breslin, PAS (corresponding author), Univ Sci Philadelphia, Monell Chem Senses Ctr, Philadelphia, PA 19104 USA.	breslin@monell.org	Keast, Russell S/P-1899-2017	Keast, Russell S/0000-0003-2147-7687; Breslin, Paul/0000-0001-5988-8401				Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Breslin PAS, 2001, CHEM SENSES, V26, P55, DOI 10.1093/chemse/26.1.55; FISCHER R, 1965, NATURE, V207, P1049, DOI 10.1038/2071049a0; Harris RE, 2005, ONCOL REP, V13, P559; Hennekens CH, 2002, AM J MANAG CARE, V8, pS691; Hu FB, 2003, NEW ENGL J MED, V348, P2595, DOI 10.1056/NEJMp030069; LEFER AM, 1984, BRIT J PHARMACOL, V83, P125, DOI 10.1111/j.1476-5381.1984.tb10126.x; Miro-Casas E, 2003, CLIN CHEM, V49, P945, DOI 10.1373/49.6.945; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Togna GI, 2003, J NUTR, V133, P2532, DOI 10.1093/jn/133.8.2532; Tuck KL, 2001, J NUTR, V131, P1993, DOI 10.1093/jn/131.7.1993; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	13	636	658	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					45	46		10.1038/437045a	http://dx.doi.org/10.1038/437045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136122				2022-12-01	WOS:000231560400033
J	Tsuda, H; Jafar-Nejad, H; Patel, AJ; Sun, Y; Chen, HK; Rose, MF; Venken, KJT; Botas, J; Orr, HT; Bellen, HJ; Zoghbi, HY				Tsuda, H; Jafar-Nejad, H; Patel, AJ; Sun, Y; Chen, HK; Rose, MF; Venken, KJT; Botas, J; Orr, HT; Bellen, HJ; Zoghbi, HY			The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/senseless proteins	CELL			English	Article							FINGER TRANSCRIPTION FACTOR; SCA1 TRANSGENIC MICE; POLYGLUTAMINE-INDUCED DISEASE; FAMILIAL PARKINSONS-DISEASE; GREEN FLUORESCENT PROTEIN; SENSORY ORGAN; GENE-EXPRESSION; CELL-TYPES; DROSOPHILA; DIFFERENTIATION	Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by an expanded glutamine tract in human Ataxin-1 (hAtx-1). The expansion stabilizes hAtx-1, leading to its accumulation. To understand how stabilized hAtx-1 induces selective neuronal degeneration, we studied Drosophila Atx-1 (dAtx-1), which has a conserved AXH domain but lacks a polyglutamine tract. Overexpression of hAtx-1 in fruit flies produces phenotypes similar to those of dAtx-1 but different from the polyglutamine peptide alone. We show that the Drosophila and mammalian transcription factors Senseless/Gfi-1 interact with Atx-1's AXH domain. In flies, overexpression of Atx-1 inhibits sensory-organ development by decreasing Senseless protein. Similarly, overexpression of wildtype and glutamine-expanded hAtx-1 reduces Gfi-1 levels in Purkinje cells. Deletion of the AXH domain abolishes the effects of glutamine-expanded hAtx-1 on Senseless/Gfi-1. Interestingly, loss of Gfi-1 mimics SCA1 phenotypes in Purkinje cells. These results indicate that the Atx-1/Gfi-1 interaction contributes to the selective Purkinje cell degeneration in SCA1.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Venken, Koen/B-9909-2013; Jafar-Nejad, Hamed/B-9216-2008	Venken, Koen/0000-0003-0741-4698; Rose, Matthew/0000-0002-1148-4130; Orr, Harry/0000-0001-6118-741X; Chen, Hung-Kai/0000-0002-2169-4924; Bellen, Hugo/0000-0001-5992-5989; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022920, R01NS022920, R01NS027699, R01NS042179, R56NS042179] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064, HD24064] Funding Source: Medline; NIGMS NIH HHS [T32-GM07526] Funding Source: Medline; NINDS NIH HHS [NS42179, NS22920, NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Clark HB, 1997, J NEUROSCI, V17, P7385; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jafar-Nejad H, 2004, MOL CELL BIOL, V24, P8803, DOI 10.1128/MCB.24.20.8803-8812.2004; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lieberman AP, 1999, ANN NEUROL, V46, P271, DOI 10.1002/1531-8249(199908)46:2<271::AID-ANA21>3.0.CO;2-M; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nolo R, 2001, GENETICS, V157, P307; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Parker DS, 2002, DEVELOPMENT, V129, P2565; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 2001, METABOLIC MOL BASES, P5741	48	155	157	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					633	644		10.1016/j.cell.2005.06.012	http://dx.doi.org/10.1016/j.cell.2005.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122429	Bronze			2022-12-01	WOS:000231555100017
J	Mort, M; Convery, I; Baxter, J; Bailey, C				Mort, M; Convery, I; Baxter, J; Bailey, C			Psychosocial effects of the 2001 UK foot and mouth disease epidemic in a rural population: qualitative diary based study	BRITISH MEDICAL JOURNAL			English	Article							HUMAN CONSEQUENCES; HEALTH; TOOL	Objectives To understand the health and social consequences of the 2001 foot and mouth disease epidemic for a rural population. Design Longitudinal qualitative analysis. Setting North Cumbria, the worst affected area in Britain. Sample Purposive sample of 54 respondents divided into six demographically balanced rural occupational and population groups. Main outcome measures 3071 weekly diaries contributed over 18 months; 72 semistructured interviews (with the 54 diarists and 18 others); 12 group discussions with diarists. Results The disease epidemic was a human tragedy, not just an animal one. Respondents' reports showed that life after the foot and mouth disease epidemic was accompanied by distress, feelings of bereavement, fear of a new disaster, loss of trust in authority and systems of control, and the undermining of the value of local knowledge. Distress was experienced across diverse groups well beyond the farming community. Many of these effects continued to feature in the diaries throughout the 18 month period. Conclusions The use of a rural citizens' panel allowed data capture from a wide spectrum of the rural population and showed that a greater number of workers and residents had traumatic experiences than has previously been reported. Recommendations for future disaster management include joint service reviews of what counts as a disaster, regular NHS and voluntary sector sharing of intelligence, debriefing and peer support for front line workers, increased community involvement in disposal site or disaster management, and wider, more flexible access to regeneration funding and rural health outreach work.	Univ Lancaster, Inst Hlth Res, Lancaster LA1 4YT, England; Univ Cent Lancashire, Preston PR1 2HE, Lancs, England; Univ Lancaster, Int Ctr Uplands, Lancaster LA1 4YW, England	Lancaster University; University of Central Lancashire; Lancaster University	Mort, M (corresponding author), Univ Lancaster, Inst Hlth Res, Lancaster LA1 4YT, England.	m.mort@lancaster.ac.uk	Bailey, Catherine/AAJ-1121-2020; Convery, Ian/C-7141-2008	Convery, Ian/0000-0003-2527-5660; Mort, Margaret Mary Elizabeth/0000-0003-0188-324X				Anderson I., 2002, FOOT MOUTH DIS 2001; Barnes DM, 1996, QUAL HEALTH RES, V6, P429, DOI 10.1177/104973239600600309; Calvert N, 2001, BRIT MED J, V323, P236, DOI 10.1136/bmj.323.7306.236/a; Campbell D, 2003, SOC LEGAL STUD, V12, P425, DOI 10.1177/0964663903012004002; Coote A., 1997, CITIZENS JURIES THEO; *CUMBR FOOT MOUTH, 2002, INQ REP; ELLIOT H, 1997, SOCIOLOGICAL RES ONL, P2; ERIKSON K, IN WAKE OF FLOOD; Erikson K. T., 1976, WAKE FLOOD; Erikson K.T., 1994, NEW SPECIES TROUBLE; FAGBO S, 2001, BMJ; Gibson G, 2001, BRIT MED J, V322, P1491, DOI 10.1136/bmj.322.7300.1491; Hunter M, 2001, BRIT MED J, V322, P881, DOI 10.1136/bmj.322.7291.881; Jones RK, 2000, QUAL HEALTH RES, V10, P555, DOI 10.1177/104973200129118543; Kashefi E, 2004, HEALTH EXPECT, V7, P290, DOI 10.1111/j.1369-7625.2004.00295.x; MCLEAN I, 2000, ABERFAN GOVT DISASTE; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; Morse JM, 2003, QUAL HEALTH RES, V13, P447, DOI 10.1177/1049732302250719; MORTON HG, 2001, BMJ; National Audit Office, 2002, 2001 OUTBR FOOT MOUT; PERROS C, 2003, NORMAL ACCIDENTS; PERROW C, 2003, NORMAL ACCIDENTS; Polanyi M, 1967, TACIT DIMENSION; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Prempeh H, 2001, BMJ-BRIT MED J, V322, P565, DOI 10.1136/bmj.322.7286.565; Ruston A, 1998, BRIT MED J, V316, P1060; Strauss A., 1990, BASICS QUALITATIVE R; SYED AA, 2002, DIABETES TODAY, V5, P75; VERBRUGGE LM, 1980, MED CARE, V18, P73, DOI 10.1097/00005650-198001000-00006; WYNNE B, 1997, RISK ENV MODERNITY N, P45; [No title captured]	31	70	73	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2005	331	7527					1234	1237		10.1136/bmj.38603.375856.68	http://dx.doi.org/10.1136/bmj.38603.375856.68			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	16214809	Green Published, Bronze			2022-12-01	WOS:000233606800017
J	Colombani, J; Bianchini, L; Layalle, S; Pondeville, E; Dauphin-Villemant, C; Antoniewski, C; Carre, C; Noselli, S; Leopold, P				Colombani, J; Bianchini, L; Layalle, S; Pondeville, E; Dauphin-Villemant, C; Antoniewski, C; Carre, C; Noselli, S; Leopold, P			Antagonistic actions of ecdysone and insulins determine final size in Drosophila	SCIENCE			English	Article							CELLULAR GROWTH; BODY-SIZE; ENZYME	All animals coordinate growth and maturation to reach their final size and shape. In insects, insulin family molecules control growth and metabolism, whereas pulses of the steroid 20-hydroxyecdysone (20E) initiate major developmental transitions. We show that 20E signaling also negatively controls animal growth rates by impeding general insulin signaling involving localization of the transcription factor dFOXO and transcription of the translation inhibitor 4E-BP. We also demonstrate that the larval fat body, equivalent to the vertebrate liver, is a key relay element for ecdysone-dependent growth inhibition. Hence, ecdysone counteracts the growth-promoting action of insulins, thus forming a humoral. regulatory loop that determines organismal size.	Univ Nice, CNRS, UMR6543, F-06108 Nice, France; Univ Paris 06, CNRS, FRE2852, F-75252 Paris, France; Inst Pasteur, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Leopold, P (corresponding author), Univ Nice, CNRS, UMR6543, Parc Valrose, F-06108 Nice, France.	leopolid@unice.fr	Layalle, Sophie/N-3815-2017; Antoniewski, Christophe/G-4519-2011	Layalle, Sophie/0000-0002-3650-0598; Antoniewski, Christophe/0000-0001-7709-2116; Pondeville, Emilie/0000-0001-8545-8472; Colombani, Julien/0000-0002-8250-4899; Noselli, stephane/0000-0002-7296-324X				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; COLOMBANI J, UNPUB; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Janning W, 1997, SEMIN CELL DEV BIOL, V8, P469, DOI 10.1006/scdb.1997.0172; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Stern D, 2003, CURR BIOL, V13, pR267, DOI 10.1016/S0960-9822(03)00197-0; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009	21	446	463	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					667	670		10.1126/science.1119432	http://dx.doi.org/10.1126/science.1119432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16179433				2022-12-01	WOS:000232997700039
J	Reddy, GV; Meyerowitz, EM				Reddy, GV; Meyerowitz, EM			Stem-cell homeostasis and growth dynamics can be uncoupled in the Arabidopsis shoot apex	SCIENCE			English	Article							MERISTEM; CLAVATA1; WUSCHEL; REGULATOR; THALIANA; LOOP; FATE; GENE	The shoot apical meristem (SAM) is a collection of stem cells that resides at the tip of each shoot and provides the cells of the shoot. It is divided into functional regions. The central zone (CZ) at the tip of the meristem is the domain of expression of the CLAVATA3 (CLV3) gene, encoding a putative ligand for a transmembrane receptor kinase, CLAVATA1, active in cells of the rib meristem (RM), located just below the CZ. We show here that CLV3 restricts its own domain of expression (the CZ) by preventing differentiation of peripheral zone cells (PZ), which surround the CZ, into CZ Celts and restricts overall SAM size by a separate, tong-range effect on cell division rate.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	meyerow@its.caltech.edu	Meyerowitz, Elliot M/A-7118-2009					Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Steeves TA, 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227	15	185	198	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					663	667		10.1126/science.1116261	http://dx.doi.org/10.1126/science.1116261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16210497				2022-12-01	WOS:000232997700038
J	Barker, DJP; Osmond, C; Forsen, TJ; Kajantie, E; Eriksson, JG				Barker, DJP; Osmond, C; Forsen, TJ; Kajantie, E; Eriksson, JG			Trajectories of growth among children who have coronary events as adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISCHEMIC-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; CHILDHOOD; COHORT; DEATH; WOMEN; OVERWEIGHT; INSULIN	BACKGROUND: Low birth weight is a risk factor for coronary heart disease. It is uncertain how postnatal growth affects disease risk. METHODS: We studied 8760 people born in Helsinki from 1934 through 1944. Childhood growth had been recorded. A total of 357 men and 87 women had been admitted to the hospital with coronary heart disease or had died from the disease. Coronary risk factors were measured in a subset of 2003 people. RESULTS: The mean body size of children who had coronary events as adults was below average at birth. At two years of age the children were thin; subsequently, their body-mass index (BMI) increased relative to that of other children and had reached average values by 11 years of age. In simultaneous regressions, the hazard ratios associated with a 1 SD increase in BMI were 0.76 (95 percent confidence interval, 0.66 to 0.87; P<0.001) at 2 years and 1.14 (95 percent confidence interval, 1.00 to 1.31; P=0.05) at 11 years among the boys. The corresponding figures for the girls were 0.62 (95 percent confidence interval, 0.46 to 0.82; P=0.001) and 1.35 (95 percent confidence interval, 1.02 to 1.78; P=0.04). Low BMI at 2 years of age and increased BMI from 2 to 11 years of age were also associated with raised fasting insulin concentrations (P<0.001 for both). CONCLUSIONS: On average, adults who had a coronary event had been small at birth and thin at two years of age and thereafter put on weight rapidly. This pattern of growth during childhood was associated with insulin resistance in later life. The risk of coronary events was more strongly related to the tempo of childhood gain in BMI than to the BMI attained at any particular age.	Univ Southampton, Southampton Gen Hosp, Dev Origins Hlth & Dis Div, Southampton, Hants, England; Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; Natl Publ Hlth Inst, Helsinki, Finland	University of Southampton; University of Southampton; Finland National Institute for Health & Welfare	Barker, DJP (corresponding author), Princess Anne Hosp, DOHaD Div, Level F 887,Coxford Rd, Southampton SO16 5YA, Hants, England.	djpb@mrc.soton.ac.uk	Barker, David JP/A-5671-2013	Osmond, Clive/0000-0002-9054-4655; Eriksson, Johan/0000-0002-2516-2060				BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 2004, HEART, V90, P20, DOI 10.1136/heart.90.1.20; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; KUCZMARSKI RJ, 2002, VITAL HLTH STAT S 11, V246; KUNST A, 1983, METHOD ENZYMAT AN, P163; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LIE RF, 1976, CLIN CHEM, V22, P1627; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Phillips DIW, 1996, DIABETOLOGIA, V39, P1119; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; ROBINSON SM, 1991, BRIT J OBSTET GYNAEC, V98, P1223, DOI 10.1111/j.1471-0528.1991.tb15393.x; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; SINGHAL A, 2004, LANCET, V363, P1462; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; WIDDOWSON EM, 1972, ARCH DIS CHILD, V47, P652, DOI 10.1136/adc.47.254.652	22	1041	1077	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1802	1809		10.1056/NEJMoa044160	http://dx.doi.org/10.1056/NEJMoa044160			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251536				2022-12-01	WOS:000232813000008
J	Page-Shafer, K; Saphonn, V; Sun, LP; Vun, MC; Cooper, DA; Kaldor, JM				Page-Shafer, K; Saphonn, V; Sun, LP; Vun, MC; Cooper, DA; Kaldor, JM			HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia	LANCET			English	Editorial Material							RISK BEHAVIOR; INFECTION; MACAQUES		Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; Minist Hlth, Natl Ctr HIV AIDS Dermatol & STDS, Phnom Penh, Cambodia; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW, Australia	University of California System; University of California San Francisco; University of New South Wales Sydney; Kirby Institute	Kaldor, JM (corresponding author), Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia.	jkaldor@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011	Page, Kimberly/0000-0002-7120-1673	PHS HHS [5UO154241] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmad K, 2004, LANCET INFECT DIS, V4, P597, DOI 10.1016/S1473-3099(04)01159-4; *AIDS VACC ADV COA, PILL DAY PREV HIV; Balant LP, 2000, INT J CLIN PHARM TH, V38, P47; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; *CAMB MIN HLTH, 2002, NAT GUID SEL PEOPL L; *CAMB MIN HLTH, 2002, ETH GUID HLTH RES IN; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CHASE M, 2004, WALL STREET J   0812, pB1; Cohen J, 2004, SCIENCE, V305, P1092; *COUNC INT ORG MED, 2002, INT ETH GUID BIOM RE; Gallant JE, 2003, CLIN INFECT DIS, V37, P944, DOI 10.1086/378068; JAMES JS, 2004, AIDS TREAT NEWS 0723, P4; Loff B, 2005, LANCET, V365, P1618, DOI 10.1016/S0140-6736(05)66502-6; Nolan ML, 2002, AIDS, V16, P1991, DOI 10.1097/00002030-200210180-00003; Ojcius David, 2004, Nat Rev Microbiol, V2, P776; Saphonn V, 2004, AIDS EDUC PREV, V16, P64, DOI 10.1521/aeap.16.3.5.64.35522; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS and WHO, 2000, ETH CONS HIV PREV VA; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; WHO/UNAIDS, 2004, AIDS, V18, pW1; World Health Organization, 2002, SCAL ANT THER RES LT	23	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2005	366	9495					1499	1503		10.1016/S0140-6736(05)67146-2	http://dx.doi.org/10.1016/S0140-6736(05)67146-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976HQ	16243095				2022-12-01	WOS:000232724600029
J	Koo, SH; Flechner, L; Qi, L; Zhang, XM; Screaton, RA; Jeffries, S; Hedrick, S; Xu, W; Boussouar, F; Brindle, P; Takemori, H; Montminy, M				Koo, SH; Flechner, L; Qi, L; Zhang, XM; Screaton, RA; Jeffries, S; Hedrick, S; Xu, W; Boussouar, F; Brindle, P; Takemori, H; Montminy, M			The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; HEPATIC GLUCONEOGENESIS; LIPID-METABOLISM; BINDING PROTEIN; GENE-EXPRESSION; INSULIN; CAMP; TRANSCRIPTION; PGC-1; LIVER	Glucose homeostasis is regulated systemically by hormones such as insulin and glucagon, and at the cellular level by energy status. Glucagon enhances glucose output from the liver during fasting by stimulating the transcription of gluconeogenic genes via the cyclic AMP-inducible factor CREB (CRE binding protein). When cellular ATP levels are low, however, the energy-sensing kinase AMPK inhibits hepatic gluconeogenesis through an unknown mechanism. Here we show that hormonal and energy-sensing pathways converge on the coactivator TORC2 (transducer of regulated CREB activity 2) to modulate glucose output. Sequestered in the cytoplasm under feeding conditions, TORC2 is dephosphorylated and transported to the nucleus where it enhances CREB-dependent transcription in response to fasting stimuli. Conversely, signals that activate AMPK attenuate the gluconeogenic programme by promoting TORC2 phosphorylation and blocking its nuclear accumulation. Individuals with type 2 diabetes often exhibit fasting hyperglycaemia due to elevated gluconeogenesis; compounds that enhance TORC2 phosphorylation may offer therapeutic benefits in this setting.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Osaka Univ, Grad Sch Med H1, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan	Salk Institute; St Jude Children's Research Hospital; Osaka University	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Boussouar, Fayçal/N-2511-2013; Koo, Seung-Hoi/E-2763-2015; Boussouar, Fayçal/E-7542-2019	Koo, Seung-Hoi/0000-0001-8769-2879; Boussouar, Fayçal/0000-0003-4529-4893; Brindle, Paul/0000-0001-7172-8478; Qi, Ling/0000-0001-8229-0184; Screaton, Robert/0000-0002-4917-9473; Xu, Wu/0000-0002-2982-3276				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Phillips Carrie A, 2002, Curr Diab Rep, V2, P523, DOI 10.1007/s11892-002-0123-1; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Radziuk Jerry, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P151; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	32	741	792	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1109	1114		10.1038/nature03967	http://dx.doi.org/10.1038/nature03967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16148943				2022-12-01	WOS:000232660500034
J	Phimister, EG				Phimister, EG			A tetraploid twist on the embryonic stem cell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447	1	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2005	353	16					1646	1647		10.1056/NEJMp058254	http://dx.doi.org/10.1056/NEJMp058254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975IC	16236733				2022-12-01	WOS:000232653200002
J	Nisoli, E; Tonello, C; Cardile, A; Cozzi, V; Bracale, R; Tedesco, L; Falcone, S; Valerio, A; Cantoni, O; Clementi, E; Moncada, S; Carruba, MO				Nisoli, E; Tonello, C; Cardile, A; Cozzi, V; Bracale, R; Tedesco, L; Falcone, S; Valerio, A; Cantoni, O; Clementi, E; Moncada, S; Carruba, MO			Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS	SCIENCE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; NITRIC-OXIDE; CELL-SURVIVAL; PPAR-GAMMA; MICE; METABOLISM; MAMMALS; WEIGHT; TISSUE	Calorie restriction extends life span in organisms ranging from yeast to mammals. Here, we report that Calorie restriction for either 3 or 12 months induced endothelial nitric oxide synthase (eNOS) expression and 3',5'-cyclic guanosine monophosphate formation in various tissues of male mice. This was accompanied by mitochondrial biogenesis, with increased oxygen consumption and adenosine triphosphate production, and an enhanced expression of sirtuin 1. These effects were strongly attenuated in eNOS null-mutant mice. Thus, nitric oxide plays a fundamental role in the processes induced by calorie restriction and may be involved in the extension of Life span in mammals.	Univ Milan, Luigi Sacco Hosp, Dept Preclin Sci, Integrated Labs Network, I-20157 Milan, Italy; Ist Auxol Italiano, I-20149 Milan, Italy; Eugenio Medea Sci Inst, I-23842 Bosisio Parini, Italy; Univ Urbino, Ist Farmacol & Farmacognosia, I-61029 Urbino, Italy; Osped San Raffaele, Dipartimento Biotecnol, Stem Cell Res Inst, I-20132 Milan, Italy; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Milan; Luigi Sacco Hospital; IRCCS Istituto Auxologico Italiano; IRCCS Eugenio Medea; University of Urbino; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London	Nisoli, E (corresponding author), Univ Milan, Luigi Sacco Hosp, Dept Preclin Sci, Integrated Labs Network, I-20157 Milan, Italy.	enzo.nisoli@unimi.it	FALCONE, Sestina/F-6103-2014; Valerio, Alessandra/B-3413-2009; Nisoli, Enzo/D-6526-2014	FALCONE, Sestina/0000-0002-3574-0602; Valerio, Alessandra/0000-0001-5844-2256; Nisoli, Enzo/0000-0002-6670-1630; BRACALE, Renata/0000-0003-3650-7033; Carruba, Michele/0000-0003-4589-387X				Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cook S, 2003, SWISS MED WKLY, V133, P360; Dere E, 2002, GENES BRAIN BEHAV, V1, P204, DOI 10.1034/j.1601-183X.2002.10402.x; Dessi-Fulgheri P, 1999, HYPERTENSION, V33, P658, DOI 10.1161/01.HYP.33.2.658; Fenster CP, 2004, FREE RADICAL BIO MED, V37, P695, DOI 10.1016/j.freeradbiomed.2004.05.021; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Larrouy D, 1999, INT J OBESITY, V23, P1327, DOI 10.1038/sj.ijo.0801106; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59	26	846	875	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					314	317		10.1126/science.1117728	http://dx.doi.org/10.1126/science.1117728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224023				2022-12-01	WOS:000232670100052
J	Dreyfus, R; Baudry, J; Roper, ML; Fermigier, M; Stone, HA; Bibette, J				Dreyfus, R; Baudry, J; Roper, ML; Fermigier, M; Stone, HA; Bibette, J			Microscopic artificial swimmers	NATURE			English	Article							LOW-REYNOLDS-NUMBER; ROD-LIKE CHAINS; DRIVEN MICROFILAMENTS; FRICTION COEFFICIENT; FILAMENTS; DYNAMICS; PROPULSION; SPHERES; FLUID	Microorganisms such as bacteria and many eukaryotic cells propel themselves with hair-like structures known as flagella, which can exhibit a variety of structures and movement patterns(1). For example, bacterial flagella are helically shaped(2) and driven at their bases by a reversible rotary engine(3), which rotates the attached flagellum to give a motion similar to that of a corkscrew. In contrast, eukaryotic cells use flagella that resemble elastic rods(4) and exhibit a beating motion: internally generated stresses give rise to a series of bends that propagate towards the tip(5-7). In contrast to this variety of swimming strategies encountered in nature, a controlled swimming motion of artificial micrometre-sized structures has not yet been realized. Here we show that a linear chain of colloidal magnetic particles linked by DNA and attached to a red blood cell can act as a flexible artificial flagellum. The filament aligns with an external uniformmagnetic field and is readily actuated by oscillating a transverse field. We find that the actuation induces a beating pattern that propels the structure, and that the external fields can be adjusted to control the velocity and the direction of motion.	ParisTech, ESPCI, CNRS,UMR 7612, Lab Colloides & Mat Div, F-75005 Paris, France; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7636, Lab Phys & mecan Milieux Heterogenes, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Dreyfus, R (corresponding author), ParisTech, ESPCI, CNRS,UMR 7612, Lab Colloides & Mat Div, 10 Rue Vauquelin, F-75005 Paris, France.	remi.dreyfus@espci.fr	Baudry, Jean/AAX-6267-2020; Baudry, Jean/A-7344-2016; Stone, Howard A/B-6435-2008; Dreyfus, Remi/H-7028-2013	Baudry, Jean/0000-0002-5526-499X; Baudry, Jean/0000-0002-5526-499X; Dreyfus, Remi/0000-0002-4498-2582; Roper, Marcus/0000-0001-8756-0112				Avron JE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.186001; Becker LE, 2003, J FLUID MECH, V490, P15, DOI 10.1017/S0022112003005184; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BRAY D, 1992, CELL MOVEMENTS MOL M, P6; BRENNEN C, 1976, Journal of Mechanochemistry and Cell Motility, V3, P207; Camalet S, 1999, PHYS REV LETT, V82, P1590, DOI 10.1103/PhysRevLett.82.1590; Cosentino Lagomarsino M, 2003, J THEOR BIOL, V224, P215, DOI 10.1016/S0022-5193(03)00159-0; COX RG, 1971, J FLUID MECH, V45, P791; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; Gibbons I.R., 1981, Journal of Cell Biology, V91, P107; Goubault C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.260802; GRAY J, 1955, J EXP BIOL, V32, P802; ISHIJIMA S, 1994, CELL STRUCT FUNCT, V19, P349, DOI 10.1247/csf.19.349; KOENIG A, IN PRESS PHYS REV LE; Lowe CP, 2003, PHILOS T ROY SOC B, V358, P1543, DOI 10.1098/rstb.2003.1340; MEUNIER A, 1994, J PHYS II, V4, P561, DOI 10.1051/jp2:1994141; Najafi A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.062901; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SCHUSTER SC, 1994, ANNU REV BIOPH BIOM, V23, P509, DOI 10.1146/annurev.bb.23.060194.002453; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; Terray A, 2002, SCIENCE, V296, P1841, DOI 10.1126/science.1072133; Wiggins CH, 1998, BIOPHYS J, V74, P1043, DOI 10.1016/S0006-3495(98)74029-9; Wiggins CH, 1998, PHYS REV LETT, V80, P3879, DOI 10.1103/PhysRevLett.80.3879; ZAHN K, 1994, J PHYS II, V4, P555, DOI 10.1051/jp2:1994146	26	1373	1398	21	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2005	437	7060					862	865		10.1038/nature04090	http://dx.doi.org/10.1038/nature04090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208366				2022-12-01	WOS:000232338600041
J	MacLennan, A; Nelson, KB; Hankins, G; Speer, M				MacLennan, A; Nelson, KB; Hankins, G; Speer, M			Who will deliver our grandchildren? Implications of cerebral palsy litigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MALPRACTICE; INTRAPARTUM; INSURANCE; INFANTS; CRISIS		NINDS, Neuroepidemiol Branch, NIH, Bethesda, MD 20892 USA; Univ Adelaide, Womens & Childrens Hosp, Dept Obstet & Gynaecol, Adelaide, SA, Australia; Univ Texas, Med Branch, Dept Obstet, Galveston, TX 77550 USA; Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Adelaide; Womens & Childrens Hospital Australia; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Nelson, KB (corresponding author), NINDS, Neuroepidemiol Branch, NIH, Bldg 10,Room 5S221, Bethesda, MD 20892 USA.	knelson@helix.nih.gov						*AM COLL OBST GYN, 2003, SURV PROF LIAB; [Anonymous], 2005, OBSTET GYNECOL, V105, P1161; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; BLynch C, 1996, BRIT J OBSTET GYNAEC, V103, P1236, DOI 10.1111/j.1471-0528.1996.tb09635.x; BUSSARD P, COMMUNICATION; *CA BIRTH DEF MON, DISC DAT ALL BIRTH D; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Dodd JM, 2005, BEST PRACT RES CL OB, V19, P131, DOI 10.1016/j.bpobgyn.2004.11.004; FREEMAN AD, 1989, J HEALTH POLIT POLIC, V14, P707, DOI 10.1215/03616878-14-4-707; Freeman JM, 2003, HARVARD MED I FORUM, P5; Gibbs RS, 2004, AM J OBSTET GYNECOL, V191, P1, DOI 10.1016/j.ajog.2004.03.026; Gibson CS, 2003, OBSTET GYNECOL SURV, V58, P209, DOI 10.1097/01.OGX.0000055205.21611.6E; Hoffman DN, 2005, HASTINGS CENT REP, V35, P15; HOHMANN SF, 1994, J HLTH CARE FINANCE, V21, P6; HOWARD PK, 2004, PHILADELPHIA IN 0516; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; MacLennan AH, 2002, MED J AUSTRALIA, V176, P425, DOI 10.5694/j.1326-5377.2002.tb04484.x; Martin JA, 2005, PEDIATRICS, V115, P619, DOI 10.1542/peds.2004-2695; Mello MM, 2005, OBSTET GYNECOL, V105, P1287, DOI 10.1097/01.AOG.0000163255.56004.b5; Milunsky A, 2003, J CHILD NEUROL, V18, P413, DOI 10.1177/08830738030180060401; Natale Renato, 2003, J Obstet Gynaecol Can, V25, P1007; Nelson KB, 2005, PEDIATR RES, V57, P494, DOI 10.1203/01.PDR.0000156477.00386.E7; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Redline RW, 2003, HUM PATHOL, V34, P523, DOI 10.1016/S0046-8177(03)00229-6; Robinson P, 2005, OBSTET GYNECOL, V105, P1296, DOI 10.1097/01.AOG.0000157468.12907.1a; *ROYAL AUSTR NZ CO, 2004, OBST CLAIMS REV; Thacker SB, 2001, COCHRANE DB SYST REV, V2; Tussing AD, 1997, MED CARE, V35, P172, DOI 10.1097/00005650-199702000-00007; Werth B., 1998, DAMAGES ONE FAMILYS	32	65	65	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2005	294	13					1688	1690		10.1001/jama.294.13.1688	http://dx.doi.org/10.1001/jama.294.13.1688			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970DC	16204669				2022-12-01	WOS:000232284400022
J	Kanner, AM				Kanner, AM			Depression and the risk of neurological disorders	LANCET			English	Editorial Material							RECURRENT MAJOR DEPRESSION; HIPPOCAMPAL VOLUME LOSS; PARKINSONS-DISEASE; REGISTER; SEIZURES; STROKE; ADULTS; STUDY/		Rush Univ, Med Ctr, Rush Epilepsy Ctr, Rush Med Coll,Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Kanner, AM (corresponding author), Rush Univ, Med Ctr, Rush Epilepsy Ctr, Rush Med Coll,Dept Neurol Sci, Chicago, IL 60612 USA.	andres_M_kanner@rush.edu						FORSGREN L, 1990, EPILEPSY RES, V6, P66, DOI 10.1016/0920-1211(90)90010-S; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Larson SL, 2001, STROKE, V32, P1979, DOI 10.1161/hs0901.094623; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; Lewis AJ, 1934, J MENT SCI, V80, P1; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; May M, 2002, STROKE, V33, P7, DOI 10.1161/hs0102.100529; Nilsson FM, 2001, ACTA PSYCHIAT SCAND, V104, P380, DOI 10.1034/j.1600-0447.2001.00372.x; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P406, DOI 10.1192/bjp.181.5.406; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034	14	17	18	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 1	2005	366	9492					1147	1148		10.1016/S0140-6736(05)67461-2	http://dx.doi.org/10.1016/S0140-6736(05)67461-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970LK	16198752				2022-12-01	WOS:000232311300008
J	Stelzl, U; Worm, U; Lalowski, M; Haenig, C; Brembeck, FH; Goehler, H; Stroedicke, M; Zenkner, M; Schoenherr, A; Koeppen, S; Timm, J; Mintzlaff, S; Abraham, C; Bock, N; Kietzmann, S; Goedde, A; Toksoz, E; Droege, A; Krobitsch, S; Korn, B; Birchmeier, W; Lehrach, H; Wanker, EE				Stelzl, U; Worm, U; Lalowski, M; Haenig, C; Brembeck, FH; Goehler, H; Stroedicke, M; Zenkner, M; Schoenherr, A; Koeppen, S; Timm, J; Mintzlaff, S; Abraham, C; Bock, N; Kietzmann, S; Goedde, A; Toksoz, E; Droege, A; Krobitsch, S; Korn, B; Birchmeier, W; Lehrach, H; Wanker, EE			A human protein-protein interaction network: A resource for annotating the proteome	CELL			English	Article							INTERACTION MAP; BETA-CATENIN; YEAST; TRANSCRIPTION; MODULARITY; BIOLOGY; MOTIFS; PP32; TOOL	Protein-protein interaction maps provide a valuable framework for a better understanding of the functional organization of the proteome. To detect interacting pairs of human proteins systematically, a protein matrix of 4456 baits and 5632 preys was screened by automated yeast two-hybrid (Y2H) interaction mating. We identified 3186 mostly novel interactions among 1705 proteins, resulting in a large, highly connected network. Independent pull-down and coimmunoprecipitation assays validated the overall quality of the Y2H interactions. Using topological and GO criteria, a scoring system was developed to define 911 high-confidence interactions among 401 proteins. Furthermore, the network was searched for interactions linking uncharacterized gene products and human disease proteins to regulatory cellular pathways. Two novel Axin-1 interactions were validated experimentally, characterizing ANP32A and CRMP1 as modulators of Writ signaling. Systematic human protein interaction screens can lead to a more comprehensive understanding of protein function and cellular processes.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; German Genome Resource Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Wanker, EE (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	erich.w@mdc-berlin.de	Lalowski, Maciej/AAB-4151-2019; Stelzl, Ulrich/J-9506-2015	Lalowski, Maciej/0000-0002-3683-4096; Stelzl, Ulrich/0000-0003-2500-3585; Wanker, Erich/0000-0001-8072-1630				Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulitzur N, 1997, J BIOL CHEM, V272, P30577, DOI 10.1074/jbc.272.48.30577; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164	45	1734	1809	3	224	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					957	968		10.1016/j.cell.2005.08.029	http://dx.doi.org/10.1016/j.cell.2005.08.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16169070	Bronze, Green Published			2022-12-01	WOS:000232130200019
J	Konneke, M; Bernhard, AE; de la Torre, JR; Walker, CB; Waterbury, JB; Stahl, DA				Konneke, M; Bernhard, AE; de la Torre, JR; Walker, CB; Waterbury, JB; Stahl, DA			Isolation of an autotrophic ammonia-oxidizing marine archaeon	NATURE			English	Article							PLANKTONIC ARCHAEA; BACTERIA	For years, microbiologists characterized the Archaea as obligate extremophiles that thrive in environments too harsh for other organisms. The limited physiological diversity among cultivated Archaea suggested that these organisms were metabolically constrained to a few environmental niches. For instance, all Crenarchaeota that are currently cultivated are sulphur-metabolizing thermophiles(1). However, landmark studies using cultivation- independent methods uncovered vast numbers of Crenarchaeota in cold oxic ocean waters(2,3). Subsequent molecular surveys demonstrated the ubiquity of these low- temperature Crenarchaeota in aquatic and terrestrial environments(4). The numerical dominance of marine Crenarchaeota - estimated at 10(28) cells in the world's oceans(5) - suggests that they have a major role in global biogeochemical cycles. Indeed, isotopic analyses of marine crenarchaeal lipids suggest that these planktonic Archaea fix inorganic carbon(6). Here we report the isolation of a marine crenarchaeote that grows chemolithoautotrophically by aerobically oxidizing ammonia to nitrite - the first observation of nitrification in the Archaea. The autotrophic metabolism of this isolate, and its close phylogenetic relationship to environmental marine crenarchaeal sequences, suggests that nitrifying marine Crenarchaeota may be important to global carbon and nitrogen cycles.	Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution	Stahl, DA (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	dastahl@u.washington.edu	de la Torre, Jose R/H-2081-2012; Koenneke, Martin/E-6893-2013	de la Torre, Jose R/0000-0002-9553-6048; Koenneke, Martin/0000-0001-6770-414X; Bernhard, Anne/0000-0002-8639-9555				Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; BOCK E, 2001, PROKARYOTES EVOLVING; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; Capone D. G., 2000, MICROBIAL ECOLOGY OC, P455; Dawson S. C., 2000, PROKARYOTES EVOLVING; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Ducklow H., 2000, MICROBIAL ECOLOGY OC, V1, P85, DOI DOI 10.1002/9780470281840; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Pearson A, 2004, APPL ENVIRON MICROB, V70, P5229, DOI 10.1128/AEM.70.9.5229-5237.2004; Pearson A, 2001, GEOCHIM COSMOCHIM AC, V65, P3123, DOI 10.1016/S0016-7037(01)00657-3; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Stickland JDH, 1972, PRACTICAL HDB SEAWAT; Swofford DL, 2002, PAUP VERSION 40 B10; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WADA E, 1971, LIMNOL OCEANOGR, V16, P766, DOI 10.4319/lo.1971.16.5.0766; Widdel F., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_2, 10.1007/978-1-4757-2191-1_21]; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0	27	1970	2157	40	978	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					543	546		10.1038/nature03911	http://dx.doi.org/10.1038/nature03911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177789				2022-12-01	WOS:000232004800048
J	Nielsen, H; Westhof, E; Johansen, S				Nielsen, H; Westhof, E; Johansen, S			An mRNA is capped by a 2 ',5 ' lariat catalyzed by a group I-like ribozyme	SCIENCE			English	Article							CORE ORGANIZATION; INTRON; ENDONUCLEASE; EXPRESSION	Twin-ribozyme introns are formed by two ribozymes belonging to the group I family and occur in some ribosomal RNA transcripts. The group l-like ribozyme, GIR1, liberates the S' end of a homing endonuclease messenger RNA in the slime mold Didymium iridis. We demonstrate that this cleavage occurs by a transesterification reaction with the joining of the first and the third nucleotide of the messenger by a 2',5'-phosphodiester linkage, Thus, a group l-like ribozyme catalyzes an RNA branching reaction similar to the first step of splicing in group II introns and spliceosomal introns. The resulting short lariat, by forming a protective 5' cap, might have been useful in a primitive RNA world.	Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, DK-2200 Copenhagen, Denmark; Univ Tromso, Inst Med Biol, Dept Mol Biotechnol, RNA Res Grp, N-9037 Tromso, Norway; Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	University of Copenhagen; UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nielsen, H (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, DK-2200 Copenhagen, Denmark.	hamra@imbg.ku.dk						AGBACK P, 1993, J BIOCHEM BIOPH METH, V27, P229, DOI 10.1016/0165-022X(93)90006-A; Birgisdottir AB, 2005, NUCLEIC ACIDS RES, V33, P2042, DOI 10.1093/nar/gki341; Burge C.B., 1999, RNA WORLD, V37, P525; Cougot N, 2004, TRENDS BIOCHEM SCI, V29, P436, DOI 10.1016/j.tibs.2004.06.008; DECATUR WA, 1995, EMBO J, V14, P4558, DOI 10.1002/j.1460-2075.1995.tb00135.x; Decatur WA, 2000, RNA, V6, P616, DOI 10.1017/S1355838200992203; Einvik C, 1997, RNA, V3, P710; Einvik C, 1998, RNA, V4, P530, DOI 10.1017/S1355838298971758; GOLDEN BL, 1999, RNA WORLD, P321; Jabri E, 1997, BIOCHEMISTRY-US, V36, P16345, DOI 10.1021/bi9718595; JOHANSEN S, 1994, CELL, V76, P725, DOI 10.1016/0092-8674(94)90511-8; Johansen S, 2002, BIOCHIMIE, V84, P905, DOI 10.1016/S0300-9084(02)01443-8; REILLY JD, 1989, METHOD ENZYMOL, V180, P177; Trotta CR, 1999, RNA WORLD, P561; Vader A, 1999, EMBO J, V18, P1003, DOI 10.1093/emboj/18.4.1003	15	53	64	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1584	1587		10.1126/science.1113645	http://dx.doi.org/10.1126/science.1113645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141078				2022-12-01	WOS:000231715000056
J	Brody, LC				Brody, LC			Treating cancer by targeting a weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brody, LC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000120, ZIAHG000120] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445	3	34	39	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					949	950		10.1056/NEJMcibr052331	http://dx.doi.org/10.1056/NEJMcibr052331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135843				2022-12-01	WOS:000231551100017
J	Gagneux, P; Moore, JJ; Varki, A				Gagneux, P; Moore, JJ; Varki, A			The ethics of research on great apes	NATURE			English	Editorial Material									Zool Soc San Diego, Conservat & Res Endangered Species, San Diego, CA 92112 USA; Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA	Zoological Society of San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gagneux, P (corresponding author), Zool Soc San Diego, Conservat & Res Endangered Species, San Diego, CA 92112 USA.							Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981	1	34	34	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					27	29		10.1038/437027a	http://dx.doi.org/10.1038/437027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136111				2022-12-01	WOS:000231560400023
J	Willimsky, G; Blankenstein, T				Willimsky, G; Blankenstein, T			Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance	NATURE			English	Article							IMMUNE SURVEILLANCE; INTERFERON-GAMMA; CANCER; ANTIGEN; BETA; MICE; IMMUNOSURVEILLANCE; CARCINOGENESIS; ACTIVATION; EXPRESSION	The recognition and elimination of tumours by T cells, a process termed cancer immunosurveillance(1), is effective against certain virus-associated cancers(2). Spontaneous tumours often induce a specific immune response and are therefore also immunogenic. However, it is not clear whether they can be controlled by T cells(3-10). The immunosurveillance hypothesis postulates that tumours, if they eventually grow, escaped T-cell recognition by losing immunogenicity(6-8). Here we show, by generating a mouse model of sporadic cancer based on rare spontaneous activation of a dormant oncogene, that immunogenic tumours do not escape their recognition but induce tolerance. In this model, tumours derive from single cells and express a tumour-specific transplantation rejection antigen. Whereas vaccinated mice remain tumour-free throughout their lifetime, naive mice always develop a progressively growing tumour. We also show that despite specific recognition by T cells, the tumours do not lose their intrinsic immunogenicity and are rejected after transplantation in T-cell-competent recipients. Furthermore, in the primary host tumour-induced tolerance is associated with the expansion of non-functional T cells. Together, our data argue against immunosurveillance of spontaneous cancer.	Inst Immunol, D-12200 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Blankenstein, T (corresponding author), Inst Immunol, Charite Campus Benjamin Franklin,Hindenburgdamm 3, D-12200 Berlin, Germany.	tblanke@mdc-berlin.de	Willimsky, Gerald/AAA-2445-2021	Willimsky, Gerald/0000-0002-9693-948X				ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; Beck C, 2001, MICROSC RES TECHNIQ, V52, P387, DOI 10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Blankenstein T, 2003, ADV CANCER RES, V90, P179, DOI 10.1016/S0065-230X(03)90006-6; BURNET M, 1964, BRIT MED BULL, V20, P154, DOI 10.1093/oxfordjournals.bmb.a070310; Cayeux S, 1997, J IMMUNOL, V158, P2834; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KLEIN G, 1960, CANCER RES, V20, P1561; KLEIN G, 1977, P NATL ACAD SCI USA, V74, P2121, DOI 10.1073/pnas.74.5.2121; KRIPKE ML, 1976, J NATL CANCER I, V57, P211, DOI 10.1093/jnci/57.1.211; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li LP, 1997, HUM GENE THER, V8, P1695, DOI 10.1089/hum.1997.8.14-1695; Meuwissen R, 2001, EXP CELL RES, V264, P100, DOI 10.1006/excr.2000.5146; MULLEN CA, 1985, J EXP MED, V162, P1665, DOI 10.1084/jem.162.5.1665; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; PREHN RT, 1994, CANCER RES, V54, P908; Qin ZH, 2004, NAT IMMUNOL, V5, P3, DOI 10.1038/ni0104-3; Sakai K, 1995, BIOCHEM BIOPH RES CO, V217, P393, DOI 10.1006/bbrc.1995.2789; Schell TD, 2000, CANCER RES, V60, P3002; Schreiber H., 2003, FUNDAMENTAL IMMUNOLO, P1557; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753	29	319	340	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					141	146		10.1038/nature03954	http://dx.doi.org/10.1038/nature03954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136144				2022-12-01	WOS:000231560400058
J	Neale, MJ; Pan, J; Keeney, S				Neale, MJ; Pan, J; Keeney, S			Endonucleolytic processing of covalent protein-linked DNA double-strand breaks	NATURE			English	Article							MEIOTIC CHROMOSOME SYNAPSIS; TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST MEIOSIS; RECOMBINATION; REPAIR; SPO11; COMPLEX; MOUSE; GENE	DNA double-strand breaks (DSBs) with protein covalently attached to 50 strand termini are formed by Spo11 to initiate meiotic recombination(1,2). The Spo11 protein must be removed for the DSB to be repaired, but the mechanism for removal is unclear(3). Here we show that meiotic DSBs in budding yeast are processed by endonucleolytic cleavage that releases Spo11 attached to an oligonucleotide with a free 3'-OH. Two discrete Spo11-oligonucleotide complexes were found in equal amounts, differing with respect to the length of the bound DNA. We propose that these forms arise from different spacings of strand cleavages flanking the DSB, with every DSB processed asymmetrically. Thus, the ends of a single DSB may be biochemically distinct at or before the initial processing step - much earlier than previously thought. SPO11- oligonucleotide complexes were identified in extracts of mouse testis, indicating that this mechanism is evolutionarily conserved. Oligonucleotide - topoisomerase II complexes were also present in extracts of vegetative yeast, although not subject to the same genetic control as for generating Spo11 - oligonucleotide complexes. Our findings suggest a general mechanism for repair of protein-linked DSBs.	Cornell Univ, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Keeney, S (corresponding author), Cornell Univ, Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	keeneys@mskcc.org	Keeney, Scott/GVR-8515-2022	Neale, Matthew/0000-0002-6453-1877; Keeney, Scott/0000-0002-1283-6417	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD040916] Funding Source: Medline; NIGMS NIH HHS [R01 GM058673] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; BARCHI M, IN PRESS MOL CELL BI; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; NITISS JL, 1992, CANCER RES, V52, P4467; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Stohr BA, 2001, GENETICS, V158, P19; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Walker JV, 2002, CANCER INVEST, V20, P570, DOI 10.1081/CNV-120002156	29	418	430	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1053	1057		10.1038/nature03872	http://dx.doi.org/10.1038/nature03872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107854	Green Accepted			2022-12-01	WOS:000231263900058
J	Eisenmesser, EZ; Millet, O; Labeikovsky, W; Korzhnev, DM; Wolf-Watz, M; Bosco, DA; Skalicky, JJ; Kay, LE; Kern, D				Eisenmesser, EZ; Millet, O; Labeikovsky, W; Korzhnev, DM; Wolf-Watz, M; Bosco, DA; Skalicky, JJ; Kay, LE; Kern, D			Intrinsic dynamics of an enzyme underlies catalysis	NATURE			English	Article							CIS-TRANS-ISOMERIZATION; TRIOSEPHOSPHATE ISOMERASE; CHEMICAL-EXCHANGE; PROTEIN DYNAMICS; LOOP MOTION; NMR; FLEXIBILITY; STATES	A unique feature of chemical catalysis mediated by enzymes is that the catalytically reactive atoms are embedded within a folded protein. Although current understanding of enzyme function has been focused on the chemical reactions and static three-dimensional structures, the dynamic nature of proteins has been proposed to have a function in catalysis(1-5). The concept of conformational substates has been described(6); however, the challenge is to unravel the intimate linkage between protein flexibility and enzymatic function. Here we show that the intrinsic plasticity of the protein is a key characteristic of catalysis. The dynamics of the prolyl cis - trans isomerase cyclophilin A ( CypA) in its substrate-free state and during catalysis were characterized with NMR relaxation experiments. The characteristic enzyme motions detected during catalysis are already present in the free enzyme with frequencies corresponding to the catalytic turnover rates. This correlation suggests that the protein motions necessary for catalysis are an intrinsic property of the enzyme and may even limit the overall turnover rate. Motion is localized not only to the active site but also to a wider dynamic network. Whereas coupled networks in proteins have been proposed previously(3,7-10), we experimentally measured the collective nature of motions with the use of mutant forms of CypA. We propose that the pre-existence of collective dynamics in enzymes before catalysis is a common feature of biocatalysts and that proteins have evolved under synergistic pressure between structure and dynamics.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	Brandeis University; Howard Hughes Medical Institute; University of Toronto; University of Toronto; University of Toronto; State University System of Florida; Florida State University	Kern, D (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	dkern@brandeis.edu	Labeikovsky, Wladimir/K-1648-2019; Millet, Oscar/F-9696-2011	Labeikovsky, Wladimir/0000-0001-6074-3269; Millet, Oscar/0000-0001-8748-4105				Agarwal PK, 2004, BIOCHEMISTRY-US, V43, P10605, DOI 10.1021/bi0495228; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Goff DC, 2004, PREV MED, V38, P85, DOI 10.1016/j.ypmed.2003.09.037; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; Jencks W.P., 1987, CATALYSIS CHEM ENZYM; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775	30	870	887	3	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					117	121		10.1038/nature04105	http://dx.doi.org/10.1038/nature04105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267559				2022-12-01	WOS:000232979000053
J	Altshuler, D; Brooks, LD; Chakravarti, A; Collins, FS; Daly, MJ; Donnelly, P; Gibbs, RA; Belmont, JW; Boudreau, A; Leal, SM; Hardenbol, P; Pasternak, S; Wheeler, DA; Willis, TD; Yu, FL; Yang, HM; Zeng, CQ; Gao, Y; Hu, HR; Hu, WT; Li, CH; Lin, W; Liu, SQ; Pan, H; Tang, XL; Wang, J; Wang, W; Yu, J; Zhang, B; Zhang, QR; Zhao, HB; Zhao, H; Zhou, J; Gabriel, SB; Barry, R; Blumenstiel, B; Camargo, A; Defelice, M; Faggart, M; Goyette, M; Gupta, S; Moore, J; Nguyen, H; Onofrio, RC; Parkin, M; Roy, J; Stahl, E; Winchester, E; Ziaugra, L; Shen, Y; Yao, ZJ; Huang, W; Chu, X; He, YG; Jin, L; Liu, YF; Shen, YY; Sun, WW; Wang, HF; Wang, Y; Wang, Y; Wang, Y; Xiong, XY; Xu, L; Waye, MMY; Tsui, SKW; Xue, H; Wong, JTF; Galver, ILM; Fan, JB; Murray, SS; Oliphant, AR; Chee, MS; Montpetit, A; Chagnon, F; Ferretti, V; Leboeuf, M; Olivier, JF; Phillips, MS; Roumy, S; Sallee, C; Verner, A; Hudson, TJ; Frazer, KA; Ballinger, DG; Cox, DR; Hinds, DA; Stuve, LL; Kwok, PY; Cai, DM; Koboldt, DC; Miller, RD; Pawlikowska, L; Taillon-Miller, P; Xiao, M; Tsui, LC; Mak, W; Sham, PC; Song, YQ; Tam, PKH; Nakamura, Y; Kawaguchi, T; Kitamoto, T; Morizono, T; Nagashima, A; Ohnishi, Y; Sekine, A; Tanaka, T; Tsunoda, T; Deloukas, P; Bird, CP; Delgado, M; Dermitzakis, ET; Gwilliam, R; Hunt, S; Morrison, J; Powell, D; Stranger, BE; Whittaker, P; Bentley, DR; Daly, MJ; de Bakker, PIW; Barrett, J; Fry, B; Maller, J; McCarroll, S; Patterson, N; Pe'er, I; Purcell, S; Richter, DJ; Sabeti, P; Saxena, R; Schaffner, SF; Varilly, P; Stein, LD; Krishnan, L; Smith, AV; Thorisson, GA; Chen, PE; Cutler, DJ; Kashuk, CS; Lin, S; Abecasis, GR; Guan, WH; Munro, HM; Qin, ZHS; Thomas, DJ; McVean, G; Bottolo, L; Eyheramendy, S; Freeman, C; Marchini, J; Myers, S; Spencer, C; Stephens, M; Cardon, LR; Clarke, G; Evans, DM; Morris, AP; Weir, BS; Tsunoda, T; Mullikin, JC; Sherry, ST; Feolo, M; Zhang, HC; Zeng, CQ; Zhao, H; Matsuda, I; Fukushima, Y; Macer, DR; Suda, E; Rotimi, CN; Adebamowo, CA; Ajayi, I; Aniagwu, T; Marshall, PA; Nkwodimmah, C; Royal, CDM; Leppert, MF; Dixon, M; Peiffer, A; Qiu, RZ; Kent, A; Kato, K; Niikawa, N; Adewole, IF; Knoppers, BM; Foster, MW; Clayton, EW; Muzny, D; Nazareth, L; Sodergren, E; Weinstock, GM; Wheeler, DA; Yakub, I; Gabriel, SB; Richter, DJ; Ziaugra, L; Birren, BW; Wilson, RK; Fulton, LL; Rogers, J; Burton, J; Carter, NP; Clee, CM; Griffiths, M; Jones, MC; McLay, K; Plumb, RW; Ross, MT; Sims, SK; Willey, DL; Chen, Z; Han, H; Kang, L; Godbout, M; Wallenburg, JC; Archeveque, PL; Bellemare, G; Saeki, K; Wang, HG; An, DC; Fu, HB; Li, Q; Wang, Z; Wang, RW; Holden, AL; Brooks, LD; McEwen, JE; Bird, CR; Guyer, MS; Nailer, PJ; Wang, VO; Peterson, JL; Shi, M; Spiegel, J; Sung, LM; Witonsky, J; Zacharia, LF; Kennedy, K; Jamieson, R; Stewart, J				Altshuler, D; Brooks, LD; Chakravarti, A; Collins, FS; Daly, MJ; Donnelly, P; Gibbs, RA; Belmont, JW; Boudreau, A; Leal, SM; Hardenbol, P; Pasternak, S; Wheeler, DA; Willis, TD; Yu, FL; Yang, HM; Zeng, CQ; Gao, Y; Hu, HR; Hu, WT; Li, CH; Lin, W; Liu, SQ; Pan, H; Tang, XL; Wang, J; Wang, W; Yu, J; Zhang, B; Zhang, QR; Zhao, HB; Zhao, H; Zhou, J; Gabriel, SB; Barry, R; Blumenstiel, B; Camargo, A; Defelice, M; Faggart, M; Goyette, M; Gupta, S; Moore, J; Nguyen, H; Onofrio, RC; Parkin, M; Roy, J; Stahl, E; Winchester, E; Ziaugra, L; Shen, Y; Yao, ZJ; Huang, W; Chu, X; He, YG; Jin, L; Liu, YF; Shen, YY; Sun, WW; Wang, HF; Wang, Y; Wang, Y; Wang, Y; Xiong, XY; Xu, L; Waye, MMY; Tsui, SKW; Xue, H; Wong, JTF; Galver, ILM; Fan, JB; Murray, SS; Oliphant, AR; Chee, MS; Montpetit, A; Chagnon, F; Ferretti, V; Leboeuf, M; Olivier, JF; Phillips, MS; Roumy, S; Sallee, C; Verner, A; Hudson, TJ; Frazer, KA; Ballinger, DG; Cox, DR; Hinds, DA; Stuve, LL; Kwok, PY; Cai, DM; Koboldt, DC; Miller, RD; Pawlikowska, L; Taillon-Miller, P; Xiao, M; Tsui, LC; Mak, W; Sham, PC; Song, YQ; Tam, PKH; Nakamura, Y; Kawaguchi, T; Kitamoto, T; Morizono, T; Nagashima, A; Ohnishi, Y; Sekine, A; Tanaka, T; Tsunoda, T; Deloukas, P; Bird, CP; Delgado, M; Dermitzakis, ET; Gwilliam, R; Hunt, S; Morrison, J; Powell, D; Stranger, BE; Whittaker, P; Bentley, DR; Daly, MJ; de Bakker, PIW; Barrett, J; Fry, B; Maller, J; McCarroll, S; Patterson, N; Pe'er, I; Purcell, S; Richter, DJ; Sabeti, P; Saxena, R; Schaffner, SF; Varilly, P; Stein, LD; Krishnan, L; Smith, AV; Thorisson, GA; Chen, PE; Cutler, DJ; Kashuk, CS; Lin, S; Abecasis, GR; Guan, WH; Munro, HM; Qin, ZHS; Thomas, DJ; McVean, G; Bottolo, L; Eyheramendy, S; Freeman, C; Marchini, J; Myers, S; Spencer, C; Stephens, M; Cardon, LR; Clarke, G; Evans, DM; Morris, AP; Weir, BS; Tsunoda, T; Mullikin, JC; Sherry, ST; Feolo, M; Zhang, HC; Zeng, CQ; Zhao, H; Matsuda, I; Fukushima, Y; Macer, DR; Suda, E; Rotimi, CN; Adebamowo, CA; Ajayi, I; Aniagwu, T; Marshall, PA; Nkwodimmah, C; Royal, CDM; Leppert, MF; Dixon, M; Peiffer, A; Qiu, RZ; Kent, A; Kato, K; Niikawa, N; Adewole, IF; Knoppers, BM; Foster, MW; Clayton, EW; Muzny, D; Nazareth, L; Sodergren, E; Weinstock, GM; Wheeler, DA; Yakub, I; Gabriel, SB; Richter, DJ; Ziaugra, L; Birren, BW; Wilson, RK; Fulton, LL; Rogers, J; Burton, J; Carter, NP; Clee, CM; Griffiths, M; Jones, MC; McLay, K; Plumb, RW; Ross, MT; Sims, SK; Willey, DL; Chen, Z; Han, H; Kang, L; Godbout, M; Wallenburg, JC; Archeveque, PL; Bellemare, G; Saeki, K; Wang, HG; An, DC; Fu, HB; Li, Q; Wang, Z; Wang, RW; Holden, AL; Brooks, LD; McEwen, JE; Bird, CR; Guyer, MS; Nailer, PJ; Wang, VO; Peterson, JL; Shi, M; Spiegel, J; Sung, LM; Witonsky, J; Zacharia, LF; Kennedy, K; Jamieson, R; Stewart, J		Int HapMap Consortium	A haplotype map of the human genome	NATURE			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISM; RECENT POSITIVE SELECTION; FACTOR-H POLYMORPHISM; LINKAGE-DISEQUILIBRIUM; RECOMBINATION RATES; SEGMENTAL DUPLICATIONS; MEIOTIC RECOMBINATION; TYROSINE-PHOSPHATASE; SCALE VARIATION; SPASTIC ATAXIA	Inherited genetic variation has a critical but as yet largely uncharacterized role in human disease. Here we report a public database of common variation in the human genome: more than one million single nucleotide polymorphisms ( SNPs) for which accurate and complete genotypes have been obtained in 269 DNA samples from four populations, including ten 500-kilobase regions in which essentially all information about common DNA variation has been extracted. These data document the generality of recombination hotspots, a block-like structure of linkage disequilibrium and low haplotype diversity, leading to substantial correlations of SNPs with many of their neighbours. We show how the HapMap resource can guide the design and analysis of genetic association studies, shed light on structural variation and recombination, and identify loci that may have been subject to natural selection during human evolution.	Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Simches Res Ctr, Boston, MA 02114 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; ParAllele Biosci Inc, San Francisco, CA 94080 USA; Chinese Acad Sci, Beijing Genom Inst, Beijing 100300, Peoples R China; Chinese Natl Human Genome Ctr, Beijing Econ Technol Dev Area, Beijing 100176, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Univ Hong Kong, Dept Biochem, Croucher Lab Human Genom, Shatin, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Illumina, San Diego, CA 92121 USA; Prognosys Biosci Inc, San Diego, CA 92121 USA; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Univ Montreal, Publ Law Res Ctr CRDP, Montreal, PQ H3C 3J7, Canada; Perlegen Sci Inc, Mountain View, CA 94043 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Hong Kong, Genome Res Ctr, Pokfulam, Hong Kong, Peoples R China; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; RIKEN, SNP Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Solexa Ltd, Saffron Walden CB10 1XL, Essex, England; Cold Spring Harbor Lab, New York, NY 11724 USA; Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Washington, Dept Stat, Washington, DC 98195 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; Natl Human Genome Res Inst, US Natl Inst Hlth, Bethesda, MD 20892 USA; US Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Beijing Normal Univ, Beijing 100875, Peoples R China; Hlth Sci Univ Hokkaido, Ishikari, Hokkaido, Japan; Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan; UNESCO, Bangkok 10110, Thailand; Univ Tsukuba, Eubios Eth Inst, Tsukuba 3058691, Japan; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Ibadan, Coll Med, Ibadan, Oyo State, Nigeria; Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA; Chinese Acad Social Sci, Ctr Appl Eth, Beijing 100054, Peoples R China; Genet Interest Grp, London N1 3QP, England; Kyoto Univ, Inst Res Humanities, Sakyo Ku, Kyoto 6068501, Japan; Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528523, Japan; Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; Vanderbilt Univ, Ctr Genet & Hlth Policy, Nashville, TN 37232 USA; Wellcome Trust Res Labs, London NW1 2BE, England; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Chinese Acad Sci, Beijing 100864, Peoples R China; Genome Canada, Ottawa, ON K2P 1P1, Canada; McGill Univ, Off Technol Transfer, Montreal, PQ H3A 2A7, Canada; Genome Quebec, Montreal, PQ H3B 1S6, Canada; Minist Educ Culture Sports Sci & Technol, Chiyoda Ku, Tokyo 1008959, Japan; Minist Sci & Technol, Beijing 100862, Peoples R China; Human Genet Resource Adm China, Beijing 100081, Peoples R China; SNP Consortium, Deerfield, IL 60015 USA; Novartis Pharmaceut, Biomarker Dev, E Hanover, NJ 07936 USA; US Natl Inst Hlth, Off Technol Transfer, Rockville, MD 20852 USA; Univ Maryland, Sch Law, Baltimore, MD 21201 USA; Frost & Sullivan, Palo Alto, CA 94303 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Baylor College of Medicine; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Chinese University of Hong Kong; Hong Kong University of Science & Technology; Illumina; McGill University; Universite de Montreal; University of California System; University of California San Francisco; Washington University (WUSTL); University of Hong Kong; University of Tokyo; RIKEN; Wellcome Trust Sanger Institute; Cold Spring Harbor Laboratory; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; University of Washington; University of Oxford; Wellcome Centre for Human Genetics; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Beijing Normal University; Health Sciences University of Hokkaido; Shinshu University; University of Tsukuba; Howard University; University of Ibadan; Case Western Reserve University; Utah System of Higher Education; University of Utah; Chinese Academy of Social Sciences; Kyoto University; Nagasaki University; University of Oklahoma System; University of Oklahoma - Norman; Vanderbilt University; Washington University (WUSTL); Chinese Academy of Sciences; McGill University; Novartis; National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore	Altshuler, D (corresponding author), Harvard Univ, Broad Inst, 1 Kendall Sq, Cambridge, MA 02139 USA.	altshuler@molbio.mgh.harvard.edu; donnelly@stats.ox.ac.uk	maller, julian B/A-9323-2009; 郑, 征/C-8514-2011; Qin, Zhaohui/Q-3133-2019; Saxena, Richa/AAG-7279-2020; Belmont, John/AAH-6084-2021; Tsunoda, Tatsuhiko/K-2061-2014; Weinstock, George M/C-6314-2013; Schaffner, Stephen F/D-1189-2011; Dermitzakis, Emmanouil/B-7687-2013; Jin, Li/M-5063-2019; Abecasis, Goncalo R/B-7840-2010; Marchini, Jonathan/ABE-9024-2020; Deloukas, Panos/B-2922-2013; Peng, Bo/A-6920-2009; Evans, David M/H-6325-2013; Thorisson, Gudmundur/E-7359-2010; Tanaka, Toshihiro/J-9310-2014; Belmont, John W/AAI-2494-2019; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Qin, Zhaohui S/E-8196-2011; Song, You-qiang/C-4401-2009; Xiao, Ming/E-7448-2012; Jin, Li/C-1468-2009; Altshuler, David M/A-4476-2009; Wheeler, David A/M-9740-2018; Sabeti, Pardis/GQH-8610-2022; Tsui, Stephen Kwok-Wing/E-4385-2015; Kwok, Pui-Yan/F-7725-2014; Daly, Mark J/B-2453-2017; Adebamowo, Clement/C-8778-2011; de Bakker, Paul IW/B-8730-2009; Tsui, Lap-chee/A-1081-2010; Smith, Albert Vernon/K-5150-2015; Song, You-Qiang/E-5207-2011; Ganesh, Dunna Sai/AGX-5170-2022; /C-4405-2009; Varilly, Patrick/C-8118-2013; Myers, Simon/A-6792-2015	Qin, Zhaohui/0000-0002-1583-146X; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Weinstock, George M/0000-0002-2997-4592; Marchini, Jonathan/0000-0003-0610-8322; Deloukas, Panos/0000-0001-9251-070X; Peng, Bo/0000-0001-8225-2284; Evans, David M/0000-0003-0663-4621; Thorisson, Gudmundur/0000-0001-5635-1860; Tanaka, Toshihiro/0000-0001-6201-9784; Belmont, John W/0000-0001-7409-3578; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Qin, Zhaohui S/0000-0002-1583-146X; Jin, Li/0000-0002-4546-2415; Altshuler, David M/0000-0002-7250-4107; Wheeler, David A/0000-0002-9056-6299; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Kwok, Pui-Yan/0000-0002-5087-3059; Daly, Mark J/0000-0002-0949-8752; Adebamowo, Clement/0000-0002-6571-2880; de Bakker, Paul IW/0000-0001-7735-7858; Smith, Albert Vernon/0000-0003-1942-5845; Song, You-Qiang/0000-0001-9407-2256; He, Yungang/0000-0002-2931-2871; Saxena, Richa/0000-0003-2233-1065; Sherry, Stephen/0000-0002-7982-076X; Bottolo, Leonardo/0000-0002-6381-2327; Eyheramendy, Susana/0000-0003-4723-9660; /0000-0001-6231-3035; Schaffner, Stephen/0000-0001-6699-3568; Varilly, Patrick/0000-0003-4619-8174; Abecasis, Goncalo/0000-0003-1509-1825; Kitamoto, Takuya/0000-0002-4008-5497; Hudson, Thomas/0000-0002-1376-4849; Myers, Simon/0000-0002-2585-9626; Kato, Kazuto/0000-0001-9006-9551; Wang, Haifeng/0000-0001-5022-0720; Stranger, Barbara/0000-0001-9021-7331; Lin, Shin/0000-0003-0118-0413; Xue, Hong/0000-0002-8133-9828; ajayi, Ikeoluwapo/0000-0001-7719-8746; Wong, J. Tze-Fei/0000-0001-8539-8537; Macer, Darryl/0000-0001-9335-4235; Hunt, Sarah/0000-0002-8350-1235; Frazer, Kelly/0000-0002-6060-8902; Witonsky, Jonathan/0000-0001-8264-0244; Richter, Daniel/0000-0002-9238-5571	NHGRI NIH HHS [R01 HG001720, R01 HG001720-06] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001720] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Dahlback B, 1997, THROMB HAEMOSTASIS, V78, P483; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ellis N, 2002, GENOME RES, V12, P339; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HILL WG, 1994, AM J HUM GENET, V54, P705; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Huang Jing, 2004, Human Genomics, V1, P287; HUDSON RR, 1985, GENETICS, V111, P147; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LECHLER R, 2005, HLA HLTH DIS; Li N, 2003, GENETICS, V165, P2213; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; MARCHINI J, IN PRESS AM J HUM GE; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; MCCARROLL SA, IN PRESS NATURE GENE; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers SR, 2003, GENETICS, V163, P375; Need AC, 2005, NAT GENET, V37, P671, DOI 10.1038/ng1593; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Nielsen R, 2005, NATURE, V434, P288, DOI 10.1038/434288a; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PEER I, UNPUB GENOME RES; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WRIGHT S, 1969, EVOLUTION GENETICS P, V2, P294; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	103	4305	4480	9	551	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1299	1320		10.1038/nature04226	http://dx.doi.org/10.1038/nature04226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16255080	Green Accepted, hybrid			2022-12-01	WOS:000232829100044
J	Berry, DA; Cronin, KA; Plevritis, SK; Fryback, DG; Clarke, L; Zelen, M; Mandelblatt, JS; Yakovlev, AY; Habbema, JDF; Feuer, EJ				Berry, DA; Cronin, KA; Plevritis, SK; Fryback, DG; Clarke, L; Zelen, M; Mandelblatt, JS; Yakovlev, AY; Habbema, JDF; Feuer, EJ		CISNET Collaborators	Effect of screening and adjuvant therapy on mortality from breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIALS; UNITED-STATES; SOCIETY GUIDELINES; FOLLOW-UP; MAMMOGRAPHY; TAMOXIFEN; PROGRESS	BACKGROUND: We used modeling techniques to assess the relative and absolute contributions of screening mammography and adjuvant treatment to the reduction in breast-cancer mortality in the United States from 1975 to 2000. METHODS: A consortium of investigators developed seven independent statistical models of breast-cancer incidence and mortality. All seven groups used the same sources to obtain data on the use of screening mammography, adjuvant treatment, and benefits of treatment with respect to the rate of death from breast cancer. RESULTS: The proportion of the total reduction in the rate of death from breast cancer attributed to screening varied in the seven models from 28 to 65 percent (median, 46 percent), with adjuvant treatment contributing the rest. The variability across models in the absolute contribution of screening was larger than it was for treatment, reflecting the greater uncertainty associated with estimating the benefit of screening. CONCLUSIONS: Seven statistical models showed that both screening mammography and treatment have helped reduce the rate of death from breast cancer in the United States.	Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Unit 447, Houston, TX 77030 USA; NCI, Bethesda, MD 20892 USA; Stanford Univ, Stanford, CA 94305 USA; Univ Wisconsin, Madison, WI USA; Cornerstone Syst, Lynden, WA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Georgetown Univ, Washington, DC USA; Univ Rochester, Rochester, NY USA; Erasmus Univ, Med Ctr, Rotterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Georgetown University; University of Rochester; Erasmus University Rotterdam; Erasmus MC	Berry, DA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Unit 447, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dberry@mdanderson.org	Boer, Robert/AFM-0525-2022; Boer, Rob/E-6473-2015; Boer, Robert/AAH-2901-2022	Boer, Robert/0000-0003-0680-001X; Boer, Rob/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X	NCI NIH HHS [U01CA86076, U01CA70040, U01CA70013, CA88270, U01CA69976, U01CA63740, CA88278, CA88283, CA88202, CA88177, U01CA63731, U01CA63736, CA88211, CA88248, U01CA86082] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA088278, U01CA086082, U01CA088177, U01CA063731, U01CA070040, U01CA088248, U01CA088270, U01CA086076, U01CA088283, U01CA088202, U01CA070013, U01CA063736, U01CA088211, U01CA069976, U01CA063740] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 1998, LANCET, V352, P930; [Anonymous], HUM MORT DAT; [Anonymous], CANC INT SURV MOD NE; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Clarke M, 1998, LANCET, V351, P1451; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Early Breast Cancer Trialists' Collaborative Group, 2002, COCHRANE DB SYST REV, V1; Goodman SN, 2002, ANN INTERN MED, V137, P363, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00015; Harlan LC, 2002, J CLIN ONCOL, V20, P1809, DOI 10.1200/JCO.2002.07.052; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Leitch AM, 1997, CA-CANCER J CLIN, V47, P150, DOI 10.3322/canjclin.47.3.150; Mariotto A, 2002, J NATL CANCER I, V94, P1626; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Nystrom L, 2002, LANCET, V360, P724; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Parkin DM, 2003, EUR J CANCER, V39, P848, DOI 10.1016/S0959-8049(02)00739-6; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Ries LAG, 2004, SEER CANC STAT REV 1; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L, 1999, CANCER, V86, P449, DOI 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.3.CO;2-H; Wand M.P., 1995, KERNEL SMOOTHING; 2005, CANC INTERVENTION SU	27	1757	1803	3	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1784	1792		10.1056/NEJMoa050518	http://dx.doi.org/10.1056/NEJMoa050518			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251534				2022-12-01	WOS:000232813000006
J	Phimister, EG				Phimister, EG			Genomic cartography - Presenting the HapMap	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226	1	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1766	1768		10.1056/NEJMp058255	http://dx.doi.org/10.1056/NEJMp058255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251532				2022-12-01	WOS:000232813000003
J	Lexau, CA; Lynfield, R; Danila, R; Pilishvili, T; Facklam, R; Farley, MM; Harrison, LH; Schaffner, W; Reingold, A; Bennett, NM; Hadler, J; Cieslak, PR; Whitney, CG				Lexau, CA; Lynfield, R; Danila, R; Pilishvili, T; Facklam, R; Farley, MM; Harrison, LH; Schaffner, W; Reingold, A; Bennett, NM; Hadler, J; Cieslak, PR; Whitney, CG		Active Bacterial Core Surveillance	Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; MORTALITY; SURVEILLANCE; INFECTIONS; RESISTANCE; IMPACT	Context A conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-valent conjugate vaccine affects pneumococcal carriage and transmission. Early after its introduction, incidence of invasive pneumococcal disease declined among older adults, a group at high risk for pneumococcal disease. Objective To determine among adults aged 50 years or older whether incidence of invasive pneumococcal disease, disease characteristics, or the spectrum of patients acquiring these illnesses have changed over the 4 years since pneumococcal conjugate vaccine licensure. Design, Setting, and Population Population-based surveillance of invasive pneumococcal disease in 8 US geographic areas (total population, 18 813 000), 1998-2003. Main Outcome Measures Incidence of invasive pneumococcal disease by pneumococcal serotype and other characteristics; frequency among case patients of comorbid conditions and other factors influencing mortality. Results Incidence of invasive pneumococcal disease among adults aged 50 years or older declined 28% (95% confidence interval [CI], -31% to -24%), from 40.8 cases/ 100 000 in 1998-1999 to 29.4 in 2002-2003. Among those aged 65 years or older, the 2002-2003 rate (41.7 cases/100 000) was lower than the Healthy People 2010 goal (42 cases/100000). Among adults aged 50 years or older, incidence of disease caused by the 7 conjugate vaccine serotypes declined 55% (95% Cl, -58% to -51%) from 22.4 to 10.2 cases/100 000. In contrast, disease caused by any of the 16 serotypes only in polysaccharide vaccine did not change, and disease caused by serotypes not in either vaccine increased somewhat, from 6.0 to 6.8 cases/100000 (13%; 95% Cl, 1% to 27%). Between 1998-1999 and 2002-2003, the proportion of case-patients with human immunodeficiency virus infection increased from 1.7% (47/ 2737) to 5.6% (124/2231) (P<.001), and those with any comorbid condition that is an indication for pneumococcal polysaccharide vaccination increased from 62.3% (1842/ 2955) to 72.0% (1721/2390) (P<.001). Conclusions Our findings indicate that use of conjugate vaccine in children has substantially benefited older adults. However, persons with certain comorbid conditions may benefit less than healthier persons from the indirect effects of the new vaccine.	Minnesota Dept Hlth, St Paul, MN 55155 USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Sch Med, Decatur, GA 30033 USA; Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Monroe Cty Hlth Dept, Rochester, NY USA; Connecticut Dept Publ Hlth, Program Epidemiol, Hartford, CT USA; Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA	Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; University of California System; University of California Berkeley	Lexau, CA (corresponding author), Minnesota Dept Hlth, 625 Robert St N, St Paul, MN 55155 USA.	catherine.lexau@health.state.mn.us						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P783; *CDCP, 1997, STREPT PNEUM; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P446; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P658; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; FLANNERY BL, 2004, INF DIS SOC AM C SEP; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; HOOK EW, 1983, JAMA-J AM MED ASSOC, V249, P1055, DOI 10.1001/jama.249.8.1055; Ingram Deborah D, 2003, Vital Health Stat 2, P1; Leino T, 2004, EPIDEMIOL INFECT, V132, P959, DOI 10.1017/S095026880400250X; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; MUFSON MA, 1974, ARCH INTERN MED, V134, P505, DOI 10.1001/archinte.134.3.505; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Rubins JB, 1999, INFECT IMMUN, V67, P5979, DOI 10.1128/IAI.67.11.5979-5984.1999; Rubins JB, 2001, DRUG AGING, V18, P305, DOI 10.2165/00002512-200118050-00001; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; *US DEP HHS, 2000, HLTH PEOPL 2010 UND; *US DHHS, NAT IMM SURV 2002 20; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	34	519	549	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2005	294	16					2043	2051		10.1001/jama.294.16.2043	http://dx.doi.org/10.1001/jama.294.16.2043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977CB	16249418				2022-12-01	WOS:000232778900024
J	Yokoyama, A; Somervaille, TCP; Smith, KS; Rozenblatt-Rosen, O; Meyerson, M; Cleary, ML				Yokoyama, A; Somervaille, TCP; Smith, KS; Rozenblatt-Rosen, O; Meyerson, M; Cleary, ML			The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis	CELL			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; MULTIPLE ENDOCRINE NEOPLASIA; LINEAGE-LEUKEMIA GENE; MYELOID PROGENITORS; MUTANT MICE; HEMATOLOGICAL MALIGNANCIES; HEMATOPOIETIC PROGENITORS; DROSOPHILA-TRITHORAX; ONCOPROTEIN MLL; FACTOR JUND	The Mixed-Lineage Leukemia (MLL) protein is a histone methyltransferase that is mutated in clinically and biologically distinctive subsets of acute leukemia. MLL normally associates with a cohort of highly conserved cofactors to form a macromolecular complex that includes menin, a product of the MEN1 tumor suppressor gene, which is mutated in heritable and sporadic endocrine tumors. We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis. Furthermore, menin is essential for maintenance of MILL-associated but not other oncogene induced myeloid transformation. Acute genetic ablation of menin reverses aberrant Hox gene expression mediated by MLL-menin promoter-associated complexes, and specifically abrogates the differentiation arrest and oncogenic properties of MLL-transformed leukemic blasts. These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity, validate a potential target for molecular therapy, and suggest central roles for menin in altered epigenetic functions underlying the pathogenesis of hematopoietic cancers.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Pathol, Boston, MA 02115 USA	Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022; Meyerson, Matthew L/E-7123-2012	Yokoyama, Akihiko/0000-0002-5639-8068; Somervaille, Tim/0000-0002-9188-4379	NATIONAL CANCER INSTITUTE [R01CA055029] Funding Source: NIH RePORTER; NCI NIH HHS [CA55029, CA116601] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Agarwal SK, 2003, P NATL ACAD SCI USA, V100, P10770, DOI 10.1073/pnas.1834524100; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Caldas C, 1998, ONCOGENE, V16, P3233, DOI 10.1038/sj.onc.1201873; Chandrasekharappa SC, 2003, J INTERN MED, V253, P606, DOI 10.1046/j.1365-2796.2003.01165.x; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Kim H, 2003, CANCER RES, V63, P6135; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mitterbauer-Hohendanner G, 2004, EUR J CLIN INVEST, V34, P12, DOI 10.1111/j.0960-135X.2004.01366.x; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Smith KS, 1999, MOL CELL BIOL, V19, P4443; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tanabe S, 1996, GENE CHROMOSOME CANC, V15, P206, DOI 10.1002/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Verlinden SFF, 1998, EXP HEMATOL, V26, P627; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	51	391	414	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					207	218		10.1016/j.cell.2005.09.025	http://dx.doi.org/10.1016/j.cell.2005.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239140	Bronze			2022-12-01	WOS:000232794100009
J	Ramadhani, MK; Elias, SG; van Noord, PAH; Grobbee, DE; Peeters, PHM; Uiterwaal, CSPM				Ramadhani, MK; Elias, SG; van Noord, PAH; Grobbee, DE; Peeters, PHM; Uiterwaal, CSPM			Innate left handedness and risk of breast cancer: case-cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WOMEN		Univ Med Care Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Uiterwaal, CSPM (corresponding author), Univ Med Care Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	c.s.p.m.uiterwaal@umcutrecht.nl	Grobbee, Diederick/C-7651-2014; Elias, Sjoerd G/E-6057-2011	Grobbee, Diederick/0000-0003-4472-4468; Elias, Sjoerd G/0000-0003-3903-4024				Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; SCHEIRS JGM, 1995, J CLIN EXP NEUROPSYC, V17, P725, DOI 10.1080/01688639508405162; Titus-Ernstoff L, 2000, EPIDEMIOLOGY, V11, P181, DOI 10.1097/00001648-200003000-00017; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z	4	22	22	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2005	331	7521					882	883		10.1136/bmj.38572.440359.AE	http://dx.doi.org/10.1136/bmj.38572.440359.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975SX	16186135	Bronze, Green Published			2022-12-01	WOS:000232683300023
J	Meech, KJ; Ageorges, N; A'Hearn, MF; Arpigny, C; Ates, A; Aycock, J; Bagnulo, S; Bailey, J; Barber, R; Barrera, L; Barrena, R; Bauer, JM; Belton, MJS; Bensch, F; Bhattacharya, B; Biver, N; Blake, G; Bocklee-Morvan, D; Boehnhardt, H; Bonev, BP; Bonev, T; Buie, MW; Burton, MG; Butner, HM; Cabanac, R; Campbell, R; Campins, H; Capria, MT; Carroll, T; Chaffee, F; Charnley, SB; Cleis, R; Coates, A; Cochran, A; Colom, P; Conrad, A; Coulson, IM; Crovisier, J; deBuizer, J; Dekany, R; de Leon, J; Dello Russo, N; Delsanti, A; DiSanti, M; Drummond, J; Dundon, L; Etzel, PB; Farnham, TL; Feldman, P; Fernandez, YR; Filipovic, MD; Fisher, S; Fitzsimmons, A; Fong, D; Fugate, R; Fujiwara, H; Fujiyoshi, T; Furusho, R; Fuse, T; Gibb, E; Groussin, O; Gulkis, S; Gurwell, M; Hadamcik, H; Hainaut, O; Harker, D; Harrington, D; Harwit, M; Hasegawa, S; Hergenrother, CW; Hirst, P; Hodapp, K; Honda, M; Howell, ES; Hutsemekers, D; Iono, D; Ip, WH; Jackson, W; Jehin, E; Jiang, ZJ; Jones, GH; Jones, PA; Kadono, T; Kamath, UW; Kaufl, HU; Kasuga, T; Kawakita, H; Kelley, MS; Kerber, F; Kidger, M; Kinoshita, D; Knight, M; Lara, L; Larson, SM; Lederer, S; Lee, CF; Levasseur-Regourd, AC; Li, JY; Li, QS; Licandro, J; Lin, ZY; Lisse, CM; LoCurto, G; Lovell, AJ; Lowry, SC; Lyke, J; Lynch, D; Ma, J; Magee-Sauer, K; Maheswar, G; Manfroid, J; Marco, O; Martin, P; Melnick, G; Miller, S; Miyata, T; Moriarty-Schieven, GH; Moskovitz, N; Mueller, BEA; Mumma, MJ; Muneer, S; Neufeld, DA; Ootsubo, T; Osip, D; Pandea, SK; Pantin, E; Paterno-Mahler, R; Patten, B; Penprase, BE; Peck, A; Petitas, G; Pinilla-Alonso, N; Pittichova, J; Pompei, E; Prabhu, TP; Qi, C; Rao, R; Rauer, H; Reitsema, H; Rodgers, SD; Rodriguez, P; Ruane, R; Ruch, G; Rujopakarn, W; Sahu, DK; Sako, S; Sakon, I; Samarasinha, N; Sarkissian, JM; Saviane, I; Schirmer, M; Schultz, P; Schulz, R; Seitzer, P; Sekiguchi, T; Selman, F; Serra-Ricart, M; Sharp, R; Snell, RL; Snodgrass, C; Stallard, T; Stecklein, G; Sterken, C; Stuwe, JA; Sugita, S; Sumner, M; Suntzeff, N; Swaters, R; Takakuwa, S; Takata, N; Thomas-Osip, J; Thompson, E; Tokunaga, AT; Tozzi, GP; Tran, H; Troy, M; Trujillo, C; Van Cleve, J; Vasundhara, R; Vazquez, R; Vilas, F; Villanueva, G; von Braun, K; Vora, P; Wainscoat, RJ; Walsh, K; Watanabe, J; Weaver, HA; Weaver, W; Weiler, M; Weissman, PR; Welsh, WF; Wilner, D; Wolk, S; Womack, M; Wooden, D; Woodney, LM; Woodward, C; Wu, ZY; Wu, JH; Yamashita, T; Yang, B; Yang, YB; Yokogawa, S; Zook, AC; Zauderer, A; Zhao, X; Zhou, X; Zucconi, JM				Meech, KJ; Ageorges, N; A'Hearn, MF; Arpigny, C; Ates, A; Aycock, J; Bagnulo, S; Bailey, J; Barber, R; Barrera, L; Barrena, R; Bauer, JM; Belton, MJS; Bensch, F; Bhattacharya, B; Biver, N; Blake, G; Bocklee-Morvan, D; Boehnhardt, H; Bonev, BP; Bonev, T; Buie, MW; Burton, MG; Butner, HM; Cabanac, R; Campbell, R; Campins, H; Capria, MT; Carroll, T; Chaffee, F; Charnley, SB; Cleis, R; Coates, A; Cochran, A; Colom, P; Conrad, A; Coulson, IM; Crovisier, J; deBuizer, J; Dekany, R; de Leon, J; Dello Russo, N; Delsanti, A; DiSanti, M; Drummond, J; Dundon, L; Etzel, PB; Farnham, TL; Feldman, P; Fernandez, YR; Filipovic, MD; Fisher, S; Fitzsimmons, A; Fong, D; Fugate, R; Fujiwara, H; Fujiyoshi, T; Furusho, R; Fuse, T; Gibb, E; Groussin, O; Gulkis, S; Gurwell, M; Hadamcik, H; Hainaut, O; Harker, D; Harrington, D; Harwit, M; Hasegawa, S; Hergenrother, CW; Hirst, P; Hodapp, K; Honda, M; Howell, ES; Hutsemekers, D; Iono, D; Ip, WH; Jackson, W; Jehin, E; Jiang, ZJ; Jones, GH; Jones, PA; Kadono, T; Kamath, UW; Kaufl, HU; Kasuga, T; Kawakita, H; Kelley, MS; Kerber, F; Kidger, M; Kinoshita, D; Knight, M; Lara, L; Larson, SM; Lederer, S; Lee, CF; Levasseur-Regourd, AC; Li, JY; Li, QS; Licandro, J; Lin, ZY; Lisse, CM; LoCurto, G; Lovell, AJ; Lowry, SC; Lyke, J; Lynch, D; Ma, J; Magee-Sauer, K; Maheswar, G; Manfroid, J; Marco, O; Martin, P; Melnick, G; Miller, S; Miyata, T; Moriarty-Schieven, GH; Moskovitz, N; Mueller, BEA; Mumma, MJ; Muneer, S; Neufeld, DA; Ootsubo, T; Osip, D; Pandea, SK; Pantin, E; Paterno-Mahler, R; Patten, B; Penprase, BE; Peck, A; Petitas, G; Pinilla-Alonso, N; Pittichova, J; Pompei, E; Prabhu, TP; Qi, C; Rao, R; Rauer, H; Reitsema, H; Rodgers, SD; Rodriguez, P; Ruane, R; Ruch, G; Rujopakarn, W; Sahu, DK; Sako, S; Sakon, I; Samarasinha, N; Sarkissian, JM; Saviane, I; Schirmer, M; Schultz, P; Schulz, R; Seitzer, P; Sekiguchi, T; Selman, F; Serra-Ricart, M; Sharp, R; Snell, RL; Snodgrass, C; Stallard, T; Stecklein, G; Sterken, C; Stuwe, JA; Sugita, S; Sumner, M; Suntzeff, N; Swaters, R; Takakuwa, S; Takata, N; Thomas-Osip, J; Thompson, E; Tokunaga, AT; Tozzi, GP; Tran, H; Troy, M; Trujillo, C; Van Cleve, J; Vasundhara, R; Vazquez, R; Vilas, F; Villanueva, G; von Braun, K; Vora, P; Wainscoat, RJ; Walsh, K; Watanabe, J; Weaver, HA; Weaver, W; Weiler, M; Weissman, PR; Welsh, WF; Wilner, D; Wolk, S; Womack, M; Wooden, D; Woodney, LM; Woodward, C; Wu, ZY; Wu, JH; Yamashita, T; Yang, B; Yang, YB; Yokogawa, S; Zook, AC; Zauderer, A; Zhao, X; Zhou, X; Zucconi, JM			Deep Impact: Observations from a worldwide Earth-based campaign	SCIENCE			English	Article							9P/TEMPEL-1	On 4 July 2005, many observatories around the world and in space observed the collision of Deep Impact with comet 9P/Tempet 1 or its aftermath. This was an unprecedented coordinated observational campaign. These data show that (i) there was new material after impact that was compositionally different from that seen before impact; (ii) the ratio of dust mass to gas mass in the ejecta was much larger than before impact; (iii) the new activity did not last more than a few days, and by 9 July the comet's behavior was indistinguishable from its pre-impact behavior; and (iv) there were interesting transient phenomena that may be correlated with cratering physics.	Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; European So Observ, Santiago 19, Chile; Univ Maryland, College Pk, MD 20742 USA; Univ Liege, B-4000 Liege, Belgium; Pomona Coll, Claremont, CA 91711 USA; Keck Observ, Kamuela, HI 96743 USA; Macquarie Univ, Australian Ctr Astrobiol, Sydney, NSW 2109, Australia; UCL, London WC1E 6BT, England; Univ Metropolitana Ciencias Educ, Santiago, Chile; Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; NASA, Jet Prop Lab, Pasadena, CA 91109 USA; Belton Space Initiat, Tucson, AZ 85716 USA; Univ Bonn, Inst Radioastron, D-53121 Bonn, Germany; CALTECH, Pasadena, CA 91125 USA; Observ Paris, F-92195 Meudon, France; Max Planck Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Toledo, Toledo, OH 43606 USA; Inst Astron, Sofia 1784, Bulgaria; Lowell Observ, Flagstaff, AZ 86001 USA; Univ New S Wales, Sydney, NSW 2052, Australia; Joint Astron Ctr, Hilo, HI 96720 USA; Canada France Hawaii Telescope Corp, Kamuela, HI 96743 USA; Univ Cent Florida, Orlando, FL 32816 USA; Inst Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; USAF, Res Lab, Kirtland AFB, NM 87117 USA; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ Texas, Austin, TX 78712 USA; Gemini Observ, Serena, Chile; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20770 USA; San Diego State Univ, San Diego, CA 92182 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; Univ Western Sydney, Sydney, NSW 1797, Australia; Gemini Observ N, Hilo, HI 96720 USA; Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Tokyo, Tokyo 1138654, Japan; Subaru Telescope, Hilo, HI 96720 USA; Waseda Univ, Tokyo 1698050, Japan; Univ Notre Dame, Notre Dame, IN 46556 USA; CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Cornell Univ, Ithaca, NY 14853 USA; Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Univ Arizona, Tucson, AZ 85721 USA; Arecibo Observ, Arecibo, PR 00612 USA; Natl Cent Univ, Taoyuan 32001, Taiwan; Univ Calif Davis, Davis, CA 95616 USA; Natl Astron Observ, Beijing 100012, Peoples R China; Australian Telescope, Natl Facil, Epping, NSW 1710, Australia; Japan Agcy Marine Earth Sci & Technol, Kanagawa 2370061, Japan; Indian Inst Astrophys, Bangalore 560034, Karnataka, India; Natl Astron Observ Japan, Tokyo 1818588, Japan; Kyoto Sangyo Univ, Kyoto 6038555, Japan; Univ Minnesota, Minneapolis, MN 55455 USA; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; Isaac Newton Grp Telescopes, E-38700 La Palma, Spain; Agnes Scott Coll, Decatur, GA 30030 USA; Aerosp Corp, Los Angeles, CA 90009 USA; Rowan Univ, Glassboro, NJ 08028 USA; Natl Opt Astron Observ, Tucson, AZ 85719 USA; Nagoya Univ, Nagoya, Aichi 4648601, Japan; Las Campanas Observ, Pasadena, CA 91101 USA; CEA, Serv Astron, F-91191 Gif Sur Yvette, France; Fdn Galileo Galilei & Telescopio Nazl Galileo, La Palma 38700, Spain; Deutsch Zentrum Luft & Raumfahrt, D-12489 Berlin, Germany; Ball Aerosp, Boulder, CO 80306 USA; European Space Agcy, Madrid 28080, Spain; Univ Michigan, Ann Arbor, MI 48109 USA; Brown Univ, Providence, RI 02912 USA; European Space Agcy, NL-2200 AG Noordwijk, Netherlands; Anglo Australian Observ, Epping, NSW 1710, Australia; Univ Massachusetts, Amherst, MA 01003 USA; Univ Brussels, B-1050 Brussels, Belgium; Leiden Observ, NL-2300 RA Leiden, Netherlands; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Univ Nacl Autonoma Mexico, Ensenada 22800, Baja California, Mexico; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Carnegie Inst Sci, Washington, DC 20015 USA; Coll William & Mary, Williamsburg, VA 23187 USA; St Cloud State Univ, St Cloud, MN 56301 USA; Observ Besancon, F-25010 Besancon, France	University of Hawaii System; University of Hawaii Manoa; European Southern Observatory; University System of Maryland; University of Maryland College Park; University of Liege; Claremont Colleges; Pomona College; Macquarie University; University of London; University College London; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Instituto de Astrofisica de Canarias; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Bonn; California Institute of Technology; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Max Planck Society; University System of Ohio; University of Toledo; Bulgarian Academy of Sciences; University of New South Wales Sydney; Canada France Hawaii Telescope; State University System of Florida; University of Central Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Defense; United States Air Force; University of London; University College London; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California State University System; San Diego State University; Johns Hopkins University; Western Sydney University; Queens University Belfast; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Waseda University; University of Notre Dame; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Diego; Cornell University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Arizona; National Aeronautics & Space Administration (NASA); National Central University; University of California System; University of California Davis; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Department of Science & Technology (India); Indian Institute of Astrophysics (IIA); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto Sangyo University; University of Minnesota System; University of Minnesota Twin Cities; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); California State University System; California State University San Bernardino; Isaac Newton Group of Telescopes; Aerospace Corporation - USA; Rowan University; National Optical Astronomy Observatory; Nagoya University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of Michigan System; University of Michigan; Brown University; European Space Agency; University of Massachusetts System; University of Massachusetts Amherst; Leiden University; Leiden University - Excl LUMC; Istituto Nazionale Astrofisica (INAF); Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; William & Mary; Minnesota State Colleges & Universities; Saint Cloud State University	Meech, KJ (corresponding author), Univ Hawaii Manoa, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	meech@ifa.hawaii.edu	Sugita, Seiji/GQI-1142-2022; Rujopakarn, Wiphu/AAV-2176-2021; Jones, Geraint H./C-1682-2008; Vázquez, Roberto/L-3613-2016; Serra-Ricart, Miguel/AAB-2812-2019; Pittichova, Jana/AAG-6364-2020; Stecklein, Gordon/Q-4099-2019; Licandro, Javier/L-7667-2014; Lara, Luisa M/F-5614-2012; Hainaut, Olivier R./AAY-7006-2021; Meech, Karen/CAH-1412-2022; Magee-Sauer, Karen/K-6061-2015; Rujopakarn, Wiphu/E-7849-2012; Pinilla-Alonso, Noemi/K-4361-2017; Russo, Neil Dello/G-2727-2015; Muneer, Sowbiya/S-5382-2019; Prabhu, Tushar/AAD-7280-2021; Filipovic, Miroslav/AAN-9577-2020; de León, Julia/H-7569-2015; Lisse, Carey M/B-7772-2016; mumma, michael j/I-2764-2013; Lee, Chin-Fei/AAZ-3391-2020; Cochran, Alyssa/GPX-7835-2022; Welsh, William/AAS-3445-2021; Charnley, Steven B/C-9538-2012; Womack, Maria/AAE-8510-2019; Weaver, Harold A/D-9188-2016; Weiler, Michael/G-2028-2016; Jackson, William/G-6983-2017; Pinilla-Alonso, Noemi/B-8583-2008; Stallard, Tom/W-8743-2019; Curto, Gaspare Lo/AAB-2630-2021; Coates, Andrew/C-2396-2008; Rao, Ramprasad/L-2115-2017; Hasegawa, Sunao/R-4768-2017	Sugita, Seiji/0000-0001-6076-3614; Jones, Geraint H./0000-0002-5859-1136; Vázquez, Roberto/0000-0002-3279-9764; Licandro, Javier/0000-0002-9214-337X; Lara, Luisa M/0000-0002-7184-920X; Magee-Sauer, Karen/0000-0002-4979-9875; Pinilla-Alonso, Noemi/0000-0002-2770-7896; Russo, Neil Dello/0000-0002-8379-7304; Filipovic, Miroslav/0000-0002-4990-9288; de León, Julia/0000-0002-0696-0411; Lisse, Carey M/0000-0002-9548-1526; mumma, michael j/0000-0003-4627-750X; Lee, Chin-Fei/0000-0002-3024-5864; Womack, Maria/0000-0003-4659-8653; Weaver, Harold A/0000-0003-0951-7762; Stallard, Tom/0000-0003-3990-670X; Coates, Andrew/0000-0002-6185-3125; Jackson, William M./0000-0002-1961-9466; Reitsema, Harold/0000-0002-4119-5700; Wilner, David/0000-0003-1526-7587; Sahu, Devendra Kumar/0000-0002-6688-0800; Meech, Karen/0000-0002-2058-5670; Drummond, Jack/0000-0001-5289-3734; Weiler, Michael/0000-0002-3007-3927; Snodgrass, Colin/0000-0001-9328-2905; Prabhu, Tushar/0000-0003-0797-5057; Suntzeff, Nicholas/0000-0002-8102-181X; DELSANTI, Audrey/0000-0002-1413-2288; Sharp, Rob/0000-0003-4877-7866; Jones, Paul/0000-0001-9429-9135; Tokunaga, Alan/0000-0001-8136-9704; Paterno-Mahler, Rachel/0000-0003-3653-3741; Fernandez, Yanga/0000-0003-1156-9721; Rao, Ramprasad/0000-0002-1407-7944; Tozzi, Gian Paolo/0000-0003-4775-5788; Vilas, Faith/0000-0003-4723-5870; Burton, Michael/0000-0001-7289-1998; Mueller, Beatrice/0000-0001-6194-3174; Samarasinha, Nalin/0000-0001-8925-7010; Wolk, Scott/0000-0002-0826-9261; Knight, Matthew/0000-0003-2781-6897; Kelley, Michael/0000-0002-6702-7676; Miller, Steven/0000-0002-7159-6871; Marco, Olivier/0000-0002-2967-6368; Schirmer, Mischa/0000-0003-2568-9994; Lowry, Stephen/0000-0002-5605-4329; Troy, Mitchell/0000-0002-0040-5409; Hasegawa, Sunao/0000-0001-6366-2608; Gurwell, Mark/0000-0003-0685-3621; Harker, David/0000-0001-6397-9082; Trujillo, Chadwick/0000-0001-9859-0894; Butner, Harold/0000-0003-4899-2064; Hodapp, Klaus/0000-0003-0786-2140; Rodriguez Pascual, Pedro/0000-0002-6505-1349; Saviane, Ivo/0000-0002-5878-5299				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; Harker DE, 2005, SCIENCE, V310, P278, DOI 10.1126/science.1119143; HUTSEMEKERS D, IN PRESS ASTRON ASTR; KAUFL HU, 2005, 8593 INT ASTR UN; Lara L.S., UNPUB; LISSE C, 2005, 8571 INT ASTR UN; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; LISSE CM, 2005, COMETS, V2, P631; Meech KJ, 2005, SPACE SCI REV, V117, P297, DOI 10.1007/s11214-005-3382-8; Mumma MJ, 2005, SCIENCE, V310, P270, DOI 10.1126/science.1119337; SCHLEICHER DG, UNPUB; Sekanina Z, 1997, EARTH MOON PLANETS, V78, P313, DOI 10.1023/A:1006286024437; Sugita S, 2005, SCIENCE, V310, P274, DOI 10.1126/science.1119091	15	139	140	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					265	269		10.1126/science.1118978	http://dx.doi.org/10.1126/science.1118978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150977				2022-12-01	WOS:000232670100038
J	Seeger, H; Heikenwalder, M; Zeller, N; Kranich, J; Schwarz, P; Gaspert, A; Seifert, B; Miele, G; Aguzzi, A				Seeger, H; Heikenwalder, M; Zeller, N; Kranich, J; Schwarz, P; Gaspert, A; Seifert, B; Miele, G; Aguzzi, A			Coincident scrapie infection and nephritis lead to urinary prion excretion	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BLOOD-TRANSFUSION; TRANSMISSION; RESISTANT; PROTEIN; PARTICLES; VARIANT; MOUSE; MICE; PRP	Prion infectivity is typically restricted to the central nervous and lymphatic systems of infected hosts, but chronic inflammation can expand the distribution of prions. We tested whether chronic inflammatory kidney disorders would trigger excretion of prion infectivity into urine. Urinary proteins from scrapie-infected mice with lymphocytic nephritis induced scrapie upon inoculation into noninfected indicator mice. Prionuria was found in presymptomatic scrapie-infected and in sick mice, whereas neither prionuria nor urinary PrPSSc was detectable in prion-infected wild-type or PrPC-overexpressing mice, or in nephritic mice inoculated with noninfectious brain. Thus, urine may provide a vector for horizontal prion transmission, and inflammation of excretory organs may influence prion spread.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Biostat, CH-8006 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Heikenwalder, Mathias/AAA-2269-2020; Aguzzi, Adriano/A-3351-2008; Miele, Gennaro/AAG-6782-2020	Miele, Gennaro/0000-0002-2028-0578; Kranich, Jan/0000-0002-9928-4132; Aguzzi, Adriano/0000-0002-0344-6708; Seifert, Burkhardt/0000-0002-5829-2478				Aguzzi A, 2005, IMMUNITY, V22, P145, DOI 10.1016/j.immuni.2004.12.007; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Furukawa H, 2004, J BIOL CHEM, V279, P23661, DOI 10.1074/jbc.M400187200; GAJDUSEK DC, 1967, SCIENCE, V155, P212; Head MW, 2005, NEUROLOGY, V64, P1794, DOI 10.1212/01.WNL.0000161842.68793.8A; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; JONES SR, 1990, AM J MED, V88, pS30, DOI 10.1016/0002-9343(90)90085-R; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Serban A, 2004, J BIOL CHEM, V279, P48817, DOI 10.1074/jbc.M409107200; Shaked GM, 2001, J BIOL CHEM, V276, P31479, DOI 10.1074/jbc.C100278200; SHIBAYAMA Y, 1982, ACTA PATHOL JAPON, V32, P695; TATEISHI J, 1980, ACTA NEUROPATHOL, V51, P127, DOI 10.1007/BF00690454	18	141	143	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					324	326		10.1126/science.1118829	http://dx.doi.org/10.1126/science.1118829			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224026				2022-12-01	WOS:000232670100055
J	Wu, JQ; Pollard, TD				Wu, JQ; Pollard, TD			Counting cytokinesis proteins globally and locally in fission yeast	SCIENCE			English	Article							SINGLE LIVING CELLS; SPINDLE-POLE BODY; SCHIZOSACCHAROMYCES-POMBE; MYOSIN-II; CONTRACTILE RING; ACTIN NUCLEATION; ARP2/3 COMPLEX; F-ACTIN; CYCLE; DIVISION	We used fluorescence microscopy to measure global and local concentrations of 28 cytoskeletal and signaling proteins fused to yellow fluorescent protein (YFP) in the fission yeast Schizosaccharomyces pombe. Native promoters controlled the expression of these functional YFP fusion proteins. Fluorescence measured by microscopy or flow cytometry was directly, proportional to protein concentration measured by quantitative immunoblotting. Global cytoplasmic concentrations ranged from 0.04 (formin Cdc12p) to 63 micromolar (actin). Proteins concentrated up to 100 times in contractile rings and 7500 times in spindle pole bodies at certain times in the cell cycle. This approach can be used to measure the global and local concentrations of any fusion protein.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol & Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Wu, Jian-qiu/G-6835-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026132] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM026132, GM-26231] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Bezanilla M, 2000, MOL BIOL CELL, V11, P79, DOI 10.1091/mbc.11.1.79; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; D'souza VM, 2001, CELL STRUCT FUNCT, V26, P555, DOI 10.1247/csf.26.555; Desautels M, 2001, J BIOL CHEM, V276, P5932, DOI 10.1074/jbc.M008715200; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Dundr M, 2002, J STRUCT BIOL, V140, P92, DOI 10.1016/S1047-8477(02)00521-X; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hirschberg K, 2000, METHOD ENZYMOL, V327, P69, DOI 10.1016/S0076-6879(00)27268-6; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; KANBE T, 1989, J CELL SCI, V94, P647; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Morrell JL, 2004, CURR BIOL, V14, P579, DOI 10.1016/j.cub.2004.03.036; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Piston DW, 1999, METHOD CELL BIOL, V58, P31; Robinson DN, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-4; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.E04-08-0734; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Wong KCY, 2002, CURR BIOL, V12, P724, DOI 10.1016/S0960-9822(02)00790-X; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	41	406	412	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					310	314		10.1126/science.1113230	http://dx.doi.org/10.1126/science.1113230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224022				2022-12-01	WOS:000232670100051
J	Xi, ZY; Khoo, CCH; Dobson, SL				Xi, ZY; Khoo, CCH; Dobson, SL			Wolbachia establishment and invasion in an Aedes aegypti laboratory population	SCIENCE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; ALBOPICTUS; INFECTION; MOSQUITO	A proposed strategy to aid in controlling the growing burden of vector-borne disease is population replacement, in which a natural vector population is replaced by a population with a reduced capacity for disease transmission. An important component of such a strategy is the drive system; which serves to spread a desired genotype into the targeted field population. Endosymbiotic Wolbachia. bacteria are potential transgene drivers, but infections do not naturally occur in some important mosquito vectors, notably Aedes aegypti. In this work, stable infections of wAlbB Wolbachia were established in A. aegypti and caused high rates of cytoplasmic incompatibility (that is, elimination of egg hatch). Laboratory cage tests demonstrated the ability of wAlbB to spread into an A. aegypti population after seeding of an uninfected population with infected females, reaching infection fixation within seven generations.	Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Dobson, SL (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	sdobson@uky.edu	Xi, Zhiyong/AAD-7936-2022; Dobson, Stephen L/E-5853-2010	Xi, Zhiyong/0000-0001-7786-012X; Dobson, Stephen L/0000-0001-5486-8225	NIAID NIH HHS [AI-51533] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Atkinson PW, 2002, GENESIS, V32, P42, DOI 10.1002/gene.10026; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; HOFFMANN AA, 1990, GENETICS, V126, P933; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015	12	351	373	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					326	328		10.1126/science.1117607	http://dx.doi.org/10.1126/science.1117607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224027				2022-12-01	WOS:000232670100056
J	Graveley, BR				Graveley, BR			Mutuallv exclusive splicing of the insect Dscam Pre-mRNA directed by competing intronic RNA secondary structures	CELL			English	Article							WEB SERVER; GENOME; EXPRESSION; DIVERSITY; SEQUENCE; ANIMALS; EXONS; WORLD	Drosophila Dscam encodes 38,016 distinct axon guidance receptors through the mutually exclusive alternative splicing of 95 variable exons. Importantly, known mechanisms that ensure the mutually exclusive splicing of pairs of exons cannot explain this phenomenon in Dscam. I have identified two classes of conserved elements in the Dscam exon 6 cluster, which contains 48 alternative exons-the docking site, located in the intron downstream of constitutive exon 5, and the selector sequences, which are located upstream of each exon 6 variant. Strikingly, each selector sequence is complementary to a portion of the docking site, and this pairing juxtaposes one, and only one, alternative exon to the upstream constitutive exon. The mutually exclusive nature of the docking site:selector sequence interactions suggests that the formation of these competing RNA structures is a central component of the mechanism guaranteeing that only one exon 6 variant is included in each Dscam mRNA.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067842] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067842-04, R01 GM067842, GM67842] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones RB, 2001, J BIOL CHEM, V276, P4158, DOI 10.1074/jbc.M006151200; Kennedy CF, 1997, MOL CELL BIOL, V17, P2774, DOI 10.1128/MCB.17.5.2774; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Powell J.R., 1997, PROGR PROSPECTS EVOL; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; SMITH CWJ, 1989, CELL, V56, P749, DOI 10.1016/0092-8674(89)90678-8; Southby J, 1999, MOL CELL BIOL, V19, P2699; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	24	188	194	2	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 7	2005	123	1					65	73		10.1016/j.cell.2005.07.028	http://dx.doi.org/10.1016/j.cell.2005.07.028			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213213	Green Accepted, Bronze			2022-12-01	WOS:000232536800009
J	Huang, CS; Shi, SH; Ule, J; Ruggiu, M; Barker, LA; Darnell, RB; Jan, YN; Jan, LY				Huang, CS; Shi, SH; Ule, J; Ruggiu, M; Barker, LA; Darnell, RB; Jan, YN; Jan, LY			Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition	CELL			English	Article							RNA-BINDING PROTEIN; ACTIVATING TRANSCRIPTION FACTOR-4; RECTIFYING POTASSIUM CHANNELS; GABA(B) RECEPTORS; CYTOPLASMIC LOCALIZATION; RAT HIPPOCAMPUS; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; SIGNALING PROTEINS; DENDRITIC SPINES	Synaptic plasticity, the cellular correlate for learning and memory, involves signaling cascades in the dendritic spine. Extensive studies have shown that long-term potentiation (LTP) of the excitatory postsynaptic current (EPSC) through glutamate receptors is induced by activation of N-methyl-D-asparate receptor (NMDA-R)-the coincidence detector-and Ca2+/calmodulin-dependent protein kinase II (CaMKII). Here we report that the same signaling pathway in the postsynaptic CA1 pyramidal neuron also causes LTP of the slow inhibitory postsynaptic current (sIPSC) mediated by metabotropic GABA(B) receptors (GABA(B)-Rs) and G protein-activated inwardly rectifying K+ (GIRK) channels, both residing in dendritic spines as well as shafts. Indicative of intriguing differences in the regulatory mechanisms for excitatory and inhibitory synaptic plasticity, LTP of sIPSC but not EPSC was abolished in mice lacking Nova-2, a neuronal-specific RNA binding protein that is an autoimmune target in paraneoplastic opsoclonus myoclonus ataxia (POMA) patients with latent cancer, reduced inhibitory control of movements, and dementia.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Oral & Craniofacial Sci, San Francisco, CA 94143 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu	Darnell, Robert B/B-9022-2008; Ule, Jernej/C-6315-2013	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Jan, Lily/0000-0003-3938-8498; Ruggiu, Matteo/0000-0002-6404-1210	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH063981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200, R01NS040955] Funding Source: NIH RePORTER; NIMH NIH HHS [MH63981] Funding Source: Medline; NINDS NIH HHS [R01 NS40955, NS047200] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSER DC, 1995, J PHARMACOL EXP THER, V274, P1393; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 2001, ION CHANNELS EXCITAB, V3; HORMIGO A, 1994, ANN NEUROL, V36, P896, DOI 10.1002/ana.410360615; Hyman JM, 2003, J NEUROSCI, V23, P11725; Isomoto S, 1998, BIOCHEM BIOPH RES CO, V253, P10, DOI 10.1006/bbrc.1998.9706; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kopysova IL, 1998, J NEUROSCI, V18, P7436; Kulik A, 2003, J NEUROSCI, V23, P11026; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LUQUE FA, 1991, ANN NEUROL, V29, P241, DOI 10.1002/ana.410290303; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Martin SC, 2004, J COMP NEUROL, V473, P16, DOI 10.1002/cne.20094; Martin SC, 2001, GENE, V278, P63, DOI 10.1016/S0378-1119(01)00678-3; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Palacios IM, 2002, CURR BIOL, V12, pR50, DOI 10.1016/S0960-9822(01)00671-6; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PRANZATELLI MR, 1992, CLIN NEUROPHARMACOL, V15, P186, DOI 10.1097/00002826-199206000-00002; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Stein V, 2003, J NEUROSCI, V23, P5503; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Vernon E, 2001, MOL CELL NEUROSCI, V17, P637, DOI 10.1006/mcne.2000.0960; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yamada M, 1998, PHARMACOL REV, V50, P723; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254	77	123	127	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					105	118		10.1016/j.cell.2005.07.033	http://dx.doi.org/10.1016/j.cell.2005.07.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213216	Bronze			2022-12-01	WOS:000232536800012
J	Yan, N; Chai, JJ; Lee, ES; Gu, LC; Liu, Q; He, JQ; Wu, JW; Kokel, D; Li, HL; Hao, Q; Xue, D; Shi, YG				Yan, N; Chai, JJ; Lee, ES; Gu, LC; Liu, Q; He, JQ; Wu, JW; Kokel, D; Li, HL; Hao, Q; Xue, D; Shi, YG			Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans	NATURE			English	Article							REGULATORS CED-9; PROTEIN; ENCODES; EGL-1; OLIGOMERIZATION; RECOGNITION; ASSOCIATION; ACTIVATION	Interplay among four genes - egl-1, ced-9, ced-4 and ced-3 - controls the onset of programmed cell death in the nematode Caenorhabditis elegans. Activation of the cell-killing protease CED-3 requires CED-4. However, CED-4 is constitutively inhibited by CED-9 until its release by EGL-1. Here we report the crystal structure of the CED-4 - CED-9 complex at 2.6 angstrom resolution, and a complete reconstitution of the CED-3 activation pathway using homogeneous proteins of CED-4, CED-9 and EGL-1. One molecule of CED-9 binds to an asymmetric dimer of CED-4, but specifically recognizes only one of the two CED-4 molecules. This specific interaction prevents CED-4 from activating CED-3. EGL-1 binding induces pronounced conformational changes in CED-9 that result in the dissociation of the CED-4 dimer from CED-9. The released CED-4 dimer further dimerizes to form a tetramer, which facilitates the autoactivation of CED-3. Together, our studies provide important insights into the regulation of cell death activation in C. elegans.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Cornell Univ, Ithaca, NY 14853 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Princeton University; University of Colorado System; University of Colorado Boulder; Gwangju Institute of Science & Technology (GIST); Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu	He, Jiaqing/A-2245-2010; Hao, Quan/C-4304-2009; Liu, Qun/A-8757-2011	He, Jiaqing/0000-0003-3954-6003; Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514; Chai, Jijie/0000-0001-7591-3873; kokel, david/0000-0002-1981-1511; Li, Huilin/0000-0001-8085-8928; Shi, Yigong/0000-0003-2030-168X; XUE, DING/0000-0002-8429-8136				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; del Peso L, 2000, J BIOL CHEM, V275, P27205; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horvitz HR, 2003, CHEMBIOCHEM, V4, P697, DOI 10.1002/cbic.200300614; Horvitz HR, 1999, CANCER RES, V59, p1701S; Hugunin M, 1996, J BIOL CHEM, V271, P3517, DOI 10.1074/jbc.271.7.3517; Irmler M, 1997, FEBS LETT, V406, P189, DOI 10.1016/S0014-5793(97)00271-8; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; Jaroszewski L, 2000, PROTEINS, V39, P197, DOI 10.1002/(SICI)1097-0134(20000515)39:3<197::AID-PROT10>3.0.CO;2-V; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ottilie S, 1997, CELL DEATH DIFFER, V4, P526, DOI 10.1038/sj.cdd.4400288; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish J, 2000, P NATL ACAD SCI USA, V97, P11916, DOI 10.1073/pnas.210391597; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Woo JS, 2003, CELL DEATH DIFFER, V10, P1310, DOI 10.1038/sj.cdd.4401303; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	40	169	181	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					831	837		10.1038/nature04002	http://dx.doi.org/10.1038/nature04002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208361				2022-12-01	WOS:000232338600035
J	Patel, HC; Bouamra, O; Woodford, M; King, AT; Yates, DW; Lecky, FE				Patel, HC; Bouamra, O; Woodford, M; King, AT; Yates, DW; Lecky, FE		Trauma Audit Res Network	Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: an observational study	LANCET			English	Article							TRAUMA CARE; MANAGEMENT; ENGLAND; CENTERS; WALES	Background Case fatality rates after all types of blunt injury have not improved since 1994 in England and Wales, possibly because not all patients with severe head injury are treated in a neurosurgical Centre. Our aims were to investigate the case fatality trends in major trauma patients with and without head injury, and to establish the effect of neurosurgical care on mortality after severe head injury. Methods We analysed prospectively collected data from the Trauma Audit and Research Network database for patients presenting between 1989 and 2003. Mortality and odds of death adjusted for case mix were compared for patients with and without head injury, and for those treated in a neurosurgical versus a non-neurosurgical Centre. Findings Patients with head injury (n=22 216) had a ten-fold higher mortality and showed less improvement in the adjusted odds of death since 1989 than did patients without head injury (n=154 231). 2305 (33%) of patients with severe head injury (presenting between 1996 and 2003) were treated only in non-neurosurgical centres; such treatment was associated with a 26% increase in mortality and a 2.15-fold increase (95% Cl 1.77-2.60) in the odds of death adjusted for case mix compared with patients treated at a neurosurgical Centre. Interpretation Since 1989 trauma system changes in England and Wales have delivered greater benefit to patients without head injury. Our data lend support to current guidelines, suggesting that treatment in a neurosurgical Centre represents an important strategy in the management of severe head injury.	Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England	University of Manchester	Lecky, FE (corresponding author), Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England.	flecky@fs1.ho.man.ac.uk	Patel, Hiren/AAL-3811-2021; King, Andrew/AAR-1656-2020	Patel, Hiren/0000-0002-1439-8801; King, Andrew/0000-0002-6546-7248; bouamra, omar/0000-0002-3155-4634				Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; [Anonymous], 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BRIGGS M, 1984, BRIT MED J, V288, P983; Cairns H, 1947, NOTES NEUROSURGICAL; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENTLEMAN D, 1992, INJURY, V23, P471, DOI 10.1016/0020-1383(92)90066-2; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; HOLLIS S, 1995, J TRAUMA, V38, P763, DOI 10.1097/00005373-199505000-00015; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lecky FE, 2002, EMERG MED J, V19, P520, DOI 10.1136/emj.19.6.520; MacKenzie EJ, 1999, J TRAUMA, V47, pS34, DOI 10.1097/00005373-199909001-00008; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Royal College of Surgeons, 1999, REP WORK PART MAN PA; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; Sherman HF, 2001, J TRAUMA, V50, P784, DOI 10.1097/00005373-200105000-00003; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; *TRAUM AUD RES NET, PS 04; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	30	237	247	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2005	366	9496					1538	1544		10.1016/S0140-6736(05)67626-X	http://dx.doi.org/10.1016/S0140-6736(05)67626-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979ZX	16257340				2022-12-01	WOS:000232984800022
J	Thiebaut de Schotten, M; Urbanski, M; Duffau, H; Voue, E; Levy, R; Dubois, B; Bartolomeo, P				Thiebaut de Schotten, M; Urbanski, M; Duffau, H; Voue, E; Levy, R; Dubois, B; Bartolomeo, P			Direct evidence for a parietal-frontal pathway subserving spatial awareness in humans	SCIENCE			English	Article							LINE BISECTION; VISUAL NEGLECT; ATTENTION; REPRESENTATION; ANATOMY; DISCONNECTION; MECHANISMS; INSIGHTS; MONKEY; BRAIN	Intraoperative electrical stimulation, which temporarily inactivates restricted regions during brain surgery, can map cognitive functions in humans with spatiotemporal resolution unmatched by other methods. Using this technique, we found that stimulation of the right inferior parietal lobule or the caudal superior temporal gyrus, but not of its rostra[ portion, determined rightward deviations on line bisection. However, the strongest shifts occurred with subcortical stimulation. Fiber tracking identified the stimulated site as a section of the superior occipitofrontal fasciculus, a poorly known parietal-frontal pathway. These findings suggest that parietal-frontal communication is necessary for the symmetrical processing of the visual scene.	Hop La Pitie Salpetriere, INSERM, U610, F-75013 Paris, France; Hop La Pitie Salpetriere, Dept Neurosurg, F-75013 Paris, France; Hop La Pitie Salpetriere, Dept Neuroimagery, F-75013 Paris, France; Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Dept Neurol, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Bartolomeo, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U610, F-75013 Paris, France.	paolo.bartotomeo@chups.jussieu.fr	Bartolomeo, Paolo/B-3046-2009; Volle, Emmanuelle/J-4164-2017; Levy, Richard/D-8411-2011; de Schotten, Michel Thiebaut/H-1496-2011	Bartolomeo, Paolo/0000-0002-2640-6426; Volle, Emmanuelle/0000-0001-8420-4155; de Schotten, Michel Thiebaut/0000-0002-0329-1814				Anderson B, 1996, BRAIN, V119, P841, DOI 10.1093/brain/119.3.841; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; DEJERINE MJ, 1895, ANATOMIE CENTRES NER; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Fink GR, 2002, NEUROPSYCHOLOGIA, V40, P119, DOI 10.1016/S0028-3932(01)00087-2; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; MARSHALL JC, 1990, COGNITIVE NEUROPSYCH, V7, P107, DOI 10.1080/02643299008253438; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Milner D., 1995, VISUAL BRAIN ACTION; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nieuwenhuys R., 1988, HUMAN CENTRAL NERVOU; Petrides M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; RORDEN C, 2005, COGNIT BRAIN RE 0219, DOI DOI 10.1016/J.COGBRAINRES.2004.10.022; Rousseaux M, 2001, REV NEUROL-FRANCE, V157, P1385; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822	27	450	451	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2005	309	5744					2226	2228		10.1126/science.1116251	http://dx.doi.org/10.1126/science.1116251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195465				2022-12-01	WOS:000232318000047
J	Du, LQ; Poovaiah, BW				Du, LQ; Poovaiah, BW			Ca2+/calmodulin is critical for brassinosteroid biosynthesis and plant growth	NATURE			English	Article							TRANSCRIPTION ACTIVATORS; ARABIDOPSIS-DET3 MUTANT; LIGHT; CALMODULIN; RECEPTOR; PROTEIN; GENE; KINASE; FAMILY; EXPRESSION	Brassinosteroids are plant-specific steroid hormones(1,2) that have an important role in coupling environmental factors, especially light, with plant growth and development(3). How the endogenous brassinosteroids change in response to environmental stimuli is largely unknown. Ca2+/calmodulin has an essential role in sensing and transducing environmental stimuli(4,5). Arabidopsis DWARF1 (DWF1) is responsible for an early step in brassinosteroid biosynthesis that converts 24-methylenecholesterol to campesterol(6,7). Here we show that DWF1 is a Ca2+/calmodulin-binding protein and this binding is critical for its function. Molecular genetic analysis using site-directed and deletion mutants revealed that loss of calmodulin binding completely abolished the function of DWF1 in planta, whereas partial loss of calmodulin binding resulted in a partial dwarf phenotype in complementation studies. These results provide direct proof that Ca2+/calmodulin-mediated signalling has a critical role in controlling the function of DWF1. Furthermore, we observed that DWF1 orthologues from other plants have a similar Ca2+/calmodulin-binding domain, implying that Ca2+/calmodulin regulation of DWF1 and its homologues is common in plants. These results raise the possibility of producing size-engineered crops by altering the Ca2+/calmodulin-binding property of their DWF1 orthologues.	Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; Washington State Univ, Dept Hort, Pullman, WA 99164 USA	Washington State University; Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu						Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Chory J, 1997, PLANT CELL ENVIRON, V20, P801, DOI 10.1046/j.1365-3040.1997.d01-99.x; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 2001, TRENDS PLANT SCI, V6, P443, DOI 10.1016/S1360-1385(01)02102-1; Du LQ, 2004, PLANT MOL BIOL, V54, P549, DOI 10.1023/B:PLAN.0000038269.98972.bb; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Kang JG, 2001, CELL, V105, P625, DOI 10.1016/S0092-8674(01)00370-1; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nemhauser JL, 2004, J EXP BOT, V55, P265, DOI 10.1093/jxb/erh024; Poovaiah BW, 1996, J PLANT PHYSIOL, V149, P553, DOI 10.1016/S0176-1617(96)80333-6; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; SHACKLOCK PS, 1992, NATURE, V358, P753, DOI 10.1038/358753a0; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636	29	108	128	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					741	745		10.1038/nature03973	http://dx.doi.org/10.1038/nature03973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193053				2022-12-01	WOS:000232157900054
J	Lanfear, DE; Jones, PG; Marsh, S; Cresci, S; McLeod, HL; Spertus, JA				Lanfear, DE; Jones, PG; Marsh, S; Cresci, S; McLeod, HL; Spertus, JA			beta(2)-Adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA(1)-ADRENERGIC RECEPTOR POLYMORPHISMS; MYOCARDIAL-INFARCTION; DESENSITIZATION; HAPLOTYPES; ALBUTEROL; QUALITY; CARE	Context Previous data support an association between polymorphisms of the beta(1)- and beta(2)-adrenergic receptors (ADRB1 and ADRB2) and surrogate end points of response to beta-adrenergic blocker therapy. However, no associations between these polymorphisms and mortality have been demonstrated. Objective To evaluate the effect of ADRB1 Arg389Gly (1165 CG), Ser49Gly (145 AG), and ADRB2 Gly16Arg (46 GA), Gln27GIu (79 CG) genotypes on survival among patients discharged with prescribed beta-blockers after an acute coronary syndrome (ACS). Design, Setting, and Patients Prospective cohort study of 735 ACS patients admitted to 2 Kansas City, Mo, medical centers between March 2001 and October 2002; 597 patients were discharged with beta-blocker therapy. Main Outcome Measure Multivariable-adjusted time to all-cause 3-year mortality. Results There were 84 deaths during follow-up. There was a significant association between ADRB2 genotype and 3-year mortality among patients prescribed beta-blocker therapy. For the 79 CG polymorphism, Kaplan-Meier 3-year mortality rates were 16% (35 deaths), 11% (27 deaths), and 6% (4 deaths) for the CC, CG, and GG genotypes, respectively (P=.03; adjusted hazard ratios [AHRs], 0.51 [95% confidence interval (0), 0.30-0.87] for CG vs CC and 0.24 (95% Cl, 0.09-0.68) for GG vs CC, P=.004). For the ADRB2 46 GA polymorphism, 3-year Kaplan-Meier mortality estimates were 10% (17 deaths), 10% (28 deaths), and 20% (20 deaths) for the GG, GA, and AA genotypes, respectively (P=.005; AHRs, 0.48 [95% Cl, 0.27-0.86] for GA vs AA and 0.44 [95% Cl, 0.22-0.85] for GG vs AA, P=.02). No mortality difference between genotypes was found among patients not discharged with beta-blocker therapy for either the 79 CG or 46 GA polymorphisms (P=.98 and P=.49, respectively). The ADRB2 diplotype and compound genotypes were predictive of survival in patients treated with beta-blockers (P=.04 and P=.002; AHRs, 5.36 [95% Cl, 1.83-15.69] and 2.41 [95% CI,0.86-6.74] for 46 A homozygous and composite heterozygous vs 79 G homozygous, respectively). No association of the ADRB1 variants with mortality was observed in either the beta-blocker or no p-blocker groups. Conclusions Patients prescribed beta-blocker therapy after an ACS have differential survival associated with their ADRB2 genotypes. Further assessment of the benefits of beta-blocker therapy in high-risk genotype groups may be warranted.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Univ Missouri, Dept Med, Kansas City, MO 64110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	McLeod, HL (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	hmcleod@im.wustl.edu	McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	AHRQ HHS [R01 HS11282-01] Funding Source: Medline; NHLBI NIH HHS [P50 HL077113] Funding Source: Medline; NIGMS NIH HHS [U01 GM63340] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011282] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1986, Lancet, V2, P57; [Anonymous], 2004, HEART DIS STROK STAT; Belfer I, 2005, EUR J HUM GENET, V13, P341, DOI 10.1038/sj.ejhg.5201313; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Chong LK, 2000, PHARMACOGENETICS, V10, P153, DOI 10.1097/00008571-200003000-00007; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Evrengul H, 2004, JPN HEART J, V45, P11, DOI 10.1536/jhj.45.11; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Heckbert SR, 2003, CIRCULATION, V107, P2021, DOI 10.1161/01.CIR.0000065231.07729.92; HENNEKENS CH, 1999, CLIN TRIALS CARDIOVA; HERLITZ J, 1988, CARDIOLOGY, V75, P117, DOI 10.1159/000174358; Hoit BD, 2000, AM HEART J, V139, P537, DOI 10.1016/S0002-8703(00)90099-1; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; Kaye DM, 2003, PHARMACOGENETICS, V13, P379, DOI 10.1097/00008571-200307000-00002; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Liggett SB, 2000, AM J RESP CRIT CARE, V161, pS197, DOI 10.1164/ajrccm.161.supplement_2.a1q4-10; Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1016/S0009-9236(03)00224-8; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Ohte N, 2002, J NUCL MED, V43, P780; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; R Development Core Team, 2005, R LANG ENV STAT COMP; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63; Terra Steven G, 2005, Pharmacogenet Genomics, V15, P227, DOI 10.1097/01213011-200504000-00006; White HL, 2003, EUR J HEART FAIL, V5, P463, DOI 10.1016/S1388-9842(03)00044-8	34	147	162	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2005	294	12					1526	1533		10.1001/jama.294.12.1526	http://dx.doi.org/10.1001/jama.294.12.1526			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967TF	16189366	Bronze			2022-12-01	WOS:000232113400023
J	Russ, WP; Lowery, DM; Mishra, P; Yaffe, MB; Ranganathan, R				Russ, WP; Lowery, DM; Mishra, P; Yaffe, MB; Ranganathan, R			Natural-like function in artificial WW domains	NATURE			English	Article							YES-ASSOCIATED PROTEIN; LIGAND RECOGNITION; PROLINE; DESIGN; SPECIFICITY; MECHANISM; REDESIGN	Protein sequences evolve through random mutagenesis with selection for optimal fitness(1). Cooperative folding into a stable tertiary structure is one aspect of fitness, but evolutionary selection ultimately operates on function, not on structure. In the accompanying paper(2), we proposed a model for the evolutionary constraint on a small protein interaction module ( the WW domain) through application of the SCA, a statistical analysis of multiple sequence alignments(3,4). Construction of artificial protein sequences directed only by the SCA showed that the information extracted by this analysis is sufficient to engineer the WW fold at atomic resolution. Here, we demonstrate that these artificial WW sequences function like their natural counterparts, showing class-specific recognition of proline- containing target peptides(5 - 8). Consistent with SCA predictions, a distributed network of residues mediates functional specificity in WW domains. The ability to recapitulate natural- like function in designed sequences shows that a relatively small quantity of sequence information is sufficient to specify the global energetics of amino acid interactions.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu						Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kraemer-Pecore CM, 2003, PROTEIN SCI, V12, P2194, DOI 10.1110/ps.03190903; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toepert F, 2001, ANGEW CHEM INT EDIT, V40, P897, DOI 10.1002/1521-3773(20010302)40:5<897::AID-ANIE897>3.0.CO;2-X; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	29	188	192	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					579	583		10.1038/nature03990	http://dx.doi.org/10.1038/nature03990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177795				2022-12-01	WOS:000232004800056
J	Zhang, J; Hupfeld, CJ; Taylor, SS; Olefsky, JM; Tsien, RY				Zhang, J; Hupfeld, CJ; Taylor, SS; Olefsky, JM; Tsien, RY			Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes	NATURE			English	Article							3T3-L1 ADIPOCYTES; BETA(2)-ADRENERGIC RECEPTOR; GENE-EXPRESSION; GRANULOSA-CELLS; CAMP; PHOSPHORYLATION; BETA-ARRESTIN-1; DESENSITIZATION; STIMULATION; ACTIVATION	Hormones mobilize intracellular second messengers and initiate signalling cascades involving protein kinases and phosphatases, which are often spatially compartmentalized by anchoring proteins to increase signalling specificity(1). These scaffold proteins may themselves be modulated by hormones(2 - 4). In adipocytes, stimulation of beta- adrenergic receptors increases cyclic AMP levels and activates protein kinase A ( PKA)(5), which stimulates lipolysis by phosphorylating hormone- sensitive lipase and perilipin(6 - 8). Acute insulin treatment activates phosphodiesterase 3B, reduces cAMP levels and quenches beta- adrenergic receptor signalling(9). In contrast, chronic hyperinsulinaemic conditions ( typical of type 2 diabetes) enhance beta- adrenergic receptor- mediated cAMP production(10). This amplification of cAMP signalling is paradoxical because it should enhance lipolysis, the opposite of the known short- term effect of hyperinsulinaemia. Here we show that in adipocytes, chronically high insulin levels inhibit beta- adrenergic receptors ( but not other cAMP- elevating stimuli) from activating PKA. We measured this using an improved fluorescent reporter and by phosphorylation of endogenous cAMP- response- element binding protein ( CREB). Disruption of PKA scaffolding mimics the interference of insulin with beta- adrenergic receptor signalling. Chronically high insulin levels may disrupt the close apposition of beta- adrenergic receptors and PKA, identifying a new mechanism for crosstalk between heterologous signal transduction pathways.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	rtsien@ucsd.edu						CARR DW, 1993, J BIOL CHEM, V268, P20729; Dalle S, 2002, MOL CELL BIOL, V22, P6272, DOI 10.1128/MCB.22.17.6272-6285.2002; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Fasshauer M, 2001, FEBS LETT, V500, P60, DOI 10.1016/S0014-5793(01)02588-1; Feliciello A, 1998, J BIOL CHEM, V273, P23361, DOI 10.1074/jbc.273.36.23361; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hupfeld CJ, 2003, P NATL ACAD SCI USA, V100, P161, DOI 10.1073/pnas.0235674100; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kosaki A, 1996, DIABETES, V45, P1744, DOI 10.2337/diabetes.45.12.1744; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; LONDOS C, 1985, J BIOL CHEM, V260, P5139; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; Salvador LM, 2004, J BIOL CHEM, V279, P27621, DOI 10.1074/jbc.M402980200; Scott JD, 1998, METH MOL B, V88, P161; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; WON W, 2004, NATURE REV MOL CELL, V5, P959; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	26	238	254	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					569	573		10.1038/nature04140	http://dx.doi.org/10.1038/nature04140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177793				2022-12-01	WOS:000232004800054
J	Weissman, I				Weissman, I			Stem cell research - Paths to cancer therapies and regenerative medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW-CELLS; COMMON LYMPHOID PROGENITORS; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; SPLEEN COLONIES; BREAST-CANCER; MOUSE EMBRYOS; T-CELLS; IN-VIVO; TRANSPLANTATION	Most tissues in complex metazoans contain a rare subset of cells that, at the single-cell level, can self-renew and also give rise to mature daughter cells. Such stem cells likely in development build tissues and are retained in adult life to regenerate them. Cancers and leukemias are apparently not an exception: rare leukemia stem cells and cancer stem cells have been isolated that contain all of the tumorigenicity of the whole tumor, and it is their properties that will guide future therapies. None of this was apparent just 20 years ago, yet this kind of stem cell thinking already provides new perspectives in medical science and could usher in new therapies. Today, political, religious, and ethical issues surround embryonic stem cell and patient-specific pluripotent stem cell research and are center stage in the attempts by governments to ban these fields for discovery and potential therapies. These interventions require physicians and physician-scientists to determine for themselves whether patient welfare or personal ethics will dominate in their practices, and whether all aspects of stem cell research can be pursued in a safe and regulated fashion.	Stanford Comprehens Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Weissman, I (corresponding author), Stanford Comprehens Canc Ctr, Inst Stem Cell Biol & Regenerat Med, B257 Beckman Ctr,MC 5329, Stanford, CA 94305 USA.	irv@stanford.edu						ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALSAM LB, 2004, NATURE, V4428, P668; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beilhack GF, 2003, DIABETES, V52, P59, DOI 10.2337/diabetes.52.1.59; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; *COMMM BIOL BIOM A, 2002, STEM CELLS FUT REG M; CUMMINGS BJ, IN PRESS P NATL ACAD; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EZINE S, 1984, NATURE, V309, P629, DOI 10.1038/309629a0; EZINE S, 1987, J IMMUNOL, V139, P2195; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fossati L, 1995, EUR J IMMUNOL, V25, P3412, DOI 10.1002/eji.1830251231; Gandy KL, 1998, TRANSPLANTATION, V65, P295, DOI 10.1097/00007890-199802150-00001; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Ikehara S, 2001, EXP HEMATOL, V29, P661, DOI 10.1016/S0301-472X(01)00645-2; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jaenisch Rudolf, 2005, V265, P107; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MANZ MG, 2004, THOMAS HEMATOPOIETIC, P69; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORTON JI, 1979, TRANSPLANTATION, V27, P133; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; *NAT AC SCI PAN SC, 2002, SCI MED ASP HUM REPR; *NAT RES COUNC I M, 2005, GUID HUM EMB STEM CE; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Shizuru JA, 2000, P NATL ACAD SCI USA, V97, P9555, DOI 10.1073/pnas.170279297; SHIZURU JA, 2004, THOMAS HEMATOPOIETIC, P324; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1988, J IMMUNOL, V141, P1877; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; TSUKAMOTO A, 1995, HEMATOPOIETIC STEM C, P85; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; UCHIDA N, 2005, 10 INT C NEUR CER LI; Vose JM, 2001, BIOL BLOOD MARROW TR, V7, P680, DOI 10.1053/bbmt.2001.v7.pm11787531; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WEISSMAN I, 1978, IMMUNOLOGY, pCH5; Weissman IL, 2002, NEW ENGL J MED, V346, P1576, DOI 10.1056/NEJMsb020693; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	89	102	108	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2005	294	11					1359	1366		10.1001/jama.294.11.1359	http://dx.doi.org/10.1001/jama.294.11.1359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965YW	16174694				2022-12-01	WOS:000231987800009
J	Di Nisio, M; Middeldorp, S; Buller, HR				Di Nisio, M; Middeldorp, S; Buller, HR			Drug therapy - Direct thrombin inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPARIN-INDUCED THROMBOCYTOPENIA; MOLECULAR-WEIGHT HEPARIN; ECARIN CLOTTING TIME; TOTAL HIP-REPLACEMENT; PERCUTANEOUS CORONARY INTERVENTION; GLYCOPROTEIN IIB/IIIA INHIBITION; NONVALVULAR ATRIAL-FIBRILLATION; RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; DEEP-VEIN THROMBOSIS		Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Gabriele DAnnunzio Univ Fdn, Sch Med, Dept Med & Aging, Chieti, Italy; Gabriele DAnnunzio Univ Fdn, Aging Res Ctr, Chieti, Italy	University of Amsterdam; Academic Medical Center Amsterdam; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Di Nisio, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med F4 138, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.dinisio@amc.uva.nl	Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; BANNER DW, 1993, ADV EXP MED BIOL, V340, P27; Bates S M, 2000, J Invasive Cardiol, V12 Suppl F, p27F; Bergqvist D, 2004, CLIN DRUG INVEST, V24, P127, DOI 10.2165/00044011-200424030-00001; BERRY CN, 1994, THROMB HAEMOSTASIS, V72, P381; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; BOSHKOV LK, 1993, BRIT J HAEMATOL, V84, P322, DOI 10.1111/j.1365-2141.1993.tb03072.x; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Callas DD, 1996, THROMB RES, V83, P463, DOI 10.1016/0049-3848(96)00155-7; CALLAS DD, 1996, ANN HEMATOL, V1, pA58; Casserly IP, 2004, THROMB RES, V113, P115, DOI 10.1016/j.thromres.2004.02.012; Chew DP, 2005, AM J CARDIOL, V95, P581, DOI 10.1016/j.amjcard.2004.11.003; Chew DP, 2003, AM J CARDIOL, V92, P919, DOI 10.1016/S0002-9149(03)00970-6; Cho L, 2003, AM J CARDIOL, V91, P1110, DOI 10.1016/S0002-9149(03)00159-0; CLARKE RJ, 1991, CIRCULATION, V83, P1510, DOI 10.1161/01.CIR.83.5.1510; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Eichler P, 2000, BLOOD, V96, P2373; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Eikelboom JW, 2000, LANCET, V356, P600; Eriksson BI, 1997, J BONE JOINT SURG AM, V79A, P326, DOI 10.2106/00004623-199703000-00002; Eriksson BI, 1997, NEW ENGL J MED, V337, P1329, DOI 10.1056/NEJM199711063371901; Eriksson BI, 2005, J THROMB HAEMOST, V3, P103, DOI 10.1111/j.1538-7836.2004.01100.x; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson BI, 2003, THROMB HAEMOSTASIS, V89, P288; Eriksson H, 1999, THROMB HAEMOSTASIS, V81, P358; Faaij RA, 2001, EUR J CLIN PHARMACOL, V57, P25, DOI 10.1007/s002280100270; Fager G, 2003, EUR J CLIN PHARMACOL, V59, P283, DOI 10.1007/s00228-003-0619-x; Fenyvesi T, 2002, SEMIN THROMB HEMOST, V28, P361, DOI 10.1055/s-2002-34305; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Fischer KG, 2002, SEMIN THROMB HEMOST, V28, P467, DOI 10.1055/s-2002-35288; *FOOD DRUG ADM CAR, 2004, INT EX SUMM FDA REV; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Francis CW, 2002, ANN INTERN MED, V137, P648, DOI 10.7326/0003-4819-137-8-200210150-00008; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Greinacher A, 2000, BLOOD, V96, P846, DOI 10.1182/blood.V96.3.846.015k09_846_851; Greinacher A, 2003, CIRCULATION, V108, P2062, DOI 10.1161/01.CIR.0000096056.37269.14; Greinacher A, 2005, CHEST, V127, P416; Gustafsson D, 2003, THROMB RES, V109, pS9, DOI 10.1016/S0049-3848(03)00249-4; Harrington RA, 2004, CHEST, V126, p513S, DOI 10.1378/chest.126.3_suppl.513S; Hauptmann J, 1999, THROMB RES, V93, P203, DOI 10.1016/S0049-3848(98)00192-3; Huhle G, 1999, BRIT J HAEMATOL, V106, P195; LaMonte MP, 2004, STROKE, V35, P1677, DOI 10.1161/01.STR.0000131549.20581.ba; Lewis BE, 2003, ARCH INTERN MED, V163, P1849, DOI 10.1001/archinte.163.15.1849; Lewis BE, 2001, CIRCULATION, V103, P1838; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; LINCOFF AM, 2003, JAMA-J AM MED ASSOC, V289, P1638; Lubenow N, 2004, BLOOD, V104, P3072, DOI 10.1182/blood-2004-02-0621; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; MARBET GA, 1993, J CARDIOVASC PHARM, V22, P364, DOI 10.1097/00005344-199309000-00004; Menon V, 2004, CHEST, V126, p549S, DOI 10.1378/chest.126.3_suppl.549S; Merry AF, 2004, ANN THORAC SURG, V77, P925, DOI 10.1016/j.athoracsur.2003.09.061; Moser M, 2001, J THROMB THROMBOLYS, V12, P165, DOI 10.1023/A:1012975522037; NURMOHAMED MT, 1994, THROMB HAEMOSTASIS, V72, P685; PARRY MAA, 1994, BIOCHEMISTRY-US, V33, P14807, DOI 10.1021/bi00253a020; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; RADZIWON P, 1996, ANN HEMATOL, V1, pA57; Robson R, 2002, CLIN PHARMACOL THER, V71, P433, DOI 10.1067/mcp.2002.124522; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sarich TC, 2003, J AM COLL CARDIOL, V41, P557, DOI 10.1016/S0735-1097(02)02868-1; Saw J, 2004, J AM COLL CARDIOL, V44, P1194, DOI 10.1016/j.jacc.2004.06.049; Schenk JF, 1996, HAEMOSTASIS, V26, P140; Schiele F, 1997, THROMB HAEMOSTASIS, V77, P834; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Swan SK, 2000, PHARMACOTHERAPY, V20, P318, DOI 10.1592/phco.20.4.318.34881; Tulinsky A, 1996, SEMIN THROMB HEMOST, V22, P117, DOI 10.1055/s-2007-998998; Van de Werf F, 2001, LANCET, V358, P605; Wahlander K, 2003, CLIN PHARMACOKINET, V42, P755; WALENGA JM, 1991, SEMIN THROMB HEMOST, V17, P103, DOI 10.1055/s-2007-1002597; Walenga JM, 2002, THROMB RES, V105, P401, DOI 10.1016/S0049-3848(02)00049-X; Wallentin L, 2003, LANCET, V362, P789, DOI 10.1016/S0140-6736(03)14287-0; Warkentin TE, 2004, CHEST, V126, p311S, DOI 10.1378/chest.126.3_suppl.311S; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 1998, CIRCULATION, V97, P544; White HD, 2001, LANCET, V358, P1855; Wolzt M, 2004, THROMB HAEMOSTASIS, V91, P1090, DOI 10.1160/TH03-09-0605; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; Yusuf S, 2002, LANCET, V359, P294	83	441	459	3	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					1028	1040		10.1056/NEJMra044440	http://dx.doi.org/10.1056/NEJMra044440			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148288	Green Published			2022-12-01	WOS:000231698200008
J	Silveira, JR; Raymond, GJ; Hughson, AG; Race, RE; Sim, VL; Hayes, SF; Caughey, B				Silveira, JR; Raymond, GJ; Hughson, AG; Race, RE; Sim, VL; Hayes, SF; Caughey, B			The most infectious prion protein particles	NATURE			English	Article							SCRAPIE INFECTIVITY; AGENT; REPLICATION; RESISTANCE; LIPOSOMES; DISEASES; SIZES; ASSAY	Neurodegenerative diseases such as Alzheimer's, Parkinson's and the transmissible spongiform encephalopathies (TSEs) are characterized by abnormal protein deposits, often with large amyloid fibrils. However, questions have arisen as to whether such fibrils or smaller subfibrillar oligomers are the prime causes of disease(1,2). Abnormal deposits in TSEs are rich in PrPres, a protease-resistant form of the PrP protein with the ability to convert the normal, protease-sensitive form of the protein (PrPsen) into PrPres (ref. 3). TSEs can be transmitted between organisms by an enigmatic agent (prion) that contains PrPres (refs 4 and 5). To evaluate systematically the relationship between infectivity, converting activity and the size of various PrPres-containing aggregates, PrPres was partially disaggregated, fractionated by size and analysed by light scattering and non-denaturing gel electrophoresis. Our analyses revealed that with respect to PrP content, infectivity and converting activity peaked markedly in 17 - 27- nm (300 - 600 kDa) particles, whereas these activities were substantially lower in large fibrils and virtually absent in oligomers of <= 5 PrP molecules. These results suggest that non-fibrillar particles, with masses equivalent to 14 - 28 PrP molecules, are the most efficient initiators of TSE disease.	NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; NIAID, Electron Microscopy Core Facil, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	bcaughey@nih.gov	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [Z01 AI000580-16] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000265, Z01AI000580] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALPER T, 1966, BIOCHEM BIOPH RES CO, V22, P278, DOI 10.1016/0006-291X(66)90478-5; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BROWN P, 1990, P NATL ACAD SCI USA, V87, P7240, DOI 10.1073/pnas.87.18.7240; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; GAST K, 1992, LASER LIGHT SCATTERI, P209; GIBBS CJ, 1978, P NATL ACAD SCI USA, V75, P6268, DOI 10.1073/pnas.75.12.6268; HOPE J, 1994, ANN NY ACAD SCI, V724, P282, DOI 10.1111/j.1749-6632.1994.tb38917.x; JEFFREY M, 1994, BRAIN RES, V656, P329, DOI 10.1016/0006-8993(94)91477-X; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; Maxson L, 2003, ANAL BIOCHEM, V323, P54, DOI 10.1016/j.ab.2003.07.028; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond G. J., 2004, TECHNIQUES PRION RES, P16; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; SAFAR J, 1990, P NATL ACAD SCI USA, V87, P6373, DOI 10.1073/pnas.87.16.6373; Silveira JR, 2004, CURR TOP MICROBIOL, V284, P1; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wahlund K-G, 2000, FIELD FLOW FRACTIONA, P279	27	707	731	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					257	261		10.1038/nature03989	http://dx.doi.org/10.1038/nature03989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148934	Green Accepted			2022-12-01	WOS:000231696900056
J	Fevre, EM; Picozzi, K; Fyfe, J; Waiswa, C; Odiit, M; Coleman, PG; Welburn, SC				Fevre, EM; Picozzi, K; Fyfe, J; Waiswa, C; Odiit, M; Coleman, PG; Welburn, SC			A burgeoning epidemic of sleeping sickness in Uganda	LANCET			English	Article								The epidemic of Trypanosoma brucei rhodesiense sleeping sickness in eastern Uganda, which began in 1998 as a result of movements of the livestock reservoir of the parasite, has continued to spread. An additional 133 000 people have been put at risk of infection in Kaberamaido, another newly affected district. The few resources committed to control interventions in Soroti district have failed to contain the epidemic. The high prevalence of the parasite in cattle presents a significant risk for transmission to human beings and further spread of this neglected zoonotic disease. Targeted interventions are urgently needed to control epidemics and reduce the high mortality resulting from sleeping sickness.	Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Makerere Univ, Fac Vet Med, Kampala, Uganda; Minist Hlth Uganda, Kampala, Uganda; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1, England	University of Edinburgh; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Fevre, EM (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland.	Eric.Fevre@ed.ac.uk		Welburn, Susan/0000-0002-9903-7086; Fevre, Eric/0000-0001-8931-4986				Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Nathan N, 2004, LANCET, V363, P1402, DOI 10.1016/S0140-6736(04)16070-4; ODIIT M, IN PRESS TROP MED IN; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9	5	72	72	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 27	2005	366	9487					745	747		10.1016/S0140-6736(05)67179-6	http://dx.doi.org/10.1016/S0140-6736(05)67179-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958UV	16125592				2022-12-01	WOS:000231474600031
J	Korner, C; Asshoff, R; Bignucolo, O; Hattenschwiler, S; Keel, SG; Pelaez-Riedl, S; Pepin, S; Siegwolf, RTW; Zotz, G				Korner, C; Asshoff, R; Bignucolo, O; Hattenschwiler, S; Keel, SG; Pelaez-Riedl, S; Pepin, S; Siegwolf, RTW; Zotz, G			Carbon flux and growth in mature deciduous forest trees exposed to elevated CO2	SCIENCE			English	Article							ATMOSPHERIC CO2; DOWN-REGULATION; ENRICHMENT; SOIL; RESPONSES; ECOSYSTEMS; LEAF; PHOTOSYNTHESIS; DIOXIDE; CANOPY	Whether rising atmospheric carbon dioxide (CO) concentrations will cause forests to grow faster and store more carbon is an open question. Using free air CO2 release in combination with a canopy crane, we found an immediate and sustained enhancement of carbon flux through 35-meter-tall temperate forest trees when exposed to elevated CO2 However, there was no overall stimulation in stem growth and leaf titter production after 4 years. Photosynthetic capacity was not reduced, leaf chemistry changes were minor, and tree species differed in their responses. Although growing vigorously, these trees did not accrete more biomass carbon in stems in response to elevated CO2, thus challenging projections of growth responses derived from tests with smaller trees.	Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; CNRS, CEFE, Ctr Funct Ecol & Evolut, F-34293 Montpellier, France; Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; Univ Laval, Fac Sci Agr & Alimentat, Quebec City, PQ G1K 7P4, Canada	University of Basel; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Laval University	Korner, C (corresponding author), Univ Basel, Inst Bot, Schonbeinstr 6, CH-4056 Basel, Switzerland.	ch.koerner@unibas.ch	Korner, Christian C/B-6592-2014; Siegwolf, Rolf TW/D-4121-2009; Keel, Sonja G./AAE-4495-2019; Gutierrez, Emilia/O-7568-2014; Zotz, Gerhard/Q-5365-2018; Bignucolo, Olivier/AAP-2975-2021; Siegwolf, Rolf Theodor Walter/GLT-9297-2022	Siegwolf, Rolf TW/0000-0002-0249-0651; Keel, Sonja G./0000-0002-2645-273X; Gutierrez, Emilia/0000-0002-6085-5700; Zotz, Gerhard/0000-0002-6823-2268; Bignucolo, Olivier/0000-0003-4735-049X; Siegwolf, Rolf Theodor Walter/0000-0002-0249-0651; Pepin, Steeve/0000-0002-2003-5687				Blaschke L, 2001, PLANT BIOLOGY, V3, P288, DOI 10.1055/s-2001-15203; Canadell Josep G., 2002, Trends in Ecology and Evolution, V17, P156, DOI 10.1016/S0169-5347(02)02451-5; CHEVILLAT VS, IN PRESS BASIC APPL; Egli P, 2001, OIKOS, V92, P279, DOI 10.1034/j.1600-0706.2001.920210.x; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gielen B, 2003, GLOBAL CHANGE BIOL, V9, P1022, DOI 10.1046/j.1365-2486.2003.00644.x; Hamilton JG, 2002, OECOLOGIA, V131, P250, DOI 10.1007/s00442-002-0884-x; Handa IT, 2005, ECOLOGY, V86, P1288, DOI 10.1890/04-0711; Hattenschwiler S, 1998, OECOLOGIA, V113, P104, DOI 10.1007/s004420050358; Herrick JD, 2001, PLANT CELL ENVIRON, V24, P53, DOI 10.1046/j.1365-3040.2001.00652.x; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Isebrands JG, 2001, ENVIRON POLLUT, V115, P359, DOI 10.1016/S0269-7491(01)00227-5; Jarvis PG, 1998, EUROPEAN FORESTS GLO; King JS, 2004, GLOBAL CHANGE BIOL, V10, P1027, DOI 10.1111/j.1529-8817.2003.00789.x; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Korner C, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P227; KORNER C, 1992, SCIENCE, V257, P1672, DOI 10.1126/science.257.5077.1672; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Leuzinger S, 2005, TREE PHYSIOL, V25, P641, DOI 10.1093/treephys/25.6.641; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Norby RJ, 2003, OECOLOGIA, V136, P574, DOI 10.1007/s00442-003-1296-2; Norby RJ, 2001, NEW PHYTOL, V150, P215, DOI 10.1046/j.1469-8137.2001.00118.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pepin S, 2002, OECOLOGIA, V133, P1, DOI 10.1007/s00442-002-1008-3; Sholtis JD, 2004, NEW PHYTOL, V162, P343, DOI 10.1111/j.1469-8137.2004.01028.x; Steinmann KTW, 2004, OECOLOGIA, V141, P489, DOI 10.1007/s00442-004-1674-4; Tangley L, 2001, SCIENCE, V292, P36, DOI 10.1126/science.292.5514.36; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x; Zotz G, 2005, PLANT BIOLOGY, V7, P369, DOI 10.1055/s-2005-837635	31	405	424	8	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1360	1362		10.1126/science.1113977	http://dx.doi.org/10.1126/science.1113977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123297				2022-12-01	WOS:000231543300040
J	Stubbs, J; Simpson, KM; Triglia, T; Plouffe, D; Tonkin, CJ; Duraisingh, MT; Maier, AG; Winzeler, EA; Cowman, AF				Stubbs, J; Simpson, KM; Triglia, T; Plouffe, D; Tonkin, CJ; Duraisingh, MT; Maier, AG; Winzeler, EA; Cowman, AF			Molecular mechanism for switching of P-falciparum invasion pathways into human erythrocytes	SCIENCE			English	Article							PHENOTYPIC VARIATION; MEROZOITE PROTEINS; MALARIA; VIVAX; RECEPTOR; EXPRESSION; DEFINES; HOMOLOG; COMPLEX	The malaria parasite, Plasmodium falciparum, exploits multiple ligand-receptor interactions, called invasion pathways, to invade the host erythrocyte. Strains of P. falciparum vary in their dependency on sialated red cell receptors for invasion. We show that switching from sialic acid-dependent to -independent invasion is reversible and depends on parasite ligand use. Expression of P. falciparum reticulocyte-binding like homolog 4 (PfRh4) correlates with sialic acid-independent invasion, and PfRh4 is essential for switching invasion pathways. Differential activation of PfRh4 represents a previously unknown mechanism to switch invasion pathways and provides P. falciparum with exquisite adaptability in the face of erythrocyte receptor polymorphisms and host immune responses.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Cooperat Res Ctr Vaccine Technol, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Scripps Res Inst, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Scripps Research Institute; Novartis	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Maier, Alex G/A-6499-2009; Winzeler, Elizabeth/AAP-6752-2020; Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013	Maier, Alex G/0000-0001-7369-1058; Winzeler, Elizabeth/0000-0002-4049-2113; Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barnwell John W., 1998, P93; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; OKOYE VCN, 1985, SCIENCE, V227, P169, DOI 10.1126/science.3880920; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6	18	211	215	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1384	1387		10.1126/science.1115257	http://dx.doi.org/10.1126/science.1115257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123303				2022-12-01	WOS:000231543300047
J	Matranga, C; Tomari, Y; Shin, C; Bartel, DP; Zamore, PD				Matranga, C; Tomari, Y; Shin, C; Bartel, DP; Zamore, PD			Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes	CELL			English	Article							INDUCED SILENCING COMPLEX; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; MICRORNA TARGETS; DISTINCT ROLES; INTERFERENCE; ARGONAUTE2; PATHWAYS; PROTEIN; RISC	In the Drosophila and mammalian RNA interference pathways, sIRNAs direct the protein Argonaute2 (Ago2) to cleave corresponding mRNA targets, silencing their expression. Ago2 is the catalytic component of the RNAi enzyme complex, RISC. For each siRNA duplex, only one strand, the guide, is assembled into the active RISC; the other strand, the passenger, is destroyed. An ATP-dependent helicase has been proposed first to separate the two siRNA strands, then the resulting single-stranded guide is thought to bind Ago2. Here, we show that Ago2 instead directly receives the double-stranded siRNA from the RISC assembly machinery. Ago2 then cleaves the siRNA passenger strand, thereby liberating the single-stranded guide. For siRNAs, virtually all RISC is assembled through this cleavage-assisted mechanism. In contrast, passenger-strained cleavage is not important for the incorporation of mIRNAs that derive from mismatched duplexes.	Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA 01605 USA; MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Whitehead Institute	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Matranga, Christian/0000-0002-9037-5468; Zamore, Phillip/0000-0002-4505-9618	NIGMS NIH HHS [GM67031, GM65236, GM62862] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM067031, R01GM062862, R01GM065236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Verma S, 1998, ANNU REV BIOCHEM, V67, P99, DOI 10.1146/annurev.biochem.67.1.99; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	53	795	918	2	85	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 8	2005	123	4					607	620		10.1016/j.cell.2005.08.044	http://dx.doi.org/10.1016/j.cell.2005.08.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16271386	Green Published, Bronze			2022-12-01	WOS:000233497400010
J	Cottam, R				Cottam, R			Is public health coercive health?	LANCET			English	Editorial Material									Croydon PCT, Croydon CR0 6SR, England		Cottam, R (corresponding author), Croydon PCT, Croydon CR0 6SR, England.	rachel.cottam@croydonpct.nhs.uk						Aristotle, 2002, NICOMACHEAN ETHICS; BLAIRS T, 2004, COMMUNICATION   1203; *DEP HLTH, 2004, RED RISK COT DEATH E; *EUROPHEN, 2004, ATT GOV INT PUBL HLT; Hawkes C., 2004, MARKETING FOOD CHILD; HERBERT N, 2004, SPECTATOR       1204; Hobsbawm Eric, 1969, BANDITS; JONES G, 2004, DAILY TELEGRAPH 1005; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	9	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 5	2005	366	9497					1592	1594		10.1016/S0140-6736(05)67644-1	http://dx.doi.org/10.1016/S0140-6736(05)67644-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980VU	16271631				2022-12-01	WOS:000233047100007
J	Balthasar, N; Dalgaard, LT; Lee, CE; Yu, J; Funahashi, H; Williams, T; Ferreira, M; Tang, V; McGovern, RA; Kenny, CD; Christiansen, LM; Edelstein, E; Choi, B; Boss, O; Aschkenasi, C; Zhang, CY; Mountjoy, K; Kishi, T; Elmquist, JK; Lowell, BB				Balthasar, N; Dalgaard, LT; Lee, CE; Yu, J; Funahashi, H; Williams, T; Ferreira, M; Tang, V; McGovern, RA; Kenny, CD; Christiansen, LM; Edelstein, E; Choi, B; Boss, O; Aschkenasi, C; Zhang, CY; Mountjoy, K; Kishi, T; Elmquist, JK; Lowell, BB			Divergence of melanocortin pathways in the control of food intake and energy expenditure	CELL			English	Article							DORSAL VAGAL COMPLEX; PARAVENTRICULAR NUCLEUS; SPINAL-CORD; TRANSGENE EXPRESSION; FRAMESHIFT MUTATION; MESSENGER-RNA; RECEPTOR; OBESITY; RAT; NEURONS	Activation of melanocortin-4-receptors (MC4Rs) reduces body fat stores by decreasing food intake and increasing energy expenditure. MC4Rs are expressed in multiple CNS sites, any number of which could mediate these effects. To identify the functionally relevant sites of MC4R expression, we generated a IoxPmodified, null Mc4r allele (IoxTB Mc4r) that can be reactivated by Cre-recombinase. Mice homozygous for the IoxTB Mc4r allele do not express MC4Rs and are markedly obese. Restoration of MC4R expression in the paraventricular hypothalamus (PVH) and a subpopulation of amygdala neurons, using Sim1-Cre transgenic mice, prevented 60% of the obesity. Of note, increased food intake, typical of Mc4r null mice, was completely rescued while reduced energy expenditure was unaffected. These findings demonstrate that MC4Rs in the PVH and/or the amygdala control food intake but that MC4Rs elsewhere control energy expenditure. Disassociation of food intake and energy expenditure reveals unexpected divergence in melanocortin pathways controlling energy balance.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Program Neurosci, Boston, MA 02215 USA; Shimane Univ, Sch Med, Dept Anat & Morphol Neurosci, Izumo, Shimane 6938501, Japan; Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1, New Zealand	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Shimane University; University of Auckland	Elmquist, JK (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, 99 Brookline Dr, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu; blowell@bidmc.harvard.edu	Mountjoy, Kathy/L-4473-2019; Dalgaard, Louise/O-3788-2015	Dalgaard, Louise/0000-0002-3598-2775	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BACON SJ, 1990, EXP BRAIN RES, V79, P589; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARNSHAD M, 1999, AM J PHYSIOL, V276, pR1569; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; Giraudo SQ, 1998, BRAIN RES, V809, P302, DOI 10.1016/S0006-8993(98)00837-3; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Hogan B., 1986, MANIPULATING MOUSE E; Holder JL, 2000, HUM MOL GENET, V9, P101; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; Kishi T, 2005, J COMP NEUROL, V482, P217, DOI 10.1002/cne.20432; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; LOEWY AD, 1981, BRAIN RES, V222, P129, DOI 10.1016/0006-8993(81)90946-X; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; MCCANN MJ, 1990, J PHYSIOL-LONDON, V428, P95, DOI 10.1113/jphysiol.1990.sp018202; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Morrison SF, 2001, CLIN EXP PHARMACOL P, V28, P138, DOI 10.1046/j.1440-1681.2001.03406.x; Mountjoy KG, 2003, ENDOCRINOLOGY, V144, P5488, DOI 10.1210/en.2003-0570; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WEINGARTEN HP, 1985, BRAIN RES BULL, V14, P551, DOI 10.1016/0361-9230(85)90104-2; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	46	783	799	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					493	505		10.1016/j.cell.2005.08.035	http://dx.doi.org/10.1016/j.cell.2005.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269339	Bronze			2022-12-01	WOS:000233264300016
J	Dasen, JS; Tice, BC; Brenner-Morton, S; Jessell, TM				Dasen, JS; Tice, BC; Brenner-Morton, S; Jessell, TM			A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity	CELL			English	Article							DEVELOPING SPINAL-CORD; SUBTYPE IDENTITY; NERVOUS-SYSTEM; HOMEOBOX GENES; EXPRESSION; SPECIFICATION; LIMB; MOTONEURONS; HINDBRAIN; PROJECTIONS	Spinal motor neurons acquire specialized "pool" identities that determine their ability to form selective connections with target muscles in the limb, but the molecular basis of this striking example of neuronal specificity has remained unclear. We show here that a Hox transcriptional regulatory network specifies motor neuron pool identity and connectivity. Two interdependent sets of Hox regulatory interactions operate within motor neurons, one assigning rostrocaudal motor pool position and a second directing motor pool diversity at a single segmental level. This Hox regulatory network directs the downstream transcriptional identity of motor neuron pools and defines the pattern of target-muscle connectivity.	Columbia Univ, Howard Hughes Med Inst, Ctr Med, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Med, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu						Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ensini M, 1998, DEVELOPMENT, V125, P969; FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V; Gaufo GO, 2003, DEVELOPMENT, V130, P5191, DOI 10.1242/dev.00730; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; HOLLYDAY M, 1990, J COMP NEUROL, V302, P575, DOI 10.1002/cne.903020313; IZPISUABELMONTE JC, 1992, DEV BIOL, V152, P26, DOI 10.1016/0012-1606(92)90153-8; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Nonchev S, 1997, COLD SPRING HARB SYM, V62, P313; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; ROMANES GJ, 1942, J ANAT, V76, P112; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; STIRLING RV, 1988, DEVELOPMENT, V103, P97; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; SULLIVAN G. E., 1962, AUSTRALIAN JOUR ZOOL, V10, P458, DOI 10.1071/ZO9620458; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; Tiret L, 1998, DEVELOPMENT, V125, P279; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	42	316	319	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					477	491		10.1016/j.cell.2005.09.009	http://dx.doi.org/10.1016/j.cell.2005.09.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269338	Bronze			2022-12-01	WOS:000233264300015
J	Insel, TR; Quirion, R				Insel, TR; Quirion, R			Psychiatry as a clinical neuroscience discipline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAJOR DEPRESSION; PREFRONTAL CORTEX; SCHIZOPHRENIA; LIFE; INTERSECTION; POLYMORPHISM; PATHWAYS; DISORDER; PROTEIN		NIMH, NIH, Bethesda, MD 20892 USA; Douglas Hosp, Inst Neurosci Mental Hlth & Addict, Canadian Inst Hlth Res, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Institute for Work & Health; McGill University	Insel, TR (corresponding author), NIMH, NIH, 6001 Execut Blvd,Room 8235, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov						Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Alberts B., 2002, MOL BIOL CELL; AMARAL DG, 2005, 4 INT M AUT RES MAY; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; [Anonymous], WORLD HLTH REP 2002; Bast RC, 2004, NEW ENGL J MED, V351, P2865, DOI 10.1056/NEJMe048300; Boguski MS, 2004, NAT NEUROSCI, V7, P429, DOI 10.1038/nn1232; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cole TB, 2005, JAMA-J AM MED ASSOC, V294, P623, DOI 10.1001/jama.294.5.623; Cowan WM, 2002, ANNU REV NEUROSCI, V25, P1, DOI 10.1146/annurev.neuro.25.112701.142853; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Insel TR, 2003, AM J PSYCHIAT, V160, P616, DOI 10.1176/appi.ajp.160.4.616; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Lesperance F, 2004, AM J PSYCHIAT, V161, P271, DOI 10.1176/appi.ajp.161.2.271; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; Martin JB, 2002, AM J PSYCHIAT, V159, P695, DOI 10.1176/appi.ajp.159.5.695; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Neumeister A, 2004, J NEUROSCI, V24, P589, DOI 10.1523/JNEUROSCI.4921-03.2004; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pennington K, 2005, BRIT J PSYCHIAT, V187, P4, DOI 10.1192/bjp.187.1.4; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Sheps DS, 2004, PSYCHOSOM MED, V66, P797, DOI 10.1097/01.psy.0000147479.29050.0a; Spedding M, 2005, NAT REV DRUG DISCOV, V4, P467, DOI 10.1038/nrd1753; Swatton JE, 2004, MOL PSYCHIATR, V9, P128, DOI 10.1038/sj.mp.4001475; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0	41	167	176	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2005	294	17					2221	2224		10.1001/jama.294.17.2221	http://dx.doi.org/10.1001/jama.294.17.2221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979PQ	16264165	Green Accepted			2022-12-01	WOS:000232957700026
J	Myong, S; Rasnik, I; Joo, C; Lohman, TM; Ha, T				Myong, S; Rasnik, I; Joo, C; Lohman, TM; Ha, T			Repetitive shuttling of a motor protein on DNA	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; REP HELICASE; CRYSTAL-STRUCTURES; MOLECULE; REPLICATION; RECOMBINATION; DOMAIN; TRANSLOCATION	Many helicases modulate recombination, an essential process that needs to be tightly controlled. Mutations in some human disease helicases cause increased recombination, genome instability and cancer. To elucidate the potential mode of action of these enzymes, here we developed a single-molecule fluorescence assay that can visualize DNA binding and translocation of Escherichia coli Rep, a superfamily 1 DNA helicase homologous to Saccharomyces cerevisiae Srs2. Individual Rep monomers were observed to move on single-stranded ( ss) DNA in the 30 to 50 direction using ATP hydrolysis. Strikingly, on hitting a blockade, such as duplex DNA or streptavidin, the protein abruptly snapped back close to its initial position, followed by further cycles of translocation and snapback. This repetitive shuttling is likely to be caused by a blockade-induced protein conformational change that enhances DNA affinity for the protein's secondary DNA binding site, thereby resulting in a transient DNA loop. Repetitive shuttling was also observed on ssDNA bounded by a stalled replication fork and an Okazaki fragment analogue, and the presence of Rep delayed formation of a filament of recombination protein RecA on ssDNA. Thus, the binding of a single Rep monomer to a stalled replication fork can lead to repetitive shuttling along the single-stranded region, possibly keeping the DNA clear of toxic recombination intermediates.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Howard Hughes Med Inst, Urbana, IL 61801 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Washington University (WUSTL)	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu	Joo, Chirlmin/B-9294-2008; Ha, Taekjip/B-9506-2009	Joo, Chirlmin/0000-0003-2803-0335; Ha, Taekjip/0000-0003-2195-6258	NIGMS NIH HHS [R01 GM065367, R01 GM045948] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045948, R01GM065367] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; DENHARDT DT, 1967, P NATL ACAD SCI USA, V57, P813, DOI 10.1073/pnas.57.3.813; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LEE MS, 1990, J BIOL CHEM, V265, P17078; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Marians KJ, 2004, PHILOS T ROY SOC B, V359, P71, DOI 10.1098/rstb.2003.1366; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Petit MA, 2002, EMBO J, V21, P3137, DOI 10.1093/emboj/cdf317; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Sandler SJ, 2000, GENETICS, V155, P487; SCOTT JF, 1978, J BIOL CHEM, V253, P3292; SCOTT JF, 1977, P NATL ACAD SCI USA, V74, P193, DOI 10.1073/pnas.74.1.193; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	34	219	221	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1321	1325		10.1038/nature04049	http://dx.doi.org/10.1038/nature04049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251956				2022-12-01	WOS:000232829100045
J	Seeberger, PH				Seeberger, PH			Exploring life's sweet spot	NATURE			English	Editorial Material									ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; Burnham Inst, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Sanford Burnham Prebys Medical Discovery Institute	Seeberger, PH (corresponding author), ETH, Organ Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.							Seeberger PH, 2003, CHEM COMMUN, P1115, DOI 10.1039/b210230g; Varki A., ESSENTIALS GLYCOBIOL, V2015, P77	2	41	42	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1239	1239		10.1038/4371239a	http://dx.doi.org/10.1038/4371239a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251936	Bronze			2022-12-01	WOS:000232829100023
J	Kaksonen, M; Toret, CP; Drubin, DG				Kaksonen, M; Toret, CP; Drubin, DG			A modular design for the clathrin- and actin-mediated endocytosis machinery	CELL			English	Article							BUDDING YEAST; ARP2/3 COMPLEX; CAPPING PROTEIN; SH3 DOMAIN; I MYOSINS; CYTOSKELETON; BINDING; RECRUITMENT; PATCHES; ORGANIZATION	Endocytosis depends on an extensive network of interacting proteins that execute a series of distinct subprocesses. Previously, we used live-cell imaging of six budding-yeast proteins to define a pathway for association of receptors, adaptors, and actin during endocytic internalization. Here, we analyzed the effects of 61 deletion mutants on the dynamics of this pathway, revealing functions for 15 proteins, and we analyzed the dynamics of 8 of these proteins. Our studies provide evidence for four protein modules that cooperate to drive coat formation, membrane invagination, actin-meshwork assembly, and vesicle scission during clathrin/actin-mediated endocytosis. We found that clathrin facilitates the initiation of endocytic-site assembly but is not needed for membrane invagination or vesicle formation. Finally, we present evidence that the actin-meshwork assembly that drives membrane invagination is nucleated proximally to the plasma membrane, opposite to the orientation observed for previously studied actin-assembly-driven motility processes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.	drubin@socrates.berkeley.edu		Kaksonen, Marko/0000-0003-3645-7689	NCRR NIH HHS [S10-RR019290] Funding Source: Medline; NIGMS NIH HHS [R01GM50399, R01GM42759] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050399, R01GM042759] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Baggett JJ, 2001, TRAFFIC, V2, P297, DOI 10.1034/j.1600-0854.2001.002005297.x; Balguerie A, 1999, J CELL SCI, V112, P2529; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chu DS, 1996, J BIOL CHEM, V271, P33123, DOI 10.1074/jbc.271.51.33123; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; Howard JP, 2002, J CELL BIOL, V157, P315, DOI 10.1083/jcb.200110027; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Martin AC, 2005, J CELL BIOL, V168, P315, DOI 10.1083/jcb.200408177; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Mochida J, 2002, GENETICS, V160, P923; Naqvi SN, 1998, CURR BIOL, V8, P959, DOI 10.1016/S0960-9822(98)70396-3; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.E04-08-0734; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Smith MG, 2001, J CELL SCI, V114, P1505; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Tang HY, 1997, MOL CELL BIOL, V17, P4294, DOI 10.1128/MCB.17.8.4294; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K; Warren DT, 2002, J CELL SCI, V115, P1703; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	50	551	558	4	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					305	320		10.1016/j.cell.2005.09.024	http://dx.doi.org/10.1016/j.cell.2005.09.024			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239147	Bronze			2022-12-01	WOS:000232794100016
J	Hu, RG; Sheng, J; Qi, X; Xu, ZM; Takahashi, TT; Varshavsky, A				Hu, RG; Sheng, J; Qi, X; Xu, ZM; Takahashi, TT; Varshavsky, A			The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators	NATURE			English	Article							RNA-PROTEIN TRANSFERASE; UBIQUITIN LIGASE; MICE LACKING; S-NITROSYLATION; DEGRADATION; RGS4; EXPRESSION; COMPONENT; AMIDASE; FAMILY	The conjugation of arginine to proteins is a part of the N- end rule pathway of protein degradation. Three amino (N)-terminal residues - aspartate, glutamate and cysteine - are arginylated by ATE1-encoded arginyl-transferases. Here we report that oxidation of N- terminal cysteine is essential for its arginylation. The in vivo oxidation of N- terminal cysteine, before its arginylation, is shown to require nitric oxide. We reconstituted this process in vitro as well. The levels of regulatory proteins bearing N- terminal cysteine, such as RGS4, RGS5 and RGS16, are greatly increased in mouse ATE1(-/-) embryos, which lack arginylation. Stabilization of these proteins, the first physiological substrates of mammalian N- end rule pathway, may underlie cardiovascular defects in ATE1(-/-) embryos. Our findings identify the N- end rule pathway as a new nitric oxide sensor that functions through its ability to destroy specific regulatory proteins bearing N- terminal cysteine, at rates controlled by nitric oxide and apparently by oxygen as well.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Xu, Zhenming/C-4134-2012; Takahashi, Terry T/F-3463-2010	hu, rong gui/0000-0001-8323-239X				Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BALZI E, 1990, J BIOL CHEM, V265, P7464; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kempf T, 2004, BIOESSAYS, V26, P608, DOI 10.1002/bies.20049; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Mulsch A, 1999, FREE RADICAL BIO MED, V27, P636, DOI 10.1016/S0891-5849(99)00122-7; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rogers JH, 2001, J MOL CELL CARDIOL, V33, P209, DOI 10.1006/jmcc.2000.1307; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tanaka K., 2004, BIOCHIM BIOPHYS ACTA, V1695, P226; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	43	230	237	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					981	986		10.1038/nature04027	http://dx.doi.org/10.1038/nature04027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222293				2022-12-01	WOS:000232496100036
J	Baggini, J; Pym, M				Baggini, J; Pym, M			End of life: the humanist view	LANCET			English	Editorial Material									Philosophers Magazine, Surrey SM2 6LZ, England; British Humanist Assoc, London W1E 6HD, England		Baggini, J (corresponding author), Philosophers Magazine, Surrey SM2 6LZ, England.	Editor@philosophers.co.uk							0	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2005	366	9492					1235	1237		10.1016/S0140-6736(05)67486-7	http://dx.doi.org/10.1016/S0140-6736(05)67486-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	970LK	16198772				2022-12-01	WOS:000232311300033
J	Verheugt, FWA; Smith, SC				Verheugt, FWA; Smith, SC			The lady aspirin for cardiovascular disease	LANCET			English	Editorial Material							PRIMARY PREVENTION; HEART; RISK; THERAPY		Univ Med Ctr, Heartctr, Dept Cardiol, Nijmegen, Netherlands; Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA	Radboud University Nijmegen; University of North Carolina; University of North Carolina Chapel Hill	Verheugt, FWA (corresponding author), Univ Med Ctr, Heartctr, Dept Cardiol, Nijmegen, Netherlands.	f.verheugt@cardio.umcn.nl	Verheugt, F.W.A./H-8105-2014					Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; DUENWALD M, 2005, NY TIMES        0816, pF5; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kjeldsen SE, 2000, J HYPERTENS, V18, P629, DOI 10.1097/00004872-200018050-00017; Levin RI, 2005, NEW ENGL J MED, V352, P1366, DOI 10.1056/NEJMe058051; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Merz NB, 2004, CIRCULATION, V109, P805, DOI 10.1161/01.CIR.0000116205.96440.FE; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417	12	8	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 1	2005	366	9492					1148	1150		10.1016/S0140-6736(05)67462-4	http://dx.doi.org/10.1016/S0140-6736(05)67462-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LK	16198753				2022-12-01	WOS:000232311300009
J	Falkowski, PG; Katz, ME; Milligan, AJ; Fennel, K; Cramer, BS; Aubry, MP; Berner, RA; Novacek, MJ; Zapol, WM				Falkowski, PG; Katz, ME; Milligan, AJ; Fennel, K; Cramer, BS; Aubry, MP; Berner, RA; Novacek, MJ; Zapol, WM			The rise of oxygen over the past 205 million years and the evolution of large placental mammals	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; CARBON; FRACTIONATION; O-2	On the basis of a carbon isotopic record of both marine carbonates and organic matter from the Triassic-Jurassic boundary to the present, we modeled oxygen concentrations over the past 205 million years. Our analysis indicates that atmospheric oxygen approximately doubled over this period, with relatively rapid increases in the early Jurassic and the Eocene. We suggest that the overall increase in oxygen, mediated by the formation of passive continental margins along the Atlantic Ocean during the opening phase of the current Wilson cycle, was a critical factor in the evolution, radiation, and subsequent increase in average size of placental mammals.	Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Yale University; American Museum of Natural History (AMNH); Harvard University; Harvard Medical School; Massachusetts General Hospital	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu	Fennel, Katja/A-7470-2009; Cramer, Benjamin/A-5303-2008	Fennel, Katja/0000-0003-3170-2331; 				Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Andrews RM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P145, DOI 10.1086/339388; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Carroll RL., 1988, VERTEBRATE PALEONTOL; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; ELSE PL, 1981, AM J PHYSIOL, V240, pR3, DOI 10.1152/ajpregu.1981.240.1.R3; Emery KO, 1972, AM ASS PET GEOL MEM, V17, P532; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; GARRELS R, 1984, AM J SCI, V303, P94; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hochachka P.W., 2002, BIOCH ADAPTATION, V480; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Huey RB, 2005, SCIENCE, V308, P398, DOI 10.1126/science.1108019; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Mortola J. P., 2001, RESP PHYSL NEWBORN M; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Sage R.F., 1999, C4 PLANT BIOL, P3; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P613; SHINE R, 2005, ANNU REV ECOL EVOL S, DOI DOI 10.1146/ANNUREV.ECOLSYS36.102003.152631; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; [No title captured]	30	215	238	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2202	2204		10.1126/science.1116047	http://dx.doi.org/10.1126/science.1116047			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195457				2022-12-01	WOS:000232318000039
J	Shelton, JD; Cassell, MM; Adetunji, J				Shelton, JD; Cassell, MM; Adetunji, J			Is poverty or wealth at the root of HIV?	LANCET			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	JShelton@USAID.GOV						*CBS MOH ORC MACR, 2004, KEN DEM HLTH SURV 20; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Halperin D, 2000, AIDS ANAL AFRICA, V11, P1; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; *TACAIDS NBS ORC M, 2005, TANZ HIV AIDS IND SU	5	103	103	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 24	2005	366	9491					1057	1058		10.1016/S0140-6736(05)67401-6	http://dx.doi.org/10.1016/S0140-6736(05)67401-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967TL	16182881				2022-12-01	WOS:000232114000007
J	Epping, MT; Wang, LM; Edel, MJ; Carlee, L; Hernandez, M; Bernards, R				Epping, MT; Wang, LM; Edel, MJ; Carlee, L; Hernandez, M; Bernards, R			The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling	CELL			English	Article							TERATOCARCINOMA STEM-CELLS; NUCLEAR-RECEPTOR; HISTONE DEACETYLASE; GENE-EXPRESSION; N-COR; TRANSCRIPTIONAL COACTIVATOR; POLYCOMB-M33-DEFICIENT MICE; CELLULAR PROLIFERATION; PROMYELOCYTIC LEUKEMIA; FUSION PROTEINS	Retinoic acid (RA) induces proliferation arrest, differentiation, and apoptosis, and defects in retinoic acid receptor (RAR) signaling have been implicated in cancer. The human tumor antigen PRAME is overexpressed in a variety of cancers, but its function has remained unclear. We identify here PRAME as a dominant repressor of RAR signaling. PRAME binds to RAR in the presence of RA, preventing ligand-induced receptor activation and target gene transcription through recruitment of Polycomb proteins. PRAME is present at RAR target promoters and inhibits RA-induced differentiation, growth arrest, and apoptosis. Conversely, knockdown of PRAME expression by RNA interference in RA-resistant human melanoma restores RAR signaling and reinstates sensitivity to the antiproliferative effects of RA in vitro and in vivo. Our data suggest that overexpression of PRAME frequently observed in human cancers confers growth or survival advantages by antagonizing RAR signaling.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Edel, Michael J/L-1954-2014	Edel, Michael J/0000-0002-5619-8680; Bernards, Rene/0000-0001-8677-3423				Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ATENCIA R, 1994, EXP CELL RES, V214, P663, DOI 10.1006/excr.1994.1304; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Core N, 1997, DEVELOPMENT, V124, P721; Demary K, 2001, CANCER LETT, V163, P103, DOI 10.1016/S0304-3835(00)00676-5; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; ONATE SA, 1995, SCIENCE, V270, P1354; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; van Baren N, 1998, BRIT J HAEMATOL, V102, P1376; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDERLEEDE BM, 1993, MOL CARCINOG, V8, P122; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	49	289	308	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					835	847		10.1016/j.cell.2005.07.003	http://dx.doi.org/10.1016/j.cell.2005.07.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179254	Green Published, Bronze			2022-12-01	WOS:000232130200009
J	Guan, JS; Xu, ZZ; Gao, H; He, SQ; Ma, GQ; Sun, T; Wang, LH; Zhang, ZN; Lena, I; Kitchen, I; Elde, R; Zimmer, A; He, C; Pei, G; Bao, L; Zhang, X				Guan, JS; Xu, ZZ; Gao, H; He, SQ; Ma, GQ; Sun, T; Wang, LH; Zhang, ZN; Lena, I; Kitchen, I; Elde, R; Zimmer, A; He, C; Pei, G; Bao, L; Zhang, X			Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia	CELL			English	Article							SECRETORY GRANULE BIOGENESIS; PROTEIN-COUPLED RECEPTOR; ROOT GANGLION NEURONS; RAT SPINAL-CORD; SUBSTANCE-P; PHYSICAL-DEPENDENCE; MU; SELECTIVITY; MORPHINE; CLONING	Opioid and tachykinin systems are involved in modulation of pain transmission in the spinal cord. Regulation of surface opioid receptors on nociceptive afferents is critical for opioid analgesia. Plasma-membrane insertion of delta-opioid receptors (DORs) is induced by stimulus-triggered exocytosis of DOR-containing large dense-core vesicles (LDCVs), but how DORs become sorted into the regulated secretory pathway is unknown. Here we report that direct interaction between protachykinin and DOR is responsible for sorting of DORs into LDCVs, allowing stimulus-induced surface insertion of DORs and DOR-mediated spinal analgesia. This interaction is mediated by the substance P domain of protachykinin and the third luminal domain of DOR. Furthermore, deletion of the preprotachykinin A gene reduced stimulus-induced surface insertion of DORs and abolished DOR-mediated spinal analgesia and morphine tolerance. Thus, protachylkinin is essential for modulation of the sensitivity of nociceptive afferents to opioids, and the opioid and tachykinin systems are directly linked by protachykinin/DOR interaction.	Chinese Acad Sci, Inst Neurosci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, SIBS, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; Univ Minnesota, Dept Cell Biol & Neuroanat, St Paul, MN 55108 USA; Univ Surrey, Sch Biomed & Mol Sci, Pharmacol Grp, Guildford GU2 7XH, Surrey, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Bonn; University of Minnesota System; University of Minnesota Twin Cities; University of Surrey	Zhang, X (corresponding author), Chinese Acad Sci, Inst Neurosci, Key Lab Neurobiol, Shanghai 200031, Peoples R China.	xu.zhang@ion.ac.cn	Léna, Isabelle/O-7956-2016; Zimmer, Andreas/B-8357-2009	Léna, Isabelle/0000-0002-1708-8497; Xu, Zhen-Zhong/0000-0001-6578-211X; Guan, Ji-Song/0000-0001-5219-0289				Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; BESSE D, 1992, BRAIN RES, V578, P115, DOI 10.1016/0006-8993(92)90237-4; Bilsky EJ, 2000, J PHARMACOL EXP THER, V293, P151; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CHENG PY, 1995, J NEUROSCI, V15, P5976; CHIWAKATA C, 1991, ENDOCRINOLOGY, V128, P2441, DOI 10.1210/endo-128-5-2441; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; EVA C, 1990, FEBS LETT, V271, P81, DOI 10.1016/0014-5793(90)80377-U; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FIELDS HL, 1980, NATURE, V284, P351, DOI 10.1038/284351a0; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gorr SU, 2001, MOL CELL ENDOCRINOL, V172, P1, DOI 10.1016/S0303-7207(00)00342-7; HELKE CJ, 1990, FASEB J, V4, P1606, DOI 10.1096/fasebj.4.6.1969374; HOKFELT T, 1975, SCIENCE, V190, P889, DOI 10.1126/science.242075; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kitchen I, 1997, BRAIN RES, V778, P73, DOI 10.1016/S0006-8993(97)00988-8; Labuz D, 1998, NEUROPEPTIDES, V32, P511, DOI 10.1016/S0143-4179(98)90079-8; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Meng F, 1996, EUR J PHARMACOL, V311, P285, DOI 10.1016/0014-2999(96)00431-1; NAWA H, 1983, NATURE, V306, P32, DOI 10.1038/306032a0; Nitsche JF, 2002, J NEUROSCI, V22, P10906; Pepin MC, 1997, J BIOL CHEM, V272, P9260; Rupniak NMJ, 1999, TRENDS PHARMACOL SCI, V20, P485, DOI 10.1016/S0165-6147(99)01396-6; Schiller PW, 1999, J MED CHEM, V42, P3520, DOI 10.1021/jm980724+; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Varga EV, 1996, MOL PHARMACOL, V50, P1619; Wang WW, 1995, P NATL ACAD SCI USA, V92, P12436, DOI 10.1073/pnas.92.26.12436; WILSON PR, 1978, EUR J PHARMACOL, V51, P323, DOI 10.1016/0014-2999(78)90423-5; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhang X, 1998, NEUROSCIENCE, V82, P223; ZHANG X, 1995, J COMP NEUROL, V352, P481, DOI 10.1002/cne.903520402; Zhang X, 1998, NEUROSCIENCE, V82, P1225; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	44	126	139	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					619	631		10.1016/j.cell.2005.06.010	http://dx.doi.org/10.1016/j.cell.2005.06.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122428	Bronze			2022-12-01	WOS:000231555100016
J	Kennedy, C; McCann, D; Campbell, MJ; Kimm, L; Thornton, R				Kennedy, C; McCann, D; Campbell, MJ; Kimm, L; Thornton, R			Universal newborn screening for permanent childhood hearing impairment: an 8-year follow-up of a controlled trial	LANCET			English	Article							IDENTIFICATION	An 8-year follow-up study of the birth cohort of babies enrolled in the Wessex controlled trial of universal newborn screening (UNS) for permanent childhood hearing impairment (PCHI) was undertaken to establish whether UNS would increase the proportion of all true cases of PCHI in children aged 7-9 years who are referred early. The proportion referred before 6 months of age increased from 11 of 35 (31%) children with true PCHI born during periods without UNS to 23 of 31 (74%) born during periods with UNS (difference 43%, 95% CI 19-60). UNS leads to early referral of PCHI.	Univ Southampton, Dept Child Hlth, Southampton, Hants, England; Univ Sheffield, Inst Primary Care & Gen Practice, Sheffield, S Yorkshire, England; MRC, Inst Hearing Res, Southampton, Hants, England	University of Southampton; University of Sheffield	Kennedy, C (corresponding author), Southampton Gen Hosp, Dept Paediat Neurol, Mailpoint 21, Southampton SO16 6YD, Hants, England.	crk1@soton.ac.uk	Campbell, Michael J/I-4253-2014	Campbell, Michael J/0000-0003-3529-2739	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BESS FH, 1994, PEDIATRICS, V94, P959; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; Davis A, 1997, HEALTH TECHNOL ASSES, V1, P1; Harris S, 2001, OXFORD ART J, V24, P89; Kennedy C, 2000, LANCET, V356, P1903, DOI 10.1016/S0140-6736(00)03267-0; Kennedy CR, 1998, LANCET, V352, P1957; *OFF NAT STAT, 2003, REF POP MOB FIG HAMP; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	9	109	122	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2005	366	9486					660	662		10.1016/S0140-6736(05)67138-3	http://dx.doi.org/10.1016/S0140-6736(05)67138-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958EB	16112302				2022-12-01	WOS:000231426400029
J	Giovannoni, SJ; Tripp, HJ; Givan, S; Podar, M; Vergin, KL; Baptista, D; Bibbs, L; Eads, J; Richardson, TH; Noordewier, M; Rappe, MS; Short, JM; Carrington, JC; Mathur, EJ				Giovannoni, SJ; Tripp, HJ; Givan, S; Podar, M; Vergin, KL; Baptista, D; Bibbs, L; Eads, J; Richardson, TH; Noordewier, M; Rappe, MS; Short, JM; Carrington, JC; Mathur, EJ			Genome streamlining in a cosmopolitan oceanic bacterium	SCIENCE			English	Article							DISSOLVED ORGANIC-CARBON; RIBOSOMAL-RNA OPERON; SARGASSO SEA; SEQUENCE; EVOLUTION; KINETICS; AFFINITY; CLADE; COPY; FLUX	The SAR11 clade consists of very small, heterotrophic marine alpha-proteobacteria that are found throughout the oceans, where they account for about 25% of all microbial cells. Pelagibacter ubique, the first cultured member of this clade, has the smallest genome and encodes the smallest number of predicted open reading frames known for a free-living microorganism. In contrast to parasitic bacteria and archaea with small genomes, P. ubique has complete biosynthetic pathways for all 20 amino acids and all but a few cofactors. P. ubique has no pseudogenes, introns, transposons, extrachromosomat elements, or inteins; few paralogs; and the shortest intergenic spacers yet observed for any cell.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Diversa Corp, San Diego, CA 92121 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA	Oregon State University; Oregon State University; University of Hawaii System	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Carrington, James C/A-4656-2012; Podar, Mircea/B-7299-2012; Short, Jay/GQY-7343-2022	Carrington, James C/0000-0003-3572-129X; Podar, Mircea/0000-0003-2776-0205; Givan, Scott/0000-0002-0630-8589				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033, DOI 10.1128/AEM.57.7.2033-2038.1991; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; GIOVANNONI SJ, IN PRESS NATURE; Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928; Hansell DA, 2001, DEEP-SEA RES PT II, V48, P1649, DOI 10.1016/S0967-0645(00)00153-3; Kimura M., 1983, NEUTRAL THEORY MOL E; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lanoil BD, 1996, GENOME RES, V6, P1160, DOI 10.1101/gr.6.12.1160; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; MelendezHevia E, 1997, EUR J BIOCHEM, V244, P527, DOI 10.1111/j.1432-1033.1997.t01-1-00527.x; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; REEVES RE, 1968, J BIOL CHEM, V243, P5486; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Strehl B, 1999, FEMS MICROBIOL LETT, V181, P261, DOI 10.1111/j.1574-6968.1999.tb08853.x; Ussery DW, 2004, MICROBIOL-SGM, V150, P749, DOI 10.1099/mic.0.27103-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	29	768	1021	2	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1242	1245		10.1126/science.1114057	http://dx.doi.org/10.1126/science.1114057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16109880				2022-12-01	WOS:000231395400046
J	Mignot, T; Merlie, JP; Zusman, DR				Mignot, T; Merlie, JP; Zusman, DR			Regulated pole-to-pole oscillations of a bacterial gliding motility protein	SCIENCE			English	Article							MYXOCOCCUS-XANTHUS; SIGNAL-TRANSDUCTION; SOCIAL MOTILITY; IV PILI; RETRACTION; REVERSAL; SYSTEM	Little is known about directed motility of bacteria that move by type IV,pilus-mediated (twitching) motility. Here, we found that during periodic cell reversals of Myxoccocus xanthus, type IV pili were disassembled at one pole and reassembled at the other pole. Accompanying these reversals, FrzS, a protein required for directed motility, moved in an oscillatory pattern between the cell poles. The frequency of the oscillations was controlled by the Frz chemosensory system, which is essential for directed motility. Pole-to-pole migration of FrzS appeared to involve movement along a filament running the length of the cell. FrzS dynamics may thus regulate cell polarity during directed motility.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zusman, DR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	zusman@uclink.berkeley.edu		Mignot, Tam/0000-0003-4338-9063	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Bustamante VH, 2004, MOL MICROBIOL, V53, P1501, DOI 10.1111/j.1365-2958.2004.04221.x; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P15760, DOI 10.1073/pnas.0407111101; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Li YN, 2003, P NATL ACAD SCI USA, V100, P5443, DOI 10.1073/pnas.0836639100; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Spormann AM, 1999, J BACTERIOL, V181, P2593, DOI 10.1128/JB.181.8.2593-2601.1999; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Ward MJ, 2000, MOL MICROBIOL, V37, P1357, DOI 10.1046/j.1365-2958.2000.02079.x	12	108	109	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					855	857		10.1126/science.1119052	http://dx.doi.org/10.1126/science.1119052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272122				2022-12-01	WOS:000233121800046
J	Giovannoni, SJ; Bibbs, L; Cho, JC; Stapels, MD; Desiderio, R; Vergin, KL; Rappe, MS; Laney, S; Wilhelm, LJ; Tripp, HJ; Mathur, EJ; Barofsky, DF				Giovannoni, SJ; Bibbs, L; Cho, JC; Stapels, MD; Desiderio, R; Vergin, KL; Rappe, MS; Laney, S; Wilhelm, LJ; Tripp, HJ; Mathur, EJ; Barofsky, DF			Proteorhodopsin in the ubiquitous marine bacterium SAR11	NATURE			English	Article							IDENTIFICATION; PHOTOTROPHY	Proteorhodopsins are light-dependent proton pumps that are predicted to have an important role in the ecology of the oceans by supplying energy for microbial metabolism(1,2). Proteorhodopsin genes were first discovered through the cloning and sequencing of large genomic DNA fragments from seawater(1). They were later shown to be widely distributed, phylogenetically diverse, and active in the oceans(3-7). Proteorhodopsin genes have not been found in cultured bacteria, and on the basis of environmental sequence data, it has not yet been possible to reconstruct the genomes of uncultured bacterial strains that have proteorhodopsin genes. Although the metabolic effect of proteorhodopsins is uncertain, they are thought to function in cells for which the primary mode of metabolism is the heterotrophic assimilation of dissolved organic carbon. Here we report that SAR11 strain HTCC1062 ('Pelagibacter ubique')(8), the first cultivated member of the extraordinarily abundant SAR11 clade, expresses a proteorhodopsin gene when cultured in autoclaved seawater and in its natural environment, the ocean. The Pelagibacter proteorhodopsin functions as a light-dependent proton pump. The gene is expressed by cells grown in either diurnal light or in darkness, and there is no difference between the growth rates or cell yields of cultures grown in light or darkness.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Diversa Corp, San Diego, CA 92121 USA	Oregon State University; Oregon State University; Oregon State University	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	chen, qi/C-8585-2011; Barofsky, Douglas F/D-2044-2017	Barofsky, Douglas F/0000-0002-5437-5778; VERGIN, KEVIN/0000-0002-8972-2813; Cho, Jang-Cheon/0000-0002-0666-3791				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kimura M., 1983, NEUTRAL THEORY MOL E; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Man-Aharonovich D, 2004, PHOTOCH PHOTOBIO SCI, V3, P459, DOI 10.1039/b316071h; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Peck RF, 2002, J BACTERIOL, V184, P2889, DOI 10.1128/JB.184.11.2889-2897.2002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Stapels Martha D, 2004, J Biomol Tech, V15, P191; Stapels MD, 2004, ANAL CHEM, V76, P5423, DOI 10.1021/ac030427z; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	21	229	241	2	93	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					82	85		10.1038/nature04032	http://dx.doi.org/10.1038/nature04032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267553				2022-12-01	WOS:000232979000045
J	Ness, KK; Mertens, AC; Hudson, MM; Wall, MM; Leisenring, WM; Oeffinger, KC; Sklar, CA; Robison, LL; Gurney, JG				Ness, KK; Mertens, AC; Hudson, MM; Wall, MM; Leisenring, WM; Oeffinger, KC; Sklar, CA; Robison, LL; Gurney, JG			Limitations on physical performance and daily activities among long-term survivors of childhood cancer	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; BRAIN-TUMORS; ADOLESCENT CANCER; ADULT SURVIVORS; RADIATION-THERAPY; NEURO-BLASTOMA; CHILDREN; COMPLICATIONS; NEUROBLASTOMA	Background: Survivors of childhood cancer may experience important disease- and treatment-related late effects, including functional limitations. Objective: This study evaluated performance limitations and restricted abilities to participate in personal care, to engage in routine activities like shopping or housework, and to attend work or school (participation restrictions) in a cohort of survivors of childhood cancer. Setting: Epidemiologic survey and 26 institutions that treat childhood cancer. Patients: Participants included 11 481 persons who were treated for primary brain cancer, leukemia, Hodgkin disease, non-Hodgkin lymphoma, kidney tumor, neuroblastoma, soft-tissue sarcoma, or malignant bone tumor before the age of 21 years and who survived at least 5 years after diagnosis. The comparison group included 3839 siblings of survivors of childhood cancer. Measurement: Medical data were abstracted, and participants or parents (if the participants were < 18 years of age at survey completion) completed a 24-page questionnaire. Results: Compared with siblings, survivors were more likely to report performance limitations (risk ratio, 1.8 [95% Cl, 1.7 to 2.0]) and to report restricted participation in personal care skills (risk ratio, 4.7 [Cl, 3.0 to 7.2]), routine activities (risk ratio, 4.7 [Cl, 3.6 to 6.2]), and the ability to attend work or school (risk ratio, 5.9 [Cl, 4.5 to 7.6]). Survivors of brain (26.6%) and bone (36.9%) cancer were most likely to report performance limitations, restricted ability to do routine activities (20.9% and 8.5%, respectively), and restricted ability to attend work or school (20.0% and 11.2%, respectively). Survivors of brain cancer were also most likely to report restricted abilities to perform personal care (10.5%). Limitations: There was the potential for participants to be healthier or more physically capable than nonparticipants or for persons to be more motivated to participate in this study if they had functional deficits. In addition, the nature of the questionnaire did not allow specific physical limitations to be measured. Conclusion: Long-term survivors of childhood cancer are at increased risk for functional limitations in physical performance and in participation in activities needed for daily living.	Univ Minnesota, Dept Pediat, Div Epidemiol & Clin Res, Minneapolis, MN 55455 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center	Ness, KK (corresponding author), Univ Minnesota, Dept Pediat, Div Epidemiol & Clin Res, Mayo Mail Code 715,420 Delaware St SE, Minneapolis, MN 55455 USA.	ness@epi.umn.edu	Ness, Kirsten K/N-2550-2018; Robison, Leslie/N-8122-2018; Wall, Melanie/AAE-7828-2019; Hudson, Melissa M/N-4441-2018	Ness, Kirsten K/0000-0002-2084-1507; Hudson, Melissa M/0000-0001-6984-2407	NATIONAL CANCER INSTITUTE [U01CA055727, U24CA055727] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA055727, CA 55727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcoser Pat Wills, 2003, J Pediatr Nurs, V18, P103, DOI 10.1053/jpdn.2003.10; Anderson DM, 2001, CANCER-AM CANCER SOC, V92, P2709, DOI 10.1002/1097-0142(20011115)92:10<2709::AID-CNCR1625>3.0.CO;2-D; AZIZKHAN RG, 1985, SURGERY, V97, P514; Balis FM, 2002, PRINCIPLES PRACTICE, V4th, P237; Boulad F, 1998, Curr Probl Pediatr, V28, P273; Crom DB, 1999, INT J CANCER, P25; Cruccetti A, 2000, J PEDIATR SURG, V35, P724, DOI 10.1053/jpsu.2000.6076; Damron TA, 1997, SEMIN SURG ONCOL, V13, P3, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<3::AID-SSU2>3.3.CO;2-5; DREYER ZE, 2002, PRINCIPLES PRACTICE, P1431; Felder-Puig R, 1998, CANCER, V83, P69, DOI 10.1002/(SICI)1097-0142(19980701)83:1<69::AID-CNCR10>3.0.CO;2-A; Foreman NK, 1999, J NEURO-ONCOL, V41, P47, DOI 10.1023/A:1006145724500; Freeman CR, 2002, MED PEDIATR ONCOL, V39, P99, DOI 10.1002/mpo.10116; GARRE ML, 1994, AM J PEDIAT HEMATOL, V16, P143; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Gurney JG, 2003, J CLIN ENDOCR METAB, V88, P4731, DOI 10.1210/jc.2003-030784; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Gustavsson A, 2003, ACTA ONCOL, V42, P589, DOI 10.1080/02841860310013346; Habrand JL, 2001, CHILD NERV SYST, V17, P121, DOI 10.1007/s003810000365; Hejna MJ, 1997, SEMIN SURG ONCOL, V13, P18, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<18::AID-SSU4>3.0.CO;2-7; Hudson Melissa M, 2004, J Pediatr Oncol Nurs, V21, P170, DOI 10.1177/1043454204264388; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Ilveskoski I, 1996, NEUROPEDIATRICS, V27, P124, DOI 10.1055/s-2007-973762; Jenkin D, 1998, MED PEDIATR ONCOL, V31, P506, DOI 10.1002/(SICI)1096-911X(199812)31:6<506::AID-MPO7>3.0.CO;2-X; Kaaijk Patricia, 2003, Expert Rev Anticancer Ther, V3, P79, DOI 10.1586/14737140.3.1.79; KAJANTI M, 1983, ANN CLIN RES, V15, P1; Kalapurakal JA, 2004, LANCET ONCOL, V5, P37, DOI 10.1016/S1470-2045(03)01322-6; Kennedy CR, 1999, INT J CANCER, P106; LANNERING B, 1990, MED PEDIATR ONCOL, V18, P304, DOI 10.1002/mpo.2950180410; Laverdiere C, 2005, PEDIATR BLOOD CANCER, V45, P324, DOI 10.1002/pbc.20331; Laverdiere C, 2005, PEDIAT ONCOL, P277; Macedoni-Luksic M, 2003, PEDIATR HEMAT ONCOL, V20, P89, DOI 10.1080/0880010390158595; MANKIN HJ, 1992, ORTHOPEDICS, V15, P1147; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Massey B, 2001, PHYS THER, V81, P9; MAYFIELD JK, 1981, J BONE JOINT SURG AM, V63, P183, DOI 10.2106/00004623-198163020-00002; McGoveran BM, 1999, CAN J SURG, V42, P37; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meister L A, 1993, Curr Probl Pediatr, V23, P102, DOI 10.1016/0045-9380(93)90019-9; Mertens AC, 2002, CANCER, V95, P2431, DOI 10.1002/cncr.10978; Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001; Nagarajan R, 2002, J CLIN ONCOL, V20, P4493, DOI 10.1200/JCO.2002.09.006; Ng Andrea K, 2004, Curr Hematol Rep, V3, P27; NITSCHKE R, 1988, J CLIN ONCOL, V6, P1271, DOI 10.1200/JCO.1988.6.8.1271; Oeffinger KC, 2004, CA-CANCER J CLIN, V54, P208, DOI 10.3322/canjclin.54.4.208; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; PASTORE G, 1987, MED PEDIATR ONCOL, V15, P1, DOI 10.1002/mpo.2950150102; PASTORE G, 1982, MED PEDIATR ONCOL, V10, P369, DOI 10.1002/mpo.2950100407; Rao BN, 2003, MED PEDIATR ONCOL, V41, P584, DOI 10.1002/mpo.10405; Refaat Y, 2002, CLIN ORTHOP RELAT R, P298; Robison LL, 2004, CANCER EPIDEM BIOMAR, V13, P1093; Robison LL, 2003, BRIT J HAEMATOL, V122, P345, DOI 10.1046/j.1365-2141.2003.04499.x; Robison LL, 2003, CURR PROB CANCER, V27, P212, DOI 10.1016/S0147-0272(03)00029-1; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Scarborough MT, 1997, SEMIN SURG ONCOL, V13, P25, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<25::AID-SSU5>3.0.CO;2-6; Schindler OS, 1998, CLIN ORTHOP RELAT R, P157; Schwartz CL, 2003, CURR OPIN PEDIATR, V15, P10, DOI 10.1097/00008480-200302000-00003; SHAMBERGER RC, 2002, PRINCIPLES PRACTICE, P351; SIM FH, 1987, CLIN ORTHOP RELAT R, P188; Sklar C, 2002, J PEDIATR ENDOCR MET, V15, P669; Sklar CA, 2000, UROL CLIN N AM, V27, P563, DOI 10.1016/S0094-0143(05)70103-8; SMITH MA, 2002, PRINCIPLES PRACTICE, P1; Smith Malcolm, 2004, J Pediatr Oncol Nurs, V21, P160, DOI 10.1177/1043454204264407; Springfield DS, 1997, SEMIN SURG ONCOL, V13, P11, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<11::AID-SSU3>3.3.CO;2-L; TARBELL NJ, 2002, PRINCIPLES PRACTICE, P369; van den Berg Hendrik, 2003, Cancer Chemother Biol Response Modif, V21, P683; World Health Organization, 2002, COMM LANG FUNCT DIS; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	67	231	233	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2005	143	9					639	647		10.7326/0003-4819-143-9-200511010-00007	http://dx.doi.org/10.7326/0003-4819-143-9-200511010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980PN	16263886				2022-12-01	WOS:000233030600003
J	Nussey, DH; Postma, E; Gienapp, P; Visser, ME				Nussey, DH; Postma, E; Gienapp, P; Visser, ME			Selection on heritable phenotypic plasticity in a wild bird population	SCIENCE			English	Article							CLIMATE-CHANGE; GENETIC-VARIATION; REACTION NORMS; LIFE-HISTORY; PHENOLOGY; RESPONSES	Theoretical and laboratory research suggests that phenotypic plasticity can evolve under selection. However, evidence for its evolutionary potential from the wild is lacking. We present evidence from a Dutch, population of great tits (Parus major) for variation in individual plasticity in the timing of reproduction, and we show that this variation is heritable. Selection favoring highly plastic individuals has intensified over a 32-year period. This temporal trend is concurrent with climate change causing a mismatch between the breeding times of the birds and their caterpillar prey. Continued selection on plasticity can act to alleviate this mismatch.	Netherlands Inst Ecol NIOO KNAW, NL-6666 ZG Heteren, Netherlands; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Edinburgh	Nussey, DH (corresponding author), Netherlands Inst Ecol NIOO KNAW, POB 40, NL-6666 ZG Heteren, Netherlands.	d.h.nussey@sms.ed.ac.uk	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Postma, Erik/B-7258-2008; Nussey, Daniel H/F-4155-2010; Visser, Marcel E/A-9151-2009; Gienapp, Phillip/A-2261-2014	Postma, Erik/0000-0003-0856-1294; Visser, Marcel E/0000-0002-1456-1939; Gienapp, Phillip/0000-0002-9368-8769				Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Brommer JE, 2005, EVOLUTION, V59, P1362; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Lynch M., 1998, AM J HUM GENET; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; NEWMAN RA, 1994, EVOLUTION, V48, P1773, DOI 10.1111/j.1558-5646.1994.tb02213.x; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; NUSSEY DH, IN PRESS BIOL LETT; PIGLIUCCI M, 2001, SYN ECO EVO, pR13; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheiner SM, 2002, J EVOLUTION BIOL, V15, P889, DOI 10.1046/j.1420-9101.2002.00468.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stinchcombe JR, 2004, J EVOLUTION BIOL, V17, P197, DOI 10.1046/j.1420-9101.2003.00641.x; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEIS AE, 1990, EVOLUTION, V44, P820, DOI 10.1111/j.1558-5646.1990.tb03807.x	23	476	485	5	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					304	306		10.1126/science.1117004	http://dx.doi.org/10.1126/science.1117004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224020				2022-12-01	WOS:000232670100049
J	Mello, MM; Brennan, TA				Mello, MM; Brennan, TA			Legal concerns and the influenza vaccine shortage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INJURY COMPENSATION PROGRAM; US		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu						*AM TRIAL LAW ASS, LAWS DO NOT CAUS VAC; Baicker K., 2005, FRONTIERS HLTH POLIC, V8; Coleman MS, 2005, HEALTH AFFAIR, V24, P635, DOI 10.1377/hlthaff.24.3.635; Danzon PM, 2005, HEALTH AFFAIR, V24, P706, DOI 10.1377/hlthaff.24.3.706; HABER P, 2004, JAMA-J AM MED ASSOC, V292, P248; *HLTH RES SERV ADM, FAQ ANSW; *I MED, 1985, VACC SUPPL INN; *I MED, 1993, CHILDR VACC IN ACH V; Lieu TA, 2005, HEALTH AFFAIR, V24, P666, DOI 10.1377/hlthaff.24.3.666; Lloyd-Puryear M, 1998, PUBLIC HEALTH REP, V113, P236; LUDDEN M, 2004, POLL MOST DONT BLAME; NEUSTADT RE, 1978, SWINE FLUE AFFAIR; Offit PA, 2005, HEALTH AFFAIR, V24, P622, DOI 10.1377/hlthaff.24.3.622; Pauly MV, 2005, HEALTH AFFAIR, V24, P680, DOI 10.1377/hlthaff.24.3.680; Poland GA, 2004, NAT IMMUNOL, V5, P1195, DOI 10.1038/ni1204-1195; Ridgway D, 1999, J HEALTH POLIT POLIC, V24, P59, DOI 10.1215/03616878-24-1-59; Schattner A, 2005, VACCINE, V23, P3876, DOI 10.1016/j.vaccine.2005.03.005; Silverstein ArthurM., 1981, PURE POLITICS IMPURE; Sloan FA, 2004, NEW ENGL J MED, V351, P2443, DOI 10.1056/NEJMsb033394; *US GAO, 2002, CHILDH VACC CHALL PR; *US HOUS REPR, 2004, JOINT HEAR FLU VACC; 2004, NY TIMES        1014, pA22; 2004, NY TIMES        1027, pA7	23	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1817	1820		10.1001/jama.294.14.1817	http://dx.doi.org/10.1001/jama.294.14.1817			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972RX	16219886				2022-12-01	WOS:000232472000022
J	Sowa, Y; Rowe, AD; Leake, MC; Yakushi, T; Homma, M; Ishijima, A; Berry, RM				Sowa, Y; Rowe, AD; Leake, MC; Yakushi, T; Homma, M; Ishijima, A; Berry, RM			Direct observation of steps in rotation of the bacterial flagellar motor	NATURE			English	Article							TORQUE-GENERATING UNITS; ESCHERICHIA-COLI; ROTARY MOTOR; NA+-DRIVEN; VIBRIO-ALGINOLYTICUS; PROTONMOTIVE FORCE; F-1-ATPASE; MECHANISM; SPEED; ROTOR	The bacterial flagellar motor is a rotary molecular machine that rotates the helical filaments that propel many species of swimming bacteria(1,2). The rotor is a set of rings up to 45 nm in diameter in the cytoplasmic membrane(3); the stator contains about ten torque-generating units anchored to the cell wall at the perimeter of the rotor(4,5). The free-energy source for the motor is an inward-directed electrochemical gradient of ions across the cytoplasmic membrane, the protonmotive force or sodium-motive force for H+-driven and Na+-driven motors, respectively. Here we demonstrate a stepping motion of a Na+-driven chimaeric flagellar motor in Escherichia coli(6) at low sodium-motive force and with controlled expression of a small number of torque-generating units. We observe 26 steps per revolution, which is consistent with the periodicity of the ring of FliG protein, the proposed site of torque generation on the rotor(7,8). Backwards steps despite the absence of the flagellar switching protein CheY indicate a small change in free energy per step, similar to that of a single ion transit.	Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Chikusa Ku, Aichi 4648603, Japan; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Aichi 4648602, Japan; JST, PRESTO, Kawagoe, Saitama 3320012, Japan	Nagoya University; University of Oxford; Nagoya University; Japan Science & Technology Agency (JST)	Berry, RM (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Chikusa Ku, Aichi 4648603, Japan.	r.berry1@physics.ox.ac.uk	Ishijima, Akihiko/F-4603-2012; Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Ishijima, Akihiko/0000-0002-8919-9268; Sowa, Yoshiyuki/0000-0002-1691-2018				ARMITAGE JP, 1985, BIOCHIM BIOPHYS ACTA, V806, P42, DOI 10.1016/0005-2728(85)90080-5; Asai Y, 2003, J MOL BIOL, V327, P453, DOI 10.1016/S0022-2836(03)00096-2; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1993, BIOPHYS J, V65, P2201, DOI 10.1016/S0006-3495(93)81278-5; BERG HC, 1976, CELL MOTILITY, VA, P47; Berry RM, 1999, ADV MICROB PHYSIOL, V41, P291, DOI 10.1016/S0065-2911(08)60169-1; BERRY RM, 1995, BIOPHYS J, V69, P280, DOI 10.1016/S0006-3495(95)79900-3; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; LIU JZ, 1990, J BACTERIOL, V172, P5236, DOI 10.1128/jb.172.9.5236-5244.1990; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2004, NATURE, V431, P1062, DOI 10.1038/nature02997; Samuel ADT, 1996, BIOPHYS J, V71, P918, DOI 10.1016/S0006-3495(96)79295-0; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sowa Y, 2003, J MOL BIOL, V327, P1043, DOI 10.1016/S0022-2836(03)00176-1; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yorimitsu T, 2001, BBA-BIOENERGETICS, V1505, P82, DOI 10.1016/S0005-2728(00)00279-6	30	237	239	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					916	919		10.1038/nature04003	http://dx.doi.org/10.1038/nature04003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208378				2022-12-01	WOS:000232338600053
J	Cowen, LE; Lindquist, S				Cowen, LE; Lindquist, S			Hsp90 potentiates the rapid evotution of new traits: Drug resistance in diverse fungi	SCIENCE			English	Article							CANDIDA-ALBICANS; MOLECULAR CHAPERONE; IN-VITRO; CALCINEURIN; EVOLUTION; CAPACITOR; STRESS; HEAT-SHOCK-PROTEIN-90; INHIBITION; MECHANISMS	Hsp90 is a molecular chaperone for many signal transducers and may influence evolution by releasing previously silent genetic variation in response to environmental change. In fungi separated by similar to 800 million years of evolution, Hsp90 potentiated the evolution of drug resistance in a different way, by enabling new mutations' to have immediate phenotypic consequences. Resistance was abrogated by Hsp90 inhibitors and by febrile temperatures, suggesting new therapeutic strategies and a clinical benefit of fever. During selection in a human host, drug resistance that was initially Hsp90-dependent evolved toward independence. Thus, Hsp90 can act in diverse ways to couple environmental contingency to the emergence and fixation of new traits.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Cowen, Leah/0000-0001-5797-0110	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30ES02109] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Anderson JB, 2003, GENETICS, V163, P1287; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; COWEN LE, UNPUB; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Imai J, 2000, MOL CELL BIOL, V20, P9262, DOI 10.1128/MCB.20.24.9262-9270.2000; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kontoyiannis DP, 2003, J ANTIMICROB CHEMOTH, V51, P313, DOI 10.1093/jac/dkg090; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	37	496	543	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2185	2189		10.1126/science.1118370	http://dx.doi.org/10.1126/science.1118370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195452				2022-12-01	WOS:000232318000034
J	Mossel, E; Vigoda, E				Mossel, E; Vigoda, E			Phylogenetic MCMC algorithms are misleading on mixtures of trees	SCIENCE			English	Article							BAYESIAN-INFERENCE; LIKELIHOOD; EVOLUTION	Markov chain Monte Carlo (MCMC) algorithms play a critical role in the Bayesian approach to phylogenetic inference. We present a theoretical analysis of the rate of convergence of many of the widely used Markov chains. For N characters generated from a uniform mixture of two trees, we prove that the Markov chains take an exponentially long (in N) number of iterations to converge to the posterior distribution. Nevertheless, the likelihood plots for sample runs of the Markov chains deceivingly suggest that the chains converge rapidly to a unique tree. Our results rely on novel mathematical understanding of the log-likelihood function on the space of phylogenetic trees. The practical implications of our work are that Bayesian MCMC methods can be misleading when the data are generated from a mixture of trees. Thus, in cases of data containing potentially conflicting phylogenetic signals, phylogenetic reconstruction should be performed separately on each signal.	Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	University of California System; University of California Berkeley; University System of Georgia; Georgia Institute of Technology	Mossel, E (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	mossel@stat.berkeley.edu; vigoda@cc.gatech.edu		Mossel, Elchanan/0000-0001-7812-7886				Bhatnagar N., 2004, P 15 ANN ACM SIAM S, P478; Billera LJ, 2001, ADV APPL MATH, V27, P733, DOI 10.1006/aama.2001.0759; CAVENDER JA, 1978, MATH BIOSCI, V40, P271, DOI 10.1016/0025-5564(78)90089-5; Chang JT, 1996, MATH BIOSCI, V134, P189, DOI 10.1016/0025-5564(95)00172-7; Chor B, 2000, MOL BIOL EVOL, V17, P1529, DOI 10.1093/oxfordjournals.molbev.a026252; Develin M., 2004, DOC MATH, V9, P1; Diaconis PW, 1998, P NATL ACAD SCI USA, V95, P14600, DOI 10.1073/pnas.95.25.14600; FARRIS JS, 1973, SYST ZOOL, V22, P50, DOI 10.2307/2412378; Felsenstein J., 2004, INFERRING PHYLOGENIE; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; Graur D., 1999, FUNDAMENTALS MOL EVO; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Li SY, 2000, J AM STAT ASSOC, V95, P493, DOI 10.2307/2669394; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nei M., 2000, MOL EVOLUTION PHYLOG; Neyman J, 1971, STAT DECISION THEORY, P1; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Sinclair A., 1993, PROGR THEORETICAL CO; Speyer D, 2004, ADV GEOM, V4, P389, DOI 10.1515/advg.2004.023; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Steel M A, 1994, J Comput Biol, V1, P153, DOI 10.1089/cmb.1994.1.153; Yang ZH, 2000, P ROY SOC B-BIOL SCI, V267, P109, DOI 10.1098/rspb.2000.0974; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	27	115	118	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2207	2209		10.1126/science.1115493	http://dx.doi.org/10.1126/science.1115493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195459				2022-12-01	WOS:000232318000041
J	Safran, RJ; Neuman, CR; McGraw, KJ; Lovette, IJ				Safran, RJ; Neuman, CR; McGraw, KJ; Lovette, IJ			Dynamic paternity allocation as a function of male plumage color in barn swallows	SCIENCE			English	Article							EXTRA-PAIR PATERNITY; FEMALE PREFERENCE; PARENTAL CARE; QUALITY; ORNAMENTATION; COMPETITION; SIGNAL; SPERM; TRAIT; BIRDS	Paternity in mate animals can be influenced by their phenotypic signals of quality. Accordingly, the behavior underlying patterns of paternity should be flexible as signals of quality change. To evaluate the dynamics of paternity allocation, we analyzed paternity before and after manipulating plumage coloration, a known signal of quality, in mate barn swallows Hirundo rustica. We found that, in successive breeding bouts, only mates whose plumage color was experimentally enhanced received greater paternity from their social mates, demonstrating evidence for flexible and dynamic paternity allocation and the importance for males of maintaining signals of quality wet[ after pair bond formation.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Cornell Lab Ornithol, Evolut Biol Program, Ithaca, NY 14850 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Cornell University; Cornell University; Arizona State University; Arizona State University-Tempe	Safran, RJ (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rsafran@princeton.edu						Andersson Malte, 1994; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Conrad KF, 1998, AUK, V115, P497, DOI 10.2307/4089213; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; Darwin C., 1871, P423; Ellegren H, 1995, MOL ECOL, V4, P739, DOI 10.1111/j.1365-294X.1995.tb00274.x; FreemanGallant CR, 1996, P ROY SOC B-BIOL SCI, V263, P157, DOI 10.1098/rspb.1996.0025; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Neff BD, 2003, NATURE, V422, P716, DOI 10.1038/nature01528; Ornborg J, 2002, BIOL J LINN SOC, V76, P237, DOI 10.1046/j.1095-8312.2002.00061.x; Otter KA, 2001, J AVIAN BIOL, V32, P338, DOI 10.1111/j.0908-8857.2001.320408.x; ROHWER S, 1978, ANIM BEHAV, V26, P1012, DOI 10.1016/0003-3472(78)90090-8; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; Smith HG, 1991, BEHAV ECOL, V2, P90, DOI 10.1093/beheco/2.1.90; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tarof SA, 2005, P ROY SOC B-BIOL SCI, V272, P1121, DOI 10.1098/rspb.2005.3053; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	28	111	115	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2210	2212		10.1126/science.1115090	http://dx.doi.org/10.1126/science.1115090			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195460				2022-12-01	WOS:000232318000042
J	Balashov, SP; Imasheva, ES; Boichenko, VA; Anton, J; Wang, JM; Lanyi, JK				Balashov, SP; Imasheva, ES; Boichenko, VA; Anton, J; Wang, JM; Lanyi, JK			Xanthorhodopsin: A proton pump with a light-harvesting carotenoid antenna	SCIENCE			English	Article							HALOBACTERIUM-HALOBIUM; SALINIBACTER-RUBER; BACTERIORHODOPSIN; IDENTIFICATION; RHODOPSIN; BACTERIA; PROTEIN; COMPLEX; CELLS; ION	Energy transfer from light-harvesting carotenoids to chlorophyll is common in photosynthesis, but such antenna pigments have not been observed in retinal-based ion pumps and photoreceptors. Here we describe xanthorhodopsin, a proton-pumping retinal protein/carotenoid complex in the eubacterium Salinibacter ruber. The wavelength dependence of the rate of pumping and difference absorption spectra measured under a variety of conditions indicate that this protein contains two chromophores, retinal and the carotenoid salinixanthin, in a molar ratio of about 1:1. The two chromophores interact strongly, and light energy absorbed by the carotenoid is transferred to the retinal with a quantum efficiency of similar to 40%. The antenna carotenoid extends the wavelength range of the collection of light for uphill transmembrane proton transport.	Univ Calif Irvine, Irvine, CA 92697 USA; Russian Acad Sci, Inst Basic Biol Problems, Pushchino 142290, Russia; Univ Alicante, E-03080 Alicante, Spain	University of California System; University of California Irvine; Russian Academy of Sciences; Universitat d'Alacant	Balashov, SP (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	balashov@uci.edu; jlanyi@orion.oac.uci.edu	Lanyi, Janos/C-3808-2011; Anton, Josefa/L-5283-2014	Anton, Josefa/0000-0002-5823-493X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029498, R37GM029498] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029498-24, GM29498, R37 GM029498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; Anton J, 2000, APPL ENVIRON MICROB, V66, P3052, DOI 10.1128/AEM.66.7.3052-3057.2000; Balashov SP, 2001, PHOTOCHEM PHOTOBIOL, V73, P453, DOI 10.1562/0031-8655(2001)073<0453:TASIOT>2.0.CO;2; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Frank H. A., 1999, ADV PHOTOSYNTHESIS, V8; Kumauchi M, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P43, DOI 10.1002/352760510X.ch3; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; LITVIN FF, 1975, BIOORG KHIM+, V1, P1767; LITVIN FF, 1977, BIOFIZIKA+, V22, P1062; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Lutnaes BF, 2002, J NAT PROD, V65, P1340, DOI 10.1021/np020125c; Montano GA, 2004, J PHYS CHEM B, V108, P10607, DOI 10.1021/jp047988u; MUKOHATA Y, 1991, PHOTOCHEM PHOTOBIOL, V54, P1039, DOI 10.1111/j.1751-1097.1991.tb02127.x; Mukohata Y, 1999, J BIOCHEM-TOKYO, V125, P649, DOI 10.1093/oxfordjournals.jbchem.a022332; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1974, FEBS LETT, V44, P257, DOI 10.1016/0014-5793(74)81152-X; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Pena A, 2005, EXTREMOPHILES, V9, P151, DOI 10.1007/s00792-005-0430-y; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; ROBERT B, 2003, ADV PHOTOSYNTHESIS R, V13, P169; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102	28	242	253	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2061	2064		10.1126/science.1118046	http://dx.doi.org/10.1126/science.1118046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179480	Green Accepted			2022-12-01	WOS:000232181900052
J	Montarras, D; Morgan, J; Collins, C; Relaix, F; Zaffran, S; Cumano, A; Partridge, T; Buckingham, M				Montarras, D; Morgan, J; Collins, C; Relaix, F; Zaffran, S; Cumano, A; Partridge, T; Buckingham, M			Direct isolation of satellite cells for skeletal muscle regeneration	SCIENCE			English	Article							STEM-CELLS; MYOBLAST TRANSPLANTATION; M-CADHERIN; EXPRESSION; QUIESCENT; CD34; FATE	Muscle satellite cells contribute to muscle regeneration. We have used a Pax3(GFP/+) mouse line to directly isolate (Pax3)(green fluorescent protein)-expressing muscle satellite cells, by flow cytometry from adult skeletal muscles, as, a homogeneous population of small, nongranular, Pax7+, CD34+, CD45-, Sca1-cells. The flow cytometry parameters thus established enabled us to isolate satellite cells from wild-type muscles. Such cells, grafted into muscles of mdx nu/nu mice, contributed both to fiber repair and to the muscle satellite cell compartment. Expansion of these cells in culture before engraftment reduced their regenerative capacity.	Inst Pasteur, Dept Dev Biol, CNRS, Unite Rech Associee 2578, F-75724 Paris, France; Inst Pasteur, INSERM, U668, Unite Dev Lymphocytes, F-75724 Paris, France; Hammersmith Hosp, Dubowitz Neuromuscular Ctr, Imperial Coll Lonson, Dept Paediat, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Ctr Clin Sci, MRC, Muscle Cell Biol Grp, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Imperial College London; University of London; University College London; Imperial College London	Montarras, D (corresponding author), Inst Pasteur, Dept Dev Biol, CNRS, Unite Rech Associee 2578, F-75724 Paris, France.	dmontarr@pasteur.fr; margab@pasteur.fr	Zaffran, Stéphane/S-7454-2019; Morgan, Jennifer/C-6475-2008; Zaffran, Stéphane/I-2955-2016	Zaffran, Stéphane/0000-0002-0811-418X; Zaffran, Stéphane/0000-0002-0811-418X; Relaix, Frederic/0000-0003-1270-1472; Collins, Charlotte/0000-0002-8715-9035; Cumano, Ana/0000-0002-4578-959X				Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; DIMARIO JX, 1995, EXP CELL RES, V216, P431, DOI 10.1006/excr.1995.1054; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Hollnagel A, 2002, MOL CELL BIOL, V22, P4760, DOI 10.1128/MCB.22.13.4760-4770.2002; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jankowski RJ, 2002, J CELL SCI, V115, P4361, DOI 10.1242/jcs.00110; MONTARRAS D, UNPUB; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; Morgan JE, 1996, MUSCLE NERVE, V19, P132, DOI 10.1002/(SICI)1097-4598(199602)19:2<132::AID-MUS2>3.0.CO;2-F; Mueller GM, 2002, HUM GENE THER, V13, P1081, DOI 10.1089/104303402753812485; Partridge T, 2004, CELL, V119, P447, DOI 10.1016/j.cell.2004.10.022; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RELAIX F, UNPUB; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Skuk D, 2002, EXP NEUROL, V175, P112, DOI 10.1006/exnr.2002.7899; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	27	771	812	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2064	2067		10.1126/science.1114758	http://dx.doi.org/10.1126/science.1114758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16141372				2022-12-01	WOS:000232181900053
J	Shaevitz, JW; Lee, JY; Fletcher, DA				Shaevitz, JW; Lee, JY; Fletcher, DA			Spiroplasma swim by a processive change in body helicity	CELL			English	Article							BACTERIAL LINEAR MOTOR; SALMONELLA FLAGELLA; MELLIFERUM BC3; MOTILITY; CHEMOTAXIS; CITRI; MOLLICUTES; SPIROCHETE; PROTEIN; CELLS	Microscopic organisms must rely on very different strategies than their macroscopic counterparts to swim through liquid. To date, the best understood method for prokaryotic swimming employs the rotation of flagella. Here, we show that Spiroplasma, tiny helical bacteria that infect plants and insects, use a very different approach. By measuring cell kinematics during free swimming, we find that propulsion is generated by the propagation of kink pairs down the length of the cell body. A processive change in the helicity of the body creates these waves and enables directional movement.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shaevitz, JW (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 459 Evans Hall, Berkeley, CA 94720 USA.	jshaevitz@berkeley.edu						Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; ARMITAGE JP, 1987, J BACTERIOL, V169, P514, DOI 10.1128/jb.169.2.514-518.1987; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Berg HC, 2002, J BACTERIOL, V184, P2063, DOI 10.1128/JB.184.8.2063-2064.2002; BERG HC, 1976, J THEOR BIOL, V56, P269, DOI 10.1016/S0022-5193(76)80074-4; BERG HC, 1978, MICROBES NATURAL ENV, V34, P285; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1992, RES MICROBIOL, V143, P597, DOI 10.1016/0923-2508(92)90117-7; Chernova AA, 2003, BIOSYSTEMS, V71, P51, DOI 10.1016/S0303-2647(03)00109-6; CHILDRRESS S, 1981, MECH SWIMMING FLYING; DANIELS MJ, 1980, J GEN MICROBIOL, V118, P429; DAVIS RE, 1978, CAN J MICROBIOL, V24, P954, DOI 10.1139/m78-158; DAVIS RE, 1973, PHYTOPATHOLOGY, V63, P403, DOI 10.1094/Phyto-63-403; Gilad R, 2003, MOL MICROBIOL, V47, P657, DOI 10.1046/j.1365-2958.2003.03200.x; Goldstein RE, 2000, PHYS REV LETT, V84, P1631, DOI 10.1103/PhysRevLett.84.1631; GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895; HOTANI H, 1976, J MOL BIOL, V106, P151, DOI 10.1016/0022-2836(76)90305-3; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Ludwig W., 1930, Zeitschrift fuer Vergleichende Physiologie, V13, P397; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; MATSUURA S, 1978, J MOL BIOL, V118, P431, DOI 10.1016/0022-2836(78)90237-1; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Schnitzer M. J., 1990, S SOC GEN MICROBIOL, V46, P15; SHIMADA K, 1975, NATURE, V254, P332, DOI 10.1038/254332a0; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; TOWNSEND R, 1985, J GEN MICROBIOL, V131, P983; TOWNSEND R, 1980, J BACTERIOL, V142, P973, DOI 10.1128/JB.142.3.973-981.1980; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; WATERBURY JB, 1985, SCIENCE, V230, P74, DOI 10.1126/science.230.4721.74; WHITCOMB RF, 1980, ANNU REV MICROBIOL, V34, P677, DOI 10.1146/annurev.mi.34.100180.003333; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wolgemuth CW, 2003, BIOPHYS J, V85, P828, DOI 10.1016/S0006-3495(03)74523-8	35	85	92	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					941	945		10.1016/j.cell.2005.07.004	http://dx.doi.org/10.1016/j.cell.2005.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179261	Bronze			2022-12-01	WOS:000232130200017
J	Munderloh, UG; Kurtti, T				Munderloh, UG; Kurtti, T			The ABCs of Lyme disease spirochaetes in ticks	LANCET			English	Editorial Material							BORRELIA-BURGDORFERI; TEMPERATURE; EXPRESSION; VACCINE		Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Munderloh, UG (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	munde001@umn.edu						deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Fernandez-Soto P, 2001, ANN TROP MED PARASIT, V95, P97, DOI 10.1080/00034980020035960; Fikrig E, 2004, INFECT IMMUN, V72, P1755, DOI 10.1128/IAI.72.3.1755-1759.2004; Munderloh UG, 2005, TICK-BORNE DISEASES OF HUMANS, P37; Obonyo M, 1999, J CLIN MICROBIOL, V37, P2137, DOI 10.1128/JCM.37.7.2137-2141.1999; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Singh SK, 2004, LANCET INFECT DIS, V4, P575; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Willett TA, 2004, P NATL ACAD SCI USA, V101, P1303, DOI 10.1073/pnas.0305680101; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960	11	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					962	964		10.1016/S0140-6736(05)67350-3	http://dx.doi.org/10.1016/S0140-6736(05)67350-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168758				2022-12-01	WOS:000231955900006
J	Garssen, B				Garssen, B			No role for extroversion and neuroticism in cancer development	LANCET			English	Editorial Material							PRONE-PERSONALITY; DISEASE		Helen Dowling Inst, NL-3582 JJ Utrecht, Netherlands		Garssen, B (corresponding author), Helen Dowling Inst, NL-3582 JJ Utrecht, Netherlands.	bgarssen@hdi.nl						Faller H, 1996, Z KLIN PSYCHOL PSYCH, V44, P104; Garssen B, 2004, CLIN PSYCHOL REV, V24, P315, DOI 10.1016/j.cpr.2004.01.002; Hansen PE, 2005, CANCER-AM CANCER SOC, V103, P1082, DOI 10.1002/cncr.20871; LINKINS RW, 1990, AM J EPIDEMIOL, V132, P962, DOI 10.1093/oxfordjournals.aje.a115739; Schulz R, 1996, PSYCHOL AGING, V11, P304, DOI 10.1037/0882-7974.11.2.304; SCHWARZ R, 1993, PSYCHOTHER PSYCH MED, V43, P1; SCHWARZ R, 1984, PSYCHOTHER PSYCHOSOM, V41, P195, DOI 10.1159/000287809	7	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					872	874		10.1016/S0140-6736(05)67295-9	http://dx.doi.org/10.1016/S0140-6736(05)67295-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962YR	16153997				2022-12-01	WOS:000231770000005
J	Heath, J; Ayres, E; Possell, M; Bardgett, RD; Black, HIJ; Grant, H; Ineson, P; Kerstiens, G				Heath, J; Ayres, E; Possell, M; Bardgett, RD; Black, HIJ; Grant, H; Ineson, P; Kerstiens, G			Rising atmospheric CO2 reduces sequestration of root-derived soil carbon	SCIENCE			English	Article							ORGANIC-MATTER; ELEVATED CO2; DIOXIDE; RESPONSES; FOREST; RESPIRATION; TURNOVER; NITROGEN; OZONE; ECOSYSTEMS	Forests have a key role as carbon sinks, which could potentially mitigate the continuing increase in atmospheric carbon dioxide concentration and associated climate change. We show that carbon dioxide enrichment, although causing short-term growth stimulation in a range of European tree species, also leads to an increase in soil microbial respiration and a marked decline in sequestration of root-derived carbon in the soil. These findings indicate that, should similar processes operate in forest ecosystems, the size of the annual terrestrial carbon sink may be substantially reduced; resulting in a positive feedback on the rate of increase in atmospheric carbon dioxide concentration.	Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England; Univ Lancaster, Inst Environm & Nat Sci, Dept Environm Sci, Lancaster LA1 4YQ, England; Lancaster Environm Ctr, Ctr Ecol & Hydrol, Soil Ecol Grp, Lancaster LA1 4AP, England; Lancaster Environm Ctr, Ctr Ecol & Hydrol, Nat Environm Res Council Life Sci Mass Spectromet, Lancaster LA1 4AP, England; Univ York, Dept Biol, Stockholm Environm Inst, York YO10 5YW, N Yorkshire, England	Lancaster University; Lancaster University; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); University of York - UK	Heath, J (corresponding author), Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England.	j.heath@lancaster.ac.uk	Ayres, Edward/A-4172-2008; Possell, Malcolm/A-5043-2009; Kerstiens, Gerhard/B-4728-2008	Ayres, Edward/0000-0001-5190-258X; Possell, Malcolm/0000-0001-5376-8433; Kerstiens, Gerhard/0000-0001-8767-7791				Ayres E, 2004, ECOL LETT, V7, P469, DOI 10.1111/j.1461-0248.2004.00604.x; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; Cheng WX, 1998, PLANT SOIL, V202, P167, DOI 10.1023/A:1004315321332; Gonzelez-Meller MA, 2004, ANN BOT-LONDON, V94, P647, DOI 10.1093/aob/mch189; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hoosbeek MR, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002127; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Ineson P, 1996, PLANT SOIL, V187, P345, DOI 10.1007/BF00017099; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Keeling C. D., 2004, TRENDS COMPENDIUM DA; King JS, 2001, OECOLOGIA, V128, P237, DOI 10.1007/s004420100656; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Larson JL, 2002, SOIL SCI SOC AM J, V66, P1848, DOI 10.2136/sssaj2002.1848; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Malhi Y, 2002, PHILOS T ROY SOC A, V360, P2925, DOI 10.1098/rsta.2002.1098; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pataki DE, 2003, BIOSCIENCE, V53, P805, DOI 10.1641/0006-3568(2003)053[0805:TCIEFU]2.0.CO;2; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Rytter RM, 2001, FOREST ECOL MANAG, V140, P177, DOI 10.1016/S0378-1127(00)00319-4; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Watson RT, 2000, LAND USE LAND USE CH; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	29	115	123	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1711	1713		10.1126/science.1110700	http://dx.doi.org/10.1126/science.1110700			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151007				2022-12-01	WOS:000231836700040
J	Colchester, ACF; Colchester, NTH				Colchester, ACF; Colchester, NTH			The origin of bovine spongiform encephalopathy: the human prion disease hypothesis	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; VARIANT CJD; BSE; TRANSMISSION; SCRAPIE; EPIDEMIOLOGY; PROTEIN	The cause of the original case or cases of bovine spongiform encephalopathy (BSE) remains an enigma. Sheep scrapie or a previously undetected sporadic bovine transmissible spongiform encephalopathy (TSE) have long been considered as candidates, but no convincing evidence to support these proposals has come to light. We present a new theory, with three related hypotheses: (1) that BSE was acquired from a human TSE (prion disease); (2) that the route of infection was oral, through animal feed containing imported mammalian raw materials contaminated with human remains; and (3) that the origin was the Indian subcontinent, from which large amounts of mammalian material were imported during the relevant time period. Human remains are known to be incorporated into meal made locally, and may still be entering exported material. Further investigations are needed into the sources of animal by-products used in animal feed manufacture, and into the the transmissibility of human TSEs to cattle.	Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7PD, Kent, England; Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	University of Kent; University of Edinburgh	Colchester, ACF (corresponding author), Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7PD, Kent, England.	a.colchester@kent.ac.uk						*AG FRANC PRESS, 2001, HUM SKULLS BON TRAD; Alley KD, 2002, BANKS GANGA; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1987, NEUROLOGY, V37, P895, DOI 10.1212/WNL.37.6.895; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; BROWN P, 2001, EARLY ONSET DEMENTIA, P361; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Chesebro B, 2004, SCIENCE, V305, P1918, DOI 10.1126/science.1103581; Cohen CH, 1999, INT J EPIDEMIOL, V28, P526, DOI 10.1093/ije/28.3.526; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Cutlip RC, 2001, CAN J VET RES, V65, P131; DUBOIS G, 1967, AURORE          0917; Ford J, 2005, J NEUROL NEUROSUR PS, V76, P608; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; *GOV E PAK, 1957, REP MARK BON E PAK, P3; Hainfellner JA, 1999, ANN NEUROL, V45, P812; Head MW, 2005, LANCET, V365, P730; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; HORN G, 2001, REV ORIGIN BSE, P1; *IND MIN FOOD AGR, 1958, REP MARK BON BON IND, P1; *MAFF, 1969, 287361 MAFF UK NAT A; NARAIN S, 1992, CTR SCI ENV ANN REPO; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Phillips NA, 2000, BSE INQUIRY; Priola SA, 2004, LANCET, V363, P2013, DOI 10.1016/S0140-6736(04)16487-8; RAO PV, 1965, INDIAN PRACT, V16, P439; SATISCHANDRA P, 1997, CREUTZFELDT SYNDROME, P1; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Tateishi J, 1996, SEMIN VIROL, V7, P175, DOI 10.1006/smvy.1996.0022; Taylor DM, 2003, BRIT MED BULL, V66, P293, DOI 10.1093/bmb/66.1.293; Taylor DM, 2003, REV SCI TECH OIE, V22, P297, DOI 10.20506/rst.22.1.1400; Taylor K, 1995, VET REC, V137, P674; WHO, 1998, GLOB SURV DIAGN THER, V2, P1, DOI DOI 10.1016/J.KJMS; WILESMITH JW, 1988, VET REC, V123, P638; 2004, ECOFRIENDS GANGA LIT	38	41	45	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					856	861		10.1016/S0140-6736(05)67218-2	http://dx.doi.org/10.1016/S0140-6736(05)67218-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139661				2022-12-01	WOS:000231627000031
J	Beckmann, K; Grskovic, M; Gebauer, F; Hentze, MW				Beckmann, K; Grskovic, M; Gebauer, F; Hentze, MW			A dual inhibitory mechanism restricts msl-2 mRNA translation for dosage compensation in Drosophila	CELL			English	Article							SEX-LETHAL; BINDING-PROTEIN; INITIATION-FACTORS; RIBOSOMAL-SUBUNIT; IN-VITRO; OSKAR; GENE; LOCALIZATION; RECRUITMENT; COMPLEX	Drosophila MSL-2 is the limiting component of the dosage compensation complex. Female flies must inhibit msl-2 mRNA translation for survival, and this inhibition is mediated by Sex-lethal (SXL) binding to sites in both the 5' and the 3' untranslated regions (UTRs). Here, we uncover the mechanism by which SXL achieves tight control of translation initiation. SXL binding to the 3'UTR regulatory region inhibits the recruitment of 43S ribosomal preinitiation complexes to the mRNA. Ribosomal complexes escaping this block and binding to the 5' end of the mRNA are challenged by SXL bound to the 5'UTR, which interferes with scanning to the downstream initiation codon of the mRNA. This failsafe mechanism thus forms the molecular basis of a critical step in dosage compensation. The results also elucidate a two step principle of translational control via multiple regulatory sites within an mRNA.	European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Grskovic, Marica/AAJ-4080-2021; Gebauer, Fatima/E-7725-2015; Hentze, Matthias W/V-3980-2017	Gebauer, Fatima/0000-0001-7563-0013; Hentze, Matthias W/0000-0002-4023-7876				ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; Deshpande G, 1996, MOL CELL BIOL, V16, P5036; Dong ZH, 1999, GENE, V237, P421, DOI 10.1016/S0378-1119(99)00303-0; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Forrest KM, 2004, DEVELOPMENT, V131, P5849, DOI 10.1242/dev.01460; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gebauer F, 1998, RNA, V4, P142; Gilfillan GD, 2004, FEBS LETT, V567, P8, DOI 10.1016/j.febslet.2004.03.110; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Grskovic M, 2003, EMBO J, V22, P5571, DOI 10.1093/emboj/cdg539; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Meise M, 1998, DEVELOPMENT, V125, P1487; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Paraskeva E, 1999, MOL CELL BIOL, V19, P807; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; PESTOVA TV, 2000, RIBOSOMAL SUBUNIT JO, P425; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sakashita E, 1996, J BIOCHEM, V120, P1028; Samuels M, 1998, NUCLEIC ACIDS RES, V26, P2625, DOI 10.1093/nar/26.11.2625; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	52	73	75	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					529	540		10.1016/j.cell.2005.06.011	http://dx.doi.org/10.1016/j.cell.2005.06.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122421	hybrid			2022-12-01	WOS:000231555100009
J	Raghoebarsing, AA; Smolders, AJP; Schmid, MC; Rijpstra, WIC; Wolters-Arts, M; Derksen, J; Jetten, MSM; Schouten, S; Damste, JSS; Lamers, LPM; Roelofs, JGM; den Camp, HJMO; Strous, M				Raghoebarsing, AA; Smolders, AJP; Schmid, MC; Rijpstra, WIC; Wolters-Arts, M; Derksen, J; Jetten, MSM; Schouten, S; Damste, JSS; Lamers, LPM; Roelofs, JGM; den Camp, HJMO; Strous, M			Methanotrophic symbionts provide carbon for photosynthesis in peat bogs	NATURE			English	Article							ACIDOPHILIC BACTERIUM; MICROBIAL-POPULATIONS; BIOMARKER RECORD; GEN. NOV.; LIPIDS; GROUNDWATER; SPHAGNUM	Wetlands are the largest natural source of atmospheric methane(1), the second most important greenhouse gas(2). Methane flux to the atmosphere depends strongly on the climate(3); however, by far the largest part of the methane formed in wetland ecosystems is recycled and does not reach the atmosphere(4,5). The biogeochemical controls on the efficient oxidation of methane are still poorly understood. Here we show that submerged Sphagnum mosses, the dominant plants in some of these habitats, consume methane through symbiosis with partly endophytic methanotrophic bacteria, leading to highly effective in situ methane recycling. Molecular probes revealed the presence of the bacteria in the hyaline cells of the plant and on stem leaves. Incubation with C-13-methane showed rapid in situ oxidation by these bacteria to carbon dioxide, which was subsequently fixed by Sphagnum, as shown by incorporation of C-13-methane into plant sterols. In this way, methane acts as a significant ( 10 - 15%) carbon source for Sphagnum. The symbiosis explains both the efficient recycling of methane and the high organic carbon burial in these wetland ecosystems.	Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Plant Cell Biol, NL-6525 ED Nijmegen, Netherlands; Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Smolders, AJP (corresponding author), Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	a.smolders@science.ru.nl; damste@nioz.nl	Camp, Huub J.M. Op den/F-5114-2011; Jetten, Mike/B-8834-2011; Lamers, Leon P.M./A-8718-2012; Strous, Marc/B-4064-2017; Smolders, Alfons J.P./H-2583-2012; Schmid, Markus C/D-2669-2012; Damste, Jaap S Sinninghe/F-6128-2011; Roelofs, Jan GM/C-1243-2011	Camp, Huub J.M. Op den/0000-0003-1990-9030; Jetten, Mike/0000-0002-4691-7039; Lamers, Leon P.M./0000-0003-3769-2154; Strous, Marc/0000-0001-9600-3828; Damste, Jaap S Sinninghe/0000-0002-8683-1854; 				AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Damste JSS, 2004, ORG GEOCHEM, V35, P561, DOI 10.1016/j.orrgeochem.2004.01.013; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Dedysh SN, 2002, INT J SYST EVOL MICR, V52, P251, DOI 10.1099/00207713-52-1-251; Dedysh SN, 2000, INT J SYST EVOL MICR, V50, P955, DOI 10.1099/00207713-50-3-955; Hein R, 1997, GLOBAL BIOGEOCHEM CY, V11, P43, DOI 10.1029/96GB03043; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; KEELEY JE, 1992, PLANT CELL ENVIRON, V15, P1021, DOI 10.1111/j.1365-3040.1992.tb01653.x; Lamers LPM, 1999, J ECOL, V87, P639, DOI 10.1046/j.1365-2745.1999.00380.x; Lomans BP, 2001, APPL ENVIRON MICROB, V67, P1044, DOI 10.1128/AEM.67.3.1044-1051.2001; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marguillier S, 1997, MAR ECOL PROG SER, V151, P115, DOI 10.3354/meps151115; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; RODHE H, 1990, SCIENCE, V248, P1217, DOI 10.1126/science.248.4960.1217; ROHMER M, 1992, BIOLOGICAL MARKERS IN SEDIMENTS AND PETROLEUM, P1; RYDIN H, 1989, PROC R SOC SER B-BIO, V237, P63, DOI 10.1098/rspb.1989.0037; Schouten S, 1998, GEOCHIM COSMOCHIM AC, V62, P1397, DOI 10.1016/S0016-7037(98)00076-3; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Smolders AJP, 2003, WETL ECOL MANAG, V11, P403, DOI 10.1023/B:WETL.0000007195.25180.94; Smolders AJP, 2002, J APPL ECOL, V39, P391, DOI 10.1046/j.1365-2664.2002.00724.x; Wolters-Arts M, 2002, PLANT CELL ENVIRON, V25, P513, DOI 10.1046/j.1365-3040.2002.00827.x; YAO R, 1992, J BACTERIOL, V174, P4683, DOI 10.1128/JB.174.14.4683-4688.1992	24	298	321	4	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1153	1156		10.1038/nature03802	http://dx.doi.org/10.1038/nature03802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121180	Green Published			2022-12-01	WOS:000231416600045
J	Woodhead, JL; Zhao, FQ; Craig, R; Egelman, EH; Alamo, L; Padron, R				Woodhead, JL; Zhao, FQ; Craig, R; Egelman, EH; Alamo, L; Padron, R			Atomic model of a myosin filament in the relaxed state	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; PHOSPHORYLATION-DEPENDENT REGULATION; THICK FILAMENTS; HEAVY-MEROMYOSIN; IMAGE-RECONSTRUCTION; STRUCTURAL-CHANGES; TARANTULA MUSCLE; SKELETAL-MUSCLE; HEADS; ARRANGEMENT	Contraction of muscle involves the cyclic interaction of myosin heads on the thick filaments with actin subunits in the thin filaments(1). Muscles relax when this interaction is blocked by molecular switches on either or both filaments(2). Insight into the relaxed ( switched OFF) structure of myosin has come from electron microscopic studies of smooth muscle myosin molecules, which are regulated by phosphorylation. These studies suggest that the OFF state is achieved by an asymmetric, intramolecular interaction between the actin-binding region of one head and the converter region of the other, switching both heads off(3). Although this is a plausible model for relaxation based on isolated myosin molecules, it does not reveal whether this structure is present in native myosin filaments. Here we analyse the structure of a phosphorylation-regulated striated muscle thick filament using cryo-electron microscopy. Three-dimensional reconstruction and atomic fitting studies suggest that the 'interacting-head' structure is also present in the filament, and that it may underlie the relaxed state of thick filaments in both smooth and myosin-regulated striated muscles over a wide range of species.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Inst Venezolano Invest Cient, Dept Biol Estructural, Caracas 1020A, Venezuela	University of Massachusetts System; University of Massachusetts Worcester; University of Virginia; Venezuelan Institute Science Research	Craig, R (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	Roger.Craig@umassmed.edu	Egelman, Edward H/A-2488-2009; Padron, Raul/E-5975-2010	Padron, Raul/0000-0002-1412-2450; Egelman, Edward/0000-0003-4844-5212	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR034711] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR034711] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Burgess S, 2002, BIOPHYS J, V82, p356A; Burgess SA, 1997, J CELL BIOL, V139, P675, DOI 10.1083/jcb.139.3.675; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; Craig R., 2004, MYOLOGY, V3, P129; CROWTHER RA, 1985, J MOL BIOL, V184, P429, DOI 10.1016/0022-2836(85)90292-X; Eakins F, 2002, J STRUCT BIOL, V137, P154, DOI 10.1006/jsbi.2002.4453; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hidalgo C, 2001, BIOPHYS J, V81, P2817, DOI 10.1016/S0006-3495(01)75923-1; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Jung HS, 2004, BIOPHYS J, V86, p403A; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Offer G, 2000, J MOL BIOL, V298, P239, DOI 10.1006/jmbi.2000.3664; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rovner AS, 1998, J BIOL CHEM, V273, P27939, DOI 10.1074/jbc.273.43.27939; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; SELLERS JR, 1981, J BIOL CHEM, V256, P9274; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; STEWART M, 1985, J CELL BIOL, V101, P402, DOI 10.1083/jcb.101.2.402; STEWART M, 1986, J MOL BIOL, V192, P831, DOI 10.1016/0022-2836(86)90032-X; SUZUKI H, 1985, J BIOL CHEM, V260, P4810; Trybus KM, 1998, J BIOL CHEM, V273, P18423, DOI 10.1074/jbc.273.29.18423; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; VIBERT P, 1992, J MOL BIOL, V223, P661, DOI 10.1016/0022-2836(92)90982-P; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; WRAY JS, 1975, NATURE, V257, P561, DOI 10.1038/257561a0; WRAY JS, 1979, NATURE, V277, P37, DOI 10.1038/277037a0	30	219	221	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1195	1199		10.1038/nature03920	http://dx.doi.org/10.1038/nature03920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121187				2022-12-01	WOS:000231416600054
J	Bamshad, M				Bamshad, M			Genetic influences on health - Does race matter?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYROSINE-PHOSPHATASE PTPN22; ETHNIC-DIFFERENCES; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; Y-CHROMOSOME; DISEASE; ASSOCIATION; POPULATION; POLYMORPHISM; ADMIXTURE	Race is frequently used by clinicians and biomedical researchers to make inferences about an individual's ancestry and to predict whether an individual carries specific genetic risk factors that influence health. The extent to which race is useful for making such predictions depends on how well race corresponds with genetic inferences of ancestry, how frequently common diseases in different racial groups are influenced by the same vs different gene variants, and whether such variants have the same effects in different racial groups. New studies of human genetic variation show that while genetic ancestry is highly correlated with geographic ancestry, its correlation with race is modest. Therefore, while data on the correspondence of race, ancestry, and health-related traits are still limited, particularly in minority populations, geographic ancestry and explicit genetic information are alternatives to race that appear to be more accurate predictors of genetic risk factors that influence health. Making accurate ancestry inferences is crucial because common diseases and drug responses are sometimes influenced by gene variants that vary in frequency or differ altogether among racial groups. Thus, operationalizing alternatives to race for clinicians will be an important step toward providing more personalized health care.	Univ Utah, Eccles Inst Human Genet, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bamshad, M (corresponding author), Univ Utah, Eccles Inst Human Genet, Dept Pediat, Salt Lake City, UT 84112 USA.	mike@genetics.utah.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046326, R21AI046326, U54AI065357, R37AI046326] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00064] Funding Source: Medline; NIAID NIH HHS [U54 AI065357-01, AI46326, U54 AI065357, AI65357] Funding Source: Medline; NICHD NIH HHS [HD48895] Funding Source: Medline; ODCDC CDC HHS [U50/CCU822097] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ODCDC CDC HHS		Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, SCI AM, V289, P78, DOI 10.1038/scientificamerican1203-78; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Basehore MJ, 2004, J ALLERGY CLIN IMMUN, V114, P80, DOI 10.1016/j.jaci.2004.05.035; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Cho MK, 2004, NAT GENET, V36, pS8, DOI 10.1038/ng1594; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 2001, INT J EPIDEMIOL, V30, pS48, DOI 10.1093/ije/30.suppl_1.S48; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Ezenwaka C, 2005, J ENDOCRINOL, V185, P439, DOI 10.1677/joe.1.06117; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Frudakis T, 2003, J FORENSIC SCI, V48, P771; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gower BA, 2003, DIABETES, V52, P1047, DOI 10.2337/diabetes.52.4.1047; Gregersen PK, 2005, IMMUNOL REV, V204, P74, DOI 10.1111/j.0105-2896.2005.00243.x; Haga SB, 2003, SCIENCE, V301, P466, DOI 10.1126/science.1087004; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; *I MED, 2003, UN TREATM CONFR RAC; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kugathasan S, 2005, INFLAMM BOWEL DIS, V11, P631, DOI 10.1097/01.MIB.0000171279.05471.21; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; LI WH, 1991, GENETICS, V129, P513; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oppenheimer GM, 2001, AM J PUBLIC HEALTH, V91, P1049, DOI 10.2105/AJPH.91.7.1049; OSBORNE NG, 1992, JAMA-J AM MED ASSOC, V267, P275, DOI 10.1001/jama.267.2.275; Pang CP, 2002, HUM MUTAT, V19, P189, DOI 10.1002/humu.10053; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Riedel MJ, 2005, HUM GENET, V116, P133, DOI 10.1007/s00439-004-1216-5; Risch N, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosskopf D, 2002, PHARMACOGENETICS, V12, P209, DOI 10.1097/00008571-200204000-00005; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Satta Y, 2004, MOL ECOL, V13, P877, DOI 10.1046/j.1365-294X.2003.02069.x; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Shriver Mark D., 2005, Human Genomics, V2, P81; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; *US CENS, 2000, GEN DEM CHAR DP 1; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798; Yu N, 2002, GENETICS, V161, P269; Zhang JH, 2003, AM J HUM GENET, V73, P1073, DOI 10.1086/379154; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	78	109	109	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2005	294	8					937	946		10.1001/jama.294.8.937	http://dx.doi.org/10.1001/jama.294.8.937			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957JM	16118384				2022-12-01	WOS:000231366100024
J	Lister, AM; Edwards, CJ; Nock, DAW; Bunce, M; van Pijlen, IA; Bradley, DG; Thomas, MG; Barnes, I				Lister, AM; Edwards, CJ; Nock, DAW; Bunce, M; van Pijlen, IA; Bradley, DG; Thomas, MG; Barnes, I			The phylogenetic position of the 'giant deer' Megaloceros giganteus	NATURE			English	Article							FALLOW-DEER; EVOLUTIONARY; PLEISTOCENE; EXTINCTION; DYNAMICS	The giant deer, or 'Irish elk', has featured extensively in debates on adaptation, sexual selection, and extinction. Its huge antlers - the largest of any deer species, living or extinct - formed a focus of much past work(1-4). Yet the phylogenetic position of the giant deer has remained an enigma. On the basis of its flattened antlers, the species was previously regarded as closely related to the living fallow deer(5-7). Recent morphological studies(8), however, have challenged that view and placed the giant deer closer to the living red deer or wapiti. Here we present a new phylogenetic analysis encompassing morphological and DNA sequence evidence, and find that both sets of data independently support a sister-group relationship of giant and fallow deer. Our results include the successful extraction and sequencing of DNA from this extinct species, and highlight the value of a joint molecular and morphological approach.	UCL, Dept Biol, London WC1E 6BT, England; Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; Univ Oxford, Dept Zool, Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Leicester, Dept Zool, Leicester LE1 7RH, Leics, England	University of London; University College London; Trinity College Dublin; University of Oxford; University of Leicester	Barnes, I (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	I.Barnes@ucl.ac.uk	Thomas, Mark G/A-2219-2012; Barnes, Ian C/B-8081-2008; Bradley, Daniel G/A-3240-2012; Edwards, Ceiridwen/F-8855-2010	Thomas, Mark G/0000-0002-2452-981X; Barnes, Ian C/0000-0001-8322-6918; Edwards, Ceiridwen/0000-0001-9126-1377; Bunce, Michael/0000-0002-0302-4206; Bradley, Daniel G/0000-0001-7335-7092; Lister, Adrian/0000-0002-7985-138X				Abbazzi L., 2004, REMARKS VALIDITY GEN, V15, P115, DOI 10.1007/BF02904712; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Croitor Roman, 2004, Palaeontologische Zeitschrift, V78, P137; GEIST V, 1999, DEER WORLD EVOLUTION; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Groves C.P., 1987, P21; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Heyer W.R., 2004, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2004.RLTS.T57115A11582955.en, DOI 10.2305/IUCN.UK.2004.RLTS.T58446A11782308.EN]; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Lister A.M., 1987, P81; LISTER AM, 1984, P ROY SOC EDINB B, V82, P205, DOI 10.1017/S0269727000003754; LISTER AM, 1996, INT J OSTEOARCHAEOL, V6, P119, DOI 10.1002/(SICI)1099-1212(199603)6:2<119::AID-OA265>3.0.CO;2-8; LYDEKKER R, 1898, DEER ALL LANDS; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; MILLAIS JG, 2006, MAMMALS GREAT BRITAI; Moen RA, 1999, EVOL ECOL RES, V1, P235; Pfeiffer Thekla, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P289; Pfeiffer Thekla, 1999, Courier Forschungsinstitut Senckenberg, V211, P1; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Randi E, 1998, P ROY SOC B-BIOL SCI, V265, P793, DOI 10.1098/rspb.1998.0362; REYNOLDS SH, 1929, MONOGRAPH BRIT MAMMA, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Soergel W., 1927, Abhandlungen der Senckenbergischen Gesellschaft, V39, P365; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; van der Made J, 1999, J HUM EVOL, V37, P389, DOI 10.1006/jhev.1998.0264; Vislobokova I., 1990, Vertebrata Palasiatica, V28, P150; Vogler U, 1997, TIERARZTL PRAX, V25, P100; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; [No title captured]	30	63	69	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					850	853		10.1038/nature04134	http://dx.doi.org/10.1038/nature04134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16148942				2022-12-01	WOS:000233777800050
J	He, CY; Pypaert, M; Warren, G				He, CY; Pypaert, M; Warren, G			Golgi duplication in Trypanosoma brucei requires Centrin2	SCIENCE			English	Article							CELL-CYCLE; GAMMA-TUBULIN; LOCALIZATION; CENTROSOMES; PROTEIN	Centrins are highly conserved components of the centrosome, which in the parasitic protozoan T. brucei comprises the basal body and nucleates the flagellum used for locomotion. Here, we found TbCentrin2 in an additional bi-lobed structure near to the Golgi apparatus. One lobe was associated with the old Golgi, and the other became associated with the newly forming Golgi as the cell grew.. Depletion of TbCentrin1 inhibited duplication of the basal body, whereas depletion of TbCentrin2 also inhibited duplication of the Golgi. Thus, a Centrin2-containing structure distinct from the basal body appears to mark the site for new Golgi assembly.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	graham.warren@yale.edu	He, Cynthia/H-9789-2012					Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Chapman MJ, 2000, Q REV BIOL, V75, P409, DOI 10.1086/393621; Djikeng A, 2004, METH MOL B, V270, P287; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Munro S, 2002, NAT CELL BIOL, V4, pE223, DOI 10.1038/ncb1002-e223; Paoletti A, 2003, MOL BIOL CELL, V14, P2793, DOI 10.1091/mbc.E02-10-0661; Rios RM, 2004, CELL, V118, P323; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Scott V, 1997, J CELL SCI, V110, P157; Selvapandiyan A, 2004, J BIOL CHEM, V279, P25703, DOI 10.1074/jbc.M402794200; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; WHALEY WG, 1975, GOLGI APPARATUS CELL, V2	18	107	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1196	1198		10.1126/science.1119969	http://dx.doi.org/10.1126/science.1119969			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16254149				2022-12-01	WOS:000233437300049
J	Abidov, A; Rozanski, A; Hachamovitch, R; Hayes, SW; Aboul-Enein, F; Cohen, I; Friedman, JD; Germano, G; Berman, DS				Abidov, A; Rozanski, A; Hachamovitch, R; Hayes, SW; Aboul-Enein, F; Cohen, I; Friedman, JD; Germano, G; Berman, DS			Prognostic significance of dyspnea in patients referred for cardiac stress testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	77th Scientific Meeting of the American-Heart-Association	NOV 07-10, 2004	New Orleans, LA	Amer Heart Assoc			CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; ALL-CAUSE MORTALITY; MYOCARDIAL-PERFUSION; HEART-DISEASE; RISK-FACTORS; EXERCISE; MANAGEMENT; SYMPTOMS; MECHANISMS	BACKGROUND: Although dyspnea is a common symptom, there has been only limited investigation of its prognostic significance among patients referred for cardiac evaluation. METHODS: We studied 17,991 patients undergoing myocardial-perfusion single-photon-emission computed tomography during stress and at rest. Patients were divided into five categories on the basis of symptoms at presentation (none, nonanginal chest pain, atypical angina, typical angina, and dyspnea). Multivariable analysis was used to assess the incremental prognostic value of symptom categories in predicting the risk of death from cardiac causes and from any cause. In addition, the prognosis associated with various symptoms at presentation was compared in subgroups selected on the basis of propensity analysis. RESULTS: After a mean (+/-SD) follow-up of 2.7+/-1.7 years, the rate of death from cardiac causes and from any cause was significantly higher among patients with dyspnea (both those previously known to have coronary artery disease and those with no known history of coronary artery disease) than among patients with other or no symptoms at presentation. Among patients with no known history of coronary artery disease, those with dyspnea had four times the risk of sudden death from cardiac causes of asymptomatic patients and more than twice the risk of patients with typical angina. Dyspnea was associated with a significant increase in the risk of death among each clinically relevant subgroup and remained an independent predictor of the risk of death from cardiac causes (P<0.001) and from any cause (P<0.001) after adjustment for other significant factors by multivariable and propensity analysis. CONCLUSIONS: In a large series of patients, self-reported dyspnea identified a subgroup of otherwise asymptomatic patients at increased risk for death from cardiac causes and from any cause. Our results suggest that an assessment of dyspnea should be incorporated into the clinical evaluation of patients referred for cardiac stress testing.	Cedars Sinai Med Ctr, Dept Imaging, Div Nucl Med, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; St Joseph Mercy Oakland Med Ctr, Dept Med, Pontiac, MI USA; St Lukes Roosevelt Hosp, Div Cardiol, New York, NY USA; Univ So Calif, Keck Sch Med, Dept Med, Div Cardiovasc, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Saint Joseph Mercy Health System (SJMHS); Mount Sinai St. Luke's; Mount Sinai West; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Berman, DS (corresponding author), Cedars Sinai Med Ctr, Dept Imaging, Div Nucl Med, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	bermand@cshs.org						Abidov A, 2003, CIRCULATION, V107, P2894, DOI 10.1161/01.CIR.0000072770.27332.75; Anisman H, 2002, BRAIN BEHAV IMMUN, V16, P513, DOI 10.1016/S0889-1591(02)00009-0; Azarbal B, 2004, J AM COLL CARDIOL, V44, P423, DOI 10.1016/j.jacc.2004.02.060; BERMAN DS, 1993, J AM COLL CARDIOL, V22, P1455, DOI 10.1016/0735-1097(93)90557-H; BONOW RO, 1992, ANN INTERN MED, V117, P502, DOI 10.7326/0003-4819-117-6-502; Cole SR, 1999, AM J CARDIOL, V84, P1401, DOI 10.1016/S0002-9149(99)00585-8; COOK DG, 1988, EUR HEART J, V9, P1215, DOI 10.1093/oxfordjournals.eurheartj.a062432; COX DR, 1972, J R STAT SOC B, V34, P187; DIAMOND GA, 1981, CIRCULATION, V63, P915, DOI 10.1161/01.CIR.63.4.915; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P444, DOI 10.1016/S0735-1097(83)80072-2; GERMANO G, 1995, J NUCL MED, V36, P2138; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; HAGMAN M, 1987, J CHRON DIS, V40, P265, DOI 10.1016/0021-9681(87)90163-9; HAGMAN M, 1981, ACTA MED SCAND, P16; Jones RC, 2004, AM J MED, V117, P380, DOI 10.1016/j.amjmed.2004.06.004; Leineweber C, 2003, J PSYCHOSOM RES, V54, P121, DOI 10.1016/S0022-3999(02)00475-0; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Montgomery D.C., 2017, DESIGN ANAL EXPT, DOI 10.1080/00224065.2005.11980315; Morise AP, 2003, J AM COLL CARDIOL, V42, P842, DOI 10.1016/S0735-1097(03)00837-4; PEPINE CJ, 1972, CIRCULATION, V46, P863, DOI 10.1161/01.CIR.46.5.863; Qureshi E, 2002, AM J CARDIOL, V90, P756, DOI 10.1016/S0002-9149(02)02605-X; ROZANSKI A, 1983, NEW ENGL J MED, V309, P518, DOI 10.1056/NEJM198309013090902; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; ROZANSKI A, 1984, ANN INTERN MED, V101, P164, DOI 10.7326/0003-4819-101-2-164; Rozanski A, 2001, CIRCULATION, V103, P2084; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; SUADICANI P, 1993, ATHEROSCLEROSIS, V101, P165, DOI 10.1016/0021-9150(93)90113-9; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; WILHELMSEN L, 1973, CIRCULATION, V48, P950, DOI 10.1161/01.CIR.48.5.950	31	202	207	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2005	353	18					1889	1898		10.1056/NEJMoa042741	http://dx.doi.org/10.1056/NEJMoa042741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	979VJ	16267320				2022-12-01	WOS:000232972800005
J	Silk, JB; Brosnan, SF; Vonk, J; Henrich, J; Povinelli, DJ; Richardson, AS; Lambeth, SP; Mascaro, J; Schapiro, SJ				Silk, JB; Brosnan, SF; Vonk, J; Henrich, J; Povinelli, DJ; Richardson, AS; Lambeth, SP; Mascaro, J; Schapiro, SJ			Chimpanzees are indifferent to the welfare of unrelated group members	NATURE			English	Article							AFFILIATION; INEQUITY; KINSHIP	Humans are an unusually prosocial species - we vote, give blood, recycle, give tithes and punish violators of social norms. Experimental evidence indicates that people willingly incur costs to help strangers in anonymous one-shot interactions(1,2), and that altruistic behaviour is motivated, at least in part, by empathy and concern for the welfare of others ( hereafter referred to as other-regarding preferences)(1-3). In contrast, cooperative behaviour in non-human primates is mainly limited to kin and reciprocating partners, and is virtually never extended to unfamiliar individuals(4). Here we present experimental tests of the existence of other-regarding preferences in non-human primates, and show that chimpanzees ( Pan troglodytes) do not take advantage of opportunities to deliver benefits to familiar individuals at no material cost to themselves, suggesting that chimpanzee behaviour is not motivated by other-regarding preferences. Chimpanzees are among the primates most likely to demonstrate prosocial behaviours. They participate in a variety of collective activities, including territorial patrols, coalitionary aggression, cooperative hunting, food sharing and joint mate guarding(5-12). Consolation of victims of aggression(13) and anecdotal accounts of solicitous treatment of injured individuals suggest that chimpanzees may feel empathy(14,15). Chimpanzees sometimes reject exchanges in which they receive less valuable rewards than others, which may be one element of a 'sense of fairness', but there is no evidence that they are averse to interactions in which they benefit more than others(16-18).	Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; Univ Texas, MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Bastrop, TX 78602 USA; Univ Louisiana Lafayette, Cognit Evolut Grp, New Iberia, LA 70560 USA	University of California System; University of California Los Angeles; Emory University; University of Texas System; UTMD Anderson Cancer Center; University of Louisiana Lafayette	Silk, JB (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA.	jsilk@anthro.ucla.edu	Vonk, Jennifer/ABB-5385-2021; , jenny/AAC-8282-2019; Vonk, Jennifer/AAB-7316-2020	Vonk, Jennifer/0000-0002-4362-5989; Kaeser, Amanda/0000-0002-0446-4465; Schapiro, Steven J./0000-0001-5406-1739				Boesch C., 2002, CHIMPANZEES TAI FORE; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Camerer CF., 2004, FDN HUMAN SOCIALITY, V97; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Crawford M.P., 1937, COMP PSYCHOL MONOGR, V14, P1; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; De Waal Frans B. M., 1996, P80; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Flack JC, 2000, J CONSCIOUSNESS STUD, V7, P1; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Henrich J, 2004, NATURE, V428, P139, DOI 10.1038/428139a; Hohmann G, 1999, BEHAVIOUR, V136, P1219, DOI 10.1163/156853999501739; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Povinelli DJ, 1999, DEVELOPING THEORIES OF INTENTION, P195; POVINELLI DJ, 1993, EVOLUTIONARY ETHICS, P277; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Richerson P. J., 2004, NOT GENES ALONE CULT; Silk J.B., 2005, MORAL SENTIMENTS MAT, P43; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; [No title captured]	29	331	342	3	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1357	1359		10.1038/nature04243	http://dx.doi.org/10.1038/nature04243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251965				2022-12-01	WOS:000232829100054
J	Harker, DE; Woodward, CE; Wooden, DH				Harker, DE; Woodward, CE; Wooden, DH			The dust grains from 9P/Tempel 1 before and after the encounter with deep impact	SCIENCE			English	Article							TELESCOPE OBSERVATIONS; INFRARED OBSERVATIONS; KUIPER-BELT; COMETS; SPECTRA; SILICATE	Gemini-N observed the properties of dust ejected from the nucleus of comet 9P/Tempel 1 before and after its encounter with Deep Impact. Marked changes were seen in the 7.8- to 13-micrometer spectral energy distribution and derived grain properties of the inner coma. A strong, broad silicate feature dominated by emission from amorphous pyroxene, amorphous olivine, and magnesium-rich crystalline olivine had developed by 1 hour after impact. The ejected dust mass is congruent to 10(4) to 10(6) kilograms on the basis of our models. Twenty-six hours later the silicate feature had faded, leaving a smooth featureless spectrum, similar to that observed before the impact, suggesting that the impact did not produce a new active region releasing small particles on the nucleus.	Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; Univ Minnesota, Dept Astron, Minneapolis, MN 55455 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Harker, DE (corresponding author), Univ Calif San Diego, Ctr Astrophys & Space Sci, 9500 Gilman Dr,Dept 0424, La Jolla, CA 92093 USA.	dharker@ucsd.edu		Harker, David/0000-0001-6397-9082				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 1998, LPS, V29, P1737; Crovisier J, 2000, ASTR SOC P, V196, P109; Delbo M, 2002, METEORIT PLANET SCI, V37, P1929, DOI 10.1111/j.1945-5100.2002.tb01174.x; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; HANNER MS, 1983, P INT C COMETARY EXP, V2, P1; Harker DE, 2002, ASTROPHYS J, V580, P579, DOI 10.1086/343091; Harker DE, 2004, ASTROPHYS J, V615, P1081, DOI 10.1086/424592; JEWITT D, 1991, ASTROPHYS SPACE SC L, V167, P19; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Lisse CM, 2005, ASTROPHYS J, V625, pL139, DOI 10.1086/431238; Lisse CM, 1998, ASTROPHYS J, V496, P971, DOI 10.1086/305397; MOLSTER FJ, 2001, LUNAR PLANET SCI, V32, P1391; REACH W, 2004, 36 ANN DIV PLAN SCI; Stern SA, 2003, NATURE, V424, P639, DOI 10.1038/nature01725; Sugita S, 2005, SCIENCE, V310, P274, DOI 10.1126/science.1119091; Wooden DH, 2004, ASTROPHYS J, V612, pL77, DOI 10.1086/424593; Wooden DH, 2002, EARTH MOON PLANETS, V89, P247; WOODEN DH, 2005, IAU S, V229; WOODEN DH, 2005, CHONDRITES PROTOPLAN; WOPENKA B, 1988, EARTH PLANET SC LETT, V88, P221, DOI 10.1016/0012-821X(88)90079-9; [No title captured]	26	97	97	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					278	280		10.1126/science.1119143	http://dx.doi.org/10.1126/science.1119143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166478				2022-12-01	WOS:000232670100041
J	Sugita, S; Ootsubo, T; Kadono, T; Honda, M; Sako, S; Miyata, T; Sakon, I; Yamashita, T; Kawakita, H; Fujiwara, H; Fujiyoshi, T; Takato, N; Fuse, T; Watanabe, J; Furusho, R; Hasegawa, S; Kasuga, T; Sekiguchi, T; Kinoshita, D; Meech, KJ; Wooden, DH; Ip, WH; A'Hearn, MF				Sugita, S; Ootsubo, T; Kadono, T; Honda, M; Sako, S; Miyata, T; Sakon, I; Yamashita, T; Kawakita, H; Fujiwara, H; Fujiyoshi, T; Takato, N; Fuse, T; Watanabe, J; Furusho, R; Hasegawa, S; Kasuga, T; Sekiguchi, T; Kinoshita, D; Meech, KJ; Wooden, DH; Ip, WH; A'Hearn, MF			Subaru telescope observations of Deep Impact	SCIENCE			English	Article							VELOCITY DISTRIBUTIONS	The impact cratering process on a comet is controversial but holds the key for interpreting observations of the Deep Impact collision with comet 9P/Tempel 1. Midinfrared data from the Cooled Mid-Infrared Camera and Spectrometer (COMICS) of the Subaru Telescope indicate that the large-scale dust plume ejected by the impact contained a large mass (similar to 10(6) kilograms) of dust and formed two wings approximately +/- 45 degrees from the symmetric center, both consistent with gravity as the primary control on the impact and its immediate aftermath. The dust distribution in the inner part of the plume, however, is inconsistent with a pure gravity control and implies that evaporation and expansion of volatiles accelerated dust.	Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan; Univ Tokyo, Inst Astron, Tokyo 113, Japan; Univ Tokyo, Dept Astron, Tokyo 113, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa, Japan; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Nagoya Univ, Div Particle & Astrophys Sci, Aichi, Japan; Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Kanagawa, Japan; Natl Astron Observ Japan, Natl Inst Nat Sci, Subaru Telescope, Hilo, HI USA; Kyoto Sangyo Univ, Dept Phys, Kamigamo, Kyodo, Japan; Natl Astron Observ Japan, Tokyo, Japan; Waseda Univ, Tokyo, Japan; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Brown University; Nagoya University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto Sangyo University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Waseda University; National Central University; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Maryland; University of Maryland College Park	Sugita, S (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Chiba, Japan.	sugita@k.u-tokyo.ac.jp	Meech, Karen/CAH-1412-2022; Sugita, Seiji/GQI-1142-2022; Hasegawa, Sunao/R-4768-2017	Sugita, Seiji/0000-0001-6076-3614; Hasegawa, Sunao/0000-0001-6366-2608; Meech, Karen/0000-0002-2058-5670				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605, DOI 10.1111/j.1945-5100.1999.tb01367.x; Croft S. K., 1980, P LUNAR PLANET SCI, P2347; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; GAULT DE, 1963, 6 P HYP IMP S CLEV 2, V2, P419; Gladman B, 2005, SCIENCE, V307, P71, DOI 10.1126/science.1100553; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; HANNER MS, 1983, P INT C COMETARY EXP, V2, P1; Harker DE, 2004, ASTROPHYS J, V615, P1081, DOI 10.1086/424592; Harker DE, 2005, SCIENCE, V310, P278, DOI 10.1126/science.1119143; HARTMANN WK, 1985, ICARUS, V63, P69, DOI 10.1016/0019-1035(85)90021-1; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Housen KR, 2003, ICARUS, V163, P102, DOI 10.1016/S0019-1035(03)00024-1; Meech KJ, 2005, SCIENCE, V310, P265, DOI 10.1126/science.1118978; Melosh H.J., 1989, IMPACT CRATERING GEO; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; SWAMY KS, 1997, PHYS COMETS; Watanabe J., 2005, IAU S AST COM MET RI, P47; Wooden DH, 2004, ASTROPHYS J, V612, pL77, DOI 10.1086/424593; YAMAMOTO S, 2005, IN PRESS ICARUS 0525	21	79	79	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					274	278		10.1126/science.1119091	http://dx.doi.org/10.1126/science.1119091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166476				2022-12-01	WOS:000232670100040
J	Mygind, PH; Fischer, RL; Schnorr, KM; Hansen, MT; Sonksen, CP; Ludvigsen, S; Raventos, D; Buskov, S; Christensen, B; De Maria, L; Taboureau, O; Yaver, D; Elvig-Jorgensen, SG; Sorensen, MV; Christensen, BE; Kjaerulff, S; Frimodt-Moller, N; Lehrer, RI; Zasloff, M; Kristensen, HH				Mygind, PH; Fischer, RL; Schnorr, KM; Hansen, MT; Sonksen, CP; Ludvigsen, S; Raventos, D; Buskov, S; Christensen, B; De Maria, L; Taboureau, O; Yaver, D; Elvig-Jorgensen, SG; Sorensen, MV; Christensen, BE; Kjaerulff, S; Frimodt-Moller, N; Lehrer, RI; Zasloff, M; Kristensen, HH			Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus	NATURE			English	Article							ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL ACTIVITY; DIRECT INACTIVATION; MECHANISM; DEFENSIN; PROTEIN; INNATE; CATHELICIDINS; DIVERGENCE; PENICILLIN	Animals and higher plants express endogenous peptide antibiotics called defensins. These small cysteine-rich peptides are active against bacteria, fungi and viruses. Here we describe plectasin - the first defensin to be isolated from a fungus, the saprophytic ascomycete Pseudoplectania nigrella. Plectasin has primary, secondary and tertiary structures that closely resemble those of defensins found in spiders, scorpions, dragonflies and mussels. Recombinant plectasin was produced at a very high, and commercially viable, yield and purity. In vitro, the recombinant peptide was especially active against Streptococcus pneumoniae, including strains resistant to conventional antibiotics. Plectasin showed extremely low toxicity in mice, and cured them of experimental peritonitis and pneumonia caused by S. pneumoniae as efficaciously as vancomycin and penicillin. These findings identify fungi as a novel source of antimicrobial defensins, and show the therapeutic potential of plectasin. They also suggest that the defensins of insects, molluscs and fungi arose from a common ancestral gene.	Novozymes AS, DK-2880 Bagsvaerd, Denmark; Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, DK-2300 Copenhagen, Denmark; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; Novozymes Inc, Davis, CA 95616 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Georgetown Univ, Med Ctr, Dept Surg, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA	Novozymes; Statens Serum Institut; Novo Nordisk; Novozymes; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Georgetown University; Georgetown University	Kristensen, HH (corresponding author), Novozymes AS, DK-2880 Bagsvaerd, Denmark.	hahk@novozymes.com	Frimodt-Moller, Niels/G-1187-2018; De Maria, Leonardo/AAH-1026-2021	Frimodt-Moller, Niels/0000-0003-1966-8302; De Maria, Leonardo/0000-0002-8061-4242; Yaver, Debbie/0000-0003-4150-6756; LUDVIGSEN, SVEND/0000-0002-5671-4542				[Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Becker F, 2004, J MICROBIOL METH, V57, P123, DOI 10.1016/j.mimet.2003.12.002; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clinical and Laboratory Standards Institute, M7A6 CLIN LAB STAND; Cole AM, 2003, EXPERT OPIN THER TAR, V7, P329, DOI 10.1517/eott.7.3.329.22436; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; del Castillo FJ, 2001, J BACTERIOL, V183, P2137, DOI 10.1128/JB.183.6.2137-2140.2001; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Erlendsdottir H, 2001, ANTIMICROB AGENTS CH, V45, P1078, DOI 10.1128/AAC.45.4.1078-1085.2001; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Frimodt-Moller N., 1999, HDB ANIMAL MODELS IN, P127, DOI [10.1016/B978-012775390-4/50153-6, DOI 10.1016/B978-012775390-4/50153-6]; Froy O, 2004, J PEPT SCI, V10, P714, DOI 10.1002/psc.578; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gennaro R, 2002, CURR PHARM DESIGN, V8, P763, DOI 10.2174/1381612023395394; Hjort C. M., 2003, Genetically engineered food: methods and detection, P86; KJAER M, 1994, METHODS ENZYMOL, V239, P288; Klugman KP, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00400402; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1985, J VIROL, V54, P467, DOI 10.1128/JVI.54.2.467-472.1985; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nakajima Y, 2003, BBA-GEN SUBJECTS, V1624, P125, DOI 10.1016/j.bbagen.2003.10.004; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Schnorr K.M., 2003, International patent application, Patent No. [2003044049, W02003044049 -A1]; SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Steinberg D A, 1997, Methods Mol Biol, V78, P169; Tossi A, 2000, BIOPOLYMERS, V55, P4; Volkoff AN, 2003, GENE, V319, P43, DOI 10.1016/S0378-1119(03)00789-3; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yoder WT, 2004, ADV FUNGAL BIOTECHNO, P201; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	46	468	516	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					975	980		10.1038/nature04051	http://dx.doi.org/10.1038/nature04051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222292				2022-12-01	WOS:000232496100035
J	Hattersley, AT; McCarthy, MI				Hattersley, AT; McCarthy, MI			Genetic Epidemiology 5 - What makes a good genetic association study?	LANCET			English	Article							COMPLEMENT FACTOR-H; SINGLE-NUCLEOTIDE POLYMORPHISMS; NUCLEAR FACTOR-4-ALPHA GENE; HAPLOTYPE RECONSTRUCTION; STATISTICAL SIGNIFICANCE; GENOTYPING ERRORS; LINKAGE DISEQUILIBRIUM; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; UPSTREAM PROMOTER	Genetic association studies are central to efforts to identify and characterise genomic variants underlying susceptibility to multifactorial disease. However, obtaining robust replication of initial association findings has proved difficult. Much of this inconsistency can be attributed to inadequacies in study design, implementation, and interpretation-inadequately powered sample groups are a major concern. Several additional factors affect the quality of any given association study, with appropriate sample-recruitment strategy, logical variant selection, minimum genotyping error, relevant data analysis, and valid interpretation all essential to generation of robust findings. Replication has a vital role in showing that associations that are identified reflect interesting biological processes rather than methodological quirks. For an unbiased view of the evidence for and against any particular association, study quality, rather than significance value, needs to play the dominant part.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	mark.mccarthy@drl.ox.ac.uk	; McCarthy, Mark/M-3763-2015	Hattersley, Andrew/0000-0001-5620-473X; McCarthy, Mark/0000-0002-4393-0510	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chistiakov DA, 2003, J MOL ENDOCRINOL, V31, P21, DOI 10.1677/jme.0.0310021; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CURTIS D, 1995, AM J HUM GENET, V56, P811; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HOPPER JL, IN PRESS LANCET; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Keavney B, 2000, LANCET, V355, P434; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knapp M, 2004, AM J HUM GENET, V74, P589, DOI 10.1086/382287; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Kraft P, 2004, AM J HUM GENET, V74, P582, DOI 10.1086/382051; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; LYKKEN DT, 1968, PSYCHOL BULL, V70, P151, DOI 10.1037/h0026141; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Mann V, 2003, BONE, V32, P711, DOI 10.1016/S8756-3282(03)00087-5; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; McCarthy MI, 2004, HUM MOL GENET, V13, pR33, DOI 10.1093/hmg/ddh057; McCarthy MI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-119; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oliphant A, 2002, BIOTECHNIQUES, P56; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Redden DT, 2003, J NUTR, V133, P3323, DOI 10.1093/jn/133.11.3323; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Teng J, 1999, GENOME RES, V9, P234; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wright FA, 2001, GENOME BIOL, V2; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	87	357	440	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2005	366	9493					1315	1323		10.1016/S0140-6736(05)67531-9	http://dx.doi.org/10.1016/S0140-6736(05)67531-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971ST	16214603				2022-12-01	WOS:000232405700031
J	Li, JS; Yang, HB; Peer, WA; Richter, G; Blakeslee, J; Bandyopadhyay, A; Titapiwantakun, B; Undurraga, S; Khodakovskaya, M; Richards, EL; Krizek, B; Murphy, AS; Gilroy, S; Gaxiola, R				Li, JS; Yang, HB; Peer, WA; Richter, G; Blakeslee, J; Bandyopadhyay, A; Titapiwantakun, B; Undurraga, S; Khodakovskaya, M; Richards, EL; Krizek, B; Murphy, AS; Gilroy, S; Gaxiola, R			Arabidopsis H+-PPase AVP1 regulates auxin-mediated organ development	SCIENCE			English	Article							THALIANA; ATPASE; EXPRESSION; EFFLUX; GENES; ROOT; ORGANIZATION; TRANSPORT; PROTEINS; GROWTH	The transport of auxin controls developmental events in plants. Here, we report that in addition to maintaining vacuolar pH, the H+-pyrophosphatase, AVP1, controls auxin transport and consequently auxin-dependent development. AVP1 overexpression results in increased cell division at the onset of organ formation, hyperplasia, and increased auxin transport. In contrast, avp1-1 null mutants have severely disrupted root and shoot development and reduced auxin transport. Changes in the expression of AVP1 affect the distribution and abundance of the P-adenosine triphosphatase and Pinformed 1 auxin efflux facilitator, two proteins implicated in auxin distribution. Thus, AVP1 facilitates the auxin fluxes that regulate organogenesis.	Univ Connecticut, Dept Plant Sci, Storrs, CT 06268 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of Connecticut; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Gaxiola, R (corresponding author), Univ Connecticut, Dept Plant Sci, Storrs, CT 06268 USA.	roberto.gaxiola@uconn.edu	Blakeslee, Joshua/G-4420-2011; Peer, Wendy/H-2970-2013; Khodakovskaya, Mariya V/F-3681-2010	Peer, Wendy/0000-0003-0046-7324; Gilroy, Simon/0000-0001-9597-6839				Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aloni R, 2003, PLANTA, V216, P841, DOI 10.1007/s00425-002-0937-8; Baxter IR, 2005, P NATL ACAD SCI USA, V102, P2649, DOI 10.1073/pnas.0406377102; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Davies JM, 1997, TRENDS PLANT SCI, V2, P9, DOI 10.1016/S1360-1385(97)82732-X; DOLAN L, 1993, DEVELOPMENT, V119, P71; Frias I, 1996, PLANT CELL, V8, P1533; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Li J. P. H., UNPUB; LOMAX TL, 1985, P NATL ACAD SCI USA, V82, P6541, DOI 10.1073/pnas.82.19.6541; Mitsuda N, 2004, PLANT CELL PHYSIOL, V45, P845, DOI 10.1093/pcp/pch101; Mitsuda N, 2001, FEBS LETT, V488, P29, DOI 10.1016/S0014-5793(00)02400-5; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Padmanaban S, 2004, PLANT PHYSIOL, V134, P1514, DOI 10.1104/pp.103.034025; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SERRANO R, 1993, FEBS LETT, V325, P108, DOI 10.1016/0014-5793(93)81424-X; Strompen G, 2005, PLANT J, V41, P125, DOI 10.1111/j.1365-313X.2004.02283.x; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Zhen RG, 1997, ADV BOT RES, V25, P297, DOI 10.1016/S0065-2296(08)60156-1	25	323	379	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					121	125		10.1126/science.1115711	http://dx.doi.org/10.1126/science.1115711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210544				2022-12-01	WOS:000232477000053
J	Montgomery, RA; Zachary, AA; Ratner, LE; Segev, DL; Hiller, JM; Houp, J; Cooper, M; Kavoussi, L; Jarrett, T; Burdick, J; Maley, WR; Melancon, JK; Kozlowski, T; Simpkins, CE; Phillips, M; Desai, A; Collins, V; Reeb, B; Kraus, E; Rabb, H; Leffell, MS; Warren, DS				Montgomery, RA; Zachary, AA; Ratner, LE; Segev, DL; Hiller, JM; Houp, J; Cooper, M; Kavoussi, L; Jarrett, T; Burdick, J; Maley, WR; Melancon, JK; Kozlowski, T; Simpkins, CE; Phillips, M; Desai, A; Collins, V; Reeb, B; Kraus, E; Rabb, H; Leffell, MS; Warren, DS			Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WAIT-LIST CANDIDATES; CROSS-MATCH; RENAL-TRANSPLANTATION; EXCHANGE PROGRAMS; REJECTION; PLASMAPHERESIS; GLOBULIN	Context First proposed 2 decades ago, live kidney paired donation (KPD) was considered a promising new approach to addressing the shortage of organs for transplantation. Ethical, administrative, and logistical barriers initially proved formidable and prevented the implementation of KPD programs in the United States. Objective To determine the feasibility and effectiveness of KPD for the management of patients with incompatible donors. Design, Setting, and Patients Prospective series of paired donations matched and transplanted from a pool of blood type or crossmatch incompatible donors and recipients with end-stage renal disease (6 conventional and 4 unconventional KPD transplants) at a US tertiary referral center (between June 2001 and November 2004) with expertise in performing transplants in patients with high immunologic risk. Intervention Kidney paired donation and live donor renal transplantation. Main Outcome Measures Patient survival, graft survival, serum creatinine levels, rejection episodes. Results A total of 22 patients received transplants through 10 paired donations including 2 triple exchanges at Johns Hopkins Hospital. At a median follow-up of 13 months (range, 1-42 months), the patient survival rate was 100% and the graft survival rate was 95.5%. Twenty-one of the 22 patients have functioning grafts with a median 6-month serum creatinine level of 1.2 mg/dL (range, 0.8-1.8 mg/dl) (106.1 mu mol/L [range, 70.7-159.1 mu mol/L]). There were no instances of antibody-mediated rejection despite the inclusion of 5 patients who were highly sensitized to HLA antigens due to previous exposure to foreign tissue. Four patients developed acute cellular rejection (18%). Conclusions This series of patients who received transplants from a single-center KPD pool provides evidence that recipients with incompatible live donors, even those with rare blood type combinations or high degrees of HLA antigen sensitization, can receive transplants through KPD with graft survival rates that appear to be equivalent to directed, compatible live donor transplants, if these results can be generalized, broader availability of KPD to the estimated 6000 patients with incompatible donors could result in a large expansion of the donor pool.	Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; Columbia Univ, Dept Surg, New York, NY 10027 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Columbia University	Montgomery, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, 720 Rutland Ave,Ross 765, Baltimore, MD 21205 USA.	rmonty@jhmi.edu	Phillips, Melissa/AAX-4174-2020	Phillips, Melissa/0000-0001-8997-4853				Fuller TF, 2004, TRANSPLANTATION, V78, P1030, DOI 10.1097/01.TP.0000135464.11616.5A; Gentry SE, 2005, AM J TRANSPLANT, V5, P1914, DOI 10.1111/j.1600-6143.2005.00964.x; Gloor JM, 2003, TRANSPLANTATION, V75, P971, DOI 10.1097/01.TP.0000058226.397.32; Glotz D, 2002, AM J TRANSPLANT, V2, P758, DOI 10.1034/j.1600-6143.2002.20809.x; Jordan Stanley C, 2003, Clin Transpl, P193; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; McLellan F, 2003, LANCET, V362, P456, DOI 10.1016/S0140-6736(03)14106-2; Montgomery RA, 2004, PEDIATR TRANSPLANT, V8, P535, DOI 10.1111/j.1399-3046.2004.00214.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Park K, 1999, TRANSPLANTATION, V67, P336, DOI 10.1097/00007890-199901270-00027; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Racusen Lorraine C, 2004, Am J Transplant, V4, P1562, DOI 10.1111/j.1600-6143.2004.00585.x; RAPAPORT FT, 1986, TRANSPLANT P, V18, P5; Ross LF, 2004, TRANSPLANTATION, V78, P641, DOI 10.1097/01.tp.0000134522.31554.05; Ross LF, 2004, AM J TRANSPLANT, V4, P1553, DOI 10.1111/j.1600-6143.2004.00574.x; Ross LF, 1997, NEW ENGL J MED, V336, P1752, DOI 10.1056/NEJM199706123362412; Ross LF, 2000, TRANSPLANTATION, V69, P1539; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Segev DL, 2005, AM J TRANSPLANT, V5, P2448, DOI 10.1111/j.1600-6143.2005.01048.x; Segev DL, 2005, JAMA-J AM MED ASSOC, V293, P1883, DOI 10.1001/jama.293.15.1883; Sonnenday CJ, 2004, AM J TRANSPLANT, V4, P1315, DOI 10.1111/j.1600-6143.2004.00507.x; Terasaki PI, 1998, TRANSPLANTATION, V65, P291; Terasaki PI, 2003, AM J TRANSPLANT, V3, P665, DOI 10.1034/j.1600-6143.2003.00135.x; United Network for Organ Sharing, ORG PROC TRANSPL NET; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; WILLIAMS GM, 1968, NEW ENGL J MED, V279, P611, DOI 10.1056/NEJM196809192791201; ZACHARY AA, 1985, TRANSPLANTATION, V39, P316, DOI 10.1097/00007890-198503000-00024; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0; Zenios SA, 2001, TRANSPLANTATION, V72, P648, DOI 10.1097/00007890-200108270-00015	29	143	144	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2005	294	13					1655	1663		10.1001/jama.294.13.1655	http://dx.doi.org/10.1001/jama.294.13.1655			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970DC	16204665				2022-12-01	WOS:000232284400018
J	Khan, J				Khan, J			Eye know it's red	LANCET			English	Editorial Material									Kings Coll Hosp London, Retinal Res Unit, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Khan, J (corresponding author), Kings Coll Hosp London, Retinal Res Unit, Normanby Bldg,Denmark Hill, London SE5 9RS, England.	jaheedkhan@yahoo.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2005	366	9496					1583	1583		10.1016/S0140-6736(05)67630-1	http://dx.doi.org/10.1016/S0140-6736(05)67630-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979ZX	16257346				2022-12-01	WOS:000232984800028
J	Sevene, E; Lewin, S; Mariano, A; Woelk, G; Oxman, AD; Matinhure, S; Cliff, J; Fernandes, B; Daniels, K				Sevene, E; Lewin, S; Mariano, A; Woelk, G; Oxman, AD; Matinhure, S; Cliff, J; Fernandes, B; Daniels, K			System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL MORTALITY		Eduardo Mondlane Univ, Fac Med, Dept Pharmacol, Maputo, Mozambique; Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe; Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; MRC S Africa, Hlth Syst Res Unit, Durban, South Africa	Eduardo Mondlane University; University of Zimbabwe	Lewin, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	simon.lewin@lshum.ac.uk	Sevene, Esperança/AAI-3532-2020; Oxman, Andrew/Y-3004-2019; Daniels, Karen/AAY-8659-2020	Oxman, Andrew/0000-0002-5608-5061; Daniels, Karen/0000-0002-4345-5406				AASERUD M, 2005, IN PRESS BMC HLTH SE; DULEY L, 1995, LANCET, V345, P1455; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; Granja AC, 1998, ANN TROP MED PARASIT, V92, P257, DOI 10.1080/00034989859816; Gravelle H., 2004, MICROECONOMICS; Green J., 2018, QUALITATIVE METHODS; Kaplan WA, 2003, HEALTH POLICY PLANN, V18, P237, DOI 10.1093/heapol/czg030; *MIN HLTH CHILD WE, 2000, ZIMB NAT HLTH PROF 2; Olliaro Piero, 2004, J HIV Ther, V9, P53; Sheth SS, 2002, LANCET, V359, P1872, DOI 10.1016/S0140-6736(02)08783-4; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *UN, 2000, 552 UN; *UN, 2000, 552 UN GEN ASS; WHO, 2003, WHO MOD LIST ESS MED; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; *WHO UN, 2004, MAT MORT 2000 EST DE; World Health Organization, 2004, PRIOR MED EUR WORLD; World Health Organization (WHO), 2005, WORLD HLTH REP 2005	20	39	39	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2005	331	7519					765	769		10.1136/bmj.331.7519.765	http://dx.doi.org/10.1136/bmj.331.7519.765			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971XB	16195297	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000232417100027
J	Futatsugi, A; Nakamura, T; Yamada, MK; Ebisui, E; Nakamura, K; Uchida, K; Kitaguchi, T; Takahashi-Iwanaga, H; Noda, T; Aruga, J; Mikoshiba, K				Futatsugi, A; Nakamura, T; Yamada, MK; Ebisui, E; Nakamura, K; Uchida, K; Kitaguchi, T; Takahashi-Iwanaga, H; Noda, T; Aruga, J; Mikoshiba, K			IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PANCREATIC ACINAR-CELLS; GLAND-CELLS; MICE; CHANNELS; TRISPHOSPHATE; EXPRESSION; INOSITOL-1,4,5-TRISPHOSPHATE; LOCALIZATION; INITIATION	Type 2 and type 3 inositol 1,4,5-trisphosphate receptors (IP3 R2 and IP(3)R3) are intracellular calcium-release channels whose physiological roles are unknown. We show exocrine dysfunction in IP3 R2 and IP3 R3 double knock-out mice, which caused difficulties in nutrient digestion. Severely impaired calcium signaling in acinar cells of the salivary glands and the pancreas in the double mutants ascribed the secretion deficits to a tack of intracellular calcium release. Despite a normal caloric intake, the double mutants were hypoglycemic and lean. These results reveal IP3 R2 and IP3 R3 as key molecules in exocrine physiology underlying energy metabolism and animal growth.	Japan Sci & Technol Agcy, Calcium Oscillat, Int Cooperat Res Project, Tokyo 1080071, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Brain Dev Res Grp, Saitama 3510198, Japan; Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Tokyo 1088639, Japan; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1708455, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tokyo; Hokkaido University; Japanese Foundation for Cancer Research	Futatsugi, A (corresponding author), Japan Sci & Technol Agcy, Calcium Oscillat, Int Cooperat Res Project, Tokyo 1080071, Japan.	afutatsu@brain.riken.jp; mikosiba@ims.u-tokyo.ac.jp	Kitaguchi, Tetsuya/F-5260-2017; Takahashi-Iwanaga, Hiromi/A-4294-2012; Noda, Tetsuo/B-1667-2016; Yamada, Maki/U-5251-2019; Mikoshiba, Katsuhiko/N-7943-2015; Aruga, Jun/H-5837-2011; KITAGUCHI, TETSUYA/AAR-1895-2021; Yamada, Maki K./A-1573-2015	Kitaguchi, Tetsuya/0000-0001-6701-1933; Aruga, Jun/0000-0001-7936-1375; KITAGUCHI, TETSUYA/0000-0001-6701-1933; Yamada, Maki K./0000-0002-1956-6069				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; EPSTEIN AN, 1964, NATURE, V201, P1342, DOI 10.1038/2011342a0; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/BF00307790; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Petersen OH, 2003, CELL CALCIUM, V33, P337, DOI 10.1016/S0143-4160(03)00047-2; PETERSEN OH, 1986, AM J PHYSIOL, V251, pG1, DOI 10.1152/ajpgi.1986.251.1.G1; PUTNEY JW, 1986, ANNU REV PHYSIOL, V48, P75, DOI 10.1146/annurev.ph.48.030186.000451; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; Yamamoto-Hino M, 1998, J CELL BIOL, V141, P135, DOI 10.1083/jcb.141.1.135; Yule DI, 1997, J BIOL CHEM, V272, P9093	25	238	246	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2232	2234		10.1126/science.1114110	http://dx.doi.org/10.1126/science.1114110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195467				2022-12-01	WOS:000232318000049
J	Qi, JH; Asano, T; Jinno, M; Matsui, K; Atsumi, K; Sakagami, Y; Ojika, M				Qi, JH; Asano, T; Jinno, M; Matsui, K; Atsumi, K; Sakagami, Y; Ojika, M			Characterization of a Phytophthora mating hormone	SCIENCE			English	Article							SEXUAL REPRODUCTION		Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Ojika, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	ojika@agr.nagoya-u.ac.jp		Matsui, Kouhei/0000-0002-9315-3203				ASHBY S. F., 1929, Trains. Brit. Mycol. Soc., V14, P18; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Jee HJ, 2002, BOT BULL ACAD SINICA, V43, P203; KO WH, 1978, J GEN MICROBIOL, V107, P15, DOI 10.1099/00221287-107-1-15; Lane CR, 2003, PLANT PATHOL, V52, P414, DOI 10.1046/j.1365-3059.2003.00835.x; SAVAGE EJ, 1968, PHYTOPATHOLOGY, V58, P1004	6	48	51	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1828	1828		10.1126/science.1114756	http://dx.doi.org/10.1126/science.1114756			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166510				2022-12-01	WOS:000231989500040
J	Kadison, R				Kadison, R			Getting an edge - Use of stimulants and antidepressants in college	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Univ Hlth Serv, Cambridge, MA 02138 USA	Harvard University	Kadison, R (corresponding author), Harvard Univ, Univ Hlth Serv, Cambridge, MA 02138 USA.							*NAT COLL HLTH ASS, 2004, REF GROUP REP; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713	2	38	38	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1089	1091		10.1056/NEJMp058047	http://dx.doi.org/10.1056/NEJMp058047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162878				2022-12-01	WOS:000231841900002
J	Seth, RB; Sun, LJ; Ea, CK; Chen, ZJJ				Seth, RB; Sun, LJ; Ea, CK; Chen, ZJJ			Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3	CELL			English	Article							VIRAL-INFECTION; RNA HELICASE; VIRUS-INFECTION; IKK-EPSILON; RIG-I; PATHWAYS; APOPTOSIS; RESPONSES; MEMBRANE; BINDING	Viral infection triggers host innate immune responses through activation of the transcription factors NF-kappa B and IRF3, which coordinately regulate the expression of type-I interferons such as interferon-beta (IFN-beta). Herein, we report the identification of a novel protein termed MAVS (mitochondrial antiviral signaling), which mediates the activation of NF-kappa B and IRF3 in response to viral infection. Silencing of MAVS expression through RNA interference abolishes the activation of NF-kappa B and IRF3 by viruses, thereby permitting viral replication. Conversely, overexpression of MAVS induces the expression of IFN-beta through activation of NF-kappa B and IRF3, thus boosting antiviral immunity. Epistasis experiments show that MAVS is required for the phosphorylation of IRF3 and I kappa B and functions downstream of RIG-I, an intracellular receptor for viral RNA. MAVS contains an N-terminal CARD-like domain and a C-terminal transmembrane domain, both of which are essential for MAVS signaling. The transmembrane domain targets MAVS to the mitochondria, implicating a new role of mitochondria in innate immunity.	Univ Texas, SW Med Ctr, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA.	zhiiian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919] Funding Source: NIH RePORTER; NCRR NIH HHS [1-S10-RR19406] Funding Source: Medline; NIAID NIH HHS [R01-AI60919] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; van Oers NSC, 2005, SCIENCE, V308, P65, DOI 10.1126/science.1110902; Wang XD, 2001, GENE DEV, V15, P2922; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674	37	2345	2479	21	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					669	682		10.1016/j.cell.2005.08.012	http://dx.doi.org/10.1016/j.cell.2005.08.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16125763	Bronze			2022-12-01	WOS:000231844300008
J	Natowicz, M				Natowicz, M			Newborn screening - Setting evidence-based policy for protection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Natowicz, M (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Holtzman NA, 2003, JAMA-J AM MED ASSOC, V290, P2606, DOI 10.1001/jama.290.19.2606; KOLATA G, 2005, NY TIMES        1027, pA1; *MAT CHILD HLTH BU, 2005, NEWB SCREEN UN SCREE; Therrell BL, 2001, MOL GENET METAB, V74, P64, DOI 10.1006/mgme.2001.3238; Tonniges TF, 2000, PEDIATRICS, V106, P389	5	34	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					867	870		10.1056/NEJMp058060	http://dx.doi.org/10.1056/NEJMp058060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135829				2022-12-01	WOS:000231551100002
J	Fruhbeck, G				Fruhbeck, G			Does a NEAT difference in energy expenditure lead to obesity?	LANCET			English	Editorial Material							FAT		Univ Navarra, Univ Navarra Clin, Dept Endocrinol, Pamplona 31008, Spain; Univ Navarra, Univ Navarra Clin, Metab Res Lab, Pamplona 31008, Spain	University of Navarra; University of Navarra	Fruhbeck, G (corresponding author), Univ Navarra, Univ Navarra Clin, Dept Endocrinol, Pamplona 31008, Spain.	gfruhbeck@unav.es						Bjorntorp P, 2001, LANCET, V358, P1006, DOI 10.1016/S0140-6736(01)06110-4; Desapriya EBR, 2004, LANCET, V364, P1488, DOI 10.1016/S0140-6736(04)17270-X; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Kotz CM, 2002, REGUL PEPTIDES, V104, P27, DOI 10.1016/S0167-0115(01)00346-9; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 1999, J CLIN ENDOCR METAB, V84, P2751, DOI 10.1210/jc.84.8.2751; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; PRENTICE AM, 1999, REPORT BRIT NUTR FDN, P61; Wang C, 2005, CELL METAB, V1, P1, DOI 10.1016/j.cmet.2004.11.002	10	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2005	366	9486					615	616		10.1016/S0140-6736(05)	http://dx.doi.org/10.1016/S0140-6736(05)			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958EB	16112286				2022-12-01	WOS:000231426400008
J	Sarin, KY; Cheung, P; Gilison, D; Lee, E; Tennen, RI; Wang, E; Artandi, MK; Oro, AE; Artandi, SE				Sarin, KY; Cheung, P; Gilison, D; Lee, E; Tennen, RI; Wang, E; Artandi, MK; Oro, AE; Artandi, SE			Conditional telomerase induction causes proliferation of hair follicle stem cells	NATURE			English	Article							LABEL-RETAINING CELLS; SELF-RENEWAL; BONE-MARROW; MICE; SKIN; CYCLE; EXPRESSION; KERATINOCYTES; EPIDERMIS; CANCER	TERT, the protein component of telomerase(1,2), serves to maintain telomere function through the de novo addition of telomere repeats to chromosome ends, and is reactivated in 90% of human cancers. In normal tissues, TERT is expressed in stem cells and in progenitor cells(3), but its role in these compartments is not fully understood. Here we show that conditional transgenic induction of TERT in mouse skin epithelium causes a rapid transition from telogen ( the resting phase of the hair follicle cycle) to anagen ( the active phase), thereby facilitating robust hair growth. TERT overexpression promotes this developmental transition by causing proliferation of quiescent, multipotent stem cells in the hair follicle bulge region. This new function for TERT does not require the telomerase RNA component, which encodes the template for telomere addition, and therefore operates through a mechanism independent of its activity in synthesizing telomere repeats. These data indicate that, in addition to its established role in extending telomeres, TERT can promote proliferation of resting stem cells through a non-canonical pathway.	Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA.	sartandi@stanford.edu		Sarin, Kavita/0000-0001-5363-3053; Oro, Anthony/0000-0002-6261-138X; Artandi, Maja/0000-0003-2342-6277	NCI NIH HHS [K08 CA082176, R55 CA109088] Funding Source: Medline; NIGMS NIH HHS [T32 GM007365] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA082176, R55CA109088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blasco MA, 2003, TRENDS CELL BIOL, V13, P289, DOI 10.1016/S0962-8924(03)00085-0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ramirez RD, 1997, J INVEST DERMATOL, V108, P113, DOI 10.1111/1523-1747.ep12285654; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Sawamura D, 1999, J INVEST DERMATOL, V112, P828, DOI 10.1046/j.1523-1747.1999.00583.x; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262	30	329	356	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					1048	1052		10.1038/nature03836	http://dx.doi.org/10.1038/nature03836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107853	Green Accepted			2022-12-01	WOS:000231263900057
J	Schroter, D; Cramer, W; Leemans, R; Prentice, IC; Araujo, MB; Arnell, NW; Bondeau, A; Bugmann, H; Carter, TR; Gracia, CA; de la Vega-Leinert, AC; Erhard, M; Ewert, F; Glendining, M; House, JI; Kankaanpaa, S; Klein, RJT; Lavorel, S; Lindner, M; Metzger, MJ; Meyer, J; Mitchell, TD; Reginster, I; Rounsevell, M; Sabate, S; Sitch, S; Smith, B; Smith, J; Smith, P; Sykes, MT; Thonicke, K; Thuiller, W; Tuck, G; Zaehle, S; Zierl, B				Schroter, D; Cramer, W; Leemans, R; Prentice, IC; Araujo, MB; Arnell, NW; Bondeau, A; Bugmann, H; Carter, TR; Gracia, CA; de la Vega-Leinert, AC; Erhard, M; Ewert, F; Glendining, M; House, JI; Kankaanpaa, S; Klein, RJT; Lavorel, S; Lindner, M; Metzger, MJ; Meyer, J; Mitchell, TD; Reginster, I; Rounsevell, M; Sabate, S; Sitch, S; Smith, B; Smith, J; Smith, P; Sykes, MT; Thonicke, K; Thuiller, W; Tuck, G; Zaehle, S; Zierl, B			Ecosystem service supply and vulnerability to global change in Europe	SCIENCE			English	Article							FUTURE SCENARIOS; CLIMATE-CHANGE; CARBON; BIODIVERSITY	Global change will alter the supply of ecosystem services that are vital for human well-being. To investigate ecosystem service supply during the 21st century, we used a range of ecosystem models and scenarios of climate and land-use change to conduct a Europe-wide assessment. Large changes in climate and land use typically resulted in large changes in ecosystem service supply. Some of these trends may be positive (for example, increases in forest area and productivity) or offer opportunities (for example, "surplus land" for agricultural extensification and bioenergy production). However, many changes increase vulnerability as a result of a decreasing supply of ecosystem services (for example, declining soil fertility, declining water availability, increasing risk of forest fires), especially in the Mediterranean and mountain regions.	Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; Univ Wageningen & Res Ctr, Dept Environm Sci, NL-6700 AA Wageningen, Netherlands; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; Univ Southampton, Sch Geog, Tyndall Ctr Climate Change Res, Southampton SO17 1BJ, Hants, England; ETH, Dept Environm Sci, CH-8092 Zurich, Switzerland; Finnish Environm Inst, Helsinki 00251, Finland; Univ Barcelona, Ctr Ecol Res & Forestry Applicat, Barcelona 08193, Spain; Forschungszentrum Karlsruhe, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; Rothamsted Res, Agr & Environm Div, Harpenden AL5 2JQ, Herts, England; Univ Grenoble 1, CNRS, Lab Ecol Alpine, F-38041 Grenoble, France; CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; European Forest Inst, Joensuu 80100, Finland; Univ E Anglia, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Catholic Univ Louvain, Dept Geog, B-1348 Louvain, Belgium; Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden; Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; S African Natl Biodivers Inst, Kirstenbosch Res Ctr, ZA-7735 Cape Town, South Africa	Potsdam Institut fur Klimafolgenforschung; Harvard University; Wageningen University & Research; University of Bristol; University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Southampton; Swiss Federal Institutes of Technology Domain; ETH Zurich; Finnish Environment Institute; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Helmholtz Association; Karlsruhe Institute of Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of East Anglia; Universite Catholique Louvain; Lund University; University of Aberdeen; South African National Biodiversity Institute	Schroter, D (corresponding author), Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany.	dagmar.schroeter@gmail.com	Arnell, Nigel/AAC-7331-2020; Cramer, Wolfgang/B-8221-2008; Sabaté, Santiago/I-3395-2016; Metzger, Marc J./B-2510-2010; Klein, Richard J.T./B-1148-2009; Carter, Timothy R/N-4411-2017; Glendining, Margaret/I-1942-2019; Rounsevell, Mark D A/C-5481-2011; Sitch, Stephen A/F-8034-2015; Bondeau, Alberte/E-9909-2012; Thuiller, Wilfried/G-3283-2010; Rounsevell, Mark D A/AAC-4498-2021; Smith, Jo U/F-7763-2012; Zaehle, Sönke/C-9528-2017; House, Joanna I/B-6477-2016; Smith, Pete/G-1041-2010; Leemans, Rik/A-1548-2009; Araújo, Miguel B/B-6117-2008; Bugmann, Harald/A-1252-2008; Smith, Benjamin/I-1212-2016; Metzger, Marc/S-3976-2019	Cramer, Wolfgang/0000-0002-9205-5812; Sabaté, Santiago/0000-0003-1854-0761; Metzger, Marc J./0000-0002-5119-5894; Klein, Richard J.T./0000-0002-9458-0944; Carter, Timothy R/0000-0002-4026-8859; Sitch, Stephen A/0000-0003-1821-8561; Bondeau, Alberte/0000-0002-8729-5061; Thuiller, Wilfried/0000-0002-5388-5274; Rounsevell, Mark D A/0000-0001-7476-9398; Smith, Jo U/0000-0001-6984-6766; Zaehle, Sönke/0000-0001-5602-7956; House, Joanna I/0000-0003-4576-3960; Smith, Pete/0000-0002-3784-1124; Leemans, Rik/0000-0002-4001-6301; Araújo, Miguel B/0000-0002-5107-7265; Smith, Benjamin/0000-0002-6987-5337; Metzger, Marc/0000-0002-5119-5894; Bugmann, Harald/0000-0003-4233-0094; Mitchell, Tim/0000-0003-4071-1977; Lindner, Marcus/0000-0002-0770-003X; de la Vega-Leinert, Anne Cristina/0000-0003-0290-249X				Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Elsasser H, 2001, MT RES DEV, V21, P335, DOI 10.1659/0276-4741(2001)021[0335:TVOTSI]2.0.CO;2; Ewert F, 2005, AGR ECOSYST ENVIRON, V107, P101, DOI [10.1016/j.agee.2004.12.003, 10.1016/j.agee.2004.12.002]; FALKENMARK M, 1989, NAT RESOUR FORUM, V13, P258, DOI 10.1111/j.1477-8947.1989.tb00348.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gottfried Michael, 1999, Diversity and Distributions, V5, P241, DOI 10.1046/j.1472-4642.1999.00058.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mea, 2003, ECOSYSTEMS HUMAN WEL; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Nakieenovie N., 2000, INTERGOVERNMENTAL PA; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Reid WV, 2005, MILLENNIUM ECOSYSTEM; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schulze ED, 2005, NATURE, V437, P205, DOI 10.1038/437205a; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; *UN ENV PROGR, 2002, 3 UNEP EARTHSC; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; *WORLD TOUR ORG, 2003, 1 INT C CLIM CHANG T; Zierl B, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003447	23	1129	1216	29	1055	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1333	1337		10.1126/science.1115233	http://dx.doi.org/10.1126/science.1115233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16254151				2022-12-01	WOS:000233600200043
J	Mueller, CA; Broz, P; Muller, SA; Ringler, P; Erne-Brand, F; Sorg, I; Kuhn, M; Engel, A; Cornelis, GR				Mueller, CA; Broz, P; Muller, SA; Ringler, P; Erne-Brand, F; Sorg, I; Kuhn, M; Engel, A; Cornelis, GR			The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles	SCIENCE			English	Article							PROTEIN SECRETION; VIRULENCE; ENTEROCOLITICA; TRANSLOCON; SYSTEM	Many pathogenic bacteria use injectisomes to deliver effector proteins into host cells through type III secretion. Injectisomes consist of a basal body embedded in the bacterial membranes and a needle. In Yersinia, translocation of effectors requires the YopB and YopD proteins, which form a pore in the target cell membrane, and the LcrV protein, which assists the assembly of the pore. Here we report that LcrV forms a distinct structure at the tip of the needle, the tip complex. This unique localization of LcrV may explain its crucial role in the translocation process and its efficacy as the main protective antigen against plague.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Maurice E Muller Inst, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	guy.cornelis@unibas.ch	Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790				BURROWS TW, 1956, NATURE, V177, P426, DOI 10.1038/177426b0; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; LAWTON WD, 1963, J INFECT DIS, V113, P39, DOI 10.1093/infdis/113.1.39; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; MUELLER CA, UNPUB; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Philipovskiy AV, 2005, INFECT IMMUN, V73, P1532, DOI 10.1128/IAI.73.3.1532-1542.2005; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005	17	267	278	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					674	676		10.1126/science.1118476	http://dx.doi.org/10.1126/science.1118476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254184				2022-12-01	WOS:000232997700041
J	Gibbs, R				Gibbs, R			Deeper into the genome	NATURE			English	Editorial Material									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Gibbs, R (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.							Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6	8	22	22	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1233	1234		10.1038/4371233a	http://dx.doi.org/10.1038/4371233a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251930	Bronze			2022-12-01	WOS:000232829100020
J	Hobson, JA				Hobson, JA			Sleep is of the brain, by the brain and for the brain	NATURE			English	Editorial Material								Sleep is a widespread biological phenomenon, and its scientific study is proceeding at multiple levels at the same time. Marked progress is being made in answering three fundamental questions: what is sleep, what are its mechanisms and what are its functions? The most salient answers to these questions have resulted from applying new techniques from basic and applied neuroscience research. The study of sleep is also shedding light on our understanding of consciousness, which undergoes alteration in parallel with sleep-induced changes in the brain.	Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hobson, JA (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 74 Fenwood Rd,401 Pk Dr,2nd Floor E, Boston, MA 02115 USA.	allan_hobson@hms.harvard.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; ALLISON T, 1976, SCIENCE, V194, P732, DOI 10.1126/science.982039; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; DEMENT W, 1958, J EXP PSYCHOL, V55, P543, DOI 10.1037/h0040031; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; Fosse R, 2001, PSYCHOL SCI, V12, P30, DOI 10.1111/1467-9280.00306; Freud S, 1949, OUTLINE PSYCHOANALYS; Hobson J. A., 1986, HDB PHYSL 1, P701; Hobson J. Allan, 2002, DREAMING VERY SHORT; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; KETY SS, 1955, T AM NEUROL ASSOC, V80, P125; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Metzinger T, 2003, BEING NO ONE; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; PAVLOV I, 1960, CONDITIONED REFLEXES; SHERRINGTON C, 1995, MAN HIS NATURE; Steriade M., 1999, Society for Neuroscience Abstracts, V25, P1661	19	168	174	4	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1254	1256		10.1038/nature04283	http://dx.doi.org/10.1038/nature04283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251949				2022-12-01	WOS:000232829100037
J	Rauh, NR; Schmidt, A; Bormann, J; Nigg, EA; Mayer, TU				Rauh, NR; Schmidt, A; Bormann, J; Nigg, EA; Mayer, TU			Calcium triggers exit from meiosis II by targeting the APC/C inhibitor XErp1 for degradation	NATURE			English	Article							CYTOSTATIC FACTOR ARREST; XENOPUS EGG EXTRACTS; PROTEIN KINASE-II; METAPHASE; DESTRUCTION; UBIQUITIN; ANAPHASE; COMPLEX; FERTILIZATION; BINDING	Vertebrate eggs awaiting fertilization are arrested at metaphase of meiosis II by a biochemical activity termed cytostatic factor (CSF)(1,2). This activity inhibits the anaphase-promoting complex/ cyclosome (APC/C), a ubiquitin ligase that triggers anaphase onset and mitotic/meiotic exit by targeting securin and M-phase cyclins for destruction(3,4,5). On fertilization a transient rise in free intracellular calcium(6) causes release from CSF arrest and thus APC/C activation. Although it has previously been shown that calcium induces the release of APC/C from CSF inhibition through calmodulin-dependent protein kinase II ( CaMKII)(7,8), the relevant substrates of this kinase have not been identified. Recently, we characterized XErp1 (Emi2), an inhibitor of the APC/C and key component of CSF activity in Xenopus egg extract(9). Here we show that calcium-activated CaMKII triggers exit from meiosis II by sensitizing the APC/C inhibitor XErp1 for polo-like kinase 1 (Plx1)-dependent degradation. Phosphorylation of XErp1 by CaMKII leads to the recruitment of Plx1 that in turn triggers the destruction of XErp1 by phosphorylating a site known to serve as a phosphorylation-dependent degradation signal. These results provide a molecular explanation for how the fertilization-induced calcium increase triggers exit from meiosis II.	Max Planck Inst Biochem, Independent Res Grp, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Mayer, TU (corresponding author), Max Planck Inst Biochem, Independent Res Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	mayer@biochem.mpg.de		Mayer, Thomas/0000-0001-6954-2287; nigg, erich/0000-0003-4835-5719				BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; Desai A, 1999, METHOD CELL BIOL, V61, P385; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; HOLLOWAY SL, 1993, CELL, V73, P13393; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LORCA T, 1991, EMBO J, V10, P2087, DOI 10.1002/j.1460-2075.1991.tb07741.x; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Zachariae W, 2005, DEV CELL, V8, P301, DOI 10.1016/j.devcel.2005.02.004	22	175	184	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1048	1052		10.1038/nature04093	http://dx.doi.org/10.1038/nature04093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16127448	Green Submitted			2022-12-01	WOS:000232496100050
J	Nutt, LK; Margolis, SS; Jensen, M; Herman, CE; Dunphy, WG; Rathmell, JC; Kornbluth, S				Nutt, LK; Margolis, SS; Jensen, M; Herman, CE; Dunphy, WG; Rathmell, JC; Kornbluth, S			Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2	CELL			English	Article							CYTOCHROME-C RELEASE; XENOPUS EGG EXTRACTS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; INDUCED APOPTOSIS; ACTIVATION; BCL-2; GROWTH; EXPRESSION; SURVIVAL; KINASE	Vertebrate female reproduction is limited by the oocyte stockpiles acquired during embryonic development. These are gradually depleted over the organism's lifetime through the process of apoptosis. The timer that triggers this cell death is yet to be identified. We used the Xenopus egg/oocyte system to examine the hypothesis that nutrient stores can regulate oocyte viability. We show that pentose-phosphate-pathway generation of NADPH is critical for oocyte survival and that the target of this regulation is caspase-2, previously shown to be required for oocyte death in mice. Pentose-phosphate-pathway-mediated inhibition of cell death was due to the inhibitory phosphorylation of caspase-2 by calcium/calmodulin-dependent protein kinase II (CaMKII). These data suggest that exhaustion of oocyte nutrients, resulting in an inability to generate NADPH, may contribute to ooctye apoptosis. These data also provide unexpected links between oocyte metabolism, CaMKII, and caspase-2.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Sarah Stedman Ctr Nutr & Metab, Durham, NC 27710 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA	Duke University; Duke University; Duke University; California Institute of Technology	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu			NCI NIH HHS [R01 CA102707, R01 CA 102727, R01 CA102707-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM080333-02, R01 GM080333, F32 GM072242-02, R01 GM 56518, R01 GM056518] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080333, R01GM056518, F32GM072242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bhuyan AK, 2001, CELL DEATH DIFFER, V8, P63, DOI 10.1038/sj.cdd.4400773; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Braun T, 2003, MOL CANCER RES, V1, P186; COHEN AI, 1954, PHYSIOL ZOOL, V27, P128, DOI 10.1086/physzool.27.2.30154521; Comin-Anduix B, 2002, J BIOL CHEM, V277, P46408, DOI 10.1074/jbc.M206150200; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Demirci B, 2003, THERIOGENOLOGY, V60, P999, DOI 10.1016/S0093-691X(03)00121-3; Demirci B, 2002, FERTIL STERIL, V77, P595, DOI 10.1016/S0015-0282(01)03205-8; Demirci B, 2001, FERTIL STERIL, V75, P754, DOI 10.1016/S0015-0282(00)01787-8; DESCHEPPER GG, 1987, HISTOCHEM J, V19, P467, DOI 10.1007/BF01675415; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; DWORKIN MB, 1989, DEV BIOL, V132, P524, DOI 10.1016/0012-1606(89)90247-9; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hutchins JRA, 2003, MOL BIOL CELL, V14, P4003, DOI 10.1091/mbc.E03-02-0061; JAEGER L, 1945, J CELL COMPAR PHYSL, V25, P97, DOI 10.1002/jcp.1030250204; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOVACEVIC Z, 1972, CANCER RES, V32, P326; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MALLER JL, 1985, CELL DIFFER DEV, V16, P211, DOI 10.1016/0045-6039(85)90570-6; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tuttle S, 2000, RADIAT RES, V153, P781, DOI 10.1667/0033-7587(2000)153[0781:GPDATO]2.0.CO;2; Ureta T, 2000, FEBS LETT, V475, P145, DOI 10.1016/S0014-5793(00)01646-X; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Voronina E, 2001, MOL REPROD DEV, V60, P553, DOI 10.1002/mrd.1120; Watanabe M, 1997, EXP CELL RES, V230, P76, DOI 10.1006/excr.1996.3366	52	190	194	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					89	103		10.1016/j.cell.2005.07.032	http://dx.doi.org/10.1016/j.cell.2005.07.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213215	Bronze, Green Accepted			2022-12-01	WOS:000232536800011
J	Carmona, RH				Carmona, RH			The global challenges of birth defects and disabilities	LANCET			English	Editorial Material							NEURAL-TUBE DEFECTS; FOLIC-ACID; PREVENTION				Carmona, RH (corresponding author), Parklawn Bldg 18-67, Rockville, MD 20857 USA.	jessica.badger@hhs.gov						[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 2005, BEH RISK FACT SURV S; Bale JR, 2003, REDUCING BIRTH DEFEC; Bale JR, 2003, IMPROVING BIRTH OUTC; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82; Centers for Disease Control and Prevention, 2005, MMWR MORB MORTAL WKL, V54, P279; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Office of the Surgeon General (US) Office on Disability (US), 2005, SURG GEN CALL ACTION; *US DEP HHS, 2005, US SURG GEN ANN NEW; Wald NJ, 2004, NEW ENGL J MED, V350, P101, DOI 10.1056/NEJMp038186	14	32	43	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2005	366	9492					1142	1144		10.1016/S0140-6736(05)67459-4	http://dx.doi.org/10.1016/S0140-6736(05)67459-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970LK	16198750				2022-12-01	WOS:000232311300006
J	Yoshida, H; Kawane, K; Koike, M; Mori, Y; Uchiyama, Y; Nagata, S				Yoshida, H; Kawane, K; Koike, M; Mori, Y; Uchiyama, Y; Nagata, S			Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells	NATURE			English	Article							APOPTOTIC CELLS; ERYTHROPOIETIN RECEPTOR; PLASMA-MEMBRANE; MICE; DIFFERENTIATION; IDENTIFICATION; PHAGOCYTOSIS; DEFICIENT; INVITRO; BINDING	Definitive erythropoiesis usually occurs in the bone marrow or fetal liver, where erythroblasts are associated with a central macrophage in anatomical units called 'blood islands'(1,2). Late in erythropoiesis, nuclei are expelled from the erythroid precursor cells and engulfed by the macrophages in the blood island(2,3). Here we show that the nuclei are engulfed by macrophages only after they are disconnected from reticulocytes, and that phosphatidylserine, which is often used as an 'eat me' signal for apoptotic cells, is also used for the engulfment of nuclei expelled from erythroblasts. We investigated the mechanism behind the enucleation and engulfment processes by isolating late-stage erythroblasts from the spleens of phlebotomized mice. When these erythroblasts were cultured, the nuclei protruded spontaneously from the erythroblasts. A weak physical force could disconnect the nuclei from the reticulocytes. The released nuclei contained an undetectable level of ATP, and quickly exposed phosphatidylserine on their surface. Fetal liver macrophages efficiently engulfed the nuclei; masking the phosphatidylserine on the nuclei with the dominant-negative form of milk-fat-globule EGF8 (MFG-E8) prevented this engulfment.	Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrated Biol Labs, Genet Lab, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Sakura Mot Picture Co Ltd, Shibuya Ku, Tokyo 1510051, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	Nagata@genetic.med.osaka-u.ac.jp	Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483				Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BESSIS M, 1978, BLOOD CELLS, V4, P155; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; GEIDUSCHEK JB, 1979, CELL, V16, P149, DOI 10.1016/0092-8674(79)90196-X; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Hanspal M, 1997, Curr Opin Hematol, V4, P142; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawasaki Y, 2002, J BIOL CHEM, V277, P27559, DOI 10.1074/jbc.M202879200; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; PANNACCIULLI IM, 1977, ACTA HAEMATOL-BASEL, V58, P27, DOI 10.1159/000207802; REPASKY EA, 1981, CELL TISSUE RES, V221, P85, DOI 10.1007/BF00216572; Sadahira Y, 1999, PATHOL INT, V49, P841, DOI 10.1046/j.1440-1827.1999.00954.x; SCHLEGEL RA, 1980, CELL, V20, P321, DOI 10.1016/0092-8674(80)90618-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Williamson Patrick, 2004, J Biol, V3, P14, DOI 10.1186/jbiol14; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	30	243	253	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					754	758		10.1038/nature03964	http://dx.doi.org/10.1038/nature03964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193055				2022-12-01	WOS:000232157900057
J	Weis, SM; Cheresh, DA				Weis, SM; Cheresh, DA			Pathophysiological consequences of VEGF-induced vascular permeability	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; CADHERIN TYROSINE PHOSPHORYLATION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED ANGIOGENESIS; FACTOR EXPRESSION; DIABETIC-RETINOPATHY; TUMOR VASCULATURE; REDUCING EDEMA; BETA-CATENIN	Although vascular endothelial growth factor ( VEGF) induces angiogenesis, it also disrupts vascular barrier function in diseased tissues. Accordingly, VEGF expression in cancer and ischaemic disease has unexpected pathophysiological consequences. By uncoupling endothelial cell - cell junctions VEGF causes vascular permeability and oedema, resulting in extensive injury to ischaemic tissues after stroke or myocardial infarction. In cancer, VEGF- mediated disruption of the vascular barrier may potentiate tumour cell extravasation, leading to widespread metastatic disease. Therefore, by blocking the vascular permeability promoting effects of VEGF it may be feasible to reduce tissue injury after ischaemic disease and minimize the invasive properties of circulating tumour cells.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu						Akiyama C, 2003, ACTA NEUROCHIR SUPPL, V86, P421; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Baish JW, 1997, MICROVASC RES, V53, P128, DOI 10.1006/mvre.1996.2005; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bates DO, 1999, MICROCIRCULATION, V6, P83, DOI 10.1038/sj.mn.7300054; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BROWN LF, 1989, AM REV RESPIR DIS, V140, P1104, DOI 10.1164/ajrccm/140.4.1104; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Cao ZX, 2004, CLIN CANCER RES, V10, P5253, DOI 10.1158/1078-0432.CCR-03-0588; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chang YS, 2000, MICROVASC RES, V59, P265, DOI 10.1006/mvre.1999.2225; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cohen AW, 1999, AM J PHYSIOL-HEART C, V277, pH2038, DOI 10.1152/ajpheart.1999.277.5.H2038; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fedor-Chaiken M, 2003, CELL COMMUN ADHES, V10, P105, DOI 10.1080/714040416; Feng D, 1999, MICROCIRCULATION, V6, P23, DOI 10.1080/713773925; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Fukuda S, 2004, J MOL CELL CARDIOL, V36, P547, DOI 10.1016/j.yjmcc.2004.02.002; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hormbrey E, 2002, CLIN EXP METASTAS, V19, P651, DOI 10.1023/A:1021379811308; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kawamoto A, 2004, CIRCULATION, V110, P1398, DOI 10.1161/01.CIR.0000141563.71410.64; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1940, DOI 10.1152/ajpcell.2001.281.6.C1940; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kuroi K, 2001, INT J BIOL MARKER, V16, P5, DOI 10.1177/172460080101600102; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Langille BL, 2001, MICROCIRCULATION, V8, P195, DOI 10.1080/713774031; Lee RJ, 2000, CIRCULATION, V102, P898; Li J, 1996, AM J PHYSIOL-HEART C, V270, pH1803, DOI 10.1152/ajpheart.1996.270.5.H1803; Liao F, 2002, CANCER RES, V62, P2567; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; McDonald DM, 1999, MICROCIRCULATION, V6, P7; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Monsky WL, 1999, CANCER RES, V59, P4129; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Ozawa M, 2001, J CELL SCI, V114, P503; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Salgado Roberto, 2001, Angiogenesis, V4, P37, DOI 10.1023/A:1016611230747; Sasaki H, 2002, J MOL CELL CARDIOL, V34, P335, DOI 10.1006/jmcc.2001.1516; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shyu KG, 2002, CARDIOVASC RES, V54, P576, DOI 10.1016/S0008-6363(02)00259-6; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Suarez S, 2001, J CELL SCI, V114, P1229; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takahashi N, 1999, CIRC RES, V84, P1194, DOI 10.1161/01.RES.84.10.1194; Tang FY, 2003, INT J CANCER, V106, P871, DOI 10.1002/ijc.11325; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vaquero Javier, 2003, Ann Hepatol, V2, P12; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wu HM, 1999, AM J PHYSIOL-HEART C, V276, pH535, DOI 10.1152/ajpheart.1999.276.2.H535; Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405; Xie KP, 2004, CYTOKINE GROWTH F R, V15, P297, DOI 10.1016/j.cytogfr.2004.04.003; Xu YR, 1999, J CELL BIOCHEM, V75, P264; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Yue XP, 1999, DEV DYNAM, V216, P28, DOI 10.1002/(SICI)1097-0177(199909)216:1<28::AID-DVDY5>3.3.CO;2-L; Zhu BQ, 2003, CANCER CELL, V4, P191, DOI 10.1016/S1535-6108(03)00219-8	100	648	675	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					497	504		10.1038/nature03987	http://dx.doi.org/10.1038/nature03987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177780				2022-12-01	WOS:000232004800039
J	Osborne, LC; Lisberger, SG; Bialek, W				Osborne, LC; Lisberger, SG; Bialek, W			A sensory source for motor variation	NATURE			English	Article							PERCEPTUAL DECISIONS; EYE-MOVEMENT; DIRECTION; AREA; INFORMATION; NEURONS	Suppose that the variability in our movements(1-9) is caused not by noise in the motor system itself, nor by fluctuations in our intentions or plans, but rather by errors in our sensory estimates of the external parameters that define the appropriate action. For tasks in which precision is at a premium, performance would be optimal if no noise were added in movement planning and execution: motor output would be as accurate as possible given the quality of sensory inputs. Here we use visually guided smooth-pursuit eye movements in primates(10) as a testing ground for this notion of optimality. In response to repeated presentations of identical target motions, nearly 92% of the variance in eye trajectory can be accounted for as a consequence of errors in sensory estimates of the speed, direction and timing of target motion, plus a small background noise that is observed both during eye movements and during fixations. The magnitudes of the inferred sensory errors agree with the observed thresholds for sensory discrimination by perceptual systems, suggesting that the very different neural processes of perception and action are limited by the same sources of noise.	Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Princeton University; Princeton University	Osborne, LC (corresponding author), Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Box 0444, San Francisco, CA 94143 USA.	osborne@phy.ucsf.edu		Osborne, Leslie/0000-0002-6080-5279	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY003878-25, R01 EY003878] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; Donchin O, 2003, J NEUROSCI, V23, P9032; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FUCHS AF, 1970, J NEUROPHYSIOL, V33, P382, DOI 10.1152/jn.1970.33.3.382; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Green DG., 1966, SIGNAL DETECTION THE, DOI 10.1901/jeab.1969.12-475; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Roitman JD, 2002, J NEUROSCI, V22, P9475; Ross J, 2001, TRENDS NEUROSCI, V24, P317, DOI 10.1016/S0166-2236(00)01827-0; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Santello M, 1998, J NEUROSCI, V18, P10105; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X	29	194	194	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					412	416		10.1038/nature03961	http://dx.doi.org/10.1038/nature03961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163357	Green Accepted			2022-12-01	WOS:000231849100054
J	Latimer, AM; Silander, JA; Cowling, RM				Latimer, AM; Silander, JA; Cowling, RM			Neutral ecological theory reveals isolation and rapid speciation in a biodiversity hot spot	SCIENCE			English	Article							CAPE FLORISTIC REGION; PLANT DIVERSITY; SOUTH-AFRICA; FLORA; FOREST; PROTEACEAE; DISPERSAL; ABUNDANCE; ENDEMISM; CLIMATE	South Africa's Mediterranean-climate fynbos shrubland is a hot spot of species diversity, but its diversity patterns contrast strongly with other high-diversity areas, including the Amazon rain forest. With its extremely high levels of endemism and species turnover, fynbos is made up of dissimilar local communities that are species-rich but relatively poor in rare species. Using neutral ecological theory, we show that the relative species-abundance distributions in fynbos can be explained by migration rates that are two orders of magnitude lower than they are in tropical rain forests. Speciation rates, which are indexed by the "biodiversity parameter" Theta, are estimated to be higher than they are in any previously examined plant system.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Nelson Mandela Metropolitan Univ, Dept Bot, Terr Ecol Res Unit, ZA-6031 Port Elizabeth, South Africa	University of Connecticut; Nelson Mandela University	Latimer, AM (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, 75 N Eagleville Rd, Storrs, CT 06269 USA.	latimer@uconn.edu	Cowling, Richard/AFU-6261-2022	Latimer, Andrew/0000-0001-8098-0448				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; [Anonymous], 1992, ECOLOGY FYNBOS; [Anonymous], 2000, STRELITZIA; BOUCHER C, 1978, Bothalia, V12, P455; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cowling RM, 1998, AUST J BOT, V46, P335, DOI 10.1071/BT97040; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1992, BIOL J LINN SOC, V47, P367, DOI 10.1111/j.1095-8312.1992.tb00675.x; COWLING RM, 2005, PLANT DIVERSITY COMP, V55, P273; Hardy OJ, 2004, FOREST ECOL MANAG, V197, P191, DOI 10.1016/j.foreco.2004.05.014; Hubbell Stephen P., 2001, V32, pi; Linder HP, 2004, PHILOS T R SOC B, V359, P1623, DOI 10.1098/rstb.2004.1534; MCDONALD DJ, 1995, PLANT SYST EVOL, V195, P137, DOI 10.1007/BF00989290; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Taylor H.C, 1996, CEDERBERG VEGETATION; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; VANWYK BE, 1988, BOTHALIA, V18, P211, DOI 10.4102/abc.v18i2.1048; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; WERGER M J A, 1974, Bothalia, V11, P309; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	27	103	106	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1722	1725		10.1126/science.1115576	http://dx.doi.org/10.1126/science.1115576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151011				2022-12-01	WOS:000231836700044
J	VandeBerg, JL; Zola, SM; Fritz, J; Lee, DR; Rowell, TJ; Satterfield, WC				VandeBerg, JL; Zola, SM; Fritz, J; Lee, DR; Rowell, TJ; Satterfield, WC			A unique biomedical resource at risk	NATURE			English	Editorial Material							MONOCLONAL-ANTIBODIES		SW Natl Primate Res Ctr, San Antonio, TX 78245 USA; Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; Primate Fdn Arizona, Mesa, AZ USA; Alamogordo Primate Facil, Alamogordo, NM USA; Univ Louisiana, Lafayette, LA USA; MD Anderson Canc Ctr, Bastrop, TX USA	Texas Biomedical Research Institute; University of Louisiana Lafayette; University of Texas System; UTMD Anderson Cancer Center	VandeBerg, JL (corresponding author), SW Natl Primate Res Ctr, San Antonio, TX 78245 USA.							Berger M, 2002, AM J MED SCI, V324, P14, DOI 10.1097/00000441-200207000-00004; Brent L, 2004, LAB ANIMAL, V33, P37, DOI 10.1038/laban0104-37; Desgranges C, 2004, PATHOL BIOL, V52, P351, DOI 10.1016/j.patbio.2003.09.017; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Murthy KK, 1998, AIDS RES HUM RETROV, V14, pS271; National Research Council, 1997, CHIMP RES STRAT THEI; Smith KA, 2004, J CLIN PATHOL, V57, P912, DOI 10.1136/jcp.2003.014407; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Wong H, 2004, DRUG METAB DISPOS, V32, P1359, DOI 10.1124/dmd.104.000943	10	30	30	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					30	32		10.1038/437030a	http://dx.doi.org/10.1038/437030a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136112				2022-12-01	WOS:000231560400024
J	Louie, T				Louie, T			Occupational hazards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Louie, T (corresponding author), Univ Med & Dent New Jersey, New Brunswick, NJ 08903 USA.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2005	353	8					757	759		10.1056/NEJMp058012	http://dx.doi.org/10.1056/NEJMp058012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957YK	16120855				2022-12-01	WOS:000231409300004
J	Vaillancourt, FH; Yeh, E; Vosburg, DA; O'Connor, SE; Walsh, CT				Vaillancourt, FH; Yeh, E; Vosburg, DA; O'Connor, SE; Walsh, CT			Cryptic chlorination by a non-haem iron enzyme during cyclopropyl amino acid biosynthesis	NATURE			English	Article							2-HIS-1-CARBOXYLATE FACIAL TRIAD; GENE-CLUSTER; PHYTOTOXIN CORONATINE; ACTIVATION; OXYGENASES; DIOXYGENASE; COMPLEX	Enzymatic incorporation of chlorine, bromine or iodine atoms occurs during the biosynthesis of more than 4,000 natural products(1). Halogenation can have significant consequences for the bioactivity of these products so there is great interest in understanding the biological catalysts that perform these reactions. Enzymes that halogenate unactivated aliphatic groups have not previously been characterized. Here we report the activity of five proteins - CmaA, CmaB, CmaC, CmaD and CmaE - in the construction of coronamic acid (CMA; 1-amino-1-carboxy-2-ethylcyclopropane), a constituent of the phytotoxin coronatine synthesized by the phytopathogenic bacterium Pseudomonas syringae(2). CMA derives from L-allo-isoleucine, which is covalently attached to CmaD through the actions of CmaA, a non-ribosomal peptide synthetase module, and CmaE, an unusual acyltransferase. We show that CmaB, a member of the non-haem Fe2+, alpha-ketoglutarate-dependent enzyme superfamily, is the first of its class to show halogenase activity, chlorinating the gamma-position of L-allo-isoleucine. Another previously undescribed enzyme, CmaC, catalyses the formation of the cyclopropyl ring from the gamma-Cl-L-allo-isoleucine product of the CmaB reaction. Together, CmaB and CmaC execute gamma-halogenation followed by intramolecular gamma-elimination, in which biological chlorination is a cryptic strategy for cyclopropyl ring formation.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvey Mudd Coll, Dept Chem, Claremont, CA 91711 USA	Harvard University; Harvard Medical School; Claremont Colleges; Harvey Mudd College	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu	Vosburg, David/P-3944-2019	Vosburg, David/0000-0003-3424-5471; Yeh, Ellen/0000-0003-3974-3816				Armstrong RN, 2000, BIOCHEMISTRY-US, V39, P13625, DOI 10.1021/bi001814v; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bugg TDH, 2001, CURR OPIN CHEM BIOL, V5, P550, DOI 10.1016/S1367-5931(00)00236-2; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; COOK GK, 1994, J AM CHEM SOC, V116, P1855, DOI 10.1021/ja00084a029; Couch R, 2004, J BACTERIOL, V186, P35, DOI 10.1128/JB.186.1.35-42.2004; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gribble GW, 2004, J CHEM EDUC, V81, P1441, DOI 10.1021/ed081p1441; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KOJIMA T, 1993, J AM CHEM SOC, V115, P11328, DOI 10.1021/ja00077a035; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; McCarthy AA, 2001, STRUCTURE, V9, P637, DOI 10.1016/S0969-2126(01)00622-0; Molnar-Perl I, 2001, J CHROMATOGR A, V913, P283, DOI 10.1016/S0021-9673(00)01200-0; PARRY RJ, 1994, CAN J CHEM, V72, P86, DOI 10.1139/v94-014; PARRY RJ, 1991, J AM CHEM SOC, V113, P1849, DOI 10.1021/ja00005a069; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Ryle MJ, 2002, CURR OPIN CHEM BIOL, V6, P193, DOI 10.1016/S1367-5931(02)00302-2; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; YOUNG SA, 1992, J BACTERIOL, V174, P1837, DOI 10.1128/jb.174.6.1837-1843.1992	30	239	249	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1191	1194		10.1038/nature03797	http://dx.doi.org/10.1038/nature03797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121186				2022-12-01	WOS:000231416600053
J	Dove-Edwin, I; Sasieni, P; Adams, J; Thomas, HJW				Dove-Edwin, I; Sasieni, P; Adams, J; Thomas, HJW			Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLON-CANCER; RISK; RECOMMENDATIONS; RELATIVES; ADENOMAS	Objective To determine to what extent individuals with various family histories of colorectal cancer (from one to three or more affected first degree relatives) benefit from colonoscopic surveillance. Design Prospective, observational study of high risk families, followed up over 16 years. Setting Tertiary referral family cancer clinic in London. Participants 1678 individuals from families registered with the clinic. Individuals were classified according to the strength of their family history: hereditary non-polyposis colorectal cancer (if they fulfilled the Amsterdam criteria), and one, two, or three affected first degree relatives (moderate risk). Interventions Colonoscopy was initially offered at five year intervals or three year intervals if an adenoma was detected. Main outcome measures The incidence of adenomas with high risk pathological features or cancer. This was analysed by age, the extent of the family history, and findings or previous colonoscopies. The cohort was flagged for cancer and death. Incidence of colorectal cancer and mortality during over 15 000 person years of follow-up were compared with those expected in the absence of surveillance. Results High risk adenomas and cancer were most common in families with hereditary non-polyposis colorectal cancer (on initial colonoscopy 5.7% and 0.9%, respectively). In the families with moderate risk, these findings were particularly uncommon under age 45 (1.1% and 0%) and on follow-up colonoscopy if advanced neoplasia was absent initially (1.7% and 0.1%). The incidence of colorectal cancer was substantially lower-80% in families with moderate risk (P = 0.00004), and 43% in families with hereditary non-polyposis colorectal cancer (P = 0.06)-than the expected incidence in the absence of surveillance when the family history was taken into account. Conclusions Colonoscopic surveillance reduces the risk of colorectal cancer in people with a strong family history, This study confirms that members of families with hereditary non-polyposis colorectal cancer require surveillance with short intervals. Individuals with a lesser family history may not require surveillance under age 45, and if advanced neoplasia is absent on initial colonoscopy, surveillance intervals may be lengthened. This would reduce the demand for colonoscopic surveillance.	Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London EC1M 6BQ, England; St Marks Hosp, Family Canc Grp, Canc Res UK Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England	Cancer Research UK; University of London; Queen Mary University London; Imperial College London	Sasieni, P (corresponding author), Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London EC1M 6BQ, England.	peter.sasieni@cancer.org.uk		Sasieni, Peter/0000-0003-1509-8744				Bradshaw N, 2003, GUT, V52, P1748, DOI 10.1136/gut.52.12.1748; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Burt RW, 2000, GASTROENTEROLOGY, V119, P837, DOI 10.1053/gast.2000.16508; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; HOULSTON RS, 1990, BRIT MED J, V301, P366, DOI 10.1136/bmj.301.6748.366; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; LOVETT E, 1976, BRIT J SURG, V63, P13, DOI 10.1002/bjs.1800630103; Lynch HT, 1999, J MED GENET, V36, P801; LYNCH HT, 1995, SEMIN SURG ONCOL, V11, P406, DOI 10.1002/ssu.2980110607; *NAT STAT, 2001, CANC STAT REGIS MN1, V28; Rijcken FEM, 2002, GUT, V50, P382, DOI 10.1136/gut.50.3.382; Sasieni P, 2003, EPIDEMIOLOGY, V14, P108, DOI 10.1097/00001648-200301000-00026; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Weber T, 1996, LANCET, V348, P465, DOI 10.1016/S0140-6736(05)64545-X; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204	15	148	150	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2005	331	7524					1047	1049		10.1136/bmj.38606.794560.EB	http://dx.doi.org/10.1136/bmj.38606.794560.EB			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983DL	16243849	Green Published, Bronze			2022-12-01	WOS:000233211200017
J	King, H; Keuky, L; Seng, S; Khun, T; Roglic, G; Pinget, M				King, H; Keuky, L; Seng, S; Khun, T; Roglic, G; Pinget, M			Diabetes and associated disorders in Cambodia: two epidemiological surveys	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; GLOBAL BURDEN; PREVALENCE; MORTALITY; INDIA	Background The Asia-Pacific region is thought to be severely affected by diabetes. However, reliable, standardised data on prevalence and characteristics of glucose. intolerance in Asian populations remain sparse. We describe the results of two field surveys undertaken in Cambodia in 2004. Methods 2246 randomly selected adults aged 25 years and older were examined in two communities, one rural (Siemreap) and one semi-urban (Kampong Cham). The diagnosis of diabetes and impaired glucose tolerance was based on 2-h blood glucose estimation using criteria recommended by the latest report of a WHO Expert Group. Blood pressure, anthropometry, habitual diet, and other relevant characteristics were also recorded. Findings Prevalence of diabetes was 5% in Siemreap and 11% in Kampong Cham. Prevalence of impaired glucose tolerance was 10% in Siemreap and 15% in Kampong Cham. About two-thirds of all cases of diabetes were undiagnosed before the survey. Prevalence of hypertension was 12% at Siemreap and 25% at Kampong Cham. People in Kampong Cham had higher estimates of central obesity than those in Siemreap. Interpretation Diabetes and hypertension are not uncommon in Cambodia. A quarter of all adults in the chosen suburban community had some degree of glucose intolerance. Since Cambodian society is relatively poor, and lifestyle is fairly traditional by international standards, these findings are unexpected.	Ctr Europeen Etud Diabet, F-67200 Strasbourg, France; Cambodian Diabet Assoc, Phnom Penh, Cambodia; WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland	World Health Organization	Pinget, M (corresponding author), Ctr Europeen Etud Diabet, F-67200 Strasbourg, France.	association-ceed@wanadoo.fr		Roglic, Gojka/0000-0003-0872-0689				Aekplakorn W, 2003, DIABETES CARE, V26, P2758, DOI 10.2337/diacare.26.10.2758; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; *DECODE STUD GROUP, 1998, BMJ-BRIT MED J, V3, P371; *GOV CAMB NAT I ST, 2004, CAMB INT POP SURV; International Diabetes Federation, 2000, DIAB ATL 2000; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lemeshow S, 1990, TITLE ADEQUACY SAMPL, DOI DOI 10.4238/vol9-1gmr757; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Shaw JE, 2003, MED J AUSTRALIA, V179, P379, DOI 10.5694/j.1326-5377.2003.tb05599.x; *US AG INT DEV MIS, QUICK FACTS; Watkins LO, 2004, CLIN CARDIOL, V27, P2, DOI 10.1002/clc.4960271503; *WHO, 1999, WHONCDNCS991; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; *WORLD BANK, 2004, GNI CAP; World Health Organisation, 1996, WHO TECHN REP SER, V862; World Health Organisation (WHO), 1995, WHO TECHN REP SER, V854; World Health Organization, 1999, WHONCDNCS992; *WORLD HLTH INF SY, DISMOD II; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205	23	70	70	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2005	366	9497					1633	1639		10.1016/S0140-6736(05)67662-3	http://dx.doi.org/10.1016/S0140-6736(05)67662-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980VU	16271644				2022-12-01	WOS:000233047100024
J	Li, WD; Shi, ZL; Yu, M; Ren, WZ; Smith, C; Epstein, JH; Wang, HZ; Crameri, G; Hu, ZH; Zhang, HJ; Zhang, JH; McEachern, J; Field, H; Daszak, P; Eaton, BT; Zhang, SY; Wang, LF				Li, WD; Shi, ZL; Yu, M; Ren, WZ; Smith, C; Epstein, JH; Wang, HZ; Crameri, G; Hu, ZH; Zhang, HJ; Zhang, JH; McEachern, J; Field, H; Daszak, P; Eaton, BT; Zhang, SY; Wang, LF			Bats are natural reservoirs of SARS-like coronaviruses	SCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; NIPAH VIRUS; IDENTIFICATION; ANTIBODIES; PROTEIN	Severe acute respiratory syndrome (SARS) emerged in 2002 to 2003 in southern China. The origin of its etiological agent, the SARS coronavirus (SARS-CoV), remains elusive. Here we report that species of bats are a natural host of coronaviruses closely related to those responsible for the SARS, outbreak. These viruses, termed SARS-like coronaviruses (SL-CoVs), display greater genetic variation than SARS-CoV isolated from humans or from civets. The human and civet isolates of SARS-CoV nestle phylogenetically within the spectrum of SL-CoVs, indicating that the virus responsible for the SARS outbreak Was a member of this coronavirus group.	Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; Dept Primary Ind & Fisheries, Moorooka, Qld, Australia; Consortium Conservat Med, New York, NY USA; Guangzhou Inst Biomed & Hlth, Guangzhou, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Shi, ZL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	zlshi@wh.iov.cn; zhangsy@ioz.ac.cn; linfa.wang@csiro.au	Ren, Wuze/D-2926-2011; Hu, Zhihong/AAS-2215-2020; Crameri, Gary/H-8441-2013; Eaton, Bryan Thomas/AAV-2103-2021; Barr, Jennifer A/H-9254-2013; Zhang, Shuyi/B-5117-2011; Shi, Zhengli/A-1013-2013; daszak, peter/U-4588-2017	Hu, Zhihong/0000-0002-1560-0928; Shi, Zhengli/0000-0001-8089-163X; daszak, peter/0000-0002-2046-5695; Barr, Jennifer/0000-0001-5266-9142; Zhang, Shuyi/0000-0001-6582-5319	FIC NIH HHS [R01-TW05869] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		AbuBakar S, 2004, EMERG INFECT DIS, V10, P2228, DOI 10.3201/eid1012.040452; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Hudson PJ., 2002, ECOLOGY WILDLIFE DIS; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kunz TH, 2003, BAT ECOLOGY, P3; LAI MC, 2001, FIELDS VIROLOGY, V2, pCH35; Lio P, 2004, TRENDS MICROBIOL, V12, P106, DOI 10.1016/j.tim.2004.01.005; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POON LLM, 2005, J VIROL, V79, P2110; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; SULKIN SE, 1974, MONOGR VIROL, V8, P170; Tripp RA, 2005, J VIROL METHODS, V128, P21, DOI 10.1016/j.jviromet.2005.03.021; Tu CC, 2004, EMERG INFECT DIS, V10, P2244, DOI 10.3201/eid1012.040520; Wang L.-F., 2001, INFECT DIS REV, V3, P52; Wang Lin-Fa, 2003, Current Genomics, V4, P263, DOI 10.2174/1389202033490385; Wu DL, 2005, J VIROL, V79, P2620, DOI 10.1128/JVI.79.4.2620-2625.2005	27	1497	1635	8	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					676	679		10.1126/science.1118391	http://dx.doi.org/10.1126/science.1118391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16195424	Green Published			2022-12-01	WOS:000232997700042
J	Tanzi, RE				Tanzi, RE			Tangles and neurodegenerative disease - A surprising twist	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TAU		Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA.		Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454				FOX M, 2005, REUTERS         0714; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977	5	16	18	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1853	1855		10.1056/NEJMcibr055003	http://dx.doi.org/10.1056/NEJMcibr055003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251544				2022-12-01	WOS:000232813000017
J	Bearhop, S; Fiedler, W; Furness, RW; Votier, SC; Waldron, S; Newton, J; Bowen, GJ; Berthold, P; Farnsworth, K				Bearhop, S; Fiedler, W; Furness, RW; Votier, SC; Waldron, S; Newton, J; Bowen, GJ; Berthold, P; Farnsworth, K			Assortative mating as a mechanism for rapid evolution of a migratory divide	SCIENCE			English	Article							STABLE-HYDROGEN; ISOTOPIC COMPOSITION; SYLVIA-ATRICAPILLA; BIRD; MICROEVOLUTION; POPULATIONS; FEATHERS; BEHAVIOR; SONGBIRD; WINTER	There have been numerous recent observations of changes in the behavior and dynamics of migratory bird populations, but the plasticity of the migratory trait and our inability to track small animals over large distances have hindered investigation of the mechanisms behind migratory change. We used habitat-specific stable isotope signatures to show that recently evolved allopatric wintering populations of European blackcaps Sylvia atricapilla pair assortatively on their sympatric breeding grounds. Birds wintering further north also produce larger clutches and fledge more young. These findings describe an important process in the evolution of migratory divides, new migration routes, and wintering quarters. Temporal segregation of breeding is a way in which subpopulations of vertebrates may become isolated in sympatry.	Queens Univ Belfast, Ctr Med Biol, Sch Biol & Biochem, Belfast BT6 7BL, Antrim, North Ireland; Max Planck Inst Ornithol, Vogelwarte Radolfzell, D-78315 Radolfzell am Bodensee, Germany; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Geog & Geomatics, Ctr Geosci, Glasgow G12 8QQ, Lanark, Scotland; Univ Plymouth, Dept Biol Sci, Plymouth PL4 8AA, Devon, England; Scottish Univ Environm Res Ctr, Life Sci Community Stable Isotope Facil, Glasgow G75 0QF, Lanark, Scotland; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Queens University Belfast; Max Planck Society; University of Glasgow; University of Glasgow; University of Plymouth; Scottish Universities Research & Reactor Center; Utah System of Higher Education; University of Utah	Bearhop, S (corresponding author), Queens Univ Belfast, Ctr Med Biol, Sch Biol & Biochem, Lisburn Rd, Belfast BT6 7BL, Antrim, North Ireland.	s.bearhop@qub.ac.uk	Fiedler, Wolfgang/AAG-4510-2021; Bowen, Gabriel J/C-1708-2008; Votier, Stephen C/G-2348-2014; Farnsworth, Keith D/B-5546-2008; Bearhop, Stuart/G-3105-2012; Newton, Jason/A-9536-2009	Fiedler, Wolfgang/0000-0003-1082-4161; Votier, Stephen C/0000-0002-0976-0167; Farnsworth, Keith D/0000-0001-8025-1114; Bearhop, Stuart/0000-0002-5864-0129; Newton, Jason/0000-0001-7594-3693; WALDRON, SUSAN/0000-0002-2683-0761				Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BERTHOLD P, 1995, BIRD STUDY, V42, P89, DOI 10.1080/00063659509477155; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; GLUE D, 2004, BR TRUST ORNITHOL NE, V254, P8; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hill GE, 1998, AUK, V115, P240, DOI 10.2307/4089135; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Monteiro LR, 1998, PHILOS T ROY SOC B, V353, P945, DOI 10.1098/rstb.1998.0259; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Przybylo R, 2001, J AVIAN BIOL, V32, P214, DOI 10.1111/j.0908-8857.2001.320302.x; Reynolds SJ, 2003, OECOLOGIA, V134, P308, DOI 10.1007/s00442-002-1126-y; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; RYTKONEN S, 1995, OECOLOGIA, V104, P386, DOI 10.1007/BF00328375; Viverette CB, 1996, AUK, V113, P32; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WEBSTER MS, 2005, BIRDS 2 WORLDS, pCH16	25	287	306	3	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2005	310	5747					502	504		10.1126/science.1115661	http://dx.doi.org/10.1126/science.1115661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239479				2022-12-01	WOS:000232786000050
J	Olcott, AN; Sessions, AL; Corsetti, FA; Kaufman, AJ; de Oliviera, TF				Olcott, AN; Sessions, AL; Corsetti, FA; Kaufman, AJ; de Oliviera, TF			Biomarker evidence for photosynthesis during Neoproterozoic glaciation	SCIENCE			English	Article							HYDROCARBON BIOMARKERS; CENTRALIAN SUPERBASIN; MICROBIAL MATS; DEATH-VALLEY; ICE SHELF; MICROFOSSILS; SEDIMENTS; GAMMACERANE; ECOSYSTEMS; SHALES	Laterally extensive black shales were deposited on the Sao Francisco craton in southeastern Brazil during low-latitude Neoproterozoic glaciation similar to 740 to 700 million years ago. These rocks contain up to 3.0 weight % organic carbon, which we interpret as representing the preserved record of abundant marine primary productivity from glacial times. Extractable biomarkers reflect a complex and productive microbial ecosystem, including both phototrophic bacteria and eukaryotes, living in a stratified ocean with thin or absent sea ice, oxic surface waters, and euxinic conditions within the photic zone. Such an environment provides important constraints for parts of the "Snowball Earth" hypothesis.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; CALTECH, Pasadena, CA 91125 USA; Univ Maryland, College Pk, MD 20742 USA	University of Southern California; California Institute of Technology; University System of Maryland; University of Maryland College Park	Olcott, AN (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	olcott@usc.edu	Sessions, Alex L/C-2752-2008; Olcott, Alison N./AAL-2020-2021; Sessions, Alex/ABC-9207-2020	Sessions, Alex L/0000-0001-6120-2763; Sessions, Alex/0000-0001-6120-2763; Olcott, Alison/0000-0002-6854-646X				Arouri K, 2000, PRECAMBRIAN RES, V100, P235, DOI 10.1016/S0301-9268(99)00076-5; Azmy K, 2001, PRECAMBRIAN RES, V112, P303, DOI 10.1016/S0301-9268(01)00194-2; Babinski M, 2005, J S AM EARTH SCI, V18, P293, DOI 10.1016/j.jsames.2004.11.010; BRODY KB, 2004, GEOL SOC AM ANN M DE; Brown TC, 2004, PALAEOGEOGR PALAEOCL, V215, P59, DOI 10.1016/j.palaeo.2004.08.004; Corsetti FA, 2003, GEOL SOC AM BULL, V115, P916, DOI 10.1130/B25066.1; Corsetti FA, 2003, P NATL ACAD SCI USA, V100, P4399, DOI 10.1073/pnas.0730560100; CORSETTI FA, IN PRESS PALAEOGEOGR; DAMSTE JSS, 1995, GEOCHIM COSMOCHIM AC, V59, P1895, DOI 10.1016/0016-7037(95)00073-9; Fairchild TR, 1996, PRECAMBRIAN RES, V80, P125, DOI 10.1016/S0301-9268(96)00009-5; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Halverson GP, 2004, BASIN RES, V16, P297, DOI 10.1111/j.1365-2117.2004.00234.x; HEDGES JI, 1995, MAR CHEM, V49, P137, DOI 10.1016/0304-4203(95)00013-H; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Jacobsen SB, 1999, CHEM GEOL, V161, P37, DOI 10.1016/S0009-2541(99)00080-7; James NP, 2005, GEOLOGY, V33, P9, DOI 10.1130/G20938.1; Kaufman AJ, 1997, P NATL ACAD SCI USA, V94, P6600, DOI 10.1073/pnas.94.13.6600; Kennedy MJ, 2001, GEOLOGY, V29, P443, DOI 10.1130/0091-7613(2001)029<0443:APCCAI>2.0.CO;2; Kenny C, 2001, WORLD DEV, V29, P1, DOI 10.1016/S0305-750X(00)00088-7; KNAUER GA, 1993, BIOGEOCHEMICAL CYCLE, P211; Koopmans MP, 1996, GEOCHIM COSMOCHIM AC, V60, P4467, DOI 10.1016/S0016-7037(96)00238-4; Li C, 2003, PRECAMBRIAN RES, V125, P337, DOI 10.1016/S0301-9268(03)00111-6; Logan GA, 1999, GEOCHIM COSMOCHIM AC, V63, P1345, DOI 10.1016/S0016-7037(99)00033-2; Logan GA, 1997, GEOCHIM COSMOCHIM AC, V61, P5391, DOI 10.1016/S0016-7037(97)00290-1; Mueller D.R., 2001, NOVA HEDWIGIA S, V123, P173; Pollard D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002525; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; REVILL AT, 1994, GEOCHIM COSMOCHIM AC, V58, P3803, DOI 10.1016/0016-7037(94)90365-4; Runnegar B, 2000, NATURE, V405, P403, DOI 10.1038/35013168; Simons DJH, 2003, ORG GEOCHEM, V34, P1177, DOI 10.1016/S0146-6380(03)00064-0; Smith WO, 1997, GEOPHYS RES LETT, V24, P233, DOI 10.1029/96GL03926; SUMMONS RE, 1992, BIOLOGICAL MARKERS IN SEDIMENTS AND PETROLEUM, P182; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P2625, DOI 10.1016/0016-7037(88)90031-2; SUMMONS RE, 1990, AM J SCI, V290A, P212; TENHAVEN HL, 1989, GEOCHIM COSMOCHIM AC, V53, P3073; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Vincent WF, 2000, NATURWISSENSCHAFTEN, V87, P137, DOI 10.1007/s001140050692; Vincent WF, 2004, CRYOBIOLOGY, V48, P103, DOI 10.1016/j.cryobiol.2004.01.006; Xiao S, 2004, GEOPHYS MONOGR SER, V146, P199, DOI 10.1029/146GM16; [No title captured]	44	91	98	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					471	474		10.1126/science.1115769	http://dx.doi.org/10.1126/science.1115769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16195425				2022-12-01	WOS:000232786000040
J	Callaghan, AJ; Marcaida, MJ; Stead, JA; McDowall, KJ; Scott, WG; Luisi, BF				Callaghan, AJ; Marcaida, MJ; Stead, JA; McDowall, KJ; Scott, WG; Luisi, BF			Structure of Escherichia coli RNase E catalytic domain and implications for RNA turnover	NATURE			English	Article							16S RIBOSOMAL-RNA; MESSENGER-RNA; RIBONUCLEASE-E; QUATERNARY STRUCTURE; TERMINAL HALF; GENE; DEGRADATION; SPECIFICITY; DEGRADOSOME; SITE	The coordinated regulation of gene expression is required for homeostasis, growth and development in all organisms. Such coordination may be partly achieved at the level of messenger RNA stability(1), in which the targeted destruction of subsets of transcripts generates the potential for cross-regulating metabolic pathways. In Escherichia coli, the balance and composition of the transcript population is affected by RNase E, an essential endoribonuclease that not only turns over RNA but also processes certain key RNA precursors(2-10). RNase E cleaves RNA internally, but its catalytic power is determined by the 50 terminus of the substrate, even if this lies at a distance from the cutting site(11-14). Here we report crystal structures of the catalytic domain of RNase E as trapped allosteric intermediates with RNA substrates. Four subunits of RNase E catalytic domain associate into an interwoven quaternary structure, explaining why the subunit organization is required for catalytic activity. The subdomain encompassing the active site is structurally congruent to a deoxyribonuclease, making an unexpected link in the evolutionary history of RNA and DNA nucleases. The structure explains how the recognition of the 50 terminus of the substrate may trigger catalysis and also sheds light on the question of how RNase E might selectively process, rather than destroy, specific RNA precursors.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of Cambridge; University of Leeds; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	ben@cryst.bioc.cam.ac.uk	McDowall, Kenneth/GYA-5735-2022; Marcaida, Maria Jose/I-1644-2017	Marcaida, Maria Jose/0000-0003-0663-5309; McDowall, Kenneth/0000-0003-2528-2190; Stead, Jonathan/0000-0002-8133-3733; Scott, William/0000-0002-9273-3564	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		APIRION D, 1978, J BIOL CHEM, V253, P1738; AVARIND L, 2001, METHOD ENZYMOL, V341, P3; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Callaghan AJ, 2005, BIOCHEMISTRY-US, V44, P4667, DOI 10.1021/bi0478244; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Callaghan AJ, 2003, BIOCHEMISTRY-US, V42, P13848, DOI 10.1021/bi0351099; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Cohen SN, 1997, MOL MICROBIOL, V23, P1099, DOI 10.1111/j.1365-2958.1997.tb02593.x; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; KUWANO M, 1977, MOL GEN GENET, V154, P279, DOI 10.1007/BF00571283; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; LUNDBERG U, 1995, RNA, V1, P327; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; MCDOWALL KJ, 1993, J BACTERIOL, V175, P4245, DOI 10.1128/JB.175.13.4245-4249.1993; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MUDD EA, 1993, MOL MICROBIOL, V9, P557, DOI 10.1111/j.1365-2958.1993.tb01716.x; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806	30	207	210	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1187	1191		10.1038/nature04084	http://dx.doi.org/10.1038/nature04084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237448	Green Published			2022-12-01	WOS:000232660500051
J	Mishra, L; Derynck, R; Mishra, B				Mishra, L; Derynck, R; Mishra, B			Transforming growth factor-beta signaling in stem cells and cancer	SCIENCE			English	Article							DIFFERENTIATION; DISRUPTION; SMAD4; FATE; INDUCTION; PATHWAYS; PROTEIN; GENES; MICE; ELF	Transforming growth factor-beta(TGF-beta) and TGF-beta-related proteins, such as the bone morphogenetic proteins, have emerged as key regulators of stem cell renewal and differentiation. These proteins have disparate roles in regulating the biology of embryonic stem cells and tumor suppression, and they help define the selection of cell fate and the progression of differentiation along a lineage. Here we illustrate their roles in embryonic stem cells and in the differentiation of neural, hematopoietic, mesenchymal, and gastrointestinal epithelial stem cells.	Georgetown Univ, Dept Surg, Med Lombardi Canc Ctr, Lab CNS Dev, Washington, DC 20007 USA; Dept Vet Affairs, Washington, DC 20049 USA; Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	Georgetown University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mishra, L (corresponding author), Georgetown Univ, Dept Surg, Med Lombardi Canc Ctr, Lab CNS Dev, Univ Med Dent Bldg,NW 212,3900 Reservoir Rd NW, Washington, DC 20007 USA.	lm229@georgetown.edu		Mishra, Lopa/0000-0002-6850-0808	NATIONAL CANCER INSTITUTE [R01CA063101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056111] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106614A, R01 CA63101] Funding Source: Medline; NIDCR NIH HHS [P60 DE 13058] Funding Source: Medline; NIDDK NIH HHS [R01 DK58637, R01 DK56111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLAKE T, 2005, SCI STKE         SEP; Chadwick K, 2005, BLOOD, V105, P1905, DOI 10.1182/blood-2004-03-0881; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fogarty MP, 2005, J NEUROBIOL, V64, P458, DOI 10.1002/neu.20166; Gangemi RMR, 2004, J NEUROCHEM, V89, P286, DOI 10.1046/j.1471-4159.2004.02310.x; GOLESTANEH N, 2005, SCI STKE         SEP; KITISIN AK, 2005, SCI STKE         SEP; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Liu B, 2003, BLOOD, V101, P124, DOI 10.1182/blood-2002-02-0398; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mishra L, 2005, CANCER BIOL THER, V4, P694, DOI 10.4161/cbt.4.7.2015; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Roberts A, 2005, ONCOGENE, V24, P5667, DOI 10.1038/sj.onc.1208915; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	31	166	183	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					68	71		10.1126/science.1118389	http://dx.doi.org/10.1126/science.1118389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210527				2022-12-01	WOS:000232477000036
J	D'Autreaux, B; Tucker, NP; Dixon, R; Spiro, S				D'Autreaux, B; Tucker, NP; Dixon, R; Spiro, S			A non-haem iron centre in the transcription factor NorR senses nitric oxide	NATURE			English	Article							ESCHERICHIA-COLI; NITROSYL COMPLEXES; ELECTRONIC-STRUCTURE; SIGNAL-TRANSDUCTION; PROTEIN; ACTIVATION; BINDING; FLAVORUBREDOXIN; INHIBITION; REDUCTION	Nitric oxide ( NO), synthesized in eukaryotes by the NO synthases, has multiple roles in signalling pathways and in protection against pathogens(1,2). Pathogenic microorganisms have apparently evolved defence mechanisms that counteract the effects of NO and related reactive nitrogen species. Regulatory proteins that sense NO mediate the primary response to NO and nitrosative stress(3-9). The only regulatory protein in enteric bacteria known to serve exclusively as an NO-responsive transcription factor is the enhancer binding protein NorR (refs 9 - 11). In Escherichia coli, NorR activates the transcription of the nor VW genes encoding a flavorubredoxin (FlRd) and an associated flavoprotein, respectively, which together have NADH-dependent NO reductase activity(10,12-14). The NO-responsive activity of NorR raises important questions concerning the mechanism of NO sensing. Here we show that the regulatory domain of NorR contains a mononuclear non-haem iron centre, which reversibly binds NO. Binding of NO stimulates the ATPase activity of NorR, enabling the activation of transcription by RNA polymerase. The mechanism of NorR reveals an unprecedented biological role for a non-haem mononitrosyl - iron complex in NO sensing.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University System of Georgia; Georgia Institute of Technology	Spiro, S (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	stephen.spiro@biology.gatech.edu	Spiro, Stephen/B-1838-2009; D'Autreaux, Benoit/M-8520-2018	Spiro, Stephen/0000-0001-5975-9984; Tucker, Nicholas/0000-0002-6331-3704; D'Autreaux, Benoit/0000-0002-1276-3019; Dixon, Ray/0000-0002-6348-639X	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000016] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; AUSTIN S, 1992, EMBO J, V11, P2219, DOI 10.1002/j.1460-2075.1992.tb05281.x; BROWN CA, 1995, J AM CHEM SOC, V117, P715, DOI 10.1021/ja00107a015; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Clay MD, 2003, P NATL ACAD SCI USA, V100, P3796, DOI 10.1073/pnas.0636858100; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hauser C, 2000, J AM CHEM SOC, V122, P4352, DOI 10.1021/ja994161i; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Li M, 2002, INORG CHEM, V41, P3444, DOI 10.1021/ic011243a; Little R, 2000, EMBO J, V19, P6041, DOI 10.1093/emboj/19.22.6041; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Ray M, 1999, INORG CHEM, V38, P3110, DOI 10.1021/ic990070a; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Serres RG, 2004, J AM CHEM SOC, V126, P5138, DOI 10.1021/ja030645+; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tucker NP, 2004, J BACTERIOL, V186, P6656, DOI 10.1128/JB.186.19.6656-6660.2004; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	30	241	244	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					769	772		10.1038/nature03953	http://dx.doi.org/10.1038/nature03953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193057				2022-12-01	WOS:000232157900060
J	Mailand, N; Diffley, JFX				Mailand, N; Diffley, JFX			CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis	CELL			English	Article							PRE-RC FORMATION; CYCLIN-A; PREREPLICATION COMPLEXES; CHROMATIN ASSOCIATION; UBIQUITIN LIGASE; MAMMALIAN CDC6; IN-VIVO; MITOSIS; PROTEINS; PHOSPHORYLATION	Cyclin-dependent kinases (CDKs) restrict DNA replication origin firing to once per cell cycle by preventing the assembly of prereplicative complexes (preRCs; licensing) outside of G1 phase. Paradoxically, under certain circumstances, CDKs such as cyclin E-cdk2 are also required to promote licensing. Here, we show that CDK phosphorylation of the essential licensing factor Cdc6 stabilizes it by preventing its association with the anaphase promoting complex/ cyclosome (APC/C). APC/C-dependent Cdc6 proteolysis prevents pre-RC assembly in quiescent cells and, when cells reenter the cell cycle from quiescence, CDK-dependent Cdc6 stabilization allows Cdc6 to accumulate before the licensing inhibitors geminin and cyclin A which are also APC/C substrates. This novel mechanism for regulating protein stability establishes a window of time prior to S phase when preRCs can assemble which we propose represents a critical function of cyclin E.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk		Diffley, John/0000-0001-5184-7680				Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermejo R, 2002, MOL BIOL CELL, V13, P3989, DOI 10.1091/mbc.E02-04-0217; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Coverley D, 1998, EXP CELL RES, V238, P63, DOI 10.1006/excr.1997.3829; Coverley D, 1996, EXP CELL RES, V225, P294, DOI 10.1006/excr.1996.0179; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Herbig U, 2000, MOL BIOL CELL, V11, P4117, DOI 10.1091/mbc.11.12.4117; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Tikhmyanova N, 2003, DEV BIOL, V260, P362, DOI 10.1016/S0012-1606(03)00253-7; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	43	270	270	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					915	926		10.1016/j.cell.2005.08.013	http://dx.doi.org/10.1016/j.cell.2005.08.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16153703	Bronze			2022-12-01	WOS:000232130200015
J	Wassen, MJ; Venterink, HO; Lapshina, ED; Tanneberger, F				Wassen, MJ; Venterink, HO; Lapshina, ED; Tanneberger, F			Endangered plants persist under phosphorus limitation	NATURE			English	Article							SPECIES RICHNESS; NUTRIENT LIMITATION; NITROGEN; RESTORATION; DIVERSITY; BIODIVERSITY; CONSTRAINTS; GRASSLAND; CAPACITY; WETLANDS	Nitrogen enrichment is widely thought to be responsible for the loss of plant species from temperate terrestrial ecosystems. This view is based on field surveys and controlled experiments showing that species richness correlates negatively with high productivity(1,2) and nitrogen enrichment(3). However, as the type of nutrient limitation has never been examined on a large geographical scale the causality of these relationships is uncertain. We investigated species richness in herbaceous terrestrial ecosystems, sampled along a transect through temperate Eurasia that represented a gradient of declining levels of atmospheric nitrogen deposition - from similar to 50 kg ha(-1) yr(-1) in western Europe to natural background values of less than 5 kg ha(-1) yr(-1) in Siberia(4). Here we show that many more endangered plant species persist under phosphorus- limited than under nitrogen- limited conditions, and we conclude that enhanced phosphorus is more likely to be the cause of species loss than nitrogen enrichment. Our results highlight the need for a better understanding of the mechanisms of phosphorus enrichment, and for a stronger focus on conservation management to reduce phosphorus availability.	Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands; ETH, Geobot Inst, CH-8044 Zurich, Switzerland; Tomsk State Univ, Dept Bot, Tomsk 634050, Russia; Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, D-17487 Greifswald, Germany	Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Tomsk State University; Ernst Moritz Arndt Universitat Greifswald	Wassen, MJ (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, POB 80115, NL-3508 TC Utrecht, Netherlands.	m.wassen@geo.uu.nl	olde Venterink, Harry/K-9547-2015; Lapshina, Elena Dmitrievna/A-4792-2014; Wassen, Martin J./L-9228-2013; Lapshina, Elena/AAC-5538-2019	olde Venterink, Harry/0000-0002-8963-1153; Wassen, Martin J./0000-0002-9735-2103; Lapshina, Elena/0000-0001-5571-7787; Tanneberger, Franziska/0000-0002-4184-9671				[Anonymous], 1979, PLANT STRATEGIES VEG; Bakker J.P., 1989, NATURE MANAGEMENT GR; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BERENDSE F, 1992, BIOL CONSERV, V62, P59, DOI 10.1016/0006-3207(92)91152-I; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Giles J, 2005, NATURE, V433, P791, DOI 10.1038/433791a; GOUGH MW, 1990, BIOL CONSERV, V51, P83, DOI 10.1016/0006-3207(90)90104-W; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Gusewell S, 2005, OIKOS, V109, P71, DOI 10.1111/j.0030-1299.2005.13587.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Jansen AJM, 1996, ECOL ENG, V7, P279, DOI 10.1016/S0925-8574(96)00022-5; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Meijden R. van der, 1991, Gorteria, V17, P75; MOORE DRJ, 1989, BIOL CONSERV, V47, P203, DOI 10.1016/0006-3207(89)90065-7; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; RICHARDSON CJ, 1985, SCIENCE, V228, P1424, DOI 10.1126/science.228.4706.1424; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Turner BL, 2001, NATURE, V411, P258, DOI 10.1038/35077146; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wassen MJ, 1996, VEGETATIO, V126, P5; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713	30	385	412	15	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					547	550		10.1038/nature03950	http://dx.doi.org/10.1038/nature03950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177790	Green Published			2022-12-01	WOS:000232004800049
J	Poulter, NR; Wedel, H; Dahlof, B; Sever, PS; Beevers, DG; Caulfield, M; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Pocock, S				Poulter, NR; Wedel, H; Dahlof, B; Sever, PS; Beevers, DG; Caulfield, M; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Pocock, S		ASCOT Investigators	Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)	LANCET			English	Article							MORTALITY; CHOLESTEROL; PREVENTION; PREDICTOR; CORONARY; DISEASE; COHORT; ADULTS; RISK; MEN	Background Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-based combination drug regimen than in those allocated an atenolol-based combination drug regimen (HR 0.86 and 0.77, respectively). Our aim was to assess to what extent these differences were due to significant differences in blood pressures and in other variables noted after randomisation. Methods We used data from ASCOT-BPLA (n=19257) and compared differences in accumulated mean blood pressure levels at sequential times in the trial with sequential differences in coronary and stroke events. Serial mean matching for differences in systolic blood pressure was used to adjust HRs for differences in these events. We used an updated Cox-regression model to assess the effects of differences in accumulated mean levels of various measures of blood pressure, serum HDL-cholesterol, triglycerides and potassium, fasting blood glucose, heart rate, and bodyweight on differences in event rates. Findings We noted no temporal link between size of differences in blood pressure and different event rates. Serial mean matching for differences in systolic blood-pressure attenuated HRs for coronary and stroke events to a similar extent as did adjustments for systolic blood-pressure differences in Cox-regression analyses. HRs for coronary events and stroke adjusted for blood pressure rose from 0.86 (0.77-0.96) to 0.88 (0.79-0.98) and from 0.77 (0.66-0.89) to 0.83 (0.72-0.96), respectively. Multivariate adjustment gave HRs of 0.94 (0.81-1.08) for coronary events (HDL cholesterol being the largest contributor) and 0.87 (0.73-1.05) for stroke events. Interpretation Multivariate adjustment accounted for about half of the differences in coronary events and for about 40% of the differences in stroke events between the treatment regimens tested in ASCOT-BPLA, but residual differences were no longer significant. These residual differences could indicate inadequate statistical adjustment but it remains possible that differential effects of the two treatment regimens on other variables also contributed to the different rates noted, particularly for stroke.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1PG, England; Nord Sch Publ Hlth, Gothenburg, Sweden; Sahlgrenska Univ Hosp Ostra, Gothenburg, Sweden; City Hosp, Birmingham, W Midlands, England; Barts & London Queen Marys Sch Med, London, England; Ulleval Hosp, Oslo, Norway; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Hosp Reykjavik, Reykjavik, Iceland; Univ Glasgow, Glasgow, Lanark, Scotland; HS Frederiksberg Hosp, Frederiksberg, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Beaumont Hosp, Dublin 9, Ireland; Royal Coll Surg, Dublin, Ireland; Karolinska Hosp, S-10401 Stockholm, Sweden; London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Sahlgrenska University Hospital; University of Birmingham; University of London; Queen Mary University London; University of Oslo; University of Michigan System; University of Michigan; Landspitali National University Hospital; University of Glasgow; University of Helsinki; Helsinki University Central Hospital; Royal College of Surgeons - Ireland; Karolinska Institutet; Karolinska University Hospital; University of London; London School of Hygiene & Tropical Medicine	Poulter, NR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1PG, England.	n.poulter@imperial.ac.uk	Stanton, Alice V/F-4697-2012; Mehlsen, Jesper/AAA-5848-2022	Caulfield, Mark/0000-0001-9295-3594				Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; COHEN JD, 1987, AM J CARDIOL, V60, P548, DOI 10.1016/0002-9149(87)90303-1; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; HOKANSON JE, 1996, J CARDIOVASC RISK, V3, P21; JACOBS DR, 1990, AM J EPIDEMIOL, V131, P32, DOI 10.1093/oxfordjournals.aje.a115483; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; SAFAR ME, 2005, HYPERTENSION, V46, P1; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sleight P, 2001, LANCET, V358, P2130, DOI 10.1016/S0140-6736(01)07186-0; Staessen JA, 2004, LANCET, V364, P931, DOI 10.1016/S0140-6736(04)17010-4; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8	18	243	266	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 10	2005	366	9489					907	913		10.1016/S0140-6736(05)67186-3	http://dx.doi.org/10.1016/S0140-6736(05)67186-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154017				2022-12-01	WOS:000231770000028
J	Mekel-Bobrov, N; Gilbert, SL; Evans, PD; Vallender, EJ; Anderson, JR; Hudson, RR; Tishkoff, SA; Lahn, BT				Mekel-Bobrov, N; Gilbert, SL; Evans, PD; Vallender, EJ; Anderson, JR; Hudson, RR; Tishkoff, SA; Lahn, BT			Ongoing adaptive evolution of ASPM, a brain size determinant in Homo sapiens	SCIENCE			English	Article							CEREBRAL CORTICAL SIZE; MAJOR DETERMINANT; GENETIC-STRUCTURE; MODERN HUMANS	The gene ASPM (abnormal spindle-like microcephaly associated) is a specific regulator of brain size, and its evolution in the lineage leading to Homo sapiens was driven by strong positive selection. Here, we show that one genetic variant of ASPM in humans arose merely about 5800 years ago and has since swept to high frequency under strong positive selection. These findings, especially the remarkably young age of the positively selected variant, suggest that the human brain is still undergoing rapid adaptive evolution.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University System of Maryland; University of Maryland College Park	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540				Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; HOUSTON S.D, 2004, 1 WRITING SCRIPT INV; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Wright S., 1978, EVOLUTION GENETICS P; Zhang JZ, 2003, GENETICS, V165, P2063; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	13	283	294	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1720	1722		10.1126/science.1116815	http://dx.doi.org/10.1126/science.1116815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151010				2022-12-01	WOS:000231836700043
J	Dorff, EN				Dorff, EN			End-of-life: Jewish perspectives	LANCET			English	Editorial Material									Univ Judaism, Bel Air, CA 90077 USA		Dorff, EN (corresponding author), Univ Judaism, 15600 Mulholland Dr, Bel Air, CA 90077 USA.	edorff@uj.edu						ADDRESS RF, 1992, TIME PREPARE PRACTIC; BLEICH JD, 1981, JUDAISM HEALING, P162; BLEICH JD, 1995, CONTEMP HALAKHIC PRO, V4, P273; BLEICH JD, 1981, JUDAISM HEALING, P134; BLEICH JD, 1981, JUDAISM HEALING, P146; BLEICH JD, 1981, JUDAISM HEALING, P129; Dorff Elliot N., 1988, LIVING TREE ROOTS GR; Dorff Elliot N., 1998, MATTERS LIFE DEATH J, P176; DORFF EN, 1998, MATTERS LIFE DEATH J, P221; DORFF EN, 1998, MATTERS LIFE DEATH J, P14; DORFF EN, 1991, UNITED SYNAGOGUE REV, V44, P21; Ellenson David H., 1995, CONT JEWISH ETHICS M, P129; FELDMAN DM, 1986, HLTH MED JEWISH TRAD; FELDMAN DM, 1984, COMPENDIUM MED ETHIC; FREEHOF SB, 1960, REFORM RESPONSA, P130; FREEHOF SB, 1974, CONT REFORM RESPONSA, P216; GOLDFARB DC, 1976, CONSERVATIVE JUDAISM, V30, P10; GOLDMAN AJ, 1978, JUDAISM CONFRONTS CO, P223; JACOB W, 1983, AM REFORM RESPONSA, P273; Jakobovits I, 1975, JEWISH MED ETHICS; JAKOBOVITS Y, 1989, TRADITION, V24, P1; KLEIN I, 2000, LIFE DEATH RESPONSIB, P435; Klein I., 1975, RESPONSA HALAKHIC ST; *RABB ASS, 1990, P CONS RABB ASS, V52; REISNER AI, 2000, LIFE DEATH RESPONSBI, P233; ROSNER F, 1979, JEWISH BIOETHICS, P358; SIEGEL S, 1976, CONSERVATIVE JUDAISM, V30, P23	27	45	47	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 3	2005	366	9488					862	865		10.1016/S0140-6736(05)67219-4	http://dx.doi.org/10.1016/S0140-6736(05)67219-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139662				2022-12-01	WOS:000231627000032
J	Reader, JS; Ordoukhanian, PT; Kim, JG; de Crecy-Lagard, V; Hwang, I; Farrand, S; Schimmel, P				Reader, JS; Ordoukhanian, PT; Kim, JG; de Crecy-Lagard, V; Hwang, I; Farrand, S; Schimmel, P			Major biocontrol of plant tumors targets tRNA synthetase	SCIENCE			English	Editorial Material							AGROCIN 84; BACTERIOCIN		Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Scripps Research Institute; Seoul National University (SNU); University of Illinois System; University of Illinois Urbana-Champaign	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	schimmel@scripps.edu	de Crecy-Lagard, Valerie/AAN-8995-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539, R01GM052465, R01GM023562] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52465, GM15539, GM23562] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		MURPHY PJ, 1981, EUR J BIOCHEM, V115, P539; READER J, UNPUB; ROBERTS WP, 1977, NATURE, V265, P379, DOI 10.1038/265379a0; RYDER MH, 1987, J BACTERIOL, V169, P4184, DOI 10.1128/jb.169.9.4184-4189.1987; SHIM JS, 1987, PHYTOPATHOLOGY, V77, P463, DOI 10.1094/Phyto-77-463; TATE ME, 1979, NATURE, V280, P697, DOI 10.1038/280697a0	6	70	77	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1533	1533		10.1126/science.1116841	http://dx.doi.org/10.1126/science.1116841			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141066				2022-12-01	WOS:000231715000041
J	Haynes, JD; Deichmann, R; Rees, G				Haynes, JD; Deichmann, R; Rees, G			Eye-specific effects of binocular rivalry in the human lateral geniculate nucleus	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ALERT MACAQUE; SUPPRESSION; ORGANIZATION; PATHWAY; MONKEY; BRAIN; SIZE; LGN; V1	When dissimilar images are presented to the two eyes, they compete for perceptual dominance so that each image is visible in turn for a few seconds while the other is suppressed. Such binocular rivalry is associated with relative suppression of local, eye-based representations(1-4) that can also be modulated by high-level influences such as perceptual grouping(3,5,6). However, it is currently unclear how early in visual processing the suppression of eye-based signals can occur. Here we use high-resolution functional magnetic resonance imaging (fMRI) in conjunction with a new binocular rivalry stimulus to show that signals recorded from the human lateral geniculate nucleus (LGN) exhibit eye-specific suppression during rivalry. Regions of the LGN that show strong eye-preference independently show strongly reduced activity during binocular rivalry when the stimulus presented in their preferred eye is perceptually suppressed. The human LGN is thus the earliest stage of visual processing that reflects eye-specific dominance and suppression.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Haynes, JD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews TJ, 1997, J NEUROSCI, V17, P2859; Andrews TJ, 2001, TRENDS COGN SCI, V5, P407, DOI 10.1016/S1364-6613(00)01756-3; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Ichida JM, 2002, J COMP NEUROL, V454, P272, DOI 10.1002/cne.10441; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Lehky SR, 1996, VISION RES, V36, P1225, DOI 10.1016/0042-6989(95)00232-4; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; MONTERO VM, 1986, EXP BRAIN RES, V62, P215; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; SCHROEDER CE, 1990, BRAIN RES, V521, P303, DOI 10.1016/0006-8993(90)91556-V; SCLAR G, 1990, VISION RES, V31, P1148; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; SOBEL KV, 2004, J VIS, V4; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; VARELA FJ, 1987, EXP BRAIN RES, V66, P10; WALES R, 1970, PERCEPT PSYCHOPHYS, V8, P90, DOI 10.3758/BF03210180; Watanabe K, 2004, VISION RES, V44, P3065, DOI 10.1016/j.visres.2004.07.011	31	255	258	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					496	499		10.1038/nature04169	http://dx.doi.org/10.1038/nature04169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16244649	Green Submitted, Green Accepted			2022-12-01	WOS:000233458200049
J	Allen, E; Ding, JQ; Wang, W; Pramanik, S; Chou, J; Yau, V; Yang, YM				Allen, E; Ding, JQ; Wang, W; Pramanik, S; Chou, J; Yau, V; Yang, YM			Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival	NATURE			English	Article							GIANT AXONAL NEUROPATHY; UBIQUITIN-PROTEASOME SYSTEM; MICROTUBULE-ASSOCIATED PROTEINS; CYTOPLASMIC DYNEIN; WALLERIAN DEGENERATION; 1B; BINDING; KINESIN; BTB; LIGASES	Giant axonal neuropathy (GAN) is a devastating sensory and motor neuropathy caused by mutations in the GAN gene, which encodes the ubiquitously expressed protein gigaxonin(1-5). Cytopathological features of GAN include axonal degeneration, with accumulation and aggregation of cytoskeletal components(6-7). Little is currently known about the molecular mechanisms underlying this recessive disorder. Here we show that gigaxonin controls protein degradation, and is essential for neuronal function and survival. We present evidence that gigaxonin binds to the ubiquitin-activating enzyme E1 through its amino-terminal BTB domain, while the carboxy-terminal kelch repeat domain interacts directly with the light chain (LC) of microtubule-associated protein 1B (MAP1B)(8). Overexpression of gigaxonin leads to enhanced degradation of MAP1B-LC, which can be antagonized by proteasome inhibitors. Ablation of gigaxonin causes a substantial accumulation of MAP1B-LC in GAN-null neurons. Moreover, we show that overexpression of MAP1B in wild-type cortical neurons leads to cell death characteristic of GAN-null neurons, whereas reducing MAP1B levels significantly improves the survival rate of null neurons. Our results identify gigaxonin as a ubiquitin scaffolding protein that controls MAP1B-LC degradation, and provide insight into the molecular mechanisms underlying human neurodegenerative disorders.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Yang, YM (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 1201 Welch Rd, Stanford, CA 94305 USA.	yyanmin@stanford.edu		Ding, Jianqing/0000-0002-2038-2603				Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bomont P, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9122; Bruno C, 2004, NEUROLOGY, V62, P13, DOI 10.1212/01.WNL.0000101676.41505.A7; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Ehlers MD, 2004, TRENDS NEUROSCI, V27, P3, DOI 10.1016/j.tins.2003.10.015; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; LAMPL Y, 1992, DEV MED CHILD NEUROL, V34, P164; LOPEZ LA, 1993, CELL MOTIL CYTOSKEL, V24, P1, DOI 10.1002/cm.970240102; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Mei X, 2000, J NEUROSCI RES, V62, P56, DOI 10.1002/1097-4547(20001001)62:1<56::AID-JNR6>3.0.CO;2-#; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; TANDAN R, 1987, J NEUROL SCI, V82, P205, DOI 10.1016/0022-510X(87)90019-0; Tazir M, 2002, NEUROMUSCULAR DISORD, V12, P849, DOI 10.1016/S0960-8966(02)00029-9; Timmerman V, 2000, NAT GENET, V26, P254, DOI 10.1038/81521; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; TUCKER RP, 1987, DEVELOPMENT, V101, P535; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Vicario-Abejon Carlos, 2004, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0302s26; VONMASSOW A, 1989, CELL MOTIL CYTOSKEL, V14, P562, DOI 10.1002/cm.970140413; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	25	97	103	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					224	228		10.1038/nature04256	http://dx.doi.org/10.1038/nature04256			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16227972				2022-12-01	WOS:000233133500049
J	Lazcano, A				Lazcano, A			Teaching evolution in Mexico: Preaching to the choir	SCIENCE			English	Editorial Material									Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Apdo Postal 70-407,Cd Univ, Mexico City 04510, DF, Mexico.	alar@correo.unam.mx		Lazcano, Antonio/0000-0001-7365-8557					0	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					787	789		10.1126/science.1115180	http://dx.doi.org/10.1126/science.1115180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272103				2022-12-01	WOS:000233121800025
J	Majumder, M; Chopra, N; Andrews, R; Hinds, BJ				Majumder, M; Chopra, N; Andrews, R; Hinds, BJ			Nanoscale hydrodynamics - Enhanced flow in carbon nanotubes	NATURE			English	Editorial Material							MEMBRANES		Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; Univ Kentucky, Ctr Appl Energy Res, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky	Majumder, M (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	bjhinds@engr.uky.edu	Majumder, Mainak/B-4667-2011; Nitin, Chopra/F-8236-2011					Chopra N, 2005, ADV FUNCT MATER, V15, P858, DOI 10.1002/adfm.200400399; Hille B, 1984, IONIC CHANNELS EXCIT; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Klein E, 2000, J MEMBRANE SCI, V179, P1, DOI 10.1016/S0376-7388(00)00514-7; Majumder M, 2005, J AM CHEM SOC, V127, P9062, DOI 10.1021/ja043013b; Mao ZG, 2001, J PHYS CHEM B, V105, P6916, DOI 10.1021/jp0103272; Skoulidas AI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185901; Sokhan VP, 2002, J CHEM PHYS, V117, P8531, DOI 10.1063/1.1512643	10	1482	1525	29	697	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					44	44		10.1038/43844a	http://dx.doi.org/10.1038/43844a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267546	Bronze			2022-12-01	WOS:000232979000034
J	Maxmen, A; Browne, WE; Martindale, MQ; Giribet, G				Maxmen, A; Browne, WE; Martindale, MQ; Giribet, G			Neuroanatomy of sea spiders implies an appendicular origin of the protocerebral segment	NATURE			English	Article							HEAD SEGMENTATION; EXPRESSION; BRAIN; CRUSTACEANS; ARTHROPODA; MORPHOLOGY; PHYLOGENY; SEROTONIN; POSITION; PATTERN	Independent specialization of arthropod body segments has led to more than a century of debate on the homology of morphologically diverse segments(1,2), each defined by a lateral appendage and a ganglion of the central nervous system. The plesiomorphic composition of the arthropod head remains enigmatic because variation in segments and corresponding appendages is extreme. Within extant arthropod classes (Chelicerata, Myriapoda, Crustacea and Hexapoda-including the insects), correspondences between the appendage-bearing second (deutocerebral) and third (tritocerebral) cephalic neuromeres have been recently resolved on the basis of immunohistochemistry(1) and Hox gene expression patterns(3,4). However, no appendage targets the first ganglion, the protocerebrum, and the corresponding segmental identity of this anterior region remains unclear(5). Reconstructions of stem-group arthropods indicate that the anteriormost region originally might have borne an ocular apparatus and a frontal appendage innervated by the protocerebrum(6). However, no study of the central nervous system in extant arthropods has been able to corroborate this idea directly, although recent analyses of cephalic gene expression patterns in insects suggest a segmental status for the protocerebral region(7-10). Here we investigate the developmental neuroanatomy of a putative basal arthropod(11), the pycnogonid sea spider, with immunohistochemical techniques. We show that the first pair of appendages, the chelifores, are innervated at an anterior position on the protocerebrum. This is the first true appendage shown to be innervated by the protocerebrum, and thus pycnogonid chelifores are not positionally homologous to appendages of extant arthropods but might, in fact, be homologous to the 'great appendages' of certain Cambrian stem-group arthropods.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Univ Hawaii, Pacific Biosci Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA	Harvard University; Harvard University; University of Hawaii System	Maxmen, A (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	amaxmen@oeb.harvard.edu	Browne, William E./AAV-4035-2021; Browne, William E/D-4267-2013; Giribet, Gonzalo/P-1086-2015	Browne, William E./0000-0001-8200-6489; Browne, William E/0000-0001-8200-6489; Giribet, Gonzalo/0000-0002-5467-8429				Bain BA, 2003, INVERTEBR REPROD DEV, V43, P193, DOI 10.1080/07924259.2003.9652540; Boyan G, 2003, ARTHROPOD STRUCT DEV, V32, P61, DOI 10.1016/S1467-8039(03)00037-9; Boyan G, 2002, ARTHROPOD STRUCT DEV, V30, P207, DOI 10.1016/S1467-8039(01)00034-2; Brusca R. C., 2003, INVERTEBRATES; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dickinson AJG, 2000, BIOL BULL-US, V199, P305, DOI 10.2307/1543187; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; FAGE, 1949, TRAITE ZOOLOGIE ANAT, P906; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; GOODRICH ES, 1897, Q J MICROSC SCI, V247, P248; Hedgpeth Joel W., 1947, SMITHSONIAN MISC COLL, V106, P1; Horridge AG, 1965, STRUCTURE FUNCTION N; King P.E., 1973, PYCNOGONIDS; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Miyazaki K, 2002, J MAR BIOL ASSOC UK, V82, P1037, DOI 10.1017/S0025315402006628; Morgan T.H., 1891, STUD BIOL LAB J HOPK, V5, P1; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Rogers BT, 1996, DEVELOPMENT, V122, P3419; SANDEMAN DC, 1988, J COMP NEUROL, V269, P465, DOI 10.1002/cne.902690402; SCHMIDTOTT U, 1995, ROUX ARCH DEV BIOL, V205, P31, DOI 10.1007/BF00188841; Siveter DJ, 2004, NATURE, V431, P978, DOI 10.1038/nature02928; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2; Vilpoux K, 2003, ARTHROPOD STRUCT DEV, V32, P349, DOI 10.1016/j.asd.2003.09.004; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Waloszek D, 2002, PALAEONTOLOGY, V45, P421, DOI 10.1111/1475-4983.00244; Whitington PM, 2004, CRUSTACEAN ISS, V15, P135; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27; Wiren E, 1918, ZOOL BIDR UPPS, V6, P41	32	68	69	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1144	1148		10.1038/nature03984	http://dx.doi.org/10.1038/nature03984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237442				2022-12-01	WOS:000232660500042
J	Ahmed, S				Ahmed, S			Tie it and trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									YSM IV, New Haven, CT 06520 USA		Ahmed, S (corresponding author), YSM IV, New Haven, CT 06520 USA.	shobi.ahmed@yale.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2005	294	15					1873	1874		10.1001/jama.294.15.1873	http://dx.doi.org/10.1001/jama.294.15.1873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974OZ	16234487				2022-12-01	WOS:000232602600001
J	Skjaerven, R; Vatten, LJ; Wilcox, AJ; Ronning, T; Irgens, LM; Lie, RT				Skjaerven, R; Vatten, LJ; Wilcox, AJ; Ronning, T; Irgens, LM; Lie, RT			Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; GESTATIONAL HYPERTENSION; ABRUPTIO PLACENTAE; ECLAMPSIA; FAMILY; PREDISPOSITION; PREGNANCIES; MORTALITY; GROWTH; WOMEN	Objectives To assess the impact on risk of pre-eclampsia of genes that work through the mother, and genes of paternal origin that work through the fetus. Design Population based cohort study. Setting Registry data from Norway. Participants Linked generational data from the medical birth registry of Norway (1967-2003): 438 597 mother-offspring units and 286 945 father-offspring units. Main outcome measures Pre-eclampsia in the second generation. Results The daughters of women who had pre-eclampsia during pregnancy had more than twice the risk of pre-eclampsia themselves (odds ratio 2.2, 95% confidence interval 2.0 to 2.4) compared with other women. Men born after a pregnancy complicated by pre-eclampsia had a moderately increased risk of fathering a pre-eclamptic pregnancy (1.5, 1.3 to 1.7). Sisters of affected men or women who were themselves born after pregnancies not complicated by pre-eclampsia, also had an increased risk (2.0, 1.7 to 2.3). Women and men born after pre-eclamptic pregnancies were more likely to trigger severe pre-eclampsia in their own pregnancy (3.0, 2.4 to 3.7, for mothers and 1.9, 1.4 to 2.5, for fathers). Conclusion Maternal genes and fetal genes from either the mother or father may trigger pre-eclampsia. The maternal association is stronger than the fetal association. The familial association predicts more severe pre-eclampsia.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway; Norwegian Univ Sci & Technol, Fac Med, N-7034 Trondheim, Norway; NIEHS, Res Triangle Pk, NC 27709 USA; Norwegian Inst Publ Hlth, Div Genes & Environm, Oslo, Norway; Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; Norwegian University of Science & Technology (NTNU); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	Skjaerven, R (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway.	Rolv.Skjaerven@smis.uib.no	Vatten, Lars/AFK-2073-2022; Wilcox, Allen J/C-7723-2019; Vatten, Lars/AAF-9380-2022	Wilcox, Allen J/0000-0002-3376-1311; 				ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; Dalaker K, 1999, CLIN GUIDELINES OBST; Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Ghidini A, 1997, OBSTET GYNECOL, V90, P542, DOI 10.1016/S0029-7844(97)00360-8; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; TEASDALE F, 1985, AM J OBSTET GYNECOL, V152, P25, DOI 10.1016/S0002-9378(85)80170-8; VATTEN LJ, 2004, BJOG, V11, P298; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203	25	193	198	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 15	2005	331	7521					877	879		10.1136/bmj.38555.462685.8F	http://dx.doi.org/10.1136/bmj.38555.462685.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975SX	16169871	Green Published, Bronze			2022-12-01	WOS:000232683300021
J	Henderson, GS				Henderson, GS			Hurricane Katrina - Finding supplies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ochsner Clin Fdn, New Orleans, LA 70121 USA	Ochsner Health System	Henderson, GS (corresponding author), Ochsner Clin Fdn, New Orleans, LA 70121 USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2005	353	15					1542	1542		10.1056/NEJMp058230	http://dx.doi.org/10.1056/NEJMp058230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972XF	16221771				2022-12-01	WOS:000232486000002
J	Grant, RM; Buchbinder, S; Cates, W; Clarke, E; Coates, T; Cohen, MS; Delaney, M; Flores, G; Goicochea, P; Gonsalves, G; Harrington, M; Lama, JR; MacQueen, KM; Moore, JP; Peterson, L; Sanchez, J; Thompson, M; Wainberg, MA				Grant, RM; Buchbinder, S; Cates, W; Clarke, E; Coates, T; Cohen, MS; Delaney, M; Flores, G; Goicochea, P; Gonsalves, G; Harrington, M; Lama, JR; MacQueen, KM; Moore, JP; Peterson, L; Sanchez, J; Thompson, M; Wainberg, MA			Promote HIV chemoprophylaxis research, don't prevent it	SCIENCE			English	Editorial Material							SIMIAN IMMUNODEFICIENCY VIRUS; NEWBORN MACAQUES; TENOFOVIR; INFECTION; TRIAL; EFFICACY; VACCINE; SAFETY		Gladstone Inst Virol & Immunol, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; Family Hlth Int, Res Triangle Pk, NC 27709 USA; Ghana Hlth Serv, Accra, Ghana; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Univ N Carolina, Chapel Hill, NC USA; Project Inform, San Francisco, CA USA; Asociac Civil Impacta Salud & Educ, Lima, Peru; Gay Mens Hlth Crisis Inc, New York, NY USA; Treatment Act Grp, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; AIDS Res Consortium Atlanta, Atlanta, GA USA; McGill Univ, AIDS Ctr, Montreal, PQ, Canada	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; San Francisco Department of Public Health; Ghana Health Service; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; McGill University	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	rgrant@itsa.ucsf.edu	Flores, Gonzalo/A-3787-2009; Flores, Gonzalo/B-1807-2014	Grant, Robert/0000-0002-0851-7085				Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; HALIMA Y, 2005, INT AIDS SOC STAK HO; HAWKINS T, 2004, 15 INT AIDS C BANGK; Horton R, 2004, NEW YORK REV BOOKS, V51, P7; *JOINT UN PROGR HI, 2004, REP GLOB AIDS EP; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; MAYER K, 2004, 2004 INT AIDS C BANG; Mills Edward, 2005, BMC Int Health Hum Rights, V5, P6, DOI 10.1186/1472-698X-5-6; PAGESHAFER K, 2005, LANCET; RUIZ MS, 2001, NO TIME LOSE GETTING; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; SUBBARAO S, 2005, 12 C RETR OPP INF BO; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; Van Rompay KKA, 2000, J VIROL, V74, P1767, DOI 10.1128/JVI.74.4.1767-1774.2000; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027	19	61	70	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2005	309	5744					2170	2171		10.1126/science.1116204	http://dx.doi.org/10.1126/science.1116204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	970NX	16195446				2022-12-01	WOS:000232318000027
J	Glasier, A; Gulmezoglu, AM				Glasier, A; Gulmezoglu, AM			Sexual and reproductive health: call for papers	LANCET			English	Editorial Material									NHS Lothian Family Planning & Well Women Serv, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH4 1NL, Midlothian, Scotland; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Edinburgh; World Health Organization	Glasier, A (corresponding author), NHS Lothian Family Planning & Well Women Serv, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk						Adler M, 2003, BRIT MED J, V327, P62, DOI 10.1136/bmj.327.7406.62; [Anonymous], [No title captured]; *AVERT, 2005, STD STAT WORLDW; *DEP REPR HLTH RES, WHO MON EV; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Goto A, 1999, JAMA-J AM MED ASSOC, V282, P2173, DOI 10.1001/jama.282.22.2173; *UN POP INF NETW, 1994, REP INT C POP DEV; *WHO, 2000, UNS AB GLOB REG EST; Zwillich T, 2005, LANCET, V365, P1677	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					969	970		10.1016/S0140-6736(05)67354-0	http://dx.doi.org/10.1016/S0140-6736(05)67354-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168762				2022-12-01	WOS:000231955900010
J	Oliveira, RF; Carneiro, LA; Canario, AVM				Oliveira, RF; Carneiro, LA; Canario, AVM			No hormonal response in tied fights	NATURE			English	Article							CICHLID FISH; CHALLENGE HYPOTHESIS; SOCIAL MODULATION; ANDROGENS		Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1149041 Lisbon, Portugal; Univ Algarve, CCMar, P-8005139 Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Oliveira, RF (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1149041 Lisbon, Portugal.	ruiol@ispa.pt	Oliveira, Rui/A-3581-2013; Canario, Adelino/C-7942-2009	Oliveira, Rui/0000-0003-1528-618X; Canario, Adelino/0000-0002-6244-6468				BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Hirschenhauser K, 2004, ANIM BEHAV, V68, P741, DOI 10.1016/j.anbehav.2003.12.015; Martin P., 1993, MEASURING BEHAV INTR, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Oliveira RF, 2004, ADV STUD BEHAV, V34, P165, DOI 10.1016/S0065-3454(04)34005-2; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1984, GEN COMP ENDOCR, V56, P349, DOI 10.1016/0016-6480(84)90077-7; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	10	129	132	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					207	208		10.1038/437207a	http://dx.doi.org/10.1038/437207a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148924	Green Published			2022-12-01	WOS:000231696900041
J	Otten, M; Kezaala, R; Fall, A; Masresha, B; Martin, R; Cairns, L; Eggers, R; Biellik, R; Grabowsky, M; Strebel, P; Okwo-Bele, JM; Nshimirimana, D				Otten, M; Kezaala, R; Fall, A; Masresha, B; Martin, R; Cairns, L; Eggers, R; Biellik, R; Grabowsky, M; Strebel, P; Okwo-Bele, JM; Nshimirimana, D			Public-health impact of accelerated measles control in the WHO African Region 2000-03	LANCET			English	Article								Background In 2000, the WHO African Region adopted a plan to accelerate efforts to lower measles mortality with the goal of decreasing the number of measles deaths to near zero. By June, 2003, 19 African countries had completed measles supplemental immunisation activities (SIA) in children aged 9 months to 14 years as part of a comprehensive measles-control strategy.. We assessed the public-health impact of these control measures by use of available surveillance data. Methods We calculated percentage decline in reported measles cases during 1-2 years after SIA, compared with 6 years before SIA. On the basis of data from 13 of the 19 countries, we assumed that the percentage decline in measles deaths equalled that in measles cases. We also examined data on routine and SIA measles vaccine coverage, measles case-based surveillance, and suspected measles outbreaks. Findings Between 2000 and June, 2003, 82.1 million children were targeted for vaccination during initial SIA in 12 countries and follow-up SIA in seven countries. The average decline in the number of reported measles cases was 91%. In 17 of the 19 countries, measles case-based surveillance confirmed that transmission of measles virus, and therefore measles deaths, had been reduced to low or very low rates. The total estimated number of deaths averted in the year 2003 was 90 043. Between 2000 and 2003 in the African Region as a whole, we estimated that the percentage decline in annual measles deaths was around 20% (90 043 of 454 000). Interpretation The burden of measles in sub-Saharan Africa can be reduced to very low levels by means of appropriate strategies, resources, and personnel.	Ctr Dis Control & Prevent, Global Measles Branch, Global Immunizat Div, Atlanta, GA 30333 USA; WHO, Reg Off Africa, Harare, Zimbabwe; WHO, Reg Off Africa, Abidjan, Cote Ivoire; WHO, Reg Off Africa, Nairobi, Kenya; Amer Red Cross, Washington, DC 20006 USA; WHO, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; World Health Organization; American Red Cross; World Health Organization	Otten, M (corresponding author), Ctr Dis Control & Prevent, Global Measles Branch, Global Immunizat Div, MS E05,1600 Clifton, Atlanta, GA 30333 USA.	motten@cdc.gov						[Anonymous], 2004, Wkly Epidemiol Rec, V79, P20; Biellik R, 2002, LANCET, V359, P1564, DOI 10.1016/S0140-6736(02)08517-3; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P581; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P28; de Quadros C A, 1998, Bull World Health Organ, V76 Suppl 2, P47; Dietz V, 1997, INT J HEALTH SERV, V27, P767, DOI 10.2190/QPCQ-FBF8-6ABX-2TB5; Hersh BS, 2000, LANCET, V355, P1943, DOI 10.1016/S0140-6736(00)02325-4; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Otten MW, 2003, J INFECT DIS, V187, pS36, DOI 10.1086/368272; *WHO, 2000, WORLD HLTH REP 2001, P145; *WHO UN CHILDR FUN, JOINT STAT STRAT RED; YAMEOGO RK, 2002, INT J EPIDEMIOL, V34, P556	12	77	79	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					832	839		10.1016/S0140-6736(05)67216-9	http://dx.doi.org/10.1016/S0140-6736(05)67216-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139658	Green Submitted			2022-12-01	WOS:000231627000028
J	Carninci, P; Kasukawa, T; Katayama, S; Gough, J; Frith, MC; Maeda, N; Oyama, R; Ravasi, T; Lenhard, B; Wells, C; Kodzius, R; Shimokawa, K; Bajic, VB; Brenner, SE; Batalov, S; Forrest, ARR; Zavolan, M; Davis, MJ; Wilming, LG; Aidinis, V; Allen, JE; Ambesi-Impiombato, X; Apweiler, R; Aturaliya, RN; Bailey, TL; Bansal, M; Baxter, L; Beisel, KW; Bersano, T; Bono, H; Chalk, AM; Chiu, KP; Choudhary, V; Christoffels, A; Clutterbuck, DR; Crowe, ML; Dalla, E; Dalrymple, BP; de Bono, B; Della Gatta, G; di Bernardo, D; Down, T; Engstrom, P; Fagiolini, M; Faulkner, G; Fletcher, CF; Fukushima, T; Furuno, M; Futaki, S; Gariboldi, M; Georgii-Hemming, P; Gingeras, TR; Gojobori, T; Green, RE; Gustincich, S; Harbers, M; Hayashi, Y; Hensch, TK; Hirokawa, N; Hill, D; Huminiecki, L; Iacono, M; Ikeo, K; Iwama, A; Ishikawa, T; Jakt, M; Kanapin, A; Katoh, M; Kawasawa, Y; Kelso, J; Kitamura, H; Kitano, H; Kollias, G; Krishnan, SPT; Kruger, A; Kummerfeld, SK; Kurochkin, IV; Lareau, LF; Lazarevic, D; Lipovich, L; Liu, J; Liuni, S; McWilliam, S; Babu, MM; Madera, M; Marchionni, L; Matsuda, H; Matsuzawa, S; Miki, H; Mignone, F; Miyake, S; Morris, K; Mottagui-Tabar, S; Mulder, N; Nakano, N; Nakauchi, H; Ng, P; Nilsson, R; Nishiguchi, S; Nishikawa, S; Nori, F; Ohara, O; Okazaki, Y; Orlando, V; Pang, KC; Pavan, WJ; Pavesi, G; Pesole, G; Petrovsky, N; Piazza, S; Reed, J; Reid, JF; Ring, BZ; Ringwald, M; Rost, B; Ruan, Y; Salzberg, SL; Sandelin, A; Schneider, C; Schonbach, C; Sekiguchi, K; Semple, CAM; Seno, S; Sessa, L; Sheng, Y; Shibata, Y; Shimada, H; Shimada, K; Silva, D; Sinclair, B; Sperling, S; Stupka, E; Sugiura, K; Sultana, R; Takenaka, Y; Taki, K; Tammoja, K; Tan, SL; Tang, S; Taylor, MS; Tegner, J; Teichmann, SA; Ueda, HR; van Nimwegen, E; Verardo, R; Wei, CL; Yagi, K; Yamanishi, H; Zabarovsky, E; Zhu, S; Zimmer, A; Hide, W; Bult, C; Grimmond, SM; Teasdale, RD; Liu, ET; Brusic, V; Quackenbush, J; Wahlestedt, C; Mattick, JS; Hume, DA; Kai, C; Sasaki, D; Tomaru, Y; Fukuda, S; Kanamori-Katayama, M; Suzuki, M; Aoki, J; Arakawa, T; Iida, J; Imamura, K; Itoh, M; Kato, T; Kawaji, H; Kawagashira, N; Kawashima, T; Kojima, M; Kondo, S; Konno, H; Nakano, K; Ninomiya, N; Nishio, T; Okada, M; Plessy, C; Shibata, K; Shiraki, T; Suzuki, S; Tagami, M; Waki, K; Watahiki, A; Okamura-Oho, Y; Suzuki, H; Kawai, J; Hayashizaki, Y				Carninci, P; Kasukawa, T; Katayama, S; Gough, J; Frith, MC; Maeda, N; Oyama, R; Ravasi, T; Lenhard, B; Wells, C; Kodzius, R; Shimokawa, K; Bajic, VB; Brenner, SE; Batalov, S; Forrest, ARR; Zavolan, M; Davis, MJ; Wilming, LG; Aidinis, V; Allen, JE; Ambesi-Impiombato, X; Apweiler, R; Aturaliya, RN; Bailey, TL; Bansal, M; Baxter, L; Beisel, KW; Bersano, T; Bono, H; Chalk, AM; Chiu, KP; Choudhary, V; Christoffels, A; Clutterbuck, DR; Crowe, ML; Dalla, E; Dalrymple, BP; de Bono, B; Della Gatta, G; di Bernardo, D; Down, T; Engstrom, P; Fagiolini, M; Faulkner, G; Fletcher, CF; Fukushima, T; Furuno, M; Futaki, S; Gariboldi, M; Georgii-Hemming, P; Gingeras, TR; Gojobori, T; Green, RE; Gustincich, S; Harbers, M; Hayashi, Y; Hensch, TK; Hirokawa, N; Hill, D; Huminiecki, L; Iacono, M; Ikeo, K; Iwama, A; Ishikawa, T; Jakt, M; Kanapin, A; Katoh, M; Kawasawa, Y; Kelso, J; Kitamura, H; Kitano, H; Kollias, G; Krishnan, SPT; Kruger, A; Kummerfeld, SK; Kurochkin, IV; Lareau, LF; Lazarevic, D; Lipovich, L; Liu, J; Liuni, S; McWilliam, S; Babu, MM; Madera, M; Marchionni, L; Matsuda, H; Matsuzawa, S; Miki, H; Mignone, F; Miyake, S; Morris, K; Mottagui-Tabar, S; Mulder, N; Nakano, N; Nakauchi, H; Ng, P; Nilsson, R; Nishiguchi, S; Nishikawa, S; Nori, F; Ohara, O; Okazaki, Y; Orlando, V; Pang, KC; Pavan, WJ; Pavesi, G; Pesole, G; Petrovsky, N; Piazza, S; Reed, J; Reid, JF; Ring, BZ; Ringwald, M; Rost, B; Ruan, Y; Salzberg, SL; Sandelin, A; Schneider, C; Schonbach, C; Sekiguchi, K; Semple, CAM; Seno, S; Sessa, L; Sheng, Y; Shibata, Y; Shimada, H; Shimada, K; Silva, D; Sinclair, B; Sperling, S; Stupka, E; Sugiura, K; Sultana, R; Takenaka, Y; Taki, K; Tammoja, K; Tan, SL; Tang, S; Taylor, MS; Tegner, J; Teichmann, SA; Ueda, HR; van Nimwegen, E; Verardo, R; Wei, CL; Yagi, K; Yamanishi, H; Zabarovsky, E; Zhu, S; Zimmer, A; Hide, W; Bult, C; Grimmond, SM; Teasdale, RD; Liu, ET; Brusic, V; Quackenbush, J; Wahlestedt, C; Mattick, JS; Hume, DA; Kai, C; Sasaki, D; Tomaru, Y; Fukuda, S; Kanamori-Katayama, M; Suzuki, M; Aoki, J; Arakawa, T; Iida, J; Imamura, K; Itoh, M; Kato, T; Kawaji, H; Kawagashira, N; Kawashima, T; Kojima, M; Kondo, S; Konno, H; Nakano, K; Ninomiya, N; Nishio, T; Okada, M; Plessy, C; Shibata, K; Shiraki, T; Suzuki, S; Tagami, M; Waki, K; Watahiki, A; Okamura-Oho, Y; Suzuki, H; Kawai, J; Hayashizaki, Y		FANTOM Consortium; RIKEN Genome Explorat Res Grp S	The transcriptional landscape of the mammalian genome	SCIENCE			English	Article							GENE-EXPRESSION; IDENTIFICATION; HUMAN-CHROMOSOME-21	This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5' and 3' boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.				yosihide@gsc.riken.jp	Pesole, Graziano/C-1408-2009; Zavolan, Mihaela/S-3888-2016; Mattick, John/ABH-6130-2020; Zimmer, Andreas/B-8357-2009; Wahlestedt, Claes/A-7039-2009; K, Rimantas/H-4512-2019; Ganesh, Dunna Sai/AGX-5170-2022; McWilliam, Sean M/H-8978-2013; Seno, Shigeto/W-1426-2019; Schönbach, Christian/B-1998-2009; Hume, David A/C-7695-2013; Grimmond, Sean/K-3246-2019; Kawaji, Hideya/N-5116-2015; Ohara, Osamu/A-9119-2012; Marchionni, Luigi/S-6774-2017; Semple, Colin A M/A-5613-2009; Davis, Melissa/B-9168-2013; Kawai, Jun/A-6451-2016; Jakt, Lars/A-6290-2009; Carninci, Piero/K-1568-2014; Pesole, Graziano/K-5283-2019; Taylor, Martin S/C-3825-2009; Teasdale, Rohan D/B-2538-2009; Hide, Winston Hide/C-7217-2009; Mohan, Babu P./I-7362-2019; Martinez, Octavio/B-7375-2009; Sugiura, Koji/AAE-2966-2019; Chalk, Alistair/O-3522-2019; Kollias, George/A-7079-2012; Christoffels, Alan/C-3269-2014; Hide, Winston A/V-2727-2017; Kanapin, Alexander/E-7632-2013; Mattick, John S/I-7789-2012; Petrovsky, Nikolai/P-1912-2017; Dalla, Emiliano/AAH-3039-2020; di Bernardo, Diego/AAF-5881-2021; Teasdale, Rohan/AAD-6698-2019; Oyama, Rieko/AAA-3346-2020; Zabarovsky, Eugene R/A-6645-2010; Kelso, Janet/N-1812-2019; Itoh, Masayoshi/N-5363-2015; Liuni, Sabino/O-2441-2015; Stupka, Elia/J-6279-2012; Pavesi, Giulio/AAB-3230-2022; Konno, Hideaki/N-4366-2014; Salzberg, Steven/Q-6514-2019; Ueda, Hiroki R/C-5037-2014; Brusic, Vladimir/B-1478-2008; Konno, Hideaki/A-9191-2012; Brenner, Steven E/A-8729-2008; Koort, Kairi/C-7575-2017; tegner, jesper N/R-5095-2017; Ravasi, Timothy/B-8777-2008; Hayashi, Yoshitaka/I-6168-2014; Hayashizaki, Yoshihide/N-6590-2015; Salzberg, Steven L/F-6162-2011; Lipovich, Leonard/B-2355-2019; Forrest, Alistair/A-6597-2008; Liu, Edison/C-4141-2008; Bono, Hidemasa/AAF-3649-2020; Plessy, Charles/N-5054-2015; Grimmond, Sean M/J-5304-2016; Sandelin, Albin/G-2881-2011; Katayama, Shintaro/F-2958-2010; Ohara, Osamu/G-5448-2015; Hide, Winston/R-3815-2019; Rost, Burkhard/A-1908-2016; Lazarevic, Dejan/AAN-1861-2020; Wells, Christine A/A-5071-2010; Hensch, Takao/L-4182-2019; Faulkner, Geoffrey J/M-3168-2014; Kurochkin, Igor/Q-5646-2019; Aidinis, Vassilis/AAF-5380-2021; van Nimwegen, Erik/ABF-1085-2021; Reid, James/G-2496-2010; Nori, Franco/B-1222-2009; Kasukawa, Takeya/N-5070-2015; di Bernardo, Diego/I-9440-2012; Chiu, Kuo-Ping/AAG-8855-2020; Dalrymple, Brian P/F-8721-2010; Nilsson, Roland/AAJ-3519-2021; Pesole, Graziano/E-9051-2014; Kanapin, Alexander A/Q-7590-2016; Waki, Kazunori/T-6444-2019; Gariboldi, Manuela/K-4744-2016; Bajic, Vladimir/D-2810-2009	Pesole, Graziano/0000-0003-3663-0859; Mattick, John/0000-0002-7680-7527; K, Rimantas/0000-0001-9417-8894; McWilliam, Sean M/0000-0002-3148-0428; Seno, Shigeto/0000-0003-3861-6444; Schönbach, Christian/0000-0002-0693-7617; Grimmond, Sean/0000-0002-8102-7998; Kawaji, Hideya/0000-0002-0575-0308; Marchionni, Luigi/0000-0002-7336-8071; Semple, Colin A M/0000-0003-1765-4118; Carninci, Piero/0000-0001-7202-7243; Taylor, Martin S/0000-0001-7656-330X; Teasdale, Rohan D/0000-0001-7455-5269; Hide, Winston Hide/0000-0002-8621-3271; Sugiura, Koji/0000-0001-8945-3353; Chalk, Alistair/0000-0002-9630-6236; Kollias, George/0000-0003-1867-3150; Christoffels, Alan/0000-0002-0420-2916; Hide, Winston A/0000-0002-8621-3271; Mattick, John S/0000-0002-7680-7527; Petrovsky, Nikolai/0000-0002-1580-5245; Dalla, Emiliano/0000-0002-4687-6011; di Bernardo, Diego/0000-0002-1911-7407; Teasdale, Rohan/0000-0001-7455-5269; Kelso, Janet/0000-0002-3618-322X; Itoh, Masayoshi/0000-0002-1772-318X; Stupka, Elia/0000-0003-3154-4011; Konno, Hideaki/0000-0002-8470-4835; Salzberg, Steven/0000-0002-8859-7432; Ueda, Hiroki R/0000-0001-8342-9176; Brusic, Vladimir/0000-0003-0523-5266; Brenner, Steven E/0000-0001-7559-6185; Koort, Kairi/0000-0001-7831-8973; tegner, jesper N/0000-0002-9568-5588; Hayashi, Yoshitaka/0000-0002-7557-4303; Salzberg, Steven L/0000-0002-8859-7432; Lipovich, Leonard/0000-0002-0531-3570; Forrest, Alistair/0000-0003-4543-1675; Bono, Hidemasa/0000-0003-4413-0651; Plessy, Charles/0000-0001-7410-6295; Grimmond, Sean M/0000-0002-8102-7998; Sandelin, Albin/0000-0002-7109-7378; Katayama, Shintaro/0000-0001-7581-5157; Ohara, Osamu/0000-0002-3328-9571; Hide, Winston/0000-0002-8621-3271; Rost, Burkhard/0000-0003-0179-8424; Wells, Christine A/0000-0003-3133-3628; Faulkner, Geoffrey J/0000-0001-5769-4494; van Nimwegen, Erik/0000-0001-6338-1312; Nori, Franco/0000-0003-3682-7432; Kasukawa, Takeya/0000-0001-5085-0802; di Bernardo, Diego/0000-0002-1911-7407; Chiu, Kuo-Ping/0000-0001-9144-0674; Dalrymple, Brian P/0000-0003-3891-5233; Pesole, Graziano/0000-0003-3663-0859; Kanapin, Alexander A/0000-0001-9802-5297; Huminiecki, Lukasz/0000-0003-1943-4450; Piazza, Silvano/0000-0002-7156-5434; Quackenbush, John/0000-0002-2702-5879; Mulder, Nicola J/0000-0003-4905-0941; lazarevic, dejan/0000-0003-4527-290X; Gustincich, Stefano/0000-0002-2749-2514; Fukuda, Shiro/0000-0002-0065-662X; Frith, Martin/0000-0003-0998-2859; Harbers, Matthias/0000-0002-5613-7220; Waki, Kazunori/0000-0001-7311-7208; Jakt, Lars Martin/0000-0002-3787-8138; Crowe, Mark/0000-0002-9514-2487; Liu, Jinfeng/0000-0002-0343-8222; Gariboldi, Manuela/0000-0001-8406-165X; Aidinis, Vassilis/0000-0001-9531-7729; Bajic, Vladimir/0000-0001-5435-4750; Zavolan, Mihaela/0000-0002-8832-2041; Kurochkin, Igor V/0000-0002-6231-9004; Lenhard, Boris/0000-0002-1114-1509; Ravasi, Timothy/0000-0002-9950-465X; Engstrom, Par/0000-0001-5265-2121; Apweiler, Rolf/0000-0001-7078-200X; Reid, James/0000-0001-6997-2850; Kummerfeld, Sarah/0000-0002-0089-2358; Rickert-Sperling, Silke/0000-0002-7135-3298; Green, Richard/0000-0003-0516-5827; fagiolini, michela/0000-0003-2807-803X; Baxter, Laura/0000-0001-7941-1088; Pang, Ken/0000-0002-6881-775X; Wilming, Laurens/0000-0002-4154-7358; Batalov, Sergey/0000-0002-0925-0554; Matsuda, Hideo/0000-0002-4701-3779; Gingeras, Thomas/0000-0001-9106-3573; de Bono, Bernard/0000-0003-0638-5274; Hume, David/0000-0002-2615-1478	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000136, Z01HG000070] Funding Source: NIH RePORTER; Telethon [TGM03P17, TGM06S01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon(Fondazione Telethon)		BAJIC V, UNPUB; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; CARNINCI P, UNPUB; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; GOUGH JE, UNPUB; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; MAEDA N, UNPUB; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; MATTICK JS, IN PRESS HUM MOL GEN; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Okazaki Y, 2003, GENOME RES, V13, P1267, DOI 10.1101/gr.1445603; RAVASI T, IN PRESS ENCY GENETI; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	23	2632	13409	20	764	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1559	1563		10.1126/science.1112014	http://dx.doi.org/10.1126/science.1112014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141072				2022-12-01	WOS:000231715000049
J	Stahley, MR; Strobel, SA				Stahley, MR; Strobel, SA			Structural evidence for a two-metal-ion mechanism of group I intron splicing	SCIENCE			English	Article							TETRAHYMENA RIBOZYME REACTION; CATALYTIC METAL-ION; CRYSTAL-STRUCTURE; ACTIVE-SITE; ANGSTROM RESOLUTION; RNA; IDENTIFICATION; POLYMERASE; GUANOSINE; PRECURSOR	We report the 3.4 angstrom crystal structure of a catalytically active group I intron splicing intermediate containing the complete intron, both exons, the scissile phosphate, and aft of the functional groups implicated in catalytic meta[ ion coordination, including the 2'-OH of the terminal guanosine. This structure suggests that, like protein phosphoryltransferases, an RNA phosphoryltransferase can use a two-metal-ion mechanism. Two Mg2+ ions are positioned 3.9 angstroms apart and are directly coordinated by all six of the biochemically predicted ligands. The evolutionary convergence of RNA and protein active sites on the same inorganic architecture highlights the intrinsic chemical capacity of the two-metal-ion catalytic mechanism for phosphoryl transfer.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	scott.strobel@yale.edu						Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; BASS BL, 1986, BIOCHEMISTRY-US, V25, P4473, DOI 10.1021/bi00364a001; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/j.molcel.2004.10.003; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; Horton NC, 2001, NAT STRUCT BIOL, V8, P290, DOI 10.1038/86149; Hougland JL, 2005, PLOS BIOL, V3, P1536, DOI 10.1371/journal.pbio.0030277; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Mei R, 1996, BIOCHEMISTRY-US, V35, P5796, DOI 10.1021/bi9527653; MORAN S, 1993, BIOCHEMISTRY-US, V32, P5247, DOI 10.1021/bi00070a037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Sjogren AS, 1997, NUCLEIC ACIDS RES, V25, P648, DOI 10.1093/nar/25.3.648; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strater N, 1996, ANGEW CHEM INT EDIT, V35, P2024, DOI 10.1002/anie.199620241; Strobel SA, 1999, CHEM BIOL, V6, P153, DOI 10.1016/S1074-5521(99)89007-3; Szewczak AA, 2002, BIOCHEMISTRY-US, V41, P2516, DOI 10.1021/bi011973u; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	32	164	177	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1587	1590		10.1126/science.1114994	http://dx.doi.org/10.1126/science.1114994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141079				2022-12-01	WOS:000231715000057
J	Greely, HT				Greely, HT			Banning genetic discrimination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFORMATION		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Greely, HT (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Greely HT, 2001, U PENN LAW REV, V149, P1483, DOI 10.2307/3312966; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755	4	31	31	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					865	867		10.1056/NEJMp058116	http://dx.doi.org/10.1056/NEJMp058116			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135828				2022-12-01	WOS:000231551100001
J	Sachedina, A				Sachedina, A			End-of-life: the Islamic view	LANCET			English	Editorial Material									Univ Virginia, Dept Religious Studies, Charlottesville, VA 22904 USA	University of Virginia	Sachedina, A (corresponding author), Univ Virginia, Dept Religious Studies, POB 400126, Charlottesville, VA 22904 USA.	aas@cms.mail.virginia.edu						AHMAD B, 1965, KITAB ALMAHASIN, P123; *ALQ ALTH BISH MAW, 1990, MAJALLA ALBUHUTH ALF, V4, P159; HABIBI H, 2001, MARGI MAGHZI DIDGAHI; HAYYAN AA, 1992, ALMUQABASAT, P132; MUHAMMAD B, 1979, JAMI ALSAHIHI KITAB, P373; RISPLERCHAIM V, 1993, ISLAMIC MED ETHICS 2, P63; Sachedina A., 1995, ENCY BIOETHICS, P1289	7	112	113	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2005	366	9487					774	779		10.1016/S0140-6736(05)67183-8	http://dx.doi.org/10.1016/S0140-6736(05)67183-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	958UV	16125596				2022-12-01	WOS:000231474600035
J	Meissner, A; Jaenisch, R				Meissner, A; Jaenisch, R			Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts	NATURE			English	Article							EMBRYONIC STEM-CELLS; GENE-THERAPY; CDX2; MICE; COMPLEMENTATION; DIFFERENTIATION; LINEAGES; CLONING	The derivation of embryonic stem (ES) cells by nuclear transfer holds great promise for research and therapy but involves the destruction of cloned human blastocysts. Proof of principle experiments have shown that 'customized' ES cells derived by nuclear transfer (NT-ESCs) can be used to correct immunodeficiency in mice. Importantly, the feasibility of the approach has been demonstrated recently in humans, bringing the clinical application of NT- ESCs within reach. Altered nuclear transfer (ANT) has been proposed as a variation of nuclear transfer because it would create abnormal nuclear transfer blastocysts that are inherently unable to implant into the uterus but would be capable of generating customized ES cells. To assess the experimental validity of this concept we have used nuclear transfer to derive mouse blastocysts from donor fibroblasts that carried a short hairpin RNA construct targeting Cdx2. Cloned blastocysts were morphologically abnormal, lacked functional trophoblast and failed to implant into the uterus. However, they efficiently generated pluripotent embryonic stem cells when explanted into culture.	MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu						ADJAYE J, STEM CELLS; BRAMBRINK T, UNPUB P NATL ACAD SC; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hurlbut WB, 2005, PERSPECT BIOL MED, V48, P211, DOI 10.1353/pbm.2005.0055; Hwang Woo Suk, 2005, Science (Washington D C), V308, P1777, DOI 10.1126/science.1112286; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Melton DA, 2004, NEW ENGL J MED, V351, P2791, DOI 10.1056/NEJMp048348; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; President's Council on Bioethics, 2005, ALT SOURC HUM PLUR S; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026	18	165	179	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					212	215		10.1038/nature04257	http://dx.doi.org/10.1038/nature04257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16227971	Bronze			2022-12-01	WOS:000234538400042
J	Meylan, E; Curran, J; Hofmann, K; Moradpour, D; Binder, M; Bartenschlager, R; Tschopp, R				Meylan, E; Curran, J; Hofmann, K; Moradpour, D; Binder, M; Bartenschlager, R; Tschopp, R			Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus	NATURE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; MEMBRANE ASSOCIATION; IKK-EPSILON; ACTIVATION; HELICASE; IDENTIFICATION; CLEAVAGE; DETERMINANTS	Antiviral immunity against a pathogen is mounted upon recognition by the host of virally associated structures. One of these viral 'signatures', double-stranded (ds) RNA, is a replication product of most viruses within infected cells and is sensed by Toll-like receptor 3 (TLR3) and the recently identified cytosolic RNA helicases RIG-I (retinoic acid inducible gene I, also known as Ddx58) and Mda5 (melanoma differentiation-associated gene 5, also known as Ifih1 or Helicard)(1). Both helicases detect dsRNA, and through their protein-interacting CARD domains, relay an undefined signal resulting in the activation of the transcription factors interferon regulatory factor 3 (IRF3) and NF-kappa B. Here we describe Cardif, a new CARD-containing adaptor protein that interacts with RIG-I and recruits IKK alpha, IKK beta and IKK epsilon kinases by means of its C-terminal region, leading to the activation of NF-kappa B and IRF3. Overexpression of Cardif results in interferon-beta and NF-kappa B promoter activation, and knockdown of Cardif by short interfering RNA inhibits RIG-I-dependent antiviral responses. Cardif is targeted and inactivated by NS3-4A, a serine protease from hepatitis C virus known to block interferon-beta production. Cardif thus functions as an adaptor, linking the cytoplasmic dsRNA receptor RIG-I to the initiation of antiviral programmes.	Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; MEMOREC Biotec GmbH, D-50829 Cologne, Germany; CHU Vaudois, Div Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland; Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany	University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ruprecht Karls University Heidelberg	Tschopp, R (corresponding author), Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Binder, Marco/E-9717-2011; Hofmann, Kay/D-6714-2011; Bartenschlager, Ralf/L-2582-2015; Moradpour, Darius/G-7918-2017	Binder, Marco/0000-0002-5805-6109; Hofmann, Kay/0000-0002-2289-9083; Bartenschlager, Ralf/0000-0001-5601-9307; Meylan, Etienne/0000-0002-0899-2230; Moradpour, Darius/0000-0003-1977-6792				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun Y.W., 1997, THESIS SHANGHAI 2 ME; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	32	1847	1957	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1167	1172		10.1038/nature04193	http://dx.doi.org/10.1038/nature04193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16177806	Green Published			2022-12-01	WOS:000232660500047
J	Mumma, MJ; DiSanti, MA; Magee-Sauer, K; Bonev, BP; Villanueva, GL; Kawakita, H; Dello Russo, N; Gibb, EL; Blake, GA; Lyke, JE; Campbell, RD; Aycock, J; Conrad, A; Hill, GM				Mumma, MJ; DiSanti, MA; Magee-Sauer, K; Bonev, BP; Villanueva, GL; Kawakita, H; Dello Russo, N; Gibb, EL; Blake, GA; Lyke, JE; Campbell, RD; Aycock, J; Conrad, A; Hill, GM			Parent volatiles in comet 9P/Tempel 1: Before and after impact	SCIENCE			English	Article								We quantified eight parent votatiles (H(2)O, C(2)H(6), HCN, CO, CH(3)OH, H(2)CO, C(2)H(2), and CH(4)) in the Jupiter-family comet Tempel 1 using high-dispersion infrared spectroscopy in the wavelength range 2.8 to 5.0 micrometers. The abundance ratio for ethane was significantly higher after impact, whereas those for methanol and hydrogen cyanide were unchanged. The abundance ratios in the ejecta are similar to those for most Oort cloud comets, but methanol and acetylene are tower in Tempel 1 by a factor of about 2. These results suggest that the volatile ices in Tempel 1 and in most Oort cloud comets originated in a common region of the protoplanetary disk.	NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; Rowan Univ, Dept Phys & Astron, Glassboro, NJ 08028 USA; Univ Toledo, Dept Phys & Astron, Ritter Astrophys Res Ctr, Toledo, OH 43606 USA; Kyoto Sangyo Univ, Dept Phys, Kita Ku, Kyoto 6038555, Japan; Johns Hopkins Univ, Appl Phys Lab, Space Dept, Planetary Explorat Grp, Laurel, MD 20723 USA; Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; WM Keck Observ, Kamuela, HI 96743 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Rowan University; University System of Ohio; University of Toledo; Kyoto Sangyo University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Missouri System; University of Missouri Saint Louis; California Institute of Technology	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA.	michael.j.mumma@nasa.gov	Magee-Sauer, Karen/K-6061-2015; Russo, Neil Dello/G-2727-2015; mumma, michael j/I-2764-2013	Magee-Sauer, Karen/0000-0002-4979-9875; Russo, Neil Dello/0000-0002-8379-7304; mumma, michael j/0000-0003-4627-750X				A'Hearn MF, 2005, SPACE SCI REV, V117, P1, DOI 10.1007/s11214-005-3387-3; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Biver N, 2002, EARTH MOON PLANETS, V90, P323, DOI 10.1023/A:1021530316352; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bocklelee-Morvan D., 2004, COMETS, P391; Delsemme AH, 2000, ICARUS, V146, P313, DOI 10.1006/icar.2000.6404; Dones L., 2005, COMETS, P153; ESPINASSE S, 1993, PLANET SPACE SCI, V41, P409, DOI 10.1016/0032-0633(93)90001-I; Gladman B, 2005, SCIENCE, V307, P71, DOI 10.1126/science.1100553; Irvine W. M., 2000, Protostars and planets 4, P1159; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Levison HF, 1996, ASTR SOC P, V107, P173; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; MORBIDELLI A, 2005, COMETS, V2, P175; Mumma MJ, 2003, ADV SPACE RES-SERIES, V31, P2563, DOI 10.1016/S0273-1177(03)00578-7; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1177; WEIDENSCHILLING SJ, 2004, COMETS, V2, P97	19	140	143	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					270	274		10.1126/science.1119337	http://dx.doi.org/10.1126/science.1119337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16166477				2022-12-01	WOS:000232670100039
J	Van Sickle, MD; Duncan, M; Kingsley, PJ; Mouihate, A; Urbani, P; Mackie, K; Stella, N; Makriyannis, A; Piomelli, D; Davison, JS; Marnett, LJ; Di Marzo, V; Pittman, QJ; Patel, KD; Sharkey, KA				Van Sickle, MD; Duncan, M; Kingsley, PJ; Mouihate, A; Urbani, P; Mackie, K; Stella, N; Makriyannis, A; Piomelli, D; Davison, JS; Marnett, LJ; Di Marzo, V; Pittman, QJ; Patel, KD; Sharkey, KA			Identification and functional characterization of brainstem cannabinoid CB2 receptors	SCIENCE			English	Article							ACID AMIDE HYDROLASE; ENDOCANNABINOID SYSTEM; ANANDAMIDE; NEURONS; CLONING; TARGET; CELLS	The presence and function of CB2 receptors in central nervous system (CNS) neurons are controversial. We report the expression of CB2 receptor messenger RNA and protein localization on brainstem neurons. These functional CB2 receptors in the brainstem were activated by a CB2 receptor agonist, 2-arachidonoylglycerol, and by elevated endogenous levels of endocannabinoids, which also act at CB1 receptors. CB2 receptors represent an alternative site of action of endocannabinoids that opens the possibility of nonpsychotropic therapeutic interventions using enhanced endocannabinoid levels in localized brain areas.	Univ Calgary, Inst Infect Immun & Inflammat, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Biochem, Nashville, TN 37232 USA; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol Psychiat & Behav Sci, Seattle, WA 98195 USA; Northeastern Univ, Dept Pharmaceut Sci, Ctr Drug Discovery, Boston, MA 02115 USA; Univ Calif Irvine, Dept Pharmacol, Gillespie Neurosci Facil, Irvine, CA 92697 USA	University of Calgary; University of Calgary; Vanderbilt University; Consiglio Nazionale delle Ricerche (CNR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Northeastern University; University of California System; University of California Irvine	Sharkey, KA (corresponding author), Univ Calgary, Inst Infect Immun & Inflammat, Calgary, AB T2N 4N1, Canada.	ksharkey@ucalgary.ca	Di Marzo, Vincenzo/AAD-7742-2019; Patel, Kamala D/AAX-1245-2021; Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013; Makriyannis, Alexandros/GRF-1518-2022	Di Marzo, Vincenzo/0000-0002-1490-3070; Mackie, Ken/0000-0001-8501-6199; Makriyannis, Alexandros/0000-0003-3272-3687; Sharkey, Keith/0000-0001-9560-1711; Pittman, Quentin/0000-0003-0984-7665; Sepers, Marja/0000-0002-6510-2804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Benito C, 2003, J NEUROSCI, V23, P11136; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Brown SM, 2002, BBA-GENE STRUCT EXPR, V1576, P255, DOI 10.1016/S0167-4781(02)00341-X; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gaetani S, 2003, TRENDS MOL MED, V9, P474, DOI 10.1016/j.molmed.2003.09.005; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Hornby PJ, 2001, AM J MED, V111, P106, DOI 10.1016/S0002-9343(01)00849-X; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; VANSICKLE MD, UNPUB	27	1131	1203	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					329	332		10.1126/science.1115740	http://dx.doi.org/10.1126/science.1115740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224028	Green Submitted			2022-12-01	WOS:000232670100057
J	Albert, AYK; Otto, SP				Albert, AYK; Otto, SP			Sexual selection can resolve sex-linked sexual antagonism	SCIENCE			English	Article							EVOLUTION; LINKAGE	Sexual selection is a potent evolutionary force. However, very few models have considered the evolution of female preferences for traits expressed in both sexes. Here we explore how female preferences coevolve with sexually antagonistic traits, which involve alleles that are beneficial to one sex but harmful to the other. We show that with a sexually antagonistic trait on the X chromosome (males XY, females XX), females evolve to prefer mates carrying alleles beneficial to daughters. In contrast, with a Z-linked trait (mates ZZ, females ZW), females more often evolve mating preferences for mates carrying alleles beneficial to sons (that is, flashy displays).	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Albert, AYK (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	albert@zoology.ubc.ca	Albert, Arianne/AAG-7518-2019; Otto, Sarah Perin/K-5625-2012	Albert, Arianne/0000-0002-3050-0888; Otto, Sarah Perin/0000-0003-3042-0818				Andersson Malte, 1994; Andres JA, 2003, J EVOLUTION BIOL, V16, P219, DOI 10.1046/j.1420-9101.2003.00525.x; FEDOROVICH RD, 1994, PHYS LOW-DIMENS STR, V1, P83; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; HASTINGS IM, 1994, P ROY SOC B-BIOL SCI, V258, P83, DOI 10.1098/rspb.1994.0146; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kirkpatrick M, 2002, GENETICS, V161, P1727; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI [10.2307/2407961, 10.1111/j.1558-5646.1982.tb05003.x]; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; OTTO SP, 1991, EVOLUTION, V45, P1443, DOI [10.2307/2409891, 10.1111/j.1558-5646.1991.tb02647.x]; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Reinhold K, 1998, BEHAV ECOL SOCIOBIOL, V44, P1, DOI 10.1007/s002650050508; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.1111/j.1558-5646.1984.tb00346.x, 10.2307/2408385]; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; SEGER J, 1986, NATURE, V319, P771, DOI 10.1038/319771a0	17	75	75	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					119	121		10.1126/science.1115328	http://dx.doi.org/10.1126/science.1115328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210543				2022-12-01	WOS:000232477000052
J	McHenry, CR; Cook, AG; Wroe, S				McHenry, CR; Cook, AG; Wroe, S			Bottom-feeding plesiosaurs	SCIENCE			English	Article							STOMACH STONES		Univ Newcastle, Sch Environm & Life Sci Geol, Newcastle, NSW 2308, Australia; Queensland Museum, Brisbane, Qld 4101, Australia; Univ Sydney, Key Ctr Microscopy & Microanal, Electron Microscope Unit, Sydney, NSW 2006, Australia	University of Newcastle; Queensland Museum; University of Sydney	McHenry, CR (corresponding author), Univ Newcastle, Sch Environm & Life Sci Geol, Newcastle, NSW 2308, Australia.	colin.mchenry@newcastle.edu.au	Wroe, Stephen/A-4462-2010	Wroe, Stephen/0000-0002-5813-9182; Wroe, Stephen/0000-0002-6365-5915				BAKKER RT, 1993, GEOLOGICAL ASS CANAD, V39, P641; Brown B., 1904, Science, V(2), P185; Cicimurri David J., 2001, Transactions of the Kansas Academy of Science, V104, P129, DOI 10.1660/0022-8443(2001)104[0129:AEWSCA]2.0.CO;2; DARBY DG, 1980, J PALEONTOL, V54, P548; Henderson DM, 2003, CAN J ZOOL, V81, P1346, DOI 10.1139/Z03-122; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Northwood C, 2005, PALAEONTOLOGY, V48, P49, DOI 10.1111/j.1475-4983.2004.00432.x; TAYLOR MA, 1981, NATURE, V290, P628, DOI 10.1038/290628a0; Thulborn Tony, 1993, Modern Geology, V18, P489; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Williston SW, 1904, SCIENCE, V20, P565, DOI 10.1126/science.20.513.565-a; WILLISTON SW, 1903, MUS PUBL GEOL SER, V2, P1	12	52	56	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					75	75		10.1126/science.1117241	http://dx.doi.org/10.1126/science.1117241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210529				2022-12-01	WOS:000232477000038
J	Dell'Anno, A; Danovaro, R				Dell'Anno, A; Danovaro, R			Extracellular DNA plays a key role in deep-sea ecosystem functioning	SCIENCE			English	Article							MARINE-SEDIMENTS; PHOSPHORUS; ATLANTIC		Polytech Univ Marche, Fac Sci, Dept Marine Sci, I-60131 Ancona, Italy	Marche Polytechnic University	Danovaro, R (corresponding author), Polytech Univ Marche, Fac Sci, Dept Marine Sci, Via Brecce Bianche, I-60131 Ancona, Italy.	r.danovaro@univpm.it	Dell'Anno, Antonio AD/G-9468-2012	Dell'Anno, Antonio AD/0000-0002-4324-7834				Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; Dell'Anno A, 2002, LIMNOL OCEANOGR, V47, P899, DOI 10.4319/lo.2002.47.3.0899; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	7	232	240	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2179	2179		10.1126/science.1117475	http://dx.doi.org/10.1126/science.1117475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195451				2022-12-01	WOS:000232318000032
J	Werner, SL; Barken, D; Hoffmann, A				Werner, SL; Barken, D; Hoffmann, A			Stimulus specificity of gene expression programs determined by temporal control of IKK activity	SCIENCE			English	Article							NF-KAPPA-B; PROTEINS; MICE	A small number of mammalian signaling pathways mediate a myriad of distinct physiological responses to diverse cellular stimuli. Temporal control of the signaling module that contains I kappa B kinase (IKK), its substrate inhibitor of NF-kappa B (I kappa B), and the key inflammatory transcription factor NF-kappa B can allow for selective gene activation. We have demonstrated that different inflammatory stimuli induce distinct IKK profiles, and we examined the underlying molecular mechanisms. Although tumor necrosis factor-alpha (TNF alpha)-induced IKK activity was rapidly attenuated by negative feedback, lipopolysaccharide (LPS) signaling and LPS-specific gene expression programs were dependent on a cytokine-mediated positive feedback mechanism. Thus, the distinct biological responses to LPS and TNF alpha depend on signaling pathway-specific mechanisms that regulate the temporal profile of IKK activity.	Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA		Hoffmann, A (corresponding author), Dept Chem & Biochem, Signaling Syst Lab, 9500 Gilman Dr,Mailcode 0375, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu			NIGMS NIH HHS [GM72024, GM071573] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024, R01GM071573] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; KEARNS JD, UNPUB; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; QUIAMBAO R, UNPUB; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	18	393	403	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1857	1861		10.1126/science.1113319	http://dx.doi.org/10.1126/science.1113319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166517				2022-12-01	WOS:000231989500050
J	Keown, D				Keown, D			End of life: the Buddhist view	LANCET			English	Editorial Material									Univ London Goldsmiths Coll, London SE14 6NW, England	University of London; Goldsmiths University London	Keown, D (corresponding author), Univ London Goldsmiths Coll, London SE14 6NW, England.	d.keown@gold.ac.uk						FLORIDA RE, 1993, STUD RELIG-SCI RELIG, V22, P35, DOI 10.1177/000842989302200103; HARVEY P, 2001, BUDDHIST STUD REV, P183; HARVEY P, 2000, INTRO BUDDHIST ETHIC, P292; Hoffenberg R, 2001, BMJ-BRIT MED J, V323, P1478, DOI 10.1136/bmj.323.7327.1478; Keown D, 1998, J Law Relig, V13, P385, DOI 10.2307/1051472; KEOWN D, 2001, BUDDHISM BIOETHICS, P144; Keown Damien, 1999, BUDDHISM ABORTION, P199; LaFleur W. A., 2001, ETHICS WORLD RELIG, P271; OLDENBERG H, 1992, VINAYA PITAKAM; Potts Michael, 2000, BRAIN DEATH CASE BRA; RATANAKUL P, 2000, CONT BUDDHIST ETHICS, P169; TAKAKUSU J, 1975, SAMANTAPASADIKA; Youngner S., 1999, DEFINITION DEATH CON; Youngner SJ, 2001, J MED PHILOS, V26, P527, DOI 10.1076/jmep.26.5.527.3002	14	42	43	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					952	955		10.1016/S0140-6736(05)67323-0	http://dx.doi.org/10.1016/S0140-6736(05)67323-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	962YR	16154024				2022-12-01	WOS:000231770000035
J	Rome, LC; Flynn, L; Goldman, EM; Yoo, TD				Rome, LC; Flynn, L; Goldman, EM; Yoo, TD			Generating electricity while walking with loads	SCIENCE			English	Article							MECHANICAL WORK; METABOLIC COST; ENERGY; MOTION; STEP; MASS	We have developed the suspended-load backpack, which converts mechanical energy from the vertical movement of carried loads (weighing 20 to 38 kilograms) to electricity during normal walking [generating up to 7.4 watts, or a 300-fold increase over previous shoe devices (20 milliwatts)]. Unexpectedly, little extra metabolic energy (as compared to that expended carrying a rigid backpack) is required during electricity generation. This is probably due to a compensatory change in gait or loading regime, which reduces the metabolic power required for walking. This electricity generation can help give field scientists, explorers, and disaster-relief workers freedom from the heavy weight of replacement batteries and thereby extend their ability to operate in remote areas.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	University of Pennsylvania; Marine Biological Laboratory - Woods Hole	Rome, LC (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lrome@sas.upenn.edu		Flynn, Louis/0000-0003-2966-0355	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038404, R01AR038404, R01AR046125] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR46125, AR38404] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALEXANDER RM, 1991, J EXP BIOL, V160, P55; [Anonymous], 2004, LOW POWER ELECT DESI; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; Cavagna GA, 2002, J EXP BIOL, V205, P3413; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P647, DOI DOI 10.1113/JPHYSI0L.1977.SP011866; Donelan JM, 2002, J EXP BIOL, V205, P3717; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; DRAKE J, 2001, WIRED, V9, P90; Ferguson RA, 2001, J PHYSIOL-LONDON, V536, P261, DOI 10.1111/j.1469-7793.2001.00261.x; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; GonzuYlez JL., 2002, INT J SOC MAT ENG RE, V10, P34, DOI DOI 10.5188/IJSMER.10.34; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; Kymissis J, 1998, SECOND INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P132, DOI 10.1109/ISWC.1998.729539; Margaria R., 1976, BIOMECHANICS ENERGET; Minetti AE, 2004, J EXP BIOL, V207, P1265, DOI 10.1242/jeb.00886; Schmidt-Nielsen K., 1988, ANIMAL PHYSL ADAPTAT; STANFORD S, 2003, P 13 INT S UNM UNT S	21	448	468	12	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1725	1728		10.1126/science.1111063	http://dx.doi.org/10.1126/science.1111063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151012				2022-12-01	WOS:000231836700045
J	Zhang, YB; Yuan, FH; Presnell, SR; Tian, KL; Gao, Y; Tomkinson, AE; Gu, LY; Li, GM				Zhang, YB; Yuan, FH; Presnell, SR; Tian, KL; Gao, Y; Tomkinson, AE; Gu, LY; Li, GM			Reconstitution of 5 '-directed human mismatch repair in a purified system	CELL			English	Article						n	NUCLEOTIDE EXCISION-REPAIR; HUMAN EXONUCLEASE-I; REPLICATION PROTEIN-A; HOMEOLOGOUS RECOMBINATION; FUNCTIONAL INTERACTIONS; MUTL-ALPHA; DNA; INSTABILITY; DEFICIENCY; COMPONENTS	This paper reports reconstitution of 5'-nick-directed mismatch repair using purified human proteins. The reconstituted system includes MutS alpha or MutS beta, MutL alpha, RPA, EXO1, HMGB1, PCNA, RFC, polymerase delta, and ligase I. In this system, MutS beta plays a limited role in repair of base-base mismatches, but it processes insertion/deletion mispairs much more efficiently than MutSa, which efficiently corrects both types of heteroduplexes. MutL alpha reduces the processivity of EXO1 and terminates EXO1-catalyzed excision upon mismatch removal. In the absence of MutL alpha, mismatch-provoked excision by EXO1 occurs extensively. RPA and HMGB1 play similar but complementary roles in stimulating MutS alpha-activated, EXO1-catalyzed excision in the presence of a mismatch, but RPA has a distinct role in facilitating MutL alpha-mediated excision termination past mismatch. Evidence is provided that efficient repair of a single mismatch requires multiple molecules of MutS alpha-MutL alpha complex. These data suggest a model for human mismatch repair involving coordinated initiation and termination of mismatch-provoked excision.	Univ Kentucky, Med Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Pathol, Med Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Mol & Cellular Biochem, Med Ctr, Lexington, KY 40536 USA; Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Greenbaum Canc Ctr, Baltimore, MD 21201 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Li, GM (corresponding author), Univ Kentucky, Med Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014; Zhang, Yanbin/F-2998-2011; Yuan, Fenghua/F-8736-2011	Zhang, Yanbin/0000-0002-7263-5510; Li, Guo-Min/0000-0002-9842-4578	NATIONAL CANCER INSTITUTE [R01CA104333, R01CA085377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER; NCI NIH HHS [CA85377, CA104333] Funding Source: Medline; NIEHS NIH HHS [ES013198] Funding Source: Medline; NIGMS NIH HHS [GM57479] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; ISACKSON PJ, 1979, J BIOL CHEM, V254, P5569; JAVAHERIAN K, 1979, NUCLEIC ACIDS RES, V6, P3569, DOI 10.1093/nar/6.11.3569; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Li GM, 1999, ONCOL RES, V11, P393; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nicholson A, 2000, GENETICS, V154, P133; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200	45	280	289	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					693	705		10.1016/j.cell.2005.06.027	http://dx.doi.org/10.1016/j.cell.2005.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143102	Bronze			2022-12-01	WOS:000231844300010
J	Wheeler, C; Vogt, TM; Armstrong, GL; Vaughan, G; Weltman, A; Nainan, OV; Dato, V; Xia, GL; Waller, K; Amon, J; Lee, TM; Highbaugh-Battle, A; Hembree, C; Evenson, S; Ruta, MA; Williams, IT; Fiore, AE; Bell, BP				Wheeler, C; Vogt, TM; Armstrong, GL; Vaughan, G; Weltman, A; Nainan, OV; Dato, V; Xia, GL; Waller, K; Amon, J; Lee, TM; Highbaugh-Battle, A; Hembree, C; Evenson, S; Ruta, MA; Williams, IT; Fiore, AE; Bell, BP			An outbreak of hepatitis A associated with green onions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTISTATE OUTBREAK; UNITED-STATES; VIRUS; EPIDEMIOLOGY; INFECTION; SURVIVAL	Background: In November 2003, a large hepatitis A outbreak was identified among patrons of a single Pennsylvania restaurant. We investigated the cause of the outbreak and factors that contributed to its unprecedented size. Methods: Demographic and clinical outcome data were collected from patients with laboratory confirmation of hepatitis A, and restaurant workers were tested for hepatitis A. A case-control study was conducted among patrons who dined at the restaurant between October 3 and October 6, 2003. Sequence analysis was performed on a 315-nucleotide region of viral RNA extracted from serum specimens. Results: Of 601 patients identified, 3 died; at least 124 were hospitalized. Of 425 patients who recalled a single dining date at the restaurant, 356 (84 percent) had dined there between October 3 and October 6. Among 240 patients in the case-control study, 218 had eaten mild salsa (91 percent), as compared with 45 of 130 controls (35 percent) (odds ratio, 19.6; 95 percent confidence interval, 11.0 to 34.9) for whom data were available. A total of 98 percent of patients and 58 percent of controls reported having eaten a menu item containing green onions (odds ratio, 33.3; 95 percent confidence interval, 12.8 to 86.2). All restaurant workers were tested, but none were identified who could have been the source of the outbreak. Sequences of hepatitis A virus from all 170 patients who were tested were identical. Mild salsa, which contained green onions grown in Mexico, was prepared in large batches at the restaurant and provided to all patrons. Conclusions: Green onions that were apparently contaminated before arrival at the restaurant caused this unusually large foodborne outbreak of hepatitis A. The inclusion of contaminated green onions in large batches that were served to all customers contributed to the size of the outbreak.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Student Epidemiol Elect Program, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Penn Dept Hlth, Harrisburg, PA 17108 USA; Ohio Dept Hlth, Columbus, OH 43266 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fiore, AE (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G37,1600 Clifton Rd, Atlanta, GA 30333 USA.	afiore@cdc.gov	Fiore, Anthony/AAO-8956-2020	Amon, Joseph/0000-0002-2455-6703				AMON J, 2004, 4 INT C EM INF DIS A; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; ARMSTRONG GA, 2003, 41 ANN M INF DIS SOC; Calvin L., EC FOOD SAFETY CASE; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1044; Croci L, 2002, INT J FOOD MICROBIOL, V73, P29, DOI 10.1016/S0168-1605(01)00689-4; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; DATTA SD, 2001, 39 ANN M INF DIS SOC; Dentinger CM, 2001, J INFECT DIS, V183, P1273, DOI 10.1086/319688; Fiore AE, 2004, CLIN INFECT DIS, V38, P705, DOI 10.1086/381671; *FOOD DRUG ADM, CONS ADV REC HEP OUT; *FOOD DRUG ADM, IMP AL 25 20 DET PHY; *FOOD DRUG ADM, GUID IND GUID MIN MI; HALLIDAY ML, 1991, J INFECT DIS, V164, P852, DOI 10.1093/infdis/164.5.852; Hutin YJF, 1999, NEW ENGL J MED, V340, P595, DOI 10.1056/NEJM199902253400802; Jean J, 2003, J FOOD PROTECT, V66, P115, DOI 10.4315/0362-028X-66.1.115; MCCAUSTLAND KA, 1982, J CLIN MICROBIOL, V16, P957, DOI 10.1128/JCM.16.5.957-958.1982; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NIU MT, 1992, J INFECT DIS, V166, P518, DOI 10.1093/infdis/166.3.518; *PUBL HLTH SERV, 2001, FOOD COD; REID TMS, 1987, EPIDEMIOL INFECT, V98, P109, DOI 10.1017/S095026880006177X; ROSENBLUM LS, 1990, AM J PUBLIC HEALTH, V80, P1075, DOI 10.2105/AJPH.80.9.1075; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; Tanaka J, 2000, VACCINE, V18, pS57, DOI 10.1016/S0264-410X(99)00466-1; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TICEHURST JR, 1987, J CLIN MICROBIOL, V25, P1822, DOI 10.1128/JCM.25.10.1822-1829.1987; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194	28	248	260	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2005	353	9					890	897		10.1056/NEJMoa050855	http://dx.doi.org/10.1056/NEJMoa050855			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959WX	16135833				2022-12-01	WOS:000231551100006
J	Handschin, C; Lin, JD; Rhee, J; Peyer, AK; Chin, S; Wu, PH; Meyer, UA; Spiegelman, BM				Handschin, C; Lin, JD; Rhee, J; Peyer, AK; Chin, S; Wu, PH; Meyer, UA; Spiegelman, BM			Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1 alpha	CELL			English	Article							SYNTHASE GENE-EXPRESSION; DELTA-AMINOLEVULINATE SYNTHASE; FORKHEAD TRANSCRIPTION FACTOR; ACUTE INTERMITTENT PORPHYRIA; ACTIVATED PROTEIN-KINASE; 5-AMINOLEVULINATE SYNTHASE; COACTIVATOR PGC-1; ACID SYNTHASE; MITOCHONDRIAL BIOGENESIS; RAT HEPATOCYTES	Inducible hepatic porphyrias are inherited genetic disorders of enzymes of heme biosynthesis. The main clinical manifestations are acute attacks of neuropsychiatric symptoms frequently precipitated by drugs, hormones, or fasting, associated with increased urinary excretion of delta-aminolevulinic acid (ALA). Acute attacks are treated by heme infusion and glucose administration, but the mechanisms underlying the precipitating effects of fasting and the beneficial effects of glucose are unknown. We show that the rate-limiting enzyme in hepatic heme biosynthesis, 5-amino-levulinate synthase (ALAS-1), is regulated by the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha). Elevation of PGC-1 alpha in mice via adenoviral vectors increases the levels of heme precursors in vivo as observed in acute attacks. The induction of ALAS-1 by fasting is lost in liver-specific PGC-1 alpha knockout animals, as is the ability of porphyrogenic drugs to dysregulate heme biosynthesis. These data show that PGC-1 alpha links nutritional status to heme biosynthesis and acute hepatic porphyria.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Basel	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Rhee, James/V-9973-2019; Wu, Pei-Hsuan/AAL-1704-2020; Handschin, Christoph/E-6886-2015	Wu, Pei-Hsuan/0000-0002-6690-0744; Handschin, Christoph/0000-0003-0603-1097	NIDDK NIH HHS [1K01DK065584, DK61562, R01DK060837, DK54477] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054477, K01DK065584, R01DK054477, R01DK061562, R01DK060837] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BONKOVSKY HL, 1992, BIOCHEM PHARMACOL, V43, P2359, DOI 10.1016/0006-2952(92)90314-9; BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CANEPA ET, 1984, BIOCHIM BIOPHYS ACTA, V804, P8, DOI 10.1016/0167-4889(84)90092-2; DAVIS JR, 1967, ARCH ENVIRON HEALTH, V15, P53, DOI 10.1080/00039896.1967.10664873; DEMATTEIS F, 1973, ENZYME, V16, P266, DOI 10.1159/000459390; DEMATTEIS F, 1973, BIOCHEM J, V134, P717, DOI 10.1042/bj1340717; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Elder GH, 1998, CLIN DERMATOL, V16, P225, DOI 10.1016/S0738-081X(97)00202-2; Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200; Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200; GIGER U, 1981, J BIOL CHEM, V256, P1182; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; KAPPAS A, 1995, PORPHYRIAS; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986; LOFTUS LS, 1991, BRIT MED J, V303, P1589, DOI 10.1136/bmj.303.6817.1589; MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7; MACALPINE I, 1966, BMJ-BRIT MED J, V5479, P65; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; Mendez M, 1999, GEN PHARMACOL, V32, P259, DOI 10.1016/S0306-3623(98)00202-X; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Pierach C A, 1999, Sudhoffs Arch, V83, P50; Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROBERT TL, 1994, NUTRITION, V10, P551; Scassa ME, 2004, J BIOL CHEM, V279, P28082, DOI 10.1074/jbc.M401792200; Scassa ME, 2001, EXP CELL RES, V271, P201, DOI 10.1006/excr.2001.5386; Scassa ME, 1998, EXP CELL RES, V244, P460, DOI 10.1006/excr.1998.4206; Thadani H, 2000, BMJ-BRIT MED J, V320, P1647, DOI 10.1136/bmj.320.7250.1647; Thunell S, 2000, SCAND J CLIN LAB INV, V60, P509, DOI 10.1080/003655100448310; Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	43	256	266	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					505	515		10.1016/j.cell.2005.06.040	http://dx.doi.org/10.1016/j.cell.2005.06.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122419	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000231555100007
J	Havlir, DV; Hammer, SM				Havlir, DV; Hammer, SM			Patients versus patients? Antiretroviral therapy in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, HIV AIDS Div, San Francisco, CA 94110 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Columbia University; Columbia University; NewYork-Presbyterian Hospital	Havlir, DV (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.								0	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2005	353	8					749	751		10.1056/NEJMp058106	http://dx.doi.org/10.1056/NEJMp058106			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957YK	16120852				2022-12-01	WOS:000231409300001
J	Watanabe, D; Suzuma, K; Matsui, S; Kurimoto, M; Kiryu, J; Kita, M; Suzuma, I; Ohashi, H; Ojima, T; Murakami, T; Kobayashi, T; Masuda, S; Nagao, M; Yoshimura, N; Takagi, H				Watanabe, D; Suzuma, K; Matsui, S; Kurimoto, M; Kiryu, J; Kita, M; Suzuma, I; Ohashi, H; Ojima, T; Murakami, T; Kobayashi, T; Masuda, S; Nagao, M; Yoshimura, N; Takagi, H			Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DEPENDENT PRODUCTION; RECEPTOR; CELLS; NEOVASCULARIZATION; INHIBITION; PROTECTS; THERAPY; BINDING; SITE	Background: Although vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, VEGF inhibition alone is insufficient to prevent retinal neovascularization. Hence, it is postulated that there are other potent ischemia-induced angiogenic factors. Erythropoietin possesses angiogenic activity, but its potential role in ocular angiogenesis is not established. Methods: We measured both erythropoietin and VEGF levels in the vitreous fluid of 144 patients with the use of radioimmunoassay and enzyme-linked immunosorbent assay. Vitreous proliferative potential was measured according to the growth of retinal endothelial cells in vitro and with soluble erythropoietin receptor. In addition, a murine model of ischemia-induced retinal neovascularization was used to evaluate erythropoietin expression and regulation in vivo. Results: The median vitreous erythropoietin level in 73 patients with proliferative diabetic retinopathy was significantly higher than that in 71 patients without diabetes (464.0 vs. 36.5 mIU per milliliter, P<0.001). The median VEGF level in patients with retinopathy was also significantly higher than that in patients without diabetes (345.0 vs. 3.9 pg per milliliter, P<0.001). Multivariate logistic-regression analyses indicated that erythropoietin and VEGF were independently associated with proliferative diabetic retinopathy and that erythropoietin was more strongly associated with the presence of proliferative diabetic retinopathy than was VEGF. Erythropoietin and VEGF gene-expression levels are up-regulated in the murine ischemic retina, and the blockade of erythropoietin inhibits retinal neovascularization in vivo and endothelial-cell proliferation in the vitreous of patients with diabetic retinopathy in vitro. Conclusions: Our data suggest that erythropoietin is a potent ischemia-induced angiogenic factor that acts independently of VEGF during retinal angiogenesis in proliferative diabetic retinopathy.	Hyogo Kenritsu Amagasaki Hosp, Dept Ophthalmol, Amagasaki, Hyogo 6600828, Japan; Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; Kyoto Univ, Grad Sch Publ Hlth, Dept Pharmacoepidmeiol, Kyoto, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Biosignals & Response, Kyoto, Japan; Otsu Red Cross Hosp, Dept Ophthalmol, Otsu, Shiga, Japan	Kyoto University; Kyoto University; Kyoto University	Takagi, H (corresponding author), Hyogo Kenritsu Amagasaki Hosp, Dept Ophthalmol, Higashidaimotsu Cho 1-1-1, Amagasaki, Hyogo 6600828, Japan.	hitoshi@kuhp.kyoto-u.ac.jp	KOBAYASHI, Toshihiro/M-2087-2013	KOBAYASHI, Toshihiro/0000-0002-7650-1763; Murakami, Tomoaki/0000-0002-0314-8807				AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Bainbridge JWB, 2002, GENE THER, V9, P320, DOI 10.1038/sj.gt.3301680; BARANY E, 1955, ACTA PHYSIOL SCAND, V34, P99, DOI 10.1111/j.1748-1716.1955.tb01229.x; Becerra SP, 2002, NEW ENGL J MED, V347, P1968, DOI 10.1056/NEJMcibr022629; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; FRIEDMAN EA, 1995, AM J KIDNEY DIS, V26, P202, DOI 10.1016/0272-6386(95)90175-2; Fuste B, 2002, THROMB HAEMOSTASIS, V88, P678; Glaspy J, 2004, ONCOLOGY-BASEL, V67, P5, DOI 10.1159/000080705; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Hamma-Kourbali Y, 2001, J BIOL CHEM, V276, P39748, DOI 10.1074/jbc.M101117200; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; Kobayashi T, 2002, BIOCHEM BIOPH RES CO, V296, P145, DOI 10.1016/S0006-291X(02)00832-X; KRANTZ SB, 1991, BLOOD, V77, P419; Kuriyama S, 1997, NEPHRON, V77, P176, DOI 10.1159/000190270; Lipton SA, 2004, NEW ENGL J MED, V350, P2516, DOI 10.1056/NEJMcibr041121; MASUDA S, 1994, J BIOL CHEM, V269, P19488; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NAGAO M, 1992, BIOCHEM BIOPH RES CO, V188, P888, DOI 10.1016/0006-291X(92)91139-H; PURCELL EF, 1954, AMA ARCH OPHTHALMOL, V51, P1; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sinclair SH, 2003, AM J OPHTHALMOL, V135, P740, DOI 10.1016/S0002-9394(02)02149-9; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Suzuma I, 2002, J BIOL CHEM, V277, P1047, DOI 10.1074/jbc.M105336200; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yasuda Y, 2001, BRIT J CANCER, V84, P836, DOI 10.1054/bjoc.2000.1666; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	40	352	394	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2005	353	8					782	792		10.1056/NEJMoa041773	http://dx.doi.org/10.1056/NEJMoa041773			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957YK	16120858				2022-12-01	WOS:000231409300007
J	Aoki, SK; Pamma, R; Hernday, AD; Bickham, JE; Braaten, BA; Low, DA				Aoki, SK; Pamma, R; Hernday, AD; Bickham, JE; Braaten, BA; Low, DA			Contact-dependent inhibition of growth in Escherichia coli	SCIENCE			English	Article							PAP; BACTERIA; SEQUENCE; ROLES	Bacteria have developed mechanisms to communicate and compete with each other for Limited environmental resources. We found that certain Escherichia coli, including uropathogenic strains, contained. a bacterial growth-inhibition system that uses direct cell-to-cell contact. Inhibition was conditional, dependent upon the growth state of the inhibitory cell and the pili expression state of the target cell. Both a large cell-surface protein designated Contact-dependent inhibitor A (CdiA) and two-partner secretion family member CdiB were required for growth inhibition. The CdiAB system may function to regulate the growth of specific cells within a differentiated bacterial population.	Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Low, DA (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	low@lifesci.ucsb.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI023348, R01AI023348] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23348] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AOKI S, UNPUB; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Jelsbak L, 2000, CURR OPIN MICROBIOL, V3, P637, DOI 10.1016/S1369-5274(00)00153-3; JOHANSON I, 1992, INFECT IMMUN, V60, P3416, DOI 10.1128/IAI.60.8.3416-3422.1992; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; KNAPP S, 1986, J BACTERIOL, V168, P22, DOI 10.1128/jb.168.1.22-30.1986; LOW D, 1987, MOL MICROBIOL, V1, P335, DOI 10.1111/j.1365-2958.1987.tb01940.x; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; RenauldMongenie G, 1996, J BACTERIOL, V178, P1053, DOI 10.1128/jb.178.4.1053-1060.1996; SCHMOLL T, 1990, MICROB PATHOGENESIS, V9, P331, DOI 10.1016/0882-4010(90)90067-Z; SPANGLER R, 1985, J BACTERIOL, V163, P167, DOI 10.1128/JB.163.1.167-173.1985; Welch R, 2001, P NATL ACAD SCI USA, V98, P14907, DOI 10.1073/pnas.261574598; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	17	294	304	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1245	1248		10.1126/science.1115109	http://dx.doi.org/10.1126/science.1115109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16109881				2022-12-01	WOS:000231395400047
J	Kim, KA; Kakitani, M; Zhao, JS; Oshima, T; Tang, T; Binnerts, M; Liu, Y; Boyle, B; Park, E; Emtage, P; Funk, WD; Tomizuka, K				Kim, KA; Kakitani, M; Zhao, JS; Oshima, T; Tang, T; Binnerts, M; Liu, Y; Boyle, B; Park, E; Emtage, P; Funk, WD; Tomizuka, K			Mitogenic influence of human R-spondin1 on the intestinal epithelium	SCIENCE			English	Article							IN-VIVO; COLORECTAL-CANCER; CELLS; PROLIFERATION; RECEPTOR; CHEMOTHERAPY; EXPRESSION; MORTALITY; CATENIN; INJURY	Several described growth factors influence the proliferation and regeneration of the intestinal epithelium. Using a transgenic mouse model, we identified a human gene, R-spondin1, with potent and specific proliferative effects on intestinal crypt cells. Human R-spondin1 (hRSpo1) is a thrombospondin domain-containing protein expressed in enteroendocrine cells as well, as in epithelial cells in various tissues. Upon injection into mice, the protein induced rapid onset of crypt cell proliferation involving beta-catenin stabilization, possibly by a process that is distinct from the canonical Wnt-mediated signaling pathway. The protein also displayed efficacy in a model of chemotherapy-induced intestinal mucositis and may have therapeutic application in gastrointestinal diseases.	Nuvelo Inc, Sunnyvale, CA 94085 USA; Kirin Brewery Co Ltd, Div Pharmaceut, Pharmaceut Res Labs, Takasaki, Gumma 3701295, Japan	Kirin Brewery Company Limited	Funk, WD (corresponding author), Nuvelo Inc, 675 Almanor Ave, Sunnyvale, CA 94085 USA.	wfunk@nuvelo.com; ktomizuka@kirin.co.jp						Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Boushey RP, 2001, CANCER RES, V61, P687; Farrell CL, 1998, CANCER RES, V58, P933; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kakitani M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni083; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; LOGAN CY, 2004, ANN REV CELL DEV BIO; Munroe DG, 1999, P NATL ACAD SCI USA, V96, P1569, DOI 10.1073/pnas.96.4.1569; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P1592, DOI 10.1053/gast.2002.33426; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Walsh NA, 2003, ENDOCRINOLOGY, V144, P4385, DOI 10.1210/en.2003-0309	22	411	453	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1256	1259		10.1126/science.1112521	http://dx.doi.org/10.1126/science.1112521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16109882				2022-12-01	WOS:000231395400051
J	Wilkins, C; Dishongh, R; Moore, SC; Whitt, MA; Chow, M; Machaca, K				Wilkins, C; Dishongh, R; Moore, SC; Whitt, MA; Chow, M; Machaca, K			RNA interference is an antiviral defence mechanism in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; VESICULAR STOMATITIS; FUNCTIONAL-ANALYSIS; VIRAL SUPPRESSORS; VIRUS; REPLICATION; INFLUENZA; SYSTEM; CELLS; PROTEINS	RNA interference (RNAi) is an evolutionarily conserved sequence-specific post-transcriptional gene silencing mechanism that is well defined genetically in Caenorhabditis elegans(1-4). RNAi has been postulated to function as an adaptive antiviral immune mechanism in the worm, but there is no experimental evidence for this. Part of the limitation is that there are no known natural viral pathogens of C. elegans. Here we describe an infection model in C. elegans using the mammalian pathogen vesicular stomatitis virus (VSV) to study the role of RNAi in antiviral immunity. VSV infection is potentiated in cells derived from RNAi-defective worm mutants (rde-1; rde-4), leading to the production of infectious progeny virus, and is inhibited in mutants with an enhanced RNAi response (rrf-3; eri-1). Because the RNAi response occurs in the absence of exogenously added VSV small interfering RNAs, these results show that RNAi is activated during VSV infection and that RNAi is a genuine antiviral immune defence mechanism in the worm.	Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Harding Univ, Dept Biol, Searcy, AR 72149 USA; Univ Tennessee, Dept Mol Sci, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Tennessee System; University of Tennessee Health Science Center	Chow, M (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	chowmarie@uams.edu; kamachaca@uams.edu	Machaca, Khaled/AAF-3579-2019; Abrams, William R/A-5782-2008	Machaca, Khaled/0000-0001-6215-2411; Wilkins, Courtney/0000-0003-4001-7686				Adelman ZN, 2002, J VIROL, V76, P12925, DOI 10.1128/JVI.76.24.12925-12933.2002; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Grishok A, 2002, ADV GENET, V46, P339; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hu WY, 2002, CURR BIOL, V12, P1301, DOI 10.1016/S0960-9822(02)00975-2; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; ROSE JK, 2004, FIELDS VIROLOGY, P1221; Roth BM, 2004, VIRUS RES, V102, P97, DOI 10.1016/j.virusres.2004.01.020; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; STILLMAN EA, 1995, J VIROL, V69, P2946, DOI 10.1128/JVI.69.5.2946-2953.1995; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8	28	243	267	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1044	1047		10.1038/nature03957	http://dx.doi.org/10.1038/nature03957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107852				2022-12-01	WOS:000231263900056
J	Hirota, T; Lipp, JJ; Toh, BH; Peters, JM				Hirota, T; Lipp, JJ; Toh, BH; Peters, JM			Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin	NATURE			English	Article							CHROMOSOME CONDENSATION; FISSION YEAST; LYSINE 9; H3; CENTROMERE; PROTEINS; CHROMATIN; CELLS; AUTOANTIGENS; RECRUITMENT	Histones are subject to numerous post-translational modifications(1). Some of these 'epigenetic' marks recruit proteins that modulate chromatin structure. For example, heterochromatin protein 1 (HP1) binds to histone H3 when its lysine 9 residue has been tri-methylated by the methyltransferase Suv39h ( refs 2 - 6). During mitosis, H3 is also phosphorylated by the kinase Aurora B-7. Although H3 phosphorylation is a hallmark of mitosis, its function remains mysterious. It has been proposed that histone phosphorylation controls the binding of proteins to chromatin(8), but any such mechanisms are unknown. Here we show that antibodies against mitotic chromosomal antigens that are associated with human autoimmune diseases(9) specifically recognize H3 molecules that are modified by both tri-methylation of lysine 9 and phosphorylation of serine 10 ( H3K9me3S10ph). The generation of H3K9me3S10ph depends on Suv39h and Aurora B, and occurs at pericentric heterochromatin during mitosis in different eukaryotes. Most HP1 typically dissociates from chromosomes during mitosis(10-12), but if phosphorylation of H3 serine 10 is inhibited, HP1 remains chromosome-bound throughout mitosis. H3 phosphorylation by Aurora B is therefore part of a 'methyl/ phos switch' mechanism(8) that displaces HP1 and perhaps other proteins from mitotic heterochromatin.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Monash Univ, Dept Immunol, Prahran, Vic 3181, Australia	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Monash University	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at						Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; EARNSHAW W, 1986, J CLIN INVEST, V77, P426, DOI 10.1172/JCI112320; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gitlits VM, 2000, J INVEST MED, V48, P172; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mellone BG, 2003, CURR OPIN GENET DEV, V13, P191, DOI 10.1016/S0959-437X(03)00019-4; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sugimoto K, 2001, CELL STRUCT FUNCT, V26, P705, DOI 10.1247/csf.26.705; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	30	491	510	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1176	1180		10.1038/nature04254	http://dx.doi.org/10.1038/nature04254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16222244				2022-12-01	WOS:000234111500055
J	Apai, D; Pascucci, I; Bouwman, J; Natta, A; Henning, T; Dullemond, CP				Apai, D; Pascucci, I; Bouwman, J; Natta, A; Henning, T; Dullemond, CP			The onset of planet formation on brown dwarf disks	SCIENCE			English	Article							STAR-FORMING REGION; T-TAURI STARS; GRAIN-GROWTH; POPULATION; SPECTRA	The onset of planet formation in protoplanetary disks is marked by the growth and crystallization of sub-micrometer-sized dust grains accompanied by dust settling toward the disk mid-plane. Here, we present infrared spectra of disks around brown dwarfs and brown dwarf candidates. We show that all three processes occur in such cool disks in, a way similar or identical to that in disks around low- and intermediate-mass stars. These results indicate that the onset of planet formation extends to disks around brown dwarfs, suggesting that planet formation is a robust process occurring in most young circumstellar disks.	Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; NASA, Ames Res Ctr, NASA Astrobiol Inst, Moffett Field, CA 94035 USA; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Osserv Astrofis Arcetri, Inst Nazl Astrofis, I-50125 Florence, Italy	University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Max Planck Society; Istituto Nazionale Astrofisica (INAF)	Apai, D (corresponding author), Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA.	apai@as.arizona.edu	Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Bouwman, Jeroen/0000-0003-4757-2500				Apai D, 2004, ASTRON ASTROPHYS, V426, pL53, DOI 10.1051/0004-6361:200400080; Bouwman J, 2001, ASTRON ASTROPHYS, V375, P950, DOI 10.1051/0004-6361:20010878; Chiang EI, 1999, ASTROPHYS J, V519, P279, DOI 10.1086/307351; Comeron F, 2000, ASTRON ASTROPHYS, V359, P269; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Dullemond CP, 2004, ASTRON ASTROPHYS, V421, P1075, DOI 10.1051/0004-6361:20040284; Forrest WJ, 2004, ASTROPHYS J SUPPL S, V154, P443, DOI 10.1086/423138; Furlan E, 2005, ASTROPHYS J, V628, pL65, DOI 10.1086/432540; Furlan E, 2005, ASTROPHYS J, V621, pL129, DOI 10.1086/429273; Gail HP, 2004, ASTRON ASTROPHYS, V413, P571, DOI 10.1051/0004-6361:20031554; GOLDREIC.P, 1973, ASTROPHYS J, V183, P1051, DOI 10.1086/152291; HENNING T, IN PRESS PLANET FORM; Klein R, 2003, ASTROPHYS J, V593, pL57, DOI 10.1086/377729; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Luhman KL, 2004, ASTROPHYS J, V602, P816, DOI 10.1086/381146; Marti BL, 2004, ASTRON ASTROPHYS, V416, P555, DOI 10.1051/0004-6361:20031720; Pascucci I, 2003, ASTROPHYS J, V590, pL111, DOI 10.1086/376773; PASCUCCI I, UNPUB; Przygodda F, 2003, ASTRON ASTROPHYS, V412, pL43, DOI 10.1051/0004-6361:20034606; van Boekel R, 2005, ASTRON ASTROPHYS, V437, P189, DOI 10.1051/0004-6361:20042339; van Boekel R, 2003, ASTRON ASTROPHYS, V400, pL21, DOI 10.1051/0004-6361:20030141; WEIDENSCHILLING SJ, 1977, ASTROPHYS SPACE SCI, V51, P153, DOI 10.1007/BF00642464	22	160	161	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2005	310	5749					834	836		10.1126/science.1118042	http://dx.doi.org/10.1126/science.1118042			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16239438	Green Submitted			2022-12-01	WOS:000233121800039
J	Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA				Sabin, CA; Phillips, AN; Yee, TT; Griffioen, A; Lee, CA			Twenty five years of HIV infection in haemophilic men in Britain: an observational study	BRITISH MEDICAL JOURNAL			English	Article							PROGRESSION; COHORT		Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Royal Free NHS Trust, Haemophilia Ctr, London, England; Royal Free NHS Trust, Haemostasis Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Sabin, CA (corresponding author), Royal Free & UC Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England.	c.sabin@pcps.ucl.ac.uk	Sabin, Caroline/C-2464-2008; Phillips, Andrew N/B-4427-2008; Yee, Thynn Thynn/H-5862-2012	Sabin, Caroline/0000-0001-5173-2760; Phillips, Andrew N/0000-0003-2384-4807; 				CHORBA TL, 1994, AM J HEMATOL, V45, P112, DOI 10.1002/ajh.2830450204; LEE CA, 1989, BRIT J HAEMATOL, V73, P228, DOI 10.1111/j.1365-2141.1989.tb00257.x; LEE CA, 1990, LANCET, V335, P426; PHILLIPS A, 1989, AIDS, V3, P737, DOI 10.1097/00002030-198911000-00008; Quintana M, 2003, HAEMOPHILIA, V9, P605, DOI 10.1046/j.1365-2516.2003.00804.x	5	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 29	2005	331	7523					997	998		10.1136/bmj.38604.468785.DE	http://dx.doi.org/10.1136/bmj.38604.468785.DE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981AU	16169870	Green Published, Bronze			2022-12-01	WOS:000233060200017
J	Hoskin, CJ; Higgie, M; McDonald, KR; Moritz, C				Hoskin, CJ; Higgie, M; McDonald, KR; Moritz, C			Reinforcement drives rapid allopatric speciation	NATURE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; EVOLUTION	Allopatric speciation results from geographic isolation between populations. In the absence of gene flow, reproductive isolation arises gradually and incidentally as a result of mutation, genetic drift and the indirect effects of natural selection driving local adaptation(1-3). In contrast, speciation by reinforcement is driven directly by natural selection against maladaptive hybridization(1,4). This gives individuals that choose the traits of their own lineage greater fitness, potentially leading to rapid speciation between the lineages(1,4). Reinforcing natural selection on a population of one of the lineages in a mosaic contact zone could also result in divergence of the population from the allopatric range of its own lineage outside the zone(4-6). Here we test this with molecular data, experimental crosses, field measurements and mate choice experiments in a mosaic contact zone between two lineages of a rainforest frog. We show that reinforcing natural selection has resulted in significant premating isolation of a population in the contact zone not only from the other lineage but also, incidentally, from the closely related main range of its own lineage. Thus we show the potential for reinforcement to drive rapid allopatric speciation.	Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; Queensland Parks & Wildlife Sci, Atherton, Qld 4883, Australia; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of Queensland; University of California System; University of California Berkeley	Hoskin, CJ (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia.	c.hoskin@sib.uq.edu.au	Moritz, Craig/A-7755-2012; Higgie, Megan/A-6131-2008; Hoskin, Conrad J/A-8407-2012	Moritz, Craig/0000-0001-5313-7279; Higgie, Megan/0000-0002-2397-0240; Hoskin, Conrad J/0000-0001-8116-6085				AGRESTI A, 1990, CATEGORICAL DATA ANA, P239; Anderson EC, 2002, GENETICS, V160, P1217; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; BIGELOW RS, 1965, EVOLUTION, V19, P449, DOI 10.2307/2406242; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Bridle JR, 2004, EVOLUTION, V58, P1394; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Butlin RK, 1997, NATURE, V387, P551, DOI 10.1038/42355; Cain ML, 1999, EVOLUTION, V53, P1343, DOI [10.2307/2640881, 10.1111/j.1558-5646.1999.tb05399.x]; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1951, A MONTAGU PAPERS, V3rd; Dolman G, 2004, MOL ECOL NOTES, V4, P185, DOI 10.1111/j.1471-8286.2004.00609.x; Gerhardt H.C., 2002, ACOUSTIC COMMUNICATI; Gosner K. L., 1960, Herpetologica, V16, P183; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Littlejohn M.J., 1981, P298; LITTLEJOHN MJ, 1968, EVOLUTION, V22, P659, DOI 10.1111/j.1558-5646.1968.tb03467.x; Mayr E, 1963, ANIMAL SPECIES EVOLU, P548; Moore J.A., 1957, SPECIES PROBLEM, P325; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Phillips BL, 2004, EVOLUTION, V58, P1536; SANDERSON N, 1989, EVOLUTION, V43, P1223, DOI [10.2307/2409358, 10.1111/j.1558-5646.1989.tb02570.x]; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SOKAL RR, 1995, BIOMETRY PRINCIPLES, P724; ZOUROS E, 1980, EVOLUTION, V34, P421, DOI 10.1111/j.1558-5646.1980.tb04830.x	28	328	337	4	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1353	1356		10.1038/nature04004	http://dx.doi.org/10.1038/nature04004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251964				2022-12-01	WOS:000232829100053
J	Havrda, DE; Omundsen, BA; Bender, W; Kirkpatrick, MA				Havrda, DE; Omundsen, BA; Bender, W; Kirkpatrick, MA			Impact of the Medicare modernization act on low-income persons	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Low-income Medicare beneficiaries without prescription benefits have high out-of-pocket medication expenses that can discourage adherence to treatment regimens. The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 created a temporary drug discount card program and a prescription benefit with low-income provisions to assist with medication expenditures for eligible seniors. Objective: To determine the impact of the new drug discount card and prescription benefit on medication expenditures by low-income Medicare recipients who require pharmaceutical company assistance for obtaining medications. Design: Retrospective, nonrandomized evaluation. Setting: Family practice physicians' office in northern Virginia. Patients: 137 Medicare recipients without prescription coverage who received assistance from pharmaceutical companies for medications. Measurements: Patients were stratified into 3 categories according to income, household size, and the federal poverty line (FPL), as defined by the new Medicare act. Participants' long-term oral and inhaled medications, dosages, and instructions for use were obtained. The MMA criteria for low-income provisions were applied for the drug discount program and for the prescription benefit. Medication costs under the new Medicare benefits were compared with those incurred without assistance and with the use of pharmaceutical company programs for the cohort and FPL categories. Results: In all income categories, medication costs were lower after enrollment in all programs than those of patients without assistance. Compared with pharmaceutical company assistance, Medicare drug discount cards resulted in less savings for all income groups. For the prescription benefit, persons with incomes less than 135% of FPL had the greatest benefit because of low-income subsidies. Persons ineligible for low-income subsidies receiving the standard benefit had a smaller reduction in out-of-pocket costs and variable monthly expenditures; they realized a superior savings with pharmaceutical company assistance programs. Limitations: The generalizability of these findings is limited because the authors used a discount pharmacy to determine drug costs for persons receiving no assistance, could not determine asset criteria for the MMA drug benefit low-income subsidy, and used a selected Medicare population. Conclusions: in a low-income Medicare population without prescription coverage, pharmaceutical company programs offered considerable savings and were superior to the Medicare drug discount cards. For the Medicare prescription plan, the greatest savings was among those eligible for low-income subsidies. Month-to-month medication costs may vary substantially for persons ineligible for such subsidies, and pharmaceutical company assistance may be a better alternative.	Shenandoah Univ, Sch Pharm, Winchester 22601, Hants, England; Amherst Family Practice, Winchester, Hants, England		Havrda, DE (corresponding author), Shenandoah Univ, Sch Pharm, 1775 N Sector Court, Winchester 22601, Hants, England.	dhavrda@su.edu						ANTOS J, 2004, PRIV DISC PUBL SUBS, P1; BRYANT J, 2004, ASSESSMENT BENEFICIA, pA1; CAPLAN C, 2003, OUT POCKET SPENDING; *CTR MED MED SERV, 2004, CMS STUD CONF SIGN S; *CTR MED MED SERV, 2004, PHARM DEM PROGR STAT; *CTR MED MED SERV, 2005, MLN MATTERS, P1; Doherty RB, 2004, ANN INTERN MED, V141, P391, DOI 10.7326/0003-4819-141-5-200409070-00100; Duke KS, 2005, AM J HEALTH-SYST PH, V62, P726, DOI 10.1093/ajhp/62.7.726; Ellingsen P, 2004, DETAILED DESCRIPTION, p[1, 4]; GROSS DJ, 2004, TRENDS MANUFACTURER, P1; Health and Safety Executive, 2004, MED DRUG DISC CARDS, P1; MAYS J, 2004, ESTIMATES MEDICARE B, P1; *MED RIGHTS CTR, 2005, STAT PRESCR DRUG RX; *PENN DEP AG, 2004, PACE PHARM ASS CONTR, P1; *PRICEWATERHOUSC, 2004, IMP MED PRESCR DRUG, P1; RICE T, 2005, LOW INCOME SUBSIDIES, P1; RODGERS J, 2004, MEICARE PRESCRIPTION, P1; SAFRAN DG, 2002, PRESCRIPTION DRUG CO, pW253; 2004, FEDERAL REGISTER, V69, P7336; 2005, FEDERAL REGISER, V70, P4464	20	9	9	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2005	143	8					600	608		10.7326/0003-4819-143-8-200510180-00011	http://dx.doi.org/10.7326/0003-4819-143-8-200510180-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975PI	16230727				2022-12-01	WOS:000232674000011
J	Tammemagi, CM; Nerenz, D; Neslund-Dudas, C; Feldkamp, C; Nathanson, D				Tammemagi, CM; Nerenz, D; Neslund-Dudas, C; Feldkamp, C; Nathanson, D			Comorbidity and survival disparities among black and white patients with breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL-DIFFERENCES; SOCIOECONOMIC-STATUS; ADMINISTRATIVE DATA; RACE; CARCINOMA; IMPACT; WOMEN; MODELS; AGE	Context Reasons for the shorter survival of black breast cancer patients compared with their white counterparts are not completely understood. Objective To evaluate the role of comorbidity in this racial disparity among breast cancer patients. Design, Setting, and Patients Historical cohort from the Henry Ford Health System (a large comprehensive health system in Detroit, Mich) followed up for a median of 10 years. Patients (n=906) included 264 black (29.1%) and 642 white (70.9%) women diagnosed as having breast cancer between 1985 and 1990. Detailed comorbidity data (268 comorbidities) and study data were abstracted from medical records and institutional, Surveillance, Epidemiology, and End Results, and Michigan State registries. Associations were analyzed with logistic and Cox regression. Main Outcome Measures Breast cancer recurrence/progression and survival to death from all, breast cancer, and competing (non-breast cancer) causes. Results Of blacks, 64 (24.9%) died of breast cancer and 95 (37.0%) died of competing causes. Comparable data for whites were 115 (18.3%) and 202 (32.1%). Blacks had worse all-cause survival (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.11-1.62), breast cancer-specific survival (HR, 1.47; 95% CI, 1.08-2.00), and competing causes survival (HR, 1.27; 95% CI, 1.00-1.63). A total of 77 adverse comorbidities were associated with reduced survival. Adverse comorbidity count was associated with all-cause (adjusted HR, 1.29; 95% CI, 1.19-1.40) and competing-causes survival but was not associated with recurrence/progression or breast cancer-specific survival. At least 1 adverse comorbidity was observed in 221 (86.0%) blacks and 407 (65.7%) whites (odds ratio, 3.20; 95% CI, 2.17-4.72). Comparisons of unadjusted and comorbidity-adjusted HRs indicated that adverse comorbidity explained 49.1% of all-cause and 76.7% of competing-causes survival disparity. Diabetes and hypertension, were particularly important in explaining disparity. Conclusions More black breast cancer patients die of competing causes than-of breast cancer. Effective control of comorbidity in black breast cancer patients should help improve life expectancy and lead to a reduction in survival disparities.	Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada; Henry Ford Hlth Syst, Ctr Hlth Serv Res, Detroit, MI USA; Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI USA; Henry Ford Hlth Syst, Dept Pathol & Lab Med, Detroit, MI USA; Henry Ford Hlth Syst, Dept Gen Surg, Detroit, MI USA	Brock University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Tammemagi, CM (corresponding author), Brock Univ, Dept Community Hlth Sci, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	martin.tammemagi@brocku.ca		Tammemagi, Martin/0000-0002-4989-5058				[Anonymous], 1982, AM J CLIN PATHOL, V77, P123; Armstrong BKWE, 1992, PRINCIPLES EXPOSURE; BASSETT MT, 1986, AM J PUBLIC HEALTH, V76, P1400, DOI 10.2105/AJPH.76.12.1400; Beahrs OH, 1992, MANUAL STAGING CANC; Bradley CJ, 2002, J NATL CANCER I, V94, P490; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411; COX DR, 1972, J R STAT SOC B, V34, P187; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DAYAL HH, 1982, J CHRON DIS, V35, P675, DOI 10.1016/0021-9681(82)90020-0; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; ELIXHAUSER A, 2004, CLIN CLASSIFICATION; Ghafoor A, 2003, CA-CANCER J CLIN, V53, P342, DOI 10.3322/canjclin.53.6.342; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hosmer D.W., 1999, APPL LOGISTIC REGRES; Houterman S, 2004, BRIT J CANCER, V90, P2332, DOI 10.1038/sj.bjc.6601844; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones BA, 2004, CANCER, V101, P1293, DOI 10.1002/cncr.20500; Joslyn SA, 2000, CANCER-AM CANCER SOC, V88, P114, DOI 10.1002/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kieszak SM, 1999, J CLIN EPIDEMIOL, V52, P137, DOI 10.1016/S0895-4356(98)00154-1; Krieger Nancy, 1997, Ethnicity and Disease, V7, P137; Lyman GH, 1997, ANN SURG ONCOL, V4, P80, DOI 10.1007/BF02316814; MALENKA DJ, 1994, J CLIN EPIDEMIOL, V47, P1027, DOI 10.1016/0895-4356(94)90118-X; Nagel G, 2004, J CANCER RES CLIN, V130, P664, DOI 10.1007/s00432-004-0594-3; Newman LA, 2001, CANCER, V91, P1834, DOI 10.1002/1097-0142(20010501)91:9<1834::AID-CNCR1204>3.0.CO;2-L; Newschaffer CJ, 1997, J CLIN EPIDEMIOL, V50, P725, DOI 10.1016/S0895-4356(97)00050-4; PARMAR MKB, 1995, SURIVAL ANAL PRACTIC; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; *PUBL HLTH SERV HL, 1994, DHHS PUBL; Roetzheim RG, 2000, CANCER-AM CANCER SOC, V89, P2202, DOI 10.1002/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SATARIANO WA, 1993, ADV EXP MED BIOL, V330, P1; SATARIANO WA, 1992, J GERONTOL, V47, P24; Simon MS, 1997, AM J OBSTET GYNECOL, V176, pS233, DOI 10.1016/S0002-9378(97)70381-8; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tammemagi CM, 2004, J CLIN EPIDEMIOL, V57, P597, DOI 10.1016/j.jclinepi.2003.11.002; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Velanovich V, 1999, SURGERY, V125, P375, DOI 10.1016/S0039-6060(99)70004-8; WEISS SE, 1995, CANCER, V76, P268, DOI 10.1002/1097-0142(19950715)76:2<268::AID-CNCR2820760217>3.0.CO;2-1; West DW, 1996, ANN EPIDEMIOL, V6, P413, DOI 10.1016/S1047-2797(96)00096-8; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yood MU, 1999, J NATL CANCER I, V91, P1487, DOI 10.1093/jnci/91.17.1487	46	305	306	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1765	1772		10.1001/jama.294.14.1765	http://dx.doi.org/10.1001/jama.294.14.1765			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972RX	16219879	Bronze			2022-12-01	WOS:000232472000015
J	Faught, E				Faught, E			Naming seizures	LANCET			English	Editorial Material							SPIKE		Univ Alabama Birmingham, Epilepsy Ctr, Civitan Int Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Faught, E (corresponding author), Univ Alabama Birmingham, Epilepsy Ctr, Civitan Int Res Ctr, Birmingham, AL 35294 USA.	faught@uab.edu	Faught, Raymond Edward/F-7767-2010					[Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; GLOOR P, 1968, EPILEPSIA, V9, P249, DOI 10.1111/j.1528-1157.1968.tb04624.x; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; Paus T, 2000, PROG BRAIN RES, V126, P65; Rodin E, 1999, CLIN NEUROPHYSIOL, V110, P1868, DOI 10.1016/S1388-2457(99)00163-7; SNEAD OC, 1995, ANN NEUROL, V37, P146, DOI 10.1002/ana.410370204; STEFAN H, 1997, EPILEPSY COMPREHENSI, P580; Tenney JR, 2004, EPILEPSIA, V45, P576, DOI 10.1111/j.0013-9580.2004.39303.x	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2005	366	9493					1251	1252		10.1016/S0140-6736(05)67509-5	http://dx.doi.org/10.1016/S0140-6736(05)67509-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971ST	16214587				2022-12-01	WOS:000232405700010
J	Kumar, S; Yogesan, K				Kumar, S; Yogesan, K			Internet-based eye care: VISION 2020	LANCET			English	Editorial Material							TELEMEDICINE; OPHTHALMOLOGY; COST		Univ Western Australia, Lions Eye Inst, Ctr Excellence E Med, Nedlands, WA 6009, Australia	Lions Eye Institute; University of Western Australia	Kumar, S (corresponding author), Univ Western Australia, Lions Eye Inst, Ctr Excellence E Med, Nedlands, WA 6009, Australia.	sajeesh@cyllene.uwa.edu.au	Kanagasingam, Yogesan/C-4631-2011; kumar, sajeesh/C-1472-2010	Kanagasingam, Yogesan/0000-0001-7321-7495; 				Blomdahl S, 2001, J TELEMED TELECARE, V7, pS25; Buckley Dermot, 2002, Aust Health Rev, V25, P11; Camara JG, 1998, TELEMED J, V4, P375, DOI 10.1089/tmj.1.1998.4.375; Constable IJ, 2000, CLIN EXP OPHTHALMOL, V28, P129, DOI 10.1046/j.1442-9071.2000.00309.x; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Johnston K, 2004, HEALTH POLICY PLANN, V19, P302, DOI 10.1093/heapol/czh035; Kennedy C, 2001, J TELEMED TELECARE, V7, pS20, DOI 10.1258/1357633011936895; Kumar S, 2005, BRIT J OPHTHALMOL, V89, P1382, DOI 10.1136/bjo.2005.072579; KUMAR S, 2003, INDIAN J OPHTHALMOL, V51, P295; Mitchell JW, 1999, HVAC&R RES, V5, P1, DOI 10.1080/10789669.1999.10391219; Samedov RN, 1998, J TELEMED TELECARE, V4, P42, DOI 10.1258/1357633981931399; Shanit D, 2002, J TELEMED TELECARE, V8, P76, DOI 10.1258/135763302320302127; *VISION 2020, 2005, RIGHT TO SIGHT; Yogesan K, 2000, J TELEMED TELECARE, V6, P41, DOI 10.1258/1357633001933934	14	15	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2005	366	9493					1244	1245		10.1016/S0140-6736(05)67505-8	http://dx.doi.org/10.1016/S0140-6736(05)67505-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971ST	16214583				2022-12-01	WOS:000232405700006
J	West, SK; Munoz, B; Mkocha, H; Holland, MJ; Aguirre, A; Solomon, AW; Foster, A; Bailey, RL; Mabey, DCW				West, SK; Munoz, B; Mkocha, H; Holland, MJ; Aguirre, A; Solomon, AW; Foster, A; Bailey, RL; Mabey, DCW			Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study	LANCET			English	Article							AZITHROMYCIN	Background Data from studies done in communities where trachoma is mesoendemic suggest that ocular infection with Chlamydia trachomatis can be eliminated after one mass treatment with antibiotics. However, there are no comparable long-term data from trachoma hyperendemic communities. Our aim, therefore, was two-fold: first, to ascertain the disease pattern of trachoma and ocular infection with C trachomatis in a trachoma hyperendemic community after mass treatment; and, second, to ascertain the risk factors for incident infection. Methods We did a longitudinal study of a trachoma hyperendemic community (n=1017) in Tanzania. We did surveys, including ocular swabs, at baseline, 2, 6, 12, and 18 months to identify the presence, and quantity, of C trachomatis after single mass treatment of all individuals aged 6 months or older with azithromycin 20 mg per kg; pregnant women without clinical disease received topical tetracycline. Findings Mass treatment (coverage 86%) significantly reduced the prevalence of infection from 57% (495 of 871) to 12% (85 of 705) at 2 months. infection remained fairly constant to 12 months, with evidence of increasing numbers and load of infection by 18 months post-treatment. Incident infection at 6 months was 3.5-times more likely if another member of the household had more than 19 organisms per swab at 2 months. Travel outside the village, and visitors to the household, did not increase the risk of infection within households up to 12 months. Interpretation In this trachoma hyperendemic community, infection levels after high antibiotic coverage persisted at a low level to 18 months, with evidence for re-emergence after 1 year. Fairly light loads of infection were associated with household transmission. Yearly mass treatment over a few years could be sufficient to eliminate infection.	Johns Hopkins Univ, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA; Kongwa Trachoma Project, Kongwa, Tanzania; London Sch Hyg & Trop Med, London WC1, England; MRC Labs, Banjul, Gambia	Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology	West, SK (corresponding author), Johns Hopkins Sch Med, Wilmer Eye Inst, Room 129,600 N Wolfe St, Baltimore, MD 21287 USA.	shwest@jhmi.edu	Holland, Martin J/K-6502-2012	Holland, Martin J/0000-0002-5828-6318; Solomon, Anthony/0000-0001-7101-6649; Mabey, David/0000-0002-0031-8276; Andreasen, Aura/0000-0003-0664-7342; Foster, Allen/0000-0003-2368-4436	Medical Research Council [MC_U190081961] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U190081961] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Smith A, 2001, Ophthalmic Epidemiol, V8, P127, DOI 10.1076/opep.8.2.127.4164; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; West SK, 1996, AM J EPIDEMIOL, V143, P73, DOI 10.1093/oxfordjournals.aje.a008659; *WHO, 1993, PREV BLINDN PRIM HLT, P16	10	100	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 8	2005	366	9493					1296	1300		10.1016/S0140-6736(05)67529-0	http://dx.doi.org/10.1016/S0140-6736(05)67529-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971ST	16214600				2022-12-01	WOS:000232405700028
J	Vasan, RS; Pencina, MJ; Cobain, M; Freiberg, MS; D'Agostino, RB				Vasan, RS; Pencina, MJ; Cobain, M; Freiberg, MS; D'Agostino, RB			Estimated risks for developing obesity in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							MAJOR WEIGHT-GAIN; BODY-MASS INDEX; LIFETIME RISK; UNITED-STATES; ALZHEIMERS-DISEASE; US ADULTS; OVERWEIGHT; WHITE; PREVALENCE; HYPERTENSION	Background: The short- and long-term risks for developing overweight or obesity are unknown. Objectives: To estimate the short-term, long-term, and lifetime risks for developing overweight or obesity in adults in the community. Design: Prospective cohort study, 1971 to 2001. Setting: Community-based study, Framingham, Massachusetts. Participants: 4117 white participants (51.9% women) from the Framingham Heart Study. Measurements: The short-term (4 years) and long-term (10 to 30 years) risks for ever becoming overweight or more (body mass index [BMI] >= 25 kg/m(2)) or obese (BMI >= 30 kg/m(2)) for men and women at 30, 40, and 50 years of age with a normal BMI (between 18.5 kg/m(2) and 25.0 kg/m(2)). Results: The observed 4-year rates of developing overweight varied from 14% to 19% in women and 26% to 30% in men. Four-year rates of developing obesity ranged from 5% to 7% in women and 7% to 9% in men. The long-term (30-year) risk estimates were similar for the 2 sexes generally; varied somewhat with age (in men, being lower for those 50 years of age); and, overall, exceeded 1 in 2 persons for overweight or more, 1 in 4 individuals for obesity, and 1 in 10 people for stage 11 obesity (BMI >= 35 kg/m(2)) across different age groups. The 30-year estimates correspond to the residual lifetime risk for overweight or more or obesity for participants 50 years of age. Limitations: These findings may not be generalizable to other races or ethnicities. Conclusions: The long-term risks for overweight or more or obesity exceeded 50% and 25%, respectively, indicating a large public health burden. These estimates suggest that the future burden of obesity-associated diseases may be substantial.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA	Framingham Heart Study	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019	Ramachandran, Vasan/0000-0001-7357-5970; Pencina, Michael/0000-0001-5798-8855	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, 2K24 HL 04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, WHO TECHN REP SER, V854, P1, DOI DOI 10.1002/(sici)1520-6300(1996)8:6<786::aid-ajhb11>3.0.co;2-i; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cupples LA, 1987, FRAMINGHAM STUDY EPI; Elandt-Johnson RC., 1980, SURVIVAL MODELS DATA; Field AE, 1999, AM J EPIDEMIOL, V150, P573, DOI 10.1093/oxfordjournals.aje.a010055; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Fortin J M, 2001, BMC Med Inform Decis Mak, V1, P2, DOI 10.1186/1472-6947-1-2; FRIEDLAENDER JS, 1977, HUM BIOL, V49, P541; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Krauss R M, 1998, Circulation, V98, P1472; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Luepker RV, 1999, J PEDIATR-US, V134, P668, DOI 10.1016/S0022-3476(99)70279-9; McTigue KM, 2002, ANN INTERN MED, V136, P857, DOI 10.7326/0003-4819-136-12-200206180-00006; MELTON LJ, 1990, AM J PUBLIC HEALTH, V80, P500, DOI 10.2105/AJPH.80.4.500; Merrill RM, 1997, CANCER EPIDEM BIOMAR, V6, P763; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Phillips RL, 1999, NEW ENGL J MED, V340, P1681; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; RISSANEN A, 1988, INT J OBESITY, V12, P391; ROOKUS MA, 1987, HUM BIOL, V59, P617; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Siervogel RM, 2000, OBES RES, V8, P422, DOI 10.1038/oby.2000.52; TAYLOR CB, 1994, EPIDEMIOLOGY, V5, P599, DOI 10.1097/00001648-199411000-00007; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1991, AM J CLIN NUTR, V53, pS1515, DOI 10.1093/ajcn/53.6.1515S; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; World Health Organization, 2000, WHO TECHN REP SER, V894, pi, DOI DOI 10.1016/J.BBI.2016.02.019; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602	36	100	106	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2005	143	7					473	480		10.7326/0003-4819-143-7-200510040-00005	http://dx.doi.org/10.7326/0003-4819-143-7-200510040-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970FM	16204159				2022-12-01	WOS:000232290600001
J	Rao, M; Sockanathan, S				Rao, M; Sockanathan, S			Transmembrane protein GDE2 induces motor neuron differentiation in vivo	SCIENCE			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; NEUROGENESIS; REQUIREMENT; EXPRESSION; IDENTITY; OLIG2	During neural development, coordinate regulation of cell-cycle exit and differentiation is essential for cell-fate specification, cell survival, and proper wiring of neuronal circuits. However, the molecules that direct these events remain poorly defined. In the developing spinal cord, the differentiation of motor neuron progenitors into postmitotic motor neurons is regulated by retinoid signaling. Here, we identify a retinoid-inducible gene, GDE2 (glycerophosphodiester phosphodiesterase 2), encoding a six-transmembrane protein that is necessary and sufficient to drive spinal motor neuron differentiation in vivo. A single amino acid mutation in the extracellular catalytic domain abolishes protein function. This reveals a critical role for glycerophosphodiester metabolism in motor neuron differentiation.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu						Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CHENG HF, 1995, J BIOL CHEM, V270, P5495, DOI 10.1074/jbc.270.10.5495; Diez del Corral R, 2003, NEURON, V40, P65; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Farah MH, 2000, DEVELOPMENT, V127, P693; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hollyday M, 2001, INT J DEV NEUROSCI, V19, P161, DOI 10.1016/S0736-5748(00)00093-9; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; PHELPS PE, 1991, J COMP NEUROL, V307, P77, DOI 10.1002/cne.903070108; Rao M, 2004, DEV DYNAM, V231, P592, DOI 10.1002/dvdy.20161; RAO MVV, UNPUB; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	25	66	71	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2212	2215		10.1126/science.1117156	http://dx.doi.org/10.1126/science.1117156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195461				2022-12-01	WOS:000232318000043
J	Williams, BR				Williams, BR			Targeting specific cell types with silencing RNA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Williams, BR (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151				Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101	1	17	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2005	353	13					1410	1411		10.1056/NEJMcibr052492	http://dx.doi.org/10.1056/NEJMcibr052492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968FB	16192490				2022-12-01	WOS:000232146200018
J	Ivanov, D; Nasmyth, K				Ivanov, D; Nasmyth, K			A topological interaction between cohesin rings and a circular minichromosome	CELL			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; ATP HYDROLYSIS; SLIDING CLAMP; PROTEINS; CHROMOSOMES; YEAST; SEPARATION; COMPLEXES; BINDING	Sister chromatid cohesion depends on a multiprotein cohesin complex containing two SMC subunits, Smc1 and Smc3, that dimerize to form V-shaped molecules with ABC-like ATPase heads at the tips of their two arms. Cohesin's Smc1 and Smc3 "heads" are connected by an alpha kleisin subunit called Scc1, forming a tripartite ring with a diameter around 40 nm. We show here that some cohesin remains tightly bound to circular minichromosomes after their purification from yeast cells and that cleavage either of cohesin's ring or of the minichromosome's DNA destroys their association. This suggests that the stable association between cohesin and chromatin detected here is topological rather than physical, which is consistent with the notion that DNA is trapped inside cohesin rings.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	knasmyth@imp.univie.ac.at		Nasmyth, Kim/0000-0001-7030-4403; Ivanov, Dmitri/0000-0002-4806-1369				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; DESHAIES RJ, 1995, P NATL ACAD SCI USA, V92, P1182, DOI 10.1073/pnas.92.4.1182; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; TINKER RL, 1994, EMBO J, V13, P5330, DOI 10.1002/j.1460-2075.1994.tb06867.x; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030	33	153	156	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 23	2005	122	6					849	860		10.1016/j.cell.2005.07.018	http://dx.doi.org/10.1016/j.cell.2005.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179255	Bronze			2022-12-01	WOS:000232130200010
J	Kurosu, H; Yamamoto, M; Clark, JD; Pastor, JV; Nandi, A; Gurnani, P; McGuinness, OP; Chikuda, H; Yamaguchi, M; Kawaguchi, H; Shimomura, I; Takayama, Y; Herz, J; Kahn, CR; Rosenblatt, KP; Kuro-o, M				Kurosu, H; Yamamoto, M; Clark, JD; Pastor, JV; Nandi, A; Gurnani, P; McGuinness, OP; Chikuda, H; Yamaguchi, M; Kawaguchi, H; Shimomura, I; Takayama, Y; Herz, J; Kahn, CR; Rosenblatt, KP; Kuro-o, M			Suppression of aging in mice by the hormone Klotho	SCIENCE			English	Article							INSULIN-RECEPTOR; LIFE-SPAN; FUNCTIONAL VARIANT; BONE-DENSITY; GENE; ASSOCIATION; LONGEVITY; MUTANT; POLYMORPHISMS; GLUCOSE	A defect in Klotho gene expression in mice accelerates the degeneration of multiple age-sensitive traits. Here, we show that overexpression of Klotho in mice extends life span. Klotho protein functions as a circulating hormone that binds to a cell-surface receptor and represses intracellular signals of insulin and insulin-like growth factor 1 (IGF1), an evolutionarily conserved mechanism for extending life span. Alleviation of aging-like phenotypes in Klotho-deficient mice was observed by perturbing insulin and IGF1 signaling, suggesting that Klotho-mediated inhibition of insulin and IGF1 signaling contributes to its anti-aging properties. Klotho protein may function as an anti-aging hormone in mammals.	Univ Texas, SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Tokyo, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo 1138655, Japan; Osaka Univ, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan; Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Med,Res Div, Boston, MA 02215 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; University of Tokyo; Osaka University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kuro-o, M (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	makoto.kuro-o@utsouthwestern.edu	Takayama, Yoshiharu/M-8826-2019; Kahn, Ronald/AAY-2435-2021; Takayama, Yoshiharu/E-3662-2010	Takayama, Yoshiharu/0000-0003-4532-7114; Kahn, Ronald/0000-0002-7583-9228; Takayama, Yoshiharu/0000-0003-4532-7114	NHLBI NIH HHS [R37 HL063762] Funding Source: Medline; NIA NIH HHS [R01 AG019712, R01AG19712, R01 AG019712-05, R01 AG025326, R01AG25326, R01 AG025326-03] Funding Source: Medline; NIDDK NIH HHS [U24 DK059637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712, R01AG025326] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; GRABNITZ F, 1991, EUR J BIOCHEM, V200, P301, DOI 10.1111/j.1432-1033.1991.tb16186.x; Halseth AE, 1999, AM J PHYSIOL-ENDOC M, V276, pE70, DOI 10.1152/ajpendo.1999.276.1.E70; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; MILLER RA, 2001, SCI AGING KNOWLEDGE, pVP6; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Takahashi Y, 2000, P NATL ACAD SCI USA, V97, P12407, DOI 10.1073/pnas.210382097; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yamada Y, 2005, J MOL MED, V83, P50, DOI 10.1007/s00109-004-0578-4	27	1272	1360	2	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1829	1833		10.1126/science.1112766	http://dx.doi.org/10.1126/science.1112766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16123266	Green Accepted			2022-12-01	WOS:000231989500041
J	Willingham, AT; Orth, AP; Batalov, S; Peters, EC; Wen, BG; Aza-Blanc, P; Hogenesch, JB; Schultz, PG				Willingham, AT; Orth, AP; Batalov, S; Peters, EC; Wen, BG; Aza-Blanc, P; Hogenesch, JB; Schultz, PG			A strategy for probing the function of noncoding RNAs finds a repressor of NFAT	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2A; T-CELL-ACTIVATION; TRANSCRIPTION FACTORS; HUMAN GENOME; CHROMOSOME-22; CALCINEURIN; SEQUENCE	Noncoding RNA molecules (ncRNAs) have been implicated in numerous biological processes including transcriptional regulation and the modulation of protein function. Yet, in spite of the apparent abundance of ncRNA, little is known about the biological role of the projected thousands of ncRNA genes present in the human genome. To facilitate functional analysis of these RNAs, we have created an arrayed library of short hairpin RNAs (shRNAs) directed against 512 evolutionally conserved putative ncRNAs and, via cell-based assays, we have begun to determine their roles in cellular pathways. Using this system, we have identified an ncRNA repressor of the nuclear factor of activated T cells (NFAT), which interacts with multiple proteins including members of the importin-beta superfamily and likely functions as a specific regulator of NFAT nuclear trafficking.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Hogenesch, JB (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hogenesch@scripps.edu; schultz@scripps.edu	Peters, Eric/W-2739-2019	Batalov, Sergey/0000-0002-0925-0554				Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Nakajima E, 2005, BIOCHEM BIOPH RES CO, V326, P249, DOI 10.1016/j.bbrc.2004.11.023; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	23	584	633	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1570	1573		10.1126/science.1115901	http://dx.doi.org/10.1126/science.1115901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141075				2022-12-01	WOS:000231715000052
J	Bhan, MK; Bahl, R; Bhatnagar, S				Bhan, MK; Bahl, R; Bhatnagar, S			Typhoid and paratyphoid fever	LANCET			English	Review							ENTERICA-SEROVAR-TYPHI; RESISTANT SALMONELLA-TYPHI; VI-CAPSULAR POLYSACCHARIDE; CONTROLLED FIELD TRIAL; INTESTINAL EPITHELIAL-CELLS; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE DEXAMETHASONE; IMMATURE BEAGLE DOGS; MULTIDRUG-RESISTANT; BONE-MARROW	Typhoid fever is estimated to have caused 21.6 million illnesses and 216 500 deaths globally in 2000, affecting all ages. There is also one case of paratyphoid fever for every four of typhoid. The global emergence of multidrug-resistant strains and of strains with reduced susceptibility to fluoroquinolones is of great concern. We discuss the occurrence of poor clinical response to fluoroquinolones despite disc sensitivity. Developments are being made in our understanding of the molecular pathogenesis, and genomic and proteomic studies reveal the possibility of new targets for diagnosis and treatment. Further, we review guidelines for use of diagnostic tests and for selection of antimicrobials in varying clinical situations. The importance of safe water, sanitation, and immunisation in the presence of increasing antibiotic resistance is paramount. Routine immunisation of school-age children with Vi or Ty21a vaccine is recommended for countries endemic for typhoid. Vi vaccine should be used for 2-5 year-old children in highly endemic settings.	All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Bhan, MK (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	mkbhan@dbt.nic.in		bhatnagar, shinjini/0000-0003-1703-5296				Abdel Fadeel M, 2004, AM J TROP MED HYG, V70, P323, DOI 10.4269/ajtmh.2004.70.323; ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; Ackers ML, 2000, JAMA-J AM MED ASSOC, V283, P2668, DOI 10.1001/jama.283.20.2668; Akinyemi KO, 2000, Z NATURFORSCH C, V55, P489; Albaqali A, 2003, AM J KIDNEY DIS, V41, P709, DOI 10.1053/ajkd.2003.50135; Asna SMZH, 2003, JPN J INFECT DIS, V56, P32; Bahl R, 2004, J HEALTH POPUL NUTR, V22, P304; Bahrmand AR, 1997, SCAND J INFECT DIS, V29, P265, DOI 10.3109/00365549709019040; Balasubramanian S, 2003, ANN TROP PAEDIATR, V23, P223; Battikhi MNG, 2003, MICROBIOLOGICA, V26, P363; Begier EM, 2004, CLIN INFECT DIS, V38, P771, DOI 10.1086/381548; Bethell DB, 1996, ARCH DIS CHILD, V74, P44, DOI 10.1136/adc.74.1.44; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bhan MK, 2002, J INFECT DIS, V186, P1857, DOI 10.1086/345762; Bhutta ZA, 1999, AM J TROP MED HYG, V61, P654, DOI 10.4269/ajtmh.1999.61.654; BHUTTA ZA, 1991, REV INFECT DIS, V13, P832; Bhutta ZA, 2000, ANTIMICROB AGENTS CH, V44, P450, DOI 10.1128/AAC.44.2.450-452.2000; BLACK RE, 1990, VACCINE, V8, P81, DOI 10.1016/0264-410X(90)90183-M; BLACK RE, 1985, B WORLD HEALTH ORGAN, V63, P899; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; Brown JC, 1996, J ANTIMICROB CHEMOTH, V37, P891, DOI 10.1093/jac/37.5.891; BURKHARDT JE, 1990, VET PATHOL, V27, P162, DOI 10.1177/030098589002700303; Butler T, 1999, J ANTIMICROB CHEMOTH, V44, P243, DOI 10.1093/jac/44.2.243; BUTLER T, 1991, REV INFECT DIS, V13, P85; Cao X T, 1999, Pediatr Infect Dis J, V18, P245; Chandel DS, 2000, EMERG INFECT DIS, V6, P420, DOI 10.3201/eid0604.000420; Chaudhry Rama, 2003, Trop Gastroenterol, V24, P198; Chen LM, 1999, J EXP MED, V189, P1479, DOI 10.1084/jem.189.9.1479; Chinh NT, 2000, ANTIMICROB AGENTS CH, V44, P1855, DOI 10.1128/AAC.44.7.1855-1859.2000; Chiu CH, 2002, NEW ENGL J MED, V346, P413, DOI 10.1056/NEJMoa012261; Chiu CH, 1999, LANCET, V354, P2001, DOI 10.1016/S0140-6736(05)76779-9; Cho JC, 1999, FEMS MICROBIOL LETT, V170, P257, DOI 10.1111/j.1574-6968.1999.tb13382.x; Connerton P, 2000, J CLIN MICROBIOL, V38, P895, DOI 10.1128/JCM.38.2.895-897.2000; COOVADIA YM, 1992, Q J MED, V82, P91; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Dharmana E, 2002, EUR J IMMUNOGENET, V29, P297, DOI 10.1046/j.1365-2370.2002.00318.x; Doherty CP, 2000, ANN TROP PAEDIATR, V20, P297, DOI 10.1080/02724936.2000.11748151; Dunstan SJ, 2001, J INFECT DIS, V183, P261, DOI 10.1086/317940; DUTTA P, 1993, ANTIMICROB AGENTS CH, V37, P1197, DOI 10.1128/AAC.37.5.1197; Dutta P, 2001, INDIAN J MED RES, V113, P210; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Elsarnagawy D, 1978, Arch Inst Pasteur Alger, V53, P282; ELSHERBINI A, 1992, J TROP PEDIATRICS, V38, P331, DOI 10.1093/tropej/38.6.331; Engels EA, 1998, BRIT MED J, V316, P110, DOI 10.1136/bmj.316.7125.110; FAROOQUI BJ, 1991, J CLIN PATHOL, V44, P258, DOI 10.1136/jcp.44.3.258; Faucher JF, 2002, CLIN INFECT DIS, V35, P1147, DOI 10.1086/342908; FERRECCIO C, 1988, J INFECT DIS, V157, P1235, DOI 10.1093/infdis/157.6.1235; Frenck RW, 2000, CLIN INFECT DIS, V31, P1134, DOI 10.1086/317450; Frenck RW, 2004, CLIN INFECT DIS, V38, P951, DOI 10.1086/382359; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gasem MH, 2003, ANTIMICROB AGENTS CH, V47, P1727, DOI 10.1128/AAC.47.5.1727-1731.2003; Gasem MH, 2002, J MED MICROBIOL, V51, P173, DOI 10.1099/0022-1317-51-2-173; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; GASEM MH, 1995, TROP GEOGR MED, V47, P164; Gendrel D, 2003, LANCET INFECT DIS, V3, P537, DOI 10.1016/S1473-3099(03)00736-9; GILMAN RH, 1975, LANCET, V1, P1211; Girgis NI, 1999, ANTIMICROB AGENTS CH, V43, P1441, DOI 10.1128/AAC.43.6.1441; GOH K T, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P55; GOTUZZO E, 1987, J CLIN MICROBIOL, V25, P1779, DOI 10.1128/JCM.25.9.1779-1781.1987; GOTUZZO E, 1994, ANTIMICROB AGENTS CH, V38, P558, DOI 10.1128/AAC.38.3.558; GOTUZZO E, 1988, J INFECT DIS, V157, P1221, DOI 10.1093/infdis/157.6.1221; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Harish BN, 2004, J MED MICROBIOL, V53, P819, DOI 10.1099/jmm.0.05451-0; Hatta M, 2002, AM J TROP MED HYG, V66, P416, DOI 10.4269/ajtmh.2002.66.416; Hermans PWM, 1996, J CLIN MICROBIOL, V34, P1373, DOI 10.1128/JCM.34.6.1373-1379.1996; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hirose K, 2002, J CLIN MICROBIOL, V40, P633, DOI 10.1128/JCM.40.02.633-636.2002; Hoa NTT, 1998, T ROY SOC TROP MED H, V92, P503, DOI 10.1016/S0035-9203(98)90891-4; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; HOFFMAN SL, 1986, AM J TROP MED HYG, V35, P836, DOI 10.4269/ajtmh.1986.35.836; HORNICK RB, 1970, NEW ENGL J MED, V283, P739, DOI 10.1056/NEJM197010012831406; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; Hosoglu S, 2004, AM J EPIDEMIOL, V160, P46, DOI 10.1093/aje/kwh172; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; JEGATHESAN M, 1983, J HYG-CAMBRIDGE, V90, P91, DOI 10.1017/S0022172400063889; JESUDASAN MV, 1990, LANCET, V336, P252, DOI 10.1016/0140-6736(90)91783-7; Jesudason M, 2002, INDIAN J MED RES, V116, P70; Jong EC, 2002, J TRAVEL MED, V9, P66, DOI 10.2310/7060.2002.21955; Kariuki S, 2004, J CLIN MICROBIOL, V42, P1477, DOI 10.1128/JCM.42.4.1477-1482.2004; Kariuki S, 2000, EMERG INFECT DIS, V6, P649, DOI 10.3201/eid0606.000616; KARMAKER S, 1991, J MED MICROBIOL, V34, P149, DOI 10.1099/00222615-34-3-149; Keddy KH, 1999, VACCINE, V17, P110, DOI 10.1016/S0264-410X(98)00160-1; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; KLUGMAN KP, 1987, LANCET, V2, P1165; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; Kops SK, 1996, MICROBIOL IMMUNOL, V40, P799, DOI 10.1111/j.1348-0421.1996.tb01145.x; LANATA CF, 1983, LANCET, V2, P441; LANG R, 1992, SCAND J INFECT DIS, V24, P793, DOI 10.3109/00365549209062466; Lanh MN, 2003, NEW ENGL J MED, V349, P1390, DOI 10.1056/NEJM200310023491423; Le TAH, 2004, J CLIN MICROBIOL, V42, P3094, DOI 10.1128/JCM.42.7.3094-3099.2004; Lee JH, 2004, DIGEST LIVER DIS, V36, P141, DOI 10.1016/j.dld.2003.10.013; Lee WS, 2000, ANN TROP PAEDIATR, V20, P125, DOI 10.1080/02724936.2000.11748121; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1990, LANCET, V336, P891; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; Loebermann M, 2004, CLIN THER, V26, P1084, DOI 10.1016/S0149-2918(04)90180-4; Luby SP, 1998, EPIDEMIOL INFECT, V120, P129, DOI 10.1017/S0950268897008558; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9; Lyczak JB, 2002, INFECT IMMUN, V70, P6416, DOI 10.1128/IAI.70.11.6416-6423.2002; Lyczak JB, 2001, CELL MICROBIOL, V3, P763, DOI 10.1046/j.1462-5822.2001.00154.x; Mandal S., 2003, Indian Journal of Experimental Biology, V41, P360; Mandal S, 2004, Indian J Med Sci, V58, P16; Mandal S, 2003, JPN J INFECT DIS, V56, P156; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Mehta G, 2001, EUR J CLIN MICROBIOL, V20, P760, DOI 10.1007/s100960100603; Memon IA, 1997, SOUTHERN MED J, V90, P1204, DOI 10.1097/00007611-199712000-00008; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Mert A, 2004, INTERNAL MED, V43, P436, DOI 10.2169/internalmedicine.43.436; Metzger WG, 2004, VACCINE, V22, P2273, DOI 10.1016/j.vaccine.2003.11.020; Mills-Robertson F, 2002, FEMS MICROBIOL LETT, V215, P249, DOI [10.1016/S0378-1097(02)00967-9, 10.1111/j.1574-6968.2002.tb11398.x]; Mirza S, 2000, J CLIN MICROBIOL, V38, P1449, DOI 10.1128/JCM.38.4.1449-1452.2000; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Mohanty S, 2003, Indian J Med Sci, V57, P199; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MORRIS JG, 1984, AM J TROP MED HYG, V33, P1198, DOI 10.4269/ajtmh.1984.33.1198; Murdoch DA, 1998, LANCET, V351, P339, DOI 10.1016/S0140-6736(05)78338-0; Nakaya H, 2003, EMERG INFECT DIS, V9, P255; NCCLS, 2004, M100S14 NCCLS; NISHIO T, 1981, ZBL BAKT MIK HYG B, V172, P415; Olopoenia LA, 2000, POSTGRAD MED J, V76, P80, DOI 10.1136/pmj.76.892.80; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Olsen SJ, 2003, EPIDEMIOL INFECT, V130, P13, DOI 10.1017/S0950268802007598; Osler W., 1912, PRINCIPLES PRACTICE, V8th, P1; PANG T, 1983, J CLIN PATHOL, V36, P471, DOI 10.1136/jcp.36.4.471; Panhotra BR, 2004, SAUDI MED J, V25, P1509; Panigrahi D, 1996, TROP MED INT HEALTH, V1, P439, DOI 10.1046/j.1365-3156.1996.d01-80.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 1999, J CLIN MICROBIOL, V37, P2882, DOI 10.1128/JCM.37.9.2882-2886.1999; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Parry CM, 2004, T ROY SOC TROP MED H, V98, P413, DOI 10.1016/j.trstmh.2003.10.014; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; PRADHAN KM, 1995, ACTA PAEDIATR, V84, P555, DOI 10.1111/j.1651-2227.1995.tb13694.x; Proell S, 2002, J TRAVEL MED, V9, P122, DOI 10.2310/7060.2002.23845; PUNJABI NH, 1988, PEDIATR INFECT DIS J, V7, P598, DOI 10.1097/00006454-198808000-00002; Rahman M, 2002, EPIDEMIOL INFECT, V129, P29, DOI 10.1017/S0950268802007203; Rajagopal A, 2002, Trop Gastroenterol, V23, P181; Reller ME, 2003, CLIN INFECT DIS, V37, P141, DOI 10.1086/375590; Renuka K, 2004, MICROB DRUG RESIST, V10, P146, DOI 10.1089/1076629041310028; ROGERSON SJ, 1991, T ROY SOC TROP MED H, V85, P113, DOI 10.1016/0035-9203(91)90180-7; ROWE B, 1990, LANCET, V336, P1065, DOI 10.1016/0140-6736(90)92532-M; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; RUBIN FA, 1990, J CLIN MICROBIOL, V28, P825, DOI 10.1128/JCM.28.4.825-827.1990; RYAN CA, 1989, REV INFECT DIS, V11, P1; Saha SK, 1999, PEDIATR INFECT DIS J, V18, P387, DOI 10.1097/00006454-199904000-00018; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; Salazar-Gonzalez RM, 2004, IMMUNOL LETT, V93, P115, DOI 10.1016/j.imlet.2004.01.010; SCHAAD UB, 1995, PEDIATR INFECT DIS J, V14, P1, DOI 10.1097/00006454-199501000-00001; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Shetty AK, 1999, J TROP PEDIATRICS, V45, P287, DOI 10.1093/tropej/45.5.287; Shlim, 1995, J Travel Med, V2, P165, DOI 10.1111/j.1708-8305.1995.tb00645.x; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Singh M, 1999, MICROBIOL IMMUNOL, V43, P535, DOI 10.1111/j.1348-0421.1999.tb02439.x; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Slinger R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-36; SMITH MD, 1994, ANTIMICROB AGENTS CH, V38, P1716, DOI 10.1128/AAC.38.8.1716; Snyder GE, 2004, AM J EMERG MED, V22, P138, DOI 10.1016/S0735-6757(03)00019-6; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Sood S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(99)00637-6; Stahlmann R, 2000, ARCH TOXICOL, V73, P564, DOI 10.1007/s002040050009; Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945; Swaddiwudhipong Witaya, 2001, Journal of the Medical Association of Thailand, V84, P1513; Tacket CO, 2004, J INFECT DIS, V190, P565, DOI 10.1086/421469; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Tatli MM, 2003, INT J ANTIMICROB AG, V21, P350, DOI 10.1016/S0924-8579(02)00388-6; TAYLOR DE, 1985, ANTIMICROB AGENTS CH, V28, P452, DOI 10.1128/AAC.28.3.452; THISYAKORN U, 1987, AM J DIS CHILD, V141, P862, DOI 10.1001/archpedi.1987.04460080048025; Thong KL, 1996, J CLIN MICROBIOL, V34, P1029, DOI 10.1128/JCM.34.4.1029-1033.1996; Thong KL, 2000, Int J Infect Dis, V4, P194, DOI 10.1016/S1201-9712(00)90108-5; Threlfall EJ, 1999, LANCET, V353, P1590, DOI 10.1016/S0140-6736(99)01001-6; Threlfall EJ, 2003, INT J ANTIMICROB AG, V22, P487, DOI 10.1016/S0924-8579(03)00262-0; Threlfall EJ, 2001, J ANTIMICROB CHEMOTH, V48, P740, DOI 10.1093/jac/48.5.740; VALLENAS C, 1985, PEDIATR INFECT DIS J, V4, P496, DOI 10.1097/00006454-198509000-00011; VANBASTEN JP, 1994, TROP GEOGR MED, V46, P336; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vinh H, 2004, PEDIATR INFECT DIS J, V23, P226, DOI 10.1097/01.inf.0000114905.87426.c2; Vinh H, 1996, ANTIMICROB AGENTS CH, V40, P958, DOI 10.1128/AAC.40.4.958; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; Wain J, 2002, LANCET INFECT DIS, V2, P163, DOI 10.1016/S1473-3099(02)00225-6; Wain J, 1999, J CLIN MICROBIOL, V37, P2466, DOI 10.1128/JCM.37.8.2466-2472.1999; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wait DA, 2001, WATER SCI TECHNOL, V43, P139, DOI 10.2166/wst.2001.0725; Walker RA, 2003, INT J ANTIMICROB AG, V22, P622, DOI 10.1016/j.ijantimicag.2003.05.005; WALLACE MR, 1993, EUR J CLIN MICROBIOL, V12, P907, DOI 10.1007/BF01992163; WANG F, 1989, J ANTIMICROB CHEMOTH, V23, P785, DOI 10.1093/jac/23.5.785; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; WATSON JP, 1992, TROP DOCT, V22, P172, DOI 10.1177/004947559202200412; Weinstein DL, 1998, INFECT IMMUN, V66, P2310, DOI 10.1128/IAI.66.5.2310-2318.1998; White NJ, 1996, LANCET, V348, P547, DOI 10.1016/S0140-6736(05)64703-4; WOODWARD TE, 1948, ANN INTERN MED, V29, P131, DOI 10.7326/0003-4819-29-1-131; World Health Organization (WHO), 2003, WHOVB0307; Yang HH, 2001, J INFECT DIS, V183, P1775, DOI 10.1086/320729; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625; YEW FS, 1991, J TROP MED HYG, V94, P352; Yoo S, 2004, J KOREAN MED SCI, V19, P15, DOI 10.3346/jkms.2004.19.1.15	205	337	359	0	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2005	366	9487					749	762		10.1016/S0140-6736(05)67181-4	http://dx.doi.org/10.1016/S0140-6736(05)67181-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958UV	16125594				2022-12-01	WOS:000231474600033
J	Bullock, TH; Bennett, MVL; Johnston, D; Josephson, R; Marder, E; Fields, RD				Bullock, TH; Bennett, MVL; Johnston, D; Josephson, R; Marder, E; Fields, RD			The Neuron Doctrine, redux	SCIENCE			English	Editorial Material							ACTION-POTENTIALS; TRIGGERS; DYNAMICS; CELLS		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, Ctr Learning & Memory, Austin, TX 78712 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; NICHHD, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Austin; University of California System; University of California Irvine; Brandeis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bullock, TH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	fieldsd@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000713] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bucher D, 2003, J NEUROSCI, V23, P6866; BULLOCK TH, 1959, SCIENCE, V129, P997, DOI 10.1126/science.129.3355.997; Bullock TH, 1997, P NATL ACAD SCI USA, V94, P1, DOI 10.1073/pnas.94.1.1; Bullock TH, 2003, NEURAL COMPUT, V15, P2013, DOI 10.1162/089976603322297269; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47; Dupree JL, 2004, NEURON GLIA BIOL, V1, P179, DOI 10.1017/S1740925X04000304; FICK A, 2004, NAT NEUROSCI, V7, P126; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Goaillard JM, 2004, J NEUROSCI, V24, P7063, DOI 10.1523/JNEUROSCI.2078-04.2004; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Pereda AE, 2004, BRAIN RES REV, V47, P227, DOI 10.1016/j.brainresrev.2004.06.010; Ramon y Cajal S., 1897, HISTOLOGY NERVOUS SY, V1; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949	24	96	98	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					791	793		10.1126/science.1114394	http://dx.doi.org/10.1126/science.1114394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272104				2022-12-01	WOS:000233121800026
J	Strogatz, SH; Abrams, DM; McRobie, A; Eckhardt, B; Ott, E				Strogatz, SH; Abrams, DM; McRobie, A; Eckhardt, B; Ott, E			Crowd synchrony on the Millennium Bridge	NATURE			English	Editorial Material							EXCITATION		Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; Univ Maryland, College Pk, MD 20742 USA; Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany	Cornell University; University System of Maryland; University of Maryland College Park; Philipps University Marburg	Strogatz, SH (corresponding author), Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA.	strogatz@cornell.edu	Strogatz, Steven H/A-1641-2014; Abrams, Daniel M/H-5532-2012; Eckhardt, Bruno/D-5948-2012; Abrams, Daniel M/F-2297-2011; O, E/F-1630-2015	Strogatz, Steven H/0000-0003-2923-3118; Eckhardt, Bruno/0000-0003-4050-3254; Abrams, Daniel M/0000-0002-6015-8358; 				DALLARD P., 2001, J BRIDGE ENG, V6, P412, DOI [10.1061/(ASCE)1084-0702(2001)6:6(412), DOI 10.1061/(ASCE)1084-0702(2001)6:6(412)]; Dallard P., 2001, STRUCT ENG, V79, P17; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Kuramoto, 1984, SPRINGER SERIES SYNE; McRobie A., 2003, BRIDGE ENG, V156, P71, DOI DOI 10.1680/BREN.2003.156.2.71); Nakamura S, 2004, J STRUCT ENG-ASCE, V130, P32, DOI 10.1061/(ASCE)0733-9445(2004)130:1(32); Newland DE, 2004, P I MECH ENG C-J MEC, V218, P477, DOI 10.1243/095440604323052274; Roberts T. M., 2003, P ICE BRIDGE ENG, V156, P155, DOI [10.1680/bren.2003.156.4.155, DOI 10.1680/BREN.2003.156.4.155]; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Winfree A.T., 1980, GEOMETRY BIOL TIME	10	402	414	15	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					43	44		10.1038/438043a	http://dx.doi.org/10.1038/438043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267545				2022-12-01	WOS:000232979000033
J	Bernal, D; Donley, JM; Shadwick, RE; Syme, DA				Bernal, D; Donley, JM; Shadwick, RE; Syme, DA			Mammal-like muscles power swimming in a cold-water shark	NATURE			English	Article							METABOLIC BIOCHEMISTRY; CONTRACTILE PROPERTIES; BODY-TEMPERATURE; LAMNA-DITROPIS; TUNA; PERFORMANCE; FISH; DESIGN; FIBERS; TUNNEL	Effects of temperature on muscle contraction and powering movement are profound, outwardly obvious, and of great consequence to survival(1,2). To cope with the effects of environmental temperature fluctuations, endothermic birds and mammals maintain a relatively warm and constant body temperature, whereas most fishes and other vertebrates are ectothermic and conform to their thermal niche, compromising performance at colder temperatures(2,3). However, within the fishes the tunas and lamnid sharks deviate from the ectothermic strategy, maintaining elevated core body temperatures(4,5) that presumably confer physiological advantages for their roles as fast and continuously swimming pelagic predators. Here we show that the salmon shark, a lamnid inhabiting cold, north Pacific waters, has become so specialized for endothermy that its red, aerobic, locomotor muscles, which power continuous swimming, seem mammal-like, functioning only within a markedly elevated temperature range ( 20 - 30 degrees C). These muscles are ineffectual if exposed to the cool water temperatures, and when warmed even 10 degrees C above ambient they still produce only 25 - 50% of the power produced at 26 degrees C. In contrast, the white muscles, powering burst swimming, do not show such a marked thermal dependence and work well across a wide range of temperatures.	Univ Massachusetts, Dept Biol, N Dartmouth, MA 02747 USA; Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Miracosta Coll, Dept Biol Sci, Oceanside, CA 92056 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Massachusetts System; University Massachusetts Dartmouth; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Calgary	Shadwick, RE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	dbernal@umassd.edu; shadwick@zoology.ubc.ca						Altringham JD, 1997, J EXP BIOL, V200, P2617; Anderson SD, 2001, COPEIA, P794; BENNETT AF, 1985, J EXP BIOL, V115, P333; Bennett AF, 1990, AM J PHYSIOL, V250, P253; Bernal D, 2003, J EXP BIOL, V206, P2845, DOI 10.1242/jeb.00504; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P205, DOI 10.1016/0010-406X(69)91336-X; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; CURTIN NA, 1988, J EXP BIOL, V140, P187; DEWAR H, 1994, J EXP BIOL, V192, P13; DICKSON KA, 1995, ENVIRON BIOL FISH, V42, P65, DOI 10.1007/BF00002352; Donley JM, 2004, NATURE, V429, P61, DOI 10.1038/nature02435; GRAHAM JB, 1990, J EXP BIOL, V151, P175; HULBERT L, 2002, SALMON SHARK LAMNA D; James RS, 1998, J EXP BIOL, V201, P901; JOHNSON TP, 1991, J COMP PHYSIOL B, V161, P27, DOI 10.1007/BF00258743; Johnston IA, 2002, J EXP BIOL, V205, P2305; Katz SL, 2002, J EXP BIOL, V205, P2251; Katz SL, 2001, NATURE, V410, P770, DOI 10.1038/35071170; PAUST B, 1989, 8601 U AL SEA GRANT; SMITH RL, 1983, J MAR BIOL ASSOC UK, V63, P243, DOI 10.1017/S0025315400049936; Syme DA, 2002, J EXP BIOL, V205, P189	22	71	72	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1349	1352		10.1038/nature04007	http://dx.doi.org/10.1038/nature04007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251963				2022-12-01	WOS:000232829100052
J	Loppin, B; Bonnefoy, E; Anselme, C; Laurencon, A; Karr, TL; Couble, P				Loppin, B; Bonnefoy, E; Anselme, C; Laurencon, A; Karr, TL; Couble, P			The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENE; METHYLATION; EXPRESSION; VARIANTS; SESAME; CHROMOSOME; ACTIVATION; ASYMMETRY; PROTEINS	In sexually reproducing animals, a crucial step in zygote formation is the decondensation of the fertilizing spermnucleus into a DNA replication-competent male pronucleus. Genome-wide nucleosome assembly on paternal DNA implies the replacement of sperm chromosomal proteins, such as protamines, by maternally provided histones(1,2). This fundamental process is specifically impaired in sesame (ssm), a unique Drosophila maternal effect mutant that prevents male pronucleus formation(3). Here we show that ssm is a point mutation in the Hira gene, thus demonstrating that the histone chaperone protein HIRA is required for nucleosome assembly during sperm nucleus decondensation. In vertebrates, HIRA has recently been shown to be critical for a nucleosome assembly pathway independent of DNA synthesis that specifically involves the H3.3 histone variant(4,5). We also show that nucleosomes containing H3.3, and not H3, are specifically assembled in paternal Drosophila chromatin before the first round of DNA replication. The exclusive marking of paternal chromosomes with H3.3 represents a primary epigenetic distinction between parental genomes in the zygote, and underlines an important consequence of the critical and highly specialized function of HIRA at fertilization.	Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; Inst Natl Sci Appl, INRA, UMR, F-69621 Villeurbanne, France; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of Bath	Loppin, B (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France.	loppin@cgmc.univ-lyon1.fr	Karr, Timothy L/G-1693-2011	LAURENCON, Anne/0000-0003-1791-1882				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; AKHMANOVA AS, 1995, GENOME, V38, P586, DOI 10.1139/g95-075; Arney KL, 2002, INT J DEV BIOL, V46, P317; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Foe Victoria E., 1993, P149; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kirov N, 1998, GENE, V212, P323, DOI 10.1016/S0378-1119(98)00143-7; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Llevadot R, 1998, BIOCHEM BIOPH RES CO, V249, P486, DOI 10.1006/bbrc.1998.9165; Loppin B, 2000, DEV BIOL, V222, P392, DOI 10.1006/dbio.2000.9718; Loppin B, 2001, CHROMOSOMA, V110, P430, DOI 10.1007/s004120100161; Loppin B, 2004, COMPREHENSIVE INSECT, P213; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McLay DW, 2003, REPRODUCTION, V125, P625, DOI 10.1530/rep.0.1250625; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Wright SJ, 1999, CURR TOP DEV BIOL, V46, P133, DOI 10.1016/S0070-2153(08)60328-2; YAMAGUCHI M, 1991, J CELL SCI, V100, P729	29	258	275	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1386	1390		10.1038/nature04059	http://dx.doi.org/10.1038/nature04059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251970				2022-12-01	WOS:000232829100060
J	Kocks, C; Cho, JH; Nehme, N; Ulvila, J; Pearson, AM; Meister, M; Strom, C; Conto, SL; Hetru, C; Stuart, LM; Stehle, T; Hoffmann, JA; Reichhart, JM; Ferrandon, D; Ramet, M; Ezekowitz, RAB				Kocks, C; Cho, JH; Nehme, N; Ulvila, J; Pearson, AM; Meister, M; Strom, C; Conto, SL; Hetru, C; Stuart, LM; Stehle, T; Hoffmann, JA; Reichhart, JM; Ferrandon, D; Ramet, M; Ezekowitz, RAB			Eater, a transmembrane protein mediating phagocytosis of bacterial pathogens in Drosophila	CELL			English	Article							SCAVENGER RECEPTOR; INNATE IMMUNITY; CELL-DEATH; RECOGNITION; HEMOCYTES; IDENTIFICATION; HEMATOPOIESIS; MECHANISMS; ENGULFMENT; COMPLEXITY	Phagocytosis is a complex, evolutionarily conserved process that plays a central role in host defense against infection. We have identified a predicted transmembrane protein, Eater, which is involved in phagocytosis in Drosophila. Transcriptional silencing of the eater gene in a macrophage cell line led to a significant reduction in the binding and internalization of bacteria. Moreover, the N terminus of the Eater protein mediated direct microbial binding which could be inhibited with scavenger receptor ligands, acetylated, and oxidized low-density lipoprotein. In vivo, eater expression was restricted to blood cells. Files lacking the eater gene displayed normal responses in NF-kappa B-like Toll and IMD signaling pathways but showed impaired phagocytosis and decreased survival after bacterial infection. Our results suggest that Eater is a major phagocytic receptor for a broad range of bacterial pathogens in Drosophila and provide a powerful model to address the role of phagocytosis in vivo.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Lab Dev Immunol,Dept Pediat, Boston, MA 02114 USA; Inst Biol Mol & Cellulaire, Ctr Natl Rech Sci, UPR9022, F-67084 Strasbourg, France; Oulu Univ, Dept Pediat, SF-90220 Oulu, Finland; Oulu Univ, Bioctr, SF-90220 Oulu, Finland; Tampere Univ, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Oulu; University of Oulu; Tampere University; Tampere University; Tampere University Hospital	Kocks, C (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Lab Dev Immunol,Dept Pediat, Boston, MA 02114 USA.	christine_kocks@hms.harvard.edu		FERRANDON, Dominique/0000-0001-7680-7773	NIAID NIH HHS [P01 AI 44220] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BRAND AH, 1993, DEVELOPMENT, V118, P401; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Horan P K, 1990, Methods Cell Biol, V33, P469; Hori S, 2000, EUR J BIOCHEM, V267, P5397, DOI 10.1046/j.1432-1327.2000.01578.x; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Krieger M, 2001, J CLIN INVEST, V108, P645, DOI 10.1172/JCI13932; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; METCHNIKOFF II, 1908, PRESENT STATE QUESTI; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rizki T.M., 1984, P579; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	41	288	300	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 21	2005	123	2					335	346		10.1016/j.cell.2005.08.034	http://dx.doi.org/10.1016/j.cell.2005.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239149	Bronze			2022-12-01	WOS:000232794100018
J	Ohrr, H; Tandan, JB; Sohn, YM; Shin, SH; Pradhan, DP; Halstead, SB				Ohrr, H; Tandan, JB; Sohn, YM; Shin, SH; Pradhan, DP; Halstead, SB			Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study	LANCET			English	Article							SA14-14-2; EFFICACY	Background In July, 1999, a single dose of live-attenuated SA 14-14-2 Japanese encephalitis vaccine was given to children aged 1-15 years in the Terai region of Nepal. Cases of natural infection occurred almost immediately. Our aim was to assess the long-term protective effect of this vaccination. Methods In 2000, this same population had a second seasonal exposure to the virus. We therefore did a case-control study to measure the prevalence of vaccination against Japanese encephalitis in 35 patients hospitalised for the disease 1 year after immunisation, and in age-sex matched village controls. Findings Of 35 children resident in Bardiya and Banke districts admitted to the Bheri Zonal Hospital with serologically confirmed Japanese encephalitis, only one had been vaccinated in 1999. In 430 age-sex matched village controls, 234 (54.4%) were vaccinated. We calculated a median unbiased estimate of the odds ratio of 0.0155, with lower and upper confidence limits of 0.0004 and 0.0986. The protective effect of vaccine after 12-15 months was 98.5% (CI 90.1-99.2%). Interpretation Our study provides evidence of sustained high protection afforded by one dose of live attenuated SA 14-14-2 vaccine in Nepalese children.	Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea; Council Tech Educ & Vocat Training, Sanothimi, Bhaktapur, Nepal; Yonsei Univ, Coll Med, Dept Paediat, Seoul 120752, South Korea; London Sch Hyg & Trop Med, London WC1, England; Bheri Zonal Hosp, Nepalganj, Nepal; Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of London; London School of Hygiene & Tropical Medicine; Uniformed Services University of the Health Sciences - USA	Ohrr, H (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea.	ohrr@yumc.yonsei.ac.kr	Pradhan, Debi Prasad/AFW-7470-2022					AO J, 1983, CHIN J MICROBIOL IMM, V3, P245; Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0; BISTA MB, 2001, JAPANESE ENCEPHALITI, P13; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; HIRJI KF, 1988, BIOMETRICS, V44, P803, DOI 10.2307/2531592; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Shepard D.S., 1993, DIS CONTROL PRIORITI, P303; Sohn YM, 1999, VACCINE, V17, P2259, DOI 10.1016/S0264-410X(99)00006-7; TSAI CJ, 1999, VACCINES, P672; Tsai TF, 1998, J INFECT DIS, V177, P221, DOI 10.1086/517358; Tsai YB, 2000, EARTHQ ENG ENG SEISM, V2, P1; *UNICEF, 1994, STAT WORLDS CHILDR; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087	16	82	89	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 15	2005	366	9494					1375	1378		10.1016/S0140-6736(05)67567-8	http://dx.doi.org/10.1016/S0140-6736(05)67567-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	973ZW	16226615				2022-12-01	WOS:000232562100029
J	Gromley, A; Yeaman, C; Rosa, J; Redick, S; Chen, CT; Mirabelle, S; Guha, M; Sillibourne, J; Doxsey, SJ				Gromley, A; Yeaman, C; Rosa, J; Redick, S; Chen, CT; Mirabelle, S; Guha, M; Sillibourne, J; Doxsey, SJ			Centriolin anchoring of exocyst and SNARE complexes at the midbody is required for secretory-vesicle-mediated abscission	CELL			English	Article							BUDDING YEAST; MEMBRANE TRAFFICKING; EPITHELIAL-CELLS; BINDING-PROTEIN; CLEAVAGE FURROW; CYTOKINESIS; CENTROSOME; SNAPIN; POLARITY; FISSION	The terminal step in cytokinesis, called abscission, requires resolution of the membrane connection between two prospective daughter cells. Our previous studies demonstrated that the coiled-coil protein centriolin localized to the midbody during cytokinesis and was required for abscission. Here we show that centriolin interacts with proteins of vesicle-targeting exocyst complexes and vesicle-fusion SNARE complexes. These complexes require centriolin for localization to a unique midbody-ring structure, and disruption of either complex inhibits abscission. Exocyst disruption induces accumulation of v-SNARE-containing vesicles at the midbody ring. In control cells, these v-SNARE vesicles colocalize with a GFP-tagged secreted polypeptide. The vesicles move to the midbody ring asymmetrically from one prospective daughter cell; the GFP signal is rapidly lost, suggesting membrane fusion; and subsequently the cell cleaves at the site of vesicle delivery/fusion. We propose that centriolin anchors protein complexes required for vesicle targeting and fusion and integrates membrane-vesicle fusion with abscission.	Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; Univ Iowa, Dept Cell Biol & Anat, Iowa City, IA 52242 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Iowa	Doxsey, SJ (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA.	stephen.doxsey@umassmed.edu	Yeaman, Charles A/A-1624-2009	Sillibourne, James/0000-0001-6755-3644; Yeaman, Charles/0000-0001-6149-628X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051994, R01GM067002, R01GM051994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051994, R01 GM067002, GM51994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Blum R, 2000, J CELL SCI, V113, P3151; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Chen C, 2004, ANN NY ACAD SCI, V1019, P355, DOI 10.1196/annals.1297.061; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; DOXSEY S, 2005, ANN REV CELL DEV, V21, P688; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Finger FP, 2002, CELL, V108, P727, DOI 10.1016/S0092-8674(02)00668-2; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; HARLOW E, ANTIBODIES LAB MANAU; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Molk JN, 2004, MOL BIOL CELL, V15, P1519, DOI 10.1091/mbc.E03-09-0708; Mondesert G, 1997, GENETICS, V147, P421; Monzo P, 2005, MOL BIOL CELL, V16, P2891, DOI 10.1091/mbc.E04-09-0773; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; PAWELETZ N, 1967, NATURWISSENSCHAFTEN, V54, P533, DOI 10.1007/BF00627210; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; SAXTON WM, 1987, J CELL BIOL, V105, P875, DOI 10.1083/jcb.105.2.875; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Strickland LI, 2004, TRENDS CELL BIOL, V14, P115, DOI 10.1016/j.tcb.2004.01.006; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Takeda T, 2004, NAT CELL BIOL, V6, P1142, DOI 10.1038/ncb1189; Thakur P, 2004, J NEUROSCI, V24, P6476, DOI 10.1523/JNEUROSCI.0590-04.2004; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Yeaman C, 2003, METHODS, V30, P198, DOI 10.1016/S1046-2023(03)00026-4	50	322	337	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					75	87		10.1016/j.cell.2005.07.027	http://dx.doi.org/10.1016/j.cell.2005.07.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213214	Bronze			2022-12-01	WOS:000232536800010
J	Lu, C; Tej, SS; Luo, SJ; Haudenschild, CD; Meyers, BC; Green, PJ				Lu, C; Tej, SS; Luo, SJ; Haudenschild, CD; Meyers, BC; Green, PJ			Elucidation of the small RNA component of the transcriptome	SCIENCE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; ARABIDOPSIS-THALIANA; INTERFERENCE; MICRORNAS; GENOME; IDENTIFICATION; ANNOTATION; EXPRESSION; MIRNA; MPSS	Small RNAs play important regulatory roles in most eukaryotes, but only a small proportion of these molecules have been identified. We sequenced more than two million small RNAs from seedlings and the inflorescence of the model plant Arabidopsis thaliana. Known and new microRNAs (miRNAs) were among the most abundant of the nonredundant set of more than 75,000 sequences, whereas more than half represented lower abundance small interfering RNAs (siRNAs) that match repetitive sequences, intergenic regions, and genes. Individual or clusters of highly regulated small RNAs were readily observed. Targets of antisense RNA or miRNA did not appear to be preferentially associated with siRNAs. Many genomic regions previously considered featureless were found to be sites of numerous small RNAs.	Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; Univ Delaware, Coll Marine Studies, Newark, DE 19711 USA; Solexa Inc, Hayward, CA 94545 USA	University of Delaware; University of Delaware; University of Delaware	Meyers, BC (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA.	meyers@dbi.udel.edu; green@dbi.udeLedu	Meyers, Blake C/B-6535-2012; Christian, Haudenschild C/D-1602-2009	Meyers, Blake C/0000-0003-3436-6097; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR16472-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wortman JR, 2003, PLANT PHYSIOL, V132, P461, DOI 10.1104/pp.103.022251; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	19	471	525	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1567	1569		10.1126/science.1114112	http://dx.doi.org/10.1126/science.1114112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141074				2022-12-01	WOS:000231715000051
J	de Waal, FBM				de Waal, FBM			A century of getting to know the chimpanzee	NATURE			English	Article							KIBALE NATIONAL-PARK; INFANTICIDE; PATERNITY	A century of research on chimpanzees, both in their natural habitat and in captivity, has brought these apes socially, emotionally and mentally much closer to us. Parallels and homologues between chimpanzee and human behaviour range from tool-technology and cultural learning to power politics and intercommunity warfare. Few behavioural domains have remained untouched by this increased knowledge, which has dramatically challenged the way we view ourselves. The sequencing of the chimpanzee genome will no doubt bring more surprises and insights. Humans do occupy a special place among the primates, but this place increasingly has to be defined against a backdrop of substantial similarity.	Emory Univ, Yerkes Natl Primate Res Ctr, Living Links, Atlanta, GA 30322 USA	Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Living Links, 954 N Gatewood Rd, Atlanta, GA 30322 USA.	dewaal@emory.edu						Arcadi AC, 1999, PRIMATES, V40, P337, DOI 10.1007/BF02557557; Aureli F, 2000, NATURAL CONFLICT RES; Boesch C, 2003, ANIMAL SOCIAL COMPLEXITY, P93; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Goodall J., 1965, P425; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Goodall J., 1979, GREAT APES, P13; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HIRAIWAHASEGAWA M, 1994, INFANTICIDE PARENTAL, P137; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Kohler W, 1925, MENTALITY APES; Ladygina-Kohts N. N., 2001, INFANT CHIMPANZEE HU; Menzel EW., 1974, BEHAVIOR NONHUMAN PR, P83; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; NISHIDA T, 1983, Primates, V24, P318, DOI 10.1007/BF02381978; Nishida Toshisada, 1992, P159; Nissen, 1931, COMP PSYCHOL MONOGR, V8, P1; OAKLEY KP, 1957, MAN TOOL MAKER; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; STANFORD CB, 1998, CHIMPANZEE RED COLUM; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Watts DP, 2004, INT J PRIMATOL, V25, P507, DOI 10.1023/B:IJOP.0000023573.56625.59; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Yerkes R. M., 1943, CHIMPANZEES LAB COLO	34	29	34	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2005	437	7055					56	59		10.1038/nature03999	http://dx.doi.org/10.1038/nature03999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	960AC	16136128				2022-12-01	WOS:000231560400042
J	Michael, HA; Mulligan, AE; Harvey, CF				Michael, HA; Mulligan, AE; Harvey, CF			Seasonal oscillations in water exchange between aquifers and the coastal ocean	NATURE			English	Article							SUBMARINE GROUNDWATER DISCHARGE; SALT WATER; INPUTS; NUTRIENT; FLORIDA; RADIUM; FLUXES; ZONE; SEA	Ground water of both terrestrial and marine origin flows into coastal surface waters as submarine groundwater discharge, and constitutes an important source of nutrients, contaminants and trace elements to the coastal ocean(1-5). Large saline discharges have been observed by direct measurements(3,6-10) and inferred from geochemical tracers(11-13), but sufficient seawater inflow has not been observed to balance this outflow. Geochemical tracers also suggest a time lag between changes in submarine groundwater discharge rates(12,14) and the seasonal oscillations of inland recharge that drive groundwater flow towards the coast. Here we use measurements of hydraulic gradients and offshore fluxes taken at Waquoit Bay, Massachusetts, together with a modelling study of a generalized coastal groundwater system to show that a shift in the freshwater - saltwater interface - controlled by seasonal changes in water table elevation - can explain large saline discharges that lag inland recharge cycles. We find that sea water is drawn into aquifers as the freshwater - saltwater interface moves landward during winter, and discharges back into coastal waters as the interface moves seaward in summer. Our results demonstrate the connection between the seasonal hydrologic cycle inland and the saline groundwater system in coastal aquifers, and suggest a potentially important seasonality in the chemical loading of coastal waters.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Marine Policy Ctr, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Harvey, CF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	charvey@mit.edu	harvey, charles F/A-8601-2012; Michael, Holly A/F-8447-2010	harvey, charles F/0000-0002-7759-4447; Michael, Holly A/0000-0003-1107-7698				[Anonymous], INTERACTIVE GRAPHICS; Bear J, 1999, SEAWATER INTRUSION C; Burnett WC, 2003, BIOGEOCHEMISTRY, V66, P3, DOI 10.1023/B:BIOG.0000006066.21240.53; Changnon SA, 1988, J CLIMATE, V1, P1239, DOI 10.1175/1520-0442(1988)001<1239:RBPASG>2.0.CO;2; COOPER HH, 1959, J GEOPHYS RES, V64, P461, DOI 10.1029/JZ064i004p00461; Crotwell AM, 2003, AQUAT GEOCHEM, V9, P191, DOI 10.1023/B:AQUA.0000022954.89019.c9; Eltahir EAB, 1999, WATER RESOUR RES, V35, P1199, DOI 10.1029/1998WR900071; JOHANNES RE, 1980, MAR ECOL PROG SER, V3, P365, DOI 10.3354/meps003365; Kelly RP, 2002, LIMNOL OCEANOGR, V47, P1796, DOI 10.4319/lo.2002.47.6.1796; Kim G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018378; KOHOUT FA, 1960, J GEOPHYS RES, V65, P2133, DOI 10.1029/JZ065i007p02133; LEE DR, 1977, LIMNOL OCEANOGR, V22, P140, DOI 10.4319/lo.1977.22.1.0140; Li L, 1999, WATER RESOUR RES, V35, P3253, DOI 10.1029/1999WR900189; Michael HA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016000; Moore WS, 1996, NATURE, V380, P612, DOI 10.1038/380612a0; Moore WS, 1996, NATURE, V382, P122, DOI 10.1038/382122a0; Moore WS, 1997, EARTH PLANET SC LETT, V150, P141, DOI 10.1016/S0012-821X(97)00083-6; Moore WS, 1999, MAR CHEM, V65, P111, DOI 10.1016/S0304-4203(99)00014-6; PAYNE R, FALMOUTH MONTHLY CLI; Robinson M, 1998, GROUND WATER MONIT R, V18, P83, DOI 10.1111/j.1745-6592.1998.tb00605.x; SIMMONS GM, 1992, MAR ECOL PROG SER, V84, P173, DOI 10.3354/meps084173; Slomp CP, 2004, J HYDROL, V295, P64, DOI 10.1016/j.jhydrol.2004.02.018; Smith L, 2003, BIOGEOCHEMISTRY, V66, P95, DOI 10.1023/B:BIOG.0000006108.80520.c9; Taniguchi M, 2005, GROUND WATER, V43, P336, DOI 10.1111/j.1745-6584.2005.0027.x; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; VALIELA I, 1990, BIOGEOCHEMISTRY, V10, P177	26	384	394	8	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2005	436	7054					1145	1148		10.1038/nature03935	http://dx.doi.org/10.1038/nature03935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121178				2022-12-01	WOS:000231416600043
J	LaCount, DJ; Vignali, M; Chettier, R; Phansalkar, A; Bell, R; Hesselberth, JR; Schoenfeld, LW; Ota, I; Sahasrabudhe, S; Kurschner, C; Fields, S; Hughes, RE				LaCount, DJ; Vignali, M; Chettier, R; Phansalkar, A; Bell, R; Hesselberth, JR; Schoenfeld, LW; Ota, I; Sahasrabudhe, S; Kurschner, C; Fields, S; Hughes, RE			A protein interaction network of the malaria parasite Plasmodium falciparum	NATURE			English	Article							YEAST; GENOMICS; ACETYLTRANSFERASE; EXPRESSION; VIRULENCE; BIOLOGY; MAP	Plasmodium falciparum causes the most severe form of malaria and kills up to 2.7 million people annually(1). Despite the global importance of P. falciparum, the vast majority of its proteins have not been characterized experimentally. Here we identify P. falciparum protein - protein interactions using a high-throughput version of the yeast two-hybrid assay that circumvents the difficulties in expressing P. falciparum proteins in Saccharomyces cerevisiae. From more than 32,000 yeast two-hybrid screens with P. falciparum protein fragments, we identified 2,846 unique interactions, most of which include at least one previously uncharacterized protein. Informatic analyses of network connectivity, coexpression of the genes encoding interacting fragments, and enrichment of specific protein domains or Gene Ontology annotations(2) were used to identify groups of interacting proteins, including one implicated in chromatin modification, transcription, messenger RNA stability and ubiquitination, and another implicated in the invasion of host cells. These data constitute the first extensive description of the protein interaction network for this important human pathogen.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Prolexys Pharmaceut Inc, Salt Lake City, UT 84111 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357730, Seattle, WA 98195 USA.	fields@u.washington.edu; rhughes@buckinstitute.org		Vignali, Marissa/0000-0002-7319-3371; Hesselberth, Jay/0000-0002-6299-179X				Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Fan Q, 2004, EUKARYOT CELL, V3, P264, DOI 10.1128/EC.3.2.264-276.2004; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sibley CH, 1997, METHODS, V13, P190, DOI 10.1006/meth.1997.0511	30	396	422	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					103	107		10.1038/nature04104	http://dx.doi.org/10.1038/nature04104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267556				2022-12-01	WOS:000232979000050
J	Fraser, JA; Giles, SS; Wenink, EC; Geunes-Boyer, SG; Wright, JR; Diezmann, S; Allen, A; Stajich, JE; Dietrich, FS; Perfect, JR; Heitman, J				Fraser, JA; Giles, SS; Wenink, EC; Geunes-Boyer, SG; Wright, JR; Diezmann, S; Allen, A; Stajich, JE; Dietrich, FS; Perfect, JR; Heitman, J			Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak	NATURE			English	Article							NEOFORMANS VAR. GATTII; PATHOGENIC YEAST; RECOMBINATION; REPRODUCTION; TOXOPLASMA; AUSTRALIA; VIRULENCE; CANADA	Genealogy can illuminate the evolutionary path of important human pathogens. In some microbes, strict clonal reproduction predominates, as with the worldwide dissemination of Mycobacterium leprae, the cause of leprosy(1). In other pathogens, sexual reproduction yields clones with novel attributes, for example, enabling the efficient, oral transmission of the parasite Toxoplasma gondii(2). However, the roles of clonal or sexual propagation in the origins of many other microbial pathogen outbreaks remain unknown, like the recent fungal meningoencephalitis outbreak on Vancouver Island, Canada, caused by Cryptococcus gattii(3). Here we show that the C. gattii outbreak isolates comprise two distinct genotypes. The majority of isolates are hypervirulent and have an identical genotype that is unique to the Pacific Northwest. A minority of the isolates are significantly less virulent and share an identical genotype with fertile isolates from an Australian recombining population. Genotypic analysis reveals evidence of sexual reproduction, in which the majority genotype is the predicted offspring. However, instead of the classic a - alpha sexual cycle, the majority outbreak clone appears to have descended from two alpha mating-type parents. Analysis of nuclear content revealed a diploid environmental isolate homozygous for the major genotype, an intermediate produced during same-sex mating. These studies demonstrate how cryptic same-sex reproduction can enable expansion of a human pathogen to a new geographical niche and contribute to the ongoing production of infectious spores. This has implications for the emergence of other microbial pathogens and inbreeding in host range expansion in the fungal and other kingdoms.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021; Fraser, James A/B-4918-2012; Stajich, Jason Eric/C-7297-2008	Fraser, James A/0000-0001-5724-5285; Stajich, Jason Eric/0000-0002-7591-0020; Diezmann, Stephanie/0000-0002-9528-1495	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039115, R01AI050113] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI039115, R01 AI050113] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALANO P, 1990, ANNU REV MICROBIOL, V44, P429, DOI 10.1146/annurev.mi.44.100190.002241; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Campbell LT, 2005, EUKARYOT CELL, V4, P1410, DOI 10.1128/EC.4.8.1410-1419.2005; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Diaz MR, 2000, SYST APPL MICROBIOL, V23, P535, DOI 10.1016/S0723-2020(00)80028-4; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; LITVINTSEVA AP, IN PRESS GENETICS; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; RUIZ A, 1981, APPL ENVIRON MICROB, V41, P1225, DOI 10.1128/AEM.41.5.1225-1229.1981; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Sukroongreung S, 1998, MED MYCOL, V36, P419, DOI 10.1080/02681219880000661; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327	30	382	409	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1360	1364		10.1038/nature04220	http://dx.doi.org/10.1038/nature04220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16222245				2022-12-01	WOS:000232829100055
J	Ju, TZ; Cummings, RD				Ju, TZ; Cummings, RD			Protein glycosylation - Chaperone mutation in Tn syndrome	NATURE			English	Editorial Material							BETA-1,3-GALACTOSYLTRANSFERASE		Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ju, TZ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	richard-cummings@ouhsc.edu		Ju, Tongzhong/0000-0002-4429-1976				Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; CARTRON JP, 1979, NATURE, V282, P621, DOI 10.1038/282621a0; CARTRON JP, 1978, LANCET, V1, P856; Felner KM, 1998, BBA-MOL BASIS DIS, V1406, P115; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julian BA, 2004, CURR OPIN NEPHROL HY, V13, P171, DOI 10.1097/00041552-200403000-00005; MOREAU R, 1957, Bull Mem Soc Med Hop Paris, V73, P569; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112	9	196	217	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1252	1252		10.1038/4371252a	http://dx.doi.org/10.1038/4371252a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251947	Bronze			2022-12-01	WOS:000232829100033
J	Rual, JF; Venkatesan, K; Hao, T; Hirozane-Kishikawa, T; Dricot, A; Li, N; Berriz, GF; Gibbons, FD; Dreze, M; Ayivi-Guedehoussou, N; Klitgord, N; Simon, C; Boxem, M; Milstein, S; Rosenberg, J; Goldberg, DS; Zhang, LV; Wong, SL; Franklin, G; Li, SM; Albala, JS; Lim, JH; Fraughton, C; Llamosas, E; Cevik, S; Bex, C; Lamesch, P; Sikorski, RS; Vandenhaute, J; Zoghbi, HY; Smolyar, A; Bosak, S; Sequerra, R; Doucette-Stamm, L; Cusick, ME; Hill, DE; Roth, FP; Vidal, M				Rual, JF; Venkatesan, K; Hao, T; Hirozane-Kishikawa, T; Dricot, A; Li, N; Berriz, GF; Gibbons, FD; Dreze, M; Ayivi-Guedehoussou, N; Klitgord, N; Simon, C; Boxem, M; Milstein, S; Rosenberg, J; Goldberg, DS; Zhang, LV; Wong, SL; Franklin, G; Li, SM; Albala, JS; Lim, JH; Fraughton, C; Llamosas, E; Cevik, S; Bex, C; Lamesch, P; Sikorski, RS; Vandenhaute, J; Zoghbi, HY; Smolyar, A; Bosak, S; Sequerra, R; Doucette-Stamm, L; Cusick, ME; Hill, DE; Roth, FP; Vidal, M			Towards a proteome-scale map of the human protein-protein interaction network	NATURE			English	Article							ORFEOME VERSION 1.1; DATABASE; GENOME; ANNOTATION; RESOURCE; PLATFORM	Systematic mapping of protein-protein interactions, or 'interactome' mapping, was initiated in model organisms, starting with defined biological processes(1,2) and then expanding to the scale of the proteome(3-7). Although far from complete, such maps have revealed global topological and dynamic features of interactome networks that relate to known biological properties(8,9), suggesting that a human interactome map will provide insight into development and disease mechanisms at a systems level. Here we describe an initial version of a proteome-scale map of human binary protein-protein interactions. Using a stringent, high-throughput yeast two-hybrid system, we tested pairwise interactions among the products of similar to 8,100 currently available Gateway-cloned open reading frames and detected similar to 2,800 interactions. This data set, called CCSB-HI1, has a verification rate of similar to 78% as revealed by an independent co-affinity purification assay, and correlates significantly with other biological attributes. The CCSB-HI1 data set increases by similar to 70% the set of available binary interactions within the tested space and reveals more than 300 new connections to over 100 disease-associated proteins. This work represents an important step towards a systematic and comprehensive human interactome project.	Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Fac Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Belgium; Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Univ, Dept Pediat, Houston, TX 77030 USA; Baylor Univ, Dept Neurol, Houston, TX 77030 USA; Baylor Univ, Dept Neurosci, Houston, TX 77030 USA; Baylor Univ, Dept Mol & Human Genet, Houston, TX 77030 USA; Arcbay Inc, Boston, MA 01915 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Baylor University; Baylor University; Baylor University; Baylor University	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, 44 Binney St, Boston, MA 02115 USA.	david_hill@dfci.harvard.edu; fritz_roth@hms.harvard.edu; marc_vidal@dfci.harvard.edu	Dreze, Matija/AAZ-3293-2020; Boxem, Mike/B-8857-2011; Hill, David E/B-6617-2011; Vidal, Marc/Y-2466-2019; Klitgord, Niels/B-5121-2009; Roth, Frederick P/H-6308-2011	Vidal, Marc/0000-0003-3391-5410; Zoghbi, Huda/0000-0002-0700-3349; Cevik, Sebiha/0000-0002-0935-1929; Roth, Frederick/0000-0002-6628-649X; Rual, Jean-Francois/0000-0003-4465-8819; /0000-0001-7002-8488	NCI NIH HHS [R33 CA132073] Funding Source: Medline; NHGRI NIH HHS [R01 HG001715, P50 HG004233, U01 HG001715, RC4 HG006066] Funding Source: Medline; NHLBI NIH HHS [U01 HL098166] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA132073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC4HG006066, U01HG001715, P50HG004233, R01HG001715] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Huang X, 2004, CLIN NEUROPATHOL, V23, P1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Walhout AJM, 1999, GENOME RES, V9, P1128, DOI 10.1101/gr.9.11.1128; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	30	2093	2187	6	270	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1173	1178		10.1038/nature04209	http://dx.doi.org/10.1038/nature04209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16189514				2022-12-01	WOS:000232660500048
J	Elvin, CM; Carr, AG; Huson, MG; Maxwell, JM; Pearson, RD; Vuocolo, T; Liyou, NE; Wong, DCC; Merritt, DJ; Dixon, NE				Elvin, CM; Carr, AG; Huson, MG; Maxwell, JM; Pearson, RD; Vuocolo, T; Liyou, NE; Wong, DCC; Merritt, DJ; Dixon, NE			Synthesis and properties of crosslinked recombinant pro-resilin	NATURE			English	Article							ELASTIC PROTEINS; SOUND PRODUCTION; IDENTIFICATION; LINKING; TIMBAL	Resilin is a member of a family of elastic proteins that includes elastin, as well as gluten, gliadin, abductin and spider silks. Resilin is found in specialized regions of the cuticle of most insects, providing low stiffness, high strain and efficient energy storage(1,2); it is best known for its roles in insect flight(3,4) and the remarkable jumping ability of fleas(5,6) and spittle bugs(7). Previously, the Drosophila melanogaster CG15920 gene was tentatively identified as one encoding a resilin-like protein(8,9) (pro-resilin). Here we report the cloning and expression of the first exon of the Drosophila CG15920 gene as a soluble protein in Escherichia coli. We show that this recombinant protein can be cast into a rubber-like biomaterial by rapid photochemical crosslinking. This observation validates the role of the putative elastic repeat motif in resilin function. The resilience ( recovery after deformation) of crosslinked recombinant resilin was found to exceed that of unfilled synthetic polybutadiene, a high resilience rubber. We believe that our work will greatly facilitate structural investigations into the functional properties of resilin and shed light on more general aspects of the structure of elastomeric proteins. In addition, the ability to rapidly cast samples of this biomaterial may enable its use in situ for both industrial and biomedical applications.	CSIRO Livestock Ind, St Lucia, Qld 4072, Australia; CSIRO Text & Fibre Technol, Geelong, Vic 3216, Australia; Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Australian National University	Elvin, CM (corresponding author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.	chris.elvin@csiro.au	Merritt, David J/D-2318-2010; elvin, chris/H-2333-2013; Dixon, Nicholas E/A-1226-2008; Huson, Mickey/K-2474-2012; Vuocolo, Tony/H-7533-2013	Merritt, David J/0000-0002-8573-7508; Dixon, Nicholas E/0000-0002-5958-6945; Huson, Mickey/0000-0003-1859-7805; Vuocolo, Tony/0000-0002-5574-8126				AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Andersen SO, 2002, ELASTOMERIC PROTEINS; ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; Anderson S O, 1966, Acta Physiol Scand Suppl, V263, P1; Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Cowie J.M.G., 1973, POLYM CHEM PHYS MODE; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027; Lehmann FO, 2001, J EXP BIOL, V204, P627; Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980; Malencik DA, 1996, BIOCHEMISTRY-US, V35, P4375, DOI 10.1021/bi9526037; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; Neville A., 1967, P R ENTOMOL SOC LOND, V32, P9; Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P457, DOI 10.1098/rstb.1975.0062; Rousseau R, 2004, BIOPHYS J, V86, P1393, DOI 10.1016/S0006-3495(04)74210-1; SINGARAVELU G, 1991, NATL ACAD SCI LETT, V14, P147; Skals N, 1999, J EXP BIOL, V202, P2937; Tatham AS, 2002, PHILOS T R SOC B, V357, P229, DOI 10.1098/rstb.2001.1031; Treloar L.R.G, 1975, PHYS TODAY, DOI [DOI 10.1002/PI.4980080107, DOI 10.1063/1.3060678]; URRY DW, 2002, ELASTOMERIC PROTEINS, P54; VARMAN AR, 1980, EXPERIENTIA, V36, P564, DOI 10.1007/BF01965802; Weis-Fogh T., 1960, J EXP BIOL, V37, P887; WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1; WEISFOGH T, 1961, CELL ORGANISM, P283; YOUNG D, 1995, J EXP BIOL, V198, P1001	30	376	408	8	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2005	437	7061					999	1002		10.1038/nature04085	http://dx.doi.org/10.1038/nature04085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222249				2022-12-01	WOS:000232496100040
J	Pasche, B; Knobloch, TJ; Bian, YS; Liu, JJ; Phukan, S; Rosman, D; Kaklamani, V; Baddi, L; Siddiqui, FS; Frankel, W; Prior, TW; Schuller, DE; Agrawal, A; Lang, J; Dolan, ME; Vokes, EE; Lane, WS; Huang, CC; Caldes, T; Di Cristofano, A; Hampel, H; Nilsson, I; von Heijne, G; Fodde, R; Murty, VVVS; de la Chapelle, A; Weghorst, CM				Pasche, B; Knobloch, TJ; Bian, YS; Liu, JJ; Phukan, S; Rosman, D; Kaklamani, V; Baddi, L; Siddiqui, FS; Frankel, W; Prior, TW; Schuller, DE; Agrawal, A; Lang, J; Dolan, ME; Vokes, EE; Lane, WS; Huang, CC; Caldes, T; Di Cristofano, A; Hampel, H; Nilsson, I; von Heijne, G; Fodde, R; Murty, VVVS; de la Chapelle, A; Weghorst, CM			Somatic acquisition and signaling of TGFBR1*6A in cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; II RECEPTOR GENE; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CARCINOMA-CELLS; OVARIAN CARCINOMAS; REPLICATION ERROR	Context TGFBR1*6A is a common polymorphism of the type I transforming growth factor 0 receptor (TGFBR1). Epidemiological studies suggest that TGFBR1*6A may act as a tumor susceptibility allele. How TGFBR1*6A contributes to cancer development is largely unknown.. Objectives To determine whether TGFBR1*6A is somatically acquired by primary tumors and metastases during cancer development and whether the 3-amino acid deletion that differentiates TGFBR1*6A from TGFBR1 is part of the mature receptor or part of the signal sequence and to investigate TGFBR1*6A signaling in cancer cells. Design, Setting, and Patients Tumor And germline tissues from 531 patients with a diagnosis of head and neck, colorectal, or breast cancer recruited from 3 centers in the United States and from 1 center in Spain from June 1, 1994, through June 30, 2004, In vitro translation assays, MCF-7 breast cancer cells stably transfected with TGFBR1*6A, TGFBR1, or the vector alone, DLD-1 colorectal cancer cells that endogenously carry TGFBR1*6A, and SW48 colorectal cancer cells that do not carry TGFBR1*6A. Main Outcome Measures TGFBR1*6A somatic acquisition in cancer. Determination of the amino terminus of the mature TGFBR1*6A and TGFBR1 receptors. Determination of TGF-beta-dependent cell proliferation. Results TGFBR1*6A was somatically acquired in 13 of 44 (29.5%) colorectal cancer metastases, in 4 of 157 (2.5%) of colorectal tumors, in 4 of 226 (1.8%) head and neck primary tumors, and in none of the 104 patients with breast cancer. TGFBR1*6A somatic acquisition is not associated with loss of heterozygosity, microsatellite instability, or a mutator phenotype. The signal sequences of TGFBR1 and TGFBR1*6A are cleaved at the same site resulting in identical mature receptors. TGFBR1*6A may switch TGF-beta growth inhibitory signals into growth stimulatory signals in MCF-7 breast cancer cells and in DLD-1 colorectal cancer cells. Conclusions TGFBR1*6A is somatically acquired in 29.5% of liver metastases from colorectal cancer and may bestow cancer cells with a growth advantage in the presence of TGF-beta. The functional consequences of this conversion appear to be mediated by the TGFBR1*6A signal sequence rather than by the mature receptor. The results highlight a new facet of TGF-beta signaling in cancer and suggest that TGFBR1*6A may represent a potential therapeutic target in cancer.	Ohio State Univ, Div Environm Hlth Sci, Sch Publ Hlth, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; Univ Chicago, Ctr Canc Res, Chicago, IL 60637 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Hosp Clin San Carlos, Oncol Mol Lab, Madrid, Spain; Fox Chase Canc Ctr, Human Genet Program, Div Populat Sci, Philadelphia, PA 19111 USA; Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Chicago; University of Chicago; Harvard University; Hospital Clinico San Carlos; Fox Chase Cancer Center; Stockholm University; Erasmus University Rotterdam; Erasmus MC; Columbia University	Pasche, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol,Canc Genet Program, 676 N St Clair St,Suite 880, Chicago, IL 60611 USA.	b-pasche@northwestern.edu	von Heijne, Gunnar/F-5576-2011; Nilsson, IngMarie/H-2887-2012; Vokes, Everett/Q-2146-2019; von Heijne, Gunnar/AAH-9389-2019; di cristofano, antonio/AAJ-3796-2020; Fodde, Riccardo/AAW-9394-2021; Di Cristofano, Antonio/B-4148-2016	von Heijne, Gunnar/0000-0002-4490-8569; di cristofano, antonio/0000-0003-2537-3228; Fodde, Riccardo/0000-0001-9839-4324; Frankel, Wendy/0000-0003-1658-1009; Weghorst, Christopher/0000-0003-2973-3980	NATIONAL CANCER INSTITUTE [P50CA090386, R01CA067941, P30CA016058, P50CA089018, U01CA067941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012704, R01DE011943, P50DE011921] Funding Source: NIH RePORTER; NCI NIH HHS [CA89018, P30 CA016058, P30 CA16058, CA67941, CA90386] Funding Source: Medline; NIDCR NIH HHS [R01 DE011943, DE/CA 11921, P01 DE12704, P01 DE012704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81; Bellone G, 2001, EUR J CANCER, V37, P224, DOI 10.1016/S0959-8049(00)00391-9; Bian Y, 2005, J CLIN ONCOL, V23, P3074, DOI 10.1200/JCO.2005.00.281; Bitzer M, 2000, GENE DEV, V14, P187; Boland CR, 1998, CANCER RES, V58, P5248; Canzian F, 1996, CANCER RES, V56, P3331; CHAOUCHI N, 1995, ONCOGENE, V11, P1615; Chen T, 2001, CANCER RES, V61, P4679; Chen TP, 1999, INT J CANCER, V82, P43; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edmonston TB, 2000, HUM PATHOL, V31, P1506, DOI 10.1053/hupa.2000.20383; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FRIEDMAN E, 1995, CANCER EPIDEM BIOMAR, V4, P549; GARRIGUEANTAR L, 1995, CANCER RES, V55, P3982; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Goggins M, 1998, CANCER RES, V58, P5329; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Im YH, 2001, CANCER RES, V61, P6665; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kaklamani V, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-28; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kaklamani VG, 2003, J CLIN ONCOL, V21, P3236, DOI 10.1200/JCO.2003.11.524; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Knobloch TJ, 2001, MUTAT RES-FUND MOL M, V479, P131, DOI 10.1016/S0027-5107(01)00157-9; Ko Y, 1998, J CELL PHYSIOL, V176, P424, DOI 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.3.CO;2-N; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; LAVARONE A, 1997, NATURE, V387, P417; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Pasche B, 1999, CANCER RES, V59, P5678; Pasche B, 1998, CANCER RES, V58, P2727; Pasche B, 2004, J CLIN ONCOL, V22, P756, DOI 10.1200/JCO.2004.99.271; Pasche B, 2002, BEST PRACT RES CL GA, V16, P331, DOI 10.1053/bega.2002.0289; Pasche B, 2001, CANCER RES, V61, P8351; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cellbio.10.1.87; Wang D, 1997, CARCINOGENESIS, V18, P2285, DOI 10.1093/carcin/18.11.2285; Wang D, 2000, CANCER RES, V60, P4507; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zhou XP, 1997, ONCOGENE, V15, P1713, DOI 10.1038/sj.onc.1201337	67	74	83	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2005	294	13					1634	1646		10.1001/jama.294.13.1634	http://dx.doi.org/10.1001/jama.294.13.1634			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970DC	16204663	Bronze			2022-12-01	WOS:000232284400016
J	Colman-Lerner, A; Gordon, A; Serra, E; Chin, T; Resnekov, O; Endy, D; Pesce, CG; Brent, R				Colman-Lerner, A; Gordon, A; Serra, E; Chin, T; Resnekov, O; Endy, D; Pesce, CG; Brent, R			Regulated cell-to-cell variation in a cell-fate decision system	NATURE			English	Article							KINASE SIGNALING SPECIFICITY; EUKARYOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; C-ELEGANS; CAENORHABDITIS-ELEGANS; PHEROMONE RESPONSE; PROTEIN-KINASE; SINGLE-CELL; YEAST; NOISE	Here we studied the quantitative behaviour and cell-to-cell variability of a prototypical eukaryotic cell-fate decision system, the mating pheromone response pathway in yeast. We dissected and measured sources of variation in system output, analysing thousands of individual, genetically identical cells. Only a small proportion of total cell-to-cell variation is caused by random fluctuations in gene transcription and translation during the response ('expression noise'). Instead, variation is dominated by differences in the capacity of individual cells to transmit signals through the pathway ('pathway capacity') and to express proteins from genes ('expression capacity'). Cells with high expression capacity express proteins at a higher rate and increase in volume more rapidly. Our results identify two mechanisms that regulate cell-to-cell variation in pathway capacity. First, the MAP kinase Fus3 suppresses variation at high pheromone levels, while the MAP kinase Kss1 enhances variation at low pheromone levels. Second, pathway capacity and expression capacity are negatively correlated, suggesting a compensatory mechanism that allows cells to respond more precisely to pheromone in the presence of a large variation in expression capacity.	Inst Mol Sci, Berkeley, CA 94704 USA; MIT, Div Biol Engn, Cambridge, MA 02139 USA	The Molecular Sciences Institute; Massachusetts Institute of Technology (MIT)	Gordon, A (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.	gordon@molsci.org; brent@molsci.org	Colman-Lerner, Alejandro/ABC-3808-2020; Serra, Eduard/K-1332-2013	Colman-Lerner, Alejandro/0000-0002-2557-8883; Serra, Eduard/0000-0003-2895-9857; Endy, Drew/0000-0001-6952-8098				Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; AUSUBEL FM, 2004, CURRENT PROTOCOLS MO; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DELBRUCK M, 1945, J BACTERIOL, V50, P131; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Guthrie C., 1991, METHODS ENZYMOLOGY G; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; JAN YN, 1995, NEURON, V14, P1; JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Karp X, 2003, GENE DEV, V17, P3100, DOI 10.1101/gad.1160803; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180	38	321	327	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					699	706		10.1038/nature03998	http://dx.doi.org/10.1038/nature03998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16170311				2022-12-01	WOS:000232157900045
J	Ueguchi-Tanaka, M; Ashikari, M; Nakajima, M; Itoh, H; Katoh, E; Kobayashi, M; Chow, TY; Hsing, YIC; Kitano, H; Yamaguchi, I; Matsuoka, M				Ueguchi-Tanaka, M; Ashikari, M; Nakajima, M; Itoh, H; Katoh, E; Kobayashi, M; Chow, TY; Hsing, YIC; Kitano, H; Yamaguchi, I; Matsuoka, M			GIBBERELLIN INSENSITIVE DWARF1 encodes a soluble receptor for gibberellin	NATURE			English	Article							SIGNALING PATHWAY; RICE; PROTEIN; MUTANT; GENE; METABOLISM; ALEURONE; SUBUNIT; CLONING; GROWTH	Gibberellins ( GAs) are phytohormones that are essential for many developmental processes in plants. It has been postulated that plants have both membrane-bound and soluble GA receptors; however, no GA receptors have yet been identified. Here we report the isolation and characterization of a new GA-insensitive dwarf mutant of rice, gid1. The GID1 gene encodes an unknown protein with similarity to the hormone-sensitive lipases, and we observed preferential localization of a GID1 - green fluorescent protein (GFP) signal in nuclei. Recombinant glutathione S-transferase (GST) - GID1 had a high affinity only for biologically active GAs, whereas mutated GST - GID1 corresponding to three gid1 alleles had no GA-binding affinity. The dissociation constant for GA(4) was estimated to be around 10(-7) M, enough to account for the GA dependency of shoot elongation. Moreover, GID1 bound to SLR1, a rice DELLA protein, in a GA-dependent manner in yeast cells. GID1 overexpression resulted in a GA-hypersensitive phenotype. Together, our results indicate that GID1 is a soluble receptor mediating GA signalling in rice.	Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan; Natl Inst Agrobiol Sci, Dept Biochem, Tsukuba, Ibaraki 3058602, Japan; RIKEN, Bioresources Ctr, Tsukuba, Ibaraki 3050074, Japan; Acad Sinica, Inst Bot, Taipei 11529, Taiwan; Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan	Nagoya University; University of Tokyo; National Institute of Agrobiological Sciences - Japan; RIKEN; Academia Sinica - Taiwan; University of Tokyo	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@nuagr1.agr.nagoya-u.ac.jp	Kobayashi, Masatomo/A-5945-2016					Davies P. J, 1995, PLANT HORMONES; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Gomi K, 2004, PLANT J, V37, P626, DOI 10.1111/j.1365-313X.2003.01990.x; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOLEY R, 1992, BIOCHEM SOC T, V20, P85, DOI 10.1042/bst0200085; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2005, PLANT CELL PHYSIOL, V46, P1392, DOI 10.1093/pcp/pci152; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; KEINSKI S, 2005, NATURE, V435, P446; KOBAYASHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P1969, DOI 10.1271/bbb.59.1969; Lovegrove A, 1998, PLANT J, V15, P311, DOI 10.1046/j.1365-313X.1998.00209.x; Manco G, 2000, ARCH BIOCHEM BIOPHYS, V373, P182, DOI 10.1006/abbi.1999.1497; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Nakajima M, 1997, BIOCHEM BIOPH RES CO, V241, P782, DOI 10.1006/bbrc.1997.7896; NAKAYAMA I, 1990, PLANT CELL PHYSIOL, V31, P195; Natsume T, 1999, BIOCHEM BIOPH RES CO, V260, P527, DOI 10.1006/bbrc.1999.0905; NISHIJIMA T, 1994, BIOSCI BIOTECH BIOCH, V58, P572, DOI 10.1271/bbb.58.572; Nishimura A, 2002, PLANT J, V30, P189, DOI 10.1046/j.1365-313X.2002.01279.x; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638	31	852	992	22	326	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					693	698		10.1038/nature04028	http://dx.doi.org/10.1038/nature04028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193045				2022-12-01	WOS:000232157900044
J	Xavier, KB; Bassler, BL				Xavier, KB; Bassler, BL			Interference with Al-2-mediated bacterial cell-cell communication	NATURE			English	Article							QUORUM-SENSING SIGNAL; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; EXPRESSION; CHOLERAE; LUMINESCENCE; SEQUENCE; AL-2; FAMILY	Bacteria communicate by means of chemical signal molecules called autoinducers. This process, called quorum sensing, allows bacteria to count the members in the community and to alter gene expression synchronously across the population. Quorum-sensing-controlled processes are often crucial for successful bacterial - host relationships - both symbiotic and pathogenic. Most quorum-sensing autoinducers promote intraspecies communication, but one autoinducer, called AI-2, is produced and detected by a wide variety of bacteria and is proposed to allow interspecies communication(1,2). Here we show that some species of bacteria can manipulate AI-2 signalling and interfere with other species' ability to assess and respond correctly to changes in cell population density. AI-2 signalling, and the interference with it, could have important ramifications for eukaryotes in the maintenance of normal microflora and in protection from pathogenic bacteria.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Bassler, BL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@molbio.princeton.edu	Xavier, Karina/B-9425-2008	Xavier, Karina/0000-0001-5210-1434; Bassler, Bonnie/0000-0002-0043-746X	NIGMS NIH HHS [R01 GM065859] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Silva AJ, 2004, J BACTERIOL, V186, P6374, DOI 10.1128/JB.186.19.6374-6382.2004; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005	19	221	240	5	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					750	753		10.1038/nature03960	http://dx.doi.org/10.1038/nature03960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193054	Green Accepted			2022-12-01	WOS:000232157900056
J	Kassai, Y; Munne, P; Hotta, YH; Penttila, E; Kavanagh, K; Ohbayashi, N; Takada, S; Thesleff, I; Jernvall, J; Itoh, N				Kassai, Y; Munne, P; Hotta, YH; Penttila, E; Kavanagh, K; Ohbayashi, N; Takada, S; Thesleff, I; Jernvall, J; Itoh, N			Regulation of mammalian tooth cusp patterning by ectodin	SCIENCE			English	Article							ENAMEL KNOT; EXPRESSION PATTERNS; BMP ANTAGONIST; MORPHOGENESIS; MOUSE; GENE; DIFFERENTIATION; CHARACTERS; EVOLUTION; TEETH	Mammalian tooth crowns have precise functional requirements but cannot be substantially remodeled after eruption. In developing teeth, epithelial, signaling centers, the enamel knots, form at future cusp positions and are the first signs of cusp patterns that distinguish species. We report that ectodin, a secreted bone morphogenetic protein (BMP) inhibitor, is expressed as a "negative'! image of mouse enamel knots. Furthermore, we show that ectodin-deficient mice have enlarged enamel knots, highly altered cusp patterns, and extra teeth. Unlike in normal teeth, excess BMP accelerates patterning in ectodin-deficient teeth. We propose that ectodin is critical for robust spatial delineation of enamel knots and cusps.	Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto 6068501, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of Helsinki; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Jernvall, J (corresponding author), Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	jernvall@fastmail.fm; itohnobu@pharm.kyoto-u.ac.jp	Munne, Pauliina/M-8629-2015	Munne, Pauliina/0000-0002-9720-9964; Takada, Shinji/0000-0003-4125-6056				Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Chen YP, 1996, DEVELOPMENT, V122, P3035; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; FISHER AR, 1971, ARCH ORAL BIOL, V16, P1481, DOI 10.1016/0003-9969(71)90084-7; GLASSTONE S, 1963, J DENT RES, V42, P1364, DOI 10.1177/00220345630420061101; GLASSTONE S, 1939, P ROY SOC LOND B BIO, V126, P315; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; MARSHALL PM, 1966, ARCH ORAL BIOL, V11, P949, DOI 10.1016/0003-9969(66)90197-X; Merino R, 1999, DEVELOPMENT, V126, P5515; Noramly S, 1998, DEVELOPMENT, V125, P3775; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024	26	224	232	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2067	2070		10.1126/science.1116848	http://dx.doi.org/10.1126/science.1116848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179481				2022-12-01	WOS:000232181900054
J	Clifford, GM; Gallus, S; Herrero, R; Munoz, N; Snijders, PJF; Vaccarella, S; Anh, PTH; Ferreccio, C; Hieu, NT; Matos, E; Molano, M; Rajkumar, R; Ronco, G; de Sanjose, S; Shin, HR; Sukvirach, S; Thomas, JO; Tunsakul, S; Meijer, CJLM; Franceschi, S				Clifford, GM; Gallus, S; Herrero, R; Munoz, N; Snijders, PJF; Vaccarella, S; Anh, PTH; Ferreccio, C; Hieu, NT; Matos, E; Molano, M; Rajkumar, R; Ronco, G; de Sanjose, S; Shin, HR; Sukvirach, S; Thomas, JO; Tunsakul, S; Meijer, CJLM; Franceschi, S		IARC HPV Prevalence Surveys Study	Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys: a pooled analysis	LANCET			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; GRADE CERVICAL LESIONS; FLOATING ABSOLUTE RISK; UNIVERSITY-STUDENTS; SOUTH-KOREA; YOUNG-WOMEN; INFECTION; POPULATION; NEOPLASIA; FEMALE	Background The proportion of women infected with human papillomavirus (HPV) varies greatly across populations, as might the distribution of HPV types. We aimed to compare HPV-type distribution in representative samples of women from different world regions. Methods Women were randomly selected from the general population of 13 areas from 11 countries (Nigeria, India, Vietnam, Thailand, Korea, Colombia, Argentina, Chile, the Netherlands, Italy, and Spain). A standardised protocol was used for cervical specimen collection. All HPV testing was by GP5+/6+ PCR-based EIA. The proportion of HPV-positive women infected with different HPV types was compared by study area and between pooled regions with age-adjusted odds ratios (ORs) with corresponding 95% floating CIS. Findings 15 613 women aged 15-74 years without cytological abnormalities were included in a pooled analysis. Age-standardised HPV prevalence varied nearly 20 times between populations, from 1.4% (95% CI 0.5-2.2) in Spain to 25.6% (22.4-28.8) in Nigeria. Although both overall HPV prevalence and HPV16 prevalence were highest in sub-Saharan Africa, HPV-positive women in Europe were significantly more likely to be infected with HPV16 than were those in sub-Saharan Africa (OR 2.64, p=0.0002), and were significantly less likely to be infected with high-risk HPV types other than HPV16 (OR 0.57, p=0.004) and/or low-risk HPV types (OR 0.44. p=0.0002). Women from South America had HPV-type distribution in between those from sub-Saharan Africa and Europe. Heterogeneity between areas of Asia was significant. Interpretation Heterogeneity in HPV type distribution among women from different populations should be taken into account when developing screening tests for the virus and predicting the effect of vaccines on the incidence of infection.	Int Agcy Res Canc, F-69372 Lyon, France; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Fdn Inst Costarricense Invest & Ensenanza Nutr &, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; Inst Nacl Cancerol, Bogota, Colombia; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Natl Canc Inst, Hanoi, Vietnam; Pontificia Univ Catolica Chile, Escuela Med, Santiago, Chile; Hung Vuong Hosp, Dept Neonatol, Ho Chi Minh City, Vietnam; Univ Buenos Aires, Inst Oncol, Buenos Aires, DF, Argentina; Christian Fellowship Community Hlth Area, Ambilikai, Tamil Nadu, India; Ctr Epidemiol & Prevenz Oncol, Turin, Italy; Inst Catala Oncol, Barcelona, Spain; Natl Canc Ctr, Res Inst, Goyang, South Korea; Natl Canc Inst, Div Res, Bangkok, Thailand; Univ Ibadan, Coll Med, Ibadan, Nigeria	World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vrije Universiteit Amsterdam; Pontificia Universidad Catolica de Chile; University of Buenos Aires; Catalan Institute of Oncology; National Cancer Center - Korea (NCC); National Cancer Institute - Thailand; University of Ibadan	Clifford, GM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	clifford@iarc.fr	Gallus, Silvano/AAB-4127-2019; Rajkumar, Rajamanickam/D-7350-2016; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; de Sanjosé Llongueras, Silvia/H-6339-2014; franceschi, silvia/M-2452-2014	Gallus, Silvano/0000-0002-8967-0400; Rajkumar, Rajamanickam/0000-0003-4904-8884; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; franceschi, silvia/0000-0003-4181-8071; ferreccio, catterina/0000-0001-6331-5534; Vaccarella, Salvatore/0000-0002-2516-2167				Anh PTH, 2003, INT J CANCER, V104, P213, DOI 10.1002/ijc.10936; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Brown DR, 2002, SEX TRANSM DIS, V29, P763, DOI 10.1097/00007435-200212000-00005; Castellsague X, 2001, LANCET, V358, P1429, DOI 10.1016/S0140-6736(01)06523-0; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; De Sanjose S, 2003, SEX TRANSM DIS, V30, P788, DOI 10.1097/01.OLQ.0000080177.82204.E0; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferreccio C, 2004, CANCER EPIDEM BIOMAR, V13, P2271; Franceschi S, 2005, J NATL CANCER I, V97, P938, DOI 10.1093/jnci/dji159; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Kjaer SK, 2002, BRIT MED J, V325, P572, DOI 10.1136/bmj.i2820; Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3&lt;412::AID-IJC1071&gt;3.0.CO;2-M; Liaw KL, 1997, INT J CANCER, V73, P775, DOI 10.1002/(SICI)1097-0215(19971127)73:5<775::AID-IJC27>3.0.CO;2-3; Matos E, 2003, SEX TRANSM DIS, V30, P593, DOI 10.1097/01.OLQ.0000085181.25063.6C; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Ronco G, 2005, EUR J CANCER, V41, P297, DOI 10.1016/j.ejca.2004.07.005; Shin HR, 2004, J INFECT DIS, V190, P468, DOI 10.1086/421279; Shin HR, 2003, INT J CANCER, V103, P413, DOI 10.1002/ijc.10825; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Sukvirach S, 2003, J INFECT DIS, V187, P1246, DOI 10.1086/373901; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876	36	772	832	0	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					991	998		10.1016/S0140-6736(05)67069-9	http://dx.doi.org/10.1016/S0140-6736(05)67069-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168781				2022-12-01	WOS:000231955900034
J	Hesketh, T; Lu, L; Xing, ZW				Hesketh, T; Lu, L; Xing, ZW			The effect of China's one-child family policy after 25 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEX-RATIOS; RURAL CHINA; SURPLUS; HEALTH; BIRTHS; MEN		UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1E 6BT, England; Zhejiang Univ, Inst Social & Family Med, Hangzhou 310027, Peoples R China; Zhejiang Normal Univ, Inst Publ Hlth, Jinhua, Peoples R China	University of London; University College London; Zhejiang University; Zhejiang Normal University	Hesketh, T (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1E 6BT, England.			Hesketh, Therese/0000-0002-7564-9221				Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; Chen H, 1997, China Popul Today, V14, P24; *CHIN POP INF RES, BAS POP DAT CHIN 194; COALE AJ, 1994, DEMOGRAPHY, V31, P459, DOI 10.2307/2061752; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Doherty JP, 2001, SOC SCI MED, V52, P745, DOI 10.1016/S0277-9536(00)00175-1; GREENHALGH S, 1987, SCIENCE, V235, P1167, DOI 10.1126/science.3823877; Gu B, 1995, Asia Pac Popul J, V10, P17; Hardee K, 2004, INT FAM PLAN PERSPEC, V30, P68, DOI 10.1363/3006804; Hesketh T, 1997, BRIT MED J, V314, P1685, DOI 10.1136/bmj.314.7095.1685; Hudson VM, 2002, INT SECURITY, V26, P5, DOI 10.1162/016228802753696753; KANG C, 2003, THESES COLLECTION 20, P88; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; LIN B, 2003, THESES COLLECTION 20, P57; Lofstedt P, 2004, REPROD HEALTH MATTER, V12, P86, DOI 10.1016/S0968-8080(04)24147-7; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; NI HY, 1994, EPIDEMIOLOGY, V5, P490; PAN JH, 2003, THESES COLLECTION 20, P16; Peng P, 1998, China Popul Today, V15, P5; Peng P, 1998, CHINA POPUL TODAY, V15, P10; Short SE, 1998, STUD FAMILY PLANN, V29, P373, DOI 10.2307/172250; Sun F, 1998, Asia Pac Popul J, V13, P75; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; TULJAPURKAR S, 1995, SCIENCE, V267, P874, DOI 10.1126/science.7846529; *UN DEV PROGR, 2003, TOT FERT RAT; *UN POP FUND, FAM PLANN HUM RIGHT; Wang J. Y., 2003, THESES COLLECTION 20, P1; Winckler EA, 2002, POPUL DEV REV, V28, P379, DOI 10.1111/j.1728-4457.2002.00379.x; *WORLD BANK HLTH N, DEV DAT; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Yang Q, 1994, Asia Pac Popul J, V9, P23; YIN Q, 2003, THESES COLLECTION 20, P116; Zhu WX, 2003, ARCH DIS CHILD, V88, P463, DOI 10.1136/adc.88.6.463; 2002, PEOPLES DAILY B 0902	34	311	314	12	215	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1171	1176		10.1056/NEJMhpr051833	http://dx.doi.org/10.1056/NEJMhpr051833			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	963YG	16162890	Green Published			2022-12-01	WOS:000231841900015
J	Check, E				Check, E			Threat of disease	NATURE			English	News Item								Most of the deaths from Hurricane Katrina have been caused by drowning, however people still living in the area may be at risk from diarrheal diseases, respiratory tract infections and mosquito-borne illnesses, especially the West Nile virus.											0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2005	437	7056					175	175						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16158498				2022-12-01	WOS:000231696900016
J	Brunet, I; Weinl, C; Piper, M; Trembleau, A; Volovitch, M; Harris, W; Prochiantz, A; Holt, C				Brunet, I; Weinl, C; Piper, M; Trembleau, A; Volovitch, M; Harris, W; Prochiantz, A; Holt, C			The transcription factor Engrailed-2 guides retinal axons	NATURE			English	Article							GANGLION-CELL AXONS; OPTIC TECTUM; TYROSINE KINASES; GROWTH CONES; EXPRESSION; PROTEIN; TRANSLATION; HOMEOPROTEIN; GUIDANCE; LIGANDS	Engrailed-2 (En-2), a homeodomain transcription factor, is expressed in a caudal-to-rostral gradient in the developing midbrain, where it has an instructive role in patterning the optic tectum - the target of topographic retinal input(1,2). In addition to its well-known role in regulating gene expression through its DNA-binding domain, En-2 may also have a role in cell - cell communication, as suggested by the presence of other domains involved in nuclear export, secretion and internalization(3). Consistent with this possibility, here we report that an external gradient of En-2 protein strongly repels growth cones of Xenopus axons originating from the temporal retina and, conversely, attracts nasal axons. Fluorescently tagged En-2 accumulates inside growth cones within minutes of exposure, and a mutant form of the protein that cannot enter cells fails to elicit axon turning. Once internalized, En-2 stimulates the rapid phosphorylation of proteins involved in translation initiation and triggers the local synthesis of new proteins. Furthermore, the turning responses of both nasal and temporal growth cones in the presence of En-2 are blocked by inhibitors of protein synthesis. The differential guidance of nasal and temporal axons reported here suggests that En-2 may participate directly in topographic map formation in the vertebrate visual system.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Holt, C (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	prochian@biologie.ens.fr; ceh@mole.bio.cam.ac.uk	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Volovitch, Michel/0000-0002-7488-764X; Trembleau, Alain/0000-0002-8290-0795; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COHEN J, 1987, DEV BIOL, V122, P407, DOI 10.1016/0012-1606(87)90305-8; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Foucher I, 2003, DEVELOPMENT, V130, P1867, DOI 10.1242/dev.00414; Friedman GC, 1996, J NEUROSCI, V16, P5498; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Itasaki N, 1996, NEURON, V16, P55, DOI 10.1016/S0896-6273(00)80023-9; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Montesinos ML, 2001, J NEUROSCI, V21, P3350, DOI 10.1523/JNEUROSCI.21-10-03350.2001; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Retaux S, 1996, TRENDS NEUROSCI, V19, P542, DOI 10.1016/S0166-2236(96)10062-X; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069	27	199	207	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					94	98		10.1038/nature04110	http://dx.doi.org/10.1038/nature04110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267555	Green Accepted			2022-12-01	WOS:000232979000048
J	Veazey, RS; Klasse, PJ; Schader, SM; Hu, QX; Ketas, TJ; Lu, M; Marx, PA; Dufour, J; Colonno, RJ; Shattock, RJ; Springer, MS; Moore, JP				Veazey, RS; Klasse, PJ; Schader, SM; Hu, QX; Ketas, TJ; Lu, M; Marx, PA; Dufour, J; Colonno, RJ; Shattock, RJ; Springer, MS; Moore, JP			Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 INFECTION; ENTRY INHIBITORS; CCR5 INHIBITOR; TRANSMISSION; TYPE-1; ANTAGONISTS; ATTACHMENT; PREVENTION; DISCOVERY	Human immunodeficiency virus type 1 (HIV-1) continues to spread, principally by heterosexual sex, but no vaccine is available(1). Hence, alternative prevention methods are needed to supplement educational and behavioural-modification programmes. One such approach is a vaginal microbicide: the application of inhibitory compounds before intercourse(2). Here, we have evaluated the microbicide concept using the rhesus macaque 'high dose'vaginal transmission model with a CCR5-receptor-using simian - human immunodeficiency virus (SHIV-162P3) and three compounds that inhibit different stages of the virus - cell attachment and entry process. These compounds are BMS-378806, a small molecule that binds the viral gp120 glycoprotein and prevents its attachment to the CD4 and CCR5 receptors(3,4), CMPD167, a small molecule that binds to CCR5 to inhibit gp120 association(5), and C52L, a bacterially expressed peptide inhibitor of gp41-mediated fusion(6). In vitro, all three compounds inhibit infection of T cells and cervical tissue explants, and C52L acts synergistically with CMPD167 or BMS-378806 to inhibit infection of cell lines. In vivo, significant protection was achieved using each compound alone and in combinations. CMPD167 and BMS-378806 were protective even when applied 6 h before challenge.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; Univ London, St Georges, London SW17 0RE, England; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Bristol Myers Squibb Co, Inst Pharmaceut, Wallingford, CT 06492 USA; Merck Res Labs, Rahway, NJ 07065 USA	Cornell University; Tulane University; University of London; Cornell University; Bristol-Myers Squibb; Merck & Company	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	jpm2003@med.cornell.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X; Hu, Qinxue/0000-0002-4594-9215				Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; Guo Q, 2003, J VIROL, V77, P10528, DOI 10.1128/JVI.77.19.10528-10536.2003; HANNA G, 11 C RETR OPP INF; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Ji H, 2000, BIOCHEMISTRY-US, V39, P676, DOI 10.1021/bi991893e; Ketas TJ, 2003, AIDS RES HUM RETROV, V19, P177, DOI 10.1089/088922203763315678; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; LU M, 2004, Patent No. 04106364A1; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Seibert C, 2004, CURR PHARM DESIGN, V10, P2041, DOI 10.2174/1381612043384312; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shen DM, 2004, BIOORG MED CHEM LETT, V14, P941, DOI 10.1016/j.bmcl.2003.12.005; SPARKS S, 2005, 12 C RETR OPP INF; Tremblay C, 2004, CURR PHARM DESIGN, V10, P1861, DOI 10.2174/1381612043384501; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Wang T, 2003, J MED CHEM, V46, P4236, DOI 10.1021/jm034082o; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wolinsky SM, 2004, VIROLOGY, V328, P19, DOI 10.1016/j.virol.2004.07.021	30	255	283	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					99	102		10.1038/nature04055	http://dx.doi.org/10.1038/nature04055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16258536				2022-12-01	WOS:000232979000049
J	Dollar, GL; Weber, U; Mlodzik, M; Sokol, SY				Dollar, GL; Weber, U; Mlodzik, M; Sokol, SY			Regulation of Lethal giant larvae by Dishevelled	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; POLARITY; APKC; COMPLEX; LOCALIZATION; POLARIZATION; HOMOLOG; ROLES; CDC42; PAR-6	The establishment of polarity in many cell types depends on Lgl, the tumour suppressor product of lethal giant larvae, which is involved in basolateral protein targeting(1-4). The conserved complex of Par3, Par6 and atypical protein kinase C5-8 phosphorylates and inactivates Lgl at the apical surface; however, the signalling mechanisms that coordinate cell polarization in development are not well defined. Here we show that a vertebrate homologue of Lgl associates with Dishevelled, an essential mediator of Wnt signalling, and that Dishevelled regulates the localization of Lgl in Xenopus ectoderm and Drosophila follicular epithelium. We show that both Lgl and Dsh are required for normal apical - basal polarity of Xenopus ectodermal cells. In addition, we show that the Wnt receptor Frizzled 8, but not Frizzled 7, causes Lgl to dissociate from the cortex with the concomitant loss of its activity in vivo. These findings suggest a molecular basis for the regulation of cell polarity by Frizzled and Dishevelled.	Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sokol, SY (corresponding author), Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, Box 1020,1 Gustave L Levy Pl, New York, NY 10029 USA.	sergei.sokol@mssm.edu		Sokol, Sergei/0000-0002-3963-9202				Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Eaton S, 2003, MECH DEVELOP, V120, P1257, DOI 10.1016/j.mod.2003.07.002; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nakaya M, 2000, DEVELOPMENT, V127, P5021; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Tada M, 2000, DEVELOPMENT, V127, P2227; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wu J, 2004, PLOS BIOL, V2, P1004, DOI 10.1371/journal.pbio.0020158; XU T, 1993, DEVELOPMENT, V117, P1223; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	30	112	115	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1376	1380		10.1038/nature04116	http://dx.doi.org/10.1038/nature04116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251968				2022-12-01	WOS:000232829100058
J	Baillat, D; Hakimi, MA; Naar, AM; Shilatifard, A; Cooch, N; Shiekhattar, R				Baillat, D; Hakimi, MA; Naar, AM; Shilatifard, A; Cooch, N; Shiekhattar, R			Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II	CELL			English	Article							3' END; BRCA2; INTERACTS; PROTEIN; RAD51; DOMAIN; RECOMBINATION; TRANSCRIPTION; INVOLVEMENT; PRECURSORS	The C-terminal domain (CTD) of RNA polymerase 11 (RNAPII) is an essential component of transcriptional regulation and RNA processing of protein-coding genes. A large body of data also implicates the CTD in the transcription and processing of RNAPII-mediated small nuclear RNAs (snRNAs). However, the identity of the complex (or complexes) that associates with the CTD and mediates the processing of snRNAs has remained elusive. Here, we describe an RNA polymerase 11 complex that contains at least 12 novel subunits, termed the Integrator, in addition to core RNAPII subunits. Two of the Integrator subunits display similarities to the subunits of the cleavage and polyadenylation specificity factor (CPSF) complex. We show that Integrator is recruited to the U1 and U2 snRNA genes and mediates the snRNAs' 3' end processing. The Integrator complex is evolutionarily conserved in metazoans and directly interacts with the C-terminal domain of the RNA polymerase 11 largest subunit.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Grenoble 1, CNRS, UMR 5163, F-38700 La Tronche, France; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	The Wistar Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Harvard University; Harvard University; Massachusetts General Hospital; Saint Louis University	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.upenn.edu	HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/Q-6475-2019; HAKIMI, Mohamed-ali/GYJ-0879-2022	HAKIMI, Mohamed-Ali/0000-0002-2547-8233; HAKIMI, Mohamed-ali/0000-0002-2547-8233; 				Bjorklund S, 2004, ADV PROTEIN CHEM, V67, P43; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; DEVEGVAR HEN, 1986, CELL, V47, P259; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; ELICEIRI GL, 1976, BIOCHEM BIOPH RES CO, V72, P507, DOI 10.1016/S0006-291X(76)80070-8; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Fury MG, 1996, EXP CELL RES, V228, P160, DOI 10.1006/excr.1996.0311; Gerber M, 2001, EMBO J, V20, P6104, DOI 10.1093/emboj/20.21.6104; HERNANDEZ N, 1986, CELL, V47, P249, DOI 10.1016/0092-8674(86)90447-2; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KLEINSCHMIDT AM, 1987, MOL CELL BIOL, V7, P3131, DOI 10.1128/MCB.7.9.3131; Kojic M, 2005, MOL CELL BIOL, V25, P2547, DOI 10.1128/MCB.25.7.2547-2557.2005; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Uguen P, 2003, EMBO J, V22, P4544, DOI 10.1093/emboj/cdg430; WIEBEN ED, 1985, J MOL BIOL, V183, P69, DOI 10.1016/0022-2836(85)90281-5; Wieland I, 2004, ONCOL REP, V12, P207; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; YOU CY, 1985, CELL, V1, P193	33	331	355	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					265	276		10.1016/j.cell.2005.08.019	http://dx.doi.org/10.1016/j.cell.2005.08.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239144	Bronze			2022-12-01	WOS:000232794100013
J	Brandman, O; Ferrett, JE; Li, R; Meyer, T				Brandman, O; Ferrett, JE; Li, R; Meyer, T			Interlinked fast and slow positive feedback loops drive reliable cell decisions	SCIENCE			English	Article							MAP KINASE; ACTIVATION; DIFFERENTIATION; GTPASE; SPECIFICATION; POLARIZATION; NETWORKS; POLARITY; FATE; MPF	Positive feedback is a ubiquitous signal transduction motif that allows systems to convert graded inputs into decisive, all-or-none outputs. Here we investigate why the positive feedback switches that regulate polarization of budding yeast, calcium signaling, Xenopus oocyte maturation, and various other processes use multiple interlinked loops rather than single positive feedback loops. Mathematical simulations revealed that linking fast and stow positive feedback loops creates a "dual-time" switch that is both rapidly inducible and resistant to noise in the upstream signaling system.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Marine Biol Lab, Physiol Course 2004, Woods Hole, MA 02543 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Stanford University; Marine Biological Laboratory - Woods Hole; Harvard University; Harvard Medical School; Stowers Institute for Medical Research	Brandman, O (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.	onn@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057063, R01 GM030179-24A1, R01 GM030179, R01 GM063702, R01 GM046383] Funding Source: Medline; NIMH NIH HHS [R01 MH064801] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrieu A, 2001, J CELL SCI, V114, P257; Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BELTRAMI E, 1995, P NATL ACAD SCI USA, V92, P8744, DOI 10.1073/pnas.92.19.8744; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; HOLMSEN H, 1991, Proceedings of the National Science Council Republic of China Part B Life Sciences, V15, P147; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Levine K, 1995, Prog Cell Cycle Res, V1, P101; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lodish H., 2004, MOL CELL BIOL; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811	29	344	348	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					496	498		10.1126/science.1113834	http://dx.doi.org/10.1126/science.1113834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239477	Green Accepted			2022-12-01	WOS:000232786000048
J	Zhang, HY; Roberts, DN; Cairns, BR				Zhang, HY; Roberts, DN; Cairns, BR			Genome-wide dynamics of Htz1, a histone H2A variant that poises repressed/basal promoters for activation through histone loss	CELL			English	Article							CHROMATIN REMODELING COMPLEX; INACTIVE X-CHROMOSOME; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC GENOME; GENE-EXPRESSION; H4 ACETYLATION; NUCLEOSOME; YEAST; HETEROCHROMATIN; OCCUPANCY	Histone variants help specialize chromatin regions; however, their impact on transcriptional regulation is largely unknown. Here, we determined the genome-wide localization and dynamics of Htz1, the yeast histone H2A variant. Htz1 localizes to hundreds of repressed/basal Pol II promoters and prefers TATA-less promoters' Specific Htz1 deposition requires the SWR1 complex, which largely colocalizes with Htz1. Htz1 occupancy correlates with particular histone modifications, and Htz1 deposition is partially reliant on Gcn5 (a histone acetyltransferase) and Bdf1, an SWR1 complex member that binds acetylated histones. Changes in growth conditions cause a striking redistribution of Htz1 from activated to repressed/basal promoters. Furthermore, Htz1 promotes full gene activation but does not generally impact repression. Importantly, Htz1 releases from purified chromatin in vitro under conditions where H2A and H3 remain associated. We suggest that Htz1 bearing nucleosomes are deposited at repressed/basal promoters but facilitate activation through their susceptibility to loss, thereby helping to expose promoter DNA.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA24014] Funding Source: Medline; NIGMS NIH HHS [R01 GM060415-05, GM60415, R01 GM060415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson JD, 1996, TRENDS BIOCHEM SCI, V21, P466, DOI 10.1016/S0968-0004(96)20028-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Owen-Hughes T, 2003, BIOCHEM SOC T, V31, P893; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004	48	379	388	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 21	2005	123	2					219	231		10.1016/j.cell.2005.08.036	http://dx.doi.org/10.1016/j.cell.2005.08.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239141	Green Accepted, Bronze			2022-12-01	WOS:000232794100010
J	Zingmond, DS; McGory, ML; Ko, CY				Zingmond, DS; McGory, ML; Ko, CY			Hospitalization before and after gastric bypass surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORBIDLY OBESE-PATIENTS; BARIATRIC SURGERY; COST-EFFECTIVENESS; CARE; METAANALYSIS; OUTCOMES; IMPACT	Context The use of Roux-en-Y gastric bypass (RYGB) has been reported to be effective in the treatment of obesity and its related comorbidities. Utilization of inpatient services after RYGB is less well understood. Objective To determine the rates and indications for inpatient hospital use before and after RYGB. Design, Setting, and Participants Retrospective study of Californians receiving RYGB in California hospitals from 1995 to 2004. Main Outcome Measure Hospitalization in the 1 to 3 years after RYGB. Results In California from 1995 to 2004, 60077 patients underwent RYGB - 11659 in 2004 alone. The rate of hospitalization in the year following RYGB was more than double the rate in the year preceding RYGB (19.3% vs 7.9%, P<.001). Furthermore, in the subset of patients (n = 24 678) with full 3-year follow-up, a mean of 8.4% were admitted a year before RYGB while 20.2% were readmitted in the year after RYGB, 18.4% in the second year after RYGB, and 14.9% in the third year after RYGB. The most common reasons for admission prior to RYGB were obesity-related problems (eg, osteoarthritis, lower extremity cellulitis), and elective operation (eg, hysterectomy), while the most common reasons for admission after RYGB were complications often thought to be procedure related, such as ventral hernia repair and gastric revision. In multivariate logistic regression models predicting 1-year readmission after RYGB, increasing Charlson Comorbidity Index score, and hospitalization in the 3-year period prior to RYGB were significantly associated with readmission within a year. Conclusions Increases in hospital use after surgery appear to be related to RYGB. Payers, clinicians, and patients must consider the not-inconsequential rate of rehospitalization after this type of surgery.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Ctr Surg Outcomes & Qual, Los Angeles, CA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Zingmond, DS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Plaza, Los Angeles, CA 90095 USA.	dzingmond@mednet.ucla.edu			NATIONAL INSTITUTE ON AGING [K08AG023024] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG023024-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agren G, 2002, OBES RES, V10, P1276, DOI 10.1038/oby.2002.173; [Anonymous], 2004, WHAT WORKS OBESITY S; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; Craig BM, 2002, AM J MED, V113, P491, DOI 10.1016/S0002-9343(02)01266-4; *CTR MED MED SERV, 2003, NAT HLTH DOLL 2003 W; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Liu JH, 2003, AM SURGEON, V69, P823; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Narbro K, 2002, ARCH INTERN MED, V162, P2061, DOI 10.1001/archinte.162.18.2061; Podnos YD, 2003, ARCH SURG-CHICAGO, V138, P957, DOI 10.1001/archsurg.138.9.957; Pope GD, 2002, J GASTROINTEST SURG, V6, P855, DOI 10.1016/S1091-255X(02)00085-9; Sampalis JS, 2004, OBES SURG, V14, P939, DOI 10.1381/0960892041719662; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Zingmond DS, 2004, J CLIN EPIDEMIOL, V57, P21, DOI 10.1016/S0895-4356(03)00250-6	19	148	150	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2005	294	15					1918	1924		10.1001/jama.294.15.1918	http://dx.doi.org/10.1001/jama.294.15.1918			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974OZ	16234498	Bronze			2022-12-01	WOS:000232602600021
J	Religa, TL; Markson, JS; Mayor, U; Freund, SMV; Fersht, AR				Religa, TL; Markson, JS; Mayor, U; Freund, SMV; Fersht, AR			Solution structure of a protein denatured state and folding intermediate	NATURE			English	Article							LONG-RANGE STRUCTURE; PARAMAGNETIC RELAXATION; STAPHYLOCOCCAL NUCLEASE; ENGRAILED HOMEODOMAIN; BACKBONE DYNAMICS; SH3 DOMAIN; NMR; PATHWAY	The most controversial area in protein folding concerns its earliest stages. Questions such as whether there are genuine folding intermediates, and whether the events at the earliest stages are just rearrangements of the denatured state(1) or progress from populated transition states(2), remain unresolved. The problem is that there is a lack of experimental high-resolution structural information about early folding intermediates and denatured states under conditions that favour folding because competent states spontaneously fold rapidly. Here we have solved directly the solution structure of a true denatured state by nuclear magnetic resonance under conditions that would normally favour folding, and directly studied its equilibrium and kinetic behaviour. We engineered a mutant of Drosophila melanogaster Engrailed homeodomain that folds and unfolds reversibly just by changing ionic strength. At high ionic strength, the mutant L16A is an ultra-fast folding native protein, just like the wild-type protein; however, at physiological ionic strength it is denatured. The denatured state is a well-ordered folding intermediate, poised to fold by docking helices and breaking some non-native interactions. It unfolds relatively progressively with increasingly denaturing conditions, and so superficially resembles a denatured state with properties that vary with conditions. Such ill-defined unfolding is a common feature of early folding intermediate states and accounts for why there are so many controversies about intermediates versus compact denatured states in protein folding.	MRC Ctr, Ctr Prot Engn, Cambridge CB2 2QH, England; Univ Cambridge, MRC Ctr, Chem Labs, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge	Fersht, AR (corresponding author), MRC Ctr, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008; Mayor, Ugo/F-5890-2011	Markson, Joseph/0000-0002-3167-3887; Mayor, Ugo/0000-0003-2812-8287				Bonvin AMJJ, 1996, J BIOMOL NMR, V7, P72; BONVIN AMJJ, 1995, J MOL BIOL, V250, P80, DOI 10.1006/jmbi.1995.0360; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Fushman D, 1998, J AM CHEM SOC, V120, P10947, DOI 10.1021/ja981686m; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953; ISHIMA R, 1995, BIOCHEMISTRY-US, V34, P3162, DOI 10.1021/bi00010a005; Koharudin LMI, 2003, J MAGN RESON, V163, P228, DOI 10.1016/S1090-7807(03)00149-6; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mayor U, 2003, J MOL BIOL, V333, P977, DOI 10.1016/j.jmb.2003.08.062; Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P2738, DOI 10.1021/bi950967t; Rios MAD, 2005, BIOCHEMISTRY-US, V44, P1243, DOI 10.1021/bi0484441; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	24	211	215	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1053	1056		10.1038/nature04054	http://dx.doi.org/10.1038/nature04054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222301				2022-12-01	WOS:000232496100051
J	Norman, KR; Fazzio, RT; Mellem, JE; Espelt, MV; Strange, K; Beckerle, MC; Maricq, AV				Norman, KR; Fazzio, RT; Mellem, JE; Espelt, MV; Strange, K; Beckerle, MC; Maricq, AV			The Rho/Rac-family guanine nucleotide exchange factor VAV-1 regulates rhythmic behaviors in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; MOSAIC ANALYSIS; B-CELLS; HOMOLOG; PROTEINS; ACTIVATION; RECEPTORS; PATHWAYS	Rhythmic behaviors are a fundamental feature of all organisms. Pharyngeal pumping, the defecation cycle, and gonadal-sheath-cell contractions are three well-characterized rhythmic behaviors in the nematode C. elegans. The periodicities of the rhythms range from subsecond (pharynx) to seconds (gonadal sheath) to minutes (defecation). However, the molecular mechanisms underlying these rhythmic behaviors are not well understood. Here, we show that the C. elegans Rho/Rac-family guanine nucleotide exchange factor, VAV-1, which is homologous to the mammalian Vav proto-oncogene, has a crucial role in all three behaviors. vav-1 mutants die as larvae because VAV-1 function is required in the pharynx for synchronous contraction of the musculature. In addition, ovulation and the defecation cycle are abnormal and arrhythmic. We show that Rho/Rac-family GTPases and the signaling molecule inositol triphosphate (IP3) act downstream of VAV-1 signaling and that the VAV-1 pathway modulates rhythmic behaviors by dynamically regulating the concentration of intracellular Ca2+.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA; Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Vanderbilt University	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu		Espelt, M Victoria/0000-0002-0388-7853	NCI NIH HHS [T32 CA93247] Funding Source: Medline; NHLBI NIH HHS [HL60591] Funding Source: Medline; NIGMS NIH HHS [F32 GM0066579-02, F32 GM066579] Funding Source: Medline; NINDS NIH HHS [R01 NS035812, NS35812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA093247] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Baylis HA, 1999, J MOL BIOL, V294, P467, DOI 10.1006/jmbi.1999.3229; Branicky R, 2001, GENETICS, V159, P997; Bui YK, 2002, MOL BIOL CELL, V13, P1641, DOI 10.1091/mbc.02-01-0008; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CHEN WI, 1993, J BIOL CHEM, V268, P320; CHEN WN, 1993, J BIOL CHEM, V268, P13280; CHEN WN, 1994, J BIOL CHEM, V269, P32394; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Hornstein I, 2003, ONCOGENE, V22, P6774, DOI 10.1038/sj.onc.1207027; Iwasaki K, 1997, TRENDS GENET, V13, P111, DOI 10.1016/S0168-9525(97)01059-7; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; LIU DWC, 1994, J NEUROSCI, V14, P1953; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Movilla N, 1999, MOL CELL BIOL, V19, P7870; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; OKKEMA PG, 1993, GENETICS, V135, P385; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; SAKUBE Y, 1993, ANN NY ACAD SCI, V707, P540, DOI 10.1111/j.1749-6632.1993.tb38121.x; Schuebel KE, 1996, ONCOGENE, V13, P363; SIMMER F, 2003, PLOS BIOL, pE12, DOI DOI 10.1317/JOURNAL.PBIO.0000012; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; THOMAS JH, 1990, GENETICS, V124, P855; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TRENT C, 1983, GENETICS, V104, P619; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; Yin XY, 2004, MOL BIOL CELL, V15, P3938, DOI 10.1091/mbc.E04-03-0198; Yochem J, 1998, GENETICS, V149, P1323; Yochem J, 2003, DEVELOPMENT, V130, P4761, DOI 10.1242/dev.00701; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	55	43	59	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					119	132		10.1016/j.cell.2005.08.001	http://dx.doi.org/10.1016/j.cell.2005.08.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213217	Bronze			2022-12-01	WOS:000232536800013
J	Aikins, AD				Aikins, AD			Healer shopping in Africa: new evidence from rural-urban qualitative study of Ghanaian diabetes experiences	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASES; CARE	Objectives To provide counterevidence to existing literature on healer shopping in Africa through a systematic analysis of illness practices by Ghanaians with diabetes; to outline approaches towards improving patient centred health care and policy development regarding diabetes in Ghana. Design Longitudinal qualitative study with individual interviews, group interviews, and ethnographies. Settings Two urban towns (Accra, Tema) and two rural towns (Nkoranza and Kintampo) in Ghana. Participants 26 urban people and 41 rural people with diabetes with diverse profiles (sex, age, education, socioeconomic status, diabetes status). Results Six focus groups, 20 interviews, and three ethnographical studies were conducted to explore experiences and illness practices. Analysis identified four kinds of illness practice: biomedical management, spiritual action, cure seeking (passive and active), and medical inaction. Most participants privileged biomedicine over other health systems and emphasised biomedical management as ideal self care practice. However, the psychosocial impact of diabetes and the high cost of biomedical care drove cure seeking and medical inaction. Cure seeking constituted healer shopping between biomedicine, ethnomedicine, and faith healing; medical inaction constituted passive disengagement from medical management and active engagement with faith healing. Crucially, although spiritual causal theories of diabetes existed, they were secondary to dietary, lifestyle, and physiological theories and did not constitute the primary motivation for cure seeking. Cure seeking within unregulated ethnomedical systems and non-pharmacological faith healing systems exacerbated the complications of diabetes. Conclusions To minimise inappropriate healer shopping and maximise committed biomedical and regulated ethnomedical management for Ghanaians with diabetes, the greatest challenges lie in providing affordable pharmaceutical drugs, standardised ethnomedical drugs, recommended foods, and psychosocial support. For health systems, the greatest challenges lie in correcting structural deficiencies that impinge on biomedical practices, regulating ethnomedical diabetes treatment, and foregrounding faith healer practices within diabetes policy discussions.	Univ Cambridge, Fac Social & Polit Sci, Dept Social & Dev Psychol, Cambridge CB2 3RQ, England	University of Cambridge	Aikins, AD (corresponding author), Univ Cambridge, Fac Social & Polit Sci, Dept Social & Dev Psychol, Cambridge CB2 3RQ, England.	ada21@cam.ac.uk						Aikins AD, 2002, SOC SCI INFORM, V41, P625, DOI 10.1177/0539018402041004007; AIKINS AD, 2004, THESIS LONDON SCH EC; Aikins ADG, 2004, J HEALTH PSYCHOL, V9, P295, DOI 10.1177/1359105304040895; Aikins ADG, 2003, J HEALTH PSYCHOL, V8, P557, DOI 10.1177/13591053030085007; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; Bediako K, 2000, AFR AFFAIRS, V99, P303, DOI 10.1093/afraf/99.395.303; De Jong J., 1991, TRADITIONAL MED SUBS; DEJONG J, 1909, TRADITIONAL MED SUBS; GASKELL G, 2000, QUALITATIVE RES TEXT, V39; *GOV GHAN MIN HLTH, 2001, HLTH NAT AN HLTH SEC; GREEN EC, 1992, SOC SCI MED, V35, P121, DOI 10.1016/0277-9536(92)90159-N; KIRBY JP, 1993, SOC SCI MED, V36, P237, DOI 10.1016/0277-9536(93)90007-Q; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krause M, 2003, J HEALTH PSYCHOL, V8, P599, DOI 10.1177/13591053030085010; Krippendorff Klaus, 1980, CONTENT ANAL; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; *MON EV TEAM, 1998, FORM BAS RES DIAB ME; Moscovici S., 2000, SOCIAL REPRESENTATIO; NKWI PN, 1994, J DIARRHOEAL DIS RES, V12, P35; NYAMWAYA D, 1987, SOC SCI MED, V25, P1277, DOI 10.1016/0277-9536(87)90126-2; OFEI F, 1996, SELF CARE BEHAV GHAN; OFEI F, 1996, UNPUB SELF CARE BEHA; Rekdal OB, 1999, MED ANTHROPOL Q, V13, P458, DOI 10.1525/maq.1999.13.4.458; ROSENTHAL K, 1995, SEMIN AVIAN EXOT PET, V4, P1; Ryan GW, 1998, SOC SCI MED, V46, P209, DOI 10.1016/S0277-9536(97)00151-2; SILVERMAN D, 2001, INTERPRETING QUALITA, V70; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1	28	111	112	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2005	331	7519					737	742		10.1136/bmj.331.7519.737	http://dx.doi.org/10.1136/bmj.331.7519.737			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971XB	16195290	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000232417100020
J	Pelejero, C; Calvo, E; McCulloch, MT; Marshall, JF; Gagan, MK; Lough, JM; Opdyke, BN				Pelejero, C; Calvo, E; McCulloch, MT; Marshall, JF; Gagan, MK; Lough, JM; Opdyke, BN			Preindustrial to modern interdecadal variability in coral reef pH	SCIENCE			English	Article							BORON ISOTOPIC COMPOSITION; ATMOSPHERIC CARBON-DIOXIDE; GREAT-BARRIER-REEF; NORTH PACIFIC; OCEAN; CALCIFICATION; SEAWATER; CO2; OSCILLATION; TEMPERATURE	The oceans are becoming more acidic due to absorption of anthropogenic carbon dioxide from the atmosphere. The impact of ocean acidification on marine ecosystems is unclear, but it will likely depend on species adaptability and the rate of change of seawater pH relative to its natural variability. To constrain the natural variability in reef-water pH, we measured boron isotopic compositions in a similar to 300-year-old massive Porites coral from the southwestern Pacific. Large variations in pH are found over similar to 50-year cycles that covary with the Interdecadal Pacific Oscillation of ocean-atmosphere anomalies, suggesting that natural pH cycles can modulate the impact of ocean acidification on coral reef ecosystems.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia	Australian National University; Australian Institute of Marine Science; Australian National University	Pelejero, C (corresponding author), CJIC, CMIMA, Inst Ciencies Mar, Barcelona 08003, Catalonia, Spain.	pelejero@cmima.csic.es; ecalvo@cmima.csic.es; Malcolm.McCulloch@anu.edu.au	McCulloch, Malcolm T/C-3651-2009; Gagan, Michael/L-5014-2018; Calvo, Eva/C-2618-2014; Lough, Janice M/L-1682-2013; Pelejero, Carles/AAF-4550-2019	McCulloch, Malcolm T/0000-0003-1538-1558; Gagan, Michael/0000-0002-8279-323X; Calvo, Eva/0000-0003-3659-4499; Lough, Janice M/0000-0002-3789-1009; Pelejero, Carles/0000-0002-7763-7769				ANDREWS JC, 1986, CONT SHELF RES, V6, P491, DOI 10.1016/0278-4343(86)90020-8; Bohm F, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000264; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CALVO E, UNPUB; CANE MA, 1983, SCIENCE, V222, P1189, DOI 10.1126/science.222.4629.1189; Dore JE, 2003, NATURE, V424, P754, DOI 10.1038/nature01885; FALLON SJ, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GLO18049; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gaillardet J, 1995, EARTH PLANET SC LETT, V136, P665, DOI 10.1016/0012-821X(95)00180-K; Gattuso JP, 1999, AM ZOOL, V39, P160; Gershunov A, 1998, B AM METEOROL SOC, V79, P2715, DOI 10.1175/1520-0477(1998)079<2715:IMOET>2.0.CO;2; Hemming NG, 1998, GLOBAL BIOGEOCHEM CY, V12, P581, DOI 10.1029/98GB02337; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.002; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 1999, AM ZOOL, V39, P146; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Minobe S, 1997, GEOPHYS RES LETT, V24, P683, DOI 10.1029/97GL00504; Palmer MR, 2003, SCIENCE, V300, P480, DOI 10.1126/science.1080796; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Reynaud S, 2004, CORAL REEFS, V23, P539, DOI 10.1007/s00338-004-0399-5; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Salinger MJ, 2001, INT J CLIMATOL, V21, P1705, DOI 10.1002/joc.691; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.1034/j.1600-0889.2003.01442.x; TAFT BA, 1991, J GEOPHYS RES-OCEANS, V96, P12599, DOI 10.1029/91JC00781; VENGOSH A, 1991, GEOCHIM COSMOCHIM AC, V55, P2901, DOI 10.1016/0016-7037(91)90455-E; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	36	149	163	6	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2204	2207		10.1126/science.1113692	http://dx.doi.org/10.1126/science.1113692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195458				2022-12-01	WOS:000232318000040
J	Frederickson, ME; Greene, MJ; Gordon, DM				Frederickson, ME; Greene, MJ; Gordon, DM			'Devil's gardens' bedevilled by ants	NATURE			English	Editorial Material							DUROIA-HIRSUTA; ALLELOPATHIC TREE; IRIDOID LACTONE; AMAZON		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Colorado, Dept Biol, Denver, CO 80217 USA; Hlth Sci Ctr, Denver, CO 80217 USA	Stanford University; University of Colorado System; University of Colorado Denver	Frederickson, ME (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	meganf@stanford.edu		Frederickson, Megan/0000-0002-9058-7137				[Anonymous], 2013, NICHE CONSTRUCTION N; Aquino R, 1999, J NAT PROD, V62, P560, DOI 10.1021/np9803631; CAMPBELL DG, 1989, BIOCHEM SYST ECOL, V17, P403, DOI 10.1016/0305-1978(89)90057-4; DAVIDSON DW, 1993, TRENDS ECOL EVOL, V8, P326, DOI 10.1016/0169-5347(93)90240-P; MORAWETZ W, 1992, BIODIVERS CONSERV, V1, P19, DOI 10.1007/BF00700248; PAGE JE, 1994, EXPERIENTIA, V50, P840, DOI 10.1007/BF01956467; Pfannes KR, 2002, REV BIOL TROP, V50, P293; Renner SS, 1998, BIOTROPICA, V30, P324, DOI 10.1111/j.1744-7429.1998.tb00067.x; Revis HC, 2004, AUK, V121, P1262, DOI 10.1642/0004-8038(2004)121[1262:BAFAOA]2.0.CO;2	9	72	80	0	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					495	496		10.1038/437495a	http://dx.doi.org/10.1038/437495a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177778				2022-12-01	WOS:000232004800035
J	Moreno-Herrero, F; de Jager, M; Dekker, NH; Kanaar, R; Wyman, C; Dekker, C				Moreno-Herrero, F; de Jager, M; Dekker, NH; Kanaar, R; Wyman, C; Dekker, C			Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA	NATURE			English	Article							STRAND BREAK REPAIR; MRE11 COMPLEX; HOOK	The human Rad50/Mre11/Nbs1 complex (hR/M/N) functions as an essential guardian of genome integrity by directing the proper processing of DNA ends, including DNA breaks(1). This biological function results from its ability to tether broken DNA molecules(2,3). hR/M/N's dynamic molecular architecture consists of a globular DNA-binding domain from which two 50-nm-long coiled coils protrude. The coiled coils are flexible(4) and their apices can self-associate(5). The flexibility of the coiled coils allows their apices to adopt an orientation favourable for interaction. However, this also allows interaction between the tips of two coiled coils within the same complex, which competes with and frustrates the intercomplex interaction required for DNA tethering. Here we show that the dynamic architecture of hR/M/N is markedly affected by DNA binding. DNAbinding by the hR/M/N globular domain leads to parallel orientation of the coiled coils; this prevents intracomplex interactions and favours intercomplex associations needed for DNA tethering. The hR/M/N complex thus is an example of a biological nanomachine in which binding to its ligand, in this case DNA, affects the functional conformation of a domain located 50 nm distant.	Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; Erasmus MC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands	Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.wyman@erasmusmc.nl; dekker@mb.tn.tudelft.nl	Moreno-Herrero, Fernando/N-2967-2013	Moreno-Herrero, Fernando/0000-0003-4083-1709; Dekker, Nynke/0000-0003-4029-0973; Dekker, Cees/0000-0001-6273-071X				Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wyman C, 2002, CURR BIOL, V12, pR446, DOI 10.1016/S0960-9822(02)00941-7	11	200	205	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					440	443		10.1038/nature03927	http://dx.doi.org/10.1038/nature03927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163361				2022-12-01	WOS:000231849100060
J	Hayakawa, T; Angata, T; Lewis, AL; Mikkelsen, TS; Varki, NM; Varki, A				Hayakawa, T; Angata, T; Lewis, AL; Mikkelsen, TS; Varki, NM; Varki, A			A human-specific gene in microglia	SCIENCE			English	Article							BRAIN		Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Lewis, Amanda/0000-0001-6195-3030	NIGMS NIH HHS [R01GM32373] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; *CHIMP SEQ AN CONS, IN PRESS NATURE; Varki A, 2004, NAT GENET, V36, P1034, DOI 10.1038/ng1004-1034; VARKI A, IN PRESS GLYCOBIOLOG	5	76	77	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1693	1693		10.1126/science.1114321	http://dx.doi.org/10.1126/science.1114321			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151003				2022-12-01	WOS:000231836700034
J	Crespo-Hernandez, CE; Cohen, B; Kohler, B				Crespo-Hernandez, CE; Cohen, B; Kohler, B			Base stacking controls excited-state dynamics in A-T DNA	NATURE			English	Article							THYMINE DIMER FORMATION; ELECTRON-TRANSFER; CROSS-LINKING; ADENINE; FLUORESCENCE; RESONANCE; POLYNUCLEOTIDES; LUMINESCENCE; SPECTROSCOPY; TEMPERATURE	Solar ultraviolet light creates excited electronic states in DNA that can decay to mutagenic photoproducts. This vulnerability is compensated for in all organisms by enzymatic repair of photodamaged DNA. As repair is energetically costly, DNA is intrinsically photostable. Single bases eliminate electronic energy non-radiatively on a subpicosecond timescale(1), but base stacking and base pairing mediate the decay of excess electronic energy in the double helix in poorly understood ways. In the past, considerable attention has been paid to excited base pairs(2). Recent reports have suggested that light-triggered motion of a proton in one of the hydrogen bonds of an isolated base pair initiates non-radiative decay to the electronic ground state(3,4). Here we show that vertical base stacking, and not base pairing, determines the fate of excited singlet electronic states in single- and double-stranded oligonucleotides composed of adenine ( A) and thymine ( T) bases. Intrastrand excimer states with lifetimes of 50 - 150 ps are formed in high yields whenever A is stacked with itself or with T. Excimers limit excitation energy to one strand at a time in the B-form double helix, enabling repair using the undamaged strand as a template.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kohler, B (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	kohler@chemistry.ohio-state.edu	Kohler, Bern/A-1728-2011; Crespo-Hernández, Carlos E./A-9915-2008; Cohen, Boiko/C-4381-2008	Kohler, Bern/0000-0001-5353-1655; Crespo-Hernández, Carlos E./0000-0002-3594-0890; Cohen, Boiko/0000-0002-5400-4678	NIGMS NIH HHS [R01 GM064563-04, R01 GM064563] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064563] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abo-Riziq A, 2005, P NATL ACAD SCI USA, V102, P20, DOI 10.1073/pnas.0408574102; AZUMI T, 1964, J CHEM PHYS, V41, P3839, DOI 10.1063/1.1725823; Cadet J, 1990, PHOTOCHEMISTRY NUCL, P1; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2004, J PHYS CHEM B, V108, P11182, DOI 10.1021/jp0496046; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; DANILOV VI, 1994, PHOTOCHEM PHOTOBIOL, V59, P125, DOI 10.1111/j.1751-1097.1994.tb05010.x; DEWEY TG, 1979, BIOCHEMISTRY-US, V18, P5757, DOI 10.1021/bi00593a002; DOUHAL A, 1995, NATURE, V378, P260, DOI 10.1038/378260a0; Douki T, 2003, NUCLEIC ACIDS RES, V31, P3134, DOI 10.1093/nar/gkg408; EISINGER J, 1966, P NATL ACAD SCI USA, V55, P1015, DOI 10.1073/pnas.55.5.1015; GLISIN VR, 1967, BIOCHIM BIOPHYS ACTA, V142, P314, DOI 10.1016/0005-2787(67)90614-4; HOSSZU JL, 1967, BIOCHEM BIOPH RES CO, V29, P327, DOI 10.1016/0006-291X(67)90457-3; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; KYPR J, 1994, J BIOMOL STRUCT DYN, V11, P1225, DOI 10.1080/07391102.1994.10508065; LAMOLA AA, 1968, P NATL ACAD SCI USA, V59, P46, DOI 10.1073/pnas.59.1.46; Lewis FD, 2002, J AM CHEM SOC, V124, P4568, DOI 10.1021/ja0177859; LOWDIN PO, 1963, REV MOD PHYS, V35, P724, DOI 10.1103/RevModPhys.35.724; Marguet S, 2005, J AM CHEM SOC, V127, P5780, DOI 10.1021/ja050648h; Markovitsi D, 2003, CHEMPHYSCHEM, V4, P303, DOI 10.1002/cphc.200390050; Ostrowski T, 2003, J ORG CHEM, V68, P6502, DOI 10.1021/jo030086p; Pecourt JML, 2001, J AM CHEM SOC, V123, P10370, DOI 10.1021/ja0161453; Plutzer C, 2003, PHYS CHEM CHEM PHYS, V5, P1158, DOI 10.1039/b212338i; RAHN RO, 1976, NUCLEIC ACIDS RES, V3, P879, DOI 10.1093/nar/3.4.879; RAHN RO, 1966, J CHEM PHYS, V45, P2947, DOI 10.1063/1.1728050; Samoylova E, 2005, J AM CHEM SOC, V127, P1782, DOI 10.1021/ja044369q; Schultz T, 2004, SCIENCE, V306, P1765, DOI 10.1126/science.1104038; VIGNY P, 1973, CR ACAD SCI D NAT, V277, P1941	29	381	382	2	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1141	1144		10.1038/nature03933	http://dx.doi.org/10.1038/nature03933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121177				2022-12-01	WOS:000231416600042
J	Haring, M; Vestergaard, G; Rachel, R; Chen, LM; Garrett, RA; Prangishvili, D				Haring, M; Vestergaard, G; Rachel, R; Chen, LM; Garrett, RA; Prangishvili, D			Virology: Independent virus development outside a host	NATURE			English	Editorial Material									Inst Pasteur, Mol Biol Gene Extremophiles Unit, F-75724 Paris, France; Univ Regensburg, D-93053 Regensburg, Germany; Univ Copenhagen, Inst Mol Biol & Physiol, Danish Archaea Ctr, DK-1307 Copenhagen, Denmark	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Regensburg; University of Copenhagen	Haring, M (corresponding author), Inst Pasteur, Mol Biol Gene Extremophiles Unit, F-75724 Paris, France.	prangish@pasteur.fr	Garrett, Roger A/M-2450-2014	Garrett, Roger A/0000-0001-8452-9099; Vestergaard, Gisle/0000-0003-2541-4974				ACKERMANN HW, 2000, 7 INT COMM TAX VIR, P111; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Prangishvili D, 2001, TRENDS MICROBIOL, V9, P39, DOI 10.1016/S0966-842X(00)01910-7; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; Swanstrom R., 1997, P263; van Regenmortel MHV, 2000, VIRUS TAXONOMY, P3	9	109	193	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1101	1102		10.1038/4361101a	http://dx.doi.org/10.1038/4361101a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121167				2022-12-01	WOS:000231416600031
J	Hoffman, LR; D'Argenio, DA; MacCoss, MJ; Zhang, ZY; Jones, RA; Miller, SI				Hoffman, LR; D'Argenio, DA; MacCoss, MJ; Zhang, ZY; Jones, RA; Miller, SI			Aminoglycoside antibiotics induce bacterial biofilm formation	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; CYCLIC DIGUANYLIC ACID; GENE-EXPRESSION; CYSTIC-FIBROSIS; CELLULOSE SYNTHESIS; TWITCHING MOTILITY; EAL DOMAIN; DI-GMP; RESISTANCE; TOBRAMYCIN	Biofilms are adherent aggregates of bacterial cells that form on biotic and abiotic surfaces, including human tissues. Biofilms resist antibiotic treatment and contribute to bacterial persistence in chronic infections(1,2). Hence, the elucidation of the mechanisms by which biofilms are formed may assist in the treatment of chronic infections, such as Pseudomonas aeruginosa in the airways of patients with cystic fibrosis(2). Here we show that subinhibitory concentrations of aminoglycoside antibiotics induce biofilm formation in P. aeruginosa and Escherichia coli. In P. aeruginosa, a gene, which we designated aminoglycoside response regulator (arr), was essential for this induction and contributed to biofilm-specific aminoglycoside resistance. The arr gene is predicted to encode an inner-membrane phosphodiesterase whose substrate is cyclic di-guanosine monophosphate (c-di-GMP) - a bacterial second messenger that regulates cell surface adhesiveness(3). We found that membranes from arr mutants had diminished c-di-GMP phosphodiesterase activity, and P. aeruginosa cells with a mutation changing a predicted catalytic residue of Arr were defective in their biofilm response to tobramycin. Furthermore, tobramycin-inducible biofilm formation was inhibited by exogenous GTP, which is known to inhibit c-di-GMP phosphodiesterase activity(4). Our results demonstrate that biofilm formation can be a specific, defensive reaction to the presence of antibiotics, and indicate that the molecular basis of this response includes alterations in the level of c-di-GMP.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Biol Chem, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Miller, SI (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	millersi@u.washington.edu	Hoffman, Lucas/AAX-1853-2021; Jones, Roger A./GRY-0637-2022	Jones, Roger A./0000-0002-6835-6615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI066251] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI066251] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIKAM D, 1989, J BACTERIOL, V171, P6649, DOI 10.1128/jb.171.12.6649-6655.1989; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bagge N, 2004, ANTIMICROB AGENTS CH, V48, P1175, DOI 10.1128/AAC.48.4.1175-1187.2004; Barclay ML, 1996, J ANTIMICROB CHEMOTH, V37, P1155, DOI 10.1093/jac/37.6.1155; Bergey D.H., 1984, BERGEYS MANUAL SYSTE; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122; Moskowitz SM, 2004, J CLIN MICROBIOL, V42, P1915, DOI 10.1128/JCM.42.5.1915-1922.2004; MUKHOPADHYAY S, 1994, RESP MED, V88, P203, DOI 10.1016/S0954-6111(05)80348-8; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; ROSS P, 1990, J BIOL CHEM, V265, P18933; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Taylor P., 1985, PHARM BASIS THERAPEU, V7th, P215; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100	28	867	931	11	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1171	1175		10.1038/nature03912	http://dx.doi.org/10.1038/nature03912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121184				2022-12-01	WOS:000231416600049
J	Chan, AT; Giovannucci, EL; Meyerhardt, JA; Schernhammer, ES; Curhan, GC; Fuchs, CS				Chan, AT; Giovannucci, EL; Meyerhardt, JA; Schernhammer, ES; Curhan, GC; Fuchs, CS			Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DOSE ASPIRIN; NF-KAPPA-B; COLON-CANCER; CYCLOOXYGENASE-2 EXPRESSION; PRIMARY PREVENTION; RANDOMIZED-TRIAL; ANALGESIC USE; REDUCED RISK; ADENOMA; CELECOXIB	Context Randomized trials of short-term aspirin use for prevention of recurrent colorectal adenoma have provided compelling evidence of a causal relationship between aspirin and colorectal neoplasia. However, data on long-term risk of colorectal cancer according to dose, timing, or duration of therapy with aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) remain limited. Objective To examine the influence of aspirin and NSAIDs in prevention of colorectal cancer. Design, Setting, and Participants Prospective cohort study of 82 911 women enrolled in the Nurses' Health Study providing data on medication use biennially since 1980 and followed up through June 1, 2000. Main Outcome Measure Incident colorectal cancer. Results Over a 20-year period, we documented 962 cases of colorectal cancer. Among women who regularly used aspirin (>= 2 standard [325-mg] tablets per week), the multivariate relative risk (RR) for colorectal cancer was 0.77 (95% confidence interval [01, 0.67-0.88) compared with nonregular users. However, significant risk reduction was not observed until more than 10 years of use (P <=.001 for trend). The benefit appeared related to dose: compared with women who reported no use, the multivariate RRs for cancer were 1.10 (95% Cl, 0.92-1.31) for women who used 0.5 to 1.5 standard aspirin tablets per week, 0.89 (95% Cl, 0.73-1.10) for 2 to 5 aspirin per week, 0.78 (95% Cl, 0.62-0.97) for 6 to 14 aspirin per week, and 0.68 (95% Cl, 0.49-0.95) for more than 14 aspirin per week (P<.001 for trend). Notably, women who used more than 14 aspirin per week for longer than 10 years in the past had a multivariate RR for cancer of 0.47 (95 % Cl, 0.31-0.71). A similar dose-response relationship was found for nonaspirin NSAIDs (P=.007 for trend). The incidence of reported major gastrointestinal bleeding events per 1000 person-years also appeared to be dose-related: 0.77 among women who denied any aspirin use; 1.07 for 0.5 to 1.5 standard aspirin tablets per week; 1.07 for 2 to 5 aspirin per week; 1.40 for 6 to 14 aspirin per week; and 1.57 for more than 14 aspirin per week. Conclusions Regular, long-term aspirin use reduces risk of colorectal cancer. Non-aspirin NSAIDs appear to have a similar effect. However, a significant benefit of aspirin is not apparent until more than a decade of use, with maximal risk reduction at doses greater than 14 tablets per week. These results suggest that optimal chemoprevention for colorectal cancer requires long-term use of aspirin doses substantially higher than those recommended for prevention of cardiovascular disease, but the dose-related risk of gastrointestinal bleeding must also be considered.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Dana Farber Harvard Canc Ctr, Canc Epidemiol Program, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 722, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014; Schernhammer, Eva S/L-7898-2018	Chan, Andrew T/0000-0001-7284-6767; Schernhammer, Eva S/0000-0002-4337-9415	NATIONAL CANCER INSTITUTE [K07CA107412, P01CA055075, P01CA087969] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BARON JA, 1909, NEW ENGL J MED, V340, P101; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chan AT, 2004, CLIN GASTROENTEROL H, V2, P704, DOI 10.1016/S1542-3565(04)00294-0; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Collet JP, 1999, BRIT J CANCER, V81, P62, DOI 10.1038/sj.bjc.6690651; Coogan PF, 2000, CANCER CAUSE CONTROL, V11, P249, DOI 10.1023/A:1008931708716; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Greene FL, 2002, AJCC CANC STAGING HD; Grodstein F, 1998, ANN INTERN MED, V128, P705, DOI 10.7326/0003-4819-128-9-199805010-00001; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Iso H, 1999, STROKE, V30, P1764, DOI 10.1161/01.STR.30.9.1764; Jessup JM, 1996, CANCER-AM CANCER SOC, V78, P918; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; LaVecchia C, 1997, BRIT J CANCER, V76, P675, DOI 10.1038/bjc.1997.444; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; MULLER AD, 1994, DIGEST DIS SCI, V39, P2480, DOI 10.1007/BF02087670; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; Rahme E, 2003, GASTROENTEROLOGY, V125, P404, DOI 10.1016/S0016-5085(03)00880-1; Reeves MJ, 1996, CANCER EPIDEM BIOMAR, V5, P955; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Ruffin MT, 1997, JNCI-J NATL CANCER I, V89, P1152, DOI 10.1093/jnci/89.15.1152; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Shureiqi I, 2000, CANCER RES, V60, P6846; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sorensen HT, 2003, BRIT J CANCER, V88, P1687, DOI 10.1038/sj.bjc.6600945; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; Tangrea JA, 2003, CANCER CAUSE CONTROL, V14, P403, DOI 10.1023/A:1024990617158; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; THUN MJ, 1993, CANCER RES, V53, P1322; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307	66	359	377	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2005	294	8					914	923		10.1001/jama.294.8.914	http://dx.doi.org/10.1001/jama.294.8.914			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957JM	16118381	Bronze, Green Accepted			2022-12-01	WOS:000231366100021
J	Lindell, D; Jaffe, JD; Johnson, ZI; Church, GM; Chisholm, SW				Lindell, D; Jaffe, JD; Johnson, ZI; Church, GM; Chisholm, SW			Photosynthesis genes in marine viruses yield proteins during host infection	NATURE			English	Article							SYNECHOCOCCUS STRAINS; PROCHLOROCOCCUS; GENOME; METABOLISM; PHAGE; LIGHT	Cyanobacteria, and the viruses ( phages) that infect them, are significant contributors to the oceanic 'gene pool'(1,2). This pool is dynamic, and the transfer of genetic material between hosts and their phages(3-6) probably influences the genetic and functional diversity of both. For example, photosynthesis genes of cyanobacterial origin have been found in phages that infect Prochlorococcus(5,7) and Synechococcus(8,9), the numerically dominant phototrophs in ocean ecosystems. These genes include psbA, which encodes the photosystem II core reaction centre protein D1, and high-light-inducible ( hli) genes. Here we show that phage psbA and hli genes are expressed during infection of Prochlorococcus and are cotranscribed with essential phage capsid genes, and that the amount of phage D1 protein increases steadily over the infective period. We also show that the expression of host photosynthesis genes declines over the course of infection and that replication of the phage genome is a function of photosynthesis. We thus propose that the phage genes are functional in photosynthesis and that they may be increasing phage fitness by supplementing the host production of these proteins.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Johnson, Zackary I/E-4601-2011	Johnson, Zackary I/0000-0003-0793-8512; church, george/0000-0001-6232-9969; Lindell, Debbie/0000-0003-0612-4517; Chisholm, Sallie/0000-0003-1480-2445				Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ADOLPH KW, 1972, VIROLOGY, V47, P370, DOI 10.1016/0042-6822(72)90272-3; Arias MC, 2003, J PHYTOPATHOL, V151, P267, DOI 10.1046/j.1439-0434.2003.00718.x; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GINZBURG D, 1968, J VIROL, V2, P695, DOI 10.1128/JVI.2.7.695-701.1968; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Johnson ZI, 2004, MAR ECOL PROG SER, V283, P73, DOI 10.3354/meps283073; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; MACKENZIE JJ, 1972, VIROLOGY, V49, P517, DOI 10.1016/0042-6822(72)90503-X; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rahoutei J, 2000, PHYSIOL PLANTARUM, V110, P286, DOI 10.1034/j.1399-3054.2000.110220.x; SHERMAN LA, 1976, VIROLOGY, V71, P199, DOI 10.1016/0042-6822(76)90105-7; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; ZINSER ER, IN PRESS APPL ENV MI	29	328	351	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2005	438	7064					86	89		10.1038/nature04111	http://dx.doi.org/10.1038/nature04111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16222247				2022-12-01	WOS:000232979000046
J	Okie, S				Okie, S			Betting on a malaria vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PLASMODIUM-FALCIPARUM INFECTION; EFFICACY; TRIAL											Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2005	353	18					1877	1881		10.1056/NEJMp058217	http://dx.doi.org/10.1056/NEJMp058217			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979VJ	16267316				2022-12-01	WOS:000232972800001
J	Chapin, FS; Sturm, M; Serreze, MC; McFadden, JP; Key, JR; Lloyd, AH; McGuire, AD; Rupp, TS; Lynch, AH; Schimel, JP; Beringer, J; Chapman, WL; Epstein, HE; Euskirchen, ES; Hinzman, LD; Jia, G; Ping, CL; Tape, KD; Thompson, CDC; Walker, DA; Welker, JM				Chapin, FS; Sturm, M; Serreze, MC; McFadden, JP; Key, JR; Lloyd, AH; McGuire, AD; Rupp, TS; Lynch, AH; Schimel, JP; Beringer, J; Chapman, WL; Epstein, HE; Euskirchen, ES; Hinzman, LD; Jia, G; Ping, CL; Tape, KD; Thompson, CDC; Walker, DA; Welker, JM			Role of land-surface changes in Arctic summer warming	SCIENCE			English	Article							CLIMATE-CHANGE; SEWARD PENINSULA; CARBON STORAGE; TUNDRA SOILS; VEGETATION; TRENDS; TEMPERATURE; TREELINE; ALASKA; VARIABILITY	A major challenge in predicting Earth's future climate state is to understand feedbacks that alter greenhouse-gas forcing. Here we synthesize field data from arctic Alaska, showing that terrestrial changes in summer albedo contribute substantially to recent high-latitude warming trends. Pronounced terrestrial summer warming in. arctic Alaska correlates with a lengthening of the snow-free season that has increased atmospheric heating locally by about 3 watts per square meter per decade (similar in magnitude to the regional heating expected over multiple decades from a doubling of atmospheric CO2). The continuation of current trends in shrub and tree expansion could further amplify this atmospheric heating by two to seven times.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska, US Geol Survey, Fairbanks, AK 99775 USA; Univ Alaska, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA; Univ Alaska, Inst No Engn, Fairbanks, AK 99775 USA; USA, Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; NOAA, Natl Environm Satellite Data & Informat Serv, Madison, WI 53706 USA; Middlebury Coll, Dept Biol, Middlebury, VT 05443 USA; Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Colorado State Univ, Dept Forest Rangeland & Watershed Stewardship, Ft Collins, CO 80523 USA; Univ Alaska Fairbanks, Palmer Res Stn, Palmer, AK 99645 USA; Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK 99501 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; National Oceanic Atmospheric Admin (NOAA) - USA; Monash University; University of California System; University of California Santa Barbara; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Colorado State University; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Anchorage	Chapin, FS (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	terry.chapin@uaf.edu	Schimel, Joshua/AAE-7380-2019; Beringer, Jason/B-8528-2008; Jia, Gensuo/AAL-2681-2020; Chapin, F Stuart/AAZ-3931-2020; Hinzman, Larry/B-3309-2013; Welker, Jeffrey/C-9493-2013; Sturm, Matthew/GXF-6926-2022; Key, Jeffrey R./AAB-7248-2020; Lynch, Amanda/B-4278-2011	Schimel, Joshua/0000-0002-1022-6623; Beringer, Jason/0000-0002-4619-8361; Jia, Gensuo/0000-0001-5950-9555; Chapin, F Stuart/0000-0002-2558-9910; Hinzman, Larry/0000-0002-5878-6814; Lynch, Amanda/0000-0003-2990-1016				Arctic Climate Impact Assessment, 2004, IMP WARM ARCT; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; BRUBAKER LB, 1995, ECOL STU AN, V113, P111; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; CHAPIN FS, 1988, OECOLOGIA, V77, P506, DOI 10.1007/BF00377266; CHAPIN FS, UNPUB; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; Comiso JC, 2003, J CLIMATE, V16, P3498, DOI 10.1175/1520-0442(2003)016<3498:WTITAF>2.0.CO;2; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; Dingman S. L., 1980, ARCTIC ECOSYSTEM COA, P30; Dye DG, 2002, HYDROL PROCESS, V16, P3065, DOI 10.1002/hyp.1089; Epstein HE, 2004, J BIOGEOGR, V31, P1917, DOI 10.1111/j.1365-2699.2004.01140.x; Eugster W, 2000, GLOBAL CHANGE BIOL, V6, P84, DOI 10.1046/j.1365-2486.2000.06015.x; Fahnestock JT, 1998, J GEOPHYS RES-ATMOS, V103, P29023, DOI 10.1029/98JD00805; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; HARTMANN B, IN PRESS J CLIM; Hobbie SE, 1998, J ECOL, V86, P449, DOI 10.1046/j.1365-2745.1998.00278.x; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jia GSJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018268; Keyser AR, 2000, GLOBAL CHANGE BIOL, V6, P185, DOI 10.1046/j.1365-2486.2000.06020.x; Liu HP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005158; Lloyd AH, 2003, PERMAFROST PERIGLAC, V14, P93, DOI 10.1002/ppp.446; LLOYD AH, IN PRESS ECOLOGY; LLOYD AH, 2003, J GEOPHYS RES, V107, P8110; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McFadden JP, 1998, J GEOPHYS RES-ATMOS, V103, P28947, DOI 10.1029/98JD02400; Michaelson GJ, 1996, ARCTIC ALPINE RES, V28, P414, DOI 10.2307/1551852; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Rupp TS, 2001, CLIMATIC CHANGE, V48, P399, DOI 10.1023/A:1010738502596; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; Silapaswan CS, 2001, CAN J REMOTE SENS, V27, P542, DOI 10.1080/07038992.2001.10854894; Smith NV, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004472; Stone RS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000286; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; STURM M, 2005, BIOGEOSCIENCES, V110, DOI DOI 10.1029/2005JG000013; SZEICZ JM, 1995, J ECOL, V83, P873, DOI 10.2307/2261424; TAPE K, 2004, THESIS U ALASKA FAIR; Thorpe N, 2002, EARTH IS FASTER NOW, P201; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Wang XJ, 2003, SCIENCE, V299, P1725, DOI 10.1126/science.1078065; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	48	959	995	15	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					657	660		10.1126/science.1117368	http://dx.doi.org/10.1126/science.1117368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16179434				2022-12-01	WOS:000232997700036
J	Crawford, PC; Dubovi, EJ; Castleman, WL; Stephenson, I; Gibbs, EPJ; Chen, L; Smith, C; Hill, RC; Ferro, P; Pompey, J; Bright, RA; Medina, MJ; Johnson, CM; Olsen, CW; Cox, NJ; Klimov, AI; Katz, JM; Donis, RO				Crawford, PC; Dubovi, EJ; Castleman, WL; Stephenson, I; Gibbs, EPJ; Chen, L; Smith, C; Hill, RC; Ferro, P; Pompey, J; Bright, RA; Medina, MJ; Johnson, CM; Olsen, CW; Cox, NJ; Klimov, AI; Katz, JM; Donis, RO		Influenza Genomics Grp	Transmission of equine influenza virus to dogs	SCIENCE			English	Article							RECEPTOR-BINDING PROPERTIES; A-VIRUSES; SIALIC-ACID; HOST-RANGE; HEMAGGLUTININS; INFECTION; DISEASE; CHILD	Molecular and antigenic analyses of three influenza viruses isolated from outbreaks of severe respiratory disease in racing greyhounds revealed that they are closely related to H3N8 equine influenza virus. Phylogenetic analysis indicated that the canine influenza virus genomes form a monophyletic group, consistent with a single interspecies virus transfer. Molecular changes in the hemagglutinin suggested adaptive evolution in the new host. The etiologic role of this virus in respiratory disease was supported by the temporal association of rising antibody titers with disease and by experimental inoculation studies. The geographic expansion of the infection and its persistence for several years indicate efficient transmission of canine influenza virus among greyhounds. Evidence of infection in pet dogs suggests that this infection may also become enzootic in this population.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA; Univ Florida, Coll Vet Med, Gainesville, FL 32611 USA; Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; Texas A&M Univ, Coll Vet Med, College Stn, TX 77841 USA; Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Cornell University; Texas A&M University System; Texas A&M University College Station; Auburn University System; Auburn University; University of Wisconsin System; University of Wisconsin Madison	Donis, RO (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA.	rvd6@cdc.gov						CHANG C P, 1976, International Journal of Zoonoses, V3, P61; DACSO CC, 1984, J CLIN MICROBIOL, V20, P833, DOI 10.1128/JCM.20.4.833-835.1984; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; HOUSE SM, 1980, OECOLOGIA, V44, P396; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KILBOURNE ED, 1976, INTERVIROLOGY, V6, P315, DOI 10.1159/000149485; Kimura K, 1998, MAYO CLIN PROC, V73, P243, DOI 10.4065/73.3.243; Kovacova A, 2002, VIRUS GENES, V24, P57, DOI 10.1023/A:1014038120979; Lai ACK, 2004, VIRUS RES, V100, P159, DOI 10.1016/j.virusres.2003.11.019; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; NIKITIN T, 1972, B WORLD HEALTH ORGAN, V47, P471; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; PATRIARCA PA, 1984, AM J EPIDEMIOL, V119, P152, DOI 10.1093/oxfordjournals.aje.a113733; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; TOP FH, 1977, J INFECT DIS, V136, pS376, DOI 10.1093/infdis/136.Supplement_3.S376; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wagner R, 2002, J GEN VIROL, V83, P601, DOI 10.1099/0022-1317-83-3-601; Webby R, 2004, NAT MED, V10, pS77, DOI 10.1038/nm1151; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0	26	468	552	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					482	485		10.1126/science.1117950	http://dx.doi.org/10.1126/science.1117950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16186182				2022-12-01	WOS:000232786000044
J	Nelissen, K; Luppino, G; Vanduffel, W; Rizzolatti, G; Orban, GA				Nelissen, K; Luppino, G; Vanduffel, W; Rizzolatti, G; Orban, GA			Observing others: Multiple action representation in the frontal lobe	SCIENCE			English	Article							PREMOTOR CORTEX; MACAQUE; MONKEY; CONNECTIONS; MECHANISMS; SHAPE; AREA; F5	Observation of actions performed by-others activates monkey ventral premotor cortex, where action meaning, but not object identity, is coded. In a functional MRI (fMRI) study, we investigated whether other monkey frontal areas respond to actions performed by others. Observation of a hand grasping objects activated four frontal areas: rostral F5 and areas 45B, 45A, and 46. Observation of an individual grasping an object also activated caudal F5, which indicates,different degrees of action abstraction in F5. Observation of shapes activated area 45, but not premotor F5. Convergence of object and action information in area 45 may be important for full comprehension of actions.	Katholieke Univ Leuven, Sch Med, Lab Neuro Psychofysiol, Louvain, Belgium; Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; Harvard Univ, Sch Med, Massachusetts Gen Hosp, MIT,Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	KU Leuven; University of Parma; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Orban, GA (corresponding author), Katholieke Univ Leuven, Sch Med, Lab Neuro Psychofysiol, Louvain, Belgium.	guy.orban@med.kuleuven.ac.be		Luppino, Giuseppe/0000-0002-0220-0618; Orban, Guy/0000-0002-8179-9584				Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M., 2004, INT J SPORT EXERC PS, V2, P376, DOI [10.1080/1612197X.2004.9671752, DOI 10.1080/1612197X.2004.9671752]; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; LIEBERMAN AM, 1993, HASKINS LAB STATUS R, V113, P1; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5	23	262	268	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					332	336		10.1126/science.1115593	http://dx.doi.org/10.1126/science.1115593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224029	Green Accepted			2022-12-01	WOS:000232670100058
J	Lo, B; Rubenfeld, G				Lo, B; Rubenfeld, G			Palliative sedation in dying patients - "We turn to it when everything else hasn't worked"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; INTENSIVE-CARE-UNIT; OPIOID-RELATED MYOCLONUS; LIFE DECISION-MAKING; TERMINAL SEDATION; CANCER-PATIENTS; SUPREME-COURT; ILL PATIENTS; END; EUTHANASIA		Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Washington, Harborview Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98104 USA	University of California System; University of California San Francisco; Harborview Medical Center; University of Washington; University of Washington Seattle	Lo, B (corresponding author), Room C 126,521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu			NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005226] Funding Source: NIH RePORTER; NINR NIH HHS [R01NR005226] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Alpers A, 1999, ARCH FAM MED, V8, P200, DOI 10.1001/archfami.8.3.200; [Anonymous], 1999, BMJ-BRIT MED J, V318, P1431, DOI 10.1136/bmj.318.7196.1431; Back AL, 2005, JAMA-J AM MED ASSOC, V293, P1374, DOI 10.1001/jama.293.11.1374; BEAUCHAMP TL, 1994, PRINCIPLES BIOMEDICA, P206; BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P128; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Boyle J, 2004, THEOR MED BIOETH, V25, P51; Braun Ted C, 2003, J Palliat Med, V6, P345, DOI 10.1089/109662103322144655; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Cherny N I, 1994, J Palliat Care, V10, P31; Clarke EB, 2004, J CRIT CARE, V19, P108, DOI 10.1016/j.jcrc.2004.05.001; Cowan JD, 2001, SUPPORT CARE CANCER, V9, P403, DOI 10.1007/s005200100235; CURTIS J, 2001, MANAGING DEATH ICU T; Fainsinger RL, 2000, J PALLIAT CARE, V16, P5, DOI 10.1177/082585970001600202; Gorsuch NM, 2000, HARVARD J LAW PUBL P, V23, P599; Green Kelly, 2003, Indiana Int Comp Law Rev, V13, P639; Hagen N, 1997, J PAIN SYMPTOM MANAG, V14, P51, DOI 10.1016/S0885-3924(97)00001-8; Hough CL, 2005, J CRIT CARE, V20, P20, DOI 10.1016/j.jcrc.2004.09.006; Jackson W Clay, 2002, Am J Hosp Palliat Care, V19, P81, DOI 10.1177/104990910201900202; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Lanuke Kathryn, 2004, J Palliat Med, V7, P257, DOI 10.1089/109662104773709378; Li Denise, 2004, Crit Care Nurse, V24, P72; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lo B, 2002, JAMA-J AM MED ASSOC, V287, P749, DOI 10.1001/jama.287.6.749; LO B, 2005, RESOLVING ETHICAL DI, P107; Lo Bernard, 2003, J Palliat Med, V6, P409, DOI 10.1089/109662103322144727; Lo Bernard, 2003, Palliat Support Care, V1, P3; McIntyre A, 2004, THEOR MED BIOETH, V25, P61, DOI 10.1023/B:META.0000025095.73394.34; McNicol E, 2003, J PAIN, V4, P231, DOI 10.1016/S1526-5900(03)00556-X; Mercadante S, 1998, PAIN, V74, P5, DOI 10.1016/S0304-3959(97)00090-0; MERCADANTE S, 1995, ANESTH ANALG, V81, P1307, DOI 10.1097/00000539-199512000-00034; Mercadante S, 2001, SUPPORT CARE CANCER, V9, P205, DOI 10.1007/s005200000230; Morita T, 2004, PALLIATIVE MED, V18, P550, DOI 10.1191/0269216304pm911oa; Morita T, 2002, J PAIN SYMPTOM MANAG, V24, P447, DOI 10.1016/S0885-3924(02)00499-2; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Orentlicher D, 1996, NEW ENGL J MED, V335, P663, DOI 10.1056/NEJM199608293350912; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Parker RA, 1999, JAMA-J AM MED ASSOC, V281, P1937, DOI 10.1001/jama.281.20.1937; President ' Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DEC FOR LIF SUST TRE, P73; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Rousseau Paul, 2003, J Palliat Med, V6, P425, DOI 10.1089/109662103322144745; Rousseau Paul, 2005, J Palliat Med, V8, P10, DOI 10.1089/jpm.2005.8.10; Rubenfeld GD, 2004, CRIT CARE CLIN, V20, P435, DOI 10.1016/j.ccc.2004.03.005; RUBENFELD GD, 2000, MANAGING DEATH ICU T; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; Sheldon Tony, 2005, BMJ, V330, P61, DOI 10.1136/bmj.330.7482.61; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Tannsjo T., 2004, TERMINAL SEDATION EU; Taylor Brigit R, 2005, J Palliat Med, V8, P144, DOI 10.1089/jpm.2005.8.144; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 2000, NEW ENGL J MED, V342, P508, DOI 10.1056/NEJM200002173420712; WARNOCK M, 1998, INTELLIGENT PERSONS, P27; Wilson Robin K, 2004, J Palliat Med, V7, P580, DOI 10.1089/1096621041838461; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	60	131	131	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1810	1816		10.1001/jama.294.14.1810	http://dx.doi.org/10.1001/jama.294.14.1810			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	972RX	16219885				2022-12-01	WOS:000232472000021
J	Allara, DL				Allara, DL			A perspective on surfaces and interfaces	NATURE			English	Editorial Material							SELF-ASSEMBLED MONOLAYERS		Penn State Univ, Dept Polymer Sci & Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Allara, DL (corresponding author), Penn State Univ, Dept Polymer Sci & Chem, 206 Chem Bldg, University Pk, PA 16802 USA.	dla3@psu.edu						BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360; Bowden F.P., 1951, AM J PHYS, V19, P428, DOI [10.1119/1.1933017, DOI 10.1119/1.1933017]; Duke CB, 2003, P NATL ACAD SCI USA, V100, P3858, DOI 10.1073/pnas.0730358100; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357	5	57	62	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2005	437	7059					638	639		10.1038/nature04234	http://dx.doi.org/10.1038/nature04234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193037				2022-12-01	WOS:000232157900036
J	Block, SD; Billings, JA				Block, SD; Billings, JA			Becoming a physician - Learning from dying	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Div Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Palliat Care Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Block, SD (corresponding author), Dana Farber Canc Inst, Div Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA.							GERTEIS M, 1993, PATIENTS EYES PROMOT; Hafferty F.W., 1991, VALLEY DEATH SOCIALI; Kubler-Ross E., 1969, DEATH DYING, DOI DOI 10.4324/9780203010495	3	30	31	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2005	353	13					1313	1315		10.1056/NEJMp048171	http://dx.doi.org/10.1056/NEJMp048171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968FB	16192474				2022-12-01	WOS:000232146200001
J	Dar, AC; Dever, TE; Sicheri, F				Dar, AC; Dever, TE; Sicheri, F			Higher-order substrate recognition of elF2 alpha by the RNA-dependent protein kinase PKR	CELL			English	Article							DOUBLE-STRANDED-RNA; INITIATION-FACTOR 2-ALPHA; CRYSTAL-STRUCTURE; PEPTIDE SUBSTRATE; ALPHA-SUBUNIT; EIF2 ALPHA; TRANSLATION; EIF2-ALPHA; ACTIVATION; BINDING	In response to binding viral double-stranded RNA by products within a cell, the RNA-dependent protein kinase PKR phosphorylates the a subunit of the translation initiation factor eIF2 on a regulatory site, Ser51. This triggers the general shutdown of protein synthesis and inhibition of viral propagation. To understand the basis for substrate recognition by and the regulation of PKR, we determined X-ray crystal structures of the catalytic domain of PKR in complex with eIF2 alpha. The structures reveal that eIF2a binds to the C-terminal catalytic lobe while catalytic-domain dimerization is mediated by the N-terminal lobe. In addition to inducing a local unfolding of the Ser51 acceptor site in eIF2 alpha, its mode of binding to PKR affords the Ser51 site full access to the catalytic cleft of PKR. The generality and implications of the structural mechanisms uncovered for PKR to the larger family of four human eIF2 alpha protein kinases are discussed.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca	Sicheri, Frank/F-8856-2013; Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DAR AC, 2005, MODULAR PROTEIN DOMA, P181; DeLano WL, 2004, PYMOL USERS MANUAL; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dey M, 2005, MOL CELL BIOL, V25, P3063, DOI 10.1128/MCB.25.8.3063-3075.2005; Dhaliwal S, 2003, J MOL BIOL, V334, P187, DOI 10.1016/j.jmb.2003.09.045; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; MELLOR H, 1991, BIOCHEM BIOPH RES CO, V178, P430, DOI 10.1016/0006-291X(91)90125-Q; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nonato MC, 2002, J BIOL CHEM, V277, P17057, DOI 10.1074/jbc.M111804200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	36	285	297	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					887	900		10.1016/j.cell.2005.06.044	http://dx.doi.org/10.1016/j.cell.2005.06.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16179258	Bronze			2022-12-01	WOS:000232130200013
J	Gillett, NP				Gillett, NP			Climate modelling - Northern Hemisphere circulation	NATURE			English	Editorial Material									Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Gillett, NP (corresponding author), Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England.	n.gillett@uea.ac.uk						Gillett NP, 2003, NATURE, V422, P292, DOI 10.1038/nature01487; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Osborn TJ, 2004, CLIM DYNAM, V22, P605, DOI 10.1007/s00382-004-0405-1; Selten FM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020739; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2	5	36	37	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2005	437	7058					496	496		10.1038/437496a	http://dx.doi.org/10.1038/437496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177779				2022-12-01	WOS:000232004800036
J	He, J; Gu, DF; Wu, XG; Reynolds, K; Duan, XF; Yao, CH; Wang, JL; Chen, C; Chen, J; Wildman, RP; Klag, MJ; Whelton, PK				He, J; Gu, DF; Wu, XG; Reynolds, K; Duan, XF; Yao, CH; Wang, JL; Chen, C; Chen, J; Wildman, RP; Klag, MJ; Whelton, PK			Major causes of death among men and women in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EMERGING TOBACCO HAZARDS; GLOBAL BURDEN; CIGARETTE-SMOKING; HYPERTENSION; PREVALENCE; MORTALITY; PREVENTION; AWARENESS; DISEASES	BACKGROUND: With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China. METHODS: Baseline data on the participants' demographic characteristics, medical history, lifestyle-related risk factors, blood pressure, and body weight were obtained in 1991 with the use of a standard protocol. The follow-up evaluation was conducted in 1999 and 2000, with a follow-up rate of 93.4 percent. RESULTS: We documented 20,033 deaths in 1,239,191 person-years of follow-up. The mortality from all causes was 1480.1 per 100,000 person-years among men and 1190.2 per 100,000 person-years among women. The five leading causes of death were malignant neoplasms (mortality, 374.1 per 100,000 person-years), diseases of the heart (319.1), cerebrovascular disease (310.5), accidents (54.0), and infectious diseases (50.5) among men and diseases of the heart (268.5), cerebrovascular disease (242.3), malignant neoplasms (214.1), pneumonia and influenza (45.9), and infectious diseases (35.3) among women. The multivariate-adjusted relative risk of death and the population attributable risk for preventable risk factors were as follows: hypertension, 1.48 (95 percent confidence interval, 1.44 to 1.53) and 11.7 percent, respectively; cigarette smoking, 1.23 (95 percent confidence interval, 1.18 to 1.27) and 7.9 percent; physical inactivity, 1.20 (95 percent confidence interval, 1.16 to 1.24) and 6.8 percent; and underweight (body-mass index [the weight in kilograms divided by the square of the height in meters] below 18.5), 1.47 (95 percent confidence interval, 1.42 to 1.53) and 5.2 percent. CONCLUSIONS: Vascular disease and cancer have become the leading causes of death among Chinese adults. Our findings suggest that control of hypertension, smoking cessation, increased physical activity, and improved nutrition should be important strategies for reducing the burden of premature death among adults in China.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; Chinese Acad Sci, Fuwai Hosp, Cardiovasc Inst, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Natl Ctr Cardiovasc Dis Control & Res, Beijing, Peoples R China; Capital Univ Med Sci, Anzhen Hosp, Beijing, Peoples R China; Sichuan Univ, W China Coll Med, Chengdu, Peoples R China; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Sichuan University; Johns Hopkins University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,Mail Stop SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], WORLD HLTH REP 2002; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Chen ZM, 1999, JAMA-J AM MED ASSOC, V281, P1893; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FROHLICH ED, 1988, CIRCULATION, V77, pA502; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; HAYS JT, 1996, PREVENTION MYOCARDIA, P99; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; HUANG ZD, 1994, J HYPERTENS, V12, P1103; KAHN HA, 1989, STAT METHODS EPIDEMI, P73; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KOCHANEK KD, 2004, NATL VITAL STAT REPO, V52; Lam TH, 1998, JAMA-J AM MED ASSOC, V279, P1350; Li YJ, 2002, J MATER SCI TECHNOL, V18, P21; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; *MIN PUBL HLTH PEO, 1990, HLTH STAT INF CHIN 1; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sen K, 2000, LANCET, V356, P577, DOI 10.1016/S0140-6736(00)02590-3; *UNDP, MILL DEV GOALS; World Health Organization, 1999, WORLD HLTH REP 1999; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; ZHANG B, 1991, MOL BIOL MED, V8, P39; 1998, OBES RES, V6, pS51	31	977	1196	5	163	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1124	1134		10.1056/NEJMsa050467	http://dx.doi.org/10.1056/NEJMsa050467			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162883				2022-12-01	WOS:000231841900007
J	Rossiter, SJ; Ransome, RD; Faulkes, CG; Le Comber, SC; Jones, G				Rossiter, SJ; Ransome, RD; Faulkes, CG; Le Comber, SC; Jones, G			Mate fidelity and intra-lineage polygyny in greater horseshoe bats	NATURE			English	Article							GENE DIVERSITY; DISPERSAL; BEHAVIOR; BIRDS	Mating strategies that lead to increased kinship within socially cooperative groups may offer inclusive fitness benefits to individuals(1-3), but can also result in higher levels of inbreeding(4-6). Here we show in a sexually segregated bat species that females avoid this conflict through two mating behaviours. First, most females revisit and breed with specific, individual males across years, so that their single offspring born in different years are full siblings. Second, relatives in the maternal line, including mothers and daughters, share breeding partners (intra-lineage polygyny) more often than expected by chance. Although these behaviours increased levels of co-ancestry among colony members, there was no concomitant rise in inbreeding. We suggest that when females engage in mate fidelity and intra-lineage polygyny, kin ties among female roost mates will be strengthened, thereby potentially contributing to social group cohesiveness. Our findings reveal the hidden complexity that can underlie polygynous breeding, and highlight a new potential route by which female mate choice could influence social evolution.	Univ London, Queen Mary, Sch Biol Sci, London E1 4NS, England; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of London; Queen Mary University London; University of Bristol	Rossiter, SJ (corresponding author), Univ London, Queen Mary, Sch Biol Sci, London E1 4NS, England.	s.j.rossiter@qmul.ac.uk	Faulkes, Chris/O-8101-2019; Le Comber, Steven/B-8315-2008; Rossiter, Stephen J/E-2111-2011; Faulkes, Chris/B-8377-2008	Jones, Gareth/0000-0002-1904-3735; Rossiter, Stephen/0000-0002-3881-4515; Faulkes, Christopher/0000-0002-5228-9075	Natural Environment Research Council [NER/I/S/2002/00732] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; Andersson Malte, 1994; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; Chapais B., 2004, KINSHIP BEHAV PRIMAT; CHESSER RK, 1991, GENETICS, V129, P573; CHESSER RK, 1991, GENETICS, V127, P437; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Dawson DA, 2004, MOL ECOL NOTES, V4, P96, DOI 10.1046/j.1471-8286.2003.00580.x; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HEPPER PG, 1991, KIN RECOGNITION, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MARSHALL TC, 2002, P ROY SOC LOND B BIO, V266, P1533; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Ransome R.D., 1991, P88; Ransome RD, 1995, PHILOS T ROY SOC B, V350, P153, DOI 10.1098/rstb.1995.0149; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; Rossiter SJ, 2000, MOL ECOL, V9, P1131, DOI 10.1046/j.1365-294x.2000.00982.x; Rossiter SJ, 2000, P ROY SOC B-BIOL SCI, V267, P545, DOI 10.1098/rspb.2000.1035; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rossiter SJ, 1999, MOL ECOL, V8, P1959, DOI 10.1046/j.1365-294x.1999.00778-2.x; Sandercock BK, 2000, CAN J ZOOL, V78, P1948, DOI 10.1139/cjz-78-11-1948; Shields W.M., 1982, PHILOPATRY INBREEDIN; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0	29	52	53	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					408	411		10.1038/nature03965	http://dx.doi.org/10.1038/nature03965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163356				2022-12-01	WOS:000231849100053
J	Faxen, K; Gilderson, G; Adelroth, P; Brzezinski, P				Faxen, K; Gilderson, G; Adelroth, P; Brzezinski, P			A mechanistic principle for proton pumping by cytochrome c oxidase	NATURE			English	Article							HEME-COPPER OXIDASES; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; MOLECULAR-DYNAMICS; OXYGEN REDUCTION; COUPLED PROTON; TRANSLOCATION; MODEL	In aerobic organisms, cellular respiration involves electron transfer to oxygen through a series of membrane-bound protein complexes. The process maintains a transmembrane electrochemical proton gradient that is used, for example, in the synthesis of ATP. In mitochondria and many bacteria, the last enzyme complex in the electron transfer chain is cytochrome c oxidase (CytcO), which catalyses the four-electron reduction of O-2 to H2O using electrons delivered by a water-soluble donor, cytochrome c(1-7). The electron transfer through CytcO, accompanied by proton uptake to form H2O drives the physical movement ( pumping) of four protons across the membrane(8) per reduced O-2. So far, the molecular mechanism of such proton pumping driven by electron transfer has not been determined in any biological system. Here we show that proton pumping in CytcO is mechanistically coupled to proton transfer to O-2 at the catalytic site, rather than to internal electron transfer. This scenario suggests a principle by which redox-driven proton pumps might operate and puts considerable constraints on possible molecular mechanisms by which CytcO translocates protons.	Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Brzezinski, P (corresponding author), Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	peterb@dbb.su.se						Adelroth P, 1998, BBA-BIOENERGETICS, V1367, P107, DOI 10.1016/S0005-2728(98)00142-X; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Brzezinski P, 2004, TRENDS BIOCHEM SCI, V29, P380, DOI 10.1016/j.tibs.2004.05.008; Brzezinski P, 2003, BBA-BIOENERGETICS, V1605, P1, DOI 10.1016/S0005-2728(03)00079-3; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karpefors M, 1998, P NATL ACAD SCI USA, V95, P13606, DOI 10.1073/pnas.95.23.13606; Lanyi JK, 2001, CURR OPIN STRUC BIOL, V11, P415, DOI 10.1016/S0959-440X(00)00226-8; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mills DA, 2003, FEBS LETT, V545, P47, DOI 10.1016/S0014-5793(03)00392-2; Namslauer A, 2003, P NATL ACAD SCI USA, V100, P15543, DOI 10.1073/pnas.2432106100; OLIVEBERG M, 1991, BIOCHEMISTRY-US, V30, P436, DOI 10.1021/bi00216a019; Papa S, 1998, FEBS LETT, V439, P1, DOI 10.1016/S0014-5793(98)01305-2; Paula S, 1999, BIOCHEMISTRY-US, V38, P3025, DOI 10.1021/bi981351h; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Rich PR, 1998, J BIOENERG BIOMEMBR, V30, P131, DOI 10.1023/A:1020524014920; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 1997, BBA-BIOENERGETICS, V1318, P6, DOI 10.1016/S0005-2728(96)00147-8; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; ZASLAVSKY D, 1993, FEBS LETT, V336, P389, DOI 10.1016/0014-5793(93)80843-J; Zhen YJ, 2002, BIOCHEMISTRY-US, V41, P2288, DOI 10.1021/bi0114628	30	220	225	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					286	289		10.1038/nature03921	http://dx.doi.org/10.1038/nature03921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148937				2022-12-01	WOS:000231696900062
J	McConkey, EH; Varki, A				McConkey, EH; Varki, A			Thoughts on the future of great ape research	SCIENCE			English	Editorial Material							CHIMPANZEE GENOME; PROJECT; EVOLUTION		Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92039 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92039 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of California System; University of California San Diego	McConkey, EH (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	mcconkey@colorado.edu; a1vark@ucsd.edu						KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; McConkey E, 2002, TRENDS GENET, V18, P446, DOI 10.1016/S0168-9525(02)02748-8; McConkey EH, 2000, SCIENCE, V289, P1295; McConkey EH, 1997, TRENDS GENET, V13, P350, DOI 10.1016/S0168-9525(97)01226-2; McConkey EH, 2004, CYTOGENET GENOME RES, V105, P157, DOI 10.1159/000078022; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Olson MV, 2004, SCIENCE, V305, P191, DOI 10.1126/science.1100975; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Varki A, 1998, SCIENCE, V282, P239	9	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1499	1501		10.1126/science.1113863	http://dx.doi.org/10.1126/science.1113863			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141054				2022-12-01	WOS:000231715000030
J	Tezcan, FA; Kaiser, JT; Mustafi, D; Walton, MY; Howard, JB; Rees, DC				Tezcan, FA; Kaiser, JT; Mustafi, D; Walton, MY; Howard, JB; Rees, DC			Nitrogenase complexes: Multiple docking sites for a nucleotide switch protein	SCIENCE			English	Article							AZOTOBACTER-VINELANDII; ELECTRON-TRANSFER; SIGNAL-TRANSDUCTION; TRANSITION-STATE; CROSS-LINKING; IRON PROTEIN; MECHANISM; INHIBITION; INSIGHTS	Adenosine triphosphate (ATP) hydrolysis in the nitrogenase complex controls the cycle of association and dissociation between the electron donor adenosine triphosphatase (ATPase) (Fe-protein) and its target catalytic protein (MoFe-protein), driving the reduction of dinitrogen into ammonia. Crystal structures in different nucleotide states have been determined that identify conformational changes in the nitrogenase complex during ATP turnover. These structures reveal distinct and mutually exclusive interaction sites on the MoFe-protein surface that are selectively populated, depending on the Fe-protein nucleotide state. A consequence of these different docking geometries is that the distance between redox cofactors, a critical determinant of the intermolecular electron transfer rate, is coupled to the nucleotide state. More generally, stabilization of distinct docking geometries by different nucleotide states, as seen for nitrogenase, could enable nucleotide hydrolysis to drive the relative motion of protein partners in molecular motors and other systems.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu		Mustafi, Debarshi/0000-0002-9164-7488				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; DEITS TL, 1990, J BIOL CHEM, V265, P3859; Duyvis MG, 1996, FEBS LETT, V380, P233, DOI 10.1016/0014-5793(96)00019-1; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jacobs D, 1995, ARCH BIOCHEM BIOPHYS, V324, P317, DOI 10.1006/abbi.1995.0044; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; Lanzilotta WN, 1996, BIOCHEMISTRY-US, V35, P7188, DOI 10.1021/bi9603985; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Miyashita O, 2004, P NATL ACAD SCI USA, V101, P16174, DOI 10.1073/pnas.0405745101; NELSON P, 2004, BIOL PHYS ENERGY LIF; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Renner KA, 1996, BIOCHEMISTRY-US, V35, P5353, DOI 10.1021/bi960441o; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schlessman JL, 1998, J MOL BIOL, V280, P669, DOI 10.1006/jmbi.1998.1898; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thorneley R.N.F., 1985, MOLYBDENUM ENZYMES, P221; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WILLING A, 1990, J BIOL CHEM, V265, P6596; WILLING AH, 1989, J BIOL CHEM, V264, P8499	32	165	167	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1377	1380		10.1126/science.1115653	http://dx.doi.org/10.1126/science.1115653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123301				2022-12-01	WOS:000231543300045
J	Costa-Mattioli, M; Gobert, D; Harding, H; Herdy, B; Azzi, M; Bruno, M; Bidinosti, M; Ben Mamou, C; Marcinkiewicz, E; Yoshida, M; Imataka, H; Cuello, AC; Seidah, N; Sossin, W; Lacaille, JC; Ron, D; Nader, K; Sonenberg, N				Costa-Mattioli, M; Gobert, D; Harding, H; Herdy, B; Azzi, M; Bruno, M; Bidinosti, M; Ben Mamou, C; Marcinkiewicz, E; Yoshida, M; Imataka, H; Cuello, AC; Seidah, N; Sossin, W; Lacaille, JC; Ron, D; Nader, K; Sonenberg, N			Translational control of hippocampal synaptic plasticity and memory by the eIF2 alpha kinase GCN2	NATURE			English	Article							LONG-TERM POTENTIATION; MAMMALIAN HOMOLOG; GENE-EXPRESSION; CA1 REGION; STORAGE; NEUROSCIENCE; ENHANCEMENT; DEGRADATION; INDUCTION	Studies on various forms of synaptic plasticity have shown a link between messenger RNA translation, learning and memory. Like memory, synaptic plasticity includes an early phase that depends on modification of pre-existing proteins, and a late phase that requires transcription and synthesis of new proteins(1,2). Activation of postsynaptic targets seems to trigger the transcription of plasticity-related genes. The new mRNAs are either translated in the soma or transported to synapses before translation. GCN2, a key protein kinase, regulates the initiation of translation. Here we report a unique feature of hippocampal slices from GCN2(-/-) mice: in CA1, a single 100-Hz train induces a strong and sustained long-termpotentiation ( late LTP or L-LTP), which is dependent on transcription and translation. In contrast, stimulation that elicits L-LTP in wild-type slices, such as four 100-Hz trains or forskolin, fails to evoke L-LTP in GCN2(-/-) slices. This aberrant synaptic plasticity is mirrored in the behaviour of GCN2(-/-) mice in the Morris water maze: after weak training, their spatial memory is enhanced, but it is impaired after more intense training. Activated GCN2 stimulates mRNA translation of ATF4, an antagonist of cyclic-AMP-response-element-binding protein ( CREB). Thus, in the hippocampus of GCN2(-/-) mice, the expression of ATF4 is reduced and CREB activity is increased. Our study provides genetic, physiological, behavioural and molecular evidence that GCN2 regulates synaptic plasticity, as well as learning and memory, through modulation of the ATF4/CREB pathway.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Psychol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Ctr Rech Sci Neurol, Dept Physiol, Montreal, PQ H3C 3J7, Canada; NYU, Sch Med, Dept Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; New York University; New York University; New York University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; RIKEN	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	nahum.sonenberg@mcgill.ca	Seidah, Nabil/I-3596-2013; Marcinkiewicz, Edyta/N-4203-2018; Cuello, A. Claudio/N-8211-2015	Seidah, Nabil/0000-0001-6503-9342; Marcinkiewicz, Edyta/0000-0002-2229-4084; Harding, Heather P/0000-0002-7359-7974; Cuello, Claudio/0000-0003-2143-2745; Ron, David/0000-0002-3014-5636	NIDDK NIH HHS [R37 DK047119, R01 DK047119] Funding Source: Medline; NIEHS NIH HHS [R01 ES008681] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Chan J, 2004, RNA, V10, P528, DOI 10.1261/rna.5200204; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lapointe V, 2004, J PHYSIOL-LONDON, V555, P125, DOI 10.1113/jphysiol.2003.053603; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Santoyo J, 1997, J BIOL CHEM, V272, P12544, DOI 10.1074/jbc.272.19.12544; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Sood R, 2000, GENETICS, V154, P787; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	30	290	311	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1166	1170		10.1038/nature03897	http://dx.doi.org/10.1038/nature03897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121183	Green Accepted, Green Published			2022-12-01	WOS:000231416600048
J	Shiber, JR				Shiber, JR			Angioedema of the arytenoids	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									E Carolina Univ, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Shiber, JR (corresponding author), E Carolina Univ, Greenville, NC 27834 USA.								0	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					E15	E15		10.1056/NEJMicm040964	http://dx.doi.org/10.1056/NEJMicm040964			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251529				2022-12-01	WOS:000232813000012
J	Nolden, M; Ehses, S; Koppen, M; Bernacchia, A; Rugarli, EI; Langer, T				Nolden, M; Ehses, S; Koppen, M; Bernacchia, A; Rugarli, EI; Langer, T			The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria	CELL			English	Article							TRANSLATIONAL ACTIVATOR PROTEINS; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; DEGRADATION; SUBUNIT; COMPLEX; GENES; MAINTENANCE; PROTEOLYSIS; MUTATIONS	AAA proteases comprise a conserved family of membrane bound ATP-dependent proteases that ensures the quality control of mitochondrial inner-membrane proteins. Inactivation of AAA proteases causes pleiotropic phenotypes in various organisms, including respiratory deficiencies, mitochondrial morphology defects, and axonal degeneration in hereditary spastic paraplegia (HSP). The molecular basis of these defects, however, remained unclear. Here, we describe a regulatory role of an AAA protease for mitochondrial protein synthesis in yeast. The mitochondrial ribosomal protein MrpL32 is processed by the m-AAA protease, allowing its association with preassembled ribosomal particles and completion of ribosome assembly in close proximity to the inner membrane. Maturation of MrpL32 and mitochondrial protein synthesis are also impaired in a HSP mouse model lacking the m-AAA protease subunit paraplegin, demonstrating functional conservation. Our findings therefore rationalize mitochondrial defects associated with m-AAA protease mutants in yeast and shed new light on the mechanism of axonal degeneration in HSR	Univ Cologne, Genet Inst, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; Telethon Inst Genet & Med, I-80131 Naples, Italy	University of Cologne; University of Cologne; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Langer, T (corresponding author), Univ Cologne, Genet Inst, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de		Langer, Thomas/0000-0003-1250-1462; Rugarli, Elena/0000-0002-5782-1067	Telethon [GGP05057] Funding Source: Medline	Telethon(Fondazione Telethon)		Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; CAMPBELL CL, 1994, MOL BIOL CELL, V5, P899, DOI 10.1091/mbc.5.8.899; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Fiori A, 2003, EUKARYOT CELL, V2, P651, DOI 10.1128/EC.2.3.651-653.2003; Galluhn D, 2004, J BIOL CHEM, V279, P38338, DOI 10.1074/jbc.M405871200; GROHMANN L, 1991, FEBS LETT, V284, P51, DOI 10.1016/0014-5793(91)80759-V; GUELIN E, 1994, YEAST, V10, P1389, DOI 10.1002/yea.320101016; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Knittler MR, 1998, J IMMUNOL, V161, P5967; Krause-Buchholz U, 2004, CURR GENET, V46, P20, DOI 10.1007/s00294-004-0503-y; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; MCMULLIN TW, 1993, J BIOL CHEM, V268, P11737; MICHAELIS U, 1991, MOL GEN GENET, V230, P177, DOI 10.1007/BF00290666; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; NOLDEN M, 2005, IN PRESS CURR TOPICS; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rep M, 1996, CURR GENET, V30, P206, DOI 10.1007/s002940050122; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; SPITHILL TW, 1978, MOL GEN GENET, V164, P155, DOI 10.1007/BF00267380; Steglich G, 1999, MOL CELL BIOL, V19, P3435; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; TATSUTA T, 2005, IN PRESS CURR TOPICS; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029; VANDERKLEI IJ, 1994, MICROSC RES TECHNIQ, V27, P284, DOI 10.1002/jemt.1070270404; VANDYCK L, 1994, J BIOL CHEM, V269, P238	41	279	285	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					277	289		10.1016/j.cell.2005.08.003	http://dx.doi.org/10.1016/j.cell.2005.08.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239145	Bronze			2022-12-01	WOS:000232794100014
J	Okie, S				Okie, S			An offshore haven for human embryonic stem-cell research?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2005	353	16					1645	1649		10.1056/NEJMp058228	http://dx.doi.org/10.1056/NEJMp058228			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975IC	16236732				2022-12-01	WOS:000232653200001
J	Santos, NC; Benz, W; Mayor, M				Santos, NC; Benz, W; Mayor, M			Extrasolar planets: Constraints for planet formation models	SCIENCE			English	Review							NEPTUNE-MASS PLANET; STATISTICAL PROPERTIES; TRANSITING PLANET; GIANT PLANETS; DETERMINISTIC MODEL; PERIOD DISTRIBUTION; ORBITAL MIGRATION; SOLAR PLANETS; BROWN DWARF; HOST STARS	Since 1995, more than 150 extrasolar planets have been discovered, most of them in orbits quite different from those of the giant planets in our own solar system. The number of discovered extrasolar planets demonstrates that planetary systems are common but also that they may possess a large variety of properties. As the number of detections grows, statistical studies of the properties of exoplanets and their host stars can be conducted to unravel some of the key physical and chemical processes leading to the formation of planetary systems.	Univ Lisbon, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Observ Geneva, CH-1290 Sauverny, Switzerland	Universidade de Lisboa; University of Bern; University of Geneva	Santos, NC (corresponding author), Univ Lisbon, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal.	nuno.santos@oal.ul.pt	Santos, Nuno C/E-9957-2011	Santos, Nuno C/0000-0003-4422-2919				Alibert Y, 2005, ASTROPHYS J, V626, pL57, DOI 10.1086/431325; Alibert Y, 2005, ASTRON ASTROPHYS, V434, P343, DOI 10.1051/0004-6361:20042032; Alibert Y, 2004, ASTRON ASTROPHYS, V417, pL25, DOI 10.1051/0004-6361:20040053; Alonso R, 2004, ASTROPHYS J, V613, pL153, DOI 10.1086/425256; Baraffe I, 2004, ASTRON ASTROPHYS, V419, pL13, DOI 10.1051/0004-6361:20040129; Beckwith SVW, 1996, NATURE, V383, P139, DOI 10.1038/383139a0; Boss AP, 2002, ICARUS, V156, P291, DOI 10.1006/icar.2002.6816; Boss AP, 2002, ASTROPHYS J, V567, pL149, DOI 10.1086/340108; Bouchy F, 2004, ASTRON ASTROPHYS, V421, pL13, DOI 10.1051/0004-6361:20040170; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Butler RP, 2004, ASTROPHYS J, V617, P580, DOI 10.1086/425173; Butler RP, 2003, ASTROPHYS J, V582, P455, DOI 10.1086/344570; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Chauvin G, 2004, ASTRON ASTROPHYS, V425, pL29, DOI 10.1051/0004-6361:200400056; Cumming A, 1999, ASTROPHYS J, V526, P890, DOI 10.1086/308020; Eggenberger A, 2004, ASTRON ASTROPHYS, V417, P353, DOI 10.1051/0004-6361:20034164; Gaudi BS, 2005, ASTROPHYS J, V623, P472, DOI 10.1086/428478; GOLDREICH P, 1980, ASTROPHYS J, V241, P425, DOI 10.1086/158356; Gonzalez G, 1998, ASTRON ASTROPHYS, V334, P221; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Halbwachs JL, 2000, ASTRON ASTROPHYS, V355, P581; Halbwachs JL, 2005, ASTRON ASTROPHYS, V431, P1129, DOI 10.1051/0004-6361:20041219; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; HENRY GW, 2000, APJ, V529, P41; Ida S, 2004, ASTROPHYS J, V616, P567, DOI 10.1086/424830; Ida S, 2004, ASTROPHYS J, V604, P388, DOI 10.1086/381724; Jorissen A, 2001, ASTRON ASTROPHYS, V379, P992, DOI 10.1051/0004-6361:20011373; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; LATHAM DW, 1989, NATURE, V339, P38, DOI 10.1038/339038a0; LIN DNC, 1986, ASTROPHYS J, V309, P846, DOI 10.1086/164653; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lissauer JJ, 2002, NATURE, V419, P355, DOI 10.1038/419355a; Livio M, 2003, MON NOT R ASTRON SOC, V346, pL42, DOI 10.1111/j.1365-2966.2003.07318.x; Marcy GW, 2002, ASTROPHYS J, V581, P1375, DOI 10.1086/344298; Marzari F, 2002, ICARUS, V156, P570, DOI 10.1006/icar.2001.6786; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; Mayor M., 2003, MESSENGER, V114, P20; Mazeh T, 2005, MON NOT R ASTRON SOC, V356, P955, DOI 10.1111/j.1365-2966.2004.08511.x; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; Moutou C, 2004, ASTRON ASTROPHYS, V424, pL31, DOI 10.1051/0004-6361:200400048; Murray N, 1998, SCIENCE, V279, P69, DOI 10.1126/science.279.5347.69; Murray N, 2002, ASTROPHYS J, V565, P608, DOI 10.1086/324536; Pinsonneault MH, 2001, ASTROPHYS J, V556, pL59, DOI 10.1086/323531; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Pont F, 2004, ASTRON ASTROPHYS, V426, pL15, DOI 10.1051/0004-6361:200400066; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Reid IN, 2002, PUBL ASTRON SOC PAC, V114, P306, DOI 10.1086/339257; Santos NC, 2001, ASTRON ASTROPHYS, V373, P1019, DOI 10.1051/0004-6361:20010648; Santos NC, 2004, ASTRON ASTROPHYS, V415, P1153, DOI 10.1051/0004-6361:20034469; Santos NC, 2004, ASTRON ASTROPHYS, V426, pL19, DOI 10.1051/0004-6361:200400076; Sari R, 2004, ASTROPHYS J, V606, pL77, DOI 10.1086/421080; Sasselov DD, 2000, ASTROPHYS J, V528, P995, DOI 10.1086/308209; Saumon D, 1996, ASTROPHYS J, V460, P993, DOI 10.1086/177027; Sozzetti A, 2004, MON NOT R ASTRON SOC, V354, P1194, DOI 10.1111/j.1365-2966.2004.08281.x; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Torres G, 2004, ASTROPHYS J, V609, P1071, DOI 10.1086/421286; Trilling DE, 1998, ASTROPHYS J, V500, P428, DOI 10.1086/305711; Udry S, 2003, ASTRON ASTROPHYS, V407, P369, DOI 10.1051/0004-6361:20030843; Udry S, 2002, ASTRON ASTROPHYS, V390, P267, DOI 10.1051/0004-6361:20020685; Vauclair S, 2004, ASTROPHYS J, V605, P874, DOI 10.1086/382668; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vogt SS, 2000, ASTROPHYS J, V536, P902, DOI 10.1086/308981; Ward WR, 1997, ASTROPHYS J, V482, pL211, DOI 10.1086/310701; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; Zucker S, 2002, ASTROPHYS J, V568, pL113, DOI 10.1086/340373	66	38	38	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					251	255		10.1126/science.1100210	http://dx.doi.org/10.1126/science.1100210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224012				2022-12-01	WOS:000232670100035
J	Corbit, KC; Aanstad, P; Singla, V; Norman, AR; Stainier, DYR; Reiter, JF				Corbit, KC; Aanstad, P; Singla, V; Norman, AR; Stainier, DYR; Reiter, JF			Vertebrate Smoothened functions at the primary cilium	NATURE			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; INTRAFLAGELLAR TRANSPORT PROTEINS; OLFACTORY CILIA; NEURONAL CILIA; LOCALIZATION; DROSOPHILA; BETA-ARRESTIN-2; CYCLOPAMINE; INHIBITION; RECEPTORS	The unanticipated involvement of several intraflagellar transport proteins in the mammalian Hedgehog (Hh) pathway has hinted at a functional connection between cilia and Hh signal transduction(1,2). Here we show that mammalian Smoothened (Smo), a seven-transmembrane protein essential for Hh signalling(3), is expressed on the primary cilium. This ciliary expression is regulated by Hh pathway activity; Sonic hedgehog or activating mutations in Smo promote ciliary localization, whereas the Smo antagonist cyclopamine inhibits ciliary localization. The translocation of Smo to primary cilia depends upon a conserved hydrophobic and basic residue sequence homologous to a domain previously shown to be required for the ciliary localization of seven-transmembrane proteins in Caenorhabditis elegans(4). Mutation of this domain not only prevents ciliary localization but also eliminates Smo activity both in cultured cells and in zebrafish embryos. Thus, Hh-dependent translocation to cilia is essential for Smo activity, suggesting that Smo acts at the primary cilium.	Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reiter, JF (corresponding author), Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.	jreiter@diabetes.ucsf.edu		Aanstad, Pia/0000-0003-3893-2973; Singla, Veena/0000-0002-5107-0717; Stainier, Didier/0000-0002-0382-0026				Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen WB, 2001, DEVELOPMENT, V128, P2385; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Salisbury JL, 2004, CURR BIOL, V14, pR765, DOI 10.1016/j.cub.2004.09.016; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TAKEMOTO DJ, 1990, CELL SIGNAL, V2, P99, DOI 10.1016/0898-6568(90)90013-Z; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	29	1043	1072	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1018	1021		10.1038/nature04117	http://dx.doi.org/10.1038/nature04117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16136078				2022-12-01	WOS:000232496100044
J	Grigg, SP; Canales, C; Hay, A; Tsiantis, M				Grigg, SP; Canales, C; Hay, A; Tsiantis, M			SERRATE coordinates shoot meristem function and leaf axial patterning in Arabidopsis	NATURE			English	Article							CLASS IIIHD-ZIP; INSERTIONAL MUTAGENESIS; GENE; ORGANOGENESIS; PHABULOSA; THALIANA; PROTEINS; POLARITY; GENOME; MEMBER	Leaves of flowering plants are determinate organs produced by pluripotent structures termed shoot apical meristems. Once specified, leaves differentiate an adaxial ( upper) side specialized for light capture, and an abaxial ( lower) side specialized for gas exchange. A functional relationship between meristem activity and the differentiation of adaxial leaf fate has been recognized for over fifty years, but the molecular basis of this interaction is unclear. In Arabidopsis thaliana, activity of the class I KNOX (KNOTTED1-like homeobox) genes SHOOTMERISTEMLESS (STM) and BREVIPEDICELLUS ( BP) is required for meristem function but excluded from leaves(1-3), whereas members of the HD-Zip III ( class III homeodomain leucine zipper) protein family function to promote both meristem activity and adaxial leaf fate(4-6). Here we show that the zinc-finger protein SERRATE acts in a microRNA ( miRNA) gene-silencing pathway to regulate expression of the HD-Zip III gene PHABULOSA (PHB) while also limiting the competence of shoot tissue to respond to KNOX expression. Thus, SERRATE acts to coordinately regulate meristem activity and leaf axial patterning.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	miltos.tsiantis@plants.ox.ac.uk						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Ori N, 2000, DEVELOPMENT, V127, P5523; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Smith HMS, 2003, PLANT CELL, V15, P1717, DOI 10.1105/tpc.012856; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286	22	173	182	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1022	1026		10.1038/nature04052	http://dx.doi.org/10.1038/nature04052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222298				2022-12-01	WOS:000232496100045
J	Spierings, D; McStay, G; Saleh, M; Bender, C; Chipuk, J; Maurer, U; Green, DR				Spierings, D; McStay, G; Saleh, M; Bender, C; Chipuk, J; Maurer, U; Green, DR			Connected to death: The (unexpurgated) mitochondrial pathway of apoptosis	SCIENCE			English	Article							CELL-DEATH	The mitochondrial pathway of apoptosis in vertebrates is dependent on the process of mitochondrial outer membrane permeabilization (MOMP), which leads to the release of proteins from the mitochondrial intermembrane space into the cytosol. "Upstairs" of this event are the Bcl-2 family proteins that regulate and mediate MOMP; "downstairs" is the activation of caspases that orchestrate the dismantling of the cell. In the Connections Map database at Science's Signal Transduction Knowledge Environment (STKE), the pathways that define the mitochondrial pathway of apotosis are illustrated, with the bulk of control occurring. "upstairs" of MOMP.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	dgreen5240@aol.com	Green, Douglas R/N-8083-2018; McStay, Gavin/K-9574-2013	Green, Douglas R/0000-0002-7332-1417; McStay, Gavin/0000-0003-1363-8719; Chipuk, Jerry Edward/0000-0002-1337-842X; Spierings, Diana/0000-0001-8403-474X; Saleh, Maya/0000-0003-1538-9146				BENDER C, 2005, SCI STKE; BENDER C, 2005, SCI STKE         OCT; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Kauffman S, 1995, HOME UNIVERSE; 2005, SCI STKE         OCT	8	226	254	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2005	310	5745					66	67		10.1126/science.1117105	http://dx.doi.org/10.1126/science.1117105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210526				2022-12-01	WOS:000232477000035
J	Gebrekristos, HT; Mlisana, KP; Karim, QA				Gebrekristos, HT; Mlisana, KP; Karim, QA			Patients readiness to start highly active antiretroviral treatment for HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH LITERACY; 21ST-CENTURY; MOTIVATION; CHALLENGE; INFECTION; THERAPY; SEARCH; SCALE		Nelson R Mandela Sch Med, CAPRISA, Durban, South Africa	University of Kwazulu Natal	Gebrekristos, HT (corresponding author), Nelson R Mandela Sch Med, CAPRISA, Durban, South Africa.	hgebrekr@jhsph.edu	Abdool Karim, Quarraisha/GVS-1160-2022; Mlisana, Koleka/N-6204-2013	Abdool Karim, Quarraisha/0000-0002-0985-477X; Mlisana, Koleka/0000-0002-8436-3268	NIAID NIH HHS [P30 AI42853-05S1, 1U19AI51794] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, U19AI051794] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Audrain J, 1997, Womens Health, V3, P139; *BHIVA WRIT COMM B, 2003, BRIT HIV ASS BHIVA G; BLUMENTHAL RN, 2001, DRUG ALCOHOL DEPEN, V62, P225; *BRIT HIV ASS, 2000, HIV MED, V1, P133; DELEON G, 1994, AM J DRUG ALCOHOL AB, V20, P495; Department of Health and Human Services, 2003, GUID US ANT AG HIV 1; Department of Health South Africa, 2003, OP PLAN COMPR HIV AI; Enriquez M, 2004, J ADV NURS, V45, P438, DOI 10.1046/j.1365-2648.2003.02928.x; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; *MIN HLTH REP UG, 2003, ANT TREATM POL; Neff JA, 2000, SUBST USE MISUSE, V35, P585, DOI 10.3109/10826080009147473; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P183, DOI 10.1093/heapro/15.3.183; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROHREN CL, 1994, PREV MED, V23, P335, DOI 10.1006/pmed.1994.1047; Skolnik PR, 2003, NEW ENGL J MED, V349, P2351, DOI 10.1056/NEJMe038173; Wagner Glenn, 2002, HIV Clin Trials, V3, P475; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	20	30	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2005	331	7519					772	775		10.1136/bmj.331.7519.772	http://dx.doi.org/10.1136/bmj.331.7519.772			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971XB	16195299	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000232417100029
J	Cecconi, C; Shank, EA; Bustamante, C; Marqusee, S				Cecconi, C; Shank, EA; Bustamante, C; Marqusee, S			Direct observation of the three-state folding of a single protein molecule	SCIENCE			English	Article							RIBONUCLEASE-H; MOLTEN GLOBULE; RNASE-H; FORCE; KINETICS; COOPERATIVITY; INTERMEDIATE; SPECTROSCOPY; EQUILIBRIUM; UBIQUITIN	We used force-measuring optical tweezers to induce complete mechanical unfolding and refolding of individual Escherichia-coli ribonuclease H (RNase H) molecules. The protein unfolds in a two-state manner and refolds through an intermediate that correlates with the transient molten globule-like intermediate observed in bulk studies. This intermediate displays unusual mechanical compliance and unfolds at substantially lower forces than the native state. In a narrow range of forces, the molecule hops between the unfolded and intermediate states in real time. Occasionally, hopping was observed to stop as the molecule crossed the folding barrier directly from the intermediate, demonstrating that the intermediate is on-pathway. These studies allow us to map the energy landscape of RNase H.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Quantitat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; marqusee@berkeley.edu	Cecconi, Ciro/K-5028-2016; Shank, Elizabeth A./AAV-9050-2021	Cecconi, Ciro/0000-0002-6101-2609; Shank, Elizabeth A./0000-0002-4804-1966; Bustamante, Carlos/0000-0002-2970-0073	NIGMS NIH HHS [GM32543, GM50945, GM008295] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050945, R01GM032543, R01GM050945, R37GM032543] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kellermayer MSZ, 1998, J STRUCT BIOL, V122, P197, DOI 10.1006/jsbi.1998.3988; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.bi.59.070190.003215; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Parker MJ, 1999, J MOL BIOL, V293, P1195, DOI 10.1006/jmbi.1999.3204; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Rhoades E, 2004, J AM CHEM SOC, V126, P14686, DOI 10.1021/ja046209k; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Roder H, 1997, CURR OPIN STRUC BIOL, V7, P15, DOI 10.1016/S0959-440X(97)80004-8; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1	27	472	484	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2057	2060		10.1126/science.1116702	http://dx.doi.org/10.1126/science.1116702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179479				2022-12-01	WOS:000232181900051
J	O'Doherty, A; Ruf, S; Mulligan, C; Hildreth, V; Errington, ML; Cooke, S; Sesay, A; Modino, S; Vanes, L; Hernandez, D; Linehan, JM; Sharpe, PT; Brandner, S; Bliss, TVP; Henderson, DJ; Nizetic, D; Tybulewicz, VLJ; Fisher, EMC				O'Doherty, A; Ruf, S; Mulligan, C; Hildreth, V; Errington, ML; Cooke, S; Sesay, A; Modino, S; Vanes, L; Hernandez, D; Linehan, JM; Sharpe, PT; Brandner, S; Bliss, TVP; Henderson, DJ; Nizetic, D; Tybulewicz, VLJ; Fisher, EMC			An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes	SCIENCE			English	Article							LONG-TERM POTENTIATION; HUMAN-CHROMOSOME FRAGMENTS; TS65DN MOUSE; GERMLINE TRANSMISSION; CEREBELLAR PHENOTYPES; RECOGNITION MEMORY; CHIMERIC MICE; MODEL; HIPPOCAMPUS; TRISOMY	Aneuploidies are common chromosomal defects that result in growth and developmental deficits and high levels of lethality in humans'. To gain insight into the biology of aneuploidies, we manipulated mouse embryonic stem cells and generated a trans-species aneuploid mouse line that stably transmits a freely segregating, almost complete human chromosome 21 (Hsa21). This "'transchromosomic" mouse line, TO, is a model of trisomy 21, which manifests as Down syndrome (DS) in humans, and has phenotypic alterations in behavior, synaptic plasticity, cerebellar neuronal number, heart development, and mandible size that relate to human DS. Transchromosomic mouse lines such as Tc1 may represent useful genetic tools for dissecting other human aneupioidies.	Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; Natl Inst Med Res, London NW7 1AA, England; Queen Marys Sch Med, Barts & London, Inst Cell & Mol Sci, Ctr Haematol, London E1 2AT, England; Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Guys Hosp, Univ London Kings Coll, Dept Craniofacial Dev, London SE1 9RT, England	University of London; University College London; University of London; University College London; MRC National Institute for Medical Research; University of London; Queen Mary University London; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tybulewicz, VLJ (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	vtybule@nimr.mrc.ac.uk; e.fisher@prion.ucl.ac.uk	Fisher, Elizabeth MC/C-2168-2008; Hernandez, Diana/AAE-4613-2021; Nizetic, Dean/F-9509-2015; Brandner, Sebastian/J-4562-2014	Fisher, Elizabeth MC/0000-0003-2850-9936; Brandner, Sebastian/0000-0002-9821-0342; Hernandez, Diana/0000-0002-1353-2175; Nizetic, Dean/0000-0001-5486-5761; cooke, samuel/0000-0002-4876-6502; Tybulewicz, Victor/0000-0003-2439-0798; Sharpe, Paul/0000-0003-2116-9561; Henderson, Deborah/0000-0002-2705-5998	Medical Research Council [MC_U117512674] Funding Source: Medline; Wellcome Trust [076700] Funding Source: Medline; MRC [MC_U117512674] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Devlin L, 2004, ARCH DIS CHILD, V89, P1177, DOI 10.1136/adc.2003.031765; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hernandez D, 1999, TRENDS GENET, V15, P241, DOI 10.1016/S0168-9525(99)01743-6; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Hsu LYF, 1998, GENETIC DISORDERS FE, V4th, P179; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kazuki Y, 2001, J HUM GENET, V46, P600, DOI 10.1007/s100380170028; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maslen CL, 2004, CURR OPIN CARDIOL, V19, P205, DOI 10.1097/00001573-200405000-00003; Nelson DL, 2004, SCIENCE, V306, P619, DOI 10.1126/science.1105226; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Scotese I, 1998, PEDIATR RES, V44, P252, DOI 10.1203/00006450-199808000-00019; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163; Shinohara T, 2000, CHROMOSOME RES, V8, P713, DOI 10.1023/A:1026741321193; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	39	309	316	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2033	2037		10.1126/science.1114535	http://dx.doi.org/10.1126/science.1114535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179473	Green Accepted			2022-12-01	WOS:000232181900043
J	Asplin, BR; Rhodes, KV; Levy, H; Lurie, N; Crain, AL; Carlin, BP; Kellermann, AL				Asplin, BR; Rhodes, KV; Levy, H; Lurie, N; Crain, AL; Carlin, BP; Kellermann, AL			Insurance status and access to urgent ambulatory care follow-up appointments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY; MEDICAID	Context There is growing pressure to avoid hospitalizing emergency department patients who can be treated safely as outpatients, but this strategy depends on timely access to follow-up care. Objective To determine the association between reported insurance status and access to follow-up appointments for serious conditions that are commonly identified during an emergency department visit. Design, Setting, and Participants Eight research assistants called 499 randomly selected ambulatory clinics in 9 US cities (May 2002-February 2003) and identified themselves as new patients who had been seen in an emergency department and needed an urgent follow-up appointment (within 1 week) for 1 of 3 clinical vignettes (pneumonia, hypertension, or possible ectopic pregnancy). The same person called each clinic twice using the same clinical vignette but different insurance status. Main Outcome Measure Proportion of callers who were offered an appointment within a week. Results Of 499 clinics contacted in the final sample, 430 completed the study protocol. Four hundred six (47.2%) of 860 total callers and 277 (64.4%) of 430 privately insured callers were offered appointments within a week. Callers who claimed to have private insurance were more likely to receive appointments than those who claimed to have Medicaid coverage (63.6% [147/231] vs 34.2% [79/231]; difference, 29.4 percentage points; 95% confidence interval, 21.2-37.6, P<.001). Callers reporting private insurance coverage had higher appointment rates than callers who reported that they were uninsured but offered to pay $20 and arrange payment of the balance (65.3% [130/199] vs 25.1% [50/199]; difference, 40.2; 95% confidence interval, 31.4-49.1; P<.001). There were no differences in appointment rates between callers who claimed to have private insurance coverage and those who reportedly were uninsured but willing to pay cash for the entire visit fee (66.3 % [132/199] vs 62.8% [125/199]; difference, 3.5; 95% confidence interval -3.7 to 10.8; P=.31). The median charge was $100 (range, $25-$600). Seventy-two percent of clinics did not attempt to determine the severity of the caller's condition. Conclusions Reported insurance status is associated with access to timely follow-up ambulatory care for potentially serious conditions. Having private insurance and being willing to pay cash may not eliminate the difficulty in obtaining urgent follow-up appointments.	Reg Hosp, Dept Emergency Med, St Paul, MN 55101 USA; HealthPartners Res Fdn, St Paul, MN USA; Univ Chicago Hosp, Dept Med, Sect Emergency Med, Chicago, IL 60637 USA; Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; RAND Corp, Arlington, VA USA; HealthPartners Res Fdn, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	University of Chicago; University of Illinois System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; RAND Corporation; HealthPartners Institute for Education & Research; University of Minnesota System; University of Minnesota Twin Cities; Emory University	Asplin, BR (corresponding author), Reg Hosp, Dept Emergency Med, 640 Jackson St, St Paul, MN 55101 USA.	Brent.R.Asplin@HealthPartners.com			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013007] Funding Source: NIH RePORTER; AHRQ HHS [K08-HS13007] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], ADV DATA; CURRIE J, 1995, AM ECON REV, V85, P106; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; *I MED COMM CONS U, 2002, CAR COV TO LITTL TOO; Institute of Medicine Committee on the Consequences of Uninsurance, 2002, HLTH INS IS FAM MATT; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2003, SHAR DEST COMM EFF U; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2001, COV MATT INS HLTH CA; Johnson LA, 2001, ANN EMERG MED, V37, P495, DOI 10.1067/mem.2001.115173; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; KNAPP RG, 1992, CLIN EPIDEMIOLOGY BI, P116; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1042, DOI 10.1001/jama.289.8.1042; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Skaggs DL, 2001, PEDIATRICS, V107, P1405, DOI 10.1542/peds.107.6.1405; Solberg LI, 2004, AM J MANAG CARE, V10, P717; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023	16	203	203	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1248	1254		10.1001/jama.294.10.1248	http://dx.doi.org/10.1001/jama.294.10.1248			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160133	Bronze			2022-12-01	WOS:000231831200022
J	Morgan, AD; Gandon, S; Buckling, A				Morgan, AD; Gandon, S; Buckling, A			The effect of migration on local adaptation in a coevolving host-parasite system	NATURE			English	Article							GENE-FOR-GENE; COEVOLUTION; VIRULENCE; MALADAPTATION; DIVERGENCE; EVOLUTION; FLOW	Antagonistic coevolution between hosts and parasites in spatially structured populations can result in local adaptation of parasites(1-5); that is, the greater infectivity of local parasites than foreign parasites on local hosts(1). Such parasite specialization on local hosts has implications for human health and agriculture. By contrast with classic single-species population-genetic models(6,7), theory indicates that parasite migration between subpopulations might increase parasite local adaptation, as long as migration does not completely homogenize populations(8-11). To test this hypothesis we developed a system-specific mathematical model and then coevolved replicate populations of the bacterium Pseudomonas fluorescens and a parasitic bacteriophage with parasite only, with host only or with no migration. Here we show that patterns of local adaptation have considerable temporal and spatial variation and that, in the absence of migration, parasites tend to be locally maladapted. However, in accord with our model, parasite migration results in parasite local adaptation, but host migration alone has no significant effect.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; CNRS, UMR 2724, IRD, F-34394 Montpellier, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Morgan, AD (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	andrew.morgan@zoo.ox.ac.uk	Morgan, Andrew D/C-4948-2008; GANDON, Sylvain/AHC-0976-2022	GANDON, Sylvain/0000-0003-2624-7856; Buckling, Angus/0000-0003-1170-4604				Agrawal A, 2002, EVOL ECOL RES, V4, P79; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CRAWLEY MJ, GLIM ECOLOGISTS, P93; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Frank SA, 1996, EVOL ECOL, V10, P307, DOI 10.1007/BF01237687; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI 10.1111/j.1558-5646.1989.tb02616.x; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Miralles R, 1999, J GEN VIROL, V80, P2051, DOI 10.1099/0022-1317-80-8-2051; Morand S, 1996, P ROY SOC B-BIOL SCI, V263, P119, DOI 10.1098/rspb.1996.0019; Mutikainen P, 2000, EVOLUTION, V54, P433; Oppliger A, 1999, J EVOLUTION BIOL, V12, P951, DOI 10.1046/j.1420-9101.1999.00101.x; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116	29	211	211	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					253	256		10.1038/nature03913	http://dx.doi.org/10.1038/nature03913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148933				2022-12-01	WOS:000231696900055
J	Richter, A; Burrows, JP; Nuss, H; Granier, C; Niemeier, U				Richter, A; Burrows, JP; Nuss, H; Granier, C; Niemeier, U			Increase in tropospheric nitrogen dioxide over China observed from space	NATURE			English	Article							OZONE MONITORING EXPERIMENT; GOME MEASUREMENTS; EMISSIONS; MODEL; NO2; RETRIEVAL; TRANSPORT; NO(X); ASIA	Emissions from fossil fuel combustion and biomass burning reduce local air quality and affect global tropospheric chemistry. Nitrogen oxides are emitted by all combustion processes and play a key part in the photochemically induced catalytic production of ozone, which results in summer smog and has increased levels of tropospheric ozone globally(1). Release of nitrogen oxide also results in nitric acid deposition, and - at least locally - increases radiative forcing effects due to the absorption of downward propagating visible light(2). Nitrogen oxide concentrations in many industrialized countries are expected to decrease(3), but rapid economic development has the potential to increase significantly the emissions of nitrogen oxides(4-7) in parts of Asia. Here we present the tropospheric column amounts of nitrogen dioxide retrieved from two satellite instruments GOME(8,9) and SCIAMACHY(10) over the years 1996 - 2004. We find substantial reductions in nitrogen dioxide concentrations over some areas of Europe and the USA, but a highly significant increase of about 50 per cent - with an accelerating trend in annual growth rate - over the industrial areas of China, more than recent bottom-up inventories suggest(6).	Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; Univ Paris 06, IPSL, Serv Aeron, F-75005 Paris, France; NOAA, CIRES, Aeron Lab, Boulder, CO 80305 USA	University of Bremen; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Richter, A (corresponding author), Univ Bremen, Inst Environm Phys, Otto Hahn Allee 1, D-28359 Bremen, Germany.	richter@iup.physik.uni-bremen.de	Granier, Claire/D-5360-2013; Burrows, John Philip/AAF-8468-2019; Burrows, John P/B-6199-2014; Richter, Andreas/C-4971-2008	Granier, Claire/0000-0001-7344-7995; Burrows, John Philip/0000-0002-6821-5580; Burrows, John P/0000-0002-6821-5580; Richter, Andreas/0000-0003-3339-212X				Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Beirle S, 2003, ATMOS CHEM PHYS, V3, P2225, DOI 10.5194/acp-3-2225-2003; Boersma KF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003962; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Chipperfield MP, 1999, J GEOPHYS RES-ATMOS, V104, P1781, DOI 10.1029/98JD02597; *EUR SPAC AG, 1995, ESA; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; Jaegle L, 2005, FARADAY DISCUSS, V130, P407, DOI 10.1039/b502128f; Koelemeijer RBA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002429; Koelemeijer RBA, 2001, J GEOPHYS RES-ATMOS, V106, P3475, DOI 10.1029/2000JD900657; Kunhikrishnan T, 2004, ATMOS ENVIRON, V38, P581, DOI 10.1016/j.atmosenv.2003.09.074; Leue C, 2001, J GEOPHYS RES-ATMOS, V106, P5493, DOI 10.1029/2000JD900572; LOVBLAD G, 2004, EMEP ASSESSMENT 1, P48; Martin RV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003453; Martin RV, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002622; Martin RV, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001027; Massie ST, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004620; OLIVIER J, 2003, POET, P4; Petritoli A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004547; Richter A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020822; Richter A, 2002, ADV SPACE RES, V29, P1673, DOI 10.1016/S0273-1177(02)00100-X; Rozanov VV, 1997, J GEOPHYS RES-ATMOS, V102, P16683, DOI 10.1029/96JD01535; Solomon S, 1999, J GEOPHYS RES-ATMOS, V104, P12047, DOI 10.1029/1999JD900035; Streets DG, 2000, ATMOS ENVIRON, V34, P363, DOI 10.1016/S1352-2310(99)00167-3; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; van Aardenne JA, 1999, ATMOS ENVIRON, V33, P633, DOI 10.1016/S1352-2310(98)00110-1; VOLZ A, 1988, NATURE, V332, P240, DOI 10.1038/332240a0; ZHAO J, 2003, SINOSPHERE J, V6, P20	29	997	1128	28	517	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					129	132		10.1038/nature04092	http://dx.doi.org/10.1038/nature04092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136141				2022-12-01	WOS:000231560400055
J	Tuske, S; Sarafianos, SG; Wang, XY; Hudson, B; Sineva, E; Mukhopadhyay, J; Birktoft, JJ; Leroy, O; Ismail, S; Clark, AD; Dharia, C; Napoli, A; Laptenko, O; Lee, J; Borukhov, S; Ebright, RH; Arnold, E				Tuske, S; Sarafianos, SG; Wang, XY; Hudson, B; Sineva, E; Mukhopadhyay, J; Birktoft, JJ; Leroy, O; Ismail, S; Clark, AD; Dharia, C; Napoli, A; Laptenko, O; Lee, J; Borukhov, S; Ebright, RH; Arnold, E			Inhibition of bacterial RNA polymerase by streptolydigin: Stabilization of a straight-bridge-helix active-center conformation	CELL			English	Article							II ELONGATION COMPLEX; STRUCTURAL BASIS; BETA-SUBUNIT; TRANSCRIPTION ELONGATION; RANDOM MUTAGENESIS; CRYSTAL-STRUCTURE; MECHANISM; RESISTANCE; INITIATION; DNA	We define the target, mechanism, and structural basis of inhibition of bacterial RNA polymerase (RNAP) by the tetramic acid antibiotic streptolydigin (Stl). Stl binds to a site adjacent to but not overlapping the RNAP active center and stabilizes an RNAP-active-center conformational state with a straight-bridge helix. The results provide direct support for the proposals that alternative straight-bridge-helix and bent-bridge-helix RNAP-active-center conformations exist and that cycling between straight-bridge-helix and bent-bridge-helix RNAP-active-center conformations is required for RNAP function. The results set bounds on models for RNAP function and suggest strategies for design of novel antibacterial agents.	Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08855 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ USA; Howard Hughes Med Inst, Piscataway, NJ USA; Univ Med & Dent New Jersey, Dept Cell Biol, Stratford, NJ 08084 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08855 USA.	ebright@mbcl.rutgers.edu; arnold@cabm.rutgers.edu	Sineva, Elena/A-5267-2008; Borukhov, Sergei/AAF-3195-2019; Ebright, Richard/O-3321-2019	Sineva, Elena/0000-0003-2307-0581; Borukhov, Sergei/0000-0002-3517-3003; Ebright, Richard/0000-0001-8915-7140; Sarafianos, Stefan G/0000-0002-5840-154X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027690, R01AI027690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, P01GM066671, R01GM054098, R37GM041376, R01GM021589] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI027690-15, R37 AI027690-13, R37 AI027690-16, R37 AI027690, AI27690, R37 AI027690-14] Funding Source: Medline; NIGMS NIH HHS [R01 GM041376, P01 GM066671, GM66671, R01 GM041376-17, R01 GM041376-15, R01 GM041376-14, R01 GM054098-05, GM21589, GM54098, R01 GM021589, R37 GM041376, R01 GM041376-16, GM41376, P01 GM066671-02, R01 GM054098] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2004, MOL CELL, V14, P753, DOI 10.1016/j.molcel.2004.05.017; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2003, SCIENCE, V302, P650, DOI 10.1126/science.1087526; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; CASSANI G, 1971, NATURE-NEW BIOL, V230, P197, DOI 10.1038/newbio230197a0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1998, J MOL BIOL, V281, P777, DOI 10.1006/jmbi.1998.1988; HEISLER LM, 1993, J BIOL CHEM, V268, P25369; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; HERMES JD, 1990, P NATL ACAD SCI USA, V87, P696, DOI 10.1073/pnas.87.2.696; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Iwata Y, 2005, ANGEW CHEM INT EDIT, V44, P1532, DOI 10.1002/anie.200462300; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; LEE VJ, 1980, J ANTIBIOT, V33, P408, DOI 10.7164/antibiotics.33.408; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCLURE WR, 1980, J BIOL CHEM, V255, P1610; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sambrook JF., 2001, MOL CLONING LAB MANU; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; SIDDHIKOL C, 1969, J BACTERIOL, V99, P151, DOI 10.1128/JB.99.1.151-155.1969; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEVA M, 2002, ACTA CRYSTALLOGR D, V50, P760; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; YANG XF, 1995, J BIOL CHEM, V270, P23930, DOI 10.1074/jbc.270.41.23930; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	61	153	165	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					541	552		10.1016/j.cell.2005.07.017	http://dx.doi.org/10.1016/j.cell.2005.07.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122422	Green Accepted, Bronze			2022-12-01	WOS:000231555100010
J	Russell, CJ; Webster, RG				Russell, CJ; Webster, RG			The genesis of a pandemic influenza virus	CELL			English	Editorial Material							SINGLE AMINO-ACID; RECEPTOR-BINDING; A VIRUSES; HEMAGGLUTININ; VIRULENCE	Pandemic influenza viruses pose a significant threat to public health worldwide. In a recent Nature paper, Taubenberger et al. (2005) now report remarkable similarities between the polymerase genes of the influenza virus that caused the 1918 Spanish influenza pandemic and those of avian influenza viruses. Meanwhile, Tumpey et al. (2005) reporting in Science show that the reconstructed 1918 Spanish influenza virus kills mice faster than any other influenza virus so far tested.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.		Russell, Charles/K-4824-2013; Russell, Charles/AAU-6006-2020	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095357] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIAID NIH HHS [AI95357] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392	12	95	113	4	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 4	2005	123	3					368	371		10.1016/j.cell.2005.10.019	http://dx.doi.org/10.1016/j.cell.2005.10.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269328	Bronze			2022-12-01	WOS:000233264300005
J	Boule, JB; Vega, LR; Zakian, VA				Boule, JB; Vega, LR; Zakian, VA			The yeast Pif1p helicase removes telomerase from telomeric DNA	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; NUCLEOPROTEIN FILAMENTS; CHROMOSOME ENDS; IN-VIVO; ELONGATION; IDENTIFICATION; DISRUPTION; SUBFAMILY; COMPLEX	Telomeres are the physical ends of eukaryotic chromosomes. Genetic studies have established that the baker's yeast Pif1p DNA helicase is a negative regulator of telomerase, the specialized reverse transcriptase that maintains telomeric DNA, but the biochemical basis for this inhibition was unknown. Here we show that in vitro, Pif1p reduces the processivity of telomerase and releases telomerase from telomeric oligonucleotides. The released telomerase is enzymatically active because it is able to lengthen a challenger oligonucleotide. In vivo, overexpression of Pif1p reduces telomerase association with telomeres, whereas depleting cells of Pif1p increases the levels of telomere-bound Est1p, a telomerase subunit that is present on the telomere when telomerase is active. We propose that Pif1p helicase activity limits telomerase action both in vivo and in vitro by displacing active telomerase from DNA ends.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@molbio.princeton.edu	Boulé, Jean-Baptiste/M-8200-2017; Vega, Leticia/AAF-4981-2021	Boulé, Jean-Baptiste/0000-0002-0994-5831; Vega, Leticia/0000-0001-7605-1048				Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Forstemann K, 2001, MOL CELL BIOL, V21, P7277, DOI 10.1128/MCB.21.21.7277-7286.2001; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Hammond PW, 1997, MOL CELL BIOL, V17, P296, DOI 10.1128/MCB.17.1.296; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Mangahas JL, 2001, MOL BIOL CELL, V12, P4078, DOI 10.1091/mbc.12.12.4078; MANTELL LL, 1994, EMBO J, V13, P3211, DOI 10.1002/j.1460-2075.1994.tb06620.x; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Monson EK, 1997, PEZ FDN SYM, V8, P97; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.0.CO;2-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh SM, 2002, EUKARYOT CELL, V1, P967, DOI 10.1128/EC.1.6.967-977.2002; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	37	187	193	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2005	438	7064					57	61		10.1038/nature04091	http://dx.doi.org/10.1038/nature04091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16121131				2022-12-01	WOS:000232979000039
J	Fredricks, DN; Fiedler, TL; Marrazzo, JM				Fredricks, DN; Fiedler, TL; Marrazzo, JM			Molecular identification of bacteria associated with bacterial vaginosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			IMMUNODEFICIENCY-VIRUS TYPE-1; GRAM STAIN; DIAGNOSTIC-CRITERIA; VAGINAL FLORA; WOMEN; MICROFLORA; INFECTION; VAGINITIS; SYMPTOMS; RISK	BACKGROUND: Bacterial vaginosis affects millions of women and is associated with several serious health conditions. The cause of bacterial vaginosis remains poorly understood despite numerous studies based on cultures. Bacteria in microbial communities can be identified without cultivation by characterizing their ribosomal DNA (rDNA) sequences. METHODS: We identified bacteria in samples of vaginal fluid with a combination of broad-range polymerase-chain-reaction (PCR) amplification of 16S rDNA with clone analysis, bacterium-specific PCR assay of 16S rDNA, and fluorescence in situ hybridization (FISH) performed directly on vaginal fluid from 27 subjects with bacterial vaginosis and 46 without the condition. Twenty-one subjects were studied with the use of broad-range PCR of 16S rDNA, and 73 subjects were studied with the use of bacterium-specific PCR. RESULTS: Women without bacterial vaginosis had 1 to 6 vaginal bacterial species (phylotypes) in each sample (mean, 3.3), as detected by broad-range PCR of 16S rDNA, and lactobacillus species were the predominant bacteria noted (83 to 100 percent of clones). Women with bacterial vaginosis had greater bacterial diversity (P<0.001), with 9 to 17 phylotypes (mean, 12.6) detected per sample and newly recognized species present in 32 to 89 percent of clones per sample library (mean, 58 percent). Thirty-five unique bacterial species were detected in the women with bacterial vaginosis, including several species with no close cultivated relatives. Bacterium-specific PCR assays showed that several bacteria that had not been previously described were highly prevalent in subjects with bacterial vaginosis but rare in healthy controls. FISH confirmed that newly recognized bacteria detected by PCR corresponded to specific bacterial morphotypes visible in vaginal fluid. CONCLUSIONS: Women with bacterial vaginosis have complex vaginal infections with many newly recognized species, including three bacteria in the Clostridiales order that were highly specific for bacterial vaginosis.	Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA; Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Fredricks, DN (corresponding author), Fred Hutchinson Canc Res Ctr, Program Infect Dis, 1100 Fairview Ave N,D3-100,Box 19024, Seattle, WA 98109 USA.	dfredric@fhcrc.org		Fredricks, David/0000-0003-2735-6800; Marrazzo, Jeanne/0000-0002-9277-7364	NIAID NIH HHS [R03AI053250, R01 AI061628, R01AI052228] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052228, R03AI053250, R01AI061628] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Burton JP, 2004, J CLIN MICROBIOL, V42, P1829, DOI 10.1128/JCM.42.4.1829-1831.2004; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; HALLEN A, 1987, GENITOURIN MED, V63, P386; HILL GB, 1994, AM J OBSTET GYNECOL, V171, P1198, DOI 10.1016/0002-9378(94)90132-5; HILLIER SL, 1995, CLIN INFECT DIS, V20, pS276, DOI 10.1093/clinids/20.Supplement_2.S276; Hillier SL, 1996, AM J OBSTET GYNECOL, V175, P435, DOI 10.1016/S0002-9378(96)70158-8; HILLIER SL, 1991, GENITOURIN MED, V67, P26; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hugenholtz P, 1998, J BACTERIOL, V180, P6793, DOI 10.1128/JB.180.24.6793-6793.1998; Klebanoff MA, 2004, OBSTET GYNECOL, V104, P267, DOI 10.1097/01.AOG.0000134783.98382.b0; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Moodley P, 2002, J INFECT DIS, V185, P69, DOI 10.1086/338027; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Peipert JF, 2001, AM J OBSTET GYNECOL, V184, P856, DOI 10.1067/mob.2001.113847; Puapermpoonsiri S, 1996, CLIN INFECT DIS, V23, P748, DOI 10.1093/clinids/23.4.748; SOBEL JD, 1989, ANN INTERN MED, V111, P551, DOI 10.7326/0003-4819-111-7-551; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; SPIEGEL CA, 1983, J INFECT DIS, V148, P817, DOI 10.1093/infdis/148.5.817; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wang RC, 2000, INT J IND ENG-THEORY, V7, P5; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0	31	813	891	3	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2005	353	18					1899	1911		10.1056/NEJMoa043802	http://dx.doi.org/10.1056/NEJMoa043802			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	979VJ	16267321				2022-12-01	WOS:000232972800006
J	Hogan, SL; Falk, RJ; Chin, H; Cai, JW; Jennette, CE; Jennette, JC; Nachman, PH				Hogan, SL; Falk, RJ; Chin, H; Cai, JW; Jennette, CE; Jennette, JC; Nachman, PH			Predictors of relapse and treatment resistance in antineutrophil cytoplasmic anti body-associated small-vessel vasculitis	ANNALS OF INTERNAL MEDICINE			English	Article							AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS; MICROSCOPIC POLYANGIITIS; PULSE CYCLOPHOSPHAMIDE; RANDOMIZED-TRIAL; DISEASE-ACTIVITY; POLYARTERITIS-NODOSA; MAINTENANCE THERAPY; COMPETING RISKS; POOR-PROGNOSIS	Background: Predictors of treatment resistance and relapse have not been well described in antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis. Objective: To identify clinical, pathologic, and serologic predictors of treatment resistance and relapse in a community-based cohort of patients with ANCA-associated vasculitis. Design: Cohort of patients identified at or near the time of biopsy diagnosis and followed as clinically indicated. Setting: The Glomerular Disease Collaborative Network. Patients: 350 patients who received a new diagnosis of ANCA-associated vasculitis between 1985 and 2003 and were followed for a median of 49 months. Measurements: Patients were categorized according to whether they had antiproteinase-3 (anti-PR3) antibodies or antimyeloperoxidase (anti-MPO) antibodies. Organ involvement was determined by biopsy or by well-defined clinical criteria. Treatment resistance was defined as progressive decline in kidney function with active urine sediment or the persistence or appearance of extrarenal manifestations. Relapse was defined as the time to the resurgence of vasculitic symptoms. Results: Treatment resistance affected 23% of 334 treated patients and was associated with female sex, black ethnicity, and presentation with severe kidney disease (odds ratio per serum creatinine elevation of 100 mu mol/L [1.13 mg/dL], 1.28 [95% Ci, 1.16 to 1.39]). The following factors were associated with relapse in 258 (77%) patients who attained remission: seropositivity for anti-PR3 antibodies (hazard ratio, 1.87 [Cl, 1.11 to 3.14]) and disease of the lung (hazard ratio, 1.71 [Cl, 1.04 to 2.81]) or upper respiratory tract (hazard ratio, 1.73 [Cl, 1.04 to 2.88]). Relapses occurred in 26% of patients with no risk factors versus 73% of patients with all 3 risk factors (hazard ratio, 3.7 [Cl, 1.4 to 9.7]). Among 143 patients attaining remission who subsequently stopped all immunosuppressant therapy, relapse rates were similar for those who had received cyclophosphamide therapy for 6 months or less (34%) compared with those treated for a longer duration (35%), even after adjusting for risk factors for relapse (hazard ratio, 1.41 [Cl, 0.80 to 2.50]). Limitations: The cohort mostly included patients with biopsyproven kidney disease. Patients were not followed with uniform treatment protocols, and only limited information about their clinical course before diagnosis was available. Conclusions: Female or black patients, or those with severe kidney disease, may be resistant to initial treatment more often than other patients with ANCA-associated small-vessel vasculitis. increased risk for relapse appears to be related to the presence of lung or upper airway disease and anti-PR3 antibody seropositivity.	Univ N Carolina, Dept Med, Div Nephrol & Hypertens, Kidney Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Hogan, SL (corresponding author), Univ N Carolina, Dept Med, Div Nephrol & Hypertens, Kidney Ctr, CB 7156,7024B Burnett Womack, Chapel Hill, NC 27599 USA.	slh@med.unc.edu		Poulton, Caroline/0000-0002-8462-2661; Jennette, John Charles/0000-0002-8081-6565	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058335] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01-DK58335] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON PD, 1995, COMPETING RISKS SURV, P29; Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338; Bajema IM, 1999, KIDNEY INT, V56, P1751, DOI 10.1046/j.1523-1755.1999.00758.x; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; BRIEDIGKEIT L, 1993, POSTGRAD MED J, V69, P856, DOI 10.1136/pgmj.69.817.856; Cotch MF, 1996, ARTHRITIS RHEUM, V39, P87, DOI 10.1002/art.1780390112; DAVENPORT A, 1995, AM J NEPHROL, V15, P201, DOI 10.1159/000168833; de Groot K, 2001, NEPHROL DIAL TRANSPL, V16, P2018, DOI 10.1093/ndt/16.10.2018; DEOLIVIERA J, 1995, AM J KIDNEY DIS, V25, P380, DOI 10.1016/0272-6386(95)90098-5; FALK RJ, 1990, ANN INTERN MED, V113, P656, DOI 10.7326/0003-4819-113-9-656; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; Franssen CFM, 2000, KIDNEY INT, V57, P2195, DOI 10.1046/j.1523-1755.2000.00080.x; Gaskin G, 2002, J AM SOC NEPHROL, V13, p2A; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; GUILLEVIN L, 1995, ARTHRITIS RHEUM, V38, P1638, DOI 10.1002/art.1780381116; Guillevin L, 2003, ARTHRIT RHEUM-ARTHR, V49, P93, DOI 10.1002/art.10922; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; HAGEN EC, 1993, BLOOD, V81, P1996; Han WK, 2003, KIDNEY INT, V63, P1079, DOI 10.1046/j.1523-1755.2003.00821.x; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Hogan SL, 1996, J AM SOC NEPHROL, V7, P23; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JAYNE DRW, 1995, QJM-MON J ASSOC PHYS, V88, P127; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JENNETTE JC, 1989, AM J PATHOL, V135, P921; Kalbfleisch J., 2002, STAT ANAL FAILURE TI, P1, DOI DOI 10.1002/9781118032985; KERR GS, 1993, ADV EXP MED BIOL, V336, P411; Klemmer PJ, 2003, AM J KIDNEY DIS, V42, P1149, DOI 10.1053/j.ajkd.2003.08.015; Koldingsnes W, 2003, J RHEUMATOL, V30, P80; Kyndt X, 1999, AM J MED, V106, P527, DOI 10.1016/S0002-9343(99)00064-9; Langford CA, 2000, ARTHRITIS RHEUM, V43, P1836, DOI 10.1002/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R; Langford CA, 2004, CLIN EXP RHEUMATOL, V22, pS3; Langford CA, 2003, AM J MED, V114, P463, DOI 10.1016/S0002-9343(03)00077-9; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim LCL, 1999, AM J CLIN PATHOL, V111, P363; Metzler C, 2004, RHEUMATOLOGY, V43, P315, DOI 10.1093/rheumatology/keh009; Nachman PH, 1996, J AM SOC NEPHROL, V7, P33; Nowack R, 1999, J AM SOC NEPHROL, V10, P1965; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Popa ER, 2003, CLIN EXP IMMUNOL, V132, P496, DOI 10.1046/j.1365-2249.2003.02157.x; Reinhold-Keller E, 2002, ARTHRIT RHEUM-ARTHR, V47, P326, DOI 10.1002/art.10459; SAVAGE COS, 1985, Q J MED, V56, P467; Segelmark W, 2003, CLIN DIAGN LAB IMMUN, V10, P769, DOI 10.1128/CDLI.10.5.769-774.2003; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Stone JH, 2005, NEW ENGL J MED, V352, P351; Tervaert JWC, 1996, SARCOIDOSIS VASC DIF, V13, P241; TERVAERT JWC, 1990, LANCET, V336, P709; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Watts RA, 2001, ANN RHEUM DIS, V60, P1156; Watts RA, 2003, CURR OPIN RHEUMATOL, V15, P11, DOI 10.1097/00002281-200301000-00003	54	322	337	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2005	143	9					621	631		10.7326/0003-4819-143-9-200511010-00005	http://dx.doi.org/10.7326/0003-4819-143-9-200511010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	980PN	16263884				2022-12-01	WOS:000233030600001
J	Lie, DC; Colamarino, SA; Song, HJ; Desire, L; Mira, H; Consiglio, A; Lein, ES; Jessberger, S; Lansford, H; Dearie, AR; Gage, FH				Lie, DC; Colamarino, SA; Song, HJ; Desire, L; Mira, H; Consiglio, A; Lein, ES; Jessberger, S; Lansford, H; Dearie, AR; Gage, FH			Wnt signalling regulates adult hippocampal neurogenesis	NATURE			English	Article							GENE-TRANSFER; IN-VITRO; PROLIFERATION; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; CELLS; LINKS	The generation of new neurons from neural stem cells is restricted to two regions of the adult mammalian central nervous system: the subventricular zone of the lateral ventricle, and the subgranular zone of the hippocampal dentate gyrus(1). In both regions, signals provided by the microenvironment regulate the maintenance, proliferation and neuronal fate commitment of the local stem cell population(1). The identity of these signals is largely unknown. Here we show that adult hippocampal stem/progenitor cells (AHPs) express receptors and signalling components for Wnt proteins, which are key regulators of neural stem cell behaviour in embryonic development(2). We also show that the Wnt/beta-catenin pathway is active and that Wnt3 is expressed in the hippocampal neurogenic niche. Overexpression of Wnt3 is sufficient to increase neurogenesis from AHPs in vitro and in vivo. By contrast, blockade of Wnt signalling reduces neurogenesis from AHPs in vitro and abolishes neurogenesis almost completely in vivo. Our data show that Wnt signalling is a principal regulator of adult hippocampal neurogenesis and provide evidence that Wnt proteins have a role in adult hippocampal function.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; GSF Natl Res Ctr Environm & Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Inst Cell Engn, Baltimore, MD 21205 USA	Salk Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University; Johns Hopkins University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chichung.lie@gsf.de; gage@salk.edu	consiglio, antonella/G-1815-2016; Lie, Dieter Chichung/S-7914-2017; Lie, Dieter Chichung/AAS-8604-2020; Jessberger, Sebastian/AAJ-4032-2020; consiglio, antonella/AAA-5864-2019	consiglio, antonella/0000-0002-3988-6254; Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; consiglio, antonella/0000-0002-3988-6254; Jessberger, Sebastian/0000-0002-0056-8275; Mira, Helena/0000-0001-8574-9544	Telethon [GFP01004] Funding Source: Medline	Telethon(Fondazione Telethon)		Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MOON RT, 2004, SCI STKE, pTR5; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Schwartz KA, 1999, MOL CARCINOGEN, V25, P132, DOI 10.1002/(SICI)1098-2744(199906)25:2<132::AID-MC8>3.0.CO;2-2; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1	27	1126	1226	7	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2005	437	7063					1370	1375		10.1038/nature04108	http://dx.doi.org/10.1038/nature04108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251967				2022-12-01	WOS:000232829100057
J	Nielsen, TA; Stenstrom, P				Nielsen, TA; Stenstrom, P			hat are the memory sources of dreaming?	NATURE			English	Article							EYE-MOVEMENT SLEEP; REM-SLEEP; EPISODIC MEMORY; CONSOLIDATION; EVENTS; HIPPOCAMPUS; HUMANS; BRAIN; FMRI	Investigators since Freud have appreciated that memories of the people, places, activities and emotions of daily life are reflected in dreams but are typically so fragmented that their predictability is nil. The mechanisms that translate such memories into dream images remain largely unknown. New research targeting relationships between dreaming, memory and the hippocampus is producing a new theory to explain how, why and when we dream of waking life events.	Hop Sacre Coeur, Dream & Nightmare Lab, Montreal, PQ H4J 1C5, Canada; Hop Sacre Coeur, Dept Psychiat, Montreal, PQ H4J 1C5, Canada; Hop Sacre Coeur, Dept Psychol, Montreal, PQ H4J 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Nielsen, TA (corresponding author), Hop Sacre Coeur, Dream & Nightmare Lab, 5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	tore.nielsen@umontreal.ca	Nielsen, Tore/D-2418-2016	Nielsen, Tore/0000-0002-9372-8652				ARKIN AM, 1991, MIND SLEEP PSYCHOL P, P265; Bjorness TE, 2005, LEARN MEMORY, V12, P352, DOI 10.1101/lm.84805; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Braun AR, 1998, SCIENCE, V279, P91, DOI 10.1126/science.279.5347.91; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CAVALLERO C, 1990, SLEEP, V13, P449; Cipolli C, 2005, BRAIN RES BULL, V65, P97, DOI 10.1016/j.brainresbull.2004.10.014; Fiss H., 1977, SLEEP RES, V6, P122; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; Freud S., 1965, INTERPRETATION DREAM; Grenier J, 2005, MEM COGNITION, V33, P280, DOI 10.3758/BF03195317; Hall C., 1966, CONTENT ANAL DREAMS, DOI DOI 10.1192/BJP.112.490.963; Hartmann E., 1998, DREAMS NIGHTMARES NE; Heckers S, 2004, HIPPOCAMPUS, V14, P153, DOI 10.1002/hipo.10189; Hobson JA, 1998, CURR OPIN NEUROBIOL, V8, P239, DOI 10.1016/S0959-4388(98)80146-3; Johnson JD, 2005, MED HYPOTHESES, V64, P499, DOI 10.1016/j.mehy.2004.09.004; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Luo J, 2005, HIPPOCAMPUS, V15, P141, DOI 10.1002/hipo.20054; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Nielsen T. A., 1991, IMAGINATION COGNITIO, V11, P353, DOI [10.2190/3LVV-L5GY-UR5V-N0TG, DOI 10.2190/3LVV-L5GY-UR5V-N0TG]; Nielsen TA, 2004, J SLEEP RES, V13, P327, DOI 10.1111/j.1365-2869.2004.00421.x; Nielsen TA, 2004, SLEEP MED REV, V8, P403, DOI 10.1016/j.smrv.2004.06.005; Paller KA, 2004, LEARN MEMORY, V11, P664, DOI 10.1101/lm.75704; Payne JD, 2004, LEARN MEMORY, V11, P671, DOI 10.1101/lm.77104; Pesant N, 2004, CLIN PSYCHOL REV, V24, P489, DOI 10.1016/j.cpr.2004.05.002; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Popp CA, 1996, J CONSULT CLIN PSYCH, V64, P1073, DOI 10.1037/0022-006X.64.5.1073; POWELL RA, 1995, PERCEPT MOTOR SKILL, V81, P95, DOI 10.2466/pms.1995.81.1.95; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Smith C, 2004, SLEEP, V27, P60; Smith C., 2003, SLEEP BRAIN PLASTICI, P117; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; TORDA C, 1969, ACTA PSYCHIAT SCAND, V45, P277, DOI 10.1111/j.1600-0447.1969.tb07128.x; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114	41	103	103	6	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1286	1289		10.1038/nature04288	http://dx.doi.org/10.1038/nature04288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977UQ	16251954				2022-12-01	WOS:000232829100042
J	Rubenfeld, GD; Caldwell, E; Peabody, E; Weaver, J; Martin, DP; Neff, M; Stern, EJ; Hudson, LD				Rubenfeld, GD; Caldwell, E; Peabody, E; Weaver, J; Martin, DP; Neff, M; Stern, EJ; Hudson, LD			Incidence and outcomes of acute lung injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; QUALITY-OF-LIFE; UNITED-STATES; SEVERE SEPSIS; MORTALITY; EPIDEMIOLOGY; SURVIVORS; FAILURE; DEFINITIONS; CARE	BACKGROUND: Acute lung injury is a critical illness syndrome consisting of acute hypoxemic respiratory failure with bilateral pulmonary infiltrates that are not attributed to left atrial hypertension. Despite recent advances in our understanding of the mechanism and treatment of acute lung injury, its incidence and outcomes in the United States have been unclear. METHODS: We conducted a prospective, population-based, cohort study in 21 hospitals in and around King County, Washington, from April 1999 through July 2000, using a validated screening protocol to identify patients who met the consensus criteria for acute lung injury. RESULTS: A total of 1113 King County residents undergoing mechanical ventilation met the criteria for acute lung injury and were 15 years of age or older. On the basis of this figure, the crude incidence of acute lung injury was 78.9 per 100,000 person-years and the age-adjusted incidence was 86.2 per 100,000 person-years. The in-hospital mortality rate was 38.5 percent. The incidence of acute lung injury increased with age from 16 per 100,000 person-years for those 15 through 19 years of age to 306 per 100,000 person-years for those 75 through 84 years of age. Mortality increased with age from 24 percent for patients 15 through 19 years of age to 60 percent for patients 85 years of age or older (P<0.001). We estimate that each year in the United States there are 190,600 cases of acute lung injury, which are associated with 74,500 deaths and 3.6 million hospital days. CONCLUSIONS: Acute lung injury has a substantial impact on public health, with an incidence in the United States that is considerably higher than previous reports have suggested.	Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Radiol, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98195 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rubenfeld, GD (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Box 359762,325 9th Ave, Seattle, WA 98104 USA.	nodrog@u.washington.edu			NHLBI NIH HHS [HL30542] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL030542] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brower RG, 2004, NEW ENGL J MED, V351, P327; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Ferguson ND, 2002, INTENS CARE MED, V28, P1073, DOI 10.1007/s00134-002-1354-y; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Gowda MS, 1997, CRIT CARE MED, V25, P41, DOI 10.1097/00003246-199701000-00010; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hughes M, 2003, ANAESTHESIA, V58, P838, DOI 10.1046/j.1365-2044.2003.03287.x; LEWANDOWSKI K, 1995, AM J RESP CRIT CARE, V151, P1121; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; *NAT HEART LUNG I, 1972, PUBL NIH; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Rainer TH, 1999, RESUSCITATION, V42, P187, DOI 10.1016/S0300-9572(99)00089-1; RUBENFELD GD, 2002, LUNG BIOL HLTH DIS, P37; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]	33	2620	2799	6	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2005	353	16					1685	1693		10.1056/NEJMoa050333	http://dx.doi.org/10.1056/NEJMoa050333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975IC	16236739				2022-12-01	WOS:000232653200008
J	Hossain, P; Sachdev, A; Malik, RA				Hossain, P; Sachdev, A; Malik, RA			Early detection of diabetic peripheral neuropathy with corneal confocal microscopy	LANCET			English	Editorial Material							SENSITIVITY; MELLITUS; RATS		Univ Southampton, Southampton Eye Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Royal Liverpool Hosp, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England; Manchester Royal Infirm, Acad Dept Med, Manchester M13 9WL, Lancs, England	University of Southampton; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester	Hossain, P (corresponding author), Univ Southampton, Southampton Eye Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	parwez@soton.ac.uk	Malik, Rayaz/H-9231-2019; Hossain, Parwez/AAB-6065-2022; Sachdev, Atul/AAE-4831-2020	Malik, Rayaz/0000-0002-7188-8903; Hossain, Parwez/0000-0002-3131-2395				Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Bragheeth MA, 2005, BRIT J OPHTHALMOL, V89, P580, DOI 10.1136/bjo.2004.046888; Greene DA, 1999, NEUROLOGY, V53, P580, DOI 10.1212/WNL.53.3.580; Grupcheva CN, 2002, CLIN EXP OPHTHALMOL, V30, P187, DOI 10.1046/j.1442-9071.2002.00507.x; Holland NR, 1997, NEUROLOGY, V48, P708, DOI 10.1212/WNL.48.3.708; Hosotani H, 1996, CURR EYE RES, V15, P1005, DOI 10.3109/02713689609017648; HYNDIUK RA, 1977, ARCH OPHTHALMOL-CHIC, V95, P2193; Iqbal I, 2005, DIABETES S1, V54, P871; Jacot JL, 1998, J OCUL PHARMACOL TH, V14, P169, DOI 10.1089/jop.1998.14.169; Jalbert I, 2003, BRIT J OPHTHALMOL, V87, P225, DOI 10.1136/bjo.87.2.225; Kallinikos P, 2004, INVEST OPHTH VIS SCI, V45, P418, DOI 10.1167/iovs.03-0637; Kawabuchi M, 1998, RESTOR NEUROL NEUROS, V13, P117; Malik RA, 2001, ACTA NEUROPATHOL, V101, P367; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Rosenberg ME, 2000, INVEST OPHTH VIS SCI, V41, P2915; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Urban P P, 1999, Electromyogr Clin Neurophysiol, V39, P267	19	122	128	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2005	366	9494					1340	1343		10.1016/S0140-6736(05)67546-0	http://dx.doi.org/10.1016/S0140-6736(05)67546-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	973ZW	16226599				2022-12-01	WOS:000232562100008
J	Keller, HU; Jorda, L; Kuppers, M; Gutierrez, PJ; Hviid, SF; Knollenberg, J; Lara, LM; Sierks, H; Barbieri, C; Lamy, P; Rickman, H; Rodrigo, R				Keller, HU; Jorda, L; Kuppers, M; Gutierrez, PJ; Hviid, SF; Knollenberg, J; Lara, LM; Sierks, H; Barbieri, C; Lamy, P; Rickman, H; Rodrigo, R			Deep impact observations by OSIRIS onboard the Rosetta spacecraft	SCIENCE			English	Article							FRAGMENTATION; NUCLEUS; RATES; DUST	The OSIRIS cameras (optical, spectroscopic, and infrared remote imaging system) onboard the European Space Agency's Rosetta spacecraft observed comet 9P/Tempel 1 for 17 days continuously around the time of NASA's Deep Impact mission. The cyanide-to-water production ratio was slightly enhanced in the impact cloud, compared with that of normal comet activity. Dust particles were flowing outward in the coma at >160 meters per second, accelerated by the gas. The slope of the brightness increase showed a dip about 200 seconds after the impact. Dust Af rho values before and long after the impact confirm the slight decrease of cometary activity. The dust-to-water mass ratio was much larger than 1.	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Lab Astrophys Marseille, F-13376 Marseille, France; CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; Deutsch Zentrum Luft & Raumfahrt, Inst Planetenforsch, D-12489 Berlin, Germany; Univ Padua, Dipartimento Astron, I-35100 Padua, Italy; Univ Padua, Ctr Interdipartimentale Studi & Attivita Spaziali, I-35100 Padua, Italy; Uppsala Astron Observ, S-75120 Uppsala, Sweden	Max Planck Society; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Helmholtz Association; German Aerospace Centre (DLR); University of Padua; University of Padua; Uppsala University	Keller, HU (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	keller@mps.mpg.de	Gutiérrez, Pedro J/AAJ-6177-2020; Rickman, Hans/X-7631-2018; Jorda, Laurent/AAA-1718-2021; Lara, Luisa M/F-5614-2012	Gutiérrez, Pedro J/0000-0002-7332-6269; Rickman, Hans/0000-0002-9603-6619; Lara, Luisa M/0000-0002-7184-920X				AHEARN MF, 1984, ASTRON J, V89, P579, DOI 10.1086/113552; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; COMBI MR, 1994, ASTRON J, V108, P304, DOI 10.1086/117070; COMBI MR, 2004, COMETS, V2, P523; CROVISIER J, 1994, J GEOPHYS RES-PLANET, V99, P3777, DOI 10.1029/93JE02088; FAMHAM T, COMMUNICATION; FESTOU MC, 1984, ASTRON ASTROPHYS, V134, pL4; Haser L., 1957, B SOC R SCI 51 GE, V43, P740; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; HUEBNER WF, 1992, AP SS, V195, P7; KELLER HU, 1990, ASTRON ASTROPHYS, V227, pL1; KONNO I, 1993, ICARUS, V101, P84, DOI 10.1006/icar.1993.1008; KUPPERS M, IN PRESS NATURE; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; Rauer H, 2003, ASTRON ASTROPHYS, V397, P1109, DOI 10.1051/0004-6361:20021550; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; SWAMY KSK, 1997, WORLD SCI SERIES AST, V2	17	50	51	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					281	283		10.1126/science.1119020	http://dx.doi.org/10.1126/science.1119020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150976	Green Published			2022-12-01	WOS:000232670100042
J	Liu, QS; Pu, L; Poo, MM				Liu, QS; Pu, L; Poo, MM			Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; GAMMA-VINYL GABA; FEEDFORWARD INHIBITION; SYNAPTIC PLASTICITY; VISUAL-CORTEX; ADDICTION; RAT; DRUGS; ABUSE	Drugs of abuse are known to cause persistent modification of neural circuits, leading to addictive behaviours(1-5). Changes in synaptic plasticity in dopamine neurons of the ventral tegmental area (VTA) may contribute to circuit modification induced by many drugs of abuse, including cocaine(6-13). Here we report that, following repeated exposure to cocaine in vivo, excitatory synapses to rat VTA dopamine neurons become highly susceptible to the induction of long-term potentiation (LTP) by correlated pre- and postsynaptic activity. This facilitated LTP induction is caused by cocaine-induced reduction of GABA(A) (gamma-aminobutyric acid) receptor- mediated inhibition of these dopamine neurons. In midbrain slices from rats treated with saline or a single dose of cocaine, LTP could not be induced in VTA dopamine neurons unless GABA-mediated inhibition was reduced by bicuculline or picrotoxin. However, LTP became readily inducible in slices from rats treated repeatedly with cocaine; this LTP induction was prevented by enhancing GABA-mediated inhibition using diazepam. Furthermore, repeated cocaine exposure reduced the amplitude of GABA-mediated synaptic currents and increased the probability of spike initiation in VTA dopamine neurons. This cocaine-induced enhancement of synaptic plasticity in the VTA may be important for the formation of drug-associated memory.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	qsliu@berkeley.edu; mpoo@berkeley.edu		Pu, Lu/0000-0001-5370-2557	NINDS NIH HHS [R01 NS037831, R01 NS036999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831, R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brodie JD, 2003, SYNAPSE, V50, P261, DOI 10.1002/syn.10278; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Gardner EL, 2002, SYNAPSE, V46, P240, DOI 10.1002/syn.10138; HERRON CE, 1985, NEUROSCI LETT, V61, P255, DOI 10.1016/0304-3940(85)90473-2; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 1999, J NEUROSCI, V19, P9780; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SCHULTZ W, 1993, J NEUROSCI, V13, P900; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Thompson AM, 2002, NEUROPHARMACOLOGY, V42, P1039, DOI 10.1016/S0028-3908(02)00059-X; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	30	243	246	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1027	1031		10.1038/nature04050	http://dx.doi.org/10.1038/nature04050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222299	Green Accepted			2022-12-01	WOS:000232496100046
J	Epstein, PR				Epstein, PR			Climate change and human health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Epstein, PR (corresponding author), Harvard Univ, Sch Med, Ctr Hlth & Global Environm, Boston, MA 02115 USA.							Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Hassol S., 2004, ACIA IMPACTS WARMING; HOUGHTON JT, 2001, 3 INT PAN CLIM CHANG; LEAF A, 1989, NEW ENGL J MED, V321, P1577, DOI 10.1056/NEJM198912073212305; McMichael AJ, 2003, CLIMATE CHANGE HUMAN, P250	5	166	169	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2005	353	14					1433	1436		10.1056/NEJMp058079	http://dx.doi.org/10.1056/NEJMp058079			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970LZ	16207843				2022-12-01	WOS:000232313000001
J	Sanders, GD; Hlatky, MA; Owens, DK				Sanders, GD; Hlatky, MA; Owens, DK			Cost-effectiveness of implantable cardioverter-defibrillators	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-LIFE; PROPHYLACTIC USE; RANDOMIZED-TRIAL; HIGH-RISK; AMIODARONE; SURVIVAL; PREVENTION; LONGEVITY	BACKGROUND: Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter-defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ventricular systolic dysfunction but who have not had a life-threatening ventricular arrhythmia. We assessed the cost-effectiveness of the ICD in the populations represented in these primary-prevention trials. METHODS: We developed a Markov model of the cost, quality of life, survival, and incremental cost-effectiveness of the prophylactic implantation of an ICD, as compared with control therapy, among patients with survival and mortality rates similar to those in each of the clinical trials. We modeled the efficacy of the ICD as a reduction in the relative risk of death on the basis of the hazard ratios reported in the individual clinical trials. RESULTS: Use of the ICD increased lifetime costs in every trial. Two trials -- the Coronary Artery Bypass Graft (CABG) Patch Trial and the Defibrillator in Acute Myocardial Infarction Trial (DINAMIT) -- found that the prophylactic implantation of an ICD did not reduce the risk of death and thus was both more expensive and less effective than control therapy. For the other six trials -- the Multicenter Automatic Defibrillator Implantation Trial (MADIT) I, MADIT II, the Multicenter Unsustained Tachycardia Trial (MUSTT), the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial, the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial, and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) -- the use of an ICD was projected to add between 1.01 and 2.99 quality-adjusted life-years (QALY) and between $68,300 and $101,500 in cost. Using base-case assumptions, we found that the cost-effectiveness of the ICD as compared with control therapy in these six populations ranged from $34,000 to $70,200 per QALY gained. Sensitivity analyses showed that this cost-effectiveness ratio would remain below $100,000 per QALY as long as the ICD reduced mortality for seven or more years. CONCLUSIONS: Prophylactic implantation of an ICD has a cost-effectiveness ratio below $100,000 per QALY gained in populations in which a significant device-related reduction in mortality has been demonstrated.	Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Duke University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Sanders, GD (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	gillian.sanders@duke.edu		Hlatky, Mark/0000-0003-4686-9441				Al-Khatib SM, 2005, AM HEART J, V149, P1020, DOI 10.1016/j.ahj.2005.02.005; [Anonymous], 2004, Technol Eval Cent Assess Program Exec Summ, V19, P1; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 2000, NEW ENGL J MED, V343, P1813; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; EVERY NR, 1995, J AM COLL CARDIOL, V26, P401, DOI 10.1016/0735-1097(95)80013-7; Every NR, 1997, CIRCULATION, V96, P1770, DOI 10.1161/01.CIR.96.6.1770; *EX OFF PRES US, BUDG US GOV; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; GABRY MD, 1987, J AM COLL CARDIOL, V9, P1349, DOI 10.1016/S0735-1097(87)80477-1; Gold MR., 1996, COST EFFECTIVENESS H; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Hauser RG, 2005, J AM COLL CARDIOL, V45, P2022, DOI 10.1016/j.jacc.2005.02.077; Hlatky MA, 2005, HEALTH AFFAIR, V24, P42, DOI 10.1377/hlthaff.24.1.42; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hsu J, 2002, AM HEART J, V144, P404, DOI 10.1067/mhj.2002.125497; Irvine J, 2002, AM HEART J, V144, P282, DOI 10.1067/mhj.2002.124049; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kuntz KM, 1996, CIRCULATION, V94, P957, DOI 10.1161/01.CIR.94.5.957; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; Lewis EF, 2001, J HEART LUNG TRANSPL, V20, P1016, DOI 10.1016/S1053-2498(01)00298-4; Lipscomb J, 1996, COST EFFECTIVENESS H, P214; Mankiw N.G., 2001, PRINCIPLES EC; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; *MEDTR, 2005, INTR DUAL CHAMB ICD; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MOYE LA, 1991, AM J CARDIOL, V68, pD70; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; SAKSENA S, 1992, J AM COLL CARDIOL, V19, P490, DOI 10.1016/S0735-1097(10)80260-8; Sanders GD, 2001, ANN INTERN MED, V135, P870, DOI 10.7326/0003-4819-135-10-200111200-00007; Shah M, 2005, AM HEART J, V149, P242; SIEBELS J, 1994, AM HEART J, V127, P1139, DOI 10.1016/0002-8703(94)90101-5; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; ZIPES DP, 1995, CIRCULATION, V92, P59, DOI 10.1161/01.CIR.92.1.59	42	389	392	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2005	353	14					1471	1480		10.1056/NEJMsa051989	http://dx.doi.org/10.1056/NEJMsa051989			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LZ	16207849				2022-12-01	WOS:000232313000007
J	Hu, DL; Bush, JWM				Hu, DL; Bush, JWM			Meniscus-climbing insects	NATURE			English	Article							WATER-SURFACE; LOCOMOTION	Water-walking insects and spiders rely on surface tension for static weight support(1,2) and use a variety of means to propel themselves along the surface(3-8). To pass from the water surface to land, they must contend with the slippery slopes of the menisci that border the water's edge. The ability to climb menisci is a skill exploited by water-walking insects as they seek land in order to lay eggs or avoid predators(4); moreover, it was a necessary adaptation for their ancestors as they evolved from terrestrials to live exclusively on the water surface(3). Many millimetre-scale water-walking insects are unable to climb menisci using their traditional means of propulsion(2,3,9). Through a combined experimental and theoretical study, here we investigate the meniscus-climbing technique that such insects use. By assuming a fixed body posture, they deform the water surface in order to generate capillary forces(10-13): they thus propel themselves laterally without moving their appendages. We develop a theoretical model for this novel mode of propulsion and use it to rationalize the climbers' characteristic body postures and predict climbing trajectories consistent with those reported here and elsewhere(3).	MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bush, JWM (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	bush@math.mit.edu						Alexander RM., 2003, PRINCIPLES ANIMAL LO; Andersen N.M., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P337; Andersen N.M, 1982, SEMIAQUATIC BUGS HEM; Baudoin R, 1955, B BIOL FR BELG, V89, P16; BIEWENER A, 2003, ANIMAL LOCMOTION; Brocher Frank, 1910, Annales de Biologie Lacustre, V4; BUSH JWM, IN PRESS ANN REV FLU, V38, P339; CHAN DYC, 1981, J COLLOID INTERF SCI, V79, P410, DOI 10.1016/0021-9797(81)90092-8; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; GIFFORD WA, 1971, CHEM ENG SCI, V26, P287, DOI 10.1016/0009-2509(71)83003-8; Gilles de Gennes P, 2003, DROPS BUBBLES PEARLS; Grzybowski BA, 2001, J PHYS CHEM B, V105, P404, DOI 10.1021/jp0026383; Hu DL, 2003, NATURE, V424, P663, DOI 10.1038/nature01793; Kralchevsky PA, 2001, CURR OPIN COLLOID IN, V6, P383, DOI 10.1016/S1359-0294(01)00105-4; Lauga E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238301; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Miyamoto S., 1955, Kontyu Tokyo, V23, P45; NICOLSON MM, 1949, P CAMB PHILOS SOC, V45, P288, DOI 10.1017/S0305004100024841; Suter RB, 1997, J EXP BIOL, V200, P2523; Suter RB, 1999, J EXP BIOL, V202, P2771; Suter RB, 2000, J ARACHNOL, V28, P201, DOI 10.1636/0161-8202(2000)028[0201:PAOTWS]2.0.CO;2; Vella D, 2005, AM J PHYS, V73, P817, DOI 10.1119/1.1898523; VOGEL S, 2003, BIOMECHANICS LIFES P; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	25	195	200	6	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					733	736		10.1038/nature03995	http://dx.doi.org/10.1038/nature03995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193052				2022-12-01	WOS:000232157900052
J	Torres-Larios, A; Swinger, KK; Krasilnikov, AS; Pan, T; Mondragon, A				Torres-Larios, A; Swinger, KK; Krasilnikov, AS; Pan, T; Mondragon, A			Crystal structure of the RNA component of bacterial ribonuclease P	NATURE			English	Article							PHOTOAFFINITY CROSS-LINKING; MAGNESIUM-IONS; RIBONUCLEOPROTEIN ENZYME; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; SUBSTRATE; RIBOZYME; RECOGNITION; BINDING; DOMAIN	Transfer RNA ( tRNA) is produced as a precursor molecule that needs to be processed at its 30 and 50 ends. Ribonuclease P is the sole endonuclease responsible for processing the 50 end of tRNA by cleaving the precursor and leading to tRNA maturation. It was one of the first catalytic RNA molecules identified(1) and consists of a single RNA component in all organisms and only one protein component in bacteria. It is a true multi- turnover ribozyme and one of only two ribozymes ( the other being the ribosome) that are conserved in all kingdoms of life. Here we show the crystal structure at 3.85 angstrom resolution of the RNA component of Thermotoga maritima ribonuclease P. The entire RNA catalytic component is revealed, as well as the arrangement of the two structural domains. The structure shows the general architecture of the RNA molecule, the inter- and intra- domain interactions, the location of the universally conserved regions, the regions involved in pre- tRNA recognition and the location of the active site. A model with bound tRNA is in agreement with all existing data and suggests the general basis for RNA - RNA recognition by this ribozyme.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu		Torres-Larios, Alfredo/0000-0002-0702-350X				Beebe JA, 1996, BIOCHEMISTRY-US, V35, P10493, DOI 10.1021/bi960870m; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen JL, 1997, RNA, V3, P557; Christian EL, 2002, EMBO J, V21, P2253, DOI 10.1093/emboj/21.9.2253; Christian EL, 2002, METHODS, V28, P307, DOI 10.1016/S1046-2023(02)00238-4; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; GUERRIERTAKADA C, 1992, P NATL ACAD SCI USA, V89, P1266, DOI 10.1073/pnas.89.4.1266; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Harris ME, 1997, RNA, V3, P561; HARRIS ME, 1994, EMBO J, V13, P3953, DOI 10.1002/j.1460-2075.1994.tb06711.x; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Kurz JC, 2000, CURR OPIN CHEM BIOL, V4, P553, DOI 10.1016/S1367-5931(00)00131-9; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Massire C, 1997, RNA, V3, P553; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; PERREAULT JP, 1993, J MOL BIOL, V230, P750, DOI 10.1006/jmbi.1993.1197; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; Siegel RW, 1996, RNA, V2, P452; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; Tsai HY, 2003, J MOL BIOL, V325, P661, DOI 10.1016/S0022-2836(02)01267-6; Zahler NH, 2003, RNA, V9, P734, DOI 10.1261/rna.5220703	30	178	184	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					584	587		10.1038/nature04074	http://dx.doi.org/10.1038/nature04074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16113684				2022-12-01	WOS:000232004800057
J	Werner, N; Kosiol, S; Schiegl, T; Ahlers, P; Walenta, K; Link, A; Bohm, M; Nickenig, G				Werner, N; Kosiol, S; Schiegl, T; Ahlers, P; Walenta, K; Link, A; Bohm, M; Nickenig, G			Circulating endothelial progenitor cells and cardiovascular outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; NEOINTIMA FORMATION; TRANSPLANTATION; MOBILIZATION; REENDOTHELIALIZATION; NEOVASCULARIZATION; ATHEROSCLEROSIS; ANGIOGENESIS; REGENERATION	BACKGROUND: Endothelial progenitor cells derived from bone marrow are believed to support the integrity of the vascular endothelium. The number and function of endothelial progenitor cells correlate inversely with cardiovascular risk factors, but the prognostic value associated with circulating endothelial progenitor cells has not been defined. METHODS: The number of endothelial progenitor cells positive for CD34 and kinase insert domain receptor (KDR) was determined with the use of flow cytometry in 519 patients with coronary artery disease as confirmed on angiography. After 12 months, we evaluated the association between baseline levels of endothelial progenitor cells and death from cardiovascular causes, the occurrence of a first major cardiovascular event (myocardial infarction, hospitalization, revascularization, or death from cardiovascular causes), revascularization, hospitalization, and death from all causes. RESULTS: A total of 43 participants died, 23 from cardiovascular causes. A first major cardiovascular event occurred in 214 patients. The cumulative event-free survival rate increased stepwise across three increasing baseline levels of endothelial progenitor cells in an analysis of death from cardiovascular causes, a first major cardiovascular event, revascularization, and hospitalization. After adjustment for age, sex, vascular risk factors, and other relevant variables, increased levels of endothelial progenitor cells were associated with a reduced risk of death from cardiovascular causes (hazard ratio, 0.31; 95 percent confidence interval, 0.16 to 0.63; P=0.001), a first major cardiovascular event (hazard ratio, 0.74; 95 percent confidence interval, 0.62 to 0.89; P=0.002), revascularization (hazard ratio, 0.77; 95 percent confidence interval, 0.62 to 0.95; P=0.02), and hospitalization (hazard ratio, 0.76; 95 percent confidence interval, 0.63 to 0.94; P=0.01). Endothelial progenitor-cell levels were not predictive of myocardial infarction or of death from all causes. CONCLUSIONS: The level of circulating CD34+KDR+ endothelial progenitor cells predicts the occurrence of cardiovascular events and death from cardiovascular causes and may help to identify patients at increased cardiovascular risk.	Univ Saarland, Dept Internal Med, Div Cardiol Angiol & Intens Care Med, D-6650 Homburg, Germany	Saarland University	Nickenig, G (corresponding author), Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany.	nickenig@med-in.uni-sb.de	Böhm, Michael/C-3638-2011					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Gehling UM, 2000, BLOOD, V95, P3106; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gill M, 2001, CIRC RES, V88, P167; Gunsilius E, 2001, CIRC RES, V88, pE1; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SCHWARTZ SM, 1976, P NATL ACAD SCI USA, V73, P651, DOI 10.1073/pnas.73.2.651; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	36	1719	1844	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2005	353	10					999	1007		10.1056/NEJMoa043814	http://dx.doi.org/10.1056/NEJMoa043814			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961YQ	16148285				2022-12-01	WOS:000231698200005
J	Guzman, MG				Guzman, MG			Deciphering dengue: The Cuban experience	SCIENCE			English	Article									Inst Med Trop Pedro Kouri, Dept Virol, PAHO WHO Collaborating Ctr Viral Dis, Havana, Cuba; Inst Med Trop Pedro Kouri, PAHO WHO Collaborating Ctr Study Dengue & Its Con, Havana, Cuba		Guzman, MG (corresponding author), Inst Med Trop Pedro Kouri, Dept Virol, PAHO WHO Collaborating Ctr Viral Dis, Autopista Novia del Mediodia,Km 6-1 2,POB Mariano, Havana, Cuba.	lupe@ipk.sld.cu						HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Ligon B Lee, 2004, Semin Pediatr Infect Dis, V15, P199, DOI 10.1053/j.spid.2004.08.001; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; ROSEN L, 1989, REV INFECT DIS, V11, pS840	4	35	40	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1495	1497		10.1126/science.1115177	http://dx.doi.org/10.1126/science.1115177			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141052				2022-12-01	WOS:000231715000028
J	Macbeth, MR; Schubert, HL; VanDemark, AP; Lingam, AT; Hill, CP; Bass, BL				Macbeth, MR; Schubert, HL; VanDemark, AP; Lingam, AT; Hill, CP; Bass, BL			Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing	SCIENCE			English	Article							PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME; COMPLEX; BINDING; POLYPHOSPHATES; METHYLATION; MYSTERIES	We report the crystal structure of the catalytic domain of human ADAR2, an RNA editing enzyme, at 1.7 angstrom resolution. The structure reveals a zinc ion in the active site and suggests how the substrate adenosine is recognized. Unexpectedly, inositol hexakisphosphate (IP6) is buried within the enzyme core, contributing to the protein fold. Although there are no reports that adenosine deaminases that act on RNA (ADARs) require a cofactor, we show that IP6 is required for activity. Amino acids that coordinate IP6 in the crystal structure are conserved in some adenosine deaminases that act on transfer RNA (tRNA) (ADATs), related enzymes that edit tRNA. Indeed, IP6 is also essential for in vivo and in vitro deamination of adenosine 37 of tRNA(ala) by ADAT1.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.	chris@biochem.utah.edu; bbass@howard.genetics.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056775, R01GM044073] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056775, R01 GM044073, GM44073, GM56775] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNONE A, 1974, NATURE, V249, P34, DOI 10.1038/249034a0; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carlow DC, 1999, BIOCHEMISTRY-US, V38, P12258, DOI 10.1021/bi990819t; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9; Grosjean H., 1998, MODULATION ROLE MODI, P113; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; KROGER M, 1979, BIOCHEMISTRY-US, V18, P3493, DOI 10.1021/bi00583a009; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; Macbeth MR, 2004, RNA, V10, P1563, DOI 10.1261/rna.7920904; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; OConnell MA, 1997, J BIOL CHEM, V272, P473; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stephens OM, 2000, BIOCHEMISTRY-US, V39, P12243, DOI 10.1021/bi0011577; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Valastro B, 2001, HIPPOCAMPUS, V11, P673, DOI 10.1002/hipo.1082; WEDEKIND JE, 1995, BIOCHEMISTRY-US, V34, P11049, DOI 10.1021/bi00035a010; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	41	298	316	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1534	1539		10.1126/science.1113150	http://dx.doi.org/10.1126/science.1113150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141067	Green Accepted			2022-12-01	WOS:000231715000042
J	Bell, T; Newman, JA; Silverman, BW; Turner, SL; Lilley, AK				Bell, T; Newman, JA; Silverman, BW; Turner, SL; Lilley, AK			The contribution of species richness and composition to bacterial services	NATURE			English	Article							MICROBIAL COMMUNITY STRUCTURE; TERRESTRIAL ECOSYSTEM; CURRENT KNOWLEDGE; BIODIVERSITY; DIVERSITY; SOIL; PRODUCTIVITY; ECOLOGY	Bacterial communities provide important services. They break down pollutants, municipal waste and ingested food, and they are the primary means by which organic matter is recycled to plants and other autotrophs. However, the processes that determine the rate at which these services are supplied are only starting to be identified. Biodiversity influences the way in which ecosystems function(1), but the form of the relationship between bacterial biodiversity and functioning remains poorly understood. Here we describe a manipulative experiment that measured how biodiversity affects the functioning of communities containing up to 72 bacterial species constructed from a collection of naturally occurring culturable bacteria. The experimental design allowed us to manipulate large numbers of bacterial species selected at random from those that were culturable. We demonstrate that there is a decelerating relationship between community respiration and increasing bacterial diversity. We also show that both synergistic interactions among bacterial species and the composition of the bacterial community are important in determining the level of ecosystem functioning.	NERC, Ctr Ecol & Hydrol, Mol Microbial Ecol Grp, Oxford OX1 3SR, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; St Peters Coll, Oxford, England; Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Oxford; University of Oxford; University of Guelph	Lilley, AK (corresponding author), NERC, Ctr Ecol & Hydrol, Mol Microbial Ecol Grp, Mansfield Rd, Oxford OX1 3SR, England.	akl@ceh.ac.uk	Turner, Sarah/K-4683-2012; Silverman, Bernard W/K-6417-2012; Newman, Jonathan/A-5932-2008	Turner, Sarah/0000-0002-8937-6922; Silverman, Bernard W/0000-0002-4059-2376; Newman, Jonathan/0000-0003-3155-4084; Bell, Thomas/0000-0002-2615-3932				Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cavigelli MA, 2001, SOIL BIOL BIOCHEM, V33, P297, DOI 10.1016/S0038-0717(00)00141-3; Cavigelli MA, 2000, ECOLOGY, V81, P1402; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Curtis TP, 2003, ENVIRON SCI TECHNOL, V37, p64A, DOI 10.1021/es0323493; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Garland JL, 1999, FEMS MICROBIOL ECOL, V30, P333, DOI 10.1111/j.1574-6941.1999.tb00661.x; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Griffiths BS, 2004, MICROB ECOL, V47, P104, DOI 10.1007/s00248-002-2043-7; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KITCHING RL, 1971, J ANIM ECOL, V40, P281, DOI 10.2307/3247; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; SASSER M, 2001, 101 MIDI INC; Schimel JP, 1998, GLOBAL CHANGE BIOL, V4, P745, DOI 10.1046/j.1365-2486.1998.00195.x; THOMPSON IP, 1993, FEMS MICROBIOL ECOL, V102, P75, DOI 10.1016/0378-1097(93)90002-J; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Yin B, 2000, APPL ENVIRON MICROB, V66, P4361, DOI 10.1128/AEM.66.10.4361-4365.2000; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zibilske L.M, 1994, METHODS SOIL ANAL 2, P835	30	622	677	17	459	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1157	1160		10.1038/nature03891	http://dx.doi.org/10.1038/nature03891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121181				2022-12-01	WOS:000231416600046
J	Pitman, RJ; Cooper, BS; Trotter, CL; Gay, NJ; Edmunds, WJ				Pitman, RJ; Cooper, BS; Trotter, CL; Gay, NJ; Edmunds, WJ			Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 5EQ, England	Health Protection Agency	Pitman, RJ (corresponding author), Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 5EQ, England.	richard.pitman@hpa.org.uk	Trotter, Caroline L/H-5077-2013	Trotter, Caroline/0000-0003-4000-2708; Cooper, Ben/0000-0002-9445-7217				KUK AYC, 2005, IN PRESS STAT MED; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; World Health Organization, COMM DIS SURV RESP S	5	61	65	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 26	2005	331	7527					1242	1243		10.1136/bmj.38573.696100.3A	http://dx.doi.org/10.1136/bmj.38573.696100.3A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16176938	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000233606800020
J	Yoo, AS; Greenwald, I				Yoo, AS; Greenwald, I			LIN-12/Notch activation leads to micro RNA-mediated down-regulation of vav in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; VULVAL DEVELOPMENT; PROTEINS; FAMILY; ENCODES; GENES; GLP-1	Cell-cell interactions and cross-talk between signaling pathways specify Caenorhabditis elegans vulval precursor cells (VPCs) to adopt a spatial pattern: a central "1 degrees" VPC, in which epidermal growth factor receptor (EGFR)-mitogen-activated protein kinase (MAPK) activity is high and LIN-12/Notch activity is low, flanked by two "2 degrees" VPCs, in which LIN-12/Notch activity is high and EGFR-MAPK activity is low. Here, we identify a microRNA gene, mir-61, as a direct transcriptional target of LIN-12 and show that expression of mir-61 promotes the 20 fate. We also identify vav-1, the ortholog of the Vav oncogene, as a target of mir-61, and show that down-regulation of VAV-1 promotes lin-12 activity in specifying the 2 degrees fate. Our results suggest that lin-12, mir-61, and vav-1 form a feedback loop that helps maximize lin-12 activity in the presumptive 2 degrees VPCs.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Greenwald, I (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St,Room 720, New York, NY 10032 USA.	greenwaid@cancercenter.columbia.edu		Yoo, Andrew/0000-0002-0304-3247	NCI NIH HHS [R01 CA095389, R01 CA095389-02, R01 CA095389-01A1, R01 CA095389-04, CA095389, R01 CA095389-03, R01 CA095389-06A1, R01 CA095389-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095389] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; GREENWALD I, 2005, WORMBOOK; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Sternberg PW, 2005, WORMBOOK, DOI 10.1895/wormbook.1.6.1; SUNDARAM M, 1993, GENETICS, V135, P765; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOO AS, UNPUB	23	108	134	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1330	1333		10.1126/science.1119481	http://dx.doi.org/10.1126/science.1119481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16239437	Green Accepted			2022-12-01	WOS:000233600200042
J	Nissen, SE; Wolski, K; Topol, EJ				Nissen, SE; Wolski, K; Topol, EJ			Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CORONARY-HEART-DISEASE; SECONDARY PREVENTION; RISK-FACTORS; TRIAL; ROSIGLITAZONE; DYSLIPIDEMIA; PIOGLITAZONE; GEMFIBROZIL; MEN	Context Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that modulate gene expression. Therapeutic agents targeting 2 distinct families of PPARs (alpha and gamma) have been introduced in the United States. The first dual-PPAR agonist, muraglitazar, was reviewed by a US Food and Drug Administration (FDA) advisory committee on September 9, 2005, resulting in a vote of 8:1 recommending approval for its use in controlling blood glucose levels in patients with type 2 diabetes. Objective To evaluate the incidence of death, myocardial infarction (MI), stroke, congestive heart failure (CHF), and transient ischemic attack (TIA) in diabetic patients treated with muraglitazar compared with controls. Design, Setting, and Participants The source material for this analysis consisted of documents about phase 2 and 3 clinical trials released under public disclosure laws for the FDA advisory committee meeting. All reviewed trials were prospective, randomized, double-blind, multicenter studies enrolling patients with type 2 diabetes and hemoglobin A,c levels between 7% and 10%. Patients (N=3725) were randomized to receive differing doses of muraglitazar, pioglitazone, or placebo as monotherapy or in combination with metformin or glyburide in trials ranging from 24 to 104 weeks. Main Outcome Measures The primary outcome was the incidence of death, nonfatal MI, or nonfatal stroke. A more comprehensive composite outcome included these events plus the incidence of CHF and TIA. Results In the muraglitazar-treated patients, death, MI, or stroke occurred in 35 of 2374 (1.47%) patients compared with 9 of 1351 (0.67%) patients in the combined placebo and pioglitazone treatment groups (controls) (relative risk [RR], 2.23; 95% confidence interval [CI], 1.07-4.66; P = .03). For the more comprehensive outcome measure that included TIA and CHF, the incidence was 50 of 2374 (2.11%) for muraglitazar compared with 11 of 1351 (0.81%) for controls (RR, 2.62; 95% CI, 1.36-5.05; P = .004). Relative risks for each of the individual components of the composite end point exceeded 2.1 but were not statistically significant. Incidence of adjudicated CHF was 13 of 2374 (0.55%) muraglitazar-treated patients and 1 of 1351 controls (0.07%) (RR, 7.43; 95% CI, 0.97-56.8; P = .053). Conclusions Compared with placebo or pioglitazone, muraglitazar was associated with an excess incidence of the composite end point of death, major adverse cardiovascular events (MI, stroke, TIA), and CHF. This agent should not be approved to treat diabetes based on laboratory end points until safety is documented in a dedicated cardiovascular events trial.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org		Topol, Eric/0000-0002-1478-4729				Buse JB, 2005, CLIN THER, V27, P1181, DOI 10.1016/j.clinthera.2005.08.005; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Despres JP, 2004, DRUGS, V64, P2177, DOI 10.2165/00003495-200464190-00003; Devasthale PV, 2005, J MED CHEM, V48, P2248, DOI 10.1021/jm0496436; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *END MET DRUG ADV, 2005, END MET DRUG ADV COM; *END MET DRUGS ADV, TABL CONT; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Lygate CA, 2003, CARDIOVASC RES, V58, P632, DOI 10.1016/S0008-6363(03)00289-X; Molavi Behzad, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P1, DOI 10.1177/107424840200700i101; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Riveline JP, 2003, DIABETES METAB, V29, P207, DOI 10.1016/S1262-3636(07)70030-7; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; SAMBANDAM N, 2005, AM J PHYSL HEART SEP; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Steiner G, 2001, LANCET, V357, P905; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Xu Y, 2005, AM J PHYSIOL-HEART C, V288, pH1314, DOI 10.1152/ajpheart.00618.2004	20	435	453	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2581	2586		10.1001/JAMA.294.20.JOC50147	http://dx.doi.org/10.1001/JAMA.294.20.JOC50147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16239637	Bronze			2022-12-01	WOS:000233436200022
J	Bunker, DE; DeClerck, F; Bradford, JC; Colwell, RK; Perfecto, I; Phillips, OL; Sankaran, M; Naeem, S				Bunker, DE; DeClerck, F; Bradford, JC; Colwell, RK; Perfecto, I; Phillips, OL; Sankaran, M; Naeem, S			Species loss and aboveground carbon storage in a tropical forest	SCIENCE			English	Article							ECOSYSTEM FUNCTION; AMAZONIAN FORESTS; PLANT DIVERSITY; BIODIVERSITY; EXTINCTION; GRASSLAND; TREE; DEFORESTATION; COMMUNITIES; SCENARIOS	Tropical forest biodiversity is declining, but the resulting effects on key ecosystem services, such as carbon storage and sequestration, remain unknown. We assessed the influence of the loss of tropical tree species on carbon storage by simulating 18 possible extinction scenarios within a well-studied 50-hectare tropical forest plot in Panama, which contains 227 tree species. Among extinction scenarios, aboveground carbon stocks varied by more than 600%, and biological insurance varied by more than 400%. These results indicate that future carbon storage in tropical forests will be influenced strongly by future species composition.	Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; Columbia Univ, Earth Inst, New York, NY 10027 USA; Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63166 USA; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Leeds, Sch Geog, Earth & Biosphere Inst, Leeds LS 9JT, W Yorkshire, England; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Columbia University; Columbia University; Missouri Botanical Gardens; University of Connecticut; University of Michigan System; University of Michigan; University of Leeds; Colorado State University	Bunker, DE (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	deb37@columbia.edu	Colwell, Robert K/C-7276-2015; DeClerck, Fabrice A.J./C-3642-2012; Phillips, Oliver L/A-1523-2011	Phillips, Oliver L/0000-0002-8993-6168	Natural Environment Research Council [NE/B503384/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 1998, TROPICAL FOREST CENS; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Duraiappah A. K., 2005, MILLENNIUM ECOSYSTEM; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; Gaston K.J., 1994, RARITY, P1, DOI [10.1007/978-94-011-0701-3_1, DOI 10.1007/978-94-011-0701-3_1, 10.1007/978-94-011-0701-3]; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Hulme M, 1998, CLIMATIC CHANGE, V39, P145, DOI 10.1023/A:1005376007729; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Laurance WF, 1999, BIOL CONSERV, V91, P101, DOI 10.1016/S0006-3207(99)00087-7; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	33	284	318	10	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2005	310	5750					1029	1031		10.1126/science.1117682	http://dx.doi.org/10.1126/science.1117682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16239439				2022-12-01	WOS:000233343400047
J	Yoshihara, M; Adolfsen, B; Galle, KT; Littleton, JT				Yoshihara, M; Adolfsen, B; Galle, KT; Littleton, JT			Retrograde signalling by Syt 4 induces presynaptic release and synapse-specific growth	SCIENCE			English	Article							PROTEIN-KINASE-A; LONG-TERM POTENTIATION; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; NEUROTRANSMITTER RELEASE; MEMORY STORAGE; DROSOPHILA; CAMP; EXPRESSION; SECRETION	The molecular pathways involved in retrograde signal transduction at synapses and the function of retrograde communication are poorly understood. Here, we demonstrate that postsynaptic calcium 2+ ion (Ca2+) influx through glutamate receptors and subsequent postsynaptic vesicle fusion trigger a robust induction of presynaptic miniature release after high-frequency stimulation at Drosophila neuromuscular. junctions. An isoform of the synaptotagmin family, synaptotagmin 4 (Syt 4), serves as a postsynaptic Ca2+ sensor to release retrograde signals that stimulate enhanced presynaptic function through activation of the cyclic adenosine monophosphate (cAMP)-cAMP-dependent protein kinase pathway. Postsynaptic Ca2+ influx also stimulates local synaptic differentiation and growth through Syt 4-mediated retrograde signals in a synapse-, specific manner.	MIT, Dept Biol, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Yoshihara, M (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	motojiro@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NINDS NIH HHS [R01 NS040296-06, R01 NS040296, R01 NS043244] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296, R01NS043244] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; AGNEL M, 1989, GENE DEV, V3, P85, DOI 10.1101/gad.3.1.85; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hebb D.O., 2002, CLIN PSYCHOL; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Yoshihara M, 2000, J NEUROSCI, V20, P8315, DOI 10.1523/JNEUROSCI.20-22-08315.2000; Yoshihara M, 1999, J NEUROSCI, V19, P2432; ZHONG Y, 1992, J NEUROSCI, V12, P644	29	104	107	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					858	863		10.1126/science.1117541	http://dx.doi.org/10.1126/science.1117541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272123				2022-12-01	WOS:000233121800047
J	Lipford, JR; Smith, GT; Chi, Y; Deshaies, RJ				Lipford, JR; Smith, GT; Chi, Y; Deshaies, RJ			A putative stimulatory role for activator turnover in gene expression	NATURE			English	Article							PROTEASOME INHIBITION; TRANSCRIPTION; GCN4; DEGRADATION; RECRUITMENT; PROTEOLYSIS; GAL4	The ubiquitin - proteasome system (UPS) promotes the destruction of target proteins by attaching to them a ubiquitin chain that is recognized by the 26S proteasome(1). The UPS influences most cellular processes, and its targets include transcriptional activators that are primary determinants of gene expression. Emerging evidence indicates that non-proteolytic functions of the UPS might stimulate transcriptional activity(2,3). Here we show that the proteolysis of some transcriptional activators by the UPS can stimulate their function. We focused on the role of UPS-dependent proteolysis in the function of inducible transcriptional activators in yeast, and found that inhibition of the proteasome(4) reduced transcription of the targets of the activators Gcn4, Gal4 and Ino2/4. In addition, mutations in SCFCdc4, the ubiquitin ligase for Gcn4 (ref. 5), or mutations in ubiquitin that prevent degradation(6), also impaired the transcription of Gcn4 targets. These transcriptional defects were manifested despite the enhanced abundance of Gcn4 on cognate promoters. Proteasome inhibition also decreased the association of RNA polymerase II with Gcn4, Gal4 and Ino2/4 targets, as did mutations in SCFCdc4 for Gcn4 targets. Expression of a stable phospho-site mutant of Gcn4 ( ref. 7) or disruption of the kinases that target Gcn4 for turnover(5,7) alleviated the sensitivity of Gcn4 activity to defects in the UPS.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Deshaies, RJ (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; APARICIO O, 2004, CURRENT PROTOCOLS MO; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Guthrie C, 1991, GUIDE YEAST GENETICS; HILT W, 1993, J BIOL CHEM, V268, P3479; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X	27	151	156	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2005	438	7064					113	116		10.1038/nature04098	http://dx.doi.org/10.1038/nature04098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979XS	16267558	Green Accepted			2022-12-01	WOS:000232979000052
J	Brengues, M; Teixeira, D; Parker, R				Brengues, M; Teixeira, D; Parker, R			Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies	SCIENCE			English	Article							DECAY; PROTEINS; COMPLEX; EXPORT; SITES; YEAST; FOCI	Eukaryotic cells contain nontranslating messenger RNA concentrated in P-bodies, which are sites where the mRNA can be decapped and degraded. We present evidence that mRNA molecules within yeast P-bodies can also return to translation. First, inhibiting delivery of new mRNAs to P-bodies leads to their disassembly independent of mRNA decay. Second, P-bodies decline in a translation initiation-dependent manner during stress recovery. Third, reporter mRNAs concentrate in P-bodies when translation initiation is blocked and resume translation and exit P-bodies when translation is restored. Fourth, stationary phase yeast have large P-bodies containing mRNAs that reenter translation when growth resumes. The reciprocal movement of mRNAs between polysomes and P-bodies is likely to be important in the control of mRNA translation and degradation. Moreover, the presence of related proteins in P-bodies and maternal mRNA storage granules suggests this mechanism is widely adapted for mRNA storage.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NIGMS NIH HHS [GM45443, R37 GM045443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Anderson P, 2002, J CELL SCI, V115, P3227; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; COLLER J, IN PRESS CELL; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678	21	554	563	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					486	489		10.1126/science.1115791	http://dx.doi.org/10.1126/science.1115791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16141371	Green Accepted			2022-12-01	WOS:000232786000045
J	Blumenthal, D				Blumenthal, D			Ecology - Interrelated causes of plant invasion	SCIENCE			English	Editorial Material							GROWTH-RATE; HERBIVORY; RELEASE; SPECIALIZATION; COMMUNITIES		ARS, USDA, Rangeland Resources Res Unit, Crops Res Lab, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA)	Blumenthal, D (corresponding author), ARS, USDA, Rangeland Resources Res Unit, Crops Res Lab, 1701 Ctr Ave, Ft Collins, CO 80526 USA.	dana.blumenthal@ars.usda.gov	Blumenthal, Dana M/J-3106-2012					Baker H. G., 1965, The genetics of colonizing species., P147; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; CEBRIAN J, 1994, FUNCT ECOL, V8, P518, DOI 10.2307/2390077; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fraser LH, 1999, J ECOL, V87, P514, DOI 10.1046/j.1365-2745.1999.00373.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hoffland E, 1996, PLANT CELL ENVIRON, V19, P1281, DOI 10.1111/j.1365-3040.1996.tb00006.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3	17	145	161	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2005	310	5746					243	244		10.1126/science.1114851	http://dx.doi.org/10.1126/science.1114851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16224008				2022-12-01	WOS:000232670100031
J	Jensen, K; Murray, F				Jensen, K; Murray, F			Intellectual property - Intellectual property landscape of the human genome	SCIENCE			English	Editorial Material							RESEARCH-AND-DEVELOPMENT; GENETIC SEQUENCES; LAW; PATENTS; FUTURE; DNA		MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Murray, F (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.	fmurray@mit.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; Caulfield T, 2000, NAT REV GENET, V1, P227, DOI 10.1038/35042087; Crease DJ, 2003, NAT REV DRUG DISCOV, V2, P407, DOI 10.1038/nrd1089; Doll JJ, 1998, SCIENCE, V280, P689, DOI 10.1126/science.280.5364.689; Dufresne G, 2004, NAT BIOTECHNOL, V22, P231, DOI 10.1038/nbt0204-231; Dufresne G, 2002, NAT BIOTECHNOL, V20, P1269, DOI 10.1038/nbt1202-1269; Eisenberg R, 2003, CR BIOL, V326, P1115, DOI 10.1016/j.crvi.2003.10.001; Fox Keller E., 2000, CENTURY GENE; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gans JS, 2000, J ECON MANAGE STRAT, V9, P485, DOI 10.1162/105864000567945; *GEORG U KENN I ET, DNA PAT DAT; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hollon T, 2000, NAT MED, V6, P362, DOI 10.1038/74591; *J HOPK U MCKUS NA, 2000, ONL MEND INH MAN; LEVIN RC, 1987, BROOKINGS PAPERS EC, V3, P783, DOI DOI 10.2307/2534454; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; *NAT GEN INF CTR, PAT DAT; Nuffield Council on Bioethics, 2002, ETH PAT DNA; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; SCOTCHMER S, 1991, J ECON PERSPECT, V5, P29, DOI 10.1257/jep.5.1.29; Stott M, 2004, NAT REV DRUG DISCOV, V3, P364, DOI 10.1038/nrd1348; Stott M, 2003, NAT BIOTECHNOL, V21, P729, DOI 10.1038/nbt0703-729; Thomas SM, 2002, NAT BIOTECHNOL, V20, P1185, DOI 10.1038/nbt1202-1185; Walsh JP, 2003, SCIENCE, V299, P1021, DOI 10.1126/science.299.5609.1021; Xu G. G., 2002, World Patent Information, V24, P95, DOI 10.1016/S0172-2190(02)00004-2; 2001, FED REG          JAN, V66, P1092	27	155	160	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					239	240		10.1126/science.1120014	http://dx.doi.org/10.1126/science.1120014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975NV	16224006				2022-12-01	WOS:000232670100029
J	Takagi, M; Absalon, MJ; McLure, KG; Kastan, MB				Takagi, M; Absalon, MJ; McLure, KG; Kastan, MB			Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin	CELL			English	Article							ATM-DEPENDENT PHOSPHORYLATION; RNA-BINDING PROTEINS; HUMAN CANCER-CELLS; MESSENGER-RNA; THYMIDYLATE SYNTHASE; UNTRANSLATED REGION; CHECKPOINT PATHWAY; ONCOPROTEIN MDM2; IN-VIVO; ACTIVATION	Increases in p53 protein levels after DNA damage have largely been attributed to an increase in the half-life of p53 protein. Here we demonstrate that increased translation of p53 mRNA is also a critical step in the induction of p53 protein in irradiated cells. Ribosomal protein L26 (RPL26) and nucleolin were found to bind to the 5' untranslated region (UTR) of p53 mRNA and to control p53 translation and induction after DNA damage. RPL26 preferentially binds to the 5'UTR after DNA damage, and its overexpression enhances association of p53 mRNA with heavier polysomes, increases the rate of p53 translation, induces G1 cell-cycle arrest, and augments irradiation-induced apoptosis. Opposite effects were seen when RPL26 expression was inhibited. In contrast, nucleolin overexpression suppresses p53 translation and induction after DNA damage, whereas nucleolin downregulation promotes p53 expression. These findings demonstrate the importance of increased translation of p53 in DNA-damage responses and suggest critical roles for RPL26 and nucleolin in affecting p53 induction.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org	Ogunwobi, Olorunseun/F-3172-2010; Takagi, Masatoshi/F-3713-2011	Takagi, Masatoshi/0000-0002-7580-9184	NCI NIH HHS [CA21765] Funding Source: Medline; NIEHS NIH HHS [ES05777] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005777, R01ES005777] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beck-Engeser GB, 2001, J EXP MED, V194, P285, DOI 10.1084/jem.194.3.285; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chu E, 1999, MOL CELL BIOL, V19, P1582; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DERENZINI M, 1995, LAB INVEST, V73, P497; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GILLET G, 1993, ONCOGENE, V8, P565; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Ju JF, 1999, P NATL ACAD SCI USA, V96, P3769, DOI 10.1073/pnas.96.7.3769; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Ohira M, 2003, ONCOGENE, V22, P5525, DOI 10.1038/sj.onc.1206853; PRICE BD, 1993, ONCOGENE, V8, P3055; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Thyagarajan B, 1998, SOMAT CELL MOLEC GEN, V24, P263, DOI 10.1023/B:SCAM.0000007129.98789.1f; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yanagida M, 2001, PROTEOMICS, V1, P1390, DOI 10.1002/1615-9861(200111)1:11<1390::AID-PROT1390>3.0.CO;2-Z; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	58	475	488	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					49	63		10.1016/j.cell.2005.07.034	http://dx.doi.org/10.1016/j.cell.2005.07.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213212	Bronze			2022-12-01	WOS:000232536800008
J	Weng, KC; Castilho, PC; Morrissette, JM; Landeira-Fernandez, AM; Holts, DB; Schallert, RJ; Goldman, KJ; Block, BA				Weng, KC; Castilho, PC; Morrissette, JM; Landeira-Fernandez, AM; Holts, DB; Schallert, RJ; Goldman, KJ; Block, BA			Satellite tagging and cardiac physiology reveal niche expansion in salmon sharks	SCIENCE			English	Article							TEMPERATURE	Shark populations are declining globally, yet the movements and habitats of most species are unknown. We used a satellite tag attached to the dorsal fin to track salmon sharks (Lamna ditropis) for up to 3.2 years. Here we show that salmon sharks have a subarctic-to-subtropical niche, ranging from 2 degrees to 24 degrees C, and they spend winter periods in waters as cold as 2 degrees to 8 degrees C. Functional assays and protein gels reveal that the expression of excitation-contraction coupling proteins is enhanced in salmon shark hearts, which may underlie the shark's ability to maintain heart function at cold temperatures and their niche expansion into subarctic seas.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, 120 Oceanview Blvd, Pacific Grove, CA 93950 USA; Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; Monterey Bay Aquarium Res Inst, Monterey, CA 93940 USA; Alaska Dept Fish & Game, Homer, AK 99603 USA	Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA; Monterey Bay Aquarium Research Institute; Alaska Department of Fish & Game	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, 120 Oceanview Blvd, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Costa, Maria/G-9555-2011; Weng, Kevin Chi-Ming/C-4709-2013	Costa, Maria/0000-0002-9887-0973; Schallert, Robert/0000-0002-3584-2668; Weng, Kevin Chi-Ming/0000-0002-7069-7152				Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; BRILL RW, 2001, TUNA PHYSL ECOLOGY E, P00079; CAREY FG, 1981, PHYSIOL ZOOL, V54, P334, DOI 10.1086/physzool.54.3.30159948; CAREY FG, 1982, COPEIA, P254; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; GOLDMAN KJ, IN PRESS FISH B; HULBERT L, 1999, TROPHIC MASS BALANCE, P42; Nagasawa Kazuya, 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P419; Norcross BL, 2001, FISH OCEANOGR, V10, P42, DOI 10.1046/j.1054-6006.2001.00040.x; PAUST B, 1986, SALMON SHARK MANUAL; PRIEDE IG, 1984, FISH RES, V2, P201, DOI 10.1016/0165-7836(84)90003-1; RANDALL J, COMMUNICATION; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003	18	162	166	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					104	106		10.1126/science.1114616	http://dx.doi.org/10.1126/science.1114616			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210538				2022-12-01	WOS:000232477000047
J	McLaughlin, JB; DePaola, A; Bopp, CA; Martinek, KA; Napolilli, NP; Allison, CG; Murray, SL; Thompson, EC; Bird, MM; Middaugh, JP				McLaughlin, JB; DePaola, A; Bopp, CA; Martinek, KA; Napolilli, NP; Allison, CG; Murray, SL; Thompson, EC; Bird, MM; Middaugh, JP			Outbreak of Vibrio parahaemolyticus gastroenteritis associated with Alaskan oysters	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALGINOLYTICUS; GENES; COAST; FOOD	BACKGROUND Vibrio parahaemolyticus, the leading cause of seafood-associated gastroenteritis in the United States, typically is associated with the consumption of raw oysters gathered from warm-water estuaries. We describe a recognized outbreak of V. parahaemolyticus infection associated with the consumption of seafood from Alaska. METHODS After we received reports of the occurrence of gastroenteritis on a cruise ship, we conducted a retrospective cohort study among passengers, as well as active surveillance throughout Alaska to identify additional cases, and an environmental study to identify sources of V. parahaemolyticus and contributors to the outbreak. RESULTS Of 189 passengers, 132 ( 70 percent) were interviewed; 22 of the interviewees ( 17 percent) met our case definition of gastroenteritis. In our multiple logistic-regression analysis, consumption of raw oysters was the only significant predictor of illness; the attack rate among people who consumed oysters was 29 percent. Active surveillance identified a total of 62 patients with gastroenteritis. V. parahaemolyticus serotype O6: K18 was isolated from the majority of patients tested and from environmental samples of oysters. Patterns on pulsed-field gel electrophoresis were highly related across clinical and oyster isolates. All oysters associated with the outbreak were harvested when mean daily water temperatures exceeded 15.0 degrees C ( the theorized threshold for the risk of V. parahaemolyticus illness from the consumption of raw oysters). Since 1997, mean water temperatures in July and August at the implicated oyster farm increased 0.21 degrees C per year (P< 0.001 by linear regression); 2004 was the only year during which mean daily temperatures in July and August at the shellfish farm did not drop below 15.0 degrees C. CONCLUSIONS This investigation extends by 1000 km the northernmost documented source of oysters that caused illness due to V. parahaemolyticus. Rising temperatures of ocean water seem to have contributed to one of the largest known outbreaks of V. parahaemolyticus in the United States.	Alaska Dept Hlth & Social Serv, Div Publ Hlth, Anchorage, AK 99503 USA; Alaska Dept Environm Conservat, Anchorage, AK USA; US FDA, Gulf Coast Seafood Lab, Dauphin Isl, AL USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	McLaughlin, JB (corresponding author), Alaska Dept Hlth & Social Serv, Div Publ Hlth, 3601 C St,Suite 540, Anchorage, AK 99503 USA.	joe_mclaughlin@health.state.ak.us						*AM PUBL HLTH ASS, 1970, REC PROC EX SEA WAT, P101; *APPL MATHS BVBA, 2002, 2002 BIONUMERICS VER; *BRIT COL SHELLF G, VIBR PAR CONTR PROGR; Cook DW, 2002, J FOOD PROTECT, V65, P1873, DOI 10.4315/0362-028X-65.12.1873; Cook DW, 2002, J FOOD PROTECT, V65, P445; *CTR FOOD SAF APPL, QUANT RISK ASS PUBL; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Daniels NA, 2000, JAMA-J AM MED ASSOC, V284, P1541, DOI 10.1001/jama.284.12.1541; DANIELS NA, 2001, JAMA-J AM MED ASSOC, V285, P169; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI 10.1128/AEM.69.3.1521-1526.2003; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; *FOOD DRUG ADM, FDA BACT AN MAN; GJERDE J, 1981, ACTA VET SCAND, V22, P331; Gonzalez-Escalona N, 2005, EMERG INFECT DIS, V11, P129, DOI 10.3201/eid1101.040762; Gooch JA, 2002, J FOOD PROTECT, V65, P970, DOI 10.4315/0362-028X-65.6.970; Greenberg E. P., 1982, Journal of Food Safety, V4, P113, DOI 10.1111/j.1745-4565.1982.tb00436.x; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; McMichael AJ, 1996, CLIMATE CHANGE HUMAN; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MIYAMOTO Y, 1969, J BACTERIOL, V100, P1147, DOI 10.1128/JB.100.2.1147-1149.1969; *NAT OC ATM ASS, STAT 46001 GULF AK 8; NISHIBUCHI M, 1992, INFECT IMMUN, V60, P3539, DOI 10.1128/IAI.60.9.3539-3545.1992; NISHIBUCHI M, 1985, INFECT IMMUN, V49, P481, DOI 10.1128/IAI.49.3.481-486.1985; Nordstrom JL, 2004, J FOOD PROTECT, V67, P2178, DOI 10.4315/0362-028X-67.10.2178; Okuda J, 1997, J CLIN MICROBIOL, V35, P1965, DOI 10.1128/JCM.35.8.1965-1971.1997; THOMPSON CA, 1976, J FOOD SCI, V41, P204, DOI 10.1111/j.1365-2621.1976.tb01138.x; *UN INT PAN CLIM C, 3 UN INT PAN CLIM CH; *UPD NAT SHELLF SA, 2002, UPD NAT SHELLF SAN P; VASCONCELOS GJ, 1975, APPL MICROBIOL, V29, P557, DOI 10.1128/AEM.29.4.557-559.1975; 1998, MMWR MORB MORTAL WKL, V47, P457	32	322	342	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2005	353	14					1463	1470		10.1056/NEJMoa051594	http://dx.doi.org/10.1056/NEJMoa051594			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LZ	16207848	Bronze			2022-12-01	WOS:000232313000006
J	Wang, XL; Kellner, AWA; Zhou, ZH; Campos, DD				Wang, XL; Kellner, AWA; Zhou, ZH; Campos, DD			Pterosaur diversity and faunal turnover in Cretaceous terrestrial ecosystems in China	NATURE			English	Article							JIUFOTANG FORMATION; INNER-MONGOLIA	New specimens and an analysis of the Jehol pterosaur faunae of northeastern China show an unexpected diversity of flying reptile groups in terrestrial Cretaceous ecosystems(1-4). Here we report two new pterosaurs that are referred to European groups previously unknown in deposits of northeastern China. Feilongus youngi, from the Yixian Formation(1,3), is closely related to the Gallodactylidae(5-6) and is distinguished by the presence of two independent sagittal crests and a protruding upper jaw. Nurhachius ignaciobritoi, from the Jiufotang Formation(2,3), has teeth formed by labiolingually compressed triangular crowns, only previously reported in Istiodactylus latidens(7) from England. With these new discoveries, the Jehol pterosaurs show a wide range of groups including both primitive and derived forms that are not matched by any other deposit in the world. The discoveries also document the turnover of pterosaur faunae, with the primitive Anurognathidae and early archaeopterodactyloids being replaced by derived pterodactyloids. Furthermore, these deposits offer an opportunity to examine the interaction and competition between birds and pterosaurs - it indicates that the avian fauna during the Lower Cretaceous ( and possibly most of the Mesozoic) dominated terrestrial, inland regions, whereas pterosaurs were more abundant in coastal areas.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Paleovertebrate Sector, BR-20940040 Rio De Janeiro, Brazil; Museu Ciencias Terra, Dept Nacl Prod Mineral, BR-22290240 Rio De Janeiro, Brazil	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Universidade Federal do Rio de Janeiro	Wang, XL (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xlinwang@263.net; kellner@acd.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447				Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bennett SC, 2002, J VERTEBR PALEONTOL, V22, P43, DOI 10.1671/0272-4634(2002)022[0043:STPOTC]2.0.CO;2; Campos Diogenes De A., 1997, Anais da Academia Brasileira de Ciencias, V69, P83; Chang M.M., 2003, JEHOL BIOTA; Czerkas S. A., 2002, FEATHERED DINOSAURS, P15; Dong Z., 2003, GLOBAL GEOLOGY, V22, P1; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Howse S.C.B., 2001, DINOSAURS ISLE WIGHT, P324; Ji SA, 1999, NATURE, V398, P573, DOI 10.1038/19221; KELLER JR, 1989, J CELL BIOCHEM, V39, P175, DOI 10.1002/jcb.240390209; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Li Jian-Jun, 2003, Acta Palaeontologica Sinica, V42, P442; Lu Jun-Chang, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P153; PONTE FC, 1996, B 4 S CRET BRAS, P123; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Viohl G., 1985, P31; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Wang XL, 2001, CHINESE SCI BULL, V46, P1112; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; WANG XL, 2002, VERTEBRAT PALASIATIC, V41, P34; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Wu XC, 1996, CAN J EARTH SCI, V33, P599, DOI 10.1139/e96-044; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	127	151	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					875	879		10.1038/nature03982	http://dx.doi.org/10.1038/nature03982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208369				2022-12-01	WOS:000232338600044
J	Godtfredsen, NS; Prescott, E; Osler, M				Godtfredsen, NS; Prescott, E; Osler, M			Effect of smoking reduction on lung cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; PROSPECTIVE COHORT; PIPE SMOKING; DOUBLE-BLIND; FOLLOW-UP; CESSATION; MORTALITY; TOBACCO; ASSOCIATION; TRIAL	Context Many smokers are unable or unwilling to completely quit smoking. A proposed means of harm reduction is to reduce the number of cigarettes smoked per day. However, it is not clear whether this strategy decreases the risk for tobacco-related diseases. Objective To assess the effects of smoking reduction on lung cancer incidence. Design, Setting, and Participants Observational population-based cohort study with up to 31 years of follow-up from the Copenhagen Centre for Prospective Population Studies, which administrates data from 3 longitudinal studies conducted in Copenhagen and suburbs, the Copenhagen City Heart Study, the Copenhagen Male Study, and the Glostrup Population Studies, Denmark. Participants were 11151 men and 8563 women (N = 19 714) aged 20 to 93 years, who attended 2 consecutive examinations with a 5- to 10-year interval between 1964 and 1988. Participants underwent a physical examination and completed self-filled questionnaires about lifestyle habits. The study population was divided into 6 groups according to smoking habits: continued heavy smokers (>= 15 cigarettes/d), reducers (reduced from >= 15 cigarettes/d by minimum of 50% without quitting), continued light smokers (1-14 cigarettes/d), quitters (stopped between first and second examination), stable ex-smokers, and never smokers. Main Outcome Measure Incident primary lung cancer cases assessed by record linkage with the National Cancer Registry until December 31, 2003. Results There were 864 incident lung cancers during follow-up. Using Cox regression, the adjusted hazard ratio (HR) for lung cancer in reducers was 0.73 (95% confidence interval [CI], 0.54-0.98) compared with persistent heavy smokers. The HR for light smokers was 0.44 (95% Cl, 0.35-0.56); for quitters, HR 0.50 (95% Cl, 0.36-0.69), for stable ex-smokers, HR 0.17 (95% Cl, 0.13-0.23), and for never smokers, HR 0.09 (95% Cl, 0.06-0.13). Conclusion Among individuals who smoke 15 or more cigarettes per day, smoking reduction by 50% significantly reduces the risk of lung cancer.	Univ Copenhagen Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, Copenhagen Ctr Prospect Populat Studies, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Hvidovre Hosp, Dept Cardiol & Pulm Med, DK-2650 Hvidovre, Denmark; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Inst Publ Hlth, Dept Social Med, Copenhagen, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Godtfredsen, NS (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Cardiol & Pulm Med 253, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	duegodt@dadlnet.dk	Osler, Merete/AAF-7885-2019; Prescott, Eva/AAJ-7441-2020	Prescott, Eva/0000-0002-4134-0349				APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; Armadans-Gil L, 1999, INT J EPIDEMIOL, V28, P614, DOI 10.1093/ije/28.4.614; Barnoya J, 2004, CANCER CAUSE CONTROL, V15, P689, DOI 10.1023/B:CACO.0000036187.13805.30; BENHAMOU E, 1989, BRIT J CANCER, V60, P601, DOI 10.1038/bjc.1989.322; BENHAMOU S, 1986, INT J CANCER, V37, P825, DOI 10.1002/ijc.2910370605; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; Bolliger Chris T, 2002, Nicotine Tob Res, V4, P433, DOI 10.1080/1462220021000018380; Bolliger CT, 2000, BMJ-BRIT MED J, V321, P329, DOI 10.1136/bmj.321.7257.329; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ebbert JO, 2003, J CLIN ONCOL, V21, P921, DOI 10.1200/JCO.2003.05.085; Fagerstrom K O, 1997, Tob Control, V6, P311; Friend K, 2001, Nicotine Tob Res, V3, P299, DOI 10.1080/14622200110072165; Godtfredsen NS, 2003, J EPIDEMIOL COMMUN H, V57, P412, DOI 10.1136/jech.57.6.412; Godtfredsen NS, 2002, THORAX, V57, P967, DOI 10.1136/thorax.57.11.967; Godtfredsen NS, 2002, AM J EPIDEMIOL, V156, P994, DOI 10.1093/aje/kwf150; Godtfredsen NS, 2001, PREV MED, V33, P46, DOI 10.1006/pmed.2001.0852; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hagerup L, 1981, Scand J Soc Med Suppl, V20, P1; Harris JE, 2004, BMJ-BRIT MED J, V328, P72, DOI 10.1136/bmj.37936.585382.44; Hecht SS, 2004, JNCI-J NATL CANCER I, V96, P107, DOI 10.1093/jnci/djh016; Hein HO, 1996, BRIT MED J, V312, P736, DOI 10.1136/bmj.312.7033.736; Henley SJ, 2004, JNCI-J NATL CANCER I, V96, P853, DOI 10.1093/jnci/djh144; HIGGINS ITT, 1988, PREV MED, V17, P116, DOI 10.1016/0091-7435(88)90077-1; Hughes JR, 2000, ADDICTION, V95, pS3; Hurt R D, 2000, Nicotine Tob Res, V2, P327, DOI 10.1080/713688154; Kabat GC, 2003, INHAL TOXICOL, V15, P1059, DOI 10.1080/08958370390228547; LANGE P, 1992, EUR RESPIR J, V5, P1111; Mendez D, 2004, AM J PUBLIC HEALTH, V94, P251, DOI 10.2105/AJPH.94.2.251; Mulder I, 2004, EUR J PUBLIC HEALTH, V14, P79, DOI 10.1093/eurpub/14.1.79; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Shapiro JA, 2000, JNCI-J NATL CANCER I, V92, P333, DOI 10.1093/jnci/92.4.333; Shields PG, 2002, JNCI-J NATL CANCER I, V94, P1435, DOI 10.1093/jnci/94.19.1435; Storm HH, 1997, DAN MED BULL, V44, P535; Thun MJ, 2001, TOB CONTROL, V10, pI4; Wald NJ, 1997, BMJ-BRIT MED J, V314, P1860, DOI 10.1136/bmj.314.7098.1860; Wennike P, 2003, ADDICTION, V98, P1395, DOI 10.1046/j.1360-0443.2003.00489.x	36	188	191	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2005	294	12					1505	1510		10.1001/jama.294.12.1505	http://dx.doi.org/10.1001/jama.294.12.1505			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967TF	16189363	Bronze			2022-12-01	WOS:000232113400020
J	Oberstrass, FC; Auweter, SD; Erat, M; Hargous, Y; Henning, A; Wenter, P; Reymond, L; Amir-Ahmady, B; Pitsch, S; Black, DL; Allain, FHT				Oberstrass, FC; Auweter, SD; Erat, M; Hargous, Y; Henning, A; Wenter, P; Reymond, L; Amir-Ahmady, B; Pitsch, S; Black, DL; Allain, FHT			Structure of PTB bound to RNA: Specific binding and implications for splicing regulation	SCIENCE			English	Article							POLYPYRIMIDINE TRACT; EXON DEFINITION; PROTEIN; RECOGNITION; REPRESSION; SITES; INHIBITION; SELECTION	The polypyrimidine tract binding protein (PTB) is a 58-kilodalton RNA binding protein involved in multiple aspects of messenger RNA metabolism, including the repression of alternative exons. We have determined the solution structures of the four RNA binding domains (RBDs) of PTB, each bound to a CUCUCU oligonucleotide. Each RBD binds RNA with a different binding specificity. RBD3 and RBD4 interact, resulting in an antiparallel orientation of their bound RNAs. Thus, PTB will induce RNA looping when bound to two separated pyrimidine tracts within the same RNA. This leads to structural models for how PTB functions as an alternative-splicing repressor.	ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; EPFL, Lab Nucl Acid Chem LCAN, CH-1015 Lausanne, Switzerland; Mol LIfe Sci PhD Program, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Allain, FHT (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch		Henning, Anke/0000-0002-2267-4861; REYMOND, Luc/0000-0001-5282-9273				Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Ashiya M, 1997, RNA, V3, P996; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; GOODING C, 1994, EMBO J, V13, P3861, DOI 10.1002/j.1460-2075.1994.tb06697.x; Gooding C, 1998, RNA, V4, P85; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Lou H, 1999, MOL CELL BIOL, V19, P78; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Perez I, 1997, RNA, V3, P764; Pilipenko EV, 2000, GENE DEV, V14, P2028; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Shen HH, 2004, RNA, V10, P787, DOI 10.1261/rna.5229704; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Southby J, 1999, MOL CELL BIOL, V19, P2699; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001	33	320	328	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2005	309	5743					2054	2057		10.1126/science.1114066	http://dx.doi.org/10.1126/science.1114066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968SF	16179478				2022-12-01	WOS:000232181900050
J	Dodge-Kafka, KL; Soughayer, J; Pare, GC; Michel, JJC; Langeberg, LK; Kapiloff, MS; Scott, JD				Dodge-Kafka, KL; Soughayer, J; Pare, GC; Michel, JJC; Langeberg, LK; Kapiloff, MS; Scott, JD			The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways	NATURE			English	Article							CYCLIC-AMP; DEPENDENT REGULATION; CARDIAC-HYPERTROPHY; PHOSPHODIESTERASE; EPAC; PHOSPHORYLATION; ACTIVATION; MYOCYTES; BINDING; RAP1	Cyclic adenosine 3', 5'- monophosphate ( cAMP) is a ubiquitous mediator of intracellular signalling events. It acts principally through stimulation of cAMP- dependent protein kinases ( PKAs)(1,2) but also activates certain ion channels and guanine nucleotide exchange factors ( Epacs)(3). Metabolism of cAMP is catalysed by phosphodiesterases ( PDEs) (4,5). Here we identify a cAMP- responsive signalling complex maintained by the muscle-specific A- kinase anchoring protein ( mAKAP) that includes PKA, PDE4D3 and Epac1. These intermolecular interactions facilitate the dissemination of distinct cAMP signals through each effector protein. Anchored PKA stimulates PDE4D3 to reduce local cAMP concentrations, whereas an mAKAP- associated ERK5 kinase module suppresses PDE4D3. PDE4D3 also functions as an adaptor protein that recruits Epac1, an exchange factor for the small GTPase Rap1, to enable cAMP- dependent attenuation of ERK5. Pharmacological and molecular manipulations of the mAKAP complex show that anchored ERK5 can induce cardiomyocyte hypertrophy. Thus, two coupled cAMP- dependent feedback loops are coordinated within the context of the mAKAP complex, suggesting that local control of cAMP signalling by AKAP proteins is more intricate than previously appreciated.	Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA.	scott@ohsu.edu		Kapiloff, Michael/0000-0002-7005-6953	NHLBI NIH HHS [R01 HL088366, R01 HL075398, R01 HL075398-02] Funding Source: Medline; NIDDK NIH HHS [P01 DK054441] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398, R01HL088366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beavo J A, 1974, Methods Enzymol, V38, P299; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Michel JJC, 2004, BIOCHEM J, V381, P587, DOI 10.1042/BJ20040846; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Pearson GW, 2002, J BIOL CHEM, V277, P48094, DOI 10.1074/jbc.M208535200; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	30	410	427	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					574	578		10.1038/nature03966	http://dx.doi.org/10.1038/nature03966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177794	Green Accepted			2022-12-01	WOS:000232004800055
J	Socolich, M; Lockless, SW; Russ, WP; Lee, H; Gardner, KH; Ranganathan, R				Socolich, M; Lockless, SW; Russ, WP; Lee, H; Gardner, KH; Ranganathan, R			Evolutionary information for specifying a protein fold	NATURE			English	Article							WW DOMAIN; MUTANT CYCLES; PDZ DOMAIN; BETA-SHEET; DETERMINANTS; DYNAMICS; CATALYSIS; PEPTIDE; PACKING; BINDING	Classical studies show that for many proteins, the information required for specifying the tertiary structure is contained in the amino acid sequence. Here, we attempt to define the sequence rules for specifying a protein fold by computationally creating artificial protein sequences using only statistical information encoded in a multiple sequence alignment and no tertiary structure information. Experimental testing of libraries of artificial WW domain sequences shows that a simple statistical energy function capturing coevolution between amino acid residues is necessary and sufficient to specify sequences that fold into native structures. The artificial proteins show thermodynamic stabilities similar to natural WW domains, and structure determination of one artificial protein shows excellent agreement with the WW fold at atomic resolution. The relative simplicity of the information used for creating sequences suggests a marked reduction to the potential complexity of the protein- folding problem.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Socolich, Michael/0000-0002-0702-1061				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen JM, 2001, BIOCHEMISTRY-US, V40, P14012, DOI 10.1021/bi011269d; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liang J, 2001, BIOPHYS J, V81, P751, DOI 10.1016/S0006-3495(01)75739-6; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200	50	306	314	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					512	518		10.1038/nature03991	http://dx.doi.org/10.1038/nature03991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177782				2022-12-01	WOS:000232004800041
J	Wood, AJJ; Drazen, JM; Greene, MF				Wood, AJJ; Drazen, JM; Greene, MF			A sad day for science at the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Wood, AJJ (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.		Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2005	353	12					1197	1199		10.1056/NEJMp058222	http://dx.doi.org/10.1056/NEJMp058222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	966DS	16141387				2022-12-01	WOS:000232000400001
J	Chemla, YR; Aathavan, K; Michaelis, J; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Chemla, YR; Aathavan, K; Michaelis, J; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C			Mechanism of force generation of a viral DNA packaging motor	CELL			English	Article							BACTERIOPHAGE-PHI-29 DNA; SINGLE-MOLECULE; PROTEIN GP16; GENOMIC DNA; RNA; TRANSLOCATION; PHAGE; FTSK; ATP; MECHANOCHEMISTRY	A large family of multimeric ATPases are involved in such diverse tasks as cell division, chromosome segregation, DNA recombination, strand separation, conjugation, and viral genome packaging. One such system is the Bacillus subtilis phage phi 29 DNA packaging motor, which generates large forces to compact its genome into a small protein capsid. Here we use optical tweezers to study, at the single-molecule level, the mechanism of force generation in this motor. We determine the kinetic parameters of the packaging motor and their dependence on external load to show that DNA translocation does not occur during ATP binding but is likely triggered by phosphate release. We also show that the motor subunits act in a coordinated, successive fashion with high processivity. Finally, we propose a minimal mechanochemical cycle of this DNA-translocating ATPase that rationalizes all of our findings. A large family of multimeric ATPases are involved in such diverse tasks as cell division, chromosome segregation, DNA recombination, strand separation, conjugation, and viral genome packaging. One such system is the Bacillus subtilis phage phi 29 DNA packaging motor, which generates large forces to compact its genome into a small protein capsid. Here we use optical tweezers to study, at the single-molecule level, the mechanism of force generation in this motor. We determine the kinetic parameters of the packaging motor and their dependence on external load to show that DNA translocation does not occur during ATP binding but is likely triggered by phosphate release. We also show that the motor subunits act in a coordinated, successive fashion with high processivity. Finally, we propose a minimal mechanochemical cycle of this DNA-translocating ATPase that rationalizes all of our findings.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Michaelis, Jens/P-2873-2016	Bustamante, Carlos/0000-0002-2970-0073; Jardine, Paul/0000-0002-1090-0550; Chemla, Yann/0000-0001-9167-0234; Michaelis, Jens/0000-0002-2739-4172	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071552, R01GM059604] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-GM-65786] Funding Source: Medline; NIGMS NIH HHS [GM-071552, R01 GM059604] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Dawid A, 2004, P NATL ACAD SCI USA, V101, P11611, DOI 10.1073/pnas.0404369101; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; JARDINE PJ, 2006, IN PRESS BACTERIOPHA; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Segel I. H., 1975, ENZYME KINETICS BEHA, P100; Shu D, 2003, VIROLOGY, V309, P108, DOI 10.1016/S0042-6822(03)00011-4; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Trottier M, 1996, J VIROL, V70, P55, DOI 10.1128/JVI.70.1.55-61.1996; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9	31	221	225	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					683	692		10.1016/j.cell.2005.06.024	http://dx.doi.org/10.1016/j.cell.2005.06.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143101	Bronze			2022-12-01	WOS:000231844300009
J	Caudron, M; Bunt, G; Bastiaens, P; Karsenti, E				Caudron, M; Bunt, G; Bastiaens, P; Karsenti, E			Spatial coordination of spindle assembly by chromosome-mediated signaling gradients	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; GTP-BOUND RAN; MITOTIC-SPINDLE; SELF-ORGANIZATION; MICROTUBULES; TRANSPORT; CHROMATIN; PROTEIN; CELLS; TPX2	During cell division, chromosomes are distributed to daughter cells by the mitotic spindle. This system requires spatial cues to reproducibly self-organize. We report that such cues are provided by chromosome-mediated interaction gradients between the small guanosine triphosphatase (GTPase) Ran and importin-beta. This produces activity gradients that determine the spatial distribution of microtubule nucleation and stabilization around chromosomes and that are essential for the self-organization of microtubules into a bipolar spindle.	European Mol Biol Lab, Cell Biol & Biophys Dept, D-69117 Heidelberg, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Bastiaens, P (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Dept, D-69117 Heidelberg, Germany.	bastiaen@embl-heidelberg.de; karsenti@embl-heidetberg.de		Caudron-Herger, Maiwen/0000-0002-7030-8153				Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Floer M, 1996, J BIOL CHEM, V271, P5313, DOI 10.1074/jbc.271.10.5313; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Karsenti E., 1984, J CELL BIOL, V99, P47; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Li HY, 2004, CELL CYCLE, V3, P993; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Smirnova EA, 1998, CELL MOTIL CYTOSKEL, V40, P22, DOI 10.1002/(SICI)1097-0169(1998)40:1<22::AID-CM3>3.0.CO;2-H; STEFFEN W, 1986, J CELL BIOL, V102, P1679, DOI 10.1083/jcb.102.5.1679; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	25	223	226	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1373	1376		10.1126/science.1115964	http://dx.doi.org/10.1126/science.1115964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123300				2022-12-01	WOS:000231543300044
J	Forde, A				Forde, A			Germany: Deciphering cellular processes	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2005	310	5747					519	520		10.1126/science.310.5747.519	http://dx.doi.org/10.1126/science.310.5747.519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239481				2022-12-01	WOS:000232786000052
J	Wood, SF				Wood, SF			Women's health and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		HUXLEY TH, 1907, APHORISMS REFLECTION; Wood AJJ, 2005, NEW ENGL J MED, V353, P1197, DOI 10.1056/NEJMp058222	2	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2005	353	16					1650	1651		10.1056/NEJMp058225	http://dx.doi.org/10.1056/NEJMp058225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975IC	16236734				2022-12-01	WOS:000232653200003
J	Morgan, SG; Bassett, KL; Wright, JM; Evans, RG; Barer, ML; Caetano, PA; Black, CD				Morgan, SG; Bassett, KL; Wright, JM; Evans, RG; Barer, ML; Caetano, PA; Black, CD			"Breakthrough" drugs and growth in expenditure on prescription drugs in Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Family Practice, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Morgan, SG (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Dept Family Practice, 429-2194 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	morgan@chspr.ubc.ca	Morgan, Steven/J-8814-2015	Morgan, Steven/0000-0002-7529-0028				*CAN I HLTH INF, 2005, DRUG EXP CAN 1985 20; Davis Peter, 2004, Aust Health Rev, V28, P171; *IMS, 2005, GLOB PHARM SAL REG 1; *PAT MED PRIC REV, 2004, ANN REP 2003, P49; World Health Organization, 2004, GUID ATC CLASS DDD A	5	57	57	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2005	331	7520					815	816		10.1136/bmj.38582.703866.AE	http://dx.doi.org/10.1136/bmj.38582.703866.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	974BC	16141448	Green Published, Bronze			2022-12-01	WOS:000232565300020
J	Ferrone, CR; Ben Porat, L; Panageas, KS; Berwick, M; Halpern, AC; Patel, A; Coit, DG				Ferrone, CR; Ben Porat, L; Panageas, KS; Berwick, M; Halpern, AC; Patel, A; Coit, DG			Clinicopathological features of and risk factors for multiple primary melanomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MELANOMA; DYSPLASTIC NAEVI; PREVALENCE; FAMILIES; NEVI	Context The,incidence of multiple primary melanomas ranges from 1.3% to 8.0% in large retrospective reviews; however, the impact of certain risk factors is not understood. Objectives To determine the incidence of multiple primary melanomas (MPM) from a prospective, single-institution, multidisciplinary database, and to describe the clinical and pathological characteristics and risk factors specific to these patients. Design and Setting Review of a prospectively maintained database at Memorial Sloan-Kettering Cancer Center in New York, NY. Patients A total of 4484 patients diagnosed with a first primary melanoma between January 1, 1996, and December 31, 2002. Main Outcome Measures Incidence of and risk factors for MPM. Results Three hundred eighty-five patients (8.6%) had 2 or more primary melanomas, with an average of 2.3 melanomas per MPM patient. Seventy-eight percent had 2 primary melanomas. For 74% of patients, the initial melanoma was the thickest tumor. Fifty-nine percent presented with their second primary tumor within 1 year. Twenty-one percent of MPM patients had a positive family history of melanoma compared with only 12% of patients with a single primary melanoma (SPM) (P<.001). Thirty-eight percent of MPM patients had dysplastic nevi compared with 18% of SPM patients (P<.001). The estimated cumulative 5-year risk of a second primary tumor for the entire cohort was 11.4%, with almost half of that risk occurring within the first year. For patients with a positive family history or dysplastic nevi, the estimated 5-year risk of MPM was significantly higher at 19.1% and 23.7%, respectively. The most striking increase in incidence for the MPM population was seen for development of a third primary melanoma from the time of second primary melanoma, which was 15.6% at 1 year and 30.9% at 5 years. Conclusions The incidence of MPM is increased in patients with a positive family history and/or dysplastic nevi. These patients should undergo intensive dermatologic screening and should consider genetic testing.	Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Dermatol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Coit, DG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	coitd@mskcc.org	Berwick, Marianne/E-9608-2010	Berwick, Marianne/0000-0001-5062-2180; halpern, allan/0000-0001-7320-1901				*AM CANC SOC, IN PRESS FACTS FIG 2; Blackwood MA, 2002, CANCER, V94, P2248, DOI 10.1002/cncr.10454; Brobeil A, 1997, ANN SURG ONCOL, V4, P19, DOI 10.1007/BF02316806; CASCINELLI N, 1975, TUMORI, V61, P481, DOI 10.1177/030089167506100508; COOKE KR, 1989, CANCER, V63, P1240, DOI 10.1002/1097-0142(19890315)63:6<1240::AID-CNCR2820630635>3.0.CO;2-9; CRUTCHER WA, 1984, LANCET, V1, P729; DiFronzo LA, 1999, ANN SURG ONCOL, V6, P705, DOI 10.1007/s10434-999-0705-0; GILES G, 1995, MELANOMA RES, V5, P433, DOI 10.1097/00008390-199512000-00007; Goggins WB, 2003, CANCER, V97, P639, DOI 10.1002/cncr.11116; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hansen CB, 2004, LANCET ONCOL, V5, P314, DOI 10.1016/S1470-2045(04)01469-X; Hughes-Davies TH, 1998, NEW ENGL J MED, V339, P347; Johnson TM, 1998, J AM ACAD DERMATOL, V39, P422, DOI 10.1016/S0190-9622(98)70318-4; KANG S, 1992, CANCER, V70, P1911, DOI 10.1002/1097-0142(19921001)70:7<1911::AID-CNCR2820700718>3.0.CO;2-Q; Mantelli M, 2002, AM J MED GENET, V107, P214, DOI 10.1002/ajmg.10137; NEUGUT AI, 1999, MULTIPLE PRIMARY CAN, P445; PACK GT, 1952, CANCER, V5, P1110, DOI 10.1002/1097-0142(195211)5:6<1110::AID-CNCR2820050607>3.0.CO;2-7; Puig S, 2005, J CLIN ONCOL, V23, P3043, DOI 10.1200/JCO.2005.08.034; SLINGLUFF CL, 1993, SURGERY, V113, P330; TITUSERNSTOFF L, 1988, CANCER RES, V48, P1016; Tucker MA, 2002, CANCER, V94, P3192, DOI 10.1002/cncr.10605	21	151	151	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2005	294	13					1647	1654		10.1001/jama.294.13.1647	http://dx.doi.org/10.1001/jama.294.13.1647			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970DC	16204664	Bronze			2022-12-01	WOS:000232284400017
J	Allen, JT; Brown, L; Sanders, R; Moore, CM; Mustard, A; Fielding, S; Lucas, M; Rixen, M; Savidge, G; Henson, S; Mayor, D				Allen, JT; Brown, L; Sanders, R; Moore, CM; Mustard, A; Fielding, S; Lucas, M; Rixen, M; Savidge, G; Henson, S; Mayor, D			Diatom carbon export enhanced by silicate upwelling in the northeast Atlantic	NATURE			English	Article							ALMERIA-ORAN FRONT; MESOSCALE SUBDUCTION; PHYTOPLANKTON; BLOOM; NUTRIENTS; OCEAN; JUNE	Diatoms are unicellular or chain-forming phytoplankton that use silicon ( Si) in cell wall construction. Their survival during periods of apparent nutrient exhaustion enhances carbon sequestration in frontal regions of the northern North Atlantic. These regions may therefore have a more important role in the 'biological pump' than they have previously been attributed(1), but how this is achieved is unknown. Diatom growth depends on silicate availability, in addition to nitrate and phosphate(2,3), but northern Atlantic waters are richer in nitrate than silicate(4). Following the spring stratification, diatoms are the first phytoplankton to bloom(2,5). Once silicate is exhausted, diatom blooms subside in a major export event(6,7). Here we show that, with nitrate still available for new production, the diatom bloom is prolonged where there is a periodic supply of new silicate: specifically, diatoms thrive by 'mining' deep-water silicate brought to the surface by an unstable ocean front. The mechanism we present here is not limited to silicate fertilization; similar mechanisms could support nitrate-,phosphate- or iron-limited frontal regions in oceans elsewhere.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; N Highland Coll, UHI Millenium Inst, Environm Res Inst, Thurso KW14 7JD, Caithness, Scotland; Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AJ, Fife, Scotland; NATO Undersea Res Ctr, I-19138 La Spezia, Italy; Queens Univ Belfast, Marine Lab, Portaferry BT22 1PF, North Ireland	NERC National Oceanography Centre; UHI Millennium Institute; University of St Andrews; NATO (North Atlantic Treaty Organisation); Queens University Belfast	Allen, JT (corresponding author), Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	jta@noc.soton.ac.uk	Sanders, Richard J/B-8717-2012; Henson, Stephanie/AAC-9709-2019; Mayor, Daniel/HDN-8520-2022; Fielding, Sophie/E-5137-2012; Allen, John Taylor/AHB-3419-2022	Sanders, Richard J/0000-0002-6884-7131; Mayor, Daniel/0000-0002-1295-0041; Fielding, Sophie/0000-0002-3152-4742; Allen, John Taylor/0000-0001-7357-6623; Moore, Mark/0000-0002-9541-6046				Allen J, 2002, SEA TECHNOL, V43, P35; ALLEN JT, 1994, DEEP-SEA RES PT I, V41, P51, DOI 10.1016/0967-0637(94)90026-4; Allen JT, 1996, J PHYS OCEANOGR, V26, P2611, DOI 10.1175/1520-0485(1996)026<2611:PVAVVA>2.0.CO;2; Allen JT, 2001, J MARINE SYST, V30, P263, DOI 10.1016/S0924-7963(01)00062-8; ALLEN JT, 2001, RRS DISCOVERY CRUISE; Brown L, 2003, LIMNOL OCEANOGR, V48, P1831, DOI 10.4319/lo.2003.48.5.1831; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; Brzezinski MA, 1997, LIMNOL OCEANOGR, V42, P856, DOI 10.4319/lo.1997.42.5.0856; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P1, DOI 10.1016/0967-0645(93)90003-6; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Garabato ACN, 2002, DEEP-SEA RES PT II, V49, P3771; HONJO S, 1993, DEEP-SEA RES PT II, V40, P587, DOI 10.1016/0967-0645(93)90034-K; Koeve W, 2001, MAR CHEM, V74, P245, DOI 10.1016/S0304-4203(01)00016-0; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Louanchi F, 2001, DEEP-SEA RES PT II, V48, P2155, DOI 10.1016/S0967-0645(00)00185-5; Lovejoy C, 2002, AQUAT MICROB ECOL, V29, P267, DOI 10.3354/ame029267; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Moore CM, 2005, DEEP-SEA RES PT I, V52, P401, DOI 10.1016/j.dsr.2004.09.003; Munk W, 2000, P ROY SOC A-MATH PHY, V456, P1217, DOI 10.1098/rspa.2000.0560; SAVIDGE G, 1995, DEEP-SEA RES PT I, V42, P599, DOI 10.1016/0967-0637(95)00016-Y; Shearman RK, 1999, J PHYS OCEANOGR, V29, P651, DOI 10.1175/1520-0485(1999)029<0651:DOTTDC>2.0.CO;2; SIERACKI ME, 1993, DEEP-SEA RES PT II, V40, P213, DOI 10.1016/0967-0645(93)90014-E; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; Sverdrup H.U., 1953, J CONS CONS PERM INT, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Yallop ML, 2001, DEEP-SEA RES PT II, V48, P825, DOI 10.1016/S0967-0645(00)00099-0; Yool A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002018	30	130	135	6	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					728	732		10.1038/nature03948	http://dx.doi.org/10.1038/nature03948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193051				2022-12-01	WOS:000232157900051
J	Warny, M; Pepin, J; Fang, A; Killgore, G; Thompson, A; Brazier, J; Frost, E; McDonald, LC				Warny, M; Pepin, J; Fang, A; Killgore, G; Thompson, A; Brazier, J; Frost, E; McDonald, LC			Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe	LANCET			English	Article							BINARY TOXIN; ADP-RIBOSYLTRANSFERASE; PATHOGENICITY LOCUS; GENES; TOXINOTYPES; POLYMORPHISM	Background Toxins A and B are the primary virulence factors of Clostridium difficile. Since 2002, an epidemic of C difficile-associated disease with increased morbidity and mortality has been present in Quebec province, Canada. We characterised the dominant strain of this epidemic to determine whether it produces higher amounts of toxins A and B than those produced by non-epidemic strains. Methods We obtained isolates from 124 patients from Centre Hospitalier Universitaire de Sherbrooke in Quebec. Additional isolates from the USA, Canada, and the UK were included to increase the genetic diversity of the toxinotypes tested. Isolate characterisation included toxinotyping, pulsed-field gel electrophoresis (PFGE), PCR ribotyping, detection of a binary toxin gene, and detection of deletions in a putative negative regulator for toxins A and B (tcdC). By use of an enzyme-linked immunoassay, we measured the in-vitro production of toxins A and B by epidemic strain and non-dominant strain isolates. Findings The epidemic strain was characterised as toxinotype III, North American PFGE type 1, and PCR-ribotype 027 (NAP1/027). This strain carried the binary toxin gene cdtB and an 18-bp deletion in tcdC. We isolated this strain from 72 patients with C difficile-associated disease (58 [67%] of 86 with health-care-associated disease; 14 [37%] of 38 with community-acquired disease). Peak median (IQR) toxin A and toxin B concentrations produced in vitro by NAP1/027 were 16 and 23 times higher, respectively, than those measured in isolates representing 12 different PFGE types, known as toxinotype 0 (toxin A, median 848 mu g/L [IQR 504-10221 vs 54 mu g/L [23-203]; toxin B, 180 mu g/L [137-210] vs 8 mu g/L [5-25]; p< 0.0001 for both toxins). Interpretation The severity of C difficile-associated disease caused by NAP1/027 could result from hyperproduction of toxins A and B. Dissemination of this strain in North America and Europe could lead to important changes in the epidemiology of C difficile-associated disease.	Acambis Inc, Cambridge, MA 02139 USA; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; Ctr Dis Control & Prevent, Atlanta, GA USA; Microbiol Cardiff Univ Hosp Wales, Natl Publ Hlth Serv Wales, Anaerobe Reference Lab, Cardiff, S Glam, Wales	Sanofi-Aventis; University of Sherbrooke; Centers for Disease Control & Prevention - USA	Warny, M (corresponding author), Acambis Inc, Cambridge, MA 02139 USA.	michel.warny@acambis.com		McDonald, L. Clifford/0000-0003-3044-5572; Frost, Eric/0000-0001-8958-4388				Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; BOYCE JM, 2005, P 15 ANN SCI M SOC H; Eggertson L, 2004, CAN MED ASSOC J, V171, P1331, DOI 10.1503/cmaj.1041694; EHRICH M, 1980, INFECT IMMUN, V28, P1041; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; *HLTH PROT AG, 2005, CDR WEEKLY, V15, P1; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Institut National de Sante Publique du Quebec, 2011, SURV DIARRH ASS CLOS; Johnson S, 2003, J CLIN MICROBIOL, V41, P1543, DOI 10.1128/JCM.41.4.1543-1547.2003; Klaassen CHW, 2002, J CLIN MICROBIOL, V40, P101, DOI 10.1128/JCM.40.1.101-104.2002; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; MARLER LM, 1992, J CLIN MICROBIOL, V30, P514, DOI 10.1128/JCM.30.2.514-516.1992; MCDONALD LC, 2004, P 42 ANN M INF DIS S; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; PATEL S, 2005, P 15 ANN SCI M SOC H; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; PEPIN J, IN PRESS CLIN INFECT; PEPIN J, IN PRESS CMAJ; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; VANSTEENBERGEN J, ISOLATION CLOSTRIDIU; Warny M, 2003, MICROBIAL PATHOGENESIS AND THE INTESTINAL EPITHELIAL CELL, P503; WREN B, 1987, J CLIN PATHOL, V40, P1397, DOI 10.1136/jcp.40.12.1397; RESULTS 1 YEAR MANDA	31	1082	1137	1	60	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 24	2005	366	9491					1079	1084		10.1016/S0140-6736(05)67420-X	http://dx.doi.org/10.1016/S0140-6736(05)67420-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967TL	16182895				2022-12-01	WOS:000232114000025
J	Bradley, P; Misura, KMS; Baker, D				Bradley, P; Misura, KMS; Baker, D			Toward high-resolution de novo structure prediction for small proteins	SCIENCE			English	Article							CHAIN; SEQUENCES; DOCKING; DESIGN	The prediction of protein structure from amino acid sequence is a grand challenge of computational molecular biology. By using a combination of improved low- and high-resolution conformational sampling methods, improved atomically detailed potential functions that capture the jigsaw puzzle-like packing of protein cores, and high-performance computing, high-resolution structure prediction (<1.5 angstroms) can be achieved for small protein domains (<85 residues). The primary bottleneck to consistent high-resolution prediction appears to be conformational sampling.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217				ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905	15	619	662	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1868	1871		10.1126/science.1113801	http://dx.doi.org/10.1126/science.1113801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166519				2022-12-01	WOS:000231989500053
J	Watson, FL; Puttmann-Holgado, R; Thomas, F; Lamar, DL; Hughes, M; Kondo, M; Rebel, VI; Schmucker, D				Watson, FL; Puttmann-Holgado, R; Thomas, F; Lamar, DL; Hughes, M; Kondo, M; Rebel, VI; Schmucker, D			Extensive diversity of Ig-superfamily proteins in the immune system of insects	SCIENCE			English	Article							GENOMIC ANALYSIS; AXON GUIDANCE; DROSOPHILA; RECEPTOR; DSCAM; EXPRESSION; DIVERSIFICATION; HEMOCYTES; PATTERN; GENES	The extensive somatic diversification of immune receptors is a hallmark of higher vertebrates. However, whether molecular diversity contributes to immune protection in invertebrates is unknown. We present evidence that Drosophila immune-competent cells have the potential to express more than 18,000 isoforms of the immunoglobulin (Ig)-superfamily receptor Down syndrome cell adhesion molecule (Dscam). Secreted protein isoforms of Dscam were detected in the hemolymph, and hemocyte-specific loss of Dscam impaired the efficiency of phagocytic uptake of bacteria, possibly due to reduced bacteria[ binding. Importantly, the molecular diversity of Dscam transcripts generated through a mechanism of alternative splicing is highly conserved across major insect orders, suggesting an unsuspected molecular complexity of the innate immune system of insects.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol,Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Schmucker, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol,Dept Neurobiol, Boston, MA 02115 USA.	dietmar_schmucker@dfci.harvard.edu		Rebel, Vivienne/0000-0002-3862-3903	NINDS NIH HHS [1RO1-NS46747-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cuthbertson BJ, 2002, IMMUNOGENETICS, V54, P442, DOI 10.1007/s00251-002-0487-z; Daly HV, 1998, INTRO INSECT BIOL DI; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; EZEKOWITZ A, 2003, INNATE IMMUNITY; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	23	520	539	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1874	1878		10.1126/science.1116887	http://dx.doi.org/10.1126/science.1116887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16109846				2022-12-01	WOS:000231989500055
J	Lee, DS; Tu, JV; Juurlink, DN; Alter, DA; Ko, DT; Austin, PC; Chong, A; Stukel, TA; Levy, D; Laupacis, A				Lee, DS; Tu, JV; Juurlink, DN; Alter, DA; Ko, DT; Austin, PC; Chong, A; Stukel, TA; Levy, D; Laupacis, A			Risk-treatment mismatch in the pharmacotherapy of heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING ENZYME-INHIBITORS; ACUTE CORONARY SYNDROMES; QUALITY-OF-CARE; ELDERLY-PATIENTS; BETA-BLOCKERS; MYOCARDIAL-INFARCTION; TASK-FORCE; UNSTABLE ANGINA; OLDER PATIENTS; MORTALITY	Context Patients with heart failure have a wide spectrum of mortality risks. To maximize the benefit of available pharmacotherapies, patients with high mortality risk should receive high rates of drug therapy. Objective To examine patterns of drug therapy and underlying mortality risk in patients with heart failure. Design, Setting, and Patients In the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) population-based cohort (1999-2001) of 9942 patients with heart failure hospitalized in Ontario, Canada, we evaluated 1418 patients with documented left ventricular ejection fraction of 40% or less and aged 79 years or younger with low-, average-, and high-predicted risk of death within 1 year; all patients survived to hospital discharge. Administration of angiotensin-converting enzyme (ACE) inhibitors, ACE inhibitors or angiotensin II receptor blockers (ARBs), and beta-adrenoreceptor antagonists was evaluated according to predicted risk of death. Main Outcome Measure Heart failure drug administration rates at time of discharge and 90 days after hospital discharge. Results At hospital discharge, prescription rates for patients in the low-, average-, and high-risk groups were 81%, 73%, 60%, respectively, for ACE inhibitors; 86%, 80%, 65%, respectively, for ACE inhibitors or ARBs; and 40%, 33%, 24%, respectively, for beta-adrenoreceptor antagonists (all P<.001 for trend). Within 90 days following hospital discharge, the rates were 83%, 76%, and 61% for ACE inhibitors; 89%, 83%, and 67% for ACE inhibitors or ARBs; and 43%, 36%, and 28% for beta-adrenoreceptor antagonists for the 3 risk groups, respectively (all P<.001 for trend). The pattern of lower rates of drug administration in those patients at increasing risk was maintained up to 1 year postdischarge (P<.001). After accounting for varying survival time and potential contraindications to therapy, low-risk patients were more likely to receive ACE inhibitors or ARBs (adjusted hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.49-1.74) and beta-adrenoreceptor antagonists (HR, 1.80; 95% CI, 1.60-2.01) compared with high-risk patients (both P<.001). Conclusions Patients with heart failure at greatest risk of death are least likely to receive ACE inhibitors, ACE inhibitors or ARBs, and beta-adrenoreceptor antagonists. Understanding the reasons underlying this mismatch may facilitate improvements in care and outcomes for patients with heart failure.	Univ Toronto, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; NHLBI, Framingham Heart Study, NIH, Framingham, MA USA	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Laupacis, A (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Room G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	alaupacis@ices.on.ca	Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Austin, Peter/0000-0003-3337-233X; Ko, Dennis/0000-0001-6840-8051; Lee, Douglas/0000-0001-7078-745X; Stukel, Therese/0000-0002-2951-1360; Tu, Jack/0000-0003-0111-722X				Ahmed A, 2002, J AM GERIATR SOC, V50, P1659, DOI 10.1046/j.1532-5415.2002.50457.x; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; American Heart Association, 2005, HEART DIS STROKE STA; Barakat K, 1999, LANCET, V353, P955, DOI 10.1016/S0140-6736(98)07114-1; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bouzamondo A, 2003, EUR J HEART FAIL, V5, P281, DOI 10.1016/S1388-9842(03)00042-4; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3; Deedwania PC, 2004, EUR HEART J, V25, P1300, DOI 10.1016/j.ehj.2004.05.022; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Furberg CD, 1996, J AM COLL CARDIOL, V27, P976, DOI 10.1016/0735-1097(96)87730-8; Gambassi G, 2000, ARCH INTERN MED, V160, P53, DOI 10.1001/archinte.160.1.53; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Good PI, 2000, PERMUTATION TESTS PR; Halon DA, 2004, J AM COLL CARDIOL, V43, P346, DOI 10.1016/j.jacc.2003.08.044; Havranek EP, 1998, ARCH INTERN MED, V158, P2024, DOI 10.1001/archinte.158.18.2024; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Johnson D, 2003, J AM COLL CARDIOL, V42, P1438, DOI 10.1016/S0735-1097(03)01058-1; Jong P, 2002, J AM COLL CARDIOL, V39, P463, DOI 10.1016/S0735-1097(01)01775-2; Juurlink DN, 2001, CAN MED ASSOC J, V165, P27; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Kotlyar E, 2002, J HEART LUNG TRANSPL, V21, P1290, DOI 10.1016/S1053-2498(02)00459-X; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Lee DS, 2003, CAN J CARDIOL, V19, P357; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; Liu P, 2003, CAN J CARDIOL, V19, P347; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 1998, EUR HEART J, V19, pP9; Morris AD, 1997, DIABETES CARE, V20, P1363, DOI 10.2337/diacare.20.9.1363; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Rathore SS, 2003, AM J MED, V114, P307, DOI 10.1016/S0002-9343(02)01531-0; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 2000, LANCET, V356, P639, DOI 10.1016/S0140-6736(00)02606-4; Rosner B., 2000, FUNDAMENTALS BIOSTAT, V5th ed.; Rouleau JL, 2004, J AM COLL CARDIOL, V43, P1423, DOI 10.1016/j.jacc.2003.11.037; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shibata MC, 2001, EUR J HEART FAIL, V3, P351, DOI 10.1016/S1388-9842(01)00144-1; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tonkin AM, 2000, LANCET, V356, P1871, DOI 10.1016/S0140-6736(00)03257-8; Tu JV, 2001, JAMA-J AM MED ASSOC, V285, P3116, DOI 10.1001/jama.285.24.3116; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	52	178	182	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2005	294	10					1240	1247		10.1001/jama.294.10.1240	http://dx.doi.org/10.1001/jama.294.10.1240			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963UI	16160132	Bronze			2022-12-01	WOS:000231831200021
J	Bell, DR; Jorgensen, P; Christophel, EM; Palmer, KL				Bell, DR; Jorgensen, P; Christophel, EM; Palmer, KL			Malaria risk - Estimation of the malaria burden	NATURE			English	Letter							PLASMODIUM-FALCIPARUM		World Hlth Org, Reg Off Western Pacific, Malaria Other Vector Borne & Parasit Dis Unit, Manila, Philippines	World Health Organization	Bell, DR (corresponding author), World Hlth Org, Reg Off Western Pacific, Malaria Other Vector Borne & Parasit Dis Unit, POB 2932, Manila, Philippines.	belld@wpro.who.int						Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Gillies M. T., 1988, Malaria: principles and practice of malariology. Volume 1., P453; Lysenko AY., 1968, MEDICINSKAJA GEOGRAF, V25, P146; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Socheat Doung, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P1; Torres EP, 1997, ACTA TROP, V63, P209, DOI 10.1016/S0001-706X(96)00622-5; *UN ENV PROGR, 2001, AS PAC ENV OUTL, V2; *WHO, 2005, MAL OTH VECT PAR DIS; *WHO EXP COMM, 2000, 20 WHO EXP COMM	10	24	25	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					E3	E4		10.1038/nature04179	http://dx.doi.org/10.1038/nature04179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148887				2022-12-01	WOS:000231696900044
J	Schuldiner, M; Collins, SR; Thompson, NJ; Denic, V; Bhamidipati, A; Punna, T; Ihmels, J; Andrews, B; Boone, C; Greenblatt, JF; Weissman, JS; Krogan, NJ				Schuldiner, M; Collins, SR; Thompson, NJ; Denic, V; Bhamidipati, A; Punna, T; Ihmels, J; Andrews, B; Boone, C; Greenblatt, JF; Weissman, JS; Krogan, NJ			Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN COMPLEXES; GLOBAL ANALYSIS; EXPRESSION; GENOME; GENE; LOCALIZATION; NETWORK	We present a strategy for generating and analyzing comprehensive genetic-interaction maps, termed E-MAPs (epistatic miniarray profiles), comprising quantitative measures of aggravating or alleviating interactions between gene pairs. Crucial to the interpretation of E-MAPs is their high-density nature made possible by focusing on logically connected gene subsets and including essential genes. Described here is the analysis of an E-MAP of genes acting in the yeast early secretory pathway. Hierarchical clustering, together with novel analytical strategies and experimental verification, revealed or clarified the role of many proteins involved in extensively studied processes such as sphingolipid metabolism and retention of HDEL proteins. At a broader level, analysis of the E-MAP delineated pathway organization and components of physical complexes and illustrated the interconnection between the various secretory processes. Extension of this strategy to other logically connected gene subsets in yeast and higher eukaryotes should provide critical insights into the functional/organizational principles of biological systems.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; University of Toronto	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Schuldiner, Maya/C-9488-2009	Schuldiner, Maya/0000-0001-9947-115X; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X				Balakrishnan R, 2005, NUCLEIC ACIDS RES, V33, pD374, DOI 10.1093/nar/gki023; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BOHNI PC, 1987, PROTEASES BIOL CONTR, P255; de Martin PE, 2005, J CELL SCI, V118, P65, DOI 10.1242/jcs.01583; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Enyenihi AH, 2003, GENETICS, V163, P47; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shahinian S, 1998, GENETICS, V149, P843; Shen J, 2003, BIOMETALS, V16, P369, DOI 10.1023/A:1022504311669; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Whyte JRC, 2002, J CELL SCI, V115, P2627	45	659	678	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					507	519		10.1016/j.cell.2005.08.031	http://dx.doi.org/10.1016/j.cell.2005.08.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269340	Bronze			2022-12-01	WOS:000233264300017
J	Perls, TT; Reisman, NR; Olshansky, SJ				Perls, TT; Reisman, NR; Olshansky, SJ			Provision or distribution of growth hormone for "antiaging": Clinical and legal issues	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; FACTOR-I; LIFE-SPAN; MEN; DEFICIENCY; THERAPY; REPLACEMENT; CANCER		Boston Med Ctr, Dept Med, Geriatr Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Baylor Coll Med, Dept Plast Surg, Houston, TX 77030 USA; St Lukes Episcopal Hosp, Houston, TX 77030 USA; Univ Illinois, Sch Publ Hlth, Chicago, IL USA	Boston Medical Center; Boston University; Baylor College of Medicine; Saint Lukes Episcopal Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Perls, TT (corresponding author), Boston Med Ctr, Dept Med, Geriatr Sect, Robinson 2400,88 E Newton St, Boston, MA 02118 USA.	thperls@bu.edu		Perls, Thomas/0000-0002-2492-4334	NATIONAL INSTITUTE ON AGING [K02AG000785] Funding Source: NIH RePORTER; NIA NIH HHS [K02 AG00785-05] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Bartke A, 2003, NEUROENDOCRINOLOGY, V78, P210, DOI 10.1159/000073704; Bartke A, 2001, J GERONTOL A-BIOL, V56, pB340, DOI 10.1093/gerona/56.8.B340; BIBBY K, BIOPEOPLE; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; CHAPPELL MA, 2004, FDA WARNING LETT ADD; COSTELLO G, FDA WARNING LETT A B; de Zegher F, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1934; GHARIB H, 2003, ENDOCR PRACT, V9, P65; Harman SM, 2004, J GERONTOL A-BIOL, V59, P652; JAMES J, 2005, AIDS TREAT NEWS, V411, P2; KAUFMAN M, 2002, WASHINGTON POST 1102, pA2; Koutkia P, 2004, JAMA-J AM MED ASSOC, V292, P210, DOI 10.1001/jama.292.2.210; Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P513, DOI 10.1210/jc.87.2.513; LANGRETH R, 2000, FORBES          1211; Lee PDK, 1996, J CLIN ENDOCR METAB, V81, P2968, DOI 10.1210/jc.81.8.2968; Lyle WG, 2002, PLAST RECONSTR SURG, V110, P1585, DOI 10.1097/00006534-200211000-00032; MARCUS R, 1990, J CLIN ENDOCR METAB, V70, P519, DOI 10.1210/jcem-70-2-519; Mehlman MJ, 2004, GERONTOLOGIST, V44, P304, DOI 10.1093/geront/44.3.304; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Perls TT, 2004, J GERONTOL A-BIOL, V59, P682; Pugeat M, 2004, Horm Res, V62 Suppl 4, P2, DOI 10.1159/000080902; Roehr Bob, 2003, BETA, V15, P12; ROTHENBERG R, 2001, FOREVER AGELESS; Schambelan M, 1996, ANN INTERN MED, V125, P873, DOI 10.7326/0003-4819-125-11-199612010-00002; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; SULLIVAN M, 1998, ANTIAGING HORMONES P; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; TRAN D, FDA WARNING LETT GEN; U.S. Senate Special Committee on Aging, 2001, SWINDL HUCKST SNAK O; *US HOUS REPR, 1984, PUBL US HOUS REPR; Vance ML, 2003, NEW ENGL J MED, V348, P779, DOI 10.1056/NEJMp020186; Verhelst J, 1997, CLIN ENDOCRINOL, V47, P485, DOI 10.1046/j.1365-2265.1997.3041112.x; Waters D, 1996, ANN INTERN MED, V125, P865, DOI 10.7326/0003-4819-125-11-199612010-00001; Wilson TA, 2003, J PEDIATR-US, V143, P415, DOI 10.1067/S0022-3476(03)00246-4; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	37	53	53	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2005	294	16					2086	2090		10.1001/jama.294.16.2086	http://dx.doi.org/10.1001/jama.294.16.2086			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977CB	16249424				2022-12-01	WOS:000232778900030
J	Santry, HP; Gillen, DL; Lauderdale, DS				Santry, HP; Gillen, DL; Lauderdale, DS			Trends in bariatric surgical procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Meeting of the Chicago-Surgical-Society	MAR 03, 2005	Chicago, IL	Chicago Surg Soc			Y GASTRIC BYPASS; UNITED-STATES; BILIOPANCREATIC DIVERSION; WEIGHT-LOSS; NATIONAL TRENDS; SURGERY; OBESITY; OUTCOMES; COMPLICATIONS; PREVALENCE	Context The increasing prevalence and associated sociodemographic disparities of morbid obesity are serious public health concerns. Bariatric surgical procedures provide greater and more durable weight reduction than behavioral and pharmacological interventions for morbid obesity. Objective To examine trends for elective bariatric surgical procedures, patient characteristics, and in-hospital complications from 1998 to 2003 in the United States. Design, Setting, and Patients The Nationwide Inpatient Sample was used to identify bariatric surgery admissions from 1998-2002 (with preliminary data for 12 states from 2003) using International Classification of Diseases, Ninth Revision, codes for foregut surgery with a confirmatory diagnosis of obesity or by diagnosis related group code for obesity surgery. Annual-estimates and trends were determined for procedures, patient characteristics, and adjusted complication rates. Main Outcome Measures Trends in bariatric surgical procedures, patient characteristics, and complications. Results The estimated number of bariatric surgical procedures increased from 13 365 in 1998 to 72 177 in 2002 (P<.001). Based on preliminary state-level data (19982003), the number of bariatric surgical procedures is projected to be 102 794 in 2003. Gastric bypass procedures accounted for more than 80% of all bariatric surgical procedures. From 1998 to 2002, there were upward trends in the proportion of females (81% to 84%; P=.003), privately insured patients (75% to 83%; P=.001), patients from ZIP code areas with highest annual household income (32% to 60%, P<.001), and patients aged 50 to 64 years (15% to 24%; P<.001). Length of stay decreased from 4.5 days in 1998 to 3.3 days in 2002 (P<.001). The adjusted in-hospital mortality rate ranged from 0.1% to 0.2%. The rates of unexpected reoperations for surgical complications ranged from 6% to 9% and pulmonary complications ranged from 4% to 7%. Rates of other in-hospital complications were low. Conclusions These findings suggest that use of bariatric surgical procedures increased substantially from 1998 to 2003, while rates of in-hospital complications were stable and length of stay decreased. However, disparities in the use of these procedures, with disproportionate and increasing use among women, those with private insurance, and those in wealthier ZIP code areas should be explored further.	Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Calif Irvine, Dept Stat, Irvine, CA USA	University of Chicago; University of Chicago; University of California System; University of California Irvine	Santry, HP (corresponding author), 5841 S Maryland Ave,MC 6040, Chicago, IL 60637 USA.	hpatel@surgery.bsd.uchicago.edu	Kohn, Geoffrey P/A-9056-2009	Santry, Heena/0000-0003-2352-1557	NATIONAL INSTITUTE ON AGING [P30AG012857] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG-12857-08] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLON N, 1982, PSYCHOL ASPECTS OBES, P130; [Anonymous], 1992, AM J CLIN NUTR S, V55, p487S; Barker FG, 2003, NEUROSURGERY, V52, P995, DOI 10.1227/01.NEU.0000057743.56678.5F; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; BRECHNER RJ, 2004, SUMMARY EVIDENCE BAR; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2002, OBES SURG, V12, P705, DOI 10.1381/096089202321019747; Byrne TK, 2001, SURG CLIN N AM, V81, P1181, DOI 10.1016/S0039-6109(05)70190-0; Carbonell AM, 2005, AM SURGEON, V71, P308; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; *CTR MED MED SERV, PROGR MEM INT CARR; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Encinosa WE, 2005, HEALTH AFFAIR, V24, P1039, DOI 10.1377/hlthaff.24.4.1039; Erickson Jennifer L, 2004, WMJ, V103, P32; Fisher BL, 2002, AM J SURG, V184, p9S, DOI 10.1016/S0002-9610(02)01173-X; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th, DOI DOI 10.1002/9780470973394; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hess DS, 1998, OBES SURG, V8, P267, DOI 10.1381/096089298765554476; July Fannie M, 2003, ABNF J, V14, P55; Kelly J, 2005, OBES RES, V13, P227, DOI 10.1038/oby.2005.31; Kral JG, 2001, SURG CLIN N AM, V81, P1039, DOI 10.1016/S0039-6109(05)70183-3; Liu JH, 2003, AM SURGEON, V69, P823; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; Livingston EH, 2004, SURGERY, V135, P288, DOI 10.1016/j.surg.2003.07.008; Livingston EH, 2003, J SURG RES, V109, P138, DOI 10.1016/S0022-4804(02)00085-9; Livingston EH, 2002, AM J SURG, V184, P103, DOI 10.1016/S0002-9610(02)00914-5; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P1761, DOI 10.1001/jama.289.14.1761; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Mun EC, 2001, GASTROENTEROLOGY, V120, P669, DOI 10.1053/gast.2001.22430; Perugini RA, 2003, ARCH SURG-CHICAGO, V138, P541, DOI 10.1001/archsurg.138.5.541; Podnos YD, 2003, ARCH SURG-CHICAGO, V138, P957, DOI 10.1001/archsurg.138.9.957; Pope GD, 2002, J GASTROINTEST SURG, V6, P855, DOI 10.1016/S1091-255X(02)00085-9; PORTIER C, 1984, COMMUN STAT-THEOR M, V13, P1, DOI 10.1080/03610928408828657; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Rabkin RA, 1998, OBES SURG, V8, P53, DOI 10.1381/096089298765555060; Ren CJ, 2000, OBES SURG, V10, P514, DOI 10.1381/096089200321593715; Resnick HE, 1998, DIABETES CARE, V21, P1828, DOI 10.2337/diacare.21.11.1828; Safadi BY, 2004, AM J SURG, V188, P606, DOI 10.1016/j.amjsurg.2004.07.021; Schauer PR, 2001, SURG CLIN N AM, V81, P1145, DOI 10.1016/S0039-6109(05)70189-4; Schauer PR, 2000, ANN SURG, V232, P515, DOI 10.1097/00000658-200010000-00007; SHEKELLE PG, 2004, AGENCY HEALTHCARE RE; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Taub DA, 2004, UROLOGY, V63, P862, DOI 10.1016/j.urology.2003.11.037; Tilghman Joan, 2003, ABNF J, V14, P66; Trus TL, 2005, SURG ENDOSC, V19, P616, DOI 10.1007/s00464-004-8827-8; Wainess RM, 2003, J GASTROINTEST SURG, V7, P879, DOI 10.1016/S1091-255X(03)00150-1; World Health Organisation, 1977, INT CLASS DIS 9 REV; Zhang Q, 2004, SOC SCI MED, V58, P1171, DOI 10.1016/S0277-9536(03)00288-0; Zizza CA, 2003, OBES RES, V11, P1519, DOI 10.1038/oby.2003.203	56	684	699	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2005	294	15					1909	1917		10.1001/jama.294.15.1909	http://dx.doi.org/10.1001/jama.294.15.1909			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	974OZ	16234497	Bronze			2022-12-01	WOS:000232602600020
J	A'Hearn, MF; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Sunshine, JM; Thomas, PC; Veverka, J; Yeomans, DK; Baca, MW; Busko, I; Crockett, CJ; Collins, SM; Desnoyer, M; Eberhardy, CA; Ernst, CM; Farnham, TL; Feaga, L; Groussin, O; Hampton, D; Ipatov, SI; Li, JY; Lindler, D; Lisse, CM; Mastrodemos, N; Owen, WM; Richardson, JE; Wellnitz, DD; White, RL				A'Hearn, MF; Belton, MJS; Delamere, WA; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Sunshine, JM; Thomas, PC; Veverka, J; Yeomans, DK; Baca, MW; Busko, I; Crockett, CJ; Collins, SM; Desnoyer, M; Eberhardy, CA; Ernst, CM; Farnham, TL; Feaga, L; Groussin, O; Hampton, D; Ipatov, SI; Li, JY; Lindler, D; Lisse, CM; Mastrodemos, N; Owen, WM; Richardson, JE; Wellnitz, DD; White, RL			Deep Impact: Excavating comet Tempel 1	SCIENCE			English	Article							P/WILD 2; NUCLEUS; EVOLUTION; MISSION; SURFACE	Deep Impact collided with comet Tempel 1, excavating a crater controlled by gravity. The comet's outer layer is composed of 1- to 100-micrometer fine particles with negligible strength (<65 pascals). Local gravitational field and average nucleus density (600 kilograms per cubic meter) are estimated from ejecta fallback. Initial ejecta were hot (>1000 kelvins). A large increase in organic material occurred during and after the event, with smaller changes in carbon dioxide relative to water. On approach, the spacecraft observed frequent natural outbursts, a mean radius of 3.0 +/- 0.1 kilometers, smooth and rough terrain, scarps, and impact craters. A thermal map indicates a surface in equilibrium with sunlight.	Univ Maryland, College Pk, MD 20742 USA; Belton Space Explorat Initiat, Tucson, AZ 85716 USA; Delamere Support Serv, Boulder, CO 80301 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Arizona, Tucson, AZ 85721 USA; Brown Univ, Providence, RI USA; SAIC, Chantilly, VA 20151 USA; Cornell Univ, Ithaca, NY 14853 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Ball Aerosp & Technol Corp, Boulder, CO 80301 USA; Sigma Sci, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	University System of Maryland; University of Maryland College Park; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; University of Arizona; Brown University; Science Applications International Corporation (SAIC); Cornell University; Space Telescope Science Institute; Ball Aerospace & Technologies; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	A'Hearn, MF (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	ma@astro.umd.edu	Lisse, Carey M/B-7772-2016; Meech, Karen/CAH-1412-2022; Ипатов, Сергей/O-2302-2014; White, Richard L/A-8143-2012; McFadden, Lucy-Ann/I-4902-2013; Ernst, Carolyn M/I-4902-2012; Wellnitz, Dennis/B-4080-2012	Lisse, Carey M/0000-0002-9548-1526; Ипатов, Сергей/0000-0002-1413-9180; McFadden, Lucy-Ann/0000-0002-0537-9975; Ernst, Carolyn M/0000-0002-9434-7886; White, Richard/0000-0002-9194-2807; Meech, Karen/0000-0002-2058-5670; Feaga, Lori/0000-0002-4230-6759; Sunshine, Jessica/0000-0002-9413-8785; Li, Jian-Yang/0000-0003-3841-9977				A'Hearn MF, 2005, SPACE SCI REV, V117, P1, DOI 10.1007/s11214-005-3387-3; Anderson JLB, 2004, METEORIT PLANET SCI, V39, P303, DOI 10.1111/j.1945-5100.2004.tb00342.x; Belton MJ, 2005, SPACE SCI REV, V117, P137, DOI 10.1007/s11214-005-3389-1; Blume WH, 2005, SPACE SCI REV, V117, P23, DOI 10.1007/s11214-005-3386-4; Britt DT, 2004, ICARUS, V167, P45, DOI 10.1016/j.icarus.2003.09.004; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Fernandez YR, 2002, ASTRON J, V123, P1050, DOI 10.1086/338436; Groussin O, 2004, ASTRON ASTROPHYS, V413, P1163, DOI 10.1051/0004-6361:20031564; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Housen KR, 1999, NATURE, V402, P155, DOI 10.1038/45985; Kolokolova L, 2004, SPACE SCI S, P577; LEBOFSKY LA, 1989, ASTEROIDS II, P128; Lisse C, 2002, EARTH MOON PLANETS, V90, P497, DOI 10.1023/A:1021519408600; Lisse CM, 2005, ASTROPHYS J, V625, pL139, DOI 10.1086/431238; Meech KJ, 2005, SCIENCE, V310, P265, DOI 10.1126/science.1118978; Melosh H.J., 1989, IMPACT CRATERING GEO; Richardson JE, 2005, SPACE SCI REV, V117, P241, DOI 10.1007/s11214-005-3393-5; Schmidt R. M., 1987, INT J IMPACT ENG, V5, P543, DOI [10.1016/0734-743X(87)90069-8, DOI 10.1016/0734-743X(87)90069-8]; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; Schultz PH, 1996, J GEOPHYS RES-PLANET, V101, P21117, DOI 10.1029/96JE02266; Sekanina Z, 2004, SCIENCE, V304, P1769, DOI 10.1126/science.1098388; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; ULICH BL, 1974, NATURE, V248, P121, DOI 10.1038/248121a0	23	581	587	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2005	310	5746					258	264		10.1126/science.1118923	http://dx.doi.org/10.1126/science.1118923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975NV	16150978				2022-12-01	WOS:000232670100037
J	Knight, TM; McCoy, MW; Chase, JM; McCoy, KA; Holt, RD				Knight, TM; McCoy, MW; Chase, JM; McCoy, KA; Holt, RD			Trophic cascades across ecosystems	NATURE			English	Article							FOOD WEBS; PREDATOR; TERRESTRIAL; VISITATION; DIVERSITY; SUBSIDIES; ECOLOGY; PREY	Predation can be intense, creating strong direct and indirect effects throughout food webs(1-4). In addition, ecologists increasingly recognize that fluxes of organisms across ecosystem boundaries can have major consequences for community dynamics(5,6). Species with complex life histories often shift habitats during their life cycles(7) and provide potent conduits coupling ecosystems(5,6). Thus, local interactions that affect predator abundance in one ecosystem ( for example a larval habitat) may have reverberating effects in another ( for example an adult habitat). Here we show that fish indirectly facilitate terrestrial plant reproduction through cascading trophic interactions across ecosystem boundaries. Fish reduce larval dragonfly abundances in ponds, leading to fewer adult dragonflies nearby. Adult dragonflies consume insect pollinators and alter their foraging behaviour. As a result, plants near ponds with fish receive more pollinator visits and are less pollen limited than plants near fish-free ponds. Our results confirm that strong species interactions can reverberate across ecosystems, and emphasize the importance of landscape-level processes in driving local species interactions.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	State University System of Florida; University of Florida; Washington University (WUSTL)	Knight, TM (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	tknight@biology2.wustl.edu		McCoy, Michael/0000-0002-7993-6236				[Anonymous], 2004, FOOD WEBS LANDSCAPE; BYERS CF, 1930, CONTRIBUTION KNOWLED; Corbet P.S., 1999, DRAGONFLIES BEHAV EC; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dunkle S. W., 1989, DRAGONFLIES FLORIDA; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Johansson F, 2003, J FRESHWATER ECOL, V18, P415, DOI 10.1080/02705060.2003.9663977; Knapp RA, 2001, ECOL MONOGR, V71, P401, DOI 10.1890/0012-9615(2001)071[0401:RAROAL]2.0.CO;2; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MORIN PJ, 1984, ECOLOGY, V65, P53, DOI 10.2307/1939457; Moyle P.B., 1986, Ecological Studies, P27; Munoz AA, 2004, OECOLOGIA, V138, P66, DOI 10.1007/s00442-003-1405-2; Murakami M, 2002, ECOL LETT, V5, P333, DOI 10.1046/j.1461-0248.2002.00321.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Needham James G., 1945, BULL BROOKLYN ENT SOC, V40, P104; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.1890/0012-9658(2002)083[1860:RWEEOR]2.0.CO;2; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Takhtajan A.L., 1997, DIVERSITY CLASSIFICA; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wright M., 1944, Journal of the Tennessee Academy of Science, V19, P295	28	355	366	6	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2005	437	7060					880	883		10.1038/nature03962	http://dx.doi.org/10.1038/nature03962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208370				2022-12-01	WOS:000232338600045
J	Massimini, M; Ferrarelli, F; Huber, R; Esser, SK; Singh, H; Tononi, G				Massimini, M; Ferrarelli, F; Huber, R; Esser, SK; Singh, H; Tononi, G			Breakdown of cortical effective connectivity during sleep	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY; COHERENCE; STATES; BRAIN; OSCILLATIONS; CORTEX; CYCLE; ELECTROENCEPHALOGRAM; SYNCHRONIZATION	When we fall asleep, consciousness fades yet the brain remains active. Why is this so? To investigate whether changes in cortical information transmission play a role, we used. transcranial magnetic stimulation together with high-density electroencephalography and asked how the activation of one cortical area (the premotor area) is transmitted to the rest of the brain. During quiet wakefulness, an initial response.(similar to 15 milliseconds) at the stimulation site was followed by a sequence of waves that moved to connected cortical areas several centimeters away. During non-rapid eye movement sleep, the initial response was stronger but was rapidly extinguished and did not propagate beyond the stimulation site. Thus, the fading of consciousness during certain stages of steep may be related to a breakdown in cortical effective connectivity.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Milan, Dept Clin Sci, I-20157 Milan, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Milan	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu	ferrarelli, fabio/C-2945-2011; Ferrarelli, Fabio/D-3219-2019; Tononi, Giulio/B-8387-2009; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Massimini, Marcello/0000-0003-2271-957X				Achermann P, 1998, NEUROSCIENCE, V85, P1195, DOI 10.1016/S0306-4522(97)00692-1; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bertini M, 2004, J SLEEP RES, V13, P31, DOI 10.1046/j.1365-2869.2003.00379.x; BULLOCK TH, 1995, P NATL ACAD SCI USA, V92, P11568, DOI 10.1073/pnas.92.25.11568; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; CRICK F, 1990, COLD SPRING HARB SYM, V55, P953; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Duckrow RB, 2005, CLIN NEUROPHYSIOL, V116, P1088, DOI 10.1016/j.clinph.2004.12.002; DUMERMUTH G, 1981, EUR NEUROL, V20, P429, DOI 10.1159/000115274; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Grosse P, 2002, NEUROLOGY, V59, P1988, DOI 10.1212/01.WNL.0000038762.11894.DA; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kakigi R, 2003, SLEEP MED, V4, P493, DOI 10.1016/S1389-9457(03)00169-2; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lee L, 2003, NEUROIMAGE, V19, P457, DOI 10.1016/S1053-8119(03)00062-4; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Marconi B, 2003, EUR J NEUROSCI, V18, P775, DOI 10.1046/j.1460-9568.2003.02807.x; Pedroarena C, 1997, P NATL ACAD SCI USA, V94, P724, DOI 10.1073/pnas.94.2.724; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Salih F, 2005, J PHYSIOL-LONDON, V565, P695, DOI 10.1113/jphysiol.2004.082040; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1974, BASIC SLEEP MECH, P144; Stickgold R, 2001, SLEEP, V24, P171, DOI 10.1093/sleep/24.2.171; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Vanderwolf CH, 2000, BRAIN RES, V855, P217, DOI 10.1016/S0006-8993(99)02351-3; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	34	932	945	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2005	309	5744					2228	2232		10.1126/science.1117256	http://dx.doi.org/10.1126/science.1117256			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195466				2022-12-01	WOS:000232318000048
J	Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JR; Guenther, MG; Kumar, RM; Murray, HL; Jenner, RG; Gifford, DK; Melton, DA; Jaenisch, R; Young, RA				Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JR; Guenther, MG; Kumar, RM; Murray, HL; Jenner, RG; Gifford, DK; Melton, DA; Jaenisch, R; Young, RA			Core transcriptional regulatory circuitry in human embryonic stem cells	CELL			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; RNA INTERFERENCE; NETWORK MOTIFS; MOUSE; PLURIPOTENCY; SOX2; DIFFERENTIATION; ENHANCER; NANOG	The transcription factors OCT4, SOX2, and NANOG have essential roles in early development and are required for the propagation of undifferentiated embryonic stem (ES) cells in culture. To gain insights into transcriptional regulation of human ES cells, we have identified OCT4, SOX2, and NANOG target genes using genome-scale location analysis. We found, surprisingly, that OCT4, SOX2, and NANOG co-occupy a substantial portion of their target genes. These target genes frequently encode transcription factors, many of which are developmentally important homeodomain proteins. Our data also indicate that OCT4, SOX2, and NANOG collaborate to form regulatory circuitry consisting of autoregulatory and feedforward loops. These results provide new insights into the transcriptional regulation of stem cells and reveal how OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, CSAIL, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Jenner, Richard/J-8683-2012; Young, Richard A/F-6495-2012	Jenner, Richard/0000-0002-2946-6811; Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X	NATIONAL CANCER INSTITUTE [F32CA094664] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069400, F32GM068273] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA094664, CA094664] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, HG002668, R01 HG002668-02] Funding Source: Medline; NIGMS NIH HHS [GM068273, GM069400, F32 GM068273, R01 GM069400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Resendis-Antonio O, 2005, TRENDS GENET, V21, P16, DOI 10.1016/j.tig.2004.11.010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RODDA DJ, 2005, IN PRESS J BIOL CHEM, V18; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thieffry D, 1998, BIOINFORMATICS, V14, P391, DOI 10.1093/bioinformatics/14.5.391; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	56	3297	3508	6	370	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	2005	122	6					947	956		10.1016/j.cell.2005.08.020	http://dx.doi.org/10.1016/j.cell.2005.08.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	967ZL	16153702	Bronze, Green Accepted			2022-12-01	WOS:000232130200018
J	Young, EA; Coryell, W				Young, EA; Coryell, W			Suicide and the hypothalamic-pituitary-adrenal axis	LANCET			English	Editorial Material							DEXAMETHASONE-SUPPRESSION TEST; GLUCOCORTICOID-RECEPTOR GENE; PARAVENTRICULAR NUCLEUS; UNIPOLAR DEPRESSION; MESSENGER-RNA; VICTIMS; POLYMORPHISM; ASSOCIATION; BEHAVIOR		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Young, EA (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	eayoung@umich.edu		coryell, william/0000-0003-3989-7276				ARATO M, 1989, BIOL PSYCHIAT, V25, P355, DOI 10.1016/0006-3223(89)90183-2; Black Donald W, 2002, Ann Clin Psychiatry, V14, P83, DOI 10.1023/A:1016839404032; CARROLL B, 1980, RECENT ADV NEUROPSYC; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Coryell W, 2001, AM J PSYCHIAT, V158, P748, DOI 10.1176/appi.ajp.158.5.748; CORYELL W, 1981, AM J PSYCHIAT, V138, P1120; DOROVINIZIS K, 1987, AM J PSYCHIAT, V144, P1214; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; LESTER D, 1992, PHARMACOPSYCHIATRY, V25, P265, DOI 10.1055/s-2007-1014419; LOPEZ JF, 1992, NEUROENDOCRINOLOGY, V56, P491, DOI 10.1159/000126266; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; NIELSEN J, IN PRESS MAYO CLIN P; NORMAN WH, 1990, ACTA PSYCHIAT SCAND, V81, P120, DOI 10.1111/j.1600-0447.1990.tb06463.x; Pfennig A, 2005, BIOL PSYCHIAT, V57, P336, DOI 10.1016/j.biopsych.2004.11.017; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; Yerevanian BI, 2004, J AFFECT DISORDERS, V83, P103, DOI 10.1016/j.jad.2004.08.009	21	9	9	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 17	2005	366	9490					959	961		10.1016/S0140-6736(05)67348-5	http://dx.doi.org/10.1016/S0140-6736(05)67348-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168756				2022-12-01	WOS:000231955900004
J	Cherian, A; Seena, S; Bullock, RK; Antony, AC				Cherian, A; Seena, S; Bullock, RK; Antony, AC			Incidence of neural tube defects in the least-developed area of India: a population-based study	LANCET			English	Article							COBALAMIN DEFICIENCY	Hospital-based records from major cities of India, where roughly a quarter of the population resides, identified the frequency of neural tube defects (NTDS) as ranging from 3.9 to 8.8 per 1000 births, but the incidence in rural areas is unknown. We did a population-based door-to-door survey of mothers living in remote dusters of villages in Balrampur District in Uttar Pradesh, a region ranked as the least-developed area in India. The data showed that the incidence of NTDs was 6.57-8.21 per 1000 livebirths, which is among the highest worldwide. India's Ministry of Health needs to produce a strategy to reduce the incidence of such defects.	Emmanuel Hosp, Assoc Prem Sewa Hosp, Balrampur, Uttar Pradesh, India; Indiana Univ, Sch Nursing, Indianapolis, IN USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 1044 W Walnut St,R4-266, Indianapolis, IN 46202 USA.	aantony@iupui.edu						Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Busby A, 2005, BMJ-BRIT MED J, V330, P574, DOI 10.1136/bmj.330.7491.574; GOPALAN C, 2004, NFI B, V25, P1; *GOV IND, NAT COMM POP REP; KULKARNI ML, 1987, LANCET, V1, P1260; Refsum H, 2001, AM J CLIN NUTR, V74, P233; VERMA IC, 1978, LANCET, V1, P879; XIAO KZ, 1990, INT J EPIDEMIOL, V19, P978	9	71	72	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					930	931		10.1016/S0140-6736(05)67319-9	http://dx.doi.org/10.1016/S0140-6736(05)67319-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16154020				2022-12-01	WOS:000231770000031
J	Evans, PD; Gilbert, SL; Mekel-Bobrov, N; Vallender, EJ; Anderson, JR; Vaez-Azizi, LM; Tishkoff, SA; Hudson, RR; Lahn, BT				Evans, PD; Gilbert, SL; Mekel-Bobrov, N; Vallender, EJ; Anderson, JR; Vaez-Azizi, LM; Tishkoff, SA; Hudson, RR; Lahn, BT			Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans	SCIENCE			English	Article							RECENT POSITIVE SELECTION; MAJOR DETERMINANT; HAPLOTYPE RECONSTRUCTION; MOLECULAR EVOLUTION; STATISTICAL-METHOD; MAPS; POPULATION; SIGNATURES; LOCUS; ASPM	The gene Microcephalin (MCPH1) regulates brain size and has evolved under strong positive selection in the human evolutionary lineage. We show that one genetic variant of Microcephalin in modern humans, which arose 37,000 years ago, increased in frequency too rapidly to be compatible with neutral drift. This indicates that it has spread under strong positive selection, although the exact nature of the selection is unknown. The finding that an important brain gene has continued to evolve adaptively in anatomically modern humans suggests the ongoing evolutionary plasticity of the human brain. It also makes Microcephalin an attractive candidate locus for studying the genetics of human variation in brain-related phenotypes.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University System of Maryland; University of Maryland College Park	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu	Vallender, Eric/A-2450-2008	Vallender, Eric/0000-0003-3506-0540				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Dobyns WB, 2002, AM J MED GENET, V112, P315, DOI 10.1002/ajmg.10580; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jerison J. H, 1973, EVOLUTION BRAIN INTE; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Spuhler J. N., 1959, EVOLUTION MANS CAPAC; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tang H, 2002, GENETICS, V161, P447; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Wright S., 1978, EVOLUTION GENETICS P; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Zhang JZ, 2003, GENETICS, V165, P2063; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	49	322	331	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1717	1720		10.1126/science.1113722	http://dx.doi.org/10.1126/science.1113722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16151009				2022-12-01	WOS:000231836700042
J	Satpute-Krishnan, P; Serio, TR				Satpute-Krishnan, P; Serio, TR			Prion protein remodelling confers an immediate phenotypic switch	NATURE			English	Article							CHAIN RELEASE FACTOR; YEAST SUP35 PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VITRO; SCRAPIE; PROPAGATION; REPLICATION; DETERMINANT; INHERITANCE; MECHANISM	In a variety of systems, proteins have been linked to processes historically limited to nucleic acids, such as infectivity and inheritance(1,2). These atypical proteins, termed prions(3), lack sequence homology but are collectively defined by their capacity to adopt multiple physical and therefore functional states in vivo. Newly synthesized prion protein generally adopts the form already present in the cell, and this in vivo folding bias directs the near faithful transmission of the corresponding phenotypic state(1,2). Switches between the prion and non-prion phenotypes can occur in vivo(2); however, the fate of existing protein during these transitions and its effects on the emergence of new traits remain major unanswered questions. Here, we determine the changes in protein-state that induce phenotypic switching for the yeast prion Sup35/[PSI+]. We show that the prion form does not need to be specified by an alternate misfolding pathway initiated during Sup35 synthesis but instead can be accessed by mature protein. This remodelling of protein from one stable form to another is accompanied by the loss of Sup35 activity, evoking a rapid change in cellular phenotype within a single cell cycle.	Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Serio, TR (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Tricia_Serio@Brown.edu	Serio, Tricia/GPP-7129-2022; Satpute-Krishnan, Prasanna/ABE-5421-2020	Serio, Tricia/0000-0003-2687-7372				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Dagkesamanskaya AR, 1997, GENETIKA+, V33, P610; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Frolova L, 1996, RNA, V2, P334; GALGOCZY DJ, 2004, P NATL ACAD SCI USA, V108, P18069; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025	30	71	74	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					262	265		10.1038/nature03981	http://dx.doi.org/10.1038/nature03981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148935				2022-12-01	WOS:000231696900057
J	Linardopoulou, EV; Williams, EM; Fan, YX; Friedman, C; Young, JM; Trask, BJ				Linardopoulou, EV; Williams, EM; Fan, YX; Friedman, C; Young, JM; Trask, BJ			Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication	NATURE			English	Article							STRAND BREAK REPAIR; OLFACTORY RECEPTOR GENE; DNA; EVOLUTION; POLYMORPHISM; REGIONS; EXPANSION; SEQUENCES; REVEALS; REPEATS	Human subtelomeres are polymorphic patchworks of interchromosomal segmental duplications at the ends of chromosomes. Here we provide evidence that these patchworks arose recently through repeated translocations between chromosome ends. We assess the relative contribution of the principal mechanisms of ectopic DNA repair to the formation of subtelomeric duplications and find that non-homologous end-joining predominates. Once subtelomeric duplications arise, they are prone to homology-based sequence transfers as shown by the incongruent phylogenetic relationships of neighbouring sections. Interchromosomal recombination of subtelomeres is a potent force for recent change. Cytogenetic and sequence analyses reveal that pieces of the subtelomeric patchwork have changed location and copy number with unprecedented frequency during primate evolution. Half of the known subtelomeric sequence has formed recently, through human-specific sequence transfers and duplications. Subtelomeric dynamics result in a gene duplication rate significantly higher than the genome average and could have both advantageous and pathological consequences in human biology. More generally, our analyses suggest an evolutionary cycle between segmental polymorphisms and genome rearrangements.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trask, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N C3-168, Seattle, WA 98109 USA.	btrask@fhcrc.org		Williams, Eleanor/0000-0002-0851-7990	NIDCD NIH HHS [R01 DC004209] Funding Source: Medline; NIGMS NIH HHS [R01 GM057070] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; *GEN PUBL POL CTR, 2004, GEN INF TRANSL; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hansen TF, 2000, J THEOR BIOL, V207, P495, DOI 10.1006/jtbi.2000.2189; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Knight SJL, 2004, METHOD CELL BIOL, V75, P799; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Linardopoulou E, 2001, HUM MOL GENET, V10, P2373, DOI 10.1093/hmg/10.21.2373; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin CL, 2002, AM J HUM GENET, V70, P972, DOI 10.1086/339768; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Monfouilloux S, 1998, GENOMICS, V51, P165, DOI 10.1006/geno.1998.5358; Nergadze SG, 2004, GENOME RES, V14, P1704, DOI 10.1101/gr.2778904; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Ricchetti M, 2003, J MOL BIOL, V328, P847, DOI 10.1016/S0022-2836(03)00315-2; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Swofford D, 2000, PAUP PHYLOGENETIC AN; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	49	279	289	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					94	100		10.1038/nature04029	http://dx.doi.org/10.1038/nature04029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136133	Green Accepted			2022-12-01	WOS:000231560400047
J	Gans, J; Wolinsky, M; Dunbar, J				Gans, J; Wolinsky, M; Dunbar, J			Computational improvements reveal great bacterial diversity and high metal toxicity in soil	SCIENCE			English	Article							SPECIES ABUNDANCE; REASSOCIATION; PATTERNS; MODELS; DNA	The complexity of soil bacterial. communities has thus far confounded effective measurement. However, with improved analytical methods, we show that the abundance distribution and total diversity can be deciphered. Reanalysis of reassociation kinetics for bacterial community DNA from pristine and metal-polluted soils showed that a power law best described the abundance distributions. More than one million distinct genomes occurred in the pristine soil, exceeding previous estimates by two orders of magnitude. Metal pollution reduced diversity more than 99.9%, revealing the highly toxic effect of metal contamination, especially for rare taxa.	Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Gans, J (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87501 USA.							Adami C, 1998, FROM ANIM ANIMAT, P221; Allen AP, 2001, ECOL LETT, V4, P1, DOI 10.1046/j.1461-0248.2001.00194.x; Bevington P.R., 2003, DATA REDUCTION ERROR, DOI DOI 10.2307/2284752; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; DAAE FL, COMMUNICATION; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; HUGHES RG, 1986, AM NAT, V128, P879, DOI 10.1086/284611; Kotz S., 2001, LAPLACE DISTRIBUTION; Narang R, 2004, MICROB ECOL, V47, P396, DOI 10.1007/s00248-003-1026-7; PEARSON WR, 1977, NUCLEIC ACIDS RES, V4, P1727, DOI 10.1093/nar/4.6.1727; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Sandaa RA, 1999, FEMS MICROBIOL ECOL, V30, P237, DOI 10.1111/j.1574-6941.1999.tb00652.x; SMITH MJ, 1975, P NATL ACAD SCI USA, V72, P4805, DOI 10.1073/pnas.72.12.4805; Sole RV, 2000, PHYSICA A, V286, P337, DOI 10.1016/S0378-4371(00)00304-6; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Wilson JB, 1996, J ECOL, V84, P527, DOI 10.2307/2261475	19	801	901	13	424	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1387	1390		10.1126/science.1112665	http://dx.doi.org/10.1126/science.1112665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123304				2022-12-01	WOS:000231543300048
J	Blackstock, O				Blackstock, O			Curing stigma - The limits of antiretrovial access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Montefiore Med Ctr, Program Primary Care & Social Med, New York, NY 10467 USA	Montefiore Medical Center	Blackstock, O (corresponding author), Montefiore Med Ctr, Program Primary Care & Social Med, New York, NY 10467 USA.								0	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2005	353	8					752	752		10.1056/NEJMp058198	http://dx.doi.org/10.1056/NEJMp058198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957YK	16120853				2022-12-01	WOS:000231409300002
J	Hung, DT; Shakhnovich, EA; Pierson, E; Mekalanos, JJ				Hung, DT; Shakhnovich, EA; Pierson, E; Mekalanos, JJ			Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATORS; PSEUDOMONAS-AERUGINOSA; EXPRESSION; GENES; TOXR; INFECTION; CASCADE	Increasing antibiotic resistance requires the development of new approaches to combating infection. Virulence gene expression in vivo represents a target for antibiotic discovery that has not yet been explored. A high-throughput, phenotypic screen was used to identify a small molecule 4-[N-(1,8-naphthalimide)]-n-butyric acid, virstatin, that inhibits virulence regulation in Vibrio cholerae. By inhibiting the transcriptional regulator ToxT, virstatin prevents expression of two critical V. cholerae virulence factors, cholera toxin and the toxin coregulated. pilus. Orogastric administration. of virstatin protects infant mice from intestinal colonization by V. cholerae.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hung, DT (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	dhung@partners.org			NIAID NIH HHS [K08 AI060708-01, AI26289] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, K08AI060708] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; BROWN RC, 1995, MOL MICROBIOL, V16, P425, DOI 10.1111/j.1365-2958.1995.tb02408.x; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; HIGGINS DE, 1992, J BACTERIOL, V174, P6974, DOI 10.1128/JB.174.21.6974-6980.1992; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; ROYCHOUDHURY S, 1993, P NATL ACAD SCI USA, V90, P965, DOI 10.1073/pnas.90.3.965; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Waldor MK., 1996, ENTERIC INFECT IMMUN, P37, DOI [10.1007/978-1-4899-0313-6_3, DOI 10.1007/978-1-4899-0313-6_3]; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102	19	276	290	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2005	310	5748					670	674		10.1126/science.1116739	http://dx.doi.org/10.1126/science.1116739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	980ET	16223984				2022-12-01	WOS:000232997700040
J	Custer, B; Busch, MP; Marfin, AA; Petersen, LR				Custer, B; Busch, MP; Marfin, AA; Petersen, LR			The cost-effectiveness of screening the u.S. blood supply for West Nile virus	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; TRANSMISSION; TRANSFUSION; DONATION; HEALTH; RECOMMENDATIONS; MEDICINE; PANEL; HCV	Background: The spread of West Nile virus across North America and evidence of transmission by transfusion prompted the U.S. Food and Drug Administration to encourage the development of methods to screen the blood supply. Objective: To assess the cost-effectiveness of nucleic acid amplification testing for West Nile virus in the U.S. blood supply. Design: Markov cohort simulation. Data Sources: Outcome probabilities estimated from nucleic acid testing done for West Nile virus in 2003, data from the Centers for Disease Control and Prevention, and published literature. Costs were taken from an economic study of West Nile virus infection and from estimated test costs. Target Populations: Transfusion recipients, 60 years of age or older, with and without underlying immunocompromise. Time Horizon: Lifetime. Perspective: Societal. Interventions: The authors compared 6 strategies, taking into consideration minipool (pools of 6 to 16 donations) versus individual donation testing, and the geographic and seasonal nature of West Nile virus activity. Outcome Measures: Costs and effects of each strategy based on the prevention of transfusion-transmitted West Nile virus. Results of Base-Case Analysis: The cost-effectiveness of annual, national minipool testing was $483 000 per quality-adjusted life-year (QALY), whereas the cost-effectiveness of annual, national individual donation testing was $897 000/QALY. The cost-effectiveness of targeted individual donation testing in an area experiencing an outbreak coupled with minipool testing elsewhere was $520 000/QALY. Results of Sensitivity Analysis: in 1-way analyses, the most important influences were the prevalence of West Nile virus and the cost of minipool testing and individual donation testing. The 95% range of results from probabilistic sensitivity analysis for targeted individual donation testing was $256 000 to $1 044 000/ QALY. Limitations: The Outcomes of West Nile virus infection were based on data from the general population rather than from the population who received transfusions. The results are most useful in the context of geographically focused outbreaks of West Nile virus infection. Conclusions: Using targeted individual donation testing to interdict blood donations that are positive for the West Nile virus is relatively cost-effective but is highly dependent on West Nile virus prevalence.	Blood Syst Res Inst, San Francisco, CA 94118 USA	Vitalant; Vitalant Research Institute	Custer, B (corresponding author), Blood Syst Res Inst, 270 Mason Ave, San Francisco, CA 94118 USA.	bcuster@bloodsystems.org						AuBuchon JP, 1997, TRANSFUSION, V37, P45, DOI 10.1046/j.1537-2995.1997.37197176950.x; BIRKMEYER JD, 1993, TRANSFUSION, V33, P544, DOI 10.1046/j.1537-2995.1993.33793325048.x; BIRKMEYER JD, 1994, ANN THORAC SURG, V57, P161, DOI 10.1016/0003-4975(94)90386-7; BUSCH MP, 2005, IN PRESS N ENGL J ME; Custer B, 2004, TRANSFUSION, V44, P1547, DOI 10.1111/j.0041-1132.2004.04227.x; Grosse S.D., 2003, PREVENTION EFFECTIVE, V2nd ed., P245; HOFFER S, 1998, PUBLICATION FEDERAL; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Jackson BR, 2000, TRANSFUSION, V40, P1063, DOI 10.1046/j.1537-2995.2000.40091063.x; Kleinman S, 2005, TRANSFUSION, V45, P469, DOI 10.1111/j.0041-1132.2005.04315.x; LLEWELYN C, 2004, EUR 19 OCT 2004 TRAN; Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; STRAMER SL, 2005, IN PRESS N ENGL J ME; *US DEP HHS FDA CT, 2002, WORKSH DEV DON SCREE; *US DEP HHS US FDA, 2005, DRAFT GUID IND ASS D; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 1980, CLIN DECISION ANAL; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Zohrabian A, 2004, EMERG INFECT DIS, V10, P1736, DOI 10.3201/eid1010.030925; 2003, MMWR MORB MORTAL WKL, V52, P769	26	58	61	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2005	143	7					486	492		10.7326/0003-4819-143-7-200510040-00007	http://dx.doi.org/10.7326/0003-4819-143-7-200510040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970FM	16204161				2022-12-01	WOS:000232290600003
J	Nair, DT; Johnson, RE; Prakash, L; Prakash, S; Aggarwal, AK				Nair, DT; Johnson, RE; Prakash, L; Prakash, S; Aggarwal, AK			Rev1 employs a novel mechanism of DNA synthesis using a protein template	SCIENCE			English	Article							POLYMERASE-IOTA; CRYSTAL-STRUCTURE; YEAST REV1; NUCLEOTIDE INCORPORATION; ERROR-PRONE; REPLICATION; BYPASS; ETA; FIDELITY; BASE	The Rev1 DNA polymerase is highly specialized for the incorporation of C opposite template G. We present here the crystal structure of yeast Rev1 bound to template G and incoming 2'-deoxycytidine 5'-triphosphate (dCTP); which reveals that the polymerase itself dictates the identity of the incoming nucleotide, as well as the identity of the templating base. Template G and incoming dCTP do not pair with each other. Instead, the template G is evicted from the DNA helix, and it makes optimal hydrogen bonds with a segment of Rev1. Also, unlike other DNA polymerases, incoming dCTP pairs with an arginine rather than the templating base, which ensures the incorporation of dCTP over other incoming nucleotides. This mechanism provides an elegant means for promoting proficient and error-free synthesis through N-2-adducted guanines that obstruct replication.	Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77755 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	aggarwal@inka.mssm.edu	Nair, Deepak T/AAR-5234-2020; Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444; Nair, Deepak/0000-0002-0677-9444				Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; NAIR DT, IN PRESS STRUCTURE C; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	26	200	204	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2219	2222		10.1126/science.1116336	http://dx.doi.org/10.1126/science.1116336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195463				2022-12-01	WOS:000232318000045
J	Orr, JC; Fabry, VJ; Aumont, O; Bopp, L; Doney, SC; Feely, RA; Gnanadesikan, A; Gruber, N; Ishida, A; Joos, F; Key, RM; Lindsay, K; Maier-Reimer, E; Matear, R; Monfray, P; Mouchet, A; Najjar, RG; Plattner, GK; Rodgers, KB; Sabine, CL; Sarmiento, JL; Schlitzer, R; Slater, RD; Totterdell, IJ; Weirig, MF; Yamanaka, Y; Yool, A				Orr, JC; Fabry, VJ; Aumont, O; Bopp, L; Doney, SC; Feely, RA; Gnanadesikan, A; Gruber, N; Ishida, A; Joos, F; Key, RM; Lindsay, K; Maier-Reimer, E; Matear, R; Monfray, P; Mouchet, A; Najjar, RG; Plattner, GK; Rodgers, KB; Sabine, CL; Sarmiento, JL; Schlitzer, R; Slater, RD; Totterdell, IJ; Weirig, MF; Yamanaka, Y; Yool, A			Anthropogenic ocean acidification over the twenty-first century and its impact on calcifying organisms	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; PRINCE-WILLIAM-SOUND; TERRA-NOVA BAY; ROSS SEA; ARAGONITE PRODUCTION; PACIFIC SECTOR; SOUTHERN-OCEAN; VERTICAL FLUX; CO2; ANTARCTICA	Today's surface ocean is saturated with respect to calcium carbonate, but increasing atmospheric carbon dioxide concentrations are reducing ocean pH and carbonate ion concentrations, and thus the level of calcium carbonate saturation. Experimental evidence suggests that if these trends continue, key marine organisms - such as corals and some plankton - will have difficulty maintaining their external calcium carbonate skeletons. Here we use 13 models of the ocean - carbon cycle to assess calcium carbonate saturation under the IS92a 'business-as-usual' scenario for future emissions of anthropogenic carbon dioxide. In our projections, Southern Ocean surface waters will begin to become undersaturated with respect to aragonite, a metastable form of calcium carbonate, by the year 2050. By 2100, this undersaturation could extend throughout the entire Southern Ocean and into the subarctic Pacific Ocean. When live pteropods were exposed to our predicted level of undersaturation during a two-day shipboard experiment, their aragonite shells showed notable dissolution. Our findings indicate that conditions detrimental to high-latitude ecosystems could develop within decades, not centuries as suggested previously.	CEA Saclay, UMR CEA CNRS, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA; Ctr IRD Bretagne, LOCEAN, F-29280 Plouzane, France; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Frontier Res Ctr Global Change, Yokohama, Kanagawa 2360001, Japan; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; CSIRO, Marine Res & Antarctic Climate & Ecosyst CRC, Hobart, Tas 7001, Australia; Univ Liege, Astrophys & Geophys Inst, B-4000 Liege, Belgium; Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; Univ Paris 06, LOCEAN, F-75252 Paris, France; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); California State University System; California State University San Marcos; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Los Angeles; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Bern; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Center Atmospheric Research (NCAR) - USA; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; NERC National Oceanography Centre; University of Southampton	Orr, JC (corresponding author), CEA Saclay, UMR CEA CNRS, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France.	orr@cea.fr	Aumont, Olivier/G-5207-2016; Mouchet, Anne/K-1911-2014; Doney, Scott C/F-9247-2010; Orr, James/C-5221-2009; bopp, laurent/ABF-5302-2020; Gruber, Nicolas/B-7013-2009; Joos, Fortunat/B-4118-2018; Plattner, Gian-Kasper/A-5245-2016; Yool, Andrew/B-4799-2012; Gnanadesikan, Anand/A-2397-2008; matear, richard J/C-5133-2011; Yamanaka, Yasuhiro/H-7393-2012; Feely, Richard A./ABI-5740-2020; MONFRAY, Patrick/AAB-8665-2020; Rodgers, Keith/AAL-4329-2021	Aumont, Olivier/0000-0003-3954-506X; Mouchet, Anne/0000-0002-8846-3063; Doney, Scott C/0000-0002-3683-2437; bopp, laurent/0000-0003-4732-4953; Gruber, Nicolas/0000-0002-2085-2310; Joos, Fortunat/0000-0002-9483-6030; Plattner, Gian-Kasper/0000-0002-3765-0045; Yool, Andrew/0000-0002-9879-2776; Gnanadesikan, Anand/0000-0001-5784-1116; matear, richard J/0000-0002-3225-0800; Yamanaka, Yasuhiro/0000-0003-3369-3248; MONFRAY, Patrick/0000-0002-3028-5591; Orr, James/0000-0002-8707-7080				Accornero A, 2003, ANTARCT SCI, V15, P175, DOI 10.1017/S0954102003001214; BATHMANN UV, 1991, DEEP-SEA RES, V38, P1341, DOI 10.1016/0198-0149(91)90031-A; Be AWH, 1977, OCEANIC MICROPALEONT, V1, P733; Berner R.A., 1977, FATE FOSSIL FUEL CO, P243; BETZER PR, 1984, SCIENCE, V226, P1074, DOI 10.1126/science.226.4678.1074; Boldt JL, 2003, T AM FISH SOC, V132, P1035, DOI 10.1577/T02-091; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Brewer PG, 1997, GEOPHYS RES LETT, V24, P1367, DOI 10.1029/97GL01179; BROECKER WS, 1979, SCIENCE, V206, P409, DOI 10.1126/science.206.4417.409; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Collier R, 2000, DEEP-SEA RES PT II, V47, P3491, DOI 10.1016/S0967-0645(00)00076-X; DADON JR, 1992, MAR BIOL, V114, P439, DOI 10.1007/BF00350035; Dayton P.K., 1990, P631; FABRY VJ, 1989, DEEP-SEA RES, V36, P1735, DOI 10.1016/0198-0149(89)90069-1; FABRY VJ, 1990, J MAR RES, V48, P209, DOI 10.1357/002224090784984614; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; FEELY RA, 1984, J GEOPHYS RES-OCEANS, V89, P631, DOI 10.1029/JC089iC06p10631; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FOSTER BA, 1993, ENVIRON BIOL FISH, V36, P313, DOI 10.1007/BF00001727; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gruber N, 1998, GLOBAL BIOGEOCHEM CY, V12, P165, DOI 10.1029/97GB03658; Haugan PM, 1996, ENERG CONVERS MANAGE, V37, P1019, DOI 10.1016/0196-8904(95)00292-8; Heinze C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020613; Honjo S, 2000, DEEP-SEA RES PT II, V47, P3521, DOI 10.1016/S0967-0645(00)00077-1; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KOBAYASHI HA, 1974, MAR BIOL, V26, P295, DOI 10.1007/BF00391513; La Mesa M, 2000, POLAR BIOL, V23, P38; LALLI C M, 1970, Journal of Experimental Marine Biology and Ecology, V4, P101, DOI 10.1016/0022-0981(70)90018-3; LALLI CM, 2004, BIODIVERSITY SERIES, V22; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Pakhomov EA, 1997, POLAR BIOL, V18, P180, DOI 10.1007/s003000050175; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; SARMIENTO JL, 1995, GLOBAL BIOGEOCHEM CY, V9, P121, DOI 10.1029/94GB01779; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Shirayama Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002618; Urban-Rich J, 2001, DEEP-SEA RES PT II, V48, P4223, DOI 10.1016/S0967-0645(01)00087-X; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	49	2961	3109	93	3059	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2005	437	7059					681	686		10.1038/nature04095	http://dx.doi.org/10.1038/nature04095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193043	Green Published, Green Submitted			2022-12-01	WOS:000232157900042
J	Bendor, D; Wang, XQ				Bendor, D; Wang, XQ			The neuronal representation of pitch in primate auditory cortex	NATURE			English	Article							HARMONIC COMPLEX TONES; TONOTOPIC ORGANIZATION; MONGOLIAN GERBIL; PERIODICITY; PERCEPTION; MONKEY; CONNECTIONS; FREQUENCY; SALIENCE; NOISE	Pitch perception is critical for identifying and segregating auditory objects(1), especially in the context of music and speech. The perception of pitch is not unique to humans and has been experimentally demonstrated in several animal species(2,3). Pitch is the subjective attribute of a sound's fundamental frequency (f(0)) that is determined by both the temporal regularity and average repetition rate of its acoustic waveform. Spectrally dissimilar sounds can have the same pitch if they share a common f(0). Even when the acoustic energy at f(0) is removed ('missing fundamental') the same pitch is still perceived(1). Despite its importance for hearing, how pitch is represented in the cerebral cortex is unknown. Here we show the existence of neurons in the auditory cortex of marmoset monkeys that respond to both pure tones and missing fundamental harmonic complex sounds with the same f(0), providing a neural correlate for pitch constancy(1). These pitch-selective neurons are located in a restricted low-frequency cortical region near the anterolateral border of the primary auditory cortex, and is consistent with the location of a pitch-selective area identified in recent imaging studies in humans(4,5).	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21025 USA	Johns Hopkins University	Bendor, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21025 USA.	dbendor@bme.jhu.edu; xwang@bme.jhu.edu		Bendor, Daniel/0000-0001-6621-793X	NIDCD NIH HHS [F31 DC006528, R01 DC003180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC006528, R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Cedolin L, 2005, J NEUROPHYSIOL, V94, P347, DOI 10.1152/jn.01114.2004; EPPLE G, 1968, FOLIA PRIMATOL BASEL, V8, P40; Fay R. R., 1988, HEARING VERTEBRATES; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; GOLDSTEIN JL, 1973, J ACOUST SOC AM, V54, P1496, DOI 10.1121/1.1914448; HEFFNER H, 1976, J ACOUST SOC AM, V59, P915, DOI 10.1121/1.380951; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; McAlpine D, 2004, J NEUROPHYSIOL, V92, P1295, DOI 10.1152/jn.00034.2004; Moore B. C. J., 2003, INTRO PSYCHOL HEARIN; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; POLLACK I, 1968, J ACOUST SOC AM, V43, P308, DOI 10.1121/1.1910780; Pressnitzer D., 2001, PHYSL PSYCHOPHYSICAL, P97; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; RITSMA RJ, 1962, J ACOUST SOC AM, V34, P1224, DOI 10.1121/1.1918307; Schouten J. F., 1940, P K NED AKAD WETENSC, V43, P991; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; SCHWARZ DWF, 1990, J NEUROPHYSIOL, V64, P282, DOI 10.1152/jn.1990.64.1.282; Suga N., 1994, COGNITIVE NEUROSCIEN, P295; TOMLINSON RWW, 1988, J ACOUST SOC AM, V84, P560, DOI 10.1121/1.396833; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; WHITFIELD IC, 1980, J ACOUST SOC AM, V67, P644, DOI 10.1121/1.383889; Yost WA, 1998, J ACOUST SOC AM, V104, P2349, DOI 10.1121/1.423746; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834	30	395	406	5	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2005	436	7054					1161	1165		10.1038/nature03867	http://dx.doi.org/10.1038/nature03867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121182	Green Accepted			2022-12-01	WOS:000231416600047
J	Richards, TA; Cavalier-Smith, T				Richards, TA; Cavalier-Smith, T			Myosin domain evolution and the primary divergence of eukaryotes	NATURE			English	Article							RNA-POLYMERASE-II; PHYLOGENETIC ANALYSIS; CLASSIFICATION; TREE; PROTEINS; SEQUENCE; DATABASE; PROTOZOA; AMOEBOZOA; RELATIVES	Eukaryotic cells have two contrasting cytoskeletal and ciliary organizations. The simplest involves a single cilium-bearing centriole, nucleating a cone of individual microtubules ( probably ancestral for unikonts: animals, fungi, Choanozoa and Amoebozoa). In contrast, bikonts ( plants, chromists and all other protozoa) were ancestrally biciliate with a younger anterior cilium, converted every cell cycle into a dissimilar posterior cilium and multiple ciliary roots of microtubule bands. Here we show by comparative genomic analysis that this fundamental cellular dichotomy also involves different myosin molecular motors. We found 37 different protein domain combinations, often lineage-specific, and many previously unidentified. The sequence phylogeny and taxonomic distribution of myosin domain combinations identified five innovations that strongly support unikont monophyly and the primary bikont/unikont bifurcation. We conclude that the eukaryotic cenancestor ( last common ancestor) had a cilium, mitochondria, pseudopodia, and myosins with three contrasting domain combinations and putative functions.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Natural History Museum London; University of Oxford	Richards, TA (corresponding author), Univ Exeter, Sch Biol & Chem Sci, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	thomr@nhm.ac.uk		Richards, Thomas/0000-0002-9692-0973				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Bolivar I, 2001, MOL BIOL EVOL, V18, P2306, DOI 10.1093/oxfordjournals.molbev.a003777; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CAVALIERSMITH T, 1991, BIOSYSTEMS, V25, P25, DOI 10.1016/0303-2647(91)90010-I; D'Aquino JA, 2003, J BACTERIOL, V185, P4081, DOI 10.1128/JB.185.14.4081-4086.2003; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Felsenstein J., 1995, PHYLIP; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hodge T, 2000, J CELL SCI, V113, P3353; Kudryavtsev A, 2005, PROTIST, V156, P215, DOI 10.1016/j.protis.2005.03.003; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Milyutina IA, 2001, GENE, V272, P131, DOI 10.1016/S0378-1119(01)00556-X; Minotto L, 2000, EXP PARASITOL, V95, P54, DOI 10.1006/expr.2000.4507; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sellers J. R., 1999, MYOSINS; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson RF, 2002, ANAT RECORD, V268, P276, DOI 10.1002/ar.10160; Titus MA, 1999, CURR BIOL, V9, P1297, DOI 10.1016/S0960-9822(00)80051-2; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5	41	299	319	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1113	1118		10.1038/nature03949	http://dx.doi.org/10.1038/nature03949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121172				2022-12-01	WOS:000231416600036
J	Hovatta, I; Tennant, RS; Helton, R; Marr, RA; Singer, O; Redwine, JM; Ellison, JA; Schadt, EE; Verma, IM; Lockhart, DJ; Barlow, C				Hovatta, I; Tennant, RS; Helton, R; Marr, RA; Singer, O; Redwine, JM; Ellison, JA; Schadt, EE; Verma, IM; Lockhart, DJ; Barlow, C			Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice	NATURE			English	Article							MALONDIALDEHYDE LEVELS; ANTIOXIDANT ENZYME; MOUSE; EXPRESSION; BRAIN; IDENTIFICATION; BEHAVIOR; STRAINS; FEAR	Anxiety and fear are normal emotional responses to threatening situations. In human anxiety disorders - such as panic disorder, obsessive - compulsive disorder, post- traumatic stress disorder, social phobia, specific phobias and generalized anxiety disorder - these responses are exaggerated. The molecular mechanisms involved in the regulation of normal and pathological anxiety are mostly unknown. However, the availability of different inbred strains of mice offers an excellent model system in which to study the genetics of certain behavioural phenotypes(1-3). Here we report, using a combination of behavioural analysis of six inbred mouse strains with quantitative gene expression profiling of several brain regions, the identification of 17 genes with expression patterns that correlate with anxiety- like behavioural phenotypes. To determine if two of the genes, glyoxalase 1 and glutathione reductase 1, have a causal role in the genesis of anxiety, we performed genetic manipulation using lentivirus- mediated gene transfer. Local overexpression of these genes in the mouse brain resulted in increased anxiety- like behaviour, while local inhibition of glyoxalase 1 expression by RNA interference decreased the anxiety- like behaviour. Both of these genes are involved in oxidative stress metabolism, linking this pathway with anxiety- related behaviour.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; BrainCells Inc, San Diego, CA 92121 USA; Neurome Inc, La Jolla, CA 92037 USA; Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA	Salk Institute; Merck & Company	Barlow, C (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cbarlow@braincellsinc.com	Hovatta, Iiris/D-6871-2012	Hovatta, Iiris/0000-0002-5990-7892				Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Camargo EE, 2001, J NUCL MED, V42, P611; Carter TA, 2001, PHYSIOL BEHAV, V73, P849, DOI 10.1016/S0031-9384(01)00522-4; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Gershenfeld HK, 1997, GENOMICS, V46, P1, DOI 10.1006/geno.1997.5002; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; HOVATTA I, 2005, DATABASING BRAIN DAT, P169; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Kuloglu M, 2002, NEUROPSYCHOBIOLOGY, V46, P186, DOI 10.1159/000067810; Kuloglu M, 2002, NEUROPSYCHOBIOLOGY, V46, P27, DOI 10.1159/000063573; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	28	366	381	1	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					662	666		10.1038/nature04250	http://dx.doi.org/10.1038/nature04250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16244648				2022-12-01	WOS:000233593100049
J	Ha, EM; Oh, CT; Bae, YS; Lee, WJ				Ha, EM; Oh, CT; Bae, YS; Lee, WJ			A direct role for dual oxidase in Drosophila gut immunity	SCIENCE			English	Article							INNATE IMMUNITY; NADPH OXIDASE; CLONING; SYSTEM; MYELOPEROXIDASE; RECOGNITION; FAMILY; CDNAS; CELLS; BURST	Because the mucosal epithelia are in constant contact with large numbers of microorganisms, these surfaces must be armed with efficient microbial control systems. Here, we show that the Drosophila nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme, dual oxidase (dDuox), is indispensable for gut antimicrobial activities. Adult flies in which dDuox expression is silenced showed a marked increase in mortality rate even after a minor infection through ingestion of microbe-contaminated food. This could be restored by the specific reintroduction of dDuox, demonstrating that this oxidase generates a unique epithelia[ oxidative burst that limits microbial proliferation in the gut. Thus, oxidant-mediated antimicrobial responses are not restricted to the phagocytes, but rather are used more broadly, including in mucosal barrier epithelia.	Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Inst Pasteur Korea, Lab Innate Immun, Seoul 136791, South Korea	Ewha Womans University; Ewha Womans University; Institut Pasteur Korea	Lee, WJ (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	lwj@ewha.ac.kr						Babior B M, 1995, Curr Opin Hematol, V2, P55; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; GRAY GR, 1973, LANCET, V2, P530; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; KLEBANOFF SJ, 1974, J BIOL CHEM, V249, P3724; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rhee S.G., 2000, SCI STKE; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014	27	556	579	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					847	850		10.1126/science.1117311	http://dx.doi.org/10.1126/science.1117311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272120				2022-12-01	WOS:000233121800044
J	Patzold, M; Tellman, S; Hausler, B; Hinson, D; Schaa, R; Tyler, GL				Patzold, M; Tellman, S; Hausler, B; Hinson, D; Schaa, R; Tyler, GL			A sporadic third layer in the ionosphere of Mars	SCIENCE			English	Article							IONS; ATMOSPHERE	The daytime martian ionosphere has been observed as a two-layer structure with electron densities that peak at attitudes between about 110 and 130 kilometers. The Mars Express Orbiter Radio Science Experiment on the European Mars Express spacecraft observed, in 10 out of 120 electron density profiles, a third ionospheric layer at attitude ranges of 65 to 110 kilometers, where electron densities, on average, peaked at 0.8 x 10(10) per cubic meter. Such a layer has been predicted to be permanent and continuous. Its origin has been attributed to ablation of meteors and charge exchange of magnesium and iron. Our observations imply that this layer is present sporadically and locally.	Univ Cologne, Inst Geophys & Meteorol, D-5000 Cologne, Germany; Univ Bundeswehr Munchen, Inst Raumfahrttech, Neubiberg, Germany; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	University of Cologne; Bundeswehr University Munich; Stanford University	Patzold, M (corresponding author), Univ Cologne, Inst Geophys & Meteorol, D-5000 Cologne, Germany.	paetzold@geo.uni-koeln.de		Hinson, David/0000-0002-1620-4011				BERTAUX JL, COMMUNICATION; FJELDBO G, 1965, J GEOPHYS RES, V70, P3701, DOI 10.1029/JZ070i015p03701; Fox JL, 2004, ADV SPACE RES-SERIES, V33, P132, DOI 10.1016/j.asr.2003.08.014; HANSON WB, 1977, J GEOPHYS RES, V82, P4352; Kopp E, 1997, J GEOPHYS RES-SPACE, V102, P9667, DOI 10.1029/97JA00384; LINDAL GF, 1979, J GEOPHYS RES, V84, P8443, DOI 10.1029/JB084iB14p08443; Molina-Cuberos GJ, 2003, PLANET SPACE SCI, V51, P239, DOI 10.1016/S0032-0633(02)00197-6; Patzold M, 2004, ESA SPEC PUBL, P141; Pesnell WD, 2000, J GEOPHYS RES-PLANET, V105, P1695, DOI 10.1029/1999JE001115; RISBETH EG, 2003, PLANET SPACE SCI, V52, P849; Rishbeth H, 2004, PLANET SPACE SCI, V52, P849, DOI 10.1016/j.pss.2004.02.007; Zasova L, 2005, PLANET SPACE SCI, V53, P1065, DOI 10.1016/j.pss.2004.12.010	12	147	150	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					837	839		10.1126/science.1117755	http://dx.doi.org/10.1126/science.1117755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272118				2022-12-01	WOS:000233121800040
J	Platten, M; Ho, PP; Youssef, S; Fontoura, P; Garren, H; Hur, EM; Gupta, R; Lee, LY; Kidd, BA; Robinson, WH; Sobel, RA; Selley, ML; Steinman, L				Platten, M; Ho, PP; Youssef, S; Fontoura, P; Garren, H; Hur, EM; Gupta, R; Lee, LY; Kidd, BA; Robinson, WH; Sobel, RA; Selley, ML; Steinman, L			Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite	SCIENCE			English	Article							ALTERED PEPTIDE LIGAND; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; T-CELL; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE-RESPONSES; NERVOUS SYSTEMS; DENDRITIC CELLS; INHIBITION; CATABOLISM	Local catabolism of, the amino acid tryptophan (Trp) by indoleamine 2,3-dioxygenase ([DO) is considered an important mechanism of regulating T cell immunity. We show that IDO transcription was increased when myelin-specific T cells were stimulated with tolerogenic altered self-peptides. Catabolites of Trp suppressed proliferation of myelin-specific T cells and inhibited production of proinflammatory T helper-1 (T(H)1) cytokines. N-(3,4,-Dimethoxycinnamoyl) anthranilic acid (3,4-DAA), an orally active syntihetic derivative of the Trp metabolite anthranilic acid, reversed paralysis in mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis (MS). Trp catabolites and their derivatives offer a new strategy for treating T(H)1-mediated autoimmune diseases such as MS.	Stanford Univ, Dept Neurol & Neurol Sci, Beckman Ctr Mol Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol Neuropathol, Stanford, CA 94305 USA; Univ Tubingen, Dept Gen Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; Univ Nova Lisboa, Fac Med Sci, Dept Immunol, P-1169056 Lisbon, Portugal; Bayhill Therapeut Inc, Palo Alto, CA 94303 USA; Vet Affairs Hlth Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA; Angiogen Pharmaceut Pty Ltd, Sydney, NSW 2000, Australia	Stanford University; Stanford University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universidade Nova de Lisboa; Geriatric Research Education & Clinical Center	Platten, M (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Beckman Ctr Mol Med, Stanford, CA 94305 USA.	michael.platten@uni-tuebingen.de; steinman@stanford.edu	Platten, Michael/F-2902-2013; Fontoura, Paulo/A-2315-2010	Platten, Michael/0000-0002-4746-887X; Steinman, Lawrence/0000-0002-2437-2250; Sobel, Raymond/0000-0002-0477-9002; /0000-0002-6848-318X; Kidd, Brian/0000-0003-2110-1145; Robinson, William/0000-0003-4385-704X; Gupta, Rohit/0000-0002-6897-7083				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Genain CP, 2000, NAT MED, V6, P1098, DOI 10.1038/80424; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Isaji M, 1998, CARDIOVASC DRUG REV, V16, P288, DOI 10.1111/j.1527-3466.1998.tb00359.x; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Steinman L, 2004, SCIENCE, V305, P212, DOI 10.1126/science.1099896; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Tan IL, 2000, MULT SCLER, V6, P99, DOI 10.1191/135245800678827626; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	30	341	364	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2005	310	5749					850	855		10.1126/science.1117634	http://dx.doi.org/10.1126/science.1117634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272121				2022-12-01	WOS:000233121800045
J	Tomlins, SA; Rhodes, DR; Perner, S; Dhanasekaran, SM; Mehra, R; Sun, XW; Varambally, S; Cao, XH; Tchinda, J; Kuefer, R; Lee, C; Montie, JE; Shah, RB; Pienta, KJ; Rubin, MA; Chinnaiyan, AM				Tomlins, SA; Rhodes, DR; Perner, S; Dhanasekaran, SM; Mehra, R; Sun, XW; Varambally, S; Cao, XH; Tchinda, J; Kuefer, R; Lee, C; Montie, JE; Shah, RB; Pienta, KJ; Rubin, MA; Chinnaiyan, AM			Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer	SCIENCE			English	Article							EWINGS-SARCOMA TRANSLOCATION; EXPRESSION PROFILES; MULTIPLE-MYELOMA; EWS GENE; LEUKEMIA; CLASSIFICATION; FAMILY; TUMOR; FUSES	Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1, were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1. Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Michigan Urol Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Ulm, Fac Med, Dept Urol, D-89075 Ulm, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Ulm University	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine St, Ann Arbor, MI 48109 USA.	arul@umich.edu	; Pienta, Kenneth/E-7679-2015	Dhanasekaran, saravana mohan/0000-0002-0489-2224; Varambally, Sooryanarayana/0000-0002-2277-1127; Rubin, Mark/0000-0002-8321-9950; Tomlins, Scott/0000-0001-8661-9821; Pienta, Kenneth/0000-0002-4138-2186	NATIONAL CANCER INSTITUTE [U01CA111275, R01CA097063, P30CA046592, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021404] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA97063, UO1 CA111275-01, P50CA69568, 5P30 CA46592] Funding Source: Medline; NIA NIH HHS [R01AG21404] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Afar DEH, 2001, CANCER RES, V61, P1686; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; JEON IS, 1995, ONCOGENE, V10, P1229; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Welsh JB, 2001, CANCER RES, V61, P5974; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745	32	2879	3037	4	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					644	648		10.1126/science.1117679	http://dx.doi.org/10.1126/science.1117679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254181				2022-12-01	WOS:000232997700032
J	Janes, PW; Saha, N; Barton, WA; Kolev, MV; Wimmer-Kleikamp, SH; Nievergall, E; Blobel, CP; Himanen, JP; Lackmann, M; Nikolov, DB				Janes, PW; Saha, N; Barton, WA; Kolev, MV; Wimmer-Kleikamp, SH; Nievergall, E; Blobel, CP; Himanen, JP; Lackmann, M; Nikolov, DB			Adam meets Eph: An ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans	CELL			English	Article							CRYSTAL-STRUCTURE; CELL-ADHESION; RECEPTOR; DISINTEGRIN; PROTEASE; ROLES; ALPHA; ENDOCYTOSIS; BINDING; FAMILY	The Eph family of receptor tyrosine kinases and their ephrin ligands are mediators of cell-cell communication. Cleavage of ephrin-A2 by the ADAM10 membrane metalloprotease enables contact repulsion between Eph- and ephrin-expressing cells. How ADAM10 interacts with ephrins in a regulated manner to cleave only Eph bound ephrin molecules remains unclear. The structure of ADAM10 disintegrin and cysteine-rich domains and the functional studies presented here define an essential substrate-recognition module for functional interaction of ADAM10 with the ephrin-A5/EphA3 complex. While ADAM10 constitutively associates with EphA3, the formation of a functional EphA3/ephrin-A5 complex creates a new molecular recognition motif for the ADAM10 cysteine-rich domain that positions the proteinase domain for effective ephrin-A5 cleavage. Surprisingly, the cleavage occurs in trans, with ADAM10 and its substrate being on the membranes of opposing cells. Our data suggest a simple mechanism for regulating ADAM10-mediated ephrin proteolysis, which ensures that only Eph bound ephrins are recognized and cleaved.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Hosp Special Surg, New York, NY 10021 USA	Monash University; Memorial Sloan Kettering Cancer Center	Lackmann, M (corresponding author), Monash Univ, Dept Biochem & Mol Biol, POB 13D, Clayton, Vic 3168, Australia.	martin.lackmann@med.monash.edu.au; nikolovd@mskcc.org	kolev, mihail/D-1476-2015	kolev, mihail/0000-0002-5226-4759; Janes, Peter/0000-0002-9039-1097	NINDS NIH HHS [R02-NS-38486] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; FLANAGAN JG, 1996, ANNU REV NEUROSCI, V21, P309; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Howard L, 1996, BIOCHEM J, V317, P45, DOI 10.1042/bj3170045; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Smith KM, 2002, J CELL BIOL, V159, P893, DOI 10.1083/jcb.200206023; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	34	345	362	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					291	304		10.1016/j.cell.2005.08.014	http://dx.doi.org/10.1016/j.cell.2005.08.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239146	Bronze			2022-12-01	WOS:000232794100015
J	Bonardi, V; Pesaresi, P; Becker, T; Schleiff, E; Wagner, R; Pfannschmidt, T; Jahns, P; Leister, D				Bonardi, V; Pesaresi, P; Becker, T; Schleiff, E; Wagner, R; Pfannschmidt, T; Jahns, P; Leister, D			Photosystem II core phosphorylation and photosynthetic acclimation require two different protein kinases	NATURE			English	Article							HARVESTING COMPLEX-II; ARABIDOPSIS-THALIANA; STATE TRANSITIONS; REDOX SIGNALS; GENE-EXPRESSION; OUTER ENVELOPE; NUCLEAR GENES; REPAIR CYCLE; IN-VIVO; CHLOROPLAST	Illumination changes elicit modifications of thylakoid proteins and reorganization of the photosynthetic machinery. This involves, in the short term, phosphorylation of photosystem II (PSII) and light-harvesting (LHCII) proteins. PSII phosphorylation is thought to be relevant for PSII turnover(1,2), whereas LHCII phosphorylation is associated with the relocation of LHCII and the redistribution of excitation energy (state transitions) between photosystems(3,4). In the long term, imbalances in energy distribution between photosystems are counteracted by adjusting photosystem stoichiometry(5,6). In the green alga Chlamydomonas and the plant Arabidopsis, state transitions require the orthologous protein kinases STT7 and STN7, respectively(7,8). Here we show that in Arabidopsis a second protein kinase, STN8, is required for the quantitative phosphorylation of PSII core proteins. However, PSII activity under high-intensity light is affected only slightly in stn8 mutants, and D1 turnover is indistinguishable from the wild type, implying that reversible protein phosphorylation is not essential for PSII repair. Acclimation to changes in light quality is defective in stn7 but not in stn8 mutants, indicating that short-term and long-term photosynthetic adaptations are coupled. Therefore the phosphorylation of LHCII, or of an unknown substrate of STN7, is also crucial for the control of photosynthetic gene expression.	Univ Munich, Dept Biol 1, Inst Bot, D-80638 Munich, Germany; Max Planck Inst Zuchtungsforsch, Abt Pflanzenzuchtung & Genet, D-50829 Cologne, Germany; Fdn Parco Tecnol Padano, I-26900 Lodi, Italy; Univ Jena, Lehrstuhl Pflanzenphysiol, D-07743 Jena, Germany; Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	University of Munich; Max Planck Society; Friedrich Schiller University of Jena; Heinrich Heine University Dusseldorf	Leister, D (corresponding author), Univ Munich, Dept Biol 1, Inst Bot, Menzinger Str 67, D-80638 Munich, Germany.	leister@lrz.uni-muenchen.de	Becker, Thomas/AAS-9404-2020; Schleiff, Enrico/C-5105-2017; Leister, Dario/D-5587-2009; Pfannschmidt, Thomas/AAH-5916-2021; Pesaresi, Paolo/F-9476-2014	Schleiff, Enrico/0000-0002-0518-3489; Leister, Dario/0000-0003-1897-8421; Pesaresi, Paolo/0000-0002-3236-7005				Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ARO EM, 1993, PLANT PHYSIOL, V103, P835, DOI 10.1104/pp.103.3.835; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Biehl A, 2005, GENE, V344, P33, DOI 10.1016/j.gene.2004.09.009; DELOSME R, 1994, BBA-BIOENERGETICS, V1185, P56, DOI 10.1016/0005-2728(94)90193-7; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; Fujita Y, 1997, PHOTOSYNTH RES, V53, P83, DOI 10.1023/A:1005870301868; Grasses T, 2002, PLANT PHYSIOL BIOCH, V40, P41, DOI 10.1016/S0981-9428(01)01346-8; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2004.02011.x; Koivuniemi A, 1995, BIOCHEMISTRY-US, V34, P16022, DOI 10.1021/bi00049a016; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Pesaresi P, 2002, PLANTA, V215, P940, DOI 10.1007/s00425-002-0835-0; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pfannschmidt T, 2001, J BIOL CHEM, V276, P36125, DOI 10.1074/jbc.M105701200; Pursiheimo S, 2001, PLANT J, V26, P317, DOI 10.1046/j.1365-313X.2001.01033.x; Qbadou S, 2003, J CELL SCI, V116, P837, DOI 10.1242/jcs.00291; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rintamaki E, 1996, J BIOL CHEM, V271, P14870, DOI 10.1074/jbc.271.25.14870; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	30	342	362	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1179	1182		10.1038/nature04016	http://dx.doi.org/10.1038/nature04016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237446	Green Published			2022-12-01	WOS:000232660500049
J	Bright, RA; Medina, MJ; Xu, XY; Perez-Oronoz, G; Wallis, TR; Davis, XHM; Povinelli, L; Cox, NJ; Klimov, AI				Bright, RA; Medina, MJ; Xu, XY; Perez-Oronoz, G; Wallis, TR; Davis, XHM; Povinelli, L; Cox, NJ; Klimov, AI			Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern	LANCET			English	Article							H5N1 INFLUENZA; NURSING-HOMES; AMANTADINE; RIMANTADINE; EMERGENCE; SURVEILLANCE; TRANSMISSION; PROPHYLAXIS; GENOME	Background Adamantanes have been used to treat influenza A virus infections for many years. Studies have shown a low incidence of resistance to these drugs among circulating influenza viruses; however, their use is rising worldwide and drug resistance has been reported among influenza A (H5N1) viruses isolated from poultry and human beings in Asia. We sought to assess adamantane resistance among influenza A viruses isolated during the past decade from countries participating in WHO's global influenza surveillance network. Methods We analysed data for influenza field isolates that were obtained worldwide and submitted to the WHO Collaborating Center for Influenza at the US Centers for Disease Control and Prevention between Oct 1, 1994, and Mar 31, 2005. We used pyrosequencing, confirmatory sequence analysis, and phenotypic testing to detect drug resistance among circulating influenza A H3N2 (n=6524), H1N1 (n=589), and H1N2 (n=83) viruses. Findings More than 7000 influenza A field isolates were screened for specific aminoacid substitutions in the M2 gene known to confer drug resistance. During the decade of surveillance a significant increase in drug resistance was noted, from 0.4% in 1994-1995 to 12.3% in 2003-2004. This increase in the proportion of resistant viruses was weighted heavily by those obtained from Asia with 61% of resistant viruses isolated since 2003 being from people in Asia. Interpretation Our data raise concerns about the appropriate use of adamantanes and draw attention to the importance of tracking the emergence and spread of drug-resistant influenza A viruses.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Influenza Branch, Atlanta, GA 30333 USA; Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA	Centers for Disease Control & Prevention - USA; University of Wisconsin System; University of Wisconsin Madison	Bright, RA (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Influenza Branch, Atlanta, GA 30333 USA.	rbright@cdc.gov						BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; BELSHE RB, 1989, J INFECT DIS, V159, P430, DOI 10.1093/infdis/159.3.430; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Boivin G, 2002, CLIN INFECT DIS, V34, pE23, DOI 10.1086/338870; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P97; *CHIN NONPR MED AS, 2002, ACT INGR OTC PROD SE; COX NJ, 1994, EUR J EPIDEMIOL, V10, P467, DOI 10.1007/BF01719678; DEGELAU J, 1992, ARCH INTERN MED, V152, P390, DOI 10.1001/archinte.152.2.390; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Englund JA, 1998, CLIN INFECT DIS, V26, P1418, DOI 10.1086/516358; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; HAY AJ, 1986, J ANTIMICROB CHEMOTH, V18, P19, DOI 10.1093/jac/18.Supplement_B.19; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HOUCK P, 1995, ARCH INTERN MED, V155, P533, DOI 10.1001/archinte.155.5.533; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; MAST EE, 1991, AM J EPIDEMIOL, V134, P988, DOI 10.1093/oxfordjournals.aje.a116184; Masuda H, 2000, MICROBIOL IMMUNOL, V44, P833, DOI 10.1111/j.1348-0421.2000.tb02571.x; *MIN HLTH RUSS FED, 1999, N287 MIN HLTH RUSS F; OXFORD JS, 1984, VIRAL CHEMOTHERAPY, V1, P169; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; SWEET C, 1991, J INFECT DIS, V164, P969, DOI 10.1093/infdis/164.5.969; Tominack R L, 1987, Infect Dis Clin North Am, V1, P459; VALETTE M, 1993, ANTIMICROB AGENTS CH, V37, P2239, DOI 10.1128/AAC.37.10.2239; Viseshakul N, 2004, VIROLOGY, V328, P169, DOI 10.1016/j.virol.2004.06.045; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Xu XY, 2002, J INFECT DIS, V186, P1490, DOI 10.1086/344738; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994; 2004, MMWR MORB MORTAL WKL, V53, P100	36	555	639	2	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2005	366	9492					1175	1181		10.1016/S0140-6736(05)67338-2	http://dx.doi.org/10.1016/S0140-6736(05)67338-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LK	16198766				2022-12-01	WOS:000232311300027
J	Whiten, A; Horner, V; de Waal, FBM				Whiten, A; Horner, V; de Waal, FBM			Conformity to cultural norms of tool use in chimpanzees	NATURE			English	Article							CAPTIVE CHIMPANZEES; TRANSMISSION; INFORMATION; EVOLUTION	Rich circumstantial evidence suggests that the extensive behavioural diversity recorded in wild great apes reflects a complexity of cultural variation unmatched by species other than our own(1-12). However, the capacity for cultural transmission assumed by this interpretation has remained difficult to test rigorously in the field, where the scope for controlled experimentation is limited(13-16). Here we show that experimentally introduced technologies will spread within different ape communities. Unobserved by group mates, we first trained a high-ranking female from each of two groups of captive chimpanzees to adopt one of two different tool-use techniques for obtaining food from the same 'Pan-pipe' apparatus, then re-introduced each female to her respective group. All but two of 32 chimpanzees mastered the new technique under the influence of their local expert, whereas none did so in a third population lacking an expert. Most chimpanzees adopted the method seeded in their group, and these traditions continued to diverge over time. A subset of chimpanzees that discovered the alternative method nevertheless went on to match the predominant approach of their companions, showing a conformity bias that is regarded as a hallmark of human culture(11).	Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland; Emory Univ, Yerkes Natl Primate Res Ctr, Field Stn, Atlanta, GA 30322 USA	University of St Andrews; Emory University	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland.	a.whiten@st-and.ac.uk		Whiten, Andrew/0000-0003-2426-5890	Biotechnology and Biological Sciences Research Council [S16447] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; BRUNER JS, 1972, AM PSYCHOL, V27, P687, DOI 10.1037/h0033144; Call Josep, 1996, P371; de Waal F, 2001, APE SUSHI MASTER CUL; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Galef Bennett G. Jr, 2003, P159, DOI 10.1017/CBO9780511584022.007; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; JACOBS RC, 1961, J ABNORM SOC PSYCH, V62, P649, DOI 10.1037/h0044182; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Lefebvre Louis, 2000, P311; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa Tetsuro, 1994, P351; McGrew William, 2004, CULTURED CHIMPANZEE; MENZEL EW, 1972, FOLIA PRIMATOL, V17, P161; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; RICHERSON PJ, 2005, NOT GENES CULTURE TR; Sherif M., 1936, PSYCHOL SOCIAL NORMS, V2nd; Tomasello M., 1999, CULTURAL ORIGINS HUM; Tonooka R, 1997, JPN PSYCHOL RES, V39, P253, DOI 10.1111/1468-5884.00058; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 2003, EVOL ANTHROPOL, V12, P92, DOI 10.1002/evan.10107; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	30	443	456	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					737	740		10.1038/nature04047	http://dx.doi.org/10.1038/nature04047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968JD	16113685				2022-12-01	WOS:000232157900053
J	Ciais, P; Reichstein, M; Viovy, N; Granier, A; Ogee, J; Allard, V; Aubinet, M; Buchmann, N; Bernhofer, C; Carrara, A; Chevallier, F; De Noblet, N; Friend, AD; Friedlingstein, P; Grunwald, T; Heinesch, B; Keronen, P; Knohl, A; Krinner, G; Loustau, D; Manca, G; Matteucci, G; Miglietta, F; Ourcival, JM; Papale, D; Pilegaard, K; Rambal, S; Seufert, G; Soussana, JF; Sanz, MJ; Schulze, ED; Vesala, T; Valentini, R				Ciais, P; Reichstein, M; Viovy, N; Granier, A; Ogee, J; Allard, V; Aubinet, M; Buchmann, N; Bernhofer, C; Carrara, A; Chevallier, F; De Noblet, N; Friend, AD; Friedlingstein, P; Grunwald, T; Heinesch, B; Keronen, P; Knohl, A; Krinner, G; Loustau, D; Manca, G; Matteucci, G; Miglietta, F; Ourcival, JM; Papale, D; Pilegaard, K; Rambal, S; Seufert, G; Soussana, JF; Sanz, MJ; Schulze, ED; Vesala, T; Valentini, R			Europe-wide reduction in primary productivity caused by the heat and drought in 2003	NATURE			English	Article							CARBON; BALANCE; GROWTH; CO2	Future climate warming is expected to enhance plant growth in temperate ecosystems and to increase carbon sequestration(1,2). But although severe regional heatwaves may become more frequent in a changing climate(3,4), their impact on terrestrial carbon cycling is unclear. Here we report measurements of ecosystem carbon dioxide fluxes, remotely sensed radiation absorbed by plants, and country- level crop yields taken during the European heatwave in 2003. We use a terrestrial biosphere simulation model(5) to assess continental- scale changes in primary productivity during 2003, and their consequences for the net carbon balance. We estimate a 30 per cent reduction in gross primary productivity over Europe, which resulted in a strong anomalous net source of carbon dioxide ( 0.5 Pg Cyr(-1)) to the atmosphere and reversed the effect of four years of net ecosystem carbon sequestration(6). Our results suggest that productivity reduction in eastern and western Europe can be explained by rainfall deficit and extreme summer heat, respectively. We also find that ecosystem respiration decreased together with gross primary productivity, rather than accelerating with the temperature rise. Model results, corroborated by historical records of crop yields, suggest that such a reduction in Europe's primary productivity is unprecedented during the last century. An increase in future drought events could turn temperate ecosystems into carbon sources, contributing to positive carbon- climate feedbacks already anticipated in the tropics and at high latitudes(1,2).	Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Univ Tuscia, DISAFRI, Dept Forest Environm & Resources, I-01100 Viterbo, Italy; Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Ctr Nancy, F-54280 Champenoux, France; INRA, Ephyse, Funct Ecol & Environm Phys, F-33612 Villenave Dornon, France; INRA, Grassland Ecosyst Res, F-63039 Clermont Ferrand, France; ETH Zentrum, Inst Plant Sci, CH-8092 Zurich, Switzerland; Fac Sci Agron Etat Gembloux, B-5030 Gembloux, Belgium; Tech Univ Dresden, Dept Meteorol, Inst Hydrol & Meteorol, D-01062 Dresden, Germany; Fdn CEAM, E-46980 Valencia, Spain; Univ Helsinki, Dept Phys Sci, FIN-00014 Helsinki, Finland; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; CNR, IBIMET, I-50144 Florence, Italy; CNRS, DREAM CEFE, F-34293 Montpellier, France; Riso Natl Lab, Biosyst Dept, DK-4000 Roskilde, Denmark	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Tuscia University; Potsdam Institut fur Klimafolgenforschung; INRAE; INRAE; VetAgro Sup; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Liege; Technische Universitat Dresden; University of Helsinki; Max Planck Society; University of California System; University of California Berkeley; European Commission Joint Research Centre; EC JRC ISPRA Site; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Technical University of Denmark	Ciais, P (corresponding author), Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France.	philippe.ciais@cea.fr	Chevallier, Frederic JM/E-9608-2016; Papale, Dario/W-7302-2019; Miglietta, Franco/B-6137-2008; Krinner, Gerhard/A-6450-2011; Reichstein, Markus/A-7494-2011; Knohl, Alexander/F-9453-2014; Ciais, Philippe M/A-6840-2011; Vesala, Timo/C-3795-2017; Krinner, Gerhard/AAB-8837-2022; Allard, Vincent/B-8806-2009; Viovy, Nicolas/S-2631-2018; Matteucci, Giorgio/N-3526-2015; Carrara, Arnaud/ABH-5319-2020; Valentini, Riccardo/D-1226-2010; Carrara, Arnaud/L-8144-2014; Schulze, Ernst-Detlef/K-9627-2014; Pilegaard, Kim/I-7137-2013; Soussana, Jean-Francois/M-2814-2017; Sanz, Maria Jose/A-6099-2016; Pilegaard, Kim/H-9026-2019; Ogée, Jérôme/C-7185-2013; de NOBLET, Nathalie I/O-8613-2015; Seufert, Günther/J-9918-2013; Zhong, Hong Lin/C-2633-2012; Rambal, Serge/H-5705-2019; Buchmann, Nina/E-6095-2011; Friedlingstein, Pierre/H-2700-2014; Soussana, Jean-Francois/P-2094-2016; Matteucci, Giorgio/AAB-7022-2021; Keronen, Petri I.K./B-6222-2008	Chevallier, Frederic JM/0000-0002-4327-3813; Papale, Dario/0000-0001-5170-8648; Miglietta, Franco/0000-0003-1474-8143; Krinner, Gerhard/0000-0002-2959-5920; Reichstein, Markus/0000-0001-5736-1112; Knohl, Alexander/0000-0002-7615-8870; Ciais, Philippe M/0000-0001-8560-4943; Vesala, Timo/0000-0002-4852-7464; Krinner, Gerhard/0000-0002-2959-5920; Allard, Vincent/0000-0003-1949-9158; Viovy, Nicolas/0000-0002-9197-6417; Matteucci, Giorgio/0000-0002-4790-9540; Carrara, Arnaud/0000-0002-9095-8807; Valentini, Riccardo/0000-0002-6756-5634; Pilegaard, Kim/0000-0002-5169-5717; Sanz, Maria Jose/0000-0003-0471-3094; Pilegaard, Kim/0000-0002-5169-5717; Ogée, Jérôme/0000-0002-3365-8584; Seufert, Günther/0000-0002-6019-6688; Rambal, Serge/0000-0001-5869-8382; Buchmann, Nina/0000-0003-0826-2980; Friedlingstein, Pierre/0000-0003-3309-4739; Soussana, Jean-Francois/0000-0002-1932-6583; Keronen, Petri/0000-0001-5019-0904; Loustau, Denis/0000-0003-3990-400X				[Anonymous], 2004, 55 TYND CTR CLIM CHA; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; BOYER JS, 1995, ANNU REV PHYTOPATHOL, V33, P251, DOI 10.1146/annurev.py.33.090195.001343; BUTTNER G, 2000, 89 EUR ENV AG; Cherbuy B, 2001, TREE PHYSIOL, V21, P9, DOI 10.1093/treephys/21.1.9; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dufresne JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013777; ELLIOTT KJ, 1994, J VEG SCI, V5, P229, DOI 10.2307/3236155; *FOOD AGR ORG, 2004, FOOD AGR ORG DAT; Goudriaan J, 2001, TERRESTRIAL GLOBAL P; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Irvine J, 1998, TREE PHYSIOL, V18, P393; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Monsi M., 1953, JAP J BOT, V14, P22, DOI DOI 10.1093/AOB/MCI052; Mucher CA, 2000, INT J REMOTE SENS, V21, P1159, DOI 10.1080/014311600210128; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003430; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Simmons A. J., 2000, ERA 40 PROJECT PLAN, P1; TYREE MT, 1988, PLANT PHYSIOL, V88, P574, DOI 10.1104/pp.88.3.574; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	28	2583	2713	131	1571	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					529	533		10.1038/nature03972	http://dx.doi.org/10.1038/nature03972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177786				2022-12-01	WOS:000232004800045
J	Hsiung, F; Ramirez-Weber, FA; Iwaki, DD; Kornberg, TB				Hsiung, F; Ramirez-Weber, FA; Iwaki, DD; Kornberg, TB			Dependence of Drosophila wing imaginal disc cytonemes on decapentaplegic	NATURE			English	Article							LONG-RANGE ACTION; GRADIENT FORMATION; MORPHOGEN GRADIENT; TRACHEAL SYSTEM; DPP; HEDGEHOG; CELLS; FGF; EXPRESSION; FILOPODIA	The anterior/ posterior ( A/ P) and dorsal/ ventral ( D/ V) compartment borders that subdivide the wing imaginal discs of Drosophila third instar larvae are each associated with a developmental organizer. Decapentaplegic ( Dpp), a member of the transforming growth factor-beta ( TGF-beta) superfamily, embodies the activity of the A/ P organizer. It is produced at the A/ P organizer and distributes in a gradient of decreasing concentration to regulate target genes, functioning non- autonomously to regulate growth and patterning of both the anterior and posterior compartments(1 - 3). Wingless ( Wg) is produced at the D/ V organizer and embodies its activity(4,5). The mechanisms that distribute Dpp and Wg are not known, but proposed mechanisms include extracellular diffusion(6), successive transfers between neighbouring cells(7,8), vesicle- mediated movement(9), and direct transfer via cytonemes(10). Cytonemes are actin-based filopodial extensions that have been found to orient towards the A/ P organizer from outlying cells. Here we show that in the wing disc, cytonemes orient towards both the A/ P and D/ V organizers, and that their presence and orientation correlates with Dpp signalling. We also show that the Dpp receptor, Thickveins ( Tkv), is present in punctae that move along cytonemes. These observations are consistent with a role for cytonemes in signal transduction.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	tkornberg@biochem.ucsf.edu						Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chou YH, 2002, DEV CELL, V3, P839, DOI 10.1016/S1534-5807(02)00362-3; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kranewitter WJ, 2001, CELL MOTIL CYTOSKEL, V49, P154, DOI 10.1002/cm.1029; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Sato M, 2000, MECH DEVELOP, V93, P127, DOI 10.1016/S0925-4773(00)00282-3; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wolf C, 2002, EMBO REP, V3, P563, DOI 10.1093/embo-reports/kvf115; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	24	154	156	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					560	563		10.1038/nature03951	http://dx.doi.org/10.1038/nature03951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16177792				2022-12-01	WOS:000232004800052
J	Arpino, G; Laucirica, R; Elledge, RM				Arpino, G; Laucirica, R; Elledge, RM			Premalignant and in situ breast disease: Biology and clinical implications	ANNALS OF INTERNAL MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; ATYPICAL DUCTAL HYPERPLASIA; TERM-FOLLOW-UP; COMPARATIVE GENOMIC HYBRIDIZATION; HEALTHY POSTMENOPAUSAL WOMEN; STEREOTAXIC CORE BIOPSY; ESTROGEN-RECEPTOR-ALPHA; CELL PROLIFERATION RATE; P53 PROTEIN EXPRESSION; NSABP PROTOCOL B-17	Most types of invasive breast cancer are thought to evolve over long periods from specific preexisting benign lesions. Of the many types of benign entities found in the human breast, only a few have clinically significant premalignant potential. Currently, the best-characterized premalignant lesions are atypical ductal hyperplasia, atypical lobular hyperplasia, and lobular carcinoma in situ. Ductal carcinoma in situ is considered to be a preinvasive malignant lesion. Two additional lesions, unfolded lobules and usual ductal hyperplasia, are sometimes considered to be very early premalignant epithelial abnormalities. Premalignant lesions are currently defined by their histologic features, and not all necessarily progress to invasive cancer. This suggests that although lesions within specific categories look alike, they must possess underlying genetic differences that cause some to remain stable and others to advance. The development of modern molecular genetic techniques has allowed breast cancer researchers to clarify the multistep model of breast carcinogenesis. Recent studies indicate that cancer evolves by highly diverse genetic mechanisms, and research into these altered pathways may identify specific early defects that might be targeted to prevent progression of premalignant lesions to invasive cancer. Current clinical management is heterogeneous and depends on histologic examination and individual patient factors. Options for breast cancer risk reduction and prevention are available.	Baylor Coll Med, Methodist Hosp, Houston, TX 77030 USA; Ben Taub Gen Hosp, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Elledge, RM (corresponding author), 6550 Fannin St,Suite 701, Houston, TX 77030 USA.	relledge@breastcenter.tmc.edu			NATIONAL CANCER INSTITUTE [P01CA030195, U19CA086809, P50CA058183] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA58183, U-19 CA86809, P01 CA30195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; Allred DC, 2002, BREAST CANCER RES TR, V76, pS36; Allred DC, 2000, J MAMMARY GLAND BIOL, V5, P351, DOI 10.1023/A:1009573710675; ALLRED DC, 1994, BREAST CANCER RES TR, V32, P13, DOI 10.1007/BF00666202; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ALLRED DC, 1997, DUCTAL CARCINOMA IN, P37; ALPERS CE, 1985, HUM PATHOL, V16, P796, DOI 10.1016/S0046-8177(85)80251-3; ANDERSEN JA, 1974, ACTA PATH MICRO IM A, VA 82, P735; Arpino G, 2004, CANCER-AM CANCER SOC, V101, P242, DOI 10.1002/cncr.20318; BARNES R, 1990, AM J CLIN PATHOL, V94, P533, DOI 10.1093/ajcp/94.5.533; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; BERARDO M, 1996, LAB INVEST, V74, pA15; Berg WA, 2001, RADIOLOGY, V218, P503, DOI 10.1148/radiology.218.2.r01fe32503; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720; BOBROW LG, 1994, SEMIN DIAGN PATHOL, V11, P199; BODIAN CA, 1993, CANCER, V71, P3908, DOI 10.1002/1097-0142(19930615)71:12<3908::AID-CNCR2820711218>3.0.CO;2-F; BODIAN CA, 1993, EPIDEMIOL REV, V15, P177, DOI 10.1093/oxfordjournals.epirev.a036103; Boecker W, 2001, J PATHOL, V195, P415, DOI 10.1002/path.982; Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.3.CO;2-Z; Bratthauer GL, 2004, VIRCHOWS ARCH, V444, P340, DOI 10.1007/s00428-004-0976-6; Buerger H, 2000, J CLIN PATHOL-MOL PA, V53, P118, DOI 10.1136/mp.53.3.118; Burak WE, 2000, ARCH SURG-CHICAGO, V135, P700, DOI 10.1001/archsurg.135.6.700; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chuaqui RF, 1997, AM J PATHOL, V150, P297; Copeland EM, 1997, ANN SURG, V225, P731; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DEPOTTER CR, 1987, HISTOPATHOLOGY, V11, P1307; Dillon EK, 1997, BRIT J CANCER, V76, P156, DOI 10.1038/bjc.1997.357; DOMAGALA W, 1993, VIRCHOWS ARCH A, V423, P497, DOI 10.1007/BF01606541; Domagala W, 1996, CLIN CANCER RES, V2, P147; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Ernster VL, 2002, J NATL CANCER I, V94, P1546; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Farrow J H, 1970, Cancer, V25, P468, DOI 10.1002/1097-0142(197002)25:2<468::AID-CNCR2820250226>3.0.CO;2-0; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Fisher ER, 2004, CANCER-AM CANCER SOC, V100, P238, DOI 10.1002/cncr.11883; Fisher ER, 1996, CANCER-AM CANCER SOC, V78, P1403, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1403::AID-CNCR6>3.0.CO;2-L; FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G; Fujii H, 1996, CANCER RES, V56, P1493; Fuqua SAW, 2000, CANCER RES, V60, P4026; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; GIRI DD, 1989, HISTOPATHOLOGY, V15, P575, DOI 10.1111/j.1365-2559.1989.tb01623.x; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; HAAGENSEN CD, 1972, SURG CLIN N AM, V52, P497; HAAGENSEN CD, 1986, LOBULAR NEOPLASIA LO, V192; HOSHI K, 1995, JPN J CANC CHEMOT S1, V22, P36; Hwang ES, 2004, CLIN CANCER RES, V10, P5160, DOI 10.1158/1078-0432.CCR-04-0165; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; KRAUS FT, 1962, CANCER, V15, P444, DOI 10.1002/1097-0142(196205/06)15:3<444::AID-CNCR2820150303>3.0.CO;2-0; LAKHANI SR, 1995, J CLIN PATHOL, V48, P611, DOI 10.1136/jcp.48.7.611; Lakhani SR, 2003, LANCET, V361, P96, DOI 10.1016/S0140-6736(03)12240-4; Lakhani SR, 1996, LAB INVEST, V74, P129; LAMBIRD PA, 1969, J AMER MED ASSOC, V210, P689; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li CI, 2002, BREAST CANCER RES TR, V75, P259, DOI 10.1023/A:1019950918046; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; LIBERMAN L, 1995, RADIOLOGY, V194, P379, DOI 10.1148/radiology.194.2.7824713; LIBERMAN L, 1995, AM J ROENTGENOL, V164, P1111, DOI 10.2214/ajr.164.5.7717215; LODATO RF, 1990, MODERN PATHOL, V3, P449; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Lu YJ, 1998, CANCER RES, V58, P4721; MALAFA M, 1990, AM SURGEON, V56, P436; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MIDULLA C, 1995, ANAL QUANT CYTOL, V17, P157; MILLIS RR, 1975, BRIT J SURG, V62, P957, DOI 10.1002/bjs.1800621209; MOHSIN SK, 2000, MODERN PATHOL, V13, pA28; MOLL R, 1993, AM J PATHOL, V143, P1731; Mommers ECM, 1999, BREAST CANCER RES TR, V58, P163, DOI 10.1023/A:1006396103777; Mommers ECM, 2001, J PATHOL, V193, P33, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q; Mommers ECM, 1998, HUM PATHOL, V29, P1539, DOI 10.1016/S0046-8177(98)90028-4; Moore MM, 1997, ANN SURG, V225, P726, DOI 10.1097/00000658-199706000-00010; Nyante SJ, 2004, HUM PATHOL, V35, P759, DOI 10.1016/j.humpath.2003.11.009; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; Orel SG, 1997, RADIOLOGY, V202, P413, DOI 10.1148/radiology.202.2.9015067; OSTEEN RT, 1994, J AM COLL SURGEONS, V178, P213; OTTESEN GL, 1993, AM J SURG PATHOL, V17, P14, DOI 10.1097/00000478-199301000-00002; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; PAGE DL, 1986, CANCER DETECT PREV, V9, P441; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; PAGE DL, 1992, HUM PATHOL, V23, P1095, DOI 10.1016/0046-8177(92)90026-Y; PAGE DL, 1990, CANCER, V66, P1326, DOI 10.1002/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P; PAGE DL, 1993, BREAST CANCER RES TR, V28, P157, DOI 10.1007/BF00666428; Page DL, 1987, DIAGNOSTIC HISTOPATH, P120; PALLIS L, 1992, ANTICANCER RES, V12, P2113; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; POLLER DN, 1991, BREAST CANCER RES TR, V20, P3, DOI 10.1007/BF01833351; PORTER PL, 1991, CANCER, V68, P331, DOI 10.1002/1097-0142(19910715)68:2<331::AID-CNCR2820680221>3.0.CO;2-X; Querzoli P, 1998, CANCER-AM CANCER SOC, V83, P89, DOI 10.1002/(SICI)1097-0142(19980701)83:1<89::AID-CNCR12>3.0.CO;2-8; RADFORD DM, 1995, CANCER RES, V55, P5180; RAMACHANDRA S, 1990, J PATHOL, V161, P7, DOI 10.1002/path.1711610104; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; ROSEN P P, 1984, P59; ROSEN PP, 1980, CANCER, V46, P919, DOI 10.1002/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z; ROSEN PP, 1999, BREAST PATHOLOGY DIA, P197; Rosenberg CL, 1997, HUM PATHOL, V28, P214, DOI 10.1016/S0046-8177(97)90109-X; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rudas M, 1997, EUR J CANCER, V33, P39, DOI 10.1016/S0959-8049(96)00368-1; SCHILDKRAUT JM, 1995, AM J OBSTET GYNECOL, V172, P908, DOI 10.1016/0002-9378(95)90020-9; Schmitt FC, 1995, EUR J CANCER, V31A, P2049, DOI 10.1016/0959-8049(95)00430-0; Schwartz GF, 1997, HUM PATHOL, V28, P1221; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; Shaaban AM, 2002, AM J PATHOL, V160, P597, DOI 10.1016/S0002-9440(10)64879-1; Silverstein MJ, 1998, J CLIN ONCOL, V16, P1367, DOI 10.1200/JCO.1998.16.4.1367; SILVERSTEIN MJ, 1995, EUR J CANCER, V31A, P1425, DOI 10.1016/0959-8049(95)00283-O; Silverstein MJ, 1999, NEW ENGL J MED, V340, P1455, DOI 10.1056/NEJM199905133401902; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Soderstrom CE, 1996, RADIOLOGY, V201, P427, DOI 10.1148/radiology.201.2.8888235; SOMERVILLE JE, 1992, J CLIN PATHOL, V45, P16, DOI 10.1136/jcp.45.1.16; TAVASSOLI FA, 1990, CANCER, V65, P518, DOI 10.1002/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O; TAVASSOLI FA, 1999, PATHOLOGY BREAST, P373; VISSCHER DW, 1991, ANAL QUANT CYTOL, V13, P418; Vos CBJ, 1997, BRIT J CANCER, V76, P1131, DOI 10.1038/bjc.1997.523; Wang JP, 2004, J NATL CANCER I, V96, P616, DOI 10.1093/jnci/djhs105; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; YOUNES M, 1995, HUM PATHOL, V26, P155, DOI 10.1016/0046-8177(95)90031-4; ZHUANG ZP, 1995, CANCER RES, V55, P467	131	137	138	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2005	143	6					446	457		10.7326/0003-4819-143-6-200509200-00009	http://dx.doi.org/10.7326/0003-4819-143-6-200509200-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967OG	16172443				2022-12-01	WOS:000232099900006
J	Hohlfeld, J; Roessingh, AD; Hirt-Burri, N; Chaubert, P; Gerber, S; Scaletta, C; Hohlfeld, P; Applegate, LA				Hohlfeld, J; Roessingh, AD; Hirt-Burri, N; Chaubert, P; Gerber, S; Scaletta, C; Hohlfeld, P; Applegate, LA			Tissue engineered fetal skin constructs for paediatric burns	LANCET			English	Article							REPAIR; CELL	Autologous skin-grafting is the gold standard for treatment of deep second and third degree bums. Available bioengineered skin products also necessitate this two-step surgical procedure. Therefore, we developed fetal skin constructs to improve healing of such degree bums. A bank of fetal skin cells was developed from one organ donation (4 cm(2) of skin allowing the preparation of several million three-dimensional skin constructs, 9 X 12 cm, on native horse Collagen). Successive fetal constructs were applied to eight patients at every change of dressing during 1-3 weeks in an outpatient setting. Complete closure was rapid (mean 15.3 days [SD 5.5]) with little hypertrophy of new skin and no retraction seen. This simple technique provided complete treatment without auto-grafting, showing that fetal skin cells might have great potential to treat bums and eventually acute and chronic wounds of other types.	Univ Lausanne Hosp, CHU Vaudois, Dept Obstet, Div Fetal Med, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, CHU Vaudois, Dept Paediat Surg, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Applegate, LA (corresponding author), Univ Lausanne Hosp, CHU Vaudois, Dept Obstet, Div Fetal Med, MAT 07, CH-1011 Lausanne, Switzerland.	Lee.Laurent-Applegate@chuv.hospvd.ch						ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; Cass DL, 1997, PEDIATR SURG INT, V12, P484, DOI 10.1007/s003830050189; FOGLIA RP, 1986, ANN SURG, V204, P402, DOI 10.1097/00000658-198610000-00008; LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001; Stelnicki EJ, 2000, PLAST RECONSTR SURG, V105, P140, DOI 10.1097/00006534-200001000-00024; Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5; Wisser D, 2004, BURNS, V30, P399, DOI 10.1016/j.burns.2003.11.012	7	108	121	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2005	366	9488					840	842		10.1016/S0140-6736(05)67107-3	http://dx.doi.org/10.1016/S0140-6736(05)67107-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960XR	16139659				2022-12-01	WOS:000231627000029
J	Jopling, CL; Yi, MK; Lancaster, AM; Lemon, SM; Sarnow, P				Jopling, CL; Yi, MK; Lancaster, AM; Lemon, SM; Sarnow, P			Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA	SCIENCE			English	Article							5' NONTRANSLATED REGION; TRANSLATION INITIATION; MESSENGER-RNA; EFFICIENT REPLICATION; HUH7 CELLS; EXPRESSION; IDENTIFICATION; ARABIDOPSIS; REPLICONS; SEQUENCES	MicroRNAs are small RNA molecules that regulate messenger RNA (mRNA) expression. MicroRNA 122 (miR-122) is specifically expressed and highly abundant in the human liver. We show that the sequestration of miR-122 in liver cells results in marked loss of autonomously replicating hepatitis C viral RNAs. A genetic interaction between miR-122 and the 5' noncoding region of the viral genome was revealed by mutational analyses of the predicted microRNA binding site and ectopic expression of miR-122 molecules containing compensatory mutations. Studies with replication-defective RNAs suggested that miR-122 did not detectably affect mRNA translation or RNA stability. Therefore, miR-122 is likely to facilitate replication of the viral RNA, suggesting that miR-122 may present a target for antiviral intervention.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Ctr Hepatitis Res, Galveston, TX 77555 USA	Stanford University; University of Texas System; University of Texas Medical Branch Galveston	Sarnow, P (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	psarnow@stanford.edu		Sarnow, Peter/0000-0002-2043-2770; Jopling, Catherine/0000-0001-6046-1456	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047365, R01AI047365, R21AI063451, U19AI040035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069007] Funding Source: NIH RePORTER; NIAID NIH HHS [AI63451, AI47365, AI40035] Funding Source: Medline; NIGMS NIH HHS [GM069007] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kim YK, 2003, RNA, V9, P599, DOI 10.1261/rna.2185603; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	34	1984	2188	5	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1577	1581		10.1126/science.1113329	http://dx.doi.org/10.1126/science.1113329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141076	Green Submitted			2022-12-01	WOS:000231715000054
J	Cowan, CA; Atienza, J; Melton, DA; Eggan, K				Cowan, CA; Atienza, J; Melton, DA; Eggan, K			Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells	SCIENCE			English	Article							HUMAN TERATOCARCINOMA CELLS; HUMAN BLASTOCYSTS; GENE-EXPRESSION; LINES; DIFFERENTIATION; PLURIPOTENCY; CLONING; NANOG	We have explored the use of embryonic stem cells as an alternative to oocytes for reprogramming human somatic nuclei. Human embryonic stem (hES) cells were fused with human fibroblasts, resulting in hybrid cells that maintain a stable tetraploid DNA content and have morphology, growth rate, and antigen expression patterns characteristic of hES cells. Differentiation of hybrid cells in vitro and in vivo yielded cell types from each embryonic germ layer. Analysis of genome-wide transcriptional activity, reporter gene activation, allele-specific gene expression, and DNA methylation showed that the somatic genome was reprogrammed to an embryonic state. These results establish that hES cells can reprogram the transcriptional state of somatic nuclei and provide a system for investigating the underlying mechanisms.	Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	Eggan@mcb.harvard.edu	Young, Richard A/F-6495-2012; Eggan, Kevin/P-7119-2018	Young, Richard A/0000-0001-8855-8647; 				Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2002, CURR OPIN GENET DEV, V12, P607, DOI 10.1016/S0959-437X(02)00346-5; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; EASTER SS, 1993, J NEUROSCI, V13, P285; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; MACDONALD DJ, 1978, CLIN CHIM ACTA, V87, P367, DOI 10.1016/0009-8981(78)90180-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	28	661	769	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1369	1373		10.1126/science.1116447	http://dx.doi.org/10.1126/science.1116447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123299				2022-12-01	WOS:000231543300043
J	Pokholok, DK; Harbison, CT; Levine, S; Cole, M; Hannett, NM; Lee, TI; Bell, GW; Walker, K; Rolfe, PA; Herbolsheimer, E; Zeitlinger, J; Lewitter, F; Gifford, DK; Young, RA				Pokholok, DK; Harbison, CT; Levine, S; Cole, M; Hannett, NM; Lee, TI; Bell, GW; Walker, K; Rolfe, PA; Herbolsheimer, E; Zeitlinger, J; Lewitter, F; Gifford, DK; Young, RA			Genome-wide map of nucleosorne acetylation and methylation in yeast	CELL			English	Article							RNA-POLYMERASE-II; GLOBAL HISTONE ACETYLATION; DNA-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; ACTIVE GENES; IN-VIVO; GCN4 PROTEIN; TRANSCRIPTIONAL ELONGATION; TARGETED RECRUITMENT; EUKARYOTIC GENOME	Eukaryotic genomes are packaged into nucleosomes whose position and chemical modification state can profoundly influence regulation of gene expression. We profiled nucleosome modifications across the yeast genome using chromatin immunoprecipitation coupled with DNA microarrays to produce high-resolution genome-wide maps of histone acetylation and methylation. These maps take into account changes in nucleosome occupancy at actively transcribed genes and, in doing so, revise previous assessments of the modifications associated with gene expression. Both acetylation and methylation of histones are associated with transcriptional activity, but the former occurs predominantly at the beginning of genes, whereas the latter can occur throughout transcribed regions. Most notably, specific methylation events are associated with the beginning, middle, and end of actively transcribed genes. These maps provide the foundation for further understanding the roles of chromatin in gene expression and genome maintenance.	Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X	NHGRI NIH HHS [HG002668] Funding Source: Medline; NIGMS NIH HHS [GM069676] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069676] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	59	1052	1078	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					517	527		10.1016/j.cell.2005.06.026	http://dx.doi.org/10.1016/j.cell.2005.06.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122420	Bronze			2022-12-01	WOS:000231555100008
J	Annema, JT; Versteegh, MI; Veselic, M; Welker, L; Mauad, T; Sont, JK; Willems, LNA; Rabe, KF				Annema, JT; Versteegh, MI; Veselic, M; Welker, L; Mauad, T; Sont, JK; Willems, LNA; Rabe, KF			Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; EUS; MANAGEMENT; LESIONS; TRIAL	Context Up to 40% of thoracotomies performed for non-small cell lung cancer are unnecessary, predominantly due to inaccurate preoperative detection of lymph node metastases and mediastinal tumor invasion (T4). Mediastinoscopy and the novel, minimally invasive technique of transesophageal ultrasound-guided fine-needle aspiration (EUS-FNA) target different mediastinal lymph node stations. In addition, EUS can identify tumor invasion in neighboring organs if tumors are located adjacent to the esophagus. Objective To investigate the additional value of EUS-FNA to mediastinoscopy in the preoperative staging of patients with non-small cell lung cancer. Design, Setting, and Patients Prospective, nonrandomized multicenter trial performed in 1 referral and 5 general hospitals in the Netherlands. During a 3-year period (2000-2003), 107 consecutive patients with potential resectable non-small cell lung cancer underwent preoperative staging by both EUS-FNA and mediastinoscopy. Patients underwent thoracotomy with tumor resection if mediastinoscopy was negative. Surgical-pathological staging was compared with preoperative findings and the added benefit of the combined strategy was assessed. Intervention The EUS-FNA examination was performed as an additional staging test to mediastinoscopy in all patients. Main Outcome Measure Detection of mediastinal tumor invasion (T4) and lymph node metastases (N2/N3) comparing the combined staging by both EUS-FNA and mediastinoscopy with staging by mediastinoscopy alone. Results The combination of EUS-FNA and mediastinoscopy identified more patients with tumor invasion or lymph node metastases (36%; 95% confidence interval [CI], 27%-46%) compared with either mediastinoscopy alone (20%; 95% Cl, 13%-29%) or EUS-FNA (28%; 95% Cl, 19%-38%) alone. This indicated that 16% of thoracotomies could have been avoided by using EUS-FNA in addition to mediastinoscopy. However, 2% of the EUS-FNA findings were false-positive. Conclusion These preliminary findings suggest that EUS-FNA, when added to mediastinoscopy, improves the preoperative staging of lung cancer due to the complementary reach of EUS-FNA in detecting mediastinal lymph node metastases and the ability to assess mediastinal tumor invasion.	Leiden Univ, Med Ctr, Dept Pulmonol C3 P, Div Pulm Med, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Div Cardiothorac Surg, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Div Pathol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Div Med Decis Making, NL-2300 RC Leiden, Netherlands; Krankenhaus Grosshansdorf, Div Pulm Med, Grosshansdorf, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Grosshansdorf Hospital	Annema, JT (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol C3 P, Div Pulm Med, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	j.t.annema@lumc.nl	Mauad, Thais/G-1254-2012; Sont, Jacob K/J-8071-2015; Rabe, Klaus F./AAW-6296-2021	Mauad, Thais/0000-0002-3354-1466; Sont, Jacob K/0000-0002-5840-0651; Rabe, Klaus F./0000-0002-7020-1401				Annema JT, 2004, LUNG CANCER, V44, P53, DOI 10.1016/j.lungcan.2003.10.013; COUGHLIN M, 1985, ANN THORAC SURG, V40, P556, DOI 10.1016/S0003-4975(10)60348-7; Detterbeck FC, 2003, CHEST, V123, p167S, DOI 10.1378/chest.123.1_suppl.167S; Fritscher-Ravens A, 2003, AM J RESP CRIT CARE, V168, P1293, DOI 10.1164/rccm.200301-050OC; Hammoud ZT, 1999, J THORAC CARDIOV SUR, V118, P894, DOI 10.1016/S0022-5223(99)70059-0; Herder GJM, 2002, THORAX, V57, P11, DOI 10.1136/thorax.57.1.11; Kramer H, 2003, ANN SURG, V238, P180, DOI 10.1097/01.SLA.0000081086.37779.1a; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Larsen SS, 2002, THORAX, V57, P98, DOI 10.1136/thorax.57.2.98; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Spiro SG, 2002, AM J RESP CRIT CARE, V166, P1166, DOI 10.1164/rccm.200202-070SO; Toloza EM, 2003, CHEST, V123, p157S, DOI 10.1378/chest.123.1_suppl.157S; Toloza EM, 2003, CHEST, V123, p137S, DOI 10.1378/chest.123.1_suppl.137S; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Varadarajulu S, 2004, GASTROINTEST ENDOSC, V59, P345, DOI 10.1016/S0016-5107(03)02541-0; VENUTA F, 1992, EUR J CARDIO-THORAC, V6, P238, DOI 10.1016/1010-7940(92)90104-6; Wallace MB, 2001, GASTROINTEST ENDOSC, V54, P441, DOI 10.1067/mge.2001.117764	20	133	138	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2005	294	8					931	936		10.1001/jama.294.8.931	http://dx.doi.org/10.1001/jama.294.8.931			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957JM	16118383	Bronze			2022-12-01	WOS:000231366100023
J	Srinivasan, M; Ruina, A				Srinivasan, M; Ruina, A			Computer optimization of a minimal biped model discovers walking and running	NATURE			English	Article							LOCOMOTION; ENERGETICS; GAITS; TRANSITION; SPEED	Although people's legs are capable of a broad range of muscle-use and gait patterns, they generally prefer just two. They walk, swinging their body over a relatively straight leg with each step, or run, bouncing up off a bent leg between aerial phases. Walking feels easiest when going slowly, and running feels easiest when going faster. More unusual gaits seem more tiring. Perhaps this is because walking and running use the least energy(1-7). Addressing this classic(1) conjecture with experiments(2,3) requires comparing walking and running with many other strange and unpractised gaits. As an alternative, a basic understanding of gait choice might be obtained by calculating energy cost by using mechanics-based models. Here we use a minimal model that can describe walking and running as well as an infinite variety of other gaits. We use computer optimization to find which gaits are indeed energetically optimal for this model. At low speeds the optimization discovers the classic inverted-pendulum walk(8-13), at high speeds it discovers a bouncing run(12,13), even without springs, and at intermediate speeds it finds a new pendular-running gait that includes walking and running as extreme cases.	Cornell Univ, Biorobot & Locomot Lab, Ithaca, NY 14853 USA	Cornell University	Srinivasan, M (corresponding author), Cornell Univ, Biorobot & Locomot Lab, 306 Kimball Hall, Ithaca, NY 14853 USA.	ms285@cornell.edu	Ruina, Andy L/A-8725-2018; Srinivasan, Manoj/E-8751-2011	Ruina, Andy L/0000-0001-5493-6048; Srinivasan, Manoj/0000-0002-7811-3617				ALEXANDER R., 1976, PERSPECTIVES EXPT BI, V1, P493; ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ALEXANDER RM, 1980, J ZOOL, V192, P97, DOI 10.1111/j.1469-7998.1980.tb04222.x; ALEXANDER RM, 2003, APPL MECH REV, V48, P461; Alexander RM., 1988, ELASTIC MECH ANIMAL; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Bertram JEA, 2002, J MOTOR BEHAV, V34, P309, DOI 10.1080/00222890209601949; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; BORELLI GA, 1680, MOTU ANIMALIUM PARS; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Bryson A., 1975, APPL OPTIMAL CONTROL, DOI [10.1201/9781315137667, DOI 10.1201/9781315137667]; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; FARLEY CT, 2005, J APPL PHYSL    0728, DOI DOI 10.1152/JAPPLPHYSIOL.00103.2005; Gill PE, 2002, SIAM J OPTIMIZ, V12, P979, DOI 10.1137/S1052623499350013; Gordon K. E, 2003, P 27 ANN M AM SOC BI; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Margaria R., 1977, BIOMECHANICS ENERGET; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Minetti AE, 1998, P ROY SOC B-BIOL SCI, V265, P1227, DOI 10.1098/rspb.1998.0424; Rashevsky N., 1944, BULL MATH BIO PHYS, V6, P1, DOI 10.1007/BF02478284; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x	30	381	394	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					72	75		10.1038/nature04113	http://dx.doi.org/10.1038/nature04113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16155564	Green Submitted			2022-12-01	WOS:000234378700036
J	Krutzfeldt, J; Rajewsky, N; Braich, R; Rajeev, KG; Tuschl, T; Manoharan, M; Stoffel, M				Krutzfeldt, J; Rajewsky, N; Braich, R; Rajeev, KG; Tuschl, T; Manoharan, M; Stoffel, M			Silencing of microRNAs in vivo with 'antagomirs'	NATURE			English	Article							RNA; INHIBITION; BIOGENESIS; EXPRESSION; TARGETS; MIRNAS	MicroRNAs ( miRNAs) are an abundant class of non- coding RNAs that are believed to be important in many biological processes through regulation of gene expression(1-3). The precise molecular function of miRNAs in mammals is largely unknown and a better understanding will require loss- of- function studies in vivo. Here we show that a novel class of chemically engineered oligonucleotides, termed ' antagomirs', are efficient and specific silencers of endogenous miRNAs in mice. Intravenous administration of antagomirs against miR- 16, miR- 122, miR- 192 and miR- 194 resulted in a marked reduction of corresponding miRNA levels in liver, lung, kidney, heart, intestine, fat, skin, bone marrow, muscle, ovaries and adrenals. The silencing of endogenous miRNAs by this novel method is specific, efficient and long-lasting. The biological significance of silencing miRNAs with the use of antagomirs was studied for miR- 122, an abundant liver-specific miRNA. Gene expression and bioinformatic analysis of messenger RNA from antagomir- treated animals revealed that the 3' untranslated regions of upregulated genes are strongly enriched in miR- 122 recognition motifs, whereas downregulated genes are depleted in these motifs. Analysis of the functional annotation of downregulated genes specifically predicted that cholesterol biosynthesis genes would be affected by miR- 122, and plasma cholesterol measurements showed reduced levels in antagomir-122- treated mice. Our findings show that antagomirs are powerful tools to silence specific miRNAs in vivo and may represent a therapeutic strategy for silencing miRNAs in disease.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@rockefeller.edu	yang, xiao-jun/B-1927-2009	Rajewsky, Nikolaus/0000-0002-4785-4332; Stoffel, Markus/0000-0003-1304-5817				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MANOHARAN M, 2005, Patent No. 2005107325; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	25	3087	3527	5	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					685	689		10.1038/nature04303	http://dx.doi.org/10.1038/nature04303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16258535				2022-12-01	WOS:000233593100054
J	Gardosi, J; Kady, SM; McGeown, P; Francis, A; Tonks, A				Gardosi, J; Kady, SM; McGeown, P; Francis, A; Tonks, A			Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLASSIFYING PERINATAL DEATH; BIRTH-WEIGHT; ANTEPARTUM STILLBIRTHS; GESTATIONAL-AGE; FETAL; MORTALITY; GROWTH	Objective To develop and test a new classification system. for stillbirths to help improve understanding of the main causes and conditions associated with fetal death. Design Population based cohort study. Setting West Midlands region. Subjects 2625 stillbirths from 1997 to 2003. Main outcome measures Categories of death according to conventional classification methods and a newly developed system (ReCoDe, relevant condition at death). Results By the conventional Wigglesworth classification, 66.2% of the stillbirths (1738 of 2625) were unexplained. The median gestational age of the unexplained group was 237 days, significantly higher than the stillbirths in the other categories (2 10 days; P < 0.001). The proportion of stillbirths that were unexplained was high regardless of whether a postmortem examination had been carried out or not (67% and 65%; P = 0.3). By the ReCoDe classification, the most common condition was fetal growth restriction (43.0%), and only 15.2% of stillbirths remained unexplained. ReCoDe identified 57.7% of the Wigglesworth unexplained stillbirths as growth restricted. The size of the category for intrapartum asphyxia was reduced from 11.7% (Wigglesworth) to 3.4% (ReCoDe). Conclusion The new ReCoDe classification system reduces the predominance of stillbirths currently categorised as unexplained. Fetal growth restriction is a common antecedent of stillbirth, but its high prevalence is hidden by current classification systems. This finding has profound implications for maternity services, and raises the question whether some hitherto "unexplained" stillbirths may be avoidable.	Perinatal Inst, Birmingham B6 5RQ, W Midlands, England		Gardosi, J (corresponding author), Perinatal Inst, Birmingham B6 5RQ, W Midlands, England.	gardosi@perinatal.nhs.uk	Francis, Andre/AAY-3807-2021; Gardosi, Jason/GXN-1375-2022	Gardosi, Jason/0000-0002-3230-1292				ALESSANDRI LM, 1992, BRIT J OBSTET GYNAEC, V99, P711, DOI 10.1111/j.1471-0528.1992.tb13868.x; BOUND JP, 1956, BMJ-BRIT MED J, V2, P1260, DOI 10.1136/bmj.2.5004.1260; BOUND JP, 1956, BRIT MED J, V2, P1191, DOI 10.1136/bmj.2.5003.1191; CHISWICK ML, 1986, J OBSTET GYNAECOLOGY, V86, P1236; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; *CONF ENQ MAT CHIL, 2005, STILLB NEON POST NEO; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; GENEST DR, 1992, OBSTET GYNECOL, V80, P575; HEPBURN M, 1986, BRIT J OBSTET GYNAEC, V93, P212, DOI 10.1111/j.1471-0528.1986.tb07895.x; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; *MAT CHILD HLTH CO, 2001, CESDI 8 ANN REP CONF; McCowan LME, 2005, BJOG-INT J OBSTET GY, V112, P1026, DOI 10.1111/j.1471-0528.2005.00656.x; MCILWAINE GM, 1979, BMJ-BRIT MED J, V2, P1103, DOI 10.1136/bmj.2.6198.1103; *SCOTT PROGR CLIN, 2000, SCOTT STILLB INF DEA; WHITFIELD CR, 1986, BRIT J OBSTET GYNAEC, V93, P694, DOI 10.1111/j.1471-0528.1986.tb08054.x; WIGGLESWORTH JS, 1980, LANCET, V2, P684; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624	22	335	348	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2005	331	7525					1113	1117		10.1136/bmj.38629.587639.7C	http://dx.doi.org/10.1136/bmj.38629.587639.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985ZI	16236774	Green Published, Bronze			2022-12-01	WOS:000233417300014
J	Bukowski, MR; Koehntop, KD; Stubna, A; Bominaar, EL; Halfen, JA; Munck, E; Nam, W; Que, L				Bukowski, MR; Koehntop, KD; Stubna, A; Bominaar, EL; Halfen, JA; Munck, E; Nam, W; Que, L			A thiolate-ligated nonheme oxoiron(IV) complex relevant to cytochrome P450	SCIENCE			English	Article							FE-IV=O COMPLEX; ENZYMES; LIGAND; CHEMISTRY; MECHANISM; P450CAM; MODELS; QM/MM; EPR	Thiolate-ligated oxoiron(IV) centers are postulated to be the key oxidants in the catalytic cycles of oxygen-activating cytochrome P450 and related enzymes. Despite considerable synthetic efforts, chemists have not succeeded in preparing an appropriate model complex. Here we report the synthesis and spectroscopic characterization of [Fe-IV(O)(TMCS)](+) where TMCS is a pentadentate ligand that provides a square pyramidal N-4(SR)(apical), where SR is thiotate, ligand environment about the iron center, which is similar to that of cytochrome P450. The rigidity of the ligand framework stabilizes the thiolate in an oxidizing environment. Reactivity studies suggest that thiolate coordination favors hydrogen-atom abstraction chemistry over oxygen-atom transfer pathways in the presence of reducing substrates.	Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Biomimet Syst, Seoul 120750, South Korea	University of Wisconsin System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; Ewha Womans University; Ewha Womans University	Halfen, JA (corresponding author), Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA.	halfenja@uwec.edu; emunck@cmu.edu; que@chem.umn.edu		Nam, Wonwoo/0000-0001-8592-4867; Bukowski, Michael/0000-0001-8381-4429	NIBIB NIH HHS [EB-001475] Funding Source: Medline; NIGMS NIH HHS [T32 GM-08700, GM-33162] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700, R37GM033162, R01GM033162] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Debrunner P. G., 1989, IRON PORPHYRINS, V3, P137; Decker A, 2004, J AM CHEM SOC, V126, P5378, DOI 10.1021/ja0498033; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Fiedler AT, 2005, J AM CHEM SOC, V127, P1675, DOI 10.1021/ja046939s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Groves J. T., 2005, CYTOCHROME P450, P1, DOI DOI 10.1007/0-387-27447-2_1; Kaizer J, 2004, J AM CHEM SOC, V126, P472, DOI 10.1021/ja037288n; Lim MH, 2003, P NATL ACAD SCI USA, V100, P3665, DOI 10.1073/pnas.0636830100; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Nam W, 2000, ANGEW CHEM INT EDIT, V39, P3646, DOI 10.1002/1521-3773(20001016)39:20<3646::AID-ANIE3646>3.0.CO;2-Q; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Rohde JU, 2004, J AM CHEM SOC, V126, P16750, DOI 10.1021/ja047667w; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Rohde JU, 2005, ANGEW CHEM INT EDIT, V44, P2255, DOI 10.1002/anie.200462631; Sastri CV, 2005, J AM CHEM SOC, V127, P12494, DOI 10.1021/ja0540573; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schoneboom JC, 2005, J AM CHEM SOC, V127, P5840, DOI 10.1021/ja0424732; Schoneboom JC, 2002, J AM CHEM SOC, V124, P8142, DOI 10.1021/ja026279w; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tani F, 2002, COORDIN CHEM REV, V226, P219, DOI 10.1016/S0010-8545(01)00444-1; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a	24	213	213	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1000	1002		10.1126/science.1119092	http://dx.doi.org/10.1126/science.1119092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16254150				2022-12-01	WOS:000233343400038
J	Lee, DY; Ezhkova, E; Li, B; Pattenden, SG; Tansey, WP; Workman, JL				Lee, DY; Ezhkova, E; Li, B; Pattenden, SG; Tansey, WP; Workman, JL			The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators	CELL			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; SWI/SNF COMPLEX; ACTIVE GENES; ACETYLATION; RECRUITMENT; H2B; H3	Promoter recruitment of the Saccharomyces cerevisiae SAGA histone acetyltransferase complex is required for RNA polymerase II-dependent transcription of several genes. SAGA is targeted to promoters through interactions with sequence-specific DNA binding transcriptional activators and facilitates preinitiation-complex assembly and transcription. Here, we show that the 19S proteasome regulatory particle (19S RP) alters SAGA to stimulate its interaction with transcriptional activators. The ATPase components of the 19S RP are required for stimulation of SAGA/activator interactions and enhance SAGA recruitment to promoters. Proteasomal ATPases genetically interact with SAGA, and their inhibition reduces global histone H3 acetylation levels and SAGA recruitment to target promoters in vivo. These results indicate that the 19S RIP modulates SAGA complex using its ATPase components, thereby facilitating subsequent transcription events at promoters.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Stowers Institute for Medical Research; Cold Spring Harbor Laboratory	Tansey, WP (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tansey@cshl.edu; jlw@stowers-institute.org	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823; Ezhkova, Elena/0000-0003-4154-1615	NIGMS NIH HHS [GM047867, GM067728] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867, R01GM067728, R37GM047867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Juan LJ, 1997, J BIOL CHEM, V272, P3635, DOI 10.1074/jbc.272.6.3635; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neuwald AF, 1999, GENOME RES, V9, P27; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Stenlund A, 2003, NAT REV MOL CELL BIO, V4, P777, DOI 10.1038/nrm1226; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; XU QL, 1995, MOL CELL BIOL, V15, P6025; Yu VPCC, 2005, MOL CELL, V17, P145, DOI 10.1016/j.molcel.2004.11.020; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	54	142	147	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 4	2005	123	3					423	436		10.1016/j.cell.2005.08.015	http://dx.doi.org/10.1016/j.cell.2005.08.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269334	Bronze			2022-12-01	WOS:000233264300011
J	Spiegelhalter, DJ				Spiegelhalter, DJ			Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE		Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Spiegelhalter, DJ (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England.	david.spiegelhalter@mrc-bsu.cam.ac.uk						Bird SM, 2005, J ROY STAT SOC A STA, V168, P1, DOI 10.1111/j.1467-985X.2004.00333.x; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Burgess JF, 2000, J HEALTH ECON, V19, P291, DOI 10.1016/S0167-6296(99)00034-X; *COMM HLTH IMPR, 2003, METH RES STAPH AUR M; Department of Health, 2004, MAND BACT SURV SCHEM; Department of Health, 2004, NAT STAND LOC ACT HL; *HEALTHC COMM, 2004, IND LIST AC TRUSTS; *HEALTHC COMM, 2005, IND LIST AC TRUSTS M; *HLTH PROT AG COMM, 2003, CDR WEEKLY, V13, P1; McCullagh P, 2019, GEN LINEAR MODELS; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; 2004, BBC NEWS        0713; 2004, BBC NEWS        1105	14	23	24	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 29	2005	331	7523					1013	1015		10.1136/bmj.331.7523.1013	http://dx.doi.org/10.1136/bmj.331.7523.1013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981AU	16254304	Green Published			2022-12-01	WOS:000233060200022
J	Kokoeva, MV; Yin, HL; Flier, JS				Kokoeva, MV; Yin, HL; Flier, JS			Neurogenesis in the hypothalamus of adult mice: Potential role in energy balance	SCIENCE			English	Article							CILIARY NEUROTROPHIC FACTOR; NEURAL PROGENITORS; FEEDING CIRCUITS; GENE-EXPRESSION; MAMMALIAN BRAIN; GROWTH-FACTOR; BODY-WEIGHT; LEPTIN; OBESITY; NEURONS	Ciliary neurotrophic factor (CNTF) induces weight loss in obese rodents and humans, and for reasons that are not understood, its effects persist after the cessation of treatment. Here we demonstrate that centrally administered CNTF induces cell proliferation in feeding centers of the murine hypothalamus. Many of the newborn cells express neuronal markers and show functional phenotypes relevant for energy-balance control, including a capacity for leptin-induced phosphorylation of signal transducer and activator of transcription 3 (STAT3). Coadministration of the mitotic blocker cytosine-beta-D-arabinofuranoside (Ara-C) eliminates the proliferation of neural cells and abrogates the tong-term, but not the short-term, effect of CNTF on body weight. These findings link the sustained effect of CNTF on energy balance to hypothalamic neurogenesis and suggest that regulated hypothalamic neurogenesis in adult mice may play a previously unappreciated role in physiology and disease.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Flier, JS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.	jflier@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019		NIDDK NIH HHS [DKR3728082] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK028082] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2001, TRENDS MOL MED, V7, P205, DOI 10.1016/S1471-4914(01)01989-X; Anderson KD, 1998, SOC NEUR ABSTR, V24, P621; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bhat RV, 1996, GLIA, V17, P169; Bjorbaek C, 1999, ENDOCRINOLOGY, V140, P2035, DOI 10.1210/en.140.5.2035; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Kelly JF, 2004, DIABETES, V53, P911, DOI 10.2337/diabetes.53.4.911; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; LEE MK, 1990, P NATL ACAD SCI USA, V87, P7195, DOI 10.1073/pnas.87.18.7195; Levison SW, 1996, EXP NEUROL, V141, P256, DOI 10.1006/exnr.1996.0160; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; SanzRodriguez C, 1997, NEUROSCI LETT, V223, P141, DOI 10.1016/S0304-3940(97)13412-7; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Weigle DS, 2003, J CLIN ENDOCR METAB, V88, P2462, DOI 10.1210/jc.2003-030151; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	518	527	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					679	683		10.1126/science.1115360	http://dx.doi.org/10.1126/science.1115360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254185				2022-12-01	WOS:000232997700043
J	Cheung, VG; Spielman, RS; Ewens, KG; Weber, TM; Morley, M; Burdick, JT				Cheung, VG; Spielman, RS; Ewens, KG; Weber, TM; Morley, M; Burdick, JT			Mapping determinants of human gene expression by regional and genome-wide association	NATURE			English	Article							COMPLEX TRAITS; DISEASE; DISSECTION; FUTURE	To study the genetic basis of natural variation in gene expression, we previously carried out genome-wide linkage analysis and mapped the determinants of similar to 1,000 expression phenotypes(1). In the present study, we carried out association analysis with dense sets of single-nucleotide polymorphism ( SNP) markers from the International HapMap Project(2). For 374 phenotypes, the association study was performed with markers only from regions with strong linkage evidence; these regions all mapped close to the expressed gene. For a subset of 27 phenotypes, analysis of genome-wide association was performed with > 770,000 markers. The association analysis with markers under the linkage peaks confirmed the linkage results and narrowed the candidate regulatory regions for many phenotypes with strong linkage evidence. The genome-wide association analysis yielded highly significant results that point to the same locations as the genome scans for about 50% of the phenotypes. For one candidate determinant, we carried out functional analyses and confirmed the variation in cis-acting regulatory activity. Our findings suggest that association studies with dense SNP maps will identify susceptibility loci or other determinants for some complex traits or diseases.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu; spielman@pobox.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM081930, R01 GM081930-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ball RD, 2005, GENETICS, V170, P859, DOI 10.1534/genetics.103.024752; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Liu XM, 2005, CANCER RES, V65, P99; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Westfall P.H., 1992, RESAMPLING BASED MUL	22	448	472	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2005	437	7063					1365	1369		10.1038/nature04244	http://dx.doi.org/10.1038/nature04244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977UQ	16251966	Green Accepted, Bronze			2022-12-01	WOS:000232829100056
J	Paterson, I; Anderson, EA				Paterson, I; Anderson, EA			The renaissance of natural products as drug candidates	SCIENCE			English	Editorial Material							SCALE SYNTHESIS		Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Paterson, I (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	ip100@cam.ac.uk	Paterson, Ian/Q-6588-2018	Paterson, Ian/0000-0002-8861-9136				AICHER TD, 1992, J AM CHEM SOC, V114, P3162, DOI 10.1021/ja00034a086; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Charest MG, 2005, SCIENCE, V308, P395, DOI 10.1126/science.1109755; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P122, DOI 10.1021/op034134j; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Paterson I, 2003, EUR J ORG CHEM, V2003, P2193, DOI 10.1002/ejoc.200300061; Shaw SJ, 2005, J AM CHEM SOC, V127, P6532, DOI 10.1021/ja051185i; Smith AB, 2000, J AM CHEM SOC, V122, P8654, DOI 10.1021/ja0015287; Wender Paul A, 2004, Curr Drug Discov Technol, V1, P1, DOI 10.2174/1570163043484888; Zhang CO, 1998, J MOL BIOL, V284, P1301, DOI 10.1006/jmbi.1998.2282; Zheng WJ, 2004, BIOORG MED CHEM LETT, V14, P5551, DOI 10.1016/j.bmcl.2004.08.069	15	425	444	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2005	310	5747					451	453		10.1126/science.1116364	http://dx.doi.org/10.1126/science.1116364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977EU	16239465				2022-12-01	WOS:000232786000032
J	Fujiwara, T; Bandi, M; Nitta, M; Ivanova, EV; Bronson, RT; Pellman, D				Fujiwara, T; Bandi, M; Nitta, M; Ivanova, EV; Bronson, RT; Pellman, D			Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells	NATURE			English	Article							MAMMALIAN-CELLS; CHROMOSOME INSTABILITY; TELOMERE DYSFUNCTION; CANCER PROGRESSION; GENOME INSTABILITY; P53; MODEL; TRANSLOCATIONS; SEGREGATION; SUPPRESSOR	A long-standing hypothesis on tumorigenesis is that cell division failure, generating genetically unstable tetraploid cells, facilitates the development of aneuploid malignancies(1-3). Here we test this idea by transiently blocking cytokinesis in p53-null (p53(-/-)) mouse mammary epithelial cells (MMECs), enabling the isolation of diploid and tetraploid cultures. The tetraploid cells had an increase in the frequency of whole-chromosome mis-segregation and chromosomal rearrangements. Only the tetraploid cells were transformed in vitro after exposure to a carcinogen. Furthermore, in the absence of carcinogen, only the tetraploid cells gave rise to malignant mammary epithelial cancers when transplanted subcutaneously into nude mice. These tumours all contained numerous non-reciprocal translocations and an 8-30-fold amplification of a chromosomal region containing a cluster of matrix metalloproteinase (MMP) genes. MMP overexpression is linked to mammary tumours in humans and animal models(4). Thus, tetraploidy enhances the frequency of chromosomal alterations and promotes tumour development in p53(-/-) MMECs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Tufts University	Pellman, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu		Ivanova, Elena/0000-0002-5069-4974				Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boutwell R K, 1974, CRC Crit Rev Toxicol, V2, P419; Boveri T, 1929, ORIGIN MALIGNANT TUM; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Murphy KL, 2000, FASEB J, V14, P2291, DOI 10.1096/fj.00-0128com; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; OLAHARSKI AJ, 2005, CARCINOGENESIS; Pihan GA, 2003, CANCER RES, V63, P1398; SHACKNEY SE, 1989, CANCER RES, V49, P3344; SHI Q, NATURE; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Stukenberg PT, 2004, J CELL BIOL, V165, P607, DOI 10.1083/jcb.200405089; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140	30	766	774	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2005	437	7061					1043	1047		10.1038/nature04217	http://dx.doi.org/10.1038/nature04217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AU	16222300				2022-12-01	WOS:000232496100049
J	Finne, P; Reunanen, A; Stenman, S; Groop, PH; Gronhagen-Riska, C				Finne, P; Reunanen, A; Stenman, S; Groop, PH; Gronhagen-Riska, C			Incidence of end-stage renal disease in patients with type 1 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECLINING INCIDENCE; IDDM PATIENTS; NEPHROPATHY; MELLITUS; MORTALITY; PROTEINURIA; FINLAND; AGE; MICROALBUMINURIA; PREDICTOR	Context End-stage renal disease (ESRD) is one of the most severe complications of type 1 diabetes. Yet, data on patients' risk of developing ESRD are sparse. Objectives To estimate the long-term risk of developing ESRD and to assess how age at diagnosis of diabetes, time period of diagnosis, and sex affect the risk. Design, Setting, and Patients A cohort of all patients younger than 30 years diagnosed as having type 1 diabetes in Finland in 1965-1999 (n=20005)was identified from the Finnish Diabetes Register. The cohort was followed up from diagnosis of diabetes until development of ESRD (dialysis or kidney transplantation as identified from the Finnish Registry for Kidney Diseases), death, or end of follow-up on December 31, 2001. Main Outcome Measure Cumulative incidence of ESRD, accounting for death as a competing risk. Results The cohort was followed up for maximally 37 years, with a median of 16.7 years. During 346851 person-years, 632 patients developed ESRD. The cumulative incidence of ESRD was 2.2% at 20 years and 7.8% at 30 years after diagnosis. The risk of developing ESRD was lowest in patients whose diagnosis occurred at younger than 5 years. The risk of ESRD was lower for patients diagnosed as having type 1 diabetes in later years. The risk did not differ significantly between sexes. Conclusions With regard to ESRD, the prognosis of type 1 diabetes has improved during the past 4 decades. Children diagnosed as having diabetes before age 5 years have the most favorable prognosis. Overall, incidence of ESRD appears to be lower than previously estimated.	Univ Helsinki, Cent Hosp, Finnish Registry Kidney Dis, Helsinki, Finland; Univ Helsinki, Cent Hosp, Natl Publ Hlth Inst, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Finne, P (corresponding author), Univ Helsinki, Biomedicum Helsinki A424B, Dept Clin Chem, POB 700, FIN-00029 Helsinki, Finland.	patrik.finne@hus.fi						ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; BORCHJOHNSEN K, 1985, DIABETOLOGIA, V28, P590, DOI 10.1007/BF00281993; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; CAILLATZUCMAN S, 1992, J CLIN INVEST, V90, P2242, DOI 10.1172/JCI116110; DEMAINE AG, 1995, DIABETOLOGIA, V38, P623, DOI 10.1007/s001250050329; Donaghue KC, 2003, DIABETES CARE, V26, P1224, DOI 10.2337/diacare.26.4.1224; EKSTRAND A, 1987, ACTA MED SCAND, V222, P251; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; *FINN REG KIDN DIS, 2004, REP 2003; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; KOFOEDENEVOLDSEN A, 1987, DIABETES, V36, P205, DOI 10.2337/diabetes.36.2.205; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Krolewski M, 1996, KIDNEY INT, V50, P2041, DOI 10.1038/ki.1996.527; LAPORTE RE, 1991, DIABETES CARE, V14, P49; MATSUSHIMA M, 1995, DIABETOLOGIA, V38, P236, DOI 10.1007/BF00400100; Schultz CJ, 1999, DIABETES CARE, V22, P495, DOI 10.2337/diacare.22.3.495; TUOMILEHTO J, 1995, INT J EPIDEMIOL, V24, P984, DOI 10.1093/ije/24.5.984; Tuomilehto J, 1997, DIABETES CARE, V20, P1081, DOI 10.2337/diacare.20.7.1081; *US REN DAT SYST, 2003, USRDS 2003 ANN DAT R; Wysocki T, 2003, DIABETES CARE, V26, P2043, DOI 10.2337/diacare.26.7.2043	24	182	186	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2005	294	14					1782	1787		10.1001/jama.294.14.1782	http://dx.doi.org/10.1001/jama.294.14.1782			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972RX	16219881	Green Accepted, Bronze			2022-12-01	WOS:000232472000017
J	Nybakken, GE; Oliphant, T; Johnson, S; Burke, S; Diamond, MS; Fremont, DH				Nybakken, GE; Oliphant, T; Johnson, S; Burke, S; Diamond, MS; Fremont, DH			Structural basis of West Nile virus neutralization by a therapeutic antibody	NATURE			English	Article							DENGUE VIRUS; ENVELOPE PROTEIN; ENCEPHALITIS-VIRUS; MEMBRANE-FUSION; DOMAIN-III; DISSEMINATED INFECTION; MONOCLONAL-ANTIBODY; BINDING; CELLS; GLYCOPROTEIN	West Nile virus is a mosquito-borne flavivirus closely related to the human epidemic-causing dengue, yellow fever and Japanese encephalitis viruses(1). In establishing infection these icosahedral viruses undergo endosomal membrane fusion catalysed by envelope glycoprotein rearrangement of the putative receptor-binding domain III (DIII) and exposure of the hydrophobic fusion loop(2-4). Humoral immunity has an essential protective function early in the course of West Nile virus infection(5,6). Here, we investigate the mechanism of neutralization by the E16 monoclonal antibody that specifically binds DIII. Structurally, the E16 antibody Fab fragment engages 16 residues positioned on four loops of DIII, a consensus neutralizing epitope sequence conserved in West Nile virus and distinct in other flaviviruses. The E16 epitope protrudes from the surface of mature virions in three distinct environments(7), and docking studies predict Fab binding will leave fivefold clustered epitopes exposed. We also show that E16 inhibits infection primarily at a step after viral attachment, potentially by blocking envelope glycoprotein conformational changes. Collectively, our results suggest that a vaccine strategy targeting the dominant DIII epitope may elicit safe and effective immune responses against flaviviral diseases.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; MacroGenics, Rockville, MD 20850 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Fremont@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Fremont, Daved/0000-0002-8544-2689				Booy FP, 1998, J MOL BIOL, V281, P95, DOI 10.1006/jmbi.1998.1920; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0; Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25; Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200; Wang T, 2004, CURR OPIN IMMUNOL, V16, P519, DOI 10.1016/j.coi.2004.05.008; Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	30	279	305	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2005	437	7059					764	768		10.1038/nature03956	http://dx.doi.org/10.1038/nature03956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16193056	Bronze, Green Published			2022-12-01	WOS:000232157900059
J	Roberts, JM; Gammill, H				Roberts, JM; Gammill, H			Pre-eclampsia and cardiovascular disease in later life	LANCET			English	Editorial Material							WOMEN; RISK; PREGNANCY; ECLAMPSIA; HISTORY		Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, JM (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	rsijmr@mail.magee.edu	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207				Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chesley LC, 2000, AM J OBSTET GYNECOL, V182, P249, DOI 10.1016/S0002-9378(00)70521-7; DAVIES AM, 1969, ISRAEL J MED SCI, V5, P1095; Funai EF, 2005, PAEDIATR PERINAT EP, V19, P59, DOI 10.1111/j.1365-3016.2004.00623.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Laivuori H, 1996, J CLIN ENDOCR METAB, V81, P2908, DOI 10.1210/jc.81.8.2908; LORENTZEN B, 1994, HYPERTENS PREGNANCY, V13, P103, DOI 10.3109/10641959409084177; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4	10	44	47	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					961	962		10.1016/S0140-6736(05)67349-7	http://dx.doi.org/10.1016/S0140-6736(05)67349-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168757				2022-12-01	WOS:000231955900005
J	O'Donovan, P; Perrett, CM; Zhang, XH; Montaner, B; Xu, YZ; Harwood, CA; McGregor, JM; Walker, SL; Hanaoka, F; Karran, P				O'Donovan, P; Perrett, CM; Zhang, XH; Montaner, B; Xu, YZ; Harwood, CA; McGregor, JM; Walker, SL; Hanaoka, F; Karran, P			Azathioprine and UVA light generate mutagenic oxidative DNA damage	SCIENCE			English	Article							NONMELANOMA SKIN-CANCER; ORGAN-TRANSPLANTATION; MAMMALIAN-CELLS; REPLICATION; POLYMERASE; THERAPY; REPAIR; ULTRAVIOLET; RISK	Oxidative stress and mutagenic DNA lesions formed by reactive oxygen species (ROS) are linked to human malignancy. Clinical treatments inducing chronic oxidative stress may therefore carry a risk of therapy-related cancer. We suggest that immunosuppression by azathioprine (Aza) may be one such treatment. Aza causes the accumulation of 6-thioguanine (6-TG) in patients' DNA. Here we demonstrate that biologically relevant doses of ultraviolet A (UVA) generate ROS in cultured cells with 6-TG-substituted DNA and that 6-TG and UVA are synergistically mutagenic. A replication-blocking DNA 6-TG photoproduct, guanine sulfonate, was bypassed by error-prone, Y-family DNA polymerases in vitro. A preliminary analysis revealed that in five of five cases, Aza treatment was associated with a selective UVA photosensitivity. These findings may partly explain the prevalence of skin cancer in long-term survivors of organ transplantation.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Open Univ, Dept Chem, Milton Keynes MK7 6AA, Bucks, England; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, London E1 2AT, England; Kings Coll London, Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, Dept Photobiol, London SE1 7EH, England; RIKEN, Discovery Res Inst, Wako, Saitama 3510198, Japan	Cancer Research UK; Open University - UK; University of London; Queen Mary University London; University of London; King's College London; RIKEN	Karran, P (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	peter.karran@cancer.org.uk	Xu, Yao/A-7700-2010	Xu, Yao/0000-0002-5713-8030; Montaner, Beatriz/0000-0001-9877-7317; Harwood, Catherine/0000-0002-1375-0965	Cancer Research UK [A6695] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; Branch P, 2000, ONCOGENE, V19, P3138, DOI 10.1038/sj.onc.1203668; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cuffari C, 2004, DIGEST DIS SCI, V49, P133, DOI 10.1023/B:DDAS.0000011614.88494.ee; DOERR IL, 1961, J ORG CHEM, V26, P3401, DOI 10.1021/jo01067a093; DRISCOLL CMH, 2002, SOLAR RAD MEASUREMEN; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; FINKEL JM, 1975, J PHARM SCI, V64, P121, DOI 10.1002/jps.2600640126; Glover MT, 1997, LANCET, V349, P398, DOI 10.1016/S0140-6736(97)80015-3; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; HEMMENS VJ, 1986, PHOTOCHEM PHOTOBIOL, V43, P247, DOI 10.1111/j.1751-1097.1986.tb05601.x; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Massey A, 2001, CURR BIOL, V11, P1142, DOI 10.1016/S0960-9822(01)00272-X; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; PHEAR G, 1989, J MOL BIOL, V209, P577, DOI 10.1016/0022-2836(89)90595-0; RACKWITZ HR, 1974, CHEM BER-RECL, V107, P2284, DOI 10.1002/cber.19741070713; Ramsay HM, 2002, BRIT J DERMATOL, V147, P950, DOI 10.1046/j.1365-2133.2002.04976.x; RAPPAPORT HP, 1993, BIOCHEMISTRY-US, V32, P3047, DOI 10.1021/bi00063a016; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; WARREN DJ, 1995, CANCER RES, V55, P1670; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	26	469	476	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2005	309	5742					1871	1874		10.1126/science.1114233	http://dx.doi.org/10.1126/science.1114233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16166520	Green Accepted			2022-12-01	WOS:000231989500054
J	Lobov, IB; Rao, S; Carroll, TJ; Vallance, JE; Ito, M; Ondr, JK; Kurup, S; Glass, DA; Patel, MS; Shu, WG; Morrisey, EE; McMahon, AP; Karsenty, G; Lang, RA				Lobov, IB; Rao, S; Carroll, TJ; Vallance, JE; Ito, M; Ondr, JK; Kurup, S; Glass, DA; Patel, MS; Shu, WG; Morrisey, EE; McMahon, AP; Karsenty, G; Lang, RA			WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature	NATURE			English	Article							RECEPTOR-RELATED PROTEIN-5; COLORECTAL-CANCER; MOUSE; EYE; PROLIFERATION; PROGRESSION; REGRESSION; ELEGANS; CATENIN; ROLES	Macrophages have a critical role in inflammatory and immune responses through their ability to recognize and engulf apoptotic cells(1). Here we show that macrophages initiate a cell-death programme in target cells by activating the canonical WNT pathway. We show in mice that macrophage WNT7b is a short-range paracrine signal required for WNT-pathway responses and programmed cell death in the vascular endothelial cells of the temporary hyaloid vessels of the developing eye. These findings indicate that macrophages can use WNT ligands to influence cell-fate decisions - including cell death - in adjacent cells, and raise the possibility that they do so in many different cellular contexts.	Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45229 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Natl Def Med Coll, Dept Anat, Tokorozawa, Saitama 3598513, Japan; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Mol Cardiol Res Ctr, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Harvard University; National Defense Medical College - Japan; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania	Lang, RA (corresponding author), Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA.	Richard.Lang@cchmc.org	Glass, Donald A/A-1908-2013; Lang, Richard/E-5578-2011; Glass, Donald/AGI-6735-2022; McMahon, Andrew P/ABE-7520-2020	Glass, Donald/0000-0003-0866-770X; /0000-0001-7061-6837; Vallance, Jefferson/0000-0001-6473-3623; Lang, Richard/0000-0002-5212-254X	NATIONAL EYE INSTITUTE [R01EY015766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087825, U01HL100405] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015766, R01 EY015766-02] Funding Source: Medline; NHLBI NIH HHS [U01 HL100405, R01 HL087825] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Perrimon N, 1996, CELL, V86, P513, DOI 10.1016/S0092-8674(00)80124-5; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	29	315	328	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					417	421		10.1038/nature03928	http://dx.doi.org/10.1038/nature03928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163358	Green Accepted			2022-12-01	WOS:000231849100055
J	Zinkel, SS; Hurov, KE; Ong, C; Abtahl, FM; Gross, A; Korsmeyer, SJ				Zinkel, SS; Hurov, KE; Ong, C; Abtahl, FM; Gross, A; Korsmeyer, SJ			A role for proapoptotic BID in the DNA-damage response	CELL			English	Article							NORMAL HUMAN FIBROBLASTS; CHECKPOINT KINASE ATR; IONIZING-RADIATION; CASEIN KINASE-2; STRAND BREAKS; BLM HELICASE; S-PHASE; PHOSPHORYLATION; REPAIR; P53	The BCL-2 family of apoptotic proteins encompasses key regulators proximal to irreversible cell damage The BH3-only members of this family act as sentinels interconnecting specific death signals to the core apoptotic pathway. Our previous data demonstrated a role for BH3-only BID in maintaining myeloid homeostasis and suppressing leukemogenesis. In the absence of Bid, mice accumulate chromosomal aberrations and develop a fatal myeloproliferative disorder resembling chronic myelomonocytic leukemia. Here, we describe a role for BID in preserving genomic integrity that places BID at an early point in the path to determine the fate of a cell. We show that BID plays an unexpected role in the intra-S phase checkpoint downstream of DNA damage distinct from its proapoptotic function. We further demonstrate that this role is mediated through BID phosphorylation by the DNA-damage kinase ATM. These results establish a link between proapoptotic Bid and the DNA-damage response.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Weizmann Inst Sci, Dept Regulat Biol, IL-7610 Rehovot, Israel	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Weizmann Institute of Science	Zinkel, SS (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	sandra.zinkel@vanderbilt.edu	Gross, Atan/ABC-2640-2020	zinkel, sandra/0000-0002-2818-9795	NCI NIH HHS [CA098394, R37 CA50239, P01 CA92625] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050239, K08CA098394, P01CA092625] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; D'Andrea AD, 2003, GENE DEV, V17, P1933, DOI 10.1101/gad.1128303; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Frei C, 2000, J CELL SCI, V113, P2641; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HAWLEY RG, 1994, ONCOGENE, V9, P1; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Kalb R, 2004, RADIAT RES, V161, P318, DOI 10.1667/RR3138; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Langland G, 2002, CANCER RES, V62, P2766; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sarno S, 2002, PHARMACOL THERAPEUT, V93, P159, DOI 10.1016/S0163-7258(02)00185-7; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 2000, ONCOGENE, V19, P6176, DOI 10.1038/sj.onc.1203971; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	53	183	195	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 26	2005	122	4					579	591		10.1016/j.cell.2005.06.022	http://dx.doi.org/10.1016/j.cell.2005.06.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122425	Bronze			2022-12-01	WOS:000231555100013
J	Gillette, MU; Sejnowski, TJ				Gillette, MU; Sejnowski, TJ			Biological clocks coordinately keep life on time	SCIENCE			English	Editorial Material							MAMMALIAN CIRCADIAN CLOCK; CELL-CYCLE		Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021					Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Dijk DJ, 2004, AVIAT SPACE ENVIR MD, V75, pA119; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	15	41	43	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1196	1198		10.1126/science.1111420	http://dx.doi.org/10.1126/science.1111420			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16109872				2022-12-01	WOS:000231395400032
J	Chung, Y; Klimanskaya, I; Becker, S; Marh, J; Lu, SJ; Johnson, J; Meisner, L; Lanza, R				Chung, Y; Klimanskaya, I; Becker, S; Marh, J; Lu, SJ; Johnson, J; Meisner, L; Lanza, R			Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres	NATURE			English	Article							IN-VITRO; HUMAN BLASTOCYSTS; 8-CELL STAGE; PROLIFERATION; ESTABLISHMENT; DERIVATION; DIAGNOSIS; INVITRO; MORULAE; BIOPSY	The most basic objection to human embryonic stem (ES) cell research is rooted in the fact that ES cell derivation deprives embryos of any further potential to develop into a complete human being(1,2). ES cell lines are conventionally isolated from the inner cell mass of blastocysts(3-5) and, in a few instances, from cleavage stage embryos(6-9). So far, there have been no reports in the literature of stem cell lines derived using an approach that does not require embryo destruction. Here we report an alternative method of establishing ES cell lines - using a technique of single-cell embryo biopsy similar to that used in pre-implantation genetic diagnosis of genetic defects(10) - that does not interfere with the developmental potential of embryos. Five putative ES and seven trophoblast stem (TS) cell lines were produced from single blastomeres, which maintained normal karyotype and markers of pluripotency or TS cells for up to more than 50 passages. The ES cells differentiated into derivatives of all three germ layers in vitro and in teratomas, and showed germ line transmission. Single-blastomere-biopsied embryos developed to term without a reduction in their developmental capacity. The ability to generate human ES cells without the destruction of ex utero embryos would reduce or eliminate the ethical concerns of many.	Adv Cell Technol, Worcester, MA 01605 USA; Univ Wisconsin, State Lab Hyg Mol Cytogenet, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53706 USA; Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC 27157 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center	Lanza, R (corresponding author), Adv Cell Technol, Worcester, MA 01605 USA.	rlanza@advancedcell.com		Lanza, Robert/0000-0002-3047-3074				ARMANT DR, 1986, DEV BIOL, V116, P519, DOI 10.1016/0012-1606(86)90152-1; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; *COMM BIOL BIOM AP, 2002, STEM CELLS FUT REG M; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Delhaise F, 1996, EUR J MORPHOL, V34, P237, DOI 10.1076/ejom.34.4.237.13046; EISTETTER HR, 1989, DEV GROWTH DIFFER, V31, P275; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GEBER S, 1995, HUM REPROD, V10, P1492, DOI 10.1093/HUMREP/10.6.1492; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; LANZA R, 2004, HDB STEM CELLS, V1; MENINO AR, 1983, BIOL REPROD, V28, P433, DOI 10.1095/biolreprod28.2.433; Mitalipova M, 2001, Cloning, V3, P59, DOI 10.1089/15204550152475563; MOORE NW, 1968, J REPROD FERTIL, V17, P527, DOI 10.1530/jrf.0.0170527; Nagy A, 2002, MANIPULATING MOUSE E, V3rd; NIEMANN H, 1993, J REPROD FERTIL, P75; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; SAITO S, 1991, BIOL REPROD, V44, P927, DOI 10.1095/biolreprod44.5.927; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; SUKOYAN MA, 1993, MOL REPROD DEV, V36, P148, DOI 10.1002/mrd.1080360205; Tao T, 2000, HUM REPROD, V15, P881, DOI 10.1093/humrep/15.4.881; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILLADSEN SM, 1981, J EMBRYOL EXP MORPH, V65, P165; WILTON LJ, 1989, BIOL REPROD, V40, P145, DOI 10.1095/biolreprod40.1.145	26	245	268	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					216	219		10.1038/nature04277	http://dx.doi.org/10.1038/nature04277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16227970	Bronze			2022-12-01	WOS:000234538400043
J	Gilliland, WD; Hawley, RS				Gilliland, WD; Hawley, RS			Cohesin and the maternal age effect	CELL			English	Editorial Material							HUMAN OOCYTES; RECOMBINATION; ANEUPLOIDY; MEIOSIS	During melosis in human oocytes, chromosome nondisjunction increases with maternal age, leading to disorders such as Down's syndrome. In a recent study in Nature Genetics, Hodges et al. (2005) show that mice with a mutation in the melosis-specific cohesin protein SMC1 beta exhibit age-dependent defects in meiosis. These defects are similar to those observed in oocytes of older human mothers. Their results implicate an age-dependent loss of function in SMC1 beta (or related proteins) in the maternal age effect of humans.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Gilliland, WD (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.			Hawley, R. Scott/0000-0002-6478-0494				ANGELL RR, 1995, CYTOGENET CELL GENET, V69, P266, DOI 10.1159/000133977; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Jeffreys CA, 2003, CURR BIOL, V13, P498, DOI 10.1016/S0960-9822(03)00134-9; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088	9	15	15	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 4	2005	123	3					371	373		10.1016/j.cell.2005.10.018	http://dx.doi.org/10.1016/j.cell.2005.10.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	983WY	16269329	Bronze			2022-12-01	WOS:000233264300006
J	Luquet, S; Perez, FA; Hnasko, TS; Palmiter, RD				Luquet, S; Perez, FA; Hnasko, TS; Palmiter, RD			NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates	SCIENCE			English	Article							NEUROPEPTIDE-Y; FOOD-INTAKE; RECEPTOR; LEPTIN; OBESITY; DEFICIENCY; GENE; AGRP	Hypothalamic neurons that express neuropeptide Y (NPY) and agouti-related protein (AgRP) are thought to be critical regulators of feeding behavior and body weight. To determine whether NPY/AgRP neurons are essential in mice, we targeted the human diphtheria toxin receptor to the Agrp locus, which allows temporally controlled ablation of NPY/AgRP neurons to occur after an injection of diphtheria toxin. Neonatal ablation of NPY/AgRP neurons had minimal effects on feeding, whereas their ablation in adults caused rapid starvation. These results suggest that network-based compensatory mechanisms can develop after the ablation of NPY/AgRP neurons in neonates but do not readily occur when these neurons become essential in adults.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	palmiter@u.washington.edu	Luquet, serge/AAT-1809-2021	Luquet, serge/0000-0001-8668-6645; Hnasko, Thomas/0000-0001-6176-8513	NIDA NIH HHS [K01 DA026504] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Krude H, 1999, ANN NY ACAD SCI, V885, P419; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Marsh DJ, 1999, BRAIN RES, V848, P66, DOI 10.1016/S0006-8993(99)01962-9; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	27	768	785	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2005	310	5748					683	685		10.1126/science.1115524	http://dx.doi.org/10.1126/science.1115524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	980ET	16254186				2022-12-01	WOS:000232997700044
J	Premawardhena, A; Fisher, CA; Olivieri, NF; de Silva, S; Arambepola, M; Perera, W; O'Donnell, A; Peto, TEA; Viprakasit, V; Merson, L; Muraca, G; Weatherall, DJ				Premawardhena, A; Fisher, CA; Olivieri, NF; de Silva, S; Arambepola, M; Perera, W; O'Donnell, A; Peto, TEA; Viprakasit, V; Merson, L; Muraca, G; Weatherall, DJ			Haemoglobin E beta thalassaemia in Sri Lanka	LANCET			English	Article								Haemoglobin E beta thalassaemia is the commonest form of severe thalassaemia in many Asian countries, but little is known about its natural history, the reasons for clinical diversity, or its management. We studied 109 Sri Lankan patients with the disorder over 5 years. 25 patients were not receiving transfusion; transfusion was stopped with no deleterious effect in a further 37. We identified several genetic and environmental factors that might contribute to the phenotypic diversity of the disorder, including modifiers of haemoglobin F production, malaria, and age-related changes in adaptive function. Our findings suggest that haemoglobin E beta thalassaemia can be managed without transfusion in many patients, even with low haemoglobin levels. Age-related changes in the pattern of adaptation to anaemia suggest that different and more cost-effective approaches to management should be explored.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Natl Thalassaemia Ctr, Gen Hosp, Kurunegala, Sri Lanka; Univ Hlth Network, Hemoglobinopathy Res, Toronto, ON, Canada; Mahidol Univ, Siriraj Hosp, Dept Paediat, Div Haematol Oncol, Bangkok 10700, Thailand	University of Oxford; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mahidol University	Weatherall, DJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	liz.rose@imm.ox.ac.uk	Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; peto, tim/0000-0003-3477-8307; Muraca, Giulia/0000-0003-4618-0839; Merson, Laura/0000-0002-4168-1960	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Fisher CA, 2003, BRIT J HAEMATOL, V121, P662, DOI 10.1046/j.1365-2141.2003.04346.x; Fucharoen S, 1997, HEMOGLOBIN, V21, P299, DOI 10.3109/03630269709000664; Premawardhena A, 2001, LANCET, V357, P1945, DOI 10.1016/S0140-6736(00)05082-0; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Viprakasit V, 2004, BLOOD, V103, P3296, DOI 10.1182/blood-2003-11-3957; Walker S. R., 1993, QUALITY LIFE ASSESSM; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth	7	73	75	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2005	366	9495					1467	1470		10.1016/S0140-6736(05)67396-5	http://dx.doi.org/10.1016/S0140-6736(05)67396-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976HQ	16243092				2022-12-01	WOS:000232724600026
J	Gao, YQ; Yang, W; Karplus, M				Gao, YQ; Yang, W; Karplus, M			A structure-based model for the synthesis and hydrolysis of ATP by F-1-ATPase	CELL			English	Article							ESCHERICHIA-COLI F-1-ATPASE; FREE-ENERGY SIMULATIONS; CATALYTIC SITES; CONFORMATIONAL-CHANGE; BOVINE F-1-ATPASE; MOLECULAR MACHINE; SYNTHASE; MECHANISM; ROTATION; F1-ATPASE	Many essential functions of living cells are performed by nanoscale protein motors. The best characterized of these is F0F1-ATP synthase, the smallest rotary motor. This rotary motor catalyzes the synthesis of ATP with high efficiency under conditions where the reactants (ADP, H2PO4-) and the product (ATP) are present in the cell at similar concentrations. We present a detailed structure-based kinetic model for the mechanism of action of F-1-ATPase and demonstrate the role of different protein conformations for substrate binding during ATP synthesis and ATP hydrolysis. The model shows that the pathway for ATP hydrolysis is not simply the pathway for ATP synthesis in reverse. The findings of the model also explain why the cellular concentration of ATP does not inhibit ATP synthesis.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Univ Strasbourg 1, Lab Chim Biophys, ISIS, F-67000 Strasbourg, France	Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu	Yang, Wei/H-5428-2011					ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Allison WS, 1998, ACCOUNTS CHEM RES, V31, P819, DOI 10.1021/ar960257v; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Antes I, 2003, BIOPHYS J, V85, P695, DOI 10.1016/S0006-3495(03)74513-5; Bockmann RA, 2002, NAT STRUCT BIOL, V9, P198, DOI 10.1038/nsb760; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Cui Q, 2004, J MOL BIOL, V340, P345, DOI 10.1016/j.jmb.2004.04.044; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Karplus M, 2004, CURR OPIN STRUC BIOL, V14, P250, DOI 10.1016/j.sbi.2004.03.012; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Ma JP, 2002, STRUCTURE, V10, P921, DOI 10.1016/S0969-2126(02)00789-X; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nakamoto RK, 2000, BBA-BIOENERGETICS, V1458, P289, DOI 10.1016/S0005-2728(00)00081-5; Nelson D. L., 2000, LEHNINGER PRINCIPLES; Nicholls D., 2002, BIOENERGETICS, V3; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1992, J BIOENERG BIOMEMBR, V24, P479, DOI 10.1007/BF00762365; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Stryer L, 1995, BIOCHEMISTRY; Sun S, 2003, EUR BIOPHYS J BIOPHY, V32, P676, DOI 10.1007/s00249-003-0335-6; VOET D, 1995, BIOCHEMISTRY-US, P433; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Yang W, 2004, J CHEM PHYS, V120, P2618, DOI 10.1063/1.1638996; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	44	123	129	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 21	2005	123	2					195	205		10.1016/j.cell.2005.10.001	http://dx.doi.org/10.1016/j.cell.2005.10.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239139	Bronze			2022-12-01	WOS:000232794100008
J	Ha, SC; Lowenhaupt, K; Rich, A; Kim, YG; Kim, KK				Ha, SC; Lowenhaupt, K; Rich, A; Kim, YG; Kim, KK			Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases	NATURE			English	Article							HANDED Z-DNA; BIOLOGICAL FUNCTION; BINDING; GENE; PROMOTER; COMPLEX; FORMS; MODEL	Left-handed Z-DNA is a higher-energy form of the double helix, stabilized by negative supercoiling generated by transcription or unwrapping nucleosomes(1). Regions near the transcription start site frequently contain sequence motifs favourable for forming Z-DNA(2), and formation of Z-DNA near the promoter region stimulates transcription(3,4). Z-DNA is also stabilized by specific protein binding; several proteins have been identified with low nanomolar binding constants(5-9). Z-DNA occurs in a dynamic state, forming as a result of physiological processes then relaxing to the right-handed B-DNA(1). Each time a DNA segment turns into Z-DNA, two B-Z junctions form. These have been examined extensively(10-12), but their structure was unknown. Here we describe the structure of a B-Z junction as revealed by X-ray crystallography at 2.6 angstrom resolution. A 15-base-pair segment of DNA is stabilized at one end in the Z conformation by Z-DNA binding proteins, while the other end remains B-DNA. Continuous stacking of bases between B-DNA and Z-DNA segments is found, with the breaking of one base pair at the junction and extrusion of the bases on each side (Fig. 1). These extruded bases may be sites for DNA modification.	Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotecnol, Suwon 440746, South Korea; MIT, Dept Biol, Cambridge, MA 02139 USA; Chung Ang Univ, Coll Med, Dept Biochem, Seoul 156756, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Massachusetts Institute of Technology (MIT); Chung Ang University; Chung Ang University Hospital	Kim, KK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	ygkimmit@cau.ac.kr; kkim@med.skku.ac.kr		/0000-0002-8187-6498				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Champ PC, 2004, NUCLEIC ACIDS RES, V32, P6501, DOI 10.1093/nar/gkh988; DAI Z, 1989, BIOCHEMISTRY-US, V28, P6991, DOI 10.1021/bi00443a032; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HERBERT A, 1995, P NATL ACAD SCI USA, V92, P7550, DOI 10.1073/pnas.92.16.7550; JIANG H, 1991, NUCLEIC ACIDS RES, V19, P6943, DOI 10.1093/nar/19.24.6943; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kwon JA, 2005, P NATL ACAD SCI USA, V102, P12759, DOI 10.1073/pnas.0506011102; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Oh DB, 2002, P NATL ACAD SCI USA, V99, P16666, DOI 10.1073/pnas.262672699; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Rothenburg S, 2001, P NATL ACAD SCI USA, V98, P8985, DOI 10.1073/pnas.121176998; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; SHEARDY RD, 1989, BIOCHEMISTRY-US, V28, P720, DOI 10.1021/bi00428a046; SHEARDY RD, 1994, BIOCHEMISTRY-US, V33, P1385, DOI 10.1021/bi00172a014; Tashiro R, 2003, ANGEW CHEM INT EDIT, V42, P6018, DOI 10.1002/anie.200352752; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1763, DOI 10.1107/S0907444901013749; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wolfl S, 1995, BBA-GENE STRUCT EXPR, V1264, P294, DOI 10.1016/0167-4781(95)00155-7	31	196	204	5	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1183	1186		10.1038/nature04088	http://dx.doi.org/10.1038/nature04088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237447				2022-12-01	WOS:000232660500050
J	Martin, A; Baker, TA; Sauer, RT				Martin, A; Baker, TA; Sauer, RT			Rebuilt AAA plus motors reveal operating principles for ATP-fuelled machines	NATURE			English	Article							CLPXP DEGRADATION MACHINE; ESCHERICHIA-COLI; DEPENDENT PROTEASES; CRYSTAL-STRUCTURE; SEQUENTIAL HYDROLYSIS; PROTEIN; HELICASE; RECOGNITION; MECHANISM; CHAPERONE	Hexamericring- shaped ATPases of the AAA+ (for ATPases associated with various cellular activities) superfamily power cellular processes in which macromolecular structures and complexes are dismantled or denatured, but the mechanisms used by these machine-like enzymes are poorly understood. By covalently linking active and inactive subunits of the ATPase ClpX to form hexamers, here we show that diverse geometric arrangements can support the enzymatic unfolding of protein substrates and translocation of the denatured polypeptide into the ClpP peptidase for degradation. These studies indicate that the ClpX power stroke is generated by ATP hydrolysis in a single subunit, rule out concerted and strict sequential ATP hydrolysis models, and provide evidence for a probabilistic sequence of nucleotide hydrolysis. This mechanism would allow any ClpX subunit in contact with a translocating polypeptide to hydrolyse ATP to drive substrate spooling into ClpP, and would prevent stalling if one subunit failed to bind or hydrolyse ATP. Energy-dependent machines with highly diverse quaternary architectures and molecular functions could operate by similar asymmetric mechanisms.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Martin, Andreas/0000-0003-0923-3284				Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hersch GL, 2005, CELL, V121, P1017, DOI 10.1016/j.cell.2005.05.024; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219	37	285	291	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2005	437	7062					1115	1120		10.1038/nature04031	http://dx.doi.org/10.1038/nature04031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975KD	16237435				2022-12-01	WOS:000232660500035
J	Barnes, JW; Brown, RH; Turtle, EP; McEwen, AS; Lorenz, RD; Janssen, M; Schaller, EL; Brown, ME; Buratti, BJ; Sotin, C; Griffith, C; Clark, R; Perry, J; Fussner, S; Barbara, J; West, R; Elachi, C; Bouchez, AH; Roe, HG; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Jaumann, R; Langevin, Y; Matson, DL; McCord, TB; Nicholson, PD; Sicardy, B				Barnes, JW; Brown, RH; Turtle, EP; McEwen, AS; Lorenz, RD; Janssen, M; Schaller, EL; Brown, ME; Buratti, BJ; Sotin, C; Griffith, C; Clark, R; Perry, J; Fussner, S; Barbara, J; West, R; Elachi, C; Bouchez, AH; Roe, HG; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Jaumann, R; Langevin, Y; Matson, DL; McCord, TB; Nicholson, PD; Sicardy, B			A 5-micron-bright spot on Titan: Evidence for surface diversity	SCIENCE			English	Article							CASSINI RADAR	Observations from the Cassini Visual and Infrared Mapping Spectrometer show an anomalously bright spot on Titan located at 80 degrees W and 20 degrees S. This area is bright in reflected tight at all. observed wavelengths, but is most noticeable at 5 microns. The spot is associated with a surface albedo feature identified in images taken by the Cassini Imaging Science Subsystem. We discuss various hypotheses about the source of the spot, reaching the conclusion that the spot is probably due to variation in surface composition, perhaps associated with recent geophysical phenomena.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; CALTECH, Pasadena, CA 91125 USA; Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44035 Nantes, France; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; WM Keck Observ, Kamuela, HI 96743 USA; CNR, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; CNR, Ist Astrofis Spaziale & Fis Cosm, Rome, Italy; Observ Paris, Meudon, France; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; German Aerosp Ctr, Inst Planetary Explorat, D-12489 Berlin, Germany; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Helmholtz Association; German Aerospace Centre (DLR); University of Washington; University of Washington Seattle; Cornell University	Barnes, JW (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	jbarnes@lpl.arizona.edu	Jaumann, Ralf/N-1001-2018; Barnes, Jason W/B-1284-2009; Lorenz, Ralph D/B-8759-2016; Bellucci, Giancarlo/ABA-9201-2020; Turtle, Elizabeth/K-8673-2012; Drossart, Pierre/H-8670-2013	Jaumann, Ralf/0000-0002-9759-6597; Barnes, Jason W/0000-0002-7755-3530; Lorenz, Ralph D/0000-0001-8528-4644; Bellucci, Giancarlo/0000-0003-0867-8679; Turtle, Elizabeth/0000-0003-1423-5751; Schaller, Emily/0000-0001-8967-5423; Cerroni, Priscilla/0000-0003-0239-2741; Capaccioni, Fabrizio/0000-0003-1631-4314; Barbara, John/0000-0002-2190-4290; Brown, Michael E./0000-0002-8255-0545				Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Hartung M, 2004, ASTRON ASTROPHYS, V421, pL17, DOI 10.1051/0004-6361:20040171; Kress ME, 2004, ICARUS, V168, P475, DOI 10.1016/j.icarus.2003.10.013; Lorenz RD, 2003, PLANET SPACE SCI, V51, P353, DOI 10.1016/S0032-0633(02)00148-4; Lunine J.I, 1992, ESA, P233; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; ROE HG, 2004, GEOPHYS RES LETT, V31, P17; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023	14	68	69	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2005	310	5745					92	95		10.1126/science.1117075	http://dx.doi.org/10.1126/science.1117075			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210535				2022-12-01	WOS:000232477000044
J	Dominski, Z; Yang, XC; Marzluff, WF				Dominski, Z; Yang, XC; Marzluff, WF			The polyadenylation factor CPSF-73 is involved in histone-pre-mRNA processing	CELL			English	Article							LOOP BINDING-PROTEIN; U7 SNRNP; 3' ENDS; CLEAVAGE; 3'-END; MECHANISM; INTERACTS; PRODUCTS; SITE	During 3' end processing, histone pre-mRNAs are cleaved 5 nucleotides after a conserved stem loop by an endonuclease dependent on the U7 small nuclear ribonucleoprotein (snRNP). The upstream cleavage product corresponds to the mature histone mRNA, while the downstream product is degraded by a 5'-3' exonuclease, also dependent on the U7 snRNP. To identify the two nuclease activities, we carried out UV-crosslinking studies using both the complete RNA substrate and the downstream cleavage product, each containing a single radioactive phosphate and a phosphorothioate modification at the cleavage site. We detected a protein migrating at 85 kDa that crosslinked to each substrate in a 1.17-dependent manner. Immunoprecipitation experiments identified this protein as CPSF-73, a known component of the cleavage/polyadenylation machinery. These studies suggest that CPSF-73 is both the endonuclease and 5'-3' exonuclease in histone-pre-mRNA processing and reveal an evolutionary link between 3' end formation of histone mRNAs and polyadenylated mRNAs.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dominski, Z (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	dominski@med.unc.edu			NIGMS NIH HHS [GM29832] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, In Silico Biol, V1, P69; BIRNSTIEL ML, 1988, STRUCTURE FUNCTION M, P155; BOND UM, 1991, GENE DEV, V5, P1709, DOI 10.1101/gad.5.9.1709; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2002, GENE DEV, V16, P58, DOI 10.1101/gad.932302; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; GICK O, 1986, EMBO J, V5, P1319, DOI 10.1002/j.1460-2075.1986.tb04362.x; Koziolkiewicz M, 1997, ANTISENSE NUCLEIC A, V7, P43, DOI 10.1089/oli.1.1997.7.43; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MOORE CL, 1985, CELL, V41, P845, DOI 10.1016/S0092-8674(85)80065-9; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; MOWRY KL, 1988, TRENDS BIOCHEM SCI, V13, P447, DOI 10.1016/0968-0004(88)90220-4; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; SCHARL EC, 1994, EMBO J, V13, P2432, DOI 10.1002/j.1460-2075.1994.tb06528.x; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; SHEETS MD, 1987, MOL CELL BIOL, V7, P1518, DOI 10.1128/MCB.7.4.1518; Sollner-Webb B, 2001, METHOD ENZYMOL, V342, P378, DOI 10.1016/S0076-6879(01)42560-2; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Wahle E, 1996, TRENDS BIOCHEM SCI, V21, P247, DOI 10.1016/S0968-0004(96)10030-X; Walther TN, 1998, RNA, V4, P1034, DOI 10.1017/S1355838298971771; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	29	156	157	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 7	2005	123	1					37	48		10.1016/j.cell.2005.08.002	http://dx.doi.org/10.1016/j.cell.2005.08.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	973QD	16213211	Bronze, Green Published			2022-12-01	WOS:000232536800007
J	Maret, S; Franken, P; Dauvilliers, Y; Ghyselinck, NB; Chambon, P; Tafti, M				Maret, S; Franken, P; Dauvilliers, Y; Ghyselinck, NB; Chambon, P; Tafti, M			Retinoic acid signaling affects cortical synchrony during steep	SCIENCE			English	Article							SLOW-WAVE SLEEP; EEG; RECEPTORS; OSCILLATIONS; EXPRESSION; ADULT; BETA	Delta oscillations, characteristic of the electroencephalogram (EEG) of slow wave steep, estimate sleep depth and need and are thought to be closely linked to the recovery function of sleep. The cellular mechanisms underlying the generation of delta waves at the cortical and thalamic levels are well documented, but the molecular regulatory mechanisms remain elusive. Here we demonstrate in the mouse that the gene encoding the retinoic acid receptor beta determines the contribution of delta oscillations to the steep EEG. Thus, retinoic acid signaling, which is involved in the patterning of the brain and dopaminergic pathways, regulates cortical synchrony in the adult.	Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Hop Gui De Chauliac, Serv Neurol B, F-34295 Montpellier, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	University of Lausanne; Stanford University; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tafti, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	medhi.tafti@unil.ch	GHYSELINCK, Norbert/I-6999-2015; Franken, Paul/A-9633-2018; Tafti, Mehdi/A-8887-2017	GHYSELINCK, Norbert/0000-0003-4042-6818; Franken, Paul/0000-0002-2500-2921; Tafti, Mehdi/0000-0002-6997-3914; Dauvilliers, yves/0000-0003-0683-6506				Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; BO P, 1988, NEUROPHARMACOLOGY, V27, P799, DOI 10.1016/0028-3908(88)90094-9; CARSKADON MA, 1982, NEUROBIOL AGING, V3, P321, DOI 10.1016/0197-4580(82)90020-3; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; FAROOQUI SM, 1994, LIFE SCI, V55, P1887, DOI 10.1016/0024-3205(94)00520-6; Feart C, 2005, NEUROBIOL AGING, V26, P729, DOI 10.1016/j.neurobiolaging.2004.06.004; FEINBERG I, 1978, ELECTROEN CLIN NEURO, V44, P202, DOI 10.1016/0013-4694(78)90266-3; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Frank MG, 1997, AM J PHYSIOL-REG I, V273, pR472, DOI 10.1152/ajpregu.1997.273.2.R472; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; MARK M, IN PRESS ANN REV PHA; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; NECKELMANN D, 1993, SLEEP, V16, P467; PEDERSEN WA, 1995, J NEUROCHEM, V69, P4198; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202	28	72	77	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2005	310	5745					111	113		10.1126/science.1117623	http://dx.doi.org/10.1126/science.1117623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210540				2022-12-01	WOS:000232477000049
J	Pascual, O; Casper, KB; Kubera, C; Zhang, J; Revilla-Sanchez, R; Sul, JY; Takano, H; Moss, SJ; McCarthy, K; Haydon, PG				Pascual, O; Casper, KB; Kubera, C; Zhang, J; Revilla-Sanchez, R; Sul, JY; Takano, H; Moss, SJ; McCarthy, K; Haydon, PG			Astrocytic purinergic signaling coordinates synaptic networks	SCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CALCIUM WAVES; ADENINE-NUCLEOTIDES; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; GLUTAMATE; ADENOSINE; RELEASE; TRANSMISSION; ATP	To investigate the rote of astrocytes in regulating synaptic transmission, we generated inducible transgenic mice that express a dominant-negative SNARE domain selectively in astrocytes to block the release of transmitters from these glial cells. By releasing adenosine triphosphate, which accumulates as adenosine, astrocytes tonically suppressed synaptic transmission, thereby enhancing the dynamic range for long-term potentiation and mediated activity-dependent, heterosynaptic depression. These results indicate that astrocytes are intricately linked in the regulation of synaptic strength and plasticity and provide a pathway for synaptic cross-talk.	Univ Penn, Sch Med, Dept Neurosci, Conte Ctr Integrat Tripartite Synapse, Philadelphia, PA 19104 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill	Haydon, PG (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Conte Ctr Integrat Tripartite Synapse, Philadelphia, PA 19104 USA.	pghaydon@mail.med.upenn.edu	Pascual, Olivier/AAE-1449-2020; Pascual, Olivier/E-9533-2017; Takano, Hajime/AAD-4589-2019	Pascual, Olivier/0000-0002-5730-9880; Pascual, Olivier/0000-0002-5730-9880; Takano, Hajime/0000-0003-3033-2412; Kubera, Cathryn/0000-0003-3598-8365				Ackley MA, 2003, J PHYSIOL-LONDON, V548, P507, DOI 10.1113/jphysiol.2002.038091; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kukley M, 2005, J NEUROSCI, V25, P2832, DOI 10.1523/JNEUROSCI.4260-04.2005; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Porkka-Heiskanen T, 2002, SLEEP MED REV, V6, P321, DOI 10.1053/smrv.2001.0201; Porter JT, 1996, J NEUROSCI, V16, P5073; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	27	929	958	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2005	310	5745					113	116		10.1126/science.1116916	http://dx.doi.org/10.1126/science.1116916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972TV	16210541				2022-12-01	WOS:000232477000050
J	Ahn, S; Joyner, AL				Ahn, S; Joyner, AL			In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog	NATURE			English	Article							MAMMALIAN BRAIN; PROGENITOR PROLIFERATION; SUBVENTRICULAR ZONE; DENTATE GYRUS; HIPPOCAMPUS; PRECURSORS; NEURONS; NEUROGENESIS; REGENERATION; ASTROCYTES	Sonic hedgehog (Shh) has been implicated in the ongoing neurogenesis in postnatal rodent brains(1,2). Here we adopted an in vivo genetic fate-mapping strategy, using Gli1 (GLI-Kruppel family member) as a sensitive readout of Shh activity, to systematically mark and follow the fate of Shh-responding cells in the adult mouse forebrain. We show that initially, only a small population of cells ( including both quiescent neural stem cells and transit-amplifying cells) responds to Shh in regions undergoing neurogenesis. This population subsequently expands markedly to continuously provide new neurons in the forebrain. Our study of the behaviour of quiescent neural stem cells provides in vivo evidence that they can self-renew for over a year and generate multiple cell types. Furthermore, we show that the neural stem cell niches in the subventricular zone and dentate gyrus are established sequentially and not until late embryonic stages.	NYU, Sch Med, Howard Hughes Med Inst, Dev Genet Program,Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Joyner, AL (corresponding author), NICHHD, Unit Dev Neurogenet, Lab Mammalian Genes & Dev, NIH, 9000 Rockville Pike,Bldg 6B, Bethesda, MD 20892 USA.	joyner@saturn.med.nyu.edu						Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yoon SO, 1996, P NATL ACAD SCI USA, V93, P11974, DOI 10.1073/pnas.93.21.11974; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	27	544	569	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					894	897		10.1038/nature03994	http://dx.doi.org/10.1038/nature03994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208373				2022-12-01	WOS:000232338600048
J	Nanork, P; Paar, J; Chapman, NC; Wongsiri, S; Oldroyd, BP				Nanork, P; Paar, J; Chapman, NC; Wongsiri, S; Oldroyd, BP			Asian honeybees parasitize the future dead	NATURE			English	Editorial Material							COLONIES		Chulalongkorn Univ, Dept Biol, Bangkok 10330, Thailand; Univ Sydney, Sch Biol Sci A12, Sydney, NSW 2006, Australia; Mahasarakham Univ, Dept Biol, Mahasarakham 44150, Thailand	Chulalongkorn University; University of Sydney; Mahasarakham University	Nanork, P (corresponding author), Chulalongkorn Univ, Dept Biol, Bangkok 10330, Thailand.	boldroyd@bio.usyd.edu.au	Oldroyd, Benjamin/A-4800-2008	Oldroyd, Benjamin/0000-0001-6831-3677; Chapman, Nadine/0000-0003-1824-0240				Halling LA, 2001, BEHAV ECOL SOCIOBIOL, V49, P509, DOI 10.1007/s002650100325; Martin CG, 2004, BEHAV ECOL SOCIOBIOL, V56, P42, DOI 10.1007/s00265-004-0755-z; Miller DG, 2001, INSECT SOC, V48, P178, DOI 10.1007/PL00001762; PAGE RE, 1994, BEHAV ECOL SOCIOBIOL, V35, P99, DOI 10.1007/BF00171499; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0	5	57	58	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					829	829		10.1038/437829a	http://dx.doi.org/10.1038/437829a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	970VB	16208359				2022-12-01	WOS:000232338600033
J	Brennan, P; Hsu, CC; Moullan, N; Szeszenia-Dabrowska, N; Lissowska, J; Zaridze, D; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; Gemignani, F; Chabrier, A; Hall, J; Hung, RJ; Boffetta, P; Canzian, F				Brennan, P; Hsu, CC; Moullan, N; Szeszenia-Dabrowska, N; Lissowska, J; Zaridze, D; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; Gemignani, F; Chabrier, A; Hall, J; Hung, RJ; Boffetta, P; Canzian, F			Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach	LANCET			English	Article							POLYMORPHISMS; ISOTHIOCYANATES; RISK; SHANGHAI; WOMEN; CHINA	Whether consumption of cruciferous vegetables protects against lung cancer is unclear, largely because of potential confounding factors. We therefore studied the role of cruciferous vegetables in lung cancer after stratifying by GSTM1 and GSTT1 status, two genes implicated in the elimination of isothiocyanates, the likely chemopreventative compound. In 2141 cases and 2168 controls, weekly consumption of cruciferous vegetables protected against lung cancer in those who were GSTM1 null (odds ratio=0.67, 95% CI 0.49-0.91), GSTT1 null (0.63, 0.37-1.07), or both (0.28, 0.11-0.67). No protective effect was seen in people who were both GSTM1 and GSTT1 positive (0.88, 0.65-1.21). Similar protective results were noted for consumption of cabbage and a combination of broccoli and brussels sprouts. These data provide strong evidence for a substantial protective effect of cruciferous vegetable consumption on lung cancer.	Int Agcy Res Canc, F-69008 Lyon, France; Inst Occupat Med, Dept Epidemiol, Lodz, Poland; Ctr Canc, Dept Canc Epidemiol & Prevent, Warsaw, Poland; M Sklodowska Curie Inst Oncol, Warsaw, Poland; Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; Foder Jozsef Natl Ctr Publ Hlth, Budapest, Hungary; Reg Author Publ Hlth, Banska Bystrika, Slovakia; Inst Publ Hlth, Bucharest, Romania; Charles Univ, Inst Hyg & Epidemiol, Fac Med 1, CR-11636 Prague, Czech Republic; Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; Palacky Univ Med, Dept Prevent Med, Olomouc, Czech Republic	World Health Organization; International Agency for Research on Cancer (IARC); Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Russian Academy of Medical Sciences; Regional Authority of Public Health Banska Bystrica; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc	Brennan, P (corresponding author), Int Agcy Res Canc, F-69008 Lyon, France.	brennan@iarc.fr	Hung, Rayjean J/A-7439-2013; Lissowska, Jolanta/AAH-3252-2020; Canzian, Federico/I-2804-2014; Janout, Vladimir/M-5133-2014; Szeszenia-Dabrowska, Neonila/F-7190-2010; hall, janet/G-1372-2013; Boffetta, Paolo/AAI-7767-2021; Bencko, Vladimir/H-8598-2017	Lissowska, Jolanta/0000-0003-2695-5799; hall, janet/0000-0002-4397-6295; Boffetta, Paolo/0000-0002-3811-2791; Bencko, Vladimir/0000-0003-1935-2228; mates, dana/0000-0002-6219-9807; GEMIGNANI, Federica/0000-0003-1297-0701; Foretova, Lenka/0000-0003-0494-2620; Hung, Rayjean/0000-0002-4486-7496; Canzian, Federico/0000-0002-4261-4583	NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 092039-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2004, IARC HDB CANC PREVEN; Fowke JH, 2003, CANCER EPIDEM BIOMAR, V12, P1536; Hecht SS, 1996, ADV EXP MED BIOL, V401, P1; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; London SJ, 2000, LANCET, V356, P724, DOI 10.1016/S0140-6736(00)02631-3; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; World Cancer Research Fund & American Institute for Cancer Research, 1997, FOOD NUTR PREV CANC; Zhao B, 2001, CANCER EPIDEM BIOMAR, V10, P1063	9	101	107	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2005	366	9496					1558	1560		10.1016/S0140-6736(05)67628-3	http://dx.doi.org/10.1016/S0140-6736(05)67628-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979ZX	16257343				2022-12-01	WOS:000232984800025
J	Pascual, G; Fong, AL; Ogawa, S; Gamliel, A; Li, AC; Perissi, V; Rose, DW; Willson, TM; Rosenfeld, MG; Glass, CK				Pascual, G; Fong, AL; Ogawa, S; Gamliel, A; Li, AC; Perissi, V; Rose, DW; Willson, TM; Rosenfeld, MG; Glass, CK			A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma	NATURE			English	Article							ACTIVATED RECEPTOR-GAMMA; OXIDE SYNTHASE GENE; MACROPHAGE ACTIVATION; TRANSCRIPTION FACTORS; COREPRESSOR COMPLEX; ANDROGEN-RECEPTOR; NUCLEAR RECEPTORS; CO-REPRESSOR; PROTEINS; LIGAND	Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has essential roles in adipogenesis and glucose homeostasis, and is a molecular target of insulin-sensitizing drugs(1-3). Although the ability of PPAR-gamma agonists to antagonize inflammatory responses by transrepression of nuclear factor kappa B (NF-kappa B) target genes is linked to antidiabetic(4) and antiatherogenic actions(5), the mechanisms remain poorly understood. Here we report the identification of a molecular pathway by which PPAR-gamma represses the transcriptional activation of inflammatory response genes in mouse macrophages. The initial step of this pathway involves ligand-dependent SUMOylation of the PPAR-gamma ligand-binding domain, which targets PPAR-gamma to nuclear receptor corepressor (NCoR)-histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters. This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation. As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state. This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-kappa B target genes that regulate immunity and homeostasis.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; GlaxoSmithKline	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021; feinstein, doug/M-9414-2019	Glass, Christopher/0000-0003-4344-3592; Perissi, Valentina/0000-0002-3716-0003	NCI NIH HHS [R01 CA052599] Funding Source: Medline; NIDDK NIH HHS [R01 DK091183, R37 DK039949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK091183] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Glass CK, 2000, GENE DEV, V14, P121; Guenther MG, 2000, GENE DEV, V14, P1048; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Janne OA, 2000, BIOCHEM SOC T, V28, P401, DOI 10.1042/0300-5127:0280401; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Tan JA, 2000, MOL ENDOCRINOL, V14, P14, DOI 10.1210/me.14.1.14; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	30	975	1021	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2005	437	7059					759	763		10.1038/nature03988	http://dx.doi.org/10.1038/nature03988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16127449	Green Accepted			2022-12-01	WOS:000232157900058
J	Telling, G				Telling, G			Anchors away - Of plaques and pathology in prion disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCRAPIE INFECTIVITY; PROTEIN		Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA	University of Kentucky	Telling, G (corresponding author), Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.		Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805				Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242	5	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2005	353	11					1177	1179		10.1056/NEJMcibr052527	http://dx.doi.org/10.1056/NEJMcibr052527			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963YG	16162891				2022-12-01	WOS:000231841900016
J	Zenz, R; Eferl, R; Kenner, L; Florin, L; Hummerich, L; Mehic, D; Scheuch, H; Angel, P; Tschachler, E; Wagner, EF				Zenz, R; Eferl, R; Kenner, L; Florin, L; Hummerich, L; Mehic, D; Scheuch, H; Angel, P; Tschachler, E; Wagner, EF			Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins	NATURE			English	Article							MICE LACKING JUNB; TRANSGENIC MICE; ACTIVATED KERATINOCYTES; DOWN-REGULATION; GROWTH-FACTOR; MOUSE MODEL; STEM-CELLS; T-CELLS; C-JUN; EXPRESSION	Psoriasis is a frequent, inflammatory disease of skin and joints with considerable morbidity. Here we report that in psoriatic lesions, epidermal keratinocytes have decreased expression of JunB, a gene localized in the psoriasis susceptibility region PSORS6. Likewise, inducible epidermal deletion of JunB and its functional companion c-Jun in adult mice leads ( within two weeks) to a phenotype resembling the histological and molecular hallmarks of psoriasis, including arthritic lesions. In contrast to the skin phenotype, the development of arthritic lesions requires T and B cells and signalling through tumour necrosis factor receptor 1 ( TNFR1). Prior to the disease onset, two chemotactic proteins (S100A8 and S100A9) previously mapped to the psoriasis susceptibility region PSORS4, are strongly induced in mutant keratinocytes in vivo and in vitro. We propose that the abrogation of JunB/activator protein 1 (AP-1) in keratinocytes triggers chemokine/cytokine expression, which recruits neutrophils and macrophages to the epidermis thereby contributing to the phenotypic changes observed in psoriasis. Thus, these data support the hypothesis that epidermal alterations are sufficient to initiate both skin lesions and arthritis in psoriasis.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, Div Mol Genet, D-69120 Heidelberg, Germany; Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria; Ctr Rech & Invest Epiderm & Sensorielles, F-9251 Neuilly, France	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@imp.univie.ac.at		Kenner, Lukas/0000-0003-2184-1338; Tschachler, Erwin/0000-0002-0248-1798; Wagner, Erwin F/0000-0001-7872-0196; Eferl, Robert/0000-0002-6074-7144				Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Black RA, 2004, NAT GENET, V36, P934, DOI 10.1038/ng0904-934; Bonifati C, 1999, INT J DERMATOL, V38, P241, DOI 10.1046/j.1365-4362.1999.00622.x; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Campbell L, 2002, BRIT J DERMATOL, V147, P701, DOI 10.1046/j.1365-2133.2002.05009.x; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cook PW, 1999, J INVEST DERMATOL, V113, P860, DOI 10.1046/j.1523-1747.1999.00753.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Galadari H, 2003, INT J DERMATOL, V42, P231, DOI 10.1046/j.1365-4362.2003.01449.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; JANCO RL, 1983, TRANSPLANTATION, V35, P501, DOI 10.1097/00007890-198305000-00023; Johansen C, 2004, BRIT J DERMATOL, V151, P600, DOI 10.1111/j.1365-2133.2004.06088.x; Karashima T, 1996, J DERMATOL SCI, V12, P246, DOI 10.1016/0923-1811(95)00480-7; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kong J, 2002, ARCH DERMATOL RES, V294, P370, DOI 10.1007/s00403-002-0348-5; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Namazi MR, 2004, AUTOIMMUNITY, V37, P67, DOI 10.1080/08916930310001637986; Nickoloff BJ, 2000, CUTIS, V65, P110; Nickoloff BJ, 2000, EXP DERMATOL, V9, P359, DOI 10.1034/j.1600-0625.2000.009005359.x; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schlingemann J, 2003, INT J CANCER, V104, P699, DOI 10.1002/ijc.11008; Schon MP, 1999, J INVEST DERMATOL, V112, P405, DOI 10.1046/j.1523-1747.1999.00538.x; Semprini S, 2002, HUM GENET, V111, P310, DOI 10.1007/s00439-002-0812-5; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679; VanBuren V, 2002, GENOME RES, V12, P1999, DOI 10.1101/gr.633802; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	50	439	480	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					369	375		10.1038/nature03963	http://dx.doi.org/10.1038/nature03963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163348				2022-12-01	WOS:000231849100044
J	Rink, J; Ghigo, E; Kalaidzidis, Y; Zerial, M				Rink, J; Ghigo, E; Kalaidzidis, Y; Zerial, M			Rab conversion as a mechanism of progression from early to late endosomes	CELL			English	Article							ENDOCYTIC PATHWAY; MEMBRANE-FUSION; PHAGOSOME MATURATION; NUCLEOTIDE EXCHANGE; SORTING ENDOSOMES; VACUOLE FUSION; YEAST VACUOLE; LIVING CELLS; TRANSPORT; PROTEIN	The mechanisms of endosome biogenesis and maintenance are largely unknown. The small GTPases Rab5 and Rab7 are key determinants of early and late endosomes, organizing effector proteins into specific membrane subdomains. Whether such Rab machineries ate indefinitely maintained on membranes or can disassemble in the course of cargo transport is an open question. Here, we combined novel image-analysis algorithms with fast live-cell imaging. We found that the level of Rab5 dynamically fluctuates on individual early endosomes, linked by fusion and fission events into a network in time. Within it, degradative cargo concentrates in progressively fewer and larger endosomes that migrate from the cell periphery to the center where Rab5 is rapidly replaced with Rab7. The class C VPS/HOPS complex, an established GEF for Rab7 interacts with Rab5 and is required for Rab5-to-Rab7 conversion. Our results reveal unexpected dynamics of Rab domains and suggest Rab conversion as the mechanism of cargo progression between early and late endosomes.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Fac Med Marseille, CNRS, UPRES A6020, Unite Rickettsies, F-13385 Marseille, France; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Eric, Ghigo/N-9427-2016; Kalaidzidis, Yannis/H-3094-2016	Kalaidzidis, Yannis/0000-0002-6137-1193				ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Verestoy J., 1999, Machine Graphics & Vision, V8, P553; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.e04-08-0735; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	48	1133	1165	3	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	2005	122	5					735	749		10.1016/j.cell.2005.06.043	http://dx.doi.org/10.1016/j.cell.2005.06.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	963ZC	16143105	Bronze			2022-12-01	WOS:000231844300013
J	Collin, D; Ritort, F; Jarzynski, C; Smith, SB; Tinoco, I; Bustamante, C				Collin, D; Ritort, F; Jarzynski, C; Smith, SB; Tinoco, I; Bustamante, C			Verification of the Crooks fluctuation theorem and recovery of RNA folding free energies	NATURE			English	Article							NONEQUILIBRIUM; MOLECULES; ERROR; FORCE	Atomic force microscopes and optical tweezers are widely used to probe the mechanical properties of individual molecules and molecular interactions, by exerting mechanical forces that induce transitions such as unfolding or dissociation. These transitions often occur under nonequilibrium conditions and are associated with hysteresis effects - features usually taken to preclude the extraction of equilibrium information from the experimental data. But fluctuation theorems(1-5) allow us to relate the work along nonequilibrium trajectories to thermodynamic free-energy differences. They have been shown to be applicable to single-molecule force measurements(6) and have already provided information on the folding free energy of a RNA hairpin(7,8). Here we show that the Crooks fluctuation theorem(9) can be used to determine folding free energies for folding and unfolding processes occurring in weak as well as strong nonequilibrium regimes, thereby providing a test of its validity under such conditions. We use optical tweezers(10) to measure repeatedly the mechanical work associated with the unfolding and refolding of a small RNA hairpin(11) and an RNA three-helix junction(12). The resultant work distributions are then analysed according to the theorem and allow us to determine the difference in folding free energy between an RNA molecule and a mutant differing only by one base pair, and the thermodynamic stabilizing effect of magnesium ions on the RNA structure.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Merck & Co Inc, Automated Biotechnol Dept, N Wales, PA 19454 USA; Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Merck & Company; University of Barcelona; United States Department of Energy (DOE); Los Alamos National Laboratory	Bustamante, C (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ritort@ffn.ub.es; carlos@alice.berkeley.edu	Jarzynski, Chris/B-4490-2009	Jarzynski, Chris/0000-0002-3464-2920; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; CARRIONVAZQUEZ M, IN PRESS BIOPHYS MON; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; Ciliberto S, 1998, J PHYS IV, V8, P215, DOI 10.1051/jp4:1998629; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; EVANS DJ, 1993, PHYS REV LETT, V71, P2401, DOI 10.1103/PhysRevLett.71.2401; Evans DJ, 2002, ADV PHYS, V51, P1529, DOI 10.1080/00018730210155133; GALLAVOTTI G, 1995, PHYS REV LETT, V74, P2694, DOI 10.1103/PhysRevLett.74.2694; Gore J, 2003, P NATL ACAD SCI USA, V100, P12564, DOI 10.1073/pnas.1635159100; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; LONG DM, 1993, FASEB J, V7, P25, DOI 10.1096/fasebj.7.1.8422971; Manosas M, 2005, BIOPHYS J, V88, P3224, DOI 10.1529/biophysj.104.045344; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Ritort F, 2002, P NATL ACAD SCI USA, V99, P13544, DOI 10.1073/pnas.172525099; RITORT F, 2003, SEMINAIRE POINCARE, V2, P193; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Serganov A, 2001, J MOL BIOL, V305, P785, DOI 10.1006/jmbi.2000.4354; Shirts MR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.140601; Smith SB, 2003, METHOD ENZYMOL, V361, P134; TURNER DH, 2000, NUCL ACIDS STRUCTURE, pCH7; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601; Zuckerman DM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.180602; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	756	762	9	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					231	234		10.1038/nature04061	http://dx.doi.org/10.1038/nature04061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16148928	Green Accepted, Green Submitted			2022-12-01	WOS:000231696900050
J	Peng, GY; Guo, Z; Kiniwa, Y; Voo, KS; Peng, WY; Fu, TH; Wang, DY; Li, YC; Wang, HY; Wang, RF				Peng, GY; Guo, Z; Kiniwa, Y; Voo, KS; Peng, WY; Fu, TH; Wang, DY; Li, YC; Wang, HY; Wang, RF			Toll-like, receptor 8-mediated reversal of CD4(+) regulatory T cell function	SCIENCE			English	Article							SINGLE-STRANDED RNA; RECOGNITION; TLR7	CD4(+) regulatory T (Treg) cells have a profound ability to suppress host immune responses, yet little is understood about how these cells are regulated. We describe a mechanism [inking Toll-like receptor (TLR) 8 signaling to the control of Treg cell function, in which synthetic and natural ligands for human TLR8 can reverse Treg cell function. This effect was independent of dendritic cells but required functional TLR8-MYD88-IRAK4 signaling in Treg cells. Adoptive transfer of TLR8 ligand-stimulated Treg cells into tumor-bearing mice enhanced antitumor immunity. These results suggest that TLR8 signaling could play a critical role in controlling immune responses to cancer and other diseases.	Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	Rongfuw@bcm.tmc.edu			NATIONAL CANCER INSTITUTE [P50CA093459, P50CA058204, P01CA094237, R01CA090327, R01CA101795] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA94237, R01CA90327, R01CA101795, P50 CA093459, P50CA58204] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; Woo EY, 2001, CANCER RES, V61, P4766	25	606	679	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1380	1384		10.1126/science.1113401	http://dx.doi.org/10.1126/science.1113401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16123302				2022-12-01	WOS:000231543300046
J	Watanabe, N; Wang, YH; Lee, HK; Ito, T; Wang, YH; Cao, W; Liu, YJ				Watanabe, N; Wang, YH; Lee, HK; Ito, T; Wang, YH; Cao, W; Liu, YJ			Hassall's corpuscles instruct dendritic cells to induce CD4(+)CD25(+) regulatory T cells in human thymus	NATURE			English	Article							EPITHELIAL-CELLS; HUMAN THYMOCYTES; GROWTH-FACTOR; GUINEA-PIG; IN-VITRO; SELECTION; EXPRESSION; SELF; PEPTIDE; DIFFERENTIATION	Hassall's corpuscles - first described in the human thymus over 150 years ago(1) - are groups of epithelial cells within the thymic medulla. The physical nature of these structures differs between mammalian species(2). Although Hassall's corpuscles have been proposed to act in both the removal of apoptotic thymocytes(3,4) and the maturation of developing thymocytes(5) within the thymus, the function of Hassall's corpuscles has remained an enigma. Here we report that human Hassall's corpuscles express thymic stromal lymphopoietin ( TSLP). Human TSLP activates thymic CD11c-positive dendritic cells to express high levels of CD80 and CD86. These TSLP-conditioned dendritic cells are then able to induce the proliferation and differentiation of CD4(+) CD8(-) CD25(-) thymic T cells into CD4(+) CD25(+) FOXP3(+) (forkhead box P3) regulatory T cells. This induction depends on peptide - major histocompatibility complex class II interactions, and the presence of CD80 and CD86, as well as interleukin 2. Immunohistochemistry studies reveal that CD25(+) CTLA4(+) (cytotoxic T-lymphocyte-associated protein 4) regulatory T cells associate in the thymic medulla with activated or mature dendritic cells and TSLP-expressing Hassall's corpuscles. These findings suggest that Hassall's corpuscles have a critical role in dendritic-cell-mediated secondary positive selection of medium-to-high affinity self-reactive T cells, leading to the generation of CD4(+) CD25(+) regulatory T cells within the thymus.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; Univ Texas, MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, YJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St, Houston, TX 77054 USA.	yjliu@mdanderson.org	Lee, Heung Kyu/C-2073-2011	Lee, Heung Kyu/0000-0002-3977-1510; Cao, Wei/0000-0002-8952-9159				Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; BLAU JN, 1967, IMMUNOLOGY, V12, P363; BLAU JN, 1965, NATURE, V208, P564, DOI 10.1038/208564a0; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Hassall AH., 1885, INHALATION TREATMENT; HE W, 1995, J IMMUNOL, V154, P3726; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Nishio H, 2001, ACTA HISTOCHEM, V103, P89, DOI 10.1078/0065-1281-00581; Romagnani P, 1998, BLOOD, V91, P3323, DOI 10.1182/blood.V91.9.3323.3323_3323_3332; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SENELAR R, 1976, BIOMEDICINE, V24, P112; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Zaitseva M, 2002, J IMMUNOL, V168, P2609, DOI 10.4049/jimmunol.168.6.2609	30	544	603	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1181	1185		10.1038/nature03886	http://dx.doi.org/10.1038/nature03886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16121185				2022-12-01	WOS:000231416600051
J	Huntley, JS				Huntley, JS			Benefits of experience - missing the perf	LANCET			English	Editorial Material									Musculoskeletal Res Unit, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Huntley, JS (corresponding author), Musculoskeletal Res Unit, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	jimhuntley@doctors.org.uk		Huntley, James/0000-0003-1826-4007					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 20	2005	366	9486					687	687		10.1016/S0140-6736(05)67142-5	http://dx.doi.org/10.1016/S0140-6736(05)67142-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958EB	16112307				2022-12-01	WOS:000231426400034
J	Gendler, LS; Joseph, KA				Gendler, LS; Joseph, KA			Breast cancer of an accessory nipple	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10032 USA	Columbia University	Gendler, LS (corresponding author), Columbia Univ, Med Ctr, New York, NY 10032 USA.			Joseph, Kathie-Ann/0000-0001-8918-9660					0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2005	353	17					1835	1835		10.1056/NEJMicm050728	http://dx.doi.org/10.1056/NEJMicm050728			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977OL	16251539				2022-12-01	WOS:000232813000011
J	Prasanth, KV; Prasanth, SG; Xuan, ZY; Hearn, S; Freier, SM; Bennett, CF; Zhang, MQ; Spector, DL				Prasanth, KV; Prasanth, SG; Xuan, ZY; Hearn, S; Freier, SM; Bennett, CF; Zhang, MQ; Spector, DL			Egulating gene expression through RNA nuclear retention	CELL			English	Article							INTERCHROMATIN GRANULE CLUSTERS; NITRIC-OXIDE SYNTHASE; IN-VIVO ANALYSIS; MESSENGER-RNA; TRANSLATIONAL CONTROL; HSR-OMEGA; ADENOSINE DEAMINASES; HUMAN TRANSCRIPTOME; NONCODING RNAS; POLY(A) RNA	Multiple mechanisms have evolved to regulate the eukaryotic genome. We have identified CTN-RNA, a mouse tissue-specific similar to 8 kb nuclear-retained poly(A)(+) RNA that regulates the level of its protein-coding partner. CTN-RNA is transcribed from the protein-coding mouse cationic amino acid transporter 2 (mCAT2) gene through alternative promoter and poly(A) site usage. CTN-RNA is diffusely distributed in nuclei and is also localized to paraspeckles. The 3'UTR of CTN-RNA contains elements for adenosine-to-inosine editing, involved in its nuclear retention. Interestingly, knockdown of CTN-RNA also downregulates mCAT2 mRNA. Under stress, CTN-RNA is posttranscriptionally cleaved to produce protein-coding mCAT2 mRNA. Our findings reveal a role of the cell nucleus in harboring RNA molecules that are not immediately needed to produce proteins but whose cytoplasmic presence is rapidly required upon physiologic stress. This mechanism of action highlights an important paradigm for the role of a nuclear-retained stable RNA transcript in regulating gene expression.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Spector, DL (corresponding author), Cold Spring Harbor Lab, 2 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	spector@cshl.org		Xuan, Zhenyu/0000-0001-9344-8493; Hearn, Stephen/0000-0002-2489-2424	NCI NIH HHS [CA13016] Funding Source: Medline; NHGRI NIH HHS [HG02600, HG01696] Funding Source: Medline; NIGMS NIH HHS [R01 GM042694, GM42694] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696, R01HG002600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; FINI ME, 1989, J CELL BIOL, V108, P2045, DOI 10.1083/jcb.108.6.2045; FINLEY KD, 1995, P NATL ACAD SCI USA, V92, P9378, DOI 10.1073/pnas.92.20.9378; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HERMAN RC, 1976, CELL, V7, P429, DOI 10.1016/0092-8674(76)90173-2; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; HOGAN NC, 1994, J CELL BIOL, V125, P21, DOI 10.1083/jcb.125.1.21; Huang CJ, 2002, NITRIC OXIDE-BIOL CH, V6, P79, DOI 10.1006/niox.2001.0402; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee J, 2003, P NATL ACAD SCI USA, V100, P4843, DOI 10.1073/pnas.0735876100; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; MacLeod CL, 1996, BIOCHEM SOC T, V24, P846, DOI 10.1042/bst0240846; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Prasanth KV, 2000, J CELL SCI, V113, P3485; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rosen GM, 2002, CHEM REV, V102, P1191, DOI 10.1021/cr010187s; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; SPECTOR DL, 2001, CELLS LAB MANUAL; Stevens BR, 1996, J BIOL CHEM, V271, P24017, DOI 10.1074/jbc.271.39.24017; Suzuki M, 2004, BIOESSAYS, V26, P833, DOI 10.1002/bies.20084; Szymaski M, 2003, INT REV CYTOL, V231, P197, DOI 10.1016/S0074-7696(03)31005-8; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; VISA N, 1993, EXP CELL RES, V208, P19, DOI 10.1006/excr.1993.1218; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	53	525	596	3	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 21	2005	123	2					249	263		10.1016/j.cell.2005.08.033	http://dx.doi.org/10.1016/j.cell.2005.08.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	977HN	16239143	Bronze			2022-12-01	WOS:000232794100012
J	Tirosh, A; Shai, I; Tekes-Manova, D; Israeli, E; Pereg, D; Shochat, T; Kochba, I; Rudich, A				Tirosh, A; Shai, I; Tekes-Manova, D; Israeli, E; Pereg, D; Shochat, T; Kochba, I; Rudich, A		Israeli Diabetes Res Grp	Normal fasting plasma glucose levels and type 2 diabetes in young men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; BLOOD-GLUCOSE; FATTY-ACIDS; FOLLOW-UP; TOLERANCE; PREVENTION; GLUCONEOGENESIS; COMPONENTS	BACKGROUND: The normal fasting plasma glucose level was recently defined as less than 100 mg per deciliter (5.55 mmol per liter). Whether higher fasting plasma glucose levels within this range independently predict type 2 diabetes in young adults is unclear. METHODS: We obtained blood measurements, data from physical examinations, and medical and lifestyle information from men in the Israel Defense Forces who were 26 to 45 years of age. RESULTS: A total of 208 incident cases of type 2 diabetes occurred during 74,309 person-years of follow-up (from 1992 through 2004) among 13,163 subjects who had baseline fasting plasma glucose levels of less than 100 mg per deciliter. A multivariate model, adjusted for age, family history of diabetes, body-mass index, physical-activity level, smoking status, and serum triglyceride levels, revealed a progressively increased risk of type 2 diabetes in men with fasting plasma glucose levels of 87 mg per deciliter (4.83 mmol per liter) or more, as compared with those whose levels were in the bottom quintile (less than 81 mg per deciliter [4.5 mmol per liter], P for trend <0.001). In multivariate models, men with serum triglyceride levels of 150 mg per deciliter (1.69 mmol per liter) or more, combined with fasting plasma glucose levels of 91 to 99 mg per deciliter (5.05 to 5.50 mmol per liter), had a hazard ratio of 8.23 (95 percent confidence interval, 3.6 to 19.0) for diabetes, as compared with men with a combined triglyceride level of less than 150 mg per deciliter and fasting glucose levels of less than 86 mg per deciliter (4.77 mmol per liter). The joint effect of a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or more and a fasting plasma glucose level of 91 to 99 mg per deciliter resulted in a hazard ratio of 8.29 (95 percent confidence interval, 3.8 to 17.8), as compared with a body-mass index of less than 25 and a fasting plasma glucose level of less than 86 mg per deciliter. CONCLUSIONS: Higher fasting plasma glucose levels within the normoglycemic range constitute an independent risk factor for type 2 diabetes among young men, and such levels may help, along with body-mass index and triglyceride levels, to identify apparently healthy men at increased risk for diabetes.	Chaim Sheba Med Ctr, Dept Internal Med A, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Israel Def Forces Med Corps, Med Corps Headquarters, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Israel Def Forces Med Corps, Ctr Med Serv, IL-52621 Tel Hashomer, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, S Daniel Abraham Int Ctr Hlth & Nutr, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; Meir Hosp, Sapir Med Ctr, Dept Internal Med A, Kefar Sava, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Tirosh, A (corresponding author), Chaim Sheba Med Ctr, Dept Internal Med A, IL-52621 Tel Hashomer, Israel.	amirt@bgumail.bgu.ac.il		Tirosh, Amir/0000-0003-2210-5906; Rudich, Assaf/0000-0002-1366-1444				American Diabetes Association, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11; Bajaj M, 2004, INT J OBESITY, V28, P783, DOI 10.1038/sj.ijo.0802625; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bloomgarden ZT, 2004, DIABETES CARE, V27, P998, DOI 10.2337/diacare.27.4.998; Boden G, 1997, DIABETES, V46, P536; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Borch-Johnsen K, 2004, DIABETOLOGIA, V47, P1396, DOI 10.1007/s00125-004-1468-6; BORTHEIRY AL, 1994, DIABETES CARE, V17, P1269, DOI 10.2337/diacare.17.11.1269; Chiasson JL, 2004, DIABETOLOGIA, V47, P969, DOI 10.1007/s00125-004-1409-4; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Durbin RJ, 2004, DIABETES OBES METAB, V6, P280, DOI 10.1111/j.1462-8902.2004.0348.x; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Genuth S, 2003, DIABETES CARE, V26, P3331, DOI 10.2337/diacare.26.12.3331; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; Kim DJ, 2003, DIABETES CARE, V26, P3354, DOI 10.2337/diacare.26.12.3354; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Navas-Nacher EL, 2001, ANN INTERN MED, V135, P71, DOI 10.7326/0003-4819-135-1-200107030-00042; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Schriger DL, 2004, DIABETES CARE, V27, P592, DOI 10.2337/diacare.27.2.592; Shaw JE, 2000, DIABETES CARE, V23, P34, DOI 10.2337/diacare.23.1.34; Simons LA, 2000, AUST NZ J MED, V30, P41, DOI 10.1111/j.1445-5994.2000.tb01053.x; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tai ES, 2004, DIABETES CARE, V27, P1728, DOI 10.2337/diacare.27.7.1728; Tanne D, 2004, STROKE, V35, P2351, DOI 10.1161/01.STR.0000140738.94047.55; Thomas GN, 2004, ARTERIOSCL THROM VAS, V24, P739, DOI 10.1161/01.ATV.0000118015.26978.07; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Torgerson JS, 2004, DIABETES CARE, V27, P856; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514	41	348	367	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2005	353	14					1454	1462		10.1056/NEJMoa050080	http://dx.doi.org/10.1056/NEJMoa050080			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970LZ	16207847	Bronze			2022-12-01	WOS:000232313000005
J	van den Elzen, P; Garg, S; Leon, L; Brigl, M; Leadbetter, EA; Gumperz, JE; Dascher, CC; Cheng, TY; Sacks, FM; Illarionov, PA; Besra, GS; Kent, SC; Moody, DB; Brenner, MB				van den Elzen, P; Garg, S; Leon, L; Brigl, M; Leadbetter, EA; Gumperz, JE; Dascher, CC; Cheng, TY; Sacks, FM; Illarionov, PA; Besra, GS; Kent, SC; Moody, DB; Brenner, MB			Apolipoprotein-mediated pathways of lipid antigen presentation	NATURE			English	Article							TRANSPORT PROTEIN; GENE-EXPRESSION; DENDRITIC CELLS; LYMPHOCYTES-T; NKT CELLS; RECEPTOR; LIPOPROTEINS; ATHEROSCLEROSIS; MACROPHAGES; METABOLISM	Peptide antigens are presented to T cells by major histocompatibility complex (MHC) molecules, with endogenous peptides presented by MHC class I and exogenous peptides presented by MHC class II. In contrast to the MHC system, CD1 molecules bind lipid antigens that are presented at the antigen-presenting cell (APC) surface to lipid antigen-reactive T cells(1). Because CD1 molecules survey endocytic compartments(2), it is self-evident that they encounter antigens from extracellular sources. However, the mechanisms of exogenous lipid antigen delivery to CD1-antigen-loading compartments are not known. Serum apolipoproteins are mediators of extracellular lipid transport for metabolic needs(3). Here we define the pathways mediating markedly efficient exogenous lipid antigen delivery by apolipoproteins to achieve T-cell activation. Apolipoprotein E binds lipid antigens and delivers them by receptor-mediated uptake into endosomal compartments containing CD1 in APCs. Apolipoprotein E mediates the presentation of serum-borne lipid antigens and can be secreted by APCs as a mechanism to survey the local environment to capture antigens or to transfer microbial lipids from infected cells to bystander APCs. Thus, the immune system has co-opted a component of lipid metabolism to develop immunological responses to lipid antigens.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Birmingham	Brenner, MB (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Garg, Salil/GXH-2201-2022; Eckhardt, Erik/G-1567-2010	Garg, Salil/0000-0002-7198-1833; Besra, Gurdyal/0000-0002-5605-0395; van den Elzen, Peter/0000-0003-3933-4780	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071590] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Heeren J, 2001, CURR OPIN LIPIDOL, V12, P255, DOI 10.1097/00041433-200106000-00003; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; KRUL ES, 1985, J CLIN INVEST, V75, P361, DOI 10.1172/JCI111708; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Mahley R.W., 2003, WILLIAMS TXB ENDOCRI, P1642; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; REBBAA A, 1995, J LIPID RES, V36, P564; Sacks F M, 1996, Vasc Med, V1, P9; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014; Tomiyasu K, 2001, ARTERIOSCL THROM VAS, V21, P1494, DOI 10.1161/hq0901.094489; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997	29	280	293	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					906	910		10.1038/nature04001	http://dx.doi.org/10.1038/nature04001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208376				2022-12-01	WOS:000232338600051
J	Zhang, SYL; Yu, Y; Roos, J; Kozak, JA; Deerinck, TJ; Ellisman, MH; Stauderman, KA; Cahalan, MD				Zhang, SYL; Yu, Y; Roos, J; Kozak, JA; Deerinck, TJ; Ellisman, MH; Stauderman, KA; Cahalan, MD			STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane	NATURE			English	Article							OPERATED CALCIUM-CHANNELS; T-LYMPHOCYTES; DEPLETION; INFLUX; CELLS; OSCILLATIONS; INHIBITION; MECHANISMS; FAMILY	As the sole Ca2+ entry mechanism in a variety of non-excitable cells, store-operated calcium (SOC) influx is important in Ca2+ signalling and many other cellular processes(1-3). A calcium-release-activated calcium ( CRAC) channel in T lymphocytes is the best-characterized SOC influx channel(4-6) and is essential to the immune response, sustained activity of CRAC channels being required for gene expression and proliferation(7-10). The molecular identity and the gating mechanism of SOC and CRAC channels have remained elusive. Previously we identified Stim and the mammalian homologue STIM1 as essential components of CRAC channel activation in Drosophila S2 cells and human T lymphocytes(11). Here we show that the expression of EF-hand mutants of Stim or STIM1 activates CRAC channels constitutively without changing Ca2+ store content. By immunofluorescence, EM localization and surface biotinylation we show that STIM1 migrates from endoplasmic-reticulum-like sites to the plasma membrane upon depletion of the Ca2+ store. We propose that STIM1 functions as the missing link between Ca2+ store depletion and SOC influx, serving as a Ca2+ sensor that translocates upon store depletion to the plasma membrane to activate CRAC channels.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA; TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Struct, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu			NCI NIH HHS [P30 CA062203] Funding Source: Medline; NINDS NIH HHS [R37 NS014609, R01 NS014609] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609, R01NS014609] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Eray M, 2001, CYTOMETRY, V43, P134, DOI 10.1002/1097-0320(20010201)43:2<134::AID-CYTO1028>3.0.CO;2-L; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Ferrari D, 2002, CELL CALCIUM, V32, P413, DOI 10.1016/S0143416002002014; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Graber MN, 1996, J BIOL CHEM, V271, P883, DOI 10.1074/jbc.271.2.883; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney JW, 2001, J CELL SCI, V114, P2223; PUTNEY JW, 2004, SCI STKE, V243, pPE37, DOI DOI 10.1126/STKE.2432004PE37; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; ROSS PE, 1995, J GEN PHYSIOL, V106, P415, DOI 10.1085/jgp.106.3.415; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982	25	1052	1113	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					902	905		10.1038/nature04147	http://dx.doi.org/10.1038/nature04147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16208375	Green Accepted			2022-12-01	WOS:000232338600050
J	Dong, CJ; Flecks, S; Unversucht, S; Haupt, C; van Pee, KH; Naismith, JH				Dong, CJ; Flecks, S; Unversucht, S; Haupt, C; van Pee, KH; Naismith, JH			Tryptophan 7-halogenase (PrnA) structure suggests a mechanism for regioselective chlorination	SCIENCE			English	Article							BIOSYNTHETIC GENE-CLUSTER; PARA-HYDROXYBENZOATE HYDROXYLASE; CATION-PI INTERACTIONS; PSEUDOMONAS-FLUORESCENS; CHLOROPEROXIDASE; STREPTOMYCES; HALOGENATION; PYRROLNITRIN; REBECCAMYCIN; DERIVATIVES	Chlorinated natural products include vancomycin and cryptophycin A. Their biosynthesis involves regioselective chlorination by flavin-dependent halogenases. We report the structural characterization of tryptophan halogenase (PrnA), which regioselectively chlorinates tryptophan. Tryptophan and flavin adenine dinucleotide (FAD) are separated by a 10 angstrom-long tunnel and bound by distinct enzyme modules. The FAD module is conserved in halogenases and is related to flavin-dependent monooxygenases. On the basis of biochemical studies, crystal structures, and by analogy with monooxygenases, we predict that FADH(2) reacts with O-2 to make peroxyflavin, which is decomposed by Cl-. The resulting HOCl is guided through the tunnel to tryptophan, where it is activated to participate in electrophilic aromatic substitution.	Univ St Andrews, EaStchem, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; Tech Univ Dresden, Inst Biochem, D-01062 Dresden, Germany	University of St Andrews; Technische Universitat Dresden	Naismith, JH (corresponding author), Univ St Andrews, EaStchem, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.		Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Haupt, Caroline/0000-0002-4748-6736	Biotechnology and Biological Sciences Research Council [BB/C000080/1, BBS/B/14426] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALA A, 2004, NATURE, V427, P561; BRESLOW R, 1969, J AM CHEM SOC, V91, P3085, DOI 10.1021/ja01039a044; Chiu HT, 2001, P NATL ACAD SCI USA, V98, P8548, DOI 10.1073/pnas.151246498; DAIRI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1099, DOI 10.1271/bbb.59.1099; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Eustaquio AS, 2003, CHEM BIOL, V10, P279, DOI 10.1016/S1074-5521(03)00051-6; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; HAGER LP, 1966, J BIOL CHEM, V241, P1769; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Hammer PE, 1999, FEMS MICROBIOL LETT, V180, P39, DOI 10.1111/j.1574-6968.1999.tb08775.x; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Hohaus K, 1997, ANGEW CHEM INT EDIT, V36, P2012, DOI 10.1002/anie.199720121; Holzer M, 2001, ADV SYNTH CATAL, V343, P591; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Ligon JM, 2000, PEST MANAG SCI, V56, P688, DOI 10.1002/1526-4998(200008)56:8<688::AID-PS186>3.0.CO;2-V; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Messerschmidt A, 1997, BIOL CHEM, V378, P309, DOI 10.1515/bchm.1997.378.3-4.309; Piraee M, 2004, MICROBIOL-SGM, V150, P85, DOI 10.1099/mic.0.26319-0; Puk O, 2002, CHEM BIOL, V9, P225, DOI 10.1016/S1074-5521(02)00101-1; Sailler B, 1999, NAT TOXINS, V7, P57, DOI 10.1002/(SICI)1522-7189(199903/04)7:2<57::AID-NT42>3.0.CO;2-F; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sundaramoorthy M, 1998, CHEM BIOL, V5, P461, DOI 10.1016/S1074-5521(98)90003-5; van Pee KH, 2003, CHEMOSPHERE, V52, P299, DOI 10.1016/S0045-6535(03)00204-2; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	32	267	281	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2005	309	5744					2216	2219		10.1126/science.1116510	http://dx.doi.org/10.1126/science.1116510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970NX	16195462	Green Accepted			2022-12-01	WOS:000232318000044
J	Alberti, KGMM; Zimmet, P; Shaw, J				Alberti, KGMM; Zimmet, P; Shaw, J			The metabolic syndrome - a new worldwide definition	LANCET			English	Editorial Material							PROVISIONAL REPORT; DIAGNOSIS; RISK		St Marys Hosp, Dept Endocrinol & Metab, London W2 1NY, England; Int Diabet Inst, Melbourne, Vic, Australia	Imperial College London	Alberti, KGMM (corresponding author), St Marys Hosp, Dept Endocrinol & Metab, Praed St, London W2 1NY, England.	George.Alberti@newcastle.ac.uk	Zimmet, Paul/O-8486-2019; Shaw, Jonathan/E-7388-2010; Greiver, Michelle/N-8764-2015	Zimmet, Paul/0000-0003-0627-0776; Shaw, Jonathan/0000-0002-6187-2203; Greiver, Michelle/0000-0001-8957-0285				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 1999, DIABETIC MED, V16, P442; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; GALE EAM, 2005, DIABETOLOGIA, V10, P1873; Genuth S, 2003, DIABETES CARE, V26, P3160; International Diabetes Federation, 2005, IDF CONS WORLDW DEF; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; KAHN R, 2005, DIABETOLOGIA    0804, DOI DOI 10.1007/S00125-005-1876-2; Kylin E., 1923, ZENTRALBLATT INNERE, V44, P105, DOI DOI 10.1002/(SICI)1096-9136(199807)15:7<539::; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; WHO, 2004, LANCET, V363, P902; Zimmet P, 2003, DIABETIC MED, V20, P693, DOI 10.1046/j.1464-5491.2003.01052.x	22	5388	5843	18	144	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2005	366	9491					1059	1062		10.1016/S0140-6736(05)67402-8	http://dx.doi.org/10.1016/S0140-6736(05)67402-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967TL	16182882				2022-12-01	WOS:000232114000008
J	Colleoni, M; Li, SG; Gelber, RD; Price, KN; Coates, AS; Castiglione-Gertsch, M; Goldhirsch, A				Colleoni, M; Li, SG; Gelber, RD; Price, KN; Coates, AS; Castiglione-Gertsch, M; Goldhirsch, A		Int Breast Canc Study Grp	Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index	LANCET			English	Article							BREAST-CANCER; OBESITY	Clinicians often reduce chemotherapy doses when treating obese patients because of concerns about overdosing. We assessed dose-response according to body-mass index (BMI) and oestrogen receptor (ER) expression of the primary tumour in premenopausal patients with node-positive breast cancer treated with classical CMF (cyclophosphamide, methotrexate, and 5-fluorouracil). Obese patients were significantly more likely to receive a lower chemotherapy dose (<85% of expected dose) for the first course than were those with normal or intermediate BMI (39% vs 16%, p<0.0001). For obese patients and for the total population, reducing the dose of chemotherapy was associated with a significantly worse outcome for the ER-negative cohort (total population hazards ratio >= 85% vs <85% 0.68 [95% CI 0.54-0.86] for disease free survival; 0.72 [0.56-0.94] for overall survival) but not for the ER-positive cohort (1.16 [0.97-1.40] for disease-free survival; 1.16 [0.94-1.44] for overall survival) [interaction p values=0.0001 for disease-free survival and 0.0019 for overall survival]. Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided.	European Inst Oncol, Div Med Oncol, I-20141 Milan, Italy; Dana Farber Canc Inst, IBCSG Stat Ctr, Boston, MA 02115 USA; Frontier Sci & Tehcnol Res Fdn, Boston, MA USA; Univ Sydney, Sydney, NSW 2006, Australia; Canc Council Australia, Sydney, NSW, Australia; IBCSG Coordinating Ctr, Bern, Switzerland; Oncol Inst So Switzerland, Lugano, Switzerland	IRCCS European Institute of Oncology (IEO); Harvard University; Dana-Farber Cancer Institute; Frontier Science Foundation; University of Sydney; Cancer Council New South Wales	Colleoni, M (corresponding author), European Inst Oncol, Div Med Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	marco.colleoni@ieo.it	Colleoni, Marco/AAN-8647-2020	Colleoni, Marco/0000-0002-5743-3013	NCI NIH HHS [CA-75362] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; GOODWIN PJ, 1990, BREAST CANCER RES TR, V16, P205, DOI 10.1007/BF01806329; HENDERSON IC, 1988, J CLIN ONCOL, V6, P1501, DOI 10.1200/JCO.1988.6.9.1501; Poikonen P, 2001, ACTA ONCOL, V40, P67; Rosner GL, 1996, J CLIN ONCOL, V14, P3000, DOI 10.1200/JCO.1996.14.11.3000	5	108	110	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 24	2005	366	9491					1108	1110		10.1016/S0140-6736(05)67110-3	http://dx.doi.org/10.1016/S0140-6736(05)67110-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967TL	16182899	Bronze			2022-12-01	WOS:000232114000029
J	Dalziel, SR; Lim, VK; Lambert, A; McCarthy, D; Parag, V; Rodgers, A; Harding, JE				Dalziel, SR; Lim, VK; Lambert, A; McCarthy, D; Parag, V; Rodgers, A; Harding, JE			Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH; CORTICOSTEROIDS; CHILDREN; OUTCOMES; AGE	Objectives To determine if antenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome alters psychological functioning and health related quality of life in adulthood. Design Follow-up of the first and largest double blind, placebo controlled, randomised trial of a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome. Setting Tertiary obstetric hospital in Auckland, New Zealand. Participants 192 adult offspring, mean age 31 years, of mothers who took part in a randomised controlled trial of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome (87 exposed to betamethasone and 105 exposed to placebo). Interventions Mothers received two doses of betamethasone or placebo 24 hours apart. Main outcome measures Cognitive functioning assessed with Wechsler abbreviated scale of intelligence; working memory and attention assessed with Benton visual retention test, paced auditory serial addition test, and Brown attention deficit disorder scale; psychiatric morbidity assessed with Beck depression inventory II, state-trait anxiety inventory, and schizotypy traits questionnaire; handedness assessed with Edinburgh handedness inventory; health related quality of life assessed with short form 36 health survey. Results No differences were found between groups exposed to betamethasone and placebo in cognitive functioning, working memory and attention, psychiatric morbidity, handedness, or health related quality of life. Conclusions Prenatal exposure to a single course of betamethasone does not alter cognitive functioning, working memory and attention, psychiatric morbidity, handedness, or health related quality of life in adulthood. Obstetricians should continue to use a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome.	Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Auckland, Dept Psychol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Lim, Vanessa/A-7158-2010; Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Rodgers, Anthony/0000-0003-1282-1896; Lambert, Anthony/0000-0001-5715-8245				[Anonymous], 1984, J PEDIATR-US, V104, P259; [Anonymous], 1994, NIH Consens Statement, V12, P1; Beck A., 1996, BECK DEPRESSION INVE; Brown GK., 1996, PSYCHOL ASSESSMENT; Brown TE., 1996, BROWN ATTENTION DEFI; Castro L, 2004, PEDIATRICS, V114, P404, DOI 10.1542/peds.114.2.404; CLARIDGE G, 1984, PERS INDIV DIFFER, V5, P633, DOI 10.1016/0191-8869(84)90111-9; Crowley P., 1996, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065]; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Doyle LW, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e2; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Huang SJ, 2001, J VAC SCI TECHNOL B, V19, P115, DOI 10.1116/1.1335678; LIGGINS GC, 1972, PEDIATRICS, V50, P515; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Scott KM, 1999, AUST NZ J PUBL HEAL, V23, P401, DOI 10.1111/j.1467-842X.1999.tb01282.x; Sivan A.B., 1992, BENTON VISUAL RETENT; Spielberger C.D., 1983, STATE TRAIT ANXIETY, DOI [10.1037/t06496-000, DOI 10.1037/T06496-000]; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; Wechsler D., 2005, WECHSLER ABBREVIATED; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	25	119	128	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2005	331	7518					665	668A		10.1136/bmj.38576.494363.E0	http://dx.doi.org/10.1136/bmj.38576.494363.E0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970HH	16143712	Green Published, Bronze			2022-12-01	WOS:000232295400017
J	Menard, C; Hagege, AA; Agbulut, O; Barro, M; Morichetti, MC; Brasselet, C; Bel, A; Messas, E; Bissery, A; Bruneval, P; Desnos, M; Puceat, M; Menasche, P				Menard, C; Hagege, AA; Agbulut, O; Barro, M; Morichetti, MC; Brasselet, C; Bel, A; Messas, E; Bissery, A; Bruneval, P; Desnos, M; Puceat, M; Menasche, P			Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study	LANCET			English	Article							BONE-MARROW-CELLS; DIFFERENTIATION; CARDIOMYOCYTES; IDENTIFICATION; INTEGRATION; EXPRESSION; MYOCYTES; REQUIRES; PATHWAY; REGIONS	Background Heart failure develops after myocardial infarction and is a major cause of morbidity and mortality. The ability to direct differentiation of embryonic stem cells (ESC) towards a cardiomyogenic phenotype makes them an attractive therapeutic option for cardiac repair, but species-specific and individual-specific immunological imprinting remains a hurdle. Our aim was to ascertain whether the purported immune privilege of ESC allows for their cross-species engraftment in a clinically relevant large-animal model. Methods We studied engraftment and differentiation of cardiac-committed mouse ESC in 18 sheep in which a myocardial infarction had been induced; nine controls received medium and nine sheep (five of which were immunosuppressed) received ESC. The gain in myocardial function was measured by echocardiography 1 month after cell transplantation. Findings Cardiac-committed murine ESC engrafted in infarcted myocardium of immunosuppressed and immunocompetent sheep, and differentiated into mature cardiomyocytes that expressed connexins. Colonisation. of the scar area by ESC was accompanied by a functional benefit of the damaged myocardium. Left-ventricular ejection fraction deteriorated in the control group by a median of 9.9% (range -20 to 0.3) relative to baseline (p=0.011) whereas in the treated group it improved by 6.6% (-5.7 to 50.8; comparison between groups p=0.002). Interpretation These findings obtained in a clinically relevant large-animal model of heart failure strengthen the potential therapeutic use of ESC to regenerate the severely dysfunctional myocardium and bring additional evidence for an immune privilege of these cells.	CNRS, FRE 2593, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; Univ Paris 05, Fac Med, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris,Dept Pathol, Paris, France; Univ Paris 05, Fac Med, Dept Cardiol, Paris, France; Univ Paris 05, Fac Med, Dept Cardiovasc Surg, Paris, France; Univ Paris 05, Fac Med, Clin Invest Ctr 92010, Paris, France; INSERM, U430, Paris, France; INSERM, U633, Lab Etud Greffes & Protheses Cardiaque, Paris, France; CHU Robert Debre, Assistance Publ Hop Paris, Ecole Chirurg, Reims, France; CHU Robert Debre, Dept Cardiol, Reims, France; Univ Paris 07, UFR Biochim, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Franche-Comte; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU de Reims; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Reims; UDICE-French Research Universities; Universite Paris Cite	Puceat, M (corresponding author), CNRS, FRE 2593, Ctr Rech Biochim Macromol, F-34293 Montpellier, France.	michel.puceat@crbm.cnrs.fr	PUCEAT, michel/R-6140-2017	Agbulut, Onnik/0000-0003-1923-8871; PUCEAT, michel/0000-0001-9055-7563; HAGEGE, Albert/0000-0003-4685-6077				Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beghetti M, 1997, AM HEART J, V134, P1107; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Bel A, 2003, CIRCULATION, V108, P247, DOI 10.1161/01.cir.0000089040.11131.d4; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Braunwald E, 2000, CIRCULATION, V102, P14; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chiu RCJ, 2004, INT J CARDIOL, V95, pS43, DOI 10.1016/S0167-5273(04)90012-5; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; ELDIN P, 1993, BIOCHEMISTRY-US, V32, P2542, DOI 10.1021/bi00061a011; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Fabricius D, 2005, TRANSPLANTATION, V79, P1040, DOI 10.1097/01.TP.0000159142.62535.37; FRANDRICH F, 2002, NAT MED, V8, P171; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Meyer N, 2000, FEBS LETT, V478, P151, DOI 10.1016/S0014-5793(00)01839-1; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ogata K, 2004, J HEART LUNG TRANSPL, V23, P515, DOI 10.1016/j.healun.2003.07.007; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajasinghe HA, 1996, TRANSPLANTATION, V62, P407, DOI 10.1097/00007890-199608150-00018; Reecy JM, 1999, DEVELOPMENT, V126, P839; Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81; Rudy Y, 2004, CIRC RES, V94, P709, DOI 10.1161/01.RES.0000125647.56687.D3; Savatier P, 1996, ONCOGENE, V12, P309; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tam P.P.L., 1999, HEART DEV, DOI [10.1016/b978-012329860-7/50003-9, DOI 10.1016/B978-012329860-7/50003-9]; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Xiao YF, 2004, ANN THORAC SURG, V77, P737, DOI 10.1016/j.athoracsur.2003.08.036; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Yoon YS, 2004, CIRCULATION, V109, P3154, DOI 10.1161/01.CIR.0000134696.08436.65	44	222	249	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2005	366	9490					1005	1012		10.1016/S0140-6736(05)67380-1	http://dx.doi.org/10.1016/S0140-6736(05)67380-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965MZ	16168783				2022-12-01	WOS:000231955900036
J	Gandia-Herrero, F; Garcia-Carmona, F; Escribano, J				Gandia-Herrero, F; Garcia-Carmona, F; Escribano, J			Floral fluorescence effect	NATURE			English	Editorial Material									Univ Murcia, Dept Bioquim & Biol Mol A, Unidad Docente Biol, Fac Vet, E-30100 Murcia, Spain	University of Murcia	Gandia-Herrero, F (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Unidad Docente Biol, Fac Vet, E-30100 Murcia, Spain.	gcarmona@um.es	Gandia-Herrero, Fernando/L-9027-2014; Garcia-Carmona, Francisco/K-6520-2017; ESCRIBANO CEBRIAN, JOSEFA/K-9113-2017	Gandia-Herrero, Fernando/0000-0003-4389-3454; ESCRIBANO CEBRIAN, JOSEFA/0000-0003-0529-1786; Garcia-Carmona, Francisco/0000-0002-1318-7690				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Gandia-Herrero F, 2005, J CHROMATOGR A, V1078, P83, DOI 10.1016/j.chroma.2005.05.013; Gandia-Herrero F, 2005, PLANT PHYSIOL, V138, P421, DOI 10.1104/pp.104.057992; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Vorobyev M, 2001, COLOR RES APPL, V26, pS214, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL45>3.0.CO;2-A; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971	10	76	79	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					334	334		10.1038/437334a	http://dx.doi.org/10.1038/437334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16163341				2022-12-01	WOS:000231849100035
J	Lafon, M				Lafon, M			Bat rabies - the Achilles heel of a viral killer?	LANCET			English	Editorial Material							VIRUS GLYCOPROTEIN; VARIANTS		Inst Pasteur, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lafon, M (corresponding author), Inst Pasteur, F-75724 Paris, France.	mlafon@pasteur.fr		Lafon, Monique/0000-0002-4423-7996				Ceccaldi PE, 1998, J NEUROVIROL, V4, P115, DOI 10.3109/13550289809113489; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Hemachudha T, 2003, J INFECT DIS, V188, P960, DOI 10.1086/378415; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lafon M, 2004, ARCH VIROL, P149; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9	10	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2005	366	9489					876	877		10.1016/S0140-6736(05)67297-2	http://dx.doi.org/10.1016/S0140-6736(05)67297-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962YR	16153999				2022-12-01	WOS:000231770000007
J	Claverie, JM				Claverie, JM			Fewer genes, more noncoding RNA	SCIENCE			English	Article							HUMAN GENOME; POLYMERASE; SEQUENCE; NUMBER	Recent studies showing that most "messenger" RNAs do not encode proteins finally explain the long-standing discrepancy between the small number of protein-coding genes found in vertebrate genomes and the much larger and ever-increasing number of polyadenylated transcripts identified by tag-sampling or microarray-based methods. Exploring the role and diversity of these numerous noncoding RNAs now constitutes a main challenge in transcription research.	Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, CNRS, UPR 2589, F-13402 Marseille, France; Univ Mediterranee Sch Med, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Claverie, JM (corresponding author), Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, CNRS, UPR 2589, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	jean-michel.claverie@igs.cnrs-mrs.fr	Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	Claverie, Jean-Michel/0000-0003-1424-0315				Boheler KR, 2003, TRENDS BIOTECHNOL, V21, P55, DOI 10.1016/S0167-7799(02)00031-8; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHEN GJ, 2005, SCIENCE         0324, V308, P1149, DOI DOI 10.1126/SCIENCE.1108625; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Davison DB, 2001, IBM J RES DEV, V45, P439, DOI 10.1147/rd.453.0439; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang F, 2000, NUCLEIC ACIDS RES, V28, P3657, DOI 10.1093/nar/28.18.3657; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shendure J, 2002, GENOME BIOL, V3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; 2000, NAT GENET, V25, P127	18	153	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1529	1530		10.1126/science.1116800	http://dx.doi.org/10.1126/science.1116800			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141064				2022-12-01	WOS:000231715000039
J	Hauser, MD				Hauser, MD			Beyond the chimpanzee genome: The threat of extinction	SCIENCE			English	Editorial Material									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Biol Anthropol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Hauser, MD (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	mdh@wjh.harvard.edu						Cavalieri P., 1994, GREAT APE PROJECT EQ; DEWAAL F, 1982, CHIMPANZEE POLITICS; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAUSER MD, 2000, WILD MINDS ANIMALS R; Huffman Michael A., 1994, P129; MATSUZAWA T, 2002, PRIMATE ORIGINS HUMA; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; PREMACK D, 2002, ORIGINAL INTELLIGENC; Tomasello M, 2003, TRENDS COGN SCI, V7, P153, DOI 10.1016/S1364-6613(03)00035-4; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wrangham R., 1996, DEMONIC MALES	12	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2005	309	5740					1498	1499		10.1126/science.1111421	http://dx.doi.org/10.1126/science.1111421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16141053				2022-12-01	WOS:000231715000029
J	Im, YJ; Raychaudhuri, S; Prinz, WA; Hurley, JH				Im, YJ; Raychaudhuri, S; Prinz, WA; Hurley, JH			Structural mechanism for sterol sensing and transport by OSBP-related proteins	NATURE			English	Article							OXYSTEROL-BINDING-PROTEIN; PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; TOCOPHEROL TRANSFER PROTEIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; LIPID-BINDING; DOMAIN; PHOSPHATIDYLCHOLINE; MEMBRANES; HOMOLOGS	The oxysterol-binding-protein (OSBP)-related proteins (ORPs) are conserved from yeast to humans(1,2), and are implicated in the regulation of sterol homeostasis(3,4) and in signal transduction pathways(5). Here we report the structure of the full-length yeast ORP Osh4 (also known as Kes1) at 1.5 - 1.9 angstrom resolution in complexes with ergosterol, cholesterol, and 7-, 20- and 25-hydroxycholesterol. We find that a single sterol molecule binds within a hydrophobic tunnel in a manner consistent with a transport function for ORPs. The entrance is blocked by a flexible amino-terminal lid and surrounded by basic residues that are critical for Osh4 function. The structure of the open state of a lid-truncated form of Osh4 was determined at 2.5 angstrom resolution. Structural analysis and limited proteolysis show that sterol binding closes the lid and stabilizes a conformation favouring transport across aqueous barriers and signal transmission. The structure of Osh4 in the absence of ligand exposes potential phospholipid-binding sites that are positioned for membrane docking and sterol exchange. On the basis of these observations, we propose a model in which sterol and membrane binding promote reciprocal conformational changes that facilitate a sterol transfer and signalling cycle.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIDDKD, Lab Cell Biochem & Biol, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Gwangju City 500712, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Gwangju Institute of Science & Technology (GIST)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov		Raychaudhuri, Sumana/0000-0002-3164-0057	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [Z01 DK036118-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060004, Z01DK036118] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOPEZGARCIA F, 2000, J MOL BIOL, V0295; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	30	317	327	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					154	158		10.1038/nature03923	http://dx.doi.org/10.1038/nature03923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16136145	Green Accepted			2022-12-01	WOS:000231560400060
J	Myer, L; Morroni, C; El-Sadr, WM				Myer, L; Morroni, C; El-Sadr, WM			Reproductive decisions in HIV-infected individuals	LANCET			English	Editorial Material							POSITIVE WOMEN; MEN; PREGNANCY		Univ Cape Town, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit, ZA-7925 Cape Town, South Africa; Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, ZA-7700 Rondebosch, South Africa; Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Programs, New York, NY USA	University of Cape Town; University of Cape Town; Columbia University	Myer, L (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit, ZA-7925 Cape Town, South Africa.	lmyer@cormack.uct.ac.za		Morroni, Chelsea/0000-0002-2026-6039				Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Dickinson BD, 2001, OBSTET GYNECOL, V98, P853, DOI 10.1016/S0029-7844(01)01532-0; Dyer SJ, 2002, HUM REPROD, V17, P1663, DOI 10.1093/humrep/17.6.1663; Feldman R, 2003, REPROD HEALTH MATTER, V11, P162, DOI 10.1016/S0968-8080(03)02284-5; Kirshenbaum SB, 2004, PERSPECT SEX REPRO H, V36, P106, DOI 10.1111/j.1931-2393.2004.tb00198.x; Myer L, 2005, REPROD HEALTH MATTER, V13, P136, DOI 10.1016/S0968-8080(05)25185-6; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Rossi AD, 2005, CONTRACEPTION, V71, P45, DOI 10.1016/j.contraception.2004.07.001; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Shelton JD, 2004, LANCET, V364, P1916, DOI 10.1016/S0140-6736(04)17489-8; VanDevanter N, 1999, AIDS CARE, V11, P181, DOI 10.1080/09540129948072; Watts DH, 2002, NEW ENGL J MED, V346, P1879, DOI 10.1056/NEJMra013338; *WHO, 2004, MED EL CONTR US	14	27	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2005	366	9487					698	700		10.1016/S0140-6736(05)67155-3	http://dx.doi.org/10.1016/S0140-6736(05)67155-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958UV	16125573				2022-12-01	WOS:000231474600009
J	Bagga, S; Bracht, J; Hunter, S; Massirer, K; Holtz, J; Eachus, R; Pasquinelli, AE				Bagga, S; Bracht, J; Hunter, S; Massirer, K; Holtz, J; Eachus, R; Pasquinelli, AE			Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation	CELL			English	Article							HETEROCHRONIC GENE LIN-14; NEGATIVE POSTTRANSCRIPTIONAL REGULATION; MICRORNA-DIRECTED CLEAVAGE; UTR SEQUENCE MOTIF; CAENORHABDITIS-ELEGANS; C-ELEGANS; DEVELOPMENTAL SWITCH; K-BOX; EXPRESSION; COMPLEX	MicroRNAs (miRNAs) are similar to 22 nucleotide RNAs that negatively regulate the expression of protein-coding genes. In a present model of miRNA function in animals, miRNAs that form imperfect duplexes with their targets inhibit protein expression without affecting mRNA levels. Here, we report that in C. elegans, regulation by the let-7miRNA results in degradation of its lin-41 target mRNA, despite the fact that its 3'UTR regulatory sequences can only partially base-pair with the miRNA. Furthermore, lin-14 and lin-28 are targets of the lin-4 miRNA, and we show that the mRNA levels for these protein-coding genes significantly decrease in response to lin-4 expression. This study reveals that mRNAs containing partial miRNA complementary sites can be targeted for degradation in vivo, raising the possibility that regulation at the level of mRNA stability may be more common than previously appreciated for the miRNA pathway.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pasquinelli, AE (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	apasquin@ucsd.edu	Massirer, Katlin Brauer/C-8321-2016	Massirer, Katlin Brauer/0000-0001-6390-2560	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER; NIAID NIH HHS [5P30 AI36214] Funding Source: Medline; NIGMS NIH HHS [GM071654-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Newbury S, 2004, RNA, V10, P59, DOI 10.1261/rna.2195504; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Page MF, 1999, MOL CELL BIOL, V19, P5943; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reinhart BJ, 2001, GENETICS, V157, P199; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	62	1068	1152	4	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 26	2005	122	4					553	563		10.1016/j.cell.2005.07.031	http://dx.doi.org/10.1016/j.cell.2005.07.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	959YI	16122423	Bronze			2022-12-01	WOS:000231555100011
J	Weylandt, KH; Kang, JX				Weylandt, KH; Kang, JX			Rethinking lipid mediators	LANCET			English	Editorial Material							POLYUNSATURATED FATTY-ACIDS; ANTI-INFLAMMATION; IMMUNE-RESPONSES; RESOLVIN E1; RECEPTOR; PROSTAGLANDINS; EXPRESSION; ASPIRIN; BRAIN; CELLS		Charite Univ Hosp, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts General Hospital	Weylandt, KH (corresponding author), Charite Univ Hosp, Dept Gastroenterol & Hepatol, Campus Virchow, D-13353 Berlin, Germany.	karsten.weylandt@charite.de						Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kang JX, 1996, P NATL ACAD SCI USA, V93, P3542, DOI 10.1073/pnas.93.8.3542; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McMahon B, 2004, AM J PHYSIOL-RENAL, V286, pF189, DOI 10.1152/ajprenal.00224.2003; MONCADA S, 1973, NATURE, V246, P217, DOI 10.1038/246217a0; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Serhan CN, 2005, PHARMACOL THERAPEUT, V105, P7, DOI 10.1016/j.pharmthera.2004.09.002; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI13416; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	19	45	51	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 20	2005	366	9486					618	620		10.1016/S0140-6736(05)67119-X	http://dx.doi.org/10.1016/S0140-6736(05)67119-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958EB	16112288				2022-12-01	WOS:000231426400010
J	Nee, S; Colegrave, N; West, SA; Grafen, A				Nee, S; Colegrave, N; West, SA; Grafen, A			The illusion of invariant quantities in life histories	SCIENCE			English	Article							BODY-SIZE; SEX-CHANGE; TRADE-OFF; REPRODUCTION; EVOLUTION; GROWTH; AGE; ANIMALS; MODELS; FISHES	Life-history theory attempts to provide evolutionary explanations for variations in the ways in which animal species live their lives. Recent analyses have suggested that the dimensionless ratios of several key life-history parameters are the same for different species, even across distant taxa. However, we show here that previous analyses may have given a false picture and created an illusion of invariants, which do not necessarily exist; essentially, this is because life-history variables have been regressed against themselves. The following question arises from our analysis: How do we identify an invariant?	Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Edinburgh; University of Oxford	Nee, S (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	sean.nee@ed.ac.uk	Colegrave, Nick/F-3916-2010; West, Stuart A/M-3608-2014	West, Stuart A/0000-0003-2152-3153; Grafen, Alan/0000-0002-1843-6457				Allsop DJ, 2003, J EVOLUTION BIOL, V16, P921, DOI 10.1046/j.1420-9101.2003.00590.x; Allsop DJ, 2003, NATURE, V425, P783, DOI 10.1038/425783a; Beddington JR, 2005, PHILOS T R SOC B, V360, P163, DOI 10.1098/rstb.2004.1582; Buston PM, 2004, NATURE, V428, DOI 10.1038/nature02512; Charnov EL, 2000, EVOL ECOL RES, V2, P1067; Charnov EL, 1997, NATURE, V387, P393, DOI 10.1038/387393a0; Charnov EL, 2002, EVOL ECOL RES, V4, P749; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; Charnov Eric L., 1993, P1; Cipriani R, 2005, J EVOLUTION BIOL, V18, P1613, DOI 10.1111/j.1420-9101.2005.00949.x; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; Economo EP, 2005, ECOL LETT, V8, P353, DOI 10.1111/j.1461-0248.2005.00737.x; Gardner A, 2005, AM NAT, V165, P551, DOI 10.1086/429526; Gemmill AW, 1999, J EVOLUTION BIOL, V12, P1148, DOI 10.1046/j.1420-9101.1999.00117.x; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; He JX, 2001, ECOLOGY, V82, P784, DOI 10.1890/0012-9658(2001)082[0784:AASAFR]2.0.CO;2; Heino M, 1999, J EVOLUTION BIOL, V12, P423; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Jones KE, 2001, EVOL ECOL RES, V3, P465; Kozlowski J, 1997, AM NAT, V149, P352; KOZLOWSKI J, 1996, P ROY SOC LOND B BIO, V263, P556; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; Mangel M, 1996, EVOL ECOL, V10, P249, DOI 10.1007/BF01237683; MILES DB, 1994, ECOLOGY, V75, P2143; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morand S, 1996, FUNCT ECOL, V10, P210, DOI 10.2307/2389845; PURVIS A, 1995, J ZOOL, V237, P259, DOI 10.1111/j.1469-7998.1995.tb02762.x; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Roff Derek, 2002, pi; SMITH JM, 1993, Q REV BIOL, V68, P557; Stearns S.C., 1992, pi; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090; Willemsen RE, 1999, J ZOOL, V248, P379, DOI 10.1111/j.1469-7998.1999.tb01037.x; Williams EH, 2003, CAN J FISH AQUAT SCI, V60, P710, DOI 10.1139/F03-059	34	70	72	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1236	1239		10.1126/science.1114488	http://dx.doi.org/10.1126/science.1114488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16109879				2022-12-01	WOS:000231395400044
